Citrus Sinensis ID: 013407
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 443 | 2.2.26 [Sep-21-2011] | |||||||
| Q2V452 | 441 | CBL-interacting serine/th | yes | no | 0.977 | 0.981 | 0.835 | 0.0 | |
| Q2QY53 | 438 | CBL-interacting protein k | yes | no | 0.979 | 0.990 | 0.834 | 0.0 | |
| Q2RAX3 | 454 | CBL-interacting protein k | yes | no | 0.979 | 0.955 | 0.804 | 0.0 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.977 | 0.986 | 0.787 | 0.0 | |
| Q6X4A2 | 449 | CBL-interacting protein k | no | no | 0.977 | 0.964 | 0.750 | 0.0 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.968 | 0.890 | 0.722 | 0.0 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.984 | 0.968 | 0.691 | 0.0 | |
| Q8LIG4 | 445 | CBL-interacting protein k | no | no | 0.979 | 0.975 | 0.694 | 0.0 | |
| Q9MAM1 | 447 | CBL-interacting serine/th | no | no | 0.986 | 0.977 | 0.677 | 0.0 | |
| Q10SC8 | 456 | CBL-interacting protein k | no | no | 0.970 | 0.942 | 0.677 | 1e-179 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 774 bits (1999), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/437 (83%), Positives = 401/437 (91%), Gaps = 4/437 (0%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+RE+AT
Sbjct: 6 QVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIAT 65
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL+KHPNVV+LYEVM SKTKIFI+LE+VTGGELFDKIVN GRMKEDEARRYFQQLI+AV
Sbjct: 66 MKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAV 125
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLKPENLLLD+YGNLK+SDFGLSALSQQVRDDGLLHT+CGTPNYVAPEV
Sbjct: 126 DYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEV 185
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
LNDRGYDG+TAD+WSCGV+L+VLLAGYLPFDDSNLMNLYKKIS+ EF CPPWLS A KL
Sbjct: 186 LNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKL 245
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHV 304
I RILDPNPMTR+T E+ EDEWFKKDYKPPVFEE+ D+N+DD++AVFKDSE EH V
Sbjct: 246 ITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSE----EHLV 301
Query: 305 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 364
TE++EEQP A+NAFE+IS+S+GLNL NLFD EQ+FKRETR T R ANEII KIEEAAKP
Sbjct: 302 TEKREEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEEAAKP 361
Query: 365 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNL 424
LGFDV KKNYKMRLEN+KAGRKGNLNVATE+FQVAPSLHMV+V K+KGDTLEFHKFYK L
Sbjct: 362 LGFDVQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKL 421
Query: 425 STCLEDVVWKTEEDMQE 441
S LE VVW E +E
Sbjct: 422 SNSLEQVVWTNNEVKKE 438
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 770 bits (1988), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/440 (83%), Positives = 405/440 (92%), Gaps = 6/440 (1%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS K+KRRVGKYE+GRTIGEGTFAKVKFAR++ETG+PVA+KILDKEKVLKHKM EQIKR
Sbjct: 1 MSTTKVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL+KHPNVVR+YEVMGSKTKI+IVLE+VTGGELFD IVNHGRM+EDEARRYFQQL
Sbjct: 61 EISTMKLIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD+YGNLKVSDFGLSALSQQ++DDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D+GYDG+ ADLWSCGVILFVLLAGYLPF+DSNLM LYKKIS AEFT PPW SF
Sbjct: 181 APEVLEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFP 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
A++L+ RILDPNPMTR+TIPEILEDEWFKK YK P F+EK DT LDDV AVF DSE
Sbjct: 241 AKRLLTRILDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSE---- 296
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 360
EHHVTE+KEE P A+NAFELIS+S GLNLGNLFD+EQ+FKRETRFTS+CP EI+ KIEE
Sbjct: 297 EHHVTEKKEE-PEALNAFELISMSAGLNLGNLFDSEQEFKRETRFTSKCPPKEIVRKIEE 355
Query: 361 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 420
AAKPLGFDV KKNYK+RLE +KAGRKGNLNVATE+ QVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 356 AAKPLGFDVQKKNYKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVRKAKGDTLEFHKF 415
Query: 421 YKNLSTCLEDVVWKTEEDMQ 440
YKNLS L+DVVWK+ +D+Q
Sbjct: 416 YKNLSRTLKDVVWKS-DDLQ 434
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 758 bits (1958), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/456 (80%), Positives = 405/456 (88%), Gaps = 22/456 (4%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS K+KRRVGKYE+GRTIGEGTFAKVKFAR++ETG+PVA+KILDKEKVLKHKM EQIKR
Sbjct: 1 MSTTKVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL+KHPNVVR+YEVMGSKT I+IVLE+VTGGELFD IVNHGRM+EDEARRYFQQL
Sbjct: 61 EISTMKLIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD+YGNLKVSDFGLSALSQQ++DDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D+GYDG+ ADLWSCGVILFVLLAGYLPF+DSNLM LYKKIS AEFT PPW SF
Sbjct: 181 APEVLEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFP 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
A++L+ RILDPNPMTRITIPEILEDEWFKK YK P F+EK DT LDDV+AVF DSE
Sbjct: 241 AKRLLTRILDPNPMTRITIPEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSE---- 296
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 360
EHHVTE+KEE P A+NAFELIS+S GLNLGNLFD+EQ+FKRETRFTS+CP EI+ KIEE
Sbjct: 297 EHHVTEKKEE-PEALNAFELISMSAGLNLGNLFDSEQEFKRETRFTSKCPPKEIVRKIEE 355
Query: 361 AAKPLGFDVHKKNY----------------KMRLENMKAGRKGNLNVATEVFQVAPSLHM 404
AAKPLGFDV KKNY K+RLE +KAGRKGNLNVATE+ QVAPSLHM
Sbjct: 356 AAKPLGFDVQKKNYKICSPCLTTICMNIPFKLRLEKVKAGRKGNLNVATEILQVAPSLHM 415
Query: 405 VEVRKAKGDTLEFHKFYKNLSTCLEDVVWKTEEDMQ 440
VEVRKAKGDTLEFHKFYKNLS L+DVVWK+ +D+Q
Sbjct: 416 VEVRKAKGDTLEFHKFYKNLSRTLKDVVWKS-DDLQ 450
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 731 bits (1888), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/437 (78%), Positives = 392/437 (89%), Gaps = 4/437 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M++PK++RRVGKYEVG+T+G+GTFAKV+ A N+ETGE VALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MNRPKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+ HPNVVRLYEV+ SKTKI+IVLEF TGGELFDKIV+ GR+KE+ AR+YFQQL
Sbjct: 61 EICTMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALS+QVR DGLLHT CGTPNY
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+TADLWSCGVILFVLLAGYLPF+DSNLM LYKKI A E+ CPPWLS
Sbjct: 181 APEVLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
A+ LI RILDPNPMTRITIPE+L D WFKK+YKP VFEEK++ NLDDV+AVFKDSE
Sbjct: 241 AKNLIVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSE---- 296
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 360
EHHVTE+KEEQP +MNAFELIS+S+ L+LGNLF+ E+ FKRETRF ++ AN+++ KIEE
Sbjct: 297 EHHVTEKKEEQPTSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEE 356
Query: 361 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 420
A+KPLGFD+ KKNYKMRLEN+ AGRKGNL VATE+FQV+PSLHM+EVRK KGDTLEFHKF
Sbjct: 357 ASKPLGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKF 416
Query: 421 YKNLSTCLEDVVWKTEE 437
YK LST L DVVWK+ E
Sbjct: 417 YKKLSTSLNDVVWKSGE 433
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 705 bits (1820), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/437 (75%), Positives = 388/437 (88%), Gaps = 4/437 (0%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
PK+KRRVGKYE+GRTIGEGTFAKV+FA+N+E EPVA+KILDKEKV KH++ EQI+RE+
Sbjct: 11 PKVKRRVGKYELGRTIGEGTFAKVRFAKNTENDEPVAIKILDKEKVQKHRLVEQIRREIC 70
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
TMKLVKHPNVVRL+EVMGSK +IFIVLE+VTGGELF+ I +GR+KE+EAR+YFQQLINA
Sbjct: 71 TMKLVKHPNVVRLFEVMGSKARIFIVLEYVTGGELFEIIATNGRLKEEEARKYFQQLINA 130
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
VDYCHSRGVYHRDLK ENLLLDA GNLKVSDFGLSAL++QV+ DGLLHTTCGTPNYVAPE
Sbjct: 131 VDYCHSRGVYHRDLKLENLLLDASGNLKVSDFGLSALTEQVKADGLLHTTCGTPNYVAPE 190
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V+ DRGYDG+ AD+WSCGVIL+VLLAG+LPF+D N++ LYKKIS A+FTCP W S A+K
Sbjct: 191 VIEDRGYDGAAADIWSCGVILYVLLAGFLPFEDDNIIALYKKISEAQFTCPSWFSTGAKK 250
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHH 303
LI RILDPNP TRITI +ILED WFKK YKPPVF+EK +T+ DDV+A F DSE + H
Sbjct: 251 LITRILDPNPTTRITISQILEDPWFKKGYKPPVFDEKYETSFDDVDAAFGDSE----DRH 306
Query: 304 VTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAK 363
V E+ E+QP +MNAFELISL++ LNL NLF+A++++KRETRFTS+CP EII KIEEAAK
Sbjct: 307 VKEETEDQPTSMNAFELISLNQALNLDNLFEAKKEYKRETRFTSQCPPKEIITKIEEAAK 366
Query: 364 PLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKN 423
PLGFD+ KKNYKMR+EN+KAGRKGNLNVATEVFQVAPSLH+VE++KAKGDTLEF KFY+
Sbjct: 367 PLGFDIQKKNYKMRMENLKAGRKGNLNVATEVFQVAPSLHVVELKKAKGDTLEFQKFYRT 426
Query: 424 LSTCLEDVVWKTEEDMQ 440
LST L+DVVWK + +++
Sbjct: 427 LSTQLKDVVWKCDGEVE 443
|
Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 660 bits (1702), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/436 (72%), Positives = 372/436 (85%), Gaps = 7/436 (1%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
VGKYE+GRT+GEGTFAKVKFARN E G+ VA+K++DKEKVLK+KM QIKRE++TMKL+K
Sbjct: 28 VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPNV+R++EVM SKTKI+ VLEFVTGGELFDKI ++GR+KEDEAR+YFQQLINAVDYCHS
Sbjct: 88 HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
RGVYHRDLKPENLLLDA G LKVSDFGLSAL QQVR+DGLLHTTCGTPNYVAPEV+N++G
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
YDG+ ADLWSCGVILFVL+AGYLPF+DSNL +LYKKI AEFTCPPW S +A+KLI RIL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267
Query: 250 DPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHVTEQKE 309
DPNP TRIT E++E+EWFKK YK P FE D +LDDV+A+F DS ++ V E++E
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKFEN-ADVSLDDVDAIFDDSGES--KNLVVERRE 324
Query: 310 E---QPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPANEIINKIEEAAKPL 365
E PV MNAFELIS S+GLNLG+LF+ + KR+TRFTS+ ANEI+ KIE AA P+
Sbjct: 325 EGLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPM 384
Query: 366 GFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNLS 425
GFDV NYKM+L K+GRKG L VATEVFQVAPSL+MVE+RK+ GDTLEFHKFYKNL+
Sbjct: 385 GFDVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLT 444
Query: 426 TCLEDVVWKTEEDMQE 441
T L+D+VWKT ++ +E
Sbjct: 445 TGLKDIVWKTIDEEKE 460
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 654 bits (1687), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 305/441 (69%), Positives = 372/441 (84%), Gaps = 5/441 (1%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS + RVG+YE+GRT+GEGTFAKVKFARN+++GE VA+KILDK+KVLKHKM QIKR
Sbjct: 1 MSVSGGRTRVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL++HPNV+R++EVM SKTKI+IV+E VTGGELFDKI + GR+KED+AR+YFQQL
Sbjct: 61 EISTMKLIRHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA G LKVSDFGLSALSQQVR+DGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEV+N++GYDG+ ADLWSCGVILFVL+AGYLPF+DSNLM+LYKKI A+F+CP W S +
Sbjct: 181 APEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
A+KLI +ILDPNP TRITI E++ +EWFKK Y+PP F E D NLDD+ ++F +S
Sbjct: 241 AKKLIKKILDPNPSTRITIAELINNEWFKKGYQPPRF-ETADVNLDDINSIFNES--GDQ 297
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFD--AEQDFKRETRFTSRCPANEIINKI 358
V E++EE+P MNAFELIS S+GLNLG LF+ ++ KRETRF SR PANEI++KI
Sbjct: 298 TQLVVERREERPSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRFASRLPANEILSKI 357
Query: 359 EEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFH 418
E AA P+GF+V K+NYK++L+ GRKG L +ATEVF+V PSL+MVE+RK+ GDTLEFH
Sbjct: 358 EAAAGPMGFNVQKRNYKLKLQGENPGRKGQLAIATEVFEVTPSLYMVELRKSNGDTLEFH 417
Query: 419 KFYKNLSTCLEDVVWKTEEDM 439
KFY N+S L+DV+WK E +
Sbjct: 418 KFYHNISNGLKDVMWKPESSI 438
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LIG4|CIPK3_ORYSJ CBL-interacting protein kinase 3 OS=Oryza sativa subsp. japonica GN=CIPK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 654 bits (1686), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 304/438 (69%), Positives = 370/438 (84%), Gaps = 4/438 (0%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K++R +GKYE+GR IG+GTFAKV+FA+N ETG+ VA+KILDK KV KH++ EQI+RE+ T
Sbjct: 11 KVRRCLGKYELGRAIGQGTFAKVRFAKNMETGDHVAIKILDKAKVQKHRLVEQIRREICT 70
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL++HPNVV L+EVMGSKT+IFIVLE+V GGEL D I GR+KEDEAR+YFQQLINAV
Sbjct: 71 MKLIQHPNVVHLHEVMGSKTRIFIVLEYVMGGELHDIIATSGRLKEDEARKYFQQLINAV 130
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLK ENLLLD GN+KVSDFGLSA+S+QV+ DGLLHTTCGTPNYVAPEV
Sbjct: 131 DYCHSRGVYHRDLKLENLLLDTAGNIKVSDFGLSAISEQVKADGLLHTTCGTPNYVAPEV 190
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
+ D+GYDG+ ADLWSCGVILFVLLAGYLPF+D N+++LY KIS A+FTCP W S A++L
Sbjct: 191 IEDKGYDGALADLWSCGVILFVLLAGYLPFEDENIVSLYNKISGAQFTCPSWFSAEAKRL 250
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHV 304
IARILDPNP TRIT ++L+D+WFKK Y+ PVF++K DV F DSE E HV
Sbjct: 251 IARILDPNPATRITTSQVLQDQWFKKGYESPVFDDKYYPYFHDVYDAFGDSE----EKHV 306
Query: 305 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 364
E EEQP MNAFELISL+KGLNL N F++++ +KRETRFTS+CP EIIN+IEEAA
Sbjct: 307 KEAMEEQPTLMNAFELISLNKGLNLDNFFESDKKYKRETRFTSQCPPKEIINRIEEAANL 366
Query: 365 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNL 424
LGF++ K+NY+MR+EN+K GRKG+LN+ATEVFQVAPSLH+VE++KAKGDTLEF KFY+ L
Sbjct: 367 LGFNIQKRNYRMRMENIKEGRKGHLNIATEVFQVAPSLHVVELKKAKGDTLEFQKFYQTL 426
Query: 425 STCLEDVVWKTEEDMQEM 442
ST L+DVVW+ E+ ++M
Sbjct: 427 STQLKDVVWELEDAAEDM 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9MAM1|CIPK9_ARATH CBL-interacting serine/threonine-protein kinase 9 OS=Arabidopsis thaliana GN=CIPK9 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 637 bits (1644), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 301/444 (67%), Positives = 371/444 (83%), Gaps = 7/444 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ P + RVG YE+GRT+GEG+FAKVK+A+N+ TG+ A+KILD+EKV +HKM EQ+KRE
Sbjct: 8 ATPASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKRE 67
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++TMKL+KHPNVV + EVM SKTKI+IVLE V GGELFDKI GR+KEDEARRYFQQLI
Sbjct: 68 ISTMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLI 127
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
NAVDYCHSRGVYHRDLKPENL+LDA G LKVSDFGLSA S+QVR+DGLLHT CGTPNYVA
Sbjct: 128 NAVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVA 187
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEVL+D+GYDG+ AD+WSCGVILFVL+AGYLPFD+ NLM LYK+I AEF+CPPW S A
Sbjct: 188 PEVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGA 247
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF-EEKKDTNLDDVEAVFKDSEVCWM 300
+++I RIL+PNP+TRI+I E+LEDEWFKK YKPP F ++ +D +DDV+A F +S+ C
Sbjct: 248 KRVIKRILEPNPITRISIAELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECL- 306
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAE-QDFKRETRFTSRCPANEIINKIE 359
VTE+K E+PV+MNAFELIS S +L NLF+ + Q K+ETRFTS+ A+EI++K+E
Sbjct: 307 ---VTEKK-EKPVSMNAFELISSSSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKME 362
Query: 360 EAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 419
E AKPLGF+V K NYK++++ K+GRKG L+VATEVF+VAPSLH+VE+RK GDTLEFHK
Sbjct: 363 ETAKPLGFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHK 422
Query: 420 FYKNLSTCLEDVVWKTEEDMQEMK 443
FYKN S+ L+DVVW T+ +E K
Sbjct: 423 FYKNFSSGLKDVVWNTDAAAEEQK 446
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10SC8|CIPK9_ORYSJ CBL-interacting protein kinase 9 OS=Oryza sativa subsp. japonica GN=CIPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 629 bits (1622), Expect = e-179, Method: Compositional matrix adjust.
Identities = 296/437 (67%), Positives = 359/437 (82%), Gaps = 7/437 (1%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
RVG+YE+G+TIGEG+FAKVK AR++ TG+ +A+K+LD+ VL+HKM EQIKRE++TMKL+
Sbjct: 23 RVGRYELGKTIGEGSFAKVKVARDTRTGDTLAIKVLDRNHVLRHKMVEQIKREISTMKLI 82
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
KHPNVV+L+EVM SK+KI++VLE+V GGELFDKIVN GR+ EDEARRYF QLINAVDYCH
Sbjct: 83 KHPNVVQLHEVMASKSKIYMVLEYVDGGELFDKIVNSGRLGEDEARRYFHQLINAVDYCH 142
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
SRGVYHRDLKPENLLLD++G LKVSDFGLSA + Q ++DGLLHT CGTPNYVAPEVL D+
Sbjct: 143 SRGVYHRDLKPENLLLDSHGALKVSDFGLSAFAPQTKEDGLLHTACGTPNYVAPEVLADK 202
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248
GYDG AD+WSCG+ILFVL+AGYLPFDD NLM LYK I A+ +CP W S A+K I RI
Sbjct: 203 GYDGMAADVWSCGIILFVLMAGYLPFDDPNLMTLYKLICKAKVSCPHWFSSGAKKFIKRI 262
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHVTEQK 308
LDPNP TRITI +ILED+WFKKDYKPP+FE+ +D +LDDV+A F S E ++ +K
Sbjct: 263 LDPNPCTRITIAQILEDDWFKKDYKPPLFEQGEDVSLDDVDAAFDCS-----EENLVAEK 317
Query: 309 EEQPVAMNAFELISLSKGLNLGNLFDAEQ--DFKRETRFTSRCPANEIINKIEEAAKPLG 366
E+P +MNAF LIS S+G NLGNLF+ E KRET FTS+C EI++KIEEA PLG
Sbjct: 318 REKPESMNAFALISRSQGFNLGNLFEKEMMGMVKRETSFTSQCTPQEIMSKIEEACGPLG 377
Query: 367 FDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNLST 426
F+V K+NYKM+L+ K GRKG L+VATEVF+VAPSLHMVE+RK GDTLEFH FY N S+
Sbjct: 378 FNVRKQNYKMKLKGDKTGRKGYLSVATEVFEVAPSLHMVELRKTGGDTLEFHNFYNNFSS 437
Query: 427 CLEDVVWKTEEDMQEMK 443
L+D+VWK+E D + K
Sbjct: 438 ELKDIVWKSESDAKAAK 454
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 443 | ||||||
| 255583653 | 466 | CBL-interacting serine/threonine-protein | 0.990 | 0.942 | 0.948 | 0.0 | |
| 224120590 | 440 | predicted protein [Populus trichocarpa] | 0.990 | 0.997 | 0.932 | 0.0 | |
| 225435981 | 439 | PREDICTED: CBL-interacting serine/threon | 0.990 | 1.0 | 0.932 | 0.0 | |
| 147815805 | 439 | hypothetical protein VITISV_010092 [Viti | 0.990 | 1.0 | 0.932 | 0.0 | |
| 224106656 | 440 | predicted protein [Populus trichocarpa] | 0.990 | 0.997 | 0.914 | 0.0 | |
| 154425355 | 441 | CBL-interacting protein kinase [Vigna un | 0.984 | 0.988 | 0.904 | 0.0 | |
| 449463875 | 444 | PREDICTED: CBL-interacting serine/threon | 0.990 | 0.988 | 0.891 | 0.0 | |
| 62857008 | 441 | Ser/Thr protein kinase [Lotus japonicus] | 0.986 | 0.990 | 0.900 | 0.0 | |
| 357493713 | 441 | CBL-interacting protein kinase [Medicago | 0.986 | 0.990 | 0.891 | 0.0 | |
| 357493719 | 476 | CBL-interacting protein kinase [Medicago | 0.986 | 0.918 | 0.825 | 0.0 |
| >gi|255583653|ref|XP_002532581.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223527690|gb|EEF29798.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 874 bits (2258), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/443 (94%), Positives = 431/443 (97%), Gaps = 4/443 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 28 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 87
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 88 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 147
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 148 INAVDYCHSRGVYHRDLKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 207
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF
Sbjct: 208 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFG 267
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
A KLI RILDPNPMTRITIPEIL DEWFKKDYK PVFEEK+DTNLDDVEAVFKDSE
Sbjct: 268 AMKLITRILDPNPMTRITIPEILVDEWFKKDYKVPVFEEKEDTNLDDVEAVFKDSE---- 323
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 360
EHHVTE+KEEQP AMNAFELIS+SKGLNLGNLFD+EQ FKRETRFTS+CPANEII+KIEE
Sbjct: 324 EHHVTEKKEEQPTAMNAFELISMSKGLNLGNLFDSEQGFKRETRFTSKCPANEIIHKIEE 383
Query: 361 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 420
AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATE+FQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 384 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEIFQVAPSLHMVEVRKAKGDTLEFHKF 443
Query: 421 YKNLSTCLEDVVWKTEEDMQEMK 443
YKNLSTCL+DVVWKTEEDMQEMK
Sbjct: 444 YKNLSTCLDDVVWKTEEDMQEMK 466
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120590|ref|XP_002330980.1| predicted protein [Populus trichocarpa] gi|116265926|gb|ABJ91211.1| CBL-interacting protein kinase 3 [Populus trichocarpa] gi|118485622|gb|ABK94661.1| unknown [Populus trichocarpa] gi|222872772|gb|EEF09903.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2221), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/444 (93%), Positives = 429/444 (96%), Gaps = 5/444 (1%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EIETMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGV+HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INVVDYCHSRGVFHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSN+MNLYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGTTADLWSCGVILFVLLAGYLPFDDSNVMNLYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
A KLI RILDPNPMTRITIPEIL DEWFKK YKPPVFEEK+DTNLDDVEAVFKDSE
Sbjct: 241 AMKLITRILDPNPMTRITIPEILVDEWFKKGYKPPVFEEKEDTNLDDVEAVFKDSE---- 296
Query: 301 EHHVTEQK-EEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIE 359
EHHVTE+K EEQP AMNAFELIS+SKGLNLGNLFD EQ+FKRETRFTSRCPANEII+KIE
Sbjct: 297 EHHVTEKKEEEQPTAMNAFELISMSKGLNLGNLFDGEQEFKRETRFTSRCPANEIIHKIE 356
Query: 360 EAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 419
EAAKPLGFDVHKKNYKMRLEN+KAGRKGNLNVATE+FQVAPSLHMVEVRKAKGDTLEFHK
Sbjct: 357 EAAKPLGFDVHKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVEVRKAKGDTLEFHK 416
Query: 420 FYKNLSTCLEDVVWKTEEDMQEMK 443
FYK+LSTCL+DVVWKTEEDMQE K
Sbjct: 417 FYKSLSTCLDDVVWKTEEDMQETK 440
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435981|ref|XP_002271894.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 3 [Vitis vinifera] gi|229609837|gb|ACQ83534.1| CBL-interacting protein kinase 18 [Vitis vinifera] gi|296083952|emb|CBI24340.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2215), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/443 (93%), Positives = 425/443 (95%), Gaps = 4/443 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ PK+KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVA+KILDKEKVLKHKMAEQIKR
Sbjct: 1 MNPPKVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVAIKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLM LYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMILYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
A KLI RILDPNPMTRITIPEILEDEWFKK YKPPVFEEK D NLDDVEAVFKDSE
Sbjct: 241 AMKLITRILDPNPMTRITIPEILEDEWFKKGYKPPVFEEKGDANLDDVEAVFKDSE---- 296
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 360
EHHVTE+ EEQP AMNAFELIS+S+GLNLGNLFD EQ FKRETRFTS+CPANEII+KIEE
Sbjct: 297 EHHVTEKTEEQPAAMNAFELISMSRGLNLGNLFDIEQGFKRETRFTSKCPANEIIHKIEE 356
Query: 361 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 420
A KPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 357 AVKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 416
Query: 421 YKNLSTCLEDVVWKTEEDMQEMK 443
YKNLSTCLEDVVWKTE+DMQE K
Sbjct: 417 YKNLSTCLEDVVWKTEDDMQETK 439
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815805|emb|CAN70422.1| hypothetical protein VITISV_010092 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2213), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/443 (93%), Positives = 424/443 (95%), Gaps = 4/443 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ PK+KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVA+KILDKEKVLKHKMAEQIKR
Sbjct: 1 MNPPKVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVAIKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLM LYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMILYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
A KLI RILDPNPMTRITIPEILEDEWFKK YKPPVFEEK D NLDDVEAVFKDSE
Sbjct: 241 AMKLITRILDPNPMTRITIPEILEDEWFKKGYKPPVFEEKGDANLDDVEAVFKDSE---- 296
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 360
EHHVTE+ EEQP AMNAFELIS+S GLNLGNLFD EQ FKRETRFTS+CPANEII+KIEE
Sbjct: 297 EHHVTEKTEEQPAAMNAFELISMSXGLNLGNLFDIEQGFKRETRFTSKCPANEIIHKIEE 356
Query: 361 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 420
A KPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 357 AVKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 416
Query: 421 YKNLSTCLEDVVWKTEEDMQEMK 443
YKNLSTCLEDVVWKTE+DMQE K
Sbjct: 417 YKNLSTCLEDVVWKTEDDMQETK 439
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106656|ref|XP_002314239.1| predicted protein [Populus trichocarpa] gi|116265928|gb|ABJ91212.1| CBL-interacting protein kinase 4 [Populus trichocarpa] gi|222850647|gb|EEE88194.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 840 bits (2171), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/444 (91%), Positives = 425/444 (95%), Gaps = 5/444 (1%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYE+GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGKYEMGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMK +KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEAR YF QL
Sbjct: 61 EVATMKRIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARGYFHQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGV+HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVFHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+ ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGAPADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
A KLI RILDPNPMTRIT+ EIL DEWFKK YK PVFEEK+DTNLDDVEAVFKDSE
Sbjct: 241 AMKLITRILDPNPMTRITVSEILVDEWFKKGYKTPVFEEKEDTNLDDVEAVFKDSE---- 296
Query: 301 EHHVTEQK-EEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIE 359
E+HVTE+K EEQP AMNAFELIS+S+GLNLGNLFD EQ+FKRETRFTS+CPANEII+KIE
Sbjct: 297 ENHVTEKKEEEQPTAMNAFELISMSRGLNLGNLFDGEQEFKRETRFTSKCPANEIIHKIE 356
Query: 360 EAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 419
EAAKPLGFDVHKKNYKMRLEN+KAGRKGNLNVATE+FQ+APSLHMVEVRKAKGDTLEFHK
Sbjct: 357 EAAKPLGFDVHKKNYKMRLENVKAGRKGNLNVATEIFQMAPSLHMVEVRKAKGDTLEFHK 416
Query: 420 FYKNLSTCLEDVVWKTEEDMQEMK 443
FYK+LSTCL+DVVWKTEEDMQE K
Sbjct: 417 FYKSLSTCLDDVVWKTEEDMQETK 440
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|154425355|dbj|BAF74756.1| CBL-interacting protein kinase [Vigna unguiculata] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2153), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/440 (90%), Positives = 418/440 (95%), Gaps = 4/440 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKI++VLEFVTGGELFDKIVNHGRM E+EARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIYVVLEFVTGGELFDKIVNHGRMSENEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLMNLYKKISAAEFTCPPWLSF+
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMNLYKKISAAEFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
ARKLI RILDP+P TRITIPEIL+DEWFKKDYKPPVFEE + NLDDVEAVFKDSE
Sbjct: 241 ARKLITRILDPDPTTRITIPEILDDEWFKKDYKPPVFEENGEINLDDVEAVFKDSE---- 296
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 360
EHHVTE+KEEQP +MNAFELIS+SKGLNL NLFD EQ FKRETRFTS+ PA+EIINKIEE
Sbjct: 297 EHHVTEKKEEQPTSMNAFELISMSKGLNLENLFDTEQGFKRETRFTSKSPADEIINKIEE 356
Query: 361 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 420
AAKPLGFDV KKNYKMRL N+KAGRKGNLNVATE+FQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 357 AAKPLGFDVQKKNYKMRLANVKAGRKGNLNVATEIFQVAPSLHMVEVRKAKGDTLEFHKF 416
Query: 421 YKNLSTCLEDVVWKTEEDMQ 440
YK LST L+DVVWKTE+DMQ
Sbjct: 417 YKKLSTSLDDVVWKTEDDMQ 436
|
Source: Vigna unguiculata Species: Vigna unguiculata Genus: Vigna Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463875|ref|XP_004149656.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 830 bits (2143), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/443 (89%), Positives = 421/443 (95%), Gaps = 4/443 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
++QPK+KR VGKYE+GRTIGEGTFAKVKFA+NSETGE VA+KILDKEKVLKHKMAEQIKR
Sbjct: 6 VNQPKVKRLVGKYEMGRTIGEGTFAKVKFAKNSETGEHVAIKILDKEKVLKHKMAEQIKR 65
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ATMKL++HP+VV+L+EVMGSKTKIFIVLEFVTGGELFDKIVNHGRM E+EARRYFQQL
Sbjct: 66 EIATMKLIQHPHVVQLFEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMSENEARRYFQQL 125
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV+DDGLLHTTCGTPNYV
Sbjct: 126 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVKDDGLLHTTCGTPNYV 185
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS
Sbjct: 186 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSLD 245
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
A KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE+K NLDDVEAVFKDSE
Sbjct: 246 AMKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEQKIANLDDVEAVFKDSE---- 301
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 360
EHHVTE+KEE P AMNAFELIS+SKGLNL NLF EQ+FKRETRFTS+C ANEI+NKIEE
Sbjct: 302 EHHVTEKKEEHPAAMNAFELISMSKGLNLANLFGTEQEFKRETRFTSKCSANEIVNKIEE 361
Query: 361 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 420
AAKPLGFDV KKNYKMRLEN+KAGRKGNLNVATE+ QVAPS+H+VE+RKAKGDTLEFHKF
Sbjct: 362 AAKPLGFDVQKKNYKMRLENVKAGRKGNLNVATEILQVAPSVHVVEMRKAKGDTLEFHKF 421
Query: 421 YKNLSTCLEDVVWKTEEDMQEMK 443
YKNLST LEDVVWKTEEDMQE K
Sbjct: 422 YKNLSTSLEDVVWKTEEDMQETK 444
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857008|dbj|BAD95889.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 829 bits (2142), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/441 (90%), Positives = 419/441 (95%), Gaps = 4/441 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MNQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVV+LYEV+GSKTKI++VLEFVTGGELFDKIVNHGRM EDEARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVQLYEVLGSKTKIYMVLEFVTGGELFDKIVNHGRMCEDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALSQQ++DDGLLHTTCGTPNYV
Sbjct: 121 INTVDYCHSRGVYHRDLKPENLLLDACGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKISAAEFTCPPWLSF+
Sbjct: 181 APEVLNDKGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISAAEFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
ARKLI RILDPNPMTRITI EILEDEWFKKDYKPP+F+E +TNLDDVEAVFKDSE
Sbjct: 241 ARKLITRILDPNPMTRITIAEILEDEWFKKDYKPPIFQENGETNLDDVEAVFKDSE---- 296
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 360
EHHVTE+KEEQP AMNAFELIS+SKGLNL NLFD EQ FKRETRFTS+ PANEII+KIEE
Sbjct: 297 EHHVTEKKEEQPTAMNAFELISMSKGLNLENLFDVEQGFKRETRFTSKSPANEIISKIEE 356
Query: 361 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 420
AAKPLGFDV KKNYKMRL N+KAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 357 AAKPLGFDVQKKNYKMRLANVKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 416
Query: 421 YKNLSTCLEDVVWKTEEDMQE 441
YK LSTCLEDVVWKTE+DMQ+
Sbjct: 417 YKKLSTCLEDVVWKTEDDMQK 437
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493713|ref|XP_003617145.1| CBL-interacting protein kinase [Medicago truncatula] gi|355518480|gb|AET00104.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2122), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/441 (89%), Positives = 415/441 (94%), Gaps = 4/441 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ATMKL+KHPNVVRLYEVMGS+TKI+IVLEFVTGGELFDKIVNHGRM E EARRYFQQL
Sbjct: 61 EIATMKLIKHPNVVRLYEVMGSRTKIYIVLEFVTGGELFDKIVNHGRMGEPEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INVVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKIS+A+FTCPPWLSF+
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISSADFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
ARKLI RILDPNPMTRIT+ EIL+DEWFKKDYKPPVFEE +TNLDDVEAVFKDSE
Sbjct: 241 ARKLITRILDPNPMTRITMAEILDDEWFKKDYKPPVFEESGETNLDDVEAVFKDSE---- 296
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 360
EHHVTE+KEEQP +MNAFELIS+S+GLNL NLFD EQ FKRETRFTS+ PA+EIINKIEE
Sbjct: 297 EHHVTEKKEEQPTSMNAFELISMSRGLNLENLFDVEQGFKRETRFTSQSPADEIINKIEE 356
Query: 361 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 420
AAKPLGFDV KKN+KMRL N KAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 357 AAKPLGFDVQKKNFKMRLANSKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 416
Query: 421 YKNLSTCLEDVVWKTEEDMQE 441
YK LST L+ VVWKTE+DMQ+
Sbjct: 417 YKKLSTSLQGVVWKTEDDMQK 437
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493719|ref|XP_003617148.1| CBL-interacting protein kinase [Medicago truncatula] gi|355518483|gb|AET00107.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 804 bits (2076), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/476 (82%), Positives = 415/476 (87%), Gaps = 39/476 (8%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEV-----------------------------------MGSKTK 85
E+ATMKL+KHPNVVRLYEV MGS+TK
Sbjct: 61 EIATMKLIKHPNVVRLYEVADMMTFLFINLTNHADTKFDDSVVLFAYPLAFSLVMGSRTK 120
Query: 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD 145
I+IVLEFVTGGELFDKIVNHGRM E EARRYFQQLIN VDYCHSRGVYHRDLKPENLLLD
Sbjct: 121 IYIVLEFVTGGELFDKIVNHGRMGEPEARRYFQQLINVVDYCHSRGVYHRDLKPENLLLD 180
Query: 146 AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG+TADLWSCGVILF
Sbjct: 181 AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGATADLWSCGVILF 240
Query: 206 VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265
VL+AGYLPFDD NLM LYKKIS+A+FTCPPWLSF+ARKLI RILDPNPMTRIT+ EIL+D
Sbjct: 241 VLVAGYLPFDDPNLMELYKKISSADFTCPPWLSFSARKLITRILDPNPMTRITMAEILDD 300
Query: 266 EWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHVTEQKEEQPVAMNAFELISLSK 325
EWFKKDYKPPVFEE +TNLDDVEAVFKDSE EHHVTE+KEEQP +MNAFELIS+S+
Sbjct: 301 EWFKKDYKPPVFEESGETNLDDVEAVFKDSE----EHHVTEKKEEQPTSMNAFELISMSR 356
Query: 326 GLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGR 385
GLNL NLFD EQ FKRETRFTS+ PA+EIINKIEEAAKPLGFDV KKN+KMRL N KAGR
Sbjct: 357 GLNLENLFDVEQGFKRETRFTSQSPADEIINKIEEAAKPLGFDVQKKNFKMRLANSKAGR 416
Query: 386 KGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNLSTCLEDVVWKTEEDMQE 441
KGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYK LST L+ VVWKTE+DMQ+
Sbjct: 417 KGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKKLSTSLQGVVWKTEDDMQK 472
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 443 | ||||||
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.977 | 0.960 | 0.835 | 1.5e-200 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.977 | 0.986 | 0.787 | 9.8e-190 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.975 | 0.896 | 0.720 | 3.1e-170 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.970 | 0.964 | 0.615 | 2e-143 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.959 | 0.955 | 0.586 | 2e-136 | |
| TAIR|locus:1005716169 | 831 | AT5G21222 [Arabidopsis thalian | 0.668 | 0.356 | 0.770 | 6.3e-124 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.927 | 0.931 | 0.545 | 1.4e-119 | |
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.966 | 0.893 | 0.516 | 3e-117 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.923 | 0.931 | 0.518 | 7.9e-117 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.959 | 0.932 | 0.506 | 1.2e-115 |
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1941 (688.3 bits), Expect = 1.5e-200, P = 1.5e-200
Identities = 365/437 (83%), Positives = 401/437 (91%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+RE+AT
Sbjct: 16 QVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIAT 75
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL+KHPNVV+LYEVM SKTKIFI+LE+VTGGELFDKIVN GRMKEDEARRYFQQLI+AV
Sbjct: 76 MKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAV 135
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLKPENLLLD+YGNLK+SDFGLSALSQQVRDDGLLHT+CGTPNYVAPEV
Sbjct: 136 DYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEV 195
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
LNDRGYDG+TAD+WSCGV+L+VLLAGYLPFDDSNLMNLYKKIS+ EF CPPWLS A KL
Sbjct: 196 LNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKL 255
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHV 304
I RILDPNPMTR+T E+ EDEWFKKDYKPPVFEE+ D+N+DD++AVFKDSE EH V
Sbjct: 256 ITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSE----EHLV 311
Query: 305 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 364
TE++EEQP A+NAFE+IS+S+GLNL NLFD EQ+FKRETR T R ANEII KIEEAAKP
Sbjct: 312 TEKREEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEEAAKP 371
Query: 365 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNL 424
LGFDV KKNYKMRLEN+KAGRKGNLNVATE+FQVAPSLHMV+V K+KGDTLEFHKFYK L
Sbjct: 372 LGFDVQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKL 431
Query: 425 STCLEDVVWKTEEDMQE 441
S LE VVW E +E
Sbjct: 432 SNSLEQVVWTNNEVKKE 448
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1839 (652.4 bits), Expect = 9.8e-190, P = 9.8e-190
Identities = 344/437 (78%), Positives = 392/437 (89%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M++PK++RRVGKYEVG+T+G+GTFAKV+ A N+ETGE VALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MNRPKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+ HPNVVRLYEV+ SKTKI+IVLEF TGGELFDKIV+ GR+KE+ AR+YFQQL
Sbjct: 61 EICTMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALS+QVR DGLLHT CGTPNY
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+TADLWSCGVILFVLLAGYLPF+DSNLM LYKKI A E+ CPPWLS
Sbjct: 181 APEVLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWM 300
A+ LI RILDPNPMTRITIPE+L D WFKK+YKP VFEEK++ NLDDV+AVFKDSE
Sbjct: 241 AKNLIVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSE---- 296
Query: 301 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 360
EHHVTE+KEEQP +MNAFELIS+S+ L+LGNLF+ E+ FKRETRF ++ AN+++ KIEE
Sbjct: 297 EHHVTEKKEEQPTSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEE 356
Query: 361 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 420
A+KPLGFD+ KKNYKMRLEN+ AGRKGNL VATE+FQV+PSLHM+EVRK KGDTLEFHKF
Sbjct: 357 ASKPLGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKF 416
Query: 421 YKNLSTCLEDVVWKTEE 437
YK LST L DVVWK+ E
Sbjct: 417 YKKLSTSLNDVVWKSGE 433
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1655 (587.6 bits), Expect = 3.1e-170, P = 3.1e-170
Identities = 317/440 (72%), Positives = 375/440 (85%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+ RVGKYE+GRT+GEGTFAKVKFARN E G+ VA+K++DKEKVLK+KM QIKRE++TMK
Sbjct: 25 RTRVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMK 84
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
L+KHPNV+R++EVM SKTKI+ VLEFVTGGELFDKI ++GR+KEDEAR+YFQQLINAVDY
Sbjct: 85 LIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDY 144
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
CHSRGVYHRDLKPENLLLDA G LKVSDFGLSAL QQVR+DGLLHTTCGTPNYVAPEV+N
Sbjct: 145 CHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVIN 204
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
++GYDG+ ADLWSCGVILFVL+AGYLPF+DSNL +LYKKI AEFTCPPW S +A+KLI
Sbjct: 205 NKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIK 264
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHVTE 306
RILDPNP TRIT E++E+EWFKK YK P FE D +LDDV+A+F DS ++ V E
Sbjct: 265 RILDPNPATRITFAEVIENEWFKKGYKAPKFENA-DVSLDDVDAIFDDSGES--KNLVVE 321
Query: 307 QKEE---QPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPANEIINKIEEAA 362
++EE PV MNAFELIS S+GLNLG+LF+ + KR+TRFTS+ ANEI+ KIE AA
Sbjct: 322 RREEGLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAA 381
Query: 363 KPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYK 422
P+GFDV NYKM+L K+GRKG L VATEVFQVAPSL+MVE+RK+ GDTLEFHKFYK
Sbjct: 382 APMGFDVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYK 441
Query: 423 NLSTCLEDVVWKT-EEDMQE 441
NL+T L+D+VWKT +E+ +E
Sbjct: 442 NLTTGLKDIVWKTIDEEKEE 461
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1402 (498.6 bits), Expect = 2.0e-143, P = 2.0e-143
Identities = 267/434 (61%), Positives = 342/434 (78%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K RRVGKYEVGRTIGEGTFAKVKFARN++TG+ VA+KI+ K +LK++M +QIKRE++
Sbjct: 3 KKMRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISI 62
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MK+V+HPN+VRLYEV+ S +KI+IVLEFVTGGELFD+IV+ GR++E E+R+YFQQL++AV
Sbjct: 63 MKIVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAV 122
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+CH +GVYHRDLKPENLLLD GNLKVSDFGLSAL Q+ + LL TTCGTPNYVAPEV
Sbjct: 123 AHCHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEV 180
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
L+ +GYDGS AD+WSCGVILFV+LAGYLPF +++L LY+KI+AAEF+CPPW S + L
Sbjct: 181 LSGQGYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFL 240
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHV 304
I RILDPNP TRI I I +D WF+ +Y P E+++ NLDD+ AVF E ++ +V
Sbjct: 241 IHRILDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENV 300
Query: 305 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPANEIINKIEEAAK 363
E+ +E P+ MNAFE+I+LS+GLNL LFD QDF KR+TRF SR +EII IE A
Sbjct: 301 -ERNDEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVAN 359
Query: 364 PLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKN 423
+GF H +N+K RLE + + + G L V E+++VAPSL MV+VRKA G+TLE+HKFYK
Sbjct: 360 SMGFKSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKK 419
Query: 424 LSTCLEDVVWKTEE 437
L + LE+++W+ E
Sbjct: 420 LCSKLENIIWRATE 433
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1336 (475.4 bits), Expect = 2.0e-136, P = 2.0e-136
Identities = 252/430 (58%), Positives = 328/430 (76%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+ R+VGKYE+GRTIGEGTFAKVKFA+N+ETGE VA+KI+D+ ++K KM +QIKRE++ M
Sbjct: 2 VVRKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIM 61
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
KLV+HP VVRLYEV+ S+TKI+I+LE++TGGELFDKIV +GR+ E EAR+YF QLI+ VD
Sbjct: 62 KLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVD 121
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
YCHS+GVYHRDLKPENLLLD+ GNLK+SDFGLSAL +Q +L TTCGTPNYVAPEVL
Sbjct: 122 YCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQ--GVTILKTTCGTPNYVAPEVL 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245
+ +GY+G+ AD+WSCGVIL+VL+AGYLPFD+ +L LY KI AEF+CP + + A+ LI
Sbjct: 180 SHKGYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLI 239
Query: 246 ARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHVT 305
RILDPNP TRITI EI +DEWF KDY P + + NLDDV A F D E T
Sbjct: 240 NRILDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGT 299
Query: 306 EQKEEQPVAMNAFELISLSKGLNLGNLFDAEQD-FKRETRFTSRCPANEIINKIEEAAKP 364
++ P+ +NAF+LI LS+GLNL LFD +D K +TRF S PAN +++ +E ++
Sbjct: 300 --RDTGPLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQS 357
Query: 365 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNL 424
+GF H +NYKMR+E + A + + +V EVF+VAPS+ MV+++ A GD E+ KFYK
Sbjct: 358 MGFKTHIRNYKMRVEGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKFYKTF 417
Query: 425 STCLEDVVWK 434
+ L+D++WK
Sbjct: 418 CSKLDDIIWK 427
|
|
| TAIR|locus:1005716169 AT5G21222 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1218 (433.8 bits), Expect = 6.3e-124, P = 6.3e-124
Identities = 228/296 (77%), Positives = 259/296 (87%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS+PK++R VGKYEVGR IGE F K++ A ++ETG+PVAL ILDK+KVLKHKMAEQIKR
Sbjct: 1 MSEPKVRRWVGKYEVGRLIGECNFGKLRSAVDTETGDPVALMILDKDKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++ MKL+ HPNVV+LYEV+ SK KI+IVLEF++GG+LFDKI N GRM EDEA+RYFQQL
Sbjct: 61 EISIMKLINHPNVVQLYEVLASKAKIYIVLEFISGGKLFDKIKNDGRMNEDEAQRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA NLKV++FGL ALSQQ DGL HT CG P+Y
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQENLKVAEFGLIALSQQAGGDGLRHTACGNPDYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+ ADLWSCGVILFVLLAGYLPF+DS+L LYKKIS+A+F+CPPWLS
Sbjct: 181 APEVLNDQGYDGAKADLWSCGVILFVLLAGYLPFEDSSLTTLYKKISSADFSCPPWLSSG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 296
+ LI RILDPNPMTRITIPEILED WFKKDYKP VFEEKK+ NL DVEAVFKDSE
Sbjct: 241 VKNLIVRILDPNPMTRITIPEILEDVWFKKDYKPAVFEEKKEANLADVEAVFKDSE 296
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
Identities = 233/427 (54%), Positives = 311/427 (72%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+YE+GR +G GTFAKV ARN +TG+ VA+K++ KEKV+K M +QIKRE++ M++VKH
Sbjct: 22 GRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKH 81
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN+V L+EVM SK+KI+ +E V GGELF K+ GR++ED AR YFQQLI+AVD+CHSR
Sbjct: 82 PNIVELHEVMASKSKIYFAMELVRGGELFAKVAK-GRLREDVARVYFQQLISAVDFCHSR 140
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GVYHRDLKPENLLLD GNLKV+DFGLSA ++ ++ DGLLHTTCGTP YVAPEV+ +GY
Sbjct: 141 GVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGY 200
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
DG+ ADLWSCGVILFVLLAGYLPF D NL+N+Y+KI +F CP WLS AR+L+ ++LD
Sbjct: 201 DGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLLD 260
Query: 251 PNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHVTEQKEE 310
PNP TRITI ++++ WFKK + + N + V A +E ++ V + KEE
Sbjct: 261 PNPNTRITIEKVMDSPWFKK-------QATRSRN-EPVAATITTTEED-VDFLVHKSKEE 311
Query: 311 QPVAMNAFELISLSKGLNLGNLFDAEQ-DFKRETRFTSRCPANEIINKIEEAAKPLG--F 367
+NAF +I+LS+G +L LF+ ++ + KRE RF + PA+ +I+ +EEAA+ +G F
Sbjct: 312 TET-LNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAAR-VGNKF 369
Query: 368 DVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKN-LST 426
DV K ++R+E + GRKG L V E+F VAPS +VEV+K GDTLE++ F L
Sbjct: 370 DVRKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTALRP 429
Query: 427 CLEDVVW 433
L+D+ W
Sbjct: 430 ALKDIFW 436
|
|
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1155 (411.6 bits), Expect = 3.0e-117, P = 3.0e-117
Identities = 231/447 (51%), Positives = 315/447 (70%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY+VGR +G+GTFAKV + R+ T + VA+K++DKEKV+K + EQIKRE++ M++ +HP
Sbjct: 11 KYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREISVMRIARHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NVV LYEVM +KT+I+ V+E+ GGELF+K+ G++++D A +YF QLINAVD+CHSR
Sbjct: 71 NVVELYEVMATKTRIYFVMEYCKGGELFNKVAK-GKLRDDVAWKYFYQLINAVDFCHSRE 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
VYHRD+KPENLLLD NLKVSDFGLSAL+ R DGLLHTTCGTP YVAPEV+N +GYD
Sbjct: 130 VYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRKGYD 189
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
G+ AD+WSCGV+LFVLLAGYLPF DSNLM +Y+KI A+F P W + R+L+ ++LDP
Sbjct: 190 GTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRRLLCKMLDP 249
Query: 252 NPMTRITIPEILEDEWFKKD-YKPPVFEEKKDTNLDDVEAVF---KDSEVCWMEH----- 302
NP TRITI I E WF+K + EK+ ++ VEA ++ E+
Sbjct: 250 NPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAGPSENGAGPS 309
Query: 303 ----HVTEQKE-EQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINK 357
VTE+ ++P +NAF+LI+LS G +L LF D KRE+RFTS+ PA+ II+K
Sbjct: 310 ENGDRVTEENHTDEPTNLNAFDLIALSAGFDLAGLFG--DDNKRESRFTSQKPASVIISK 367
Query: 358 IEEAAKPLGFDVHKKNYKM-RLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 416
+EE A+ L + K+ + +LE +K GRKG L++ E+FQV P+ H+VEV+K+ GDTLE
Sbjct: 368 LEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEVKKSNGDTLE 427
Query: 417 FHKFY-KNLSTCLEDVVWKTEEDMQEM 442
+ K ++L L D+VW + + E+
Sbjct: 428 YQKLVAEDLRPALSDIVWVWQGEKDEL 454
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1151 (410.2 bits), Expect = 7.9e-117, P = 7.9e-117
Identities = 221/426 (51%), Positives = 311/426 (73%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE+GR +G+GTFAKV ARN +TGE VA+K++DK+KV K + +QIKRE++ M+LV+HP
Sbjct: 11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+VV L+EVM SKTKI+ +E+V GGELFDK V+ G++KE+ AR+YFQQLI A+DYCHSRG
Sbjct: 71 HVVFLHEVMASKTKIYFAMEYVKGGELFDK-VSKGKLKENIARKYFQQLIGAIDYCHSRG 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
VYHRDLKPENLLLD G+LK+SDFGLSAL + + DGLLHTTCGTP YVAPEV+ +GYD
Sbjct: 130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
G+ AD+WSCGV+L+VLLAG+LPF + NL+ +Y+KI+ EF CP W +KL++RILDP
Sbjct: 190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249
Query: 252 NPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHVTEQKEEQ 311
NP +RI I +I+E+ WF+K +K E K ++++ D + +
Sbjct: 250 NPNSRIKIEKIMENSWFQKGFKK--IETPKSPESHQIDSLISDVHAAF---------SVK 298
Query: 312 PVAMNAFELIS-LSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE-AAKPLGFDV 369
P++ NAF+LIS LS+G +L LF+ E+ + E++FT++ A EI++K EE A F++
Sbjct: 299 PMSYNAFDLISSLSQGFDLSGLFEKEE--RSESKFTTKKDAKEIVSKFEEIATSSERFNL 356
Query: 370 HKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFY-KNLSTCL 428
K + +++E+ + GRKG+L + E+F+V S HMVE +K+ GDT+E+ +F + L L
Sbjct: 357 TKSDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDRELRPSL 416
Query: 429 EDVVWK 434
+D+VWK
Sbjct: 417 KDIVWK 422
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1140 (406.4 bits), Expect = 1.2e-115, P = 1.2e-115
Identities = 222/438 (50%), Positives = 308/438 (70%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YEVGR +G+GTFAKV F R++ T E VA+K++DK+KV++ +++QIKRE++ M++ KHP
Sbjct: 11 RYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKREISVMRIAKHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NVV LYEVM +K++I+ V+E+ GGELF+K+ G++KED A +YF QLI+AVD+CHSRG
Sbjct: 71 NVVELYEVMATKSRIYFVIEYCKGGELFNKVAK-GKLKEDVAWKYFYQLISAVDFCHSRG 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
VYHRD+KPENLLLD NLKVSDFGLSAL+ R DGLLHTTCGTP YVAPEV+N +GY+
Sbjct: 130 VYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRKGYE 189
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
G+ AD+WSCGV+LFVLLAGYLPF D+NLM +Y+KI A+F CP W + ++L+ ++LDP
Sbjct: 190 GTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVKRLLCKMLDP 249
Query: 252 NPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD--DVEAVFKDSEVCWMEHHVTEQKE 309
N TRITI +I E WF+K ++KK ++ V E + +
Sbjct: 250 NHETRITIAKIKESSWFRKGLH---LKQKKMEKMEKQQVREATNPMEAGGSGQNENGENH 306
Query: 310 EQP--VAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGF 367
E P +NAF++I+LS G L LF D KRE+RF S+ PA+EII+K+ E AK L
Sbjct: 307 EPPRLATLNAFDIIALSTGFGLAGLFGDVYD-KRESRFASQKPASEIISKLVEVAKCLKL 365
Query: 368 DVHKKNYKM-RLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYK-NLS 425
+ K+ + +LE +K G+ G L + E+FQV P+ H+VEV+K GDT+E+ K + +L
Sbjct: 366 KIRKQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGDTMEYQKLVEEDLR 425
Query: 426 TCLEDVVW--KTEEDMQE 441
L D+VW + E++ +E
Sbjct: 426 PALADIVWVWQGEKEKEE 443
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6X4A2 | CIPKV_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7505 | 0.9774 | 0.9643 | no | no |
| Q2V452 | CIPK3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8352 | 0.9774 | 0.9818 | yes | no |
| Q2QY53 | CIPKW_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8340 | 0.9796 | 0.9908 | yes | no |
| Q84VQ3 | CIPKQ_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7871 | 0.9774 | 0.9863 | no | no |
| Q93VD3 | CIPKN_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7224 | 0.9683 | 0.8900 | no | no |
| Q2RAX3 | CIPKX_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8048 | 0.9796 | 0.9559 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 443 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-107 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-94 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-79 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-76 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-70 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-66 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-63 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-63 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-61 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-60 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-53 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-53 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-52 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 8e-52 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-50 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-49 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-49 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-47 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-47 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-47 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-46 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-46 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-46 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-46 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-45 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-45 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-45 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-45 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-44 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-43 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-43 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-43 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-43 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-43 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-42 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-41 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-41 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-40 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-40 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-40 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-40 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-40 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-39 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-39 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-39 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-38 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-38 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-38 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-38 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-38 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-38 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-38 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-37 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-37 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-37 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-37 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-37 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-37 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-36 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-36 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-36 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-36 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-36 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-35 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-35 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-35 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-34 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-34 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-34 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-34 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-34 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-34 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-34 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-33 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-33 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-33 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-33 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-32 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-32 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-32 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-32 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-32 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-32 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-31 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-31 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-31 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-30 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-30 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-30 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-30 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-29 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-29 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-29 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-29 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-28 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-28 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-28 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-28 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-28 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-28 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-28 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-27 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-27 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-27 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-27 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-27 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-26 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 1e-26 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-25 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-25 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-24 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-24 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-23 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-23 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-22 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-22 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-22 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-21 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-20 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-20 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-20 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-14 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-12 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 3e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 317 bits (814), Expect = e-107
Identities = 116/260 (44%), Positives = 174/260 (66%), Gaps = 10/260 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ +GEG+F KV AR+ +TG+ VA+K++ K+K+ K + E+I RE+ +K +KHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VRLY+V + K+++V+E+ GG+LFD + GR+ EDEAR Y +Q+++A++Y HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRDLKPEN+LLD G++K++DFGL+ Q+ L T GTP Y+APEVL +GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 193 STADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAAEFTCPPW---LSFTARKLIARI 248
+ D+WS GVIL+ LL G PF D L+ L+KKI + PP +S A+ LI ++
Sbjct: 176 A-VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 249 LDPNPMTRITIPEILEDEWF 268
L +P R+T E L+ +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 282 bits (725), Expect = 9e-94
Identities = 104/263 (39%), Positives = 154/263 (58%), Gaps = 10/263 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ R +G G+F V A++ TG+ VA+KIL K K K + +RE+ ++ + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VRL + K +++V+E+ GG+LFD + G + EDEA++ Q++ ++Y HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRDLKPEN+LLD G +K++DFGL+ + ++ L T GTP Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-----EFTCPPWLSF--TARKLI 245
D+WS GVIL+ LL G PF N+++ + I EF P W S A+ LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 246 ARILDPNPMTRITIPEILEDEWF 268
+ L+ +P R T EIL+ WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 245 bits (629), Expect = 7e-79
Identities = 97/262 (37%), Positives = 153/262 (58%), Gaps = 11/262 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +T+G G+F +V R+ +G+ ALKIL K K++K K E + E ++ ++HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V LY + +++V+E+V GGELF + GR E AR Y Q++ A++Y HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPENLLLD+ G +K++DFG + R G +T CGTP Y+APE++ +GY G
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFA-----KRVKGRTYTLCGTPEYLAPEIILSKGY-G 176
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D W+ G++++ +LAGY PF D N + +Y+KI + P + S A+ LI +L +
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 253 PMTRI-----TIPEILEDEWFK 269
R+ + +I WF
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 7e-76
Identities = 98/253 (38%), Positives = 150/253 (59%), Gaps = 6/253 (2%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G+F KV R +TG+ A+K+L K+K++K K E E + + HP +V+L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++ K+++VLE+ GGELF + GR E+ AR Y +++ A++Y HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PEN+LLDA G++K++DFGL+ + +T CGTP Y+APEVL +GY G D W
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258
S GV+L+ +L G PF + +Y+KI P +LS AR LI+ +L +P R+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 259 ---IPEILEDEWF 268
EI +F
Sbjct: 238 SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 1e-70
Identities = 96/249 (38%), Positives = 139/249 (55%), Gaps = 37/249 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+GEG F V AR+ +TG+ VA+KI+ KE + E++ RE+ +K + HPN+V+LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 79 VMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V + +++V+E+ GG L D + N G++ EDE R Q++ ++Y HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 138 KPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
KPEN+LLD+ G +K++DFGLS L D LL T GTP Y+APEVL +GY +D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
+WS GVIL+ L P L + LI ++L +P R
Sbjct: 177 IWSLGVILYEL---------------------------PEL----KDLIRKMLQKDPEKR 205
Query: 257 ITIPEILED 265
+ EILE
Sbjct: 206 PSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 3e-66
Identities = 90/279 (32%), Positives = 152/279 (54%), Gaps = 24/279 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
++ G+ IGEG+F+ V A+ ET + A+KILDK +++K K + +K E + +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+++LY + ++ VLE+ GEL I +G + E R Y +++ A++Y HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS------ALSQQVRDDGLLHTT------------ 173
+ HRDLKPEN+LLD ++K++DFG + + + + D +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233
GT YV+PE+LN+ G ++DLW+ G I++ +L G PF SN ++KI E++
Sbjct: 183 VGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 234 PPWLSFTARKLIARILDPNPMTRITI----PEILEDEWF 268
PP A+ LI ++L +P R+ + E+ +F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 1e-63
Identities = 90/259 (34%), Positives = 140/259 (54%), Gaps = 11/259 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE+ + IG+G+F KV R G+ LK +D + K E EV +K + HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYC 127
N+++ YE K K+ IV+E+ GG+L KI + E++ +F QL A+ Y
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HSR + HRD+KP+N+ L + G +K+ DFG+S LS L T GTP Y++PE+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS---TVDLAKTVVGTPYYLSPELCQ 176
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLI 245
++ Y+ +D+WS G +L+ L PF+ NL+ L KI ++ P S R L+
Sbjct: 177 NKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV 235
Query: 246 ARILDPNPMTRITIPEILE 264
+ +L +P R +I +IL+
Sbjct: 236 SSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 6e-63
Identities = 88/262 (33%), Positives = 145/262 (55%), Gaps = 12/262 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
I +G + +V A+ TG+ A+K++ K +++ +Q+ E + + P VV+LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K +++V+E++ GG+L + N G + ED AR Y +++ A++Y HS G+ HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLL------HTTCGTPNYVAPEVLNDRGYDG 192
P+N+L+D+ G+LK++DFGLS + R L GTP+Y+APEV+ +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--PWLSFTARKLIARILD 250
T D WS G IL+ L G PF +++ I + P +S A LI+++L
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 251 PNPMTRI---TIPEILEDEWFK 269
P+P R+ +I EI +FK
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 2e-61
Identities = 94/249 (37%), Positives = 148/249 (59%), Gaps = 6/249 (2%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
++ +E+G T+G G+F +V+ A++ TGE A+K L K ++LK K + + +E + + +
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
HP +V + + +++ +LEFV GGELF + GR D A+ Y +L+ A +Y H
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
S+ + +RDLKPENLLLD G++KV+DFG +++V D T CGTP Y+APEV+ +
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFG---FAKKVPDR--TFTLCGTPEYLAPEVIQSK 190
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248
G+ G D W+ GV+L+ +AGY PF D +Y+KI A P W AR L+ +
Sbjct: 191 GH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249
Query: 249 LDPNPMTRI 257
L + R+
Sbjct: 250 LQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 1e-60
Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 17/261 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G F +V+ + ALK + K +++ E I E ++ HP +V+LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K I++++E+ GGEL+ + + G E AR Y ++ A +Y H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PENLLLD+ G +K+ DFG +++++ T CGTP YVAPE++ ++GYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFG---FAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYW 176
Query: 199 SCGVILFVLLAGYLPF--DDSNLMNLYKKI----SAAEFTCPPWLSFTARKLIARILDPN 252
S G++L+ LL G PF DD + M +Y I EF P ++ A+ LI ++L N
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRN 234
Query: 253 PMTRI-----TIPEILEDEWF 268
P R+ I +I + +WF
Sbjct: 235 PEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 9e-60
Identities = 79/263 (30%), Positives = 136/263 (51%), Gaps = 9/263 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ G +G G+F V A + +TGE +A+K ++ + E ++RE+ + ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHP 59
Query: 72 NVVRLYEVMGSKTKIF--IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
N+VR Y + K I LE+V+GG L + G++ E R+Y +Q++ + Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ HRD+K N+L+D+ G +K++DFG + + + GTP ++APEV+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPP---WLSFTARKLI 245
Y G AD+WS G + + G P+ + N M KI ++ P LS A+ +
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG-EPPEIPEHLSEEAKDFL 237
Query: 246 ARILDPNPMTRITIPEILEDEWF 268
+ L +P R T E+L+ +
Sbjct: 238 RKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 183 bits (465), Expect = 1e-53
Identities = 96/346 (27%), Positives = 151/346 (43%), Gaps = 27/346 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + R +GEG+F +V AR+ + VALK+L K+ K K E+ RE+ + + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 72 -NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
N+V+LY+ + +++V+E+V GG L D + GR + E EA Q+++A++Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 128 HSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSAL----SQQVRDDGLLHTTCGTPNYVAP 182
HS+G+ HRD+KPEN+LLD G +K+ DFGL+ L L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 183 EVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFTC--- 233
EVL Y S++D+WS G+ L+ LL G PF+ + K I
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 234 ------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDD 287
P +S A L+ ++L +P R++ L + D
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 288 VEAVFKDSEVCWMEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLF 333
+ + + G
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSS 343
|
Length = 384 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 6e-53
Identities = 90/278 (32%), Positives = 153/278 (55%), Gaps = 20/278 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
E +T+G GTF +V R+ + ALK++ +V++ K + + E +K V HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++RL+ + +++++E+V GGELF + N GR Y +++ A++Y HS+ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLD G++K++DFG ++++RD T CGTP Y+APEV+ +G+
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFG---FAKKLRDR--TWTLCGTPEYLAPEVIQSKGH-N 176
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D W+ G++++ +L GY PF D N +Y+KI A + P L A+ LI ++L +
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236
Query: 253 PMTRI-----TIPEILEDEWFK---------KDYKPPV 276
R+ ++ WFK + KPP+
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPI 274
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 7e-52
Identities = 87/260 (33%), Positives = 141/260 (54%), Gaps = 11/260 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+ IG+G F +V AR+ TG+ VA+K++ K + + K E+I E+ +K KHP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKK--EKIINEIQILKKCKHP 57
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V+ Y K +++IV+EF +GG L D + + + E + ++L+ ++Y HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
G+ HRD+K N+LL + G +K+ DFGLSA Q+ D +T GTP ++APEV+N + Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIAR 247
D AD+WS G+ L G P+ + M KI+ P S + + +
Sbjct: 175 DY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 248 ILDPNPMTRITIPEILEDEW 267
L NP R T ++L+ +
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 8e-52
Identities = 70/111 (63%), Positives = 85/111 (76%), Gaps = 1/111 (0%)
Query: 316 NAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKN-Y 374
NAF+LISLS GL+L LF+ E + KRETRFTSR PA EII K+EEAAK LGF V KK
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 375 KMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNLS 425
++LE K GRKG L V+ EVF+V PSL +VEV+K+ GDTLE+HKF+K+L
Sbjct: 61 GVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLL 111
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-50
Identities = 90/266 (33%), Positives = 137/266 (51%), Gaps = 16/266 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
YEV TIG+G+F V+ R G+ + K +D + K +Q+ EV ++ +KHP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHP 59
Query: 72 NVVRLY--EVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVD 125
N+VR Y + S ++IV+E+ GG+L I ++E+ R QL+ A+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 126 YCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
CH+R V HRDLKP N+ LDA N+K+ DFGL+ + D T GTP Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYM 177
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSF 239
+PE LN YD + D+WS G +++ L A PF N + L KI +F P S
Sbjct: 178 SPEQLNHMSYDEKS-DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236
Query: 240 TARKLIARILDPNPMTRITIPEILED 265
++I +L+ +P R + E+L+
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 1e-49
Identities = 104/326 (31%), Positives = 158/326 (48%), Gaps = 57/326 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMAEQIKREVATMKL 67
+EV + IG G F +V R+ +TG+ A+K+L K ++K H AE R++ +
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE---RDI--LAD 57
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
P +V+LY + +++V+E++ GG+L + ++ E+ AR Y +L+ A+D
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---------------LSQQVRDDGLLH- 171
H G HRD+KP+N+L+DA G++K++DFGL + RD+ L+
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 172 -----------TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
+T GTP+Y+APEVL Y D WS GVIL+ +L G+ PF L
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQ 236
Query: 221 NLYKKISAAE--FTCPP--WLSFTARKLIARIL-DP-NPMTRITIPEILEDEWFKK---- 270
Y KI + PP +S A LI R+L DP + + EI +FK
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFE--EIKSHPFFKGIDWE 294
Query: 271 ---DYKPPV---FEEKKDT-NLDDVE 289
+ KPP DT N DD E
Sbjct: 295 NLRETKPPFVPELSSPLDTSNFDDFE 320
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 9e-49
Identities = 88/306 (28%), Positives = 135/306 (44%), Gaps = 74/306 (24%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATMK 66
YE +GEGT+ V AR+ +TGE VALK LD E+ E I RE++ +K
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-------EGIPSTALREISLLK 53
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGE-----LFDKIVNHGRMKEDEARRYFQQLI 121
+KHPN+V+L +V+ ++ K+++V E+ + DK G + + + QL+
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDK--RPGPLSPNLIKSIMYQLL 108
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN-- 178
+ YCHS + HRDLKP+N+L++ G LK++DFGL+ A +R T
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--------TYTHEVV 160
Query: 179 ---YVAPEVL-NDRGYDGSTADLWSCGVIL------FVLLAG------------------ 210
Y APE+L + Y + D+WS G I L G
Sbjct: 161 TLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT 219
Query: 211 --------YLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEI 262
LP D + + P L L++++L NP RI+ E
Sbjct: 220 EESWPGVTKLP-DYKPTFPKFPPKDLEKVL--PRLDPEGIDLLSKMLQYNPAKRISAKEA 276
Query: 263 LEDEWF 268
L+ +F
Sbjct: 277 LKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 4e-47
Identities = 86/259 (33%), Positives = 132/259 (50%), Gaps = 15/259 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLY 77
I +G F V A+ TG+ A+K+L K ++ +K E A M + P V +LY
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
SK +++V+E++ GG+ I G + ED A++Y +++ V+ H RG+ HRD+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
KPENLL+D G+LK++DFGLS + + GTP+Y+APE + G D +D
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVG-DDKMSDW 176
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNP 253
WS G ++F L GY PF ++ I + P + S A LI R+L +P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 254 MTRI---TIPEILEDEWFK 269
R+ EI +FK
Sbjct: 237 AKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 7e-47
Identities = 72/248 (29%), Positives = 135/248 (54%), Gaps = 7/248 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ R IG+G F KV + +T + A+K ++K+K ++ + E ++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L+ + +++V++ + GG+L + + E++ + + +++ A++Y HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRD+KP+N+LLD G++ ++DF ++ +V D L +T GTP Y+APEVL +GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 193 STADLWSCGVILFVLLAGYLPFD--DSNLMNLYK-KISAAEFTCPPWLSFTARKLIARIL 249
D WS GV + L G P+ + + + K A+ P S A I ++L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 250 DPNPMTRI 257
+ +P R+
Sbjct: 238 ERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 8e-47
Identities = 90/276 (32%), Positives = 143/276 (51%), Gaps = 29/276 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G + +V A+ +TGE VALK + K + K + E + K +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+++ +E+V GG+ + N G + ED AR Y ++ AVD H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLL---HTTCGTPNYVAPEVLNDRGYDGSTA 195
PEN L+DA G++K++DFGLS G++ ++ G+P+Y+APEVL +GYD T
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTV 179
Query: 196 DLWSCGVILFVLLAGYLPFDDS-------NLMNLYKKISAAEFTCPPW-LSFTARKLIAR 247
D WS G +L+ L G+ PF S NL + + + P + LS A LI +
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239
Query: 248 ILDPNPMTRI-TIPEILEDEWFKK-------DYKPP 275
+++ +P R ++ +I +FK+ + KPP
Sbjct: 240 LIN-DPSRRFGSLEDIKNHPFFKEVDWNELRELKPP 274
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 1e-46
Identities = 86/245 (35%), Positives = 143/245 (58%), Gaps = 7/245 (2%)
Query: 17 RTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKH-KMAEQIKREVATMKLVKHPN 72
+ +G+G + KV R ++TG+ A+K+L K ++++ K K E ++ VKHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L + K++++LE+++GGELF + G ED A Y ++ A+++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLDA G++K++DFGL + + + + HT CGT Y+APE+L G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D WS G +++ +L G PF N KI + PP+L+ AR L+ ++L N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 253 PMTRI 257
P +R+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 80/261 (30%), Positives = 130/261 (49%), Gaps = 11/261 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++G IG G F V N ETG+ VA+K + EK+ + + I +E+ +K +KHP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V+ + + ++I+LE+ G L I G E Y Q++ + Y H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K N+L G +K++DFG++ ++ + GTP ++APEV+ G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGA- 176
Query: 192 GSTA-DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW---LSFTARKLIAR 247
STA D+WS G + LL G P+ D N M +I + PP +S + + +
Sbjct: 177 -STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI--VQDDHPPLPEGISPELKDFLMQ 233
Query: 248 ILDPNPMTRITIPEILEDEWF 268
+P R T ++L+ W
Sbjct: 234 CFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 85/242 (35%), Positives = 138/242 (57%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVR 75
R +G+G+F KV AR E+G A+K+L K+ +L+ E E + L + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY + ++F V+EFV GG+L I R E AR Y ++ +A+ + H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +L G+ PF+ N +L++ I E P WLS A ++ + NP
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-46
Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 23/267 (8%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
G IG GTF KV A N +TGE +A+K + + K ++I E+ ++L+KHPN+V+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA--RRYFQQLINAVDYCHSRGVY 133
Y V + K++I +E+ +GG L + ++ HGR+ DE R Y QL+ + Y HS G+
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 134 HRDLKPENLLLDAYGNLKVSDFG----LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
HRD+KP N+ LD G +K+ DFG L + + + + GTP Y+APEV+
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--EEVQSLAGTPAYMAPEVITGGK 179
Query: 190 YDG--STADLWSCGVILFVLLAGYLPFD--DSNLMNLYKKISAAEFTCPPW-----LSFT 240
G AD+WS G ++ + G P+ D+ ++ + A PP LS
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-HVGAGH--KPPIPDSLQLSPE 236
Query: 241 ARKLIARILDPNPMTRITIPEILEDEW 267
+ + R L+ +P R T E+L+ +
Sbjct: 237 GKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-46
Identities = 90/257 (35%), Positives = 138/257 (53%), Gaps = 8/257 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG+ A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + ED AR Y ++++A+ Y HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LK ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 257 I-----TIPEILEDEWF 268
+ EI+E +F
Sbjct: 238 LGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 2e-45
Identities = 85/241 (35%), Positives = 133/241 (55%), Gaps = 3/241 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + E+ AR Y ++++A++Y HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 257 I 257
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 94/279 (33%), Positives = 159/279 (56%), Gaps = 27/279 (9%)
Query: 17 RTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G+F KV R + G+ A+K+L K+ LK + + K E + V HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+L+ ++ K++++L+F+ GG+LF ++ E++ + Y +L A+D+ HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
+RDLKPEN+LLD G++K++DFGLS + + + ++ CGT Y+APEV+N RG+ S
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 194 TADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
AD WS GV++F +L G LPF D M + I A+ P +LS A+ L+ +
Sbjct: 179 -ADWWSFGVLMFEMLTGSLPFQGKDRKETMTM---ILKAKLGMPQFLSPEAQSLLRALFK 234
Query: 251 PNPMTRI-TIPEILED----------EW---FKKDYKPP 275
NP R+ P+ +E+ +W ++++ KPP
Sbjct: 235 RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPP 273
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 87/242 (35%), Positives = 134/242 (55%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV A++ G+ A+K+L K+ +LK K + I E + K VKHP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL++V GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + T CGTP Y+APEVL + YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF + +Y I P +S +AR L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 84/242 (34%), Positives = 138/242 (57%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T E A+K+L K+ +L+ E E + L KHP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +K ++F V+E+V GG+L I GR E AR Y +++ + + H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++DFG+ + + T CGTP+Y+APE+L+ + Y +
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPYGPA-V 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +LAG PF+ + L++ I E P WLS A+ ++ L NP
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 8e-44
Identities = 91/270 (33%), Positives = 146/270 (54%), Gaps = 9/270 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV + TG A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHR 135
+ ++ V+E+ GGELF + ED AR Y ++++A+DY HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK ENL+LD G++K++DFGL + ++D + T CGTP Y+APEVL D Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W GV+++ ++ G LPF + + L++ I E P LS A+ L++ +L +P
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 256 RI-----TIPEILEDEWFKKDYKPPVFEEK 280
R+ EI++ ++F V+E+K
Sbjct: 238 RLGGGPDDAKEIMQHKFFAGIVWQDVYEKK 267
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 85/241 (35%), Positives = 134/241 (55%), Gaps = 3/241 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R +G+ A+KIL KE ++ E +K +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+K ++ V+E+V GGELF + ED R Y ++++A+DY HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LK ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I + P LS A+ L++ +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 257 I 257
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 1e-43
Identities = 92/269 (34%), Positives = 134/269 (49%), Gaps = 15/269 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F KV R +T ALK + K ++ E + V P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
S K+++VL F+ GGELF + GR AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PEN+LLD G++ + DFGL L+ ++DD +T CGTP Y+APE+L GY D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258
+ GV+L+ +L G PF D N+ +Y+KI P A+ L+ +L +P R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 259 I---------PEILEDEWFK---KDYKPP 275
P + W K K +PP
Sbjct: 238 YNGAQEIKNHPFFSQLSWKKLLMKGIQPP 266
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 87/272 (31%), Positives = 141/272 (51%), Gaps = 16/272 (5%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV 68
+E+ R +G G + KV R + G+ A+K+L K ++ K K AE + E ++ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ + TK+ ++L++V GGELF + E E R Y +++ A+D+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN- 186
H G+ +RD+K EN+LLD+ G++ ++DFGLS ++ ++ CGT Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRG 180
Query: 187 -DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTA 241
G+D D WS GV+ F LL G PF N +IS P +S A
Sbjct: 181 GSGGHD-KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239
Query: 242 RKLIARILDPNPMTRI---TIPEILEDEWFKK 270
R I ++L+ +P R+ EI +F+
Sbjct: 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 6e-43
Identities = 87/242 (35%), Positives = 136/242 (56%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV-ATMKLVKHPNVVR 75
+ IG+G+F KV AR+ + A+K+L K+ +LK K + I E +K VKHP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL+++ GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + +G T CGTP Y+APEVL+ + YD T
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF N +Y I P ++ +AR L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 9e-43
Identities = 91/273 (33%), Positives = 138/273 (50%), Gaps = 17/273 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV A+ G A+K+L K+ +LK K I E + K +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL++V GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + V + T CGTP Y+APEVL YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF ++ +Y I P + A L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 256 RI-TIPEILE------------DEWFKKDYKPP 275
R+ + LE D+ + K PP
Sbjct: 238 RLGAKADFLEIKNHVFFSPINWDDLYHKRITPP 270
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-42
Identities = 95/262 (36%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHP 71
+ IG+G+F KV A+ G+ A+K+L K+ VL KH MAE R V +K VKHP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAE---RNV-LLKNVKHP 56
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V L+ + K++ VL+FV GGELF + E AR Y ++ +A+ Y HS
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN 116
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ +RDLKPEN+LLD+ G++ ++DFGL D T CGTP Y+APEV+ + YD
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT--TFCGTPEYLAPEVIRKQPYD 174
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
+T D W G +L+ +L G PF ++ +Y I P S TA ++ +L+
Sbjct: 175 -NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEK 233
Query: 252 NPMTRI----TIPEILEDEWFK 269
+ R+ EI E +F+
Sbjct: 234 DRQRRLGAKEDFLEIQEHPFFE 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 90/300 (30%), Positives = 139/300 (46%), Gaps = 57/300 (19%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE----QIKREVATMKLV 68
YE IGEGT+ +V ARN +TGE VALK K+ E RE+ ++ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKL 55
Query: 69 KHPNVVRLYEVMGSKTK--IFIVLEFV----TGGELFDKIVNHGRMK--EDEARRYFQQL 120
+HPN+VRL E++ SK K I++V E++ TG +++ +K E + + Y +QL
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG------LLDSPEVKFTESQIKCYMKQL 109
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS G+ HRD+K N+L++ G LK++DFGL A R+ T Y
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYR 168
Query: 181 APEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------SAA 229
PE+L Y D+WS G IL L G F S + +KI +
Sbjct: 169 PPELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 230 EFTCPPW---------------------LSFTARKLIARILDPNPMTRITIPEILEDEWF 268
+ PW + +A L+ ++L +P RI+ + L+ E+F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 97/309 (31%), Positives = 143/309 (46%), Gaps = 64/309 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-I-LDKEKVLKHKMAEQIKREVATMKLVK 69
+YE G+ +GEGT+A V AR+ ETG VA+K I L + K K + RE+ ++ +K
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
HPN++ L +V G K+ I +V EF+ + DK + + + + Y + ++Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMTLRGLEY 117
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-------- 178
HS + HRDLKP NLL+ + G LK++DFGL+ + G+PN
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQVV 164
Query: 179 ---YVAPEVLNDRGYDGSTADLWSCGVILFVLLAG--YLPFDDSNLMNLYKKISAA---- 229
Y APE+L + G D+WS G I LL +LP DS++ L KI A
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQL-GKIFEALGTP 222
Query: 230 ------EFTCPP-WLSFTARK-----------------LIARILDPNPMTRITIPEILED 265
T P ++ F L+ R+L NP RIT + LE
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282
Query: 266 EWFKKDYKP 274
+F D P
Sbjct: 283 PYFSNDPAP 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 72/201 (35%), Positives = 109/201 (54%), Gaps = 6/201 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y++ IGEG V A++ ETGE VALK + + L+ + Q RE+ ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSR 130
VV+L +V + +V+E++ L + + + R + E + + Y + L+ V Y H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL-NDRG 189
G+ HRDLKP NLL+ A G LK++DFGL+ L + L T Y APE+L R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARL-FSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 190 YDGSTADLWSCGVILFVLLAG 210
YD DLW+ G I LL G
Sbjct: 178 YDPG-VDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 4e-41
Identities = 99/331 (29%), Positives = 152/331 (45%), Gaps = 56/331 (16%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+K L K ++L+ + ++ E + +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+LY + +++++E++ GG++ ++ E+E R Y + I A+D H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-------------------------SALSQQVRDD 167
HRD+KP+NLLLDA G++K+SDFGL +S+ +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 168 GLLHT-----------TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
T T GTP+Y+APEV GY D WS GVI++ +L GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 217 SNLMNLYKKISAAEFTC--PP--WLSFTARKLIARILDPNPMTRITIP---EILEDEWFK 269
N Y+KI + T P LS A+ LI R+ R+ EI +FK
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
Query: 270 -------KDYKPPVFEEKK---DT-NLDDVE 289
++ P+ E K DT N DD E
Sbjct: 301 GVDWEHIRERPAPIIPELKSITDTSNFDDFE 331
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 5e-41
Identities = 80/266 (30%), Positives = 133/266 (50%), Gaps = 17/266 (6%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKLVKH 70
E + +G+G+ V R+ TG+ ALK + E+ K Q+ RE+ T++ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----QLLRELKTLRSCES 58
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS- 129
P VV+ Y + +I IVLE++ GG L D + G++ E +Q++ +DY H+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R + HRD+KP NLL+++ G +K++DFG+S + + D +T GT Y++PE +
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGE- 175
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----SFTARKL 244
AD+WS G+ L G PF + ++ + A PP L S R
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235
Query: 245 IARILDPNPMTRITIPEILEDEWFKK 270
I+ L +P R + E+L+ + KK
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 81/264 (30%), Positives = 141/264 (53%), Gaps = 13/264 (4%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+G +++ + IG+G F+ V A G VALK + +++ K + +E+ +K +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ ++ IVLE G+L I + + K E +YF QL +A++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEV 184
+ HS+ + HRD+KP N+ + A G +K+ D GL S + H+ GTP Y++PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLVGTPYYMSPER 177
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA- 241
+++ GY+ + D+WS G +L+ + A PF D NL +L KKI ++ P ++
Sbjct: 178 IHENGYNFKS-DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236
Query: 242 -RKLIARILDPNPMTRITIPEILE 264
R L++R ++P+P R I +L+
Sbjct: 237 LRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 80/242 (33%), Positives = 136/242 (56%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T E A+K+L K+ +L+ + E + L KHP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +K ++F V+E+V GG+L +I + E +R Y ++ A+ + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+++ ++AG PF+ N +L++ I + P WLS A ++ + NP
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 73/253 (28%), Positives = 130/253 (51%), Gaps = 6/253 (2%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNV 73
G+ +G+G F +V + +TG +A+K + + K ++ E+ +K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+ Y + + I +E++ GG + D++ +G + E R+Y +Q++ V+Y HS +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDG 192
HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++ GY G
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-G 185
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIARILD 250
AD+WS G + +L P+ + M KI+ P +S AR + R
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245
Query: 251 PNPMTRITIPEIL 263
N R + E+L
Sbjct: 246 ENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 92/286 (32%), Positives = 152/286 (53%), Gaps = 22/286 (7%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE---VATMKLVKHPNVVR 75
IG+GTF +V R +T A+K+L K++++ K E + L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L + + +++V ++++GGELF + GR ED A+ Y +L+ A+++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGST 194
DLKPEN+LLDA G++ + DFGLS + D+ +T CGT Y+APEV L+++GY
Sbjct: 121 DLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 195 ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-WLSFTARKLIARILDPNP 253
D WS GV++F + G+ PF + +Y+ I+ + P LS R+ + +L+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 254 MTRI----TIPEILEDEWF---------KKDYKPPVFEEKKDTNLD 286
R+ E+ E +F KK PP F+ D++ D
Sbjct: 238 QHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPP-FKPIVDSDED 282
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 5e-40
Identities = 87/251 (34%), Positives = 138/251 (54%), Gaps = 11/251 (4%)
Query: 3 QPKIKRRVGKYE---VGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQI 58
+PK K ++ KYE RT+G G+F +V A +E PVA+K +K K++K K + +
Sbjct: 20 EPKRKNKM-KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 59 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + + HP V LY ++ +++VLEFV GGE F + + R D Y
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA 138
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q++ +Y S + +RDLKPENLLLD G +K++DFG + + D +T CGTP
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPE 193
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y+APE+L + G+ G AD W+ G+ ++ +L G PF + + +Y+KI P +L
Sbjct: 194 YIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252
Query: 239 FTARKLIARIL 249
+ L+ ++L
Sbjct: 253 NNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 82/251 (32%), Positives = 140/251 (55%), Gaps = 13/251 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV +T A+K++ KE V + + ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+EFV+GG+L + ++ E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G++K++D+G+ + +R T CGTPNY+APE+L Y S
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 196 DLWSCGVILFVLLAGYLPFD-----DSNLMN----LYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PFD D+ N L++ I + P LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 247 RILDPNPMTRI 257
L+ +P R+
Sbjct: 238 GFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 88/281 (31%), Positives = 151/281 (53%), Gaps = 15/281 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE--QIKREVATMKLVKHPNVV 74
+ +G+G+F KV A T E A+K L K+ VL+ E ++R V + +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLT 59
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
L+ +K +F V+E++ GG+L I + GR E AR Y ++I + + H +G+ +
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLK +N+LLD G++K++DFG+ + + +G T CGTP+Y+APE+L + Y+ S
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
Query: 195 ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPM 254
D WS GV+L+ +L G PF + L+ I P W+S A+ ++++ + +P
Sbjct: 178 -DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT 236
Query: 255 TRITIPEILEDEWFKK--DYK-------PPVFEEKKDTNLD 286
R+ + + F + D++ PP F+ K + D
Sbjct: 237 KRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSD 277
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 76/257 (29%), Positives = 130/257 (50%), Gaps = 7/257 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
++ G +G G+F V N + G+ A+K L + + +Q+++E+A + ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPN+V+ + ++I LE V GG L + +G E R Y +Q++ ++Y H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R HRD+K N+L+D G +K++DFG +++QV + + G+P ++APEV+ +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFG---MAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPWLSFTARKLIAR 247
G AD+WS G + + G P+ + KI S P LS A+ I +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 248 ILDPNPMTRITIPEILE 264
L +P R T E+LE
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 87/258 (33%), Positives = 139/258 (53%), Gaps = 10/258 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YE+ + IGEG+F K+ A+ E +K +D K + K E K+EV + +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRM-KEDEARRYFQQLINAVDYCHS 129
N+V + ++FIV+E+ GG+L +I G + ED+ +F Q+ + + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 130 RGVYHRDLKPENLLLDAYGNL-KVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVLND 187
R + HRD+K +N+ L G + K+ DFG +++Q+ D L TC GTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFG---IARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIA 246
R Y+ T D+WS G +L+ L PF+ +NL L KI F P S R LI+
Sbjct: 177 RPYNNKT-DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235
Query: 247 RILDPNPMTRITIPEILE 264
++ +P R +I IL+
Sbjct: 236 QLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 6e-39
Identities = 99/316 (31%), Positives = 163/316 (51%), Gaps = 28/316 (8%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K++ + Y+V + IG G F +V+ R+ + + A+K+L K +++K + E
Sbjct: 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
M P VV+L+ +++V+E++ GG+L + + N+ + E A+ Y +++ A+
Sbjct: 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLAL 155
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAP 182
D HS G+ HRD+KP+N+LLD +G+LK++DFG ++ + G++ T GTP+Y++P
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVRCDTAVGTPDYISP 212
Query: 183 EVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPP 235
EVL + GY G D WS GV LF +L G PF +L+ Y KI ++ F
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272
Query: 236 WLSFTARKLIARILDPNP--MTRITIPEILEDEWFKKDY----------KPPVFEEKKD- 282
+S A+ LI L + R + EI + +FK D P V E D
Sbjct: 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDI 332
Query: 283 --TNLDDVEAVFKDSE 296
+N DD+E D E
Sbjct: 333 DSSNFDDIEDDKGDVE 348
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 81/256 (31%), Positives = 141/256 (55%), Gaps = 14/256 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEK-VLKHKMAEQIKREVATMKLV 68
+E+ + +G G + KV R +TG+ A+K+L K V K K E + E ++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ ++ K+ ++L++V+GGE+F + EDE R Y ++I A+++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ +RD+K EN+LLD+ G++ ++DFGLS LS++ ++ CGT Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT---YSFCGTIEYMAPEII 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTA 241
+G G D WS G+++F LL G PF N ++S C P ++ A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 242 RKLIARILDPNPMTRI 257
+ L+ ++L +P R+
Sbjct: 239 QDLLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 81/267 (30%), Positives = 135/267 (50%), Gaps = 16/267 (5%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK-------ILDKEKVLKHKMAEQIKREVATMKLV 68
G IG+GT+ +V A N TGE +A+K I + + M + ++ E+ T+K +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
H N+V+ ++ + I LE+V GG + + +GR +E R + +Q++ + Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND- 187
S+G+ HRDLK +NLL+DA G K+SDFG+S S + D+ + G+ ++APEV++
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 188 -RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP------PWLSFT 240
+GY D+WS G ++ + AG P+ D + K+ P LS
Sbjct: 186 SQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244
Query: 241 ARKLIARILDPNPMTRITIPEILEDEW 267
A + NP R T E+L+ +
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 70/256 (27%), Positives = 124/256 (48%), Gaps = 11/256 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V + +G+G++ V + + ALK +D + + + + + E+ + V HPN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVDYCH 128
++ E K+ IV+E+ G+L I + + E E R F QL+ + H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ + HRDLK N+LL A +K+ D G+S + ++ + T GTP+Y+APEV R
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVWKGR 176
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIAR 247
Y +D+WS G +L+ + PF+ ++ +L K+ ++ PP S + I
Sbjct: 177 PYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235
Query: 248 ILDPNPMTRITIPEIL 263
+L P R +IL
Sbjct: 236 MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 84/257 (32%), Positives = 141/257 (54%), Gaps = 14/257 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A + TG VA+K +D + K + E + EV M+ +HPN+V +Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ + H++GV HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQV-RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+++LL + G +K+SDFG A +S++V R L+ GTP ++APEV++ Y G+ D
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPY-GTEVD 197
Query: 197 LWSCGVILFVLLAGYLP-FDDSNL--MNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
+WS G+++ ++ G P F++ L M + + +S R + R+L +P
Sbjct: 198 IWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257
Query: 254 MTRITIPEILEDEWFKK 270
R T E+L + K
Sbjct: 258 AQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 83/268 (30%), Positives = 141/268 (52%), Gaps = 31/268 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + I G + V R+ ET + A+K ++K+ ++ +Q+ E + ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV ++ +K + +V+E+V GG+ + N G + D AR YF + + A++Y H+ G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT------------------- 173
HRDLKP+NLL+ + G++K++DFGLS + GL+ T
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKI-------GLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 174 -CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 232
CGTP Y+APEV+ +GY G D W+ G+IL+ L G +PF L+ ++ + +
Sbjct: 176 VCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234
Query: 233 CPPW---LSFTARKLIARILDPNPMTRI 257
P L A+ LI+R+L NP+ R+
Sbjct: 235 WPEGDEALPADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 6e-38
Identities = 81/258 (31%), Positives = 140/258 (54%), Gaps = 11/258 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + IGEG+F K ++ E G+ +K ++ K + K E+ ++EVA + +KHP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCH 128
N+V+ E ++IV+++ GG+L+ KI N R ED+ +F Q+ A+ + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
R + HRD+K +N+ L G +K+ DFG++ L+ V L T GTP Y++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICEN 175
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246
R Y+ + +D+W+ G +L+ + F+ N+ NL KI + S+ R L++
Sbjct: 176 RPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234
Query: 247 RILDPNPMTRITIPEILE 264
++ NP R ++ ILE
Sbjct: 235 QLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 7e-38
Identities = 96/309 (31%), Positives = 156/309 (50%), Gaps = 28/309 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V + IG G F +V+ R+ + + A+K+L K +++K + E M
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V+L+ +++V+E++ GG+L + + N+ + E AR Y +++ A+D HS G
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGF 163
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAPEVLNDRGY 190
HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PEVL +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 191 D---GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPPWLSFTARK 243
D G D WS GV L+ +L G PF +L+ Y KI ++ F +S A+
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280
Query: 244 LIARILDPNP--MTRITIPEILEDEWFKKDY---------KPPVFEEKK---DT-NLDDV 288
LI L + R + EI +FK D PV E DT N DD+
Sbjct: 281 LICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDI 340
Query: 289 EAVFKDSEV 297
E K+ E
Sbjct: 341 EDDDKNEET 349
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-38
Identities = 81/222 (36%), Positives = 117/222 (52%), Gaps = 17/222 (7%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKL 67
KYEV +GEG + V RN TGE VA+K + ++ +K + REV ++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK----KTALREVKVLRQ 56
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFV--TGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
++H N+V L E K ++++V E+V T EL + + G + D R Y QL+ A+
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIA 114
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV 184
YCHS + HRD+KPEN+L+ G LK+ DFG + AL + L T Y APE+
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPEL 172
Query: 185 L-NDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYK 224
L D Y G D+W+ G I+ LL G F DS++ LY
Sbjct: 173 LVGDTNY-GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 80/268 (29%), Positives = 137/268 (51%), Gaps = 21/268 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ IGEG +V A + TG+ VA+K K ++ K E I E+ MK KHP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIK---KMRLRKQNK-ELIINEILIMKDCKHP 75
Query: 72 NVVRLYE---VMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYC 127
N+V Y+ V +++V+E++ GG L D I + RM E + ++++ ++Y
Sbjct: 76 NIVDYYDSYLVGDE---LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HS+ V HRD+K +N+LL G++K++DFG +A L+++ ++ GTP ++APEV+
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK---SKRNSVVGTPYWMAPEVIK 189
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAA---EFTCPPWLSFTAR 242
+ Y D+WS G++ + G P + L L+ I+ P S +
Sbjct: 190 RKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGIPPLKNPEKWSPEFK 247
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKK 270
+ + L +P R + E+L+ + KK
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 2e-37
Identities = 82/251 (32%), Positives = 141/251 (56%), Gaps = 13/251 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV R +T A+K++ KE V + + ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+E+V GG+L + ++ E+ AR Y ++ A++Y H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++D+G+ + +R T CGTPNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 196 DLWSCGVILFVLLAGYLPFD--------DSNLMN-LYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PFD D N + L++ I + P LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 247 RILDPNPMTRI 257
L+ +P R+
Sbjct: 238 SFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 86/272 (31%), Positives = 133/272 (48%), Gaps = 23/272 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ IG G A V A E VA+K +D EK +++++EV M HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD---KIVNHGRMKEDEARRYFQQLINAVDYCHS 129
VV+ Y ++++V+ +++GG L D G + E ++++ ++Y HS
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQV-RDDGLLHTTCGTPNYVAPEVLN- 186
G HRD+K N+LL G++K++DFG+SA L+ R + T GTP ++APEV+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFTCPPWLSFTA---- 241
GYD AD+WS G+ L G P+ M L + PP L A
Sbjct: 181 VHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND----PPSLETGADYKK 235
Query: 242 -----RKLIARILDPNPMTRITIPEILEDEWF 268
RK+I+ L +P R T E+L+ ++F
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 97/308 (31%), Positives = 157/308 (50%), Gaps = 28/308 (9%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
++ + YEV + IG G F +V+ R+ T + A+K+L K +++K + E M
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
P VV+L+ +++V+E++ GG+L + + N+ + E AR Y +++ A+D
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALD 156
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAPE 183
HS G HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PE
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMNKEGMVRCDTAVGTPDYISPE 213
Query: 184 VLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPPW 236
VL + GY G D WS GV L+ +L G PF +L+ Y KI ++ F
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273
Query: 237 LSFTARKLIARILDPNP--MTRITIPEILEDEWFKKDY----------KPPVFEEKKD-- 282
+S A+ LI L + R + EI +FK D P V + D
Sbjct: 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDID 333
Query: 283 -TNLDDVE 289
+N DD+E
Sbjct: 334 TSNFDDIE 341
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 6e-37
Identities = 85/287 (29%), Positives = 146/287 (50%), Gaps = 22/287 (7%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLY 77
+G+G+F KV A T E A+KIL K+ +++ E E + L P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L I G+ KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LDA G++K++DFG+ + + T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI 257
W+ GV+L+ +LAG PFD + L++ I + P LS A + +L +P R+
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
Query: 258 TI-----PEILEDEWFKK-------------DYKPPVFEEKKDTNLD 286
+I E +F++ +KP V + N D
Sbjct: 245 GCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFD 291
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 8e-37
Identities = 80/249 (32%), Positives = 141/249 (56%), Gaps = 11/249 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVR 75
R IG G++AKV R + + A+K++ KE V + + ++ E + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++F+V+E+V GG+L + ++ E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G++K++D+G+ + + T CGTPNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 196 DLWSCGVILFVLLAGYLPFD---DSNLMN----LYKKISAAEFTCPPWLSFTARKLIARI 248
D W+ GV++F ++AG PFD D+ MN L++ I P +LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 249 LDPNPMTRI 257
L+ +P R+
Sbjct: 238 LNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 90/308 (29%), Positives = 148/308 (48%), Gaps = 43/308 (13%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+G +V R TG+ ALK+LDK++++K +++ E + + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
Y ++T + +V+++ GGELF + + E+ AR Y +++ A++Y H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALS----QQVRDDGL-----------LHTT------ 173
RDLKPEN+LL G++ +SDF LS S V T
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 174 ------CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
GT Y+APEV++ G+ GS D W+ G++L+ +L G PF SN + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 228 AAEFTCP--PWLSFTARKLIARILDPNPMTRI----TIPEILEDEWFK-------KDYKP 274
E T P P +S +AR LI ++L +P R+ EI + +F+ + P
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTP 305
Query: 275 PVFEEKKD 282
P+ D
Sbjct: 306 PIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 83/268 (30%), Positives = 131/268 (48%), Gaps = 34/268 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL---DKEKVLKHKMAEQIKREVATMKLVKH 70
E IG G V + TG ALK++ ++ V + QI RE+ ++ V H
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNH 131
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PNVV+ +++ +I ++LEF+ GG L + + D AR Q+++ + Y H R
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRR 187
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV----LN 186
+ HRD+KP NLL+++ N+K++DFG+S + Q D +++ GT Y++PE LN
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLN 245
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPF------DDSNLMNLYKKISAAEFTCPPWLSFT 240
YDG D+WS GV + G PF D ++LM A + PP T
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM------CAICMSQPPEAPAT 299
Query: 241 A----RKLIARILDPNPMTRITIPEILE 264
A R I+ L P R + ++L+
Sbjct: 300 ASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 88/264 (33%), Positives = 135/264 (51%), Gaps = 25/264 (9%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G+G F KV A++ ETG A KI+ E+ L+ M E + + KHPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-----IDILSECKHPNIVGL 67
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
YE + K++I++EF GG L ++ R + E + R +Q++ A+++ HS V HR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGY 190
DLK N+LL G++K++DFG+SA ++ T GTP ++APEV+ D Y
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNK--STLQKRDTFIGTPYWMAPEVVACETFKDNPY 185
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKL 244
D AD+WS G+ L L P + N M + KI +E PP L S +
Sbjct: 186 D-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PPTLDQPSKWSSSFNDF 241
Query: 245 IARILDPNPMTRITIPEILEDEWF 268
+ L +P R T E+L+ +
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 76/243 (31%), Positives = 111/243 (45%), Gaps = 42/243 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +TIG G F +V R +T A+K L K VL A +K E + +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+LY K ++ V++++ GG++ ++ G +ED AR Y +L A++ H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSA------------LSQQVRDDG------------ 168
HRD+KP+N+L+D G++K++DFGL R D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL GY D WS GVIL+ +L G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 241
Query: 212 LPF 214
PF
Sbjct: 242 PPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 6e-36
Identities = 77/244 (31%), Positives = 131/244 (53%), Gaps = 4/244 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T + A+K L K+ VL E E + L +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY +K +F V+E++ GG+L I + + A Y ++I + + HS+G+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G++K++DFG+ + + D T CGTP+Y+APE+L + Y ++
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D WS GV+L+ +L G PF + L++ I P WL+ A+ ++ ++ P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237
Query: 256 RITI 259
R+ +
Sbjct: 238 RLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 78/259 (30%), Positives = 132/259 (50%), Gaps = 11/259 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE R +G G F V R + V +K + E++ K + E +KL+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
N++ YE + IV+E+ GG L + I + ED +F Q++ A+ + H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 130 RGVYHRDLKPENLLLDAYGN-LKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLND 187
+ + HRDLK +N+LLD + +K+ DFG+S LS + + +T GTP Y++PE+
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----AYTVVGTPCYISPELCEG 175
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIA 246
+ Y+ +D+W+ G +L+ L + F+ +NL L KI + F S R+LI
Sbjct: 176 KPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234
Query: 247 RILDPNPMTRITIPEILED 265
+L+ +P R + +I+
Sbjct: 235 SMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 80/255 (31%), Positives = 135/255 (52%), Gaps = 4/255 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A GE A+K L K+ VL E E + L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY +K +F V+EF+ GG+L I + GR A Y +++ + + HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD G++K++DFG+ + V D T CGTP+Y+APE+L Y S
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV- 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D WS GV+L+ +L G PF + L++ I P W++ ++ ++ ++ + +P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 256 RITIPEILEDEWFKK 270
R+ + + F K
Sbjct: 238 RLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 77/240 (32%), Positives = 134/240 (55%), Gaps = 4/240 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77
+G+G+F KV A T E A+KIL K+ V++ E E + L K P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L +I GR KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI 257
W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P R+
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 71/202 (35%), Positives = 111/202 (54%), Gaps = 11/202 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y+ IGEGT+ V AR+ TGE VA+K + K + + + RE+ +K + HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSR 130
+++L +V K +++V EF+ K++ + + E + Y QL+ + +CHS
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVL-NDR 188
G+ HRDLKPENLL++ G LK++DFG L++ +T T Y APE+L D+
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFG---LARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 189 GYDGSTADLWSCGVILFVLLAG 210
GY + D+WS G I LL+
Sbjct: 175 GY-STPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 78/240 (32%), Positives = 134/240 (55%), Gaps = 4/240 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77
+G+G+F KV A T E A+KIL K+ V++ E E + L K P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L I G+ KE +A Y ++ + + H RG+ +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI 257
W+ GV+L+ +LAG PFD + L++ I + P LS A + ++ +P R+
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REV-ATMKLVKH 70
Y+V + +G+GTF V ARN ETGE VA+K + K+K + E + REV + KL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKF--YSWEECMNLREVKSLRKLNEH 57
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCH 128
PN+V+L EV +++ V E++ G L+ + + E R Q++ + + H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
G +HRDLKPENLL+ +K++DFG L++++R T Y APE+L
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFG---LAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 189 GYDGSTADLWSCGVILF 205
S D+W+ G I+
Sbjct: 174 TSYSSPVDIWALGCIMA 190
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 77/256 (30%), Positives = 145/256 (56%), Gaps = 13/256 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARN---SETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV 68
+E+ + +G G + KV R ++G+ A+K+L K ++ K K E + E ++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ + TK+ ++L+++ GGELF + R KE E + Y +++ A+++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL-- 185
H G+ +RD+K EN+LLD+ G++ ++DFGLS + + ++ CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRG 180
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTA 241
D G+D D WS GV+++ LL G PF + ++ + ++I +E P +S A
Sbjct: 181 GDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 242 RKLIARILDPNPMTRI 257
+ +I R+L +P R+
Sbjct: 240 KDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 89/288 (30%), Positives = 136/288 (47%), Gaps = 49/288 (17%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+GEGT+A V RN TGE VALK LD E+ RE++ MK +KH N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRL 63
Query: 77 YEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
++V+ ++ K+ +V E++ + D G + + + + QL+ + +CH V H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG----TPNYVAPEVL-NDRG 189
RDLKP+NLL++ G LK++DFGL+ R G+ T T Y AP+VL R
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKI--SAAEFTCP---------- 234
Y S D+WS G I+ ++ G F ++ + + +I + E T P
Sbjct: 178 YSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 235 --------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268
P L+ R+L NP RI+ + L+ WF
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-34
Identities = 78/194 (40%), Positives = 107/194 (55%), Gaps = 20/194 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
IGEGT+ V AR+ TGE VALK + + E V + RE++ +K + HPN+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-----REISLLKELNHPNIV 61
Query: 75 RLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RL +V+ S+ K+++V EF+ + D G + + Y QL+ + YCHS V
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHRV 120
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGY 190
HRDLKP+NLL+D G LK++DFGL+ A VR H T Y APE+ L R Y
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVV-TLWYRAPEILLGSRQY 177
Query: 191 DGSTA-DLWSCGVI 203
ST D+WS G I
Sbjct: 178 --STPVDIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 7e-34
Identities = 81/272 (29%), Positives = 132/272 (48%), Gaps = 38/272 (13%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+KIL K +L+ + I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+++ K +++++EF+ GG++ ++ + E+ + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDD------------------------ 167
HRD+KP+NLLLDA G++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 168 --------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L ++T GTP+Y+APEV GY+ D WS GVI++ +L GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 220 MNLYKKIS--AAEFTCPPW--LSFTARKLIAR 247
Y+K+ PP +S A+ LI R
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 9e-34
Identities = 72/249 (28%), Positives = 125/249 (50%), Gaps = 15/249 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V +G G F +V+ R TG+ A+K++ K +L + + E + + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+ +L K +++V+E+ GG+L + + + ED A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVLND-R 188
HRD+KPEN+L+D G++K++DFG +A ++ + ++++ GTP+Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 189 GYDGST----ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPPWLSFT 240
G T D WS GVI + ++ G PF + Y I +F P +S
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 241 ARKLIARIL 249
LI +L
Sbjct: 240 FLDLIQSLL 248
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 80/282 (28%), Positives = 126/282 (44%), Gaps = 50/282 (17%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ IG+G F +V+ + +TG+ A+K L K ++ K +K E + P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y +++++EF+ GG+L ++ + ED R Y + + A++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDG---------------------------- 168
+KP+N+L+D G++K+SDFGLS + D
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
+ ++T GTP+Y+APE+ +GY G D WS G I+F L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 212 LPFDDSNLMNLYKKISAAE----FTCPPWLSFTARKLIARIL 249
PF N Y+KI F LS A LI R++
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 79/262 (30%), Positives = 131/262 (50%), Gaps = 18/262 (6%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK--ILD----KEKVLKHKMAEQIKREVATMKLVK 69
G IG G+F V N+ +GE +A+K L K K M + + RE+A +K ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H N+V+ + I LE+V GG + + N+G +E R + +Q++ ++Y H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-------GTPNYVAP 182
RG+ HRD+K N+L+D G +K+SDFG +S+++ + L T G+ ++AP
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFG---ISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTA 241
EV+ Y AD+WS G ++ +L G PF D + KI A P +S A
Sbjct: 182 EVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA 240
Query: 242 RKLIARILDPNPMTRITIPEIL 263
+ + + + R T E+L
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 78/242 (32%), Positives = 119/242 (49%), Gaps = 7/242 (2%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI---KREVATMKLVKHPNVVR 75
+G G F KV A +TGE A+K L K ++ E + KR T +HP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ ++ + V+E+ GG+L I + E A Y ++ + Y H + +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +NLLLD G +K++DFGL D T CGTP ++APEVL + Y +
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAV- 182
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W GV+++ +L G PF + ++ I E P +LS A ++ R+L NP
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242
Query: 256 RI 257
R+
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-33
Identities = 76/256 (29%), Positives = 125/256 (48%), Gaps = 9/256 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y R +G+G F + R +E V K ++ + L K E+ + L++HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSR 130
++ Y + I +E+ GG L+DKIV +E+ Y Q+++AV Y H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVLNDRG 189
G+ HRD+K N+ L G +K+ DFG +S+ + + + T GTP Y++PE+
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFG---ISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248
Y+ +D+W+ G +L+ LL FD +N +NL KI +T S L+ +
Sbjct: 178 YN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236
Query: 249 LDPNPMTRITIPEILE 264
L +P R T E+L+
Sbjct: 237 LQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 72/265 (27%), Positives = 129/265 (48%), Gaps = 12/265 (4%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILD---KEKVLKHKMAEQIKREVATMKLVKHPN 72
G+ +G G F+ AR+ +TG +A+K + + ++ E +++E+ M + HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++R+ + + +E++ GG + + +G KE Y +QL+ + Y H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 133 YHRDLKPENLLLDAYGN-LKVSDFGLSA-LSQQVRDDGLLH-TTCGTPNYVAPEVLNDRG 189
HRD+K NLL+D+ G L+++DFG +A L+ + G GT ++APEVL
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISAAEFT--CPPWLSFTARKL 244
Y G + D+WS G ++ + P++ N KI++A P LS R +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 245 IARILDPNPMTRITIPEILEDEWFK 269
R L+ P R E+L+ F+
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 8e-33
Identities = 82/272 (30%), Positives = 132/272 (48%), Gaps = 38/272 (13%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+KIL K +L+ + I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+++ K +++++EF+ GG++ ++ + E+E + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDD------------------------ 167
HRD+KP+NLLLD+ G++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 168 --------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L +T GTP+Y+APEV GY+ D WS GVI++ +L GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 220 MNLYKKIS--AAEFTCPPW--LSFTARKLIAR 247
YKK+ PP +S A+ LI R
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-33
Identities = 80/255 (31%), Positives = 132/255 (51%), Gaps = 11/255 (4%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ + + + IG G F++V A G PVALK + ++ K +E+ +K +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ Y ++ IVLE G+L I + + K E +YF QL +A++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ HSR V HRD+KP N+ + A G +K+ D GL H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERI 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA-- 241
++ GY+ +D+WS G +L+ + A PF D NL +L KKI ++ P ++
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 242 RKLIARILDPNPMTR 256
R+L+ ++P+P R
Sbjct: 238 RQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 83/278 (29%), Positives = 140/278 (50%), Gaps = 29/278 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKL 67
+ E+ IG G + V ++ TG VALKI+ + V I+REVA +
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV------SDIQREVALLSQ 55
Query: 68 VKH---PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
++ PN+ + Y +++I++E+ GG + ++ G + E ++++ A+
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL 114
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y H GV HRD+K N+L+ GN+K+ DFG++AL Q T GTP ++APEV
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEV 172
Query: 185 LND-RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----S 238
+ + + YD + AD+WS G+ ++ + G P+ D + I ++ PP L S
Sbjct: 173 ITEGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYS 228
Query: 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
R+ +A LD P R++ E+L+ +W K K PV
Sbjct: 229 KLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 79/263 (30%), Positives = 137/263 (52%), Gaps = 11/263 (4%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +++ + IG G F++V A +PVALK + +++ K + +E+ +K +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ + ++ IVLE G+L I + K E +YF QL +AV+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ HSR V HRD+KP N+ + A G +K+ D GL H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA-- 241
++ GY+ +D+WS G +L+ + A PF D NL +L +KI ++ P ++
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 242 RKLIARILDPNPMTRITIPEILE 264
R+L++ + P+P R I + +
Sbjct: 238 RELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 75/265 (28%), Positives = 135/265 (50%), Gaps = 16/265 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ + IG+G+F +V A + T + VA+K++D E+ E I++E+ + + P
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+ + Y +K++I++E+ GG D ++ G++ E ++++ ++Y H G
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL G++K++DFG+S Q+ +T GTP ++APEV+ GY
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----SFTARKLI 245
D AD+WS G+ L G P D + M + I PP L S + +
Sbjct: 176 D-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PPSLEGNKFSKPFKDFV 231
Query: 246 ARILDPNPMTRITIPEILEDEWFKK 270
+ L+ +P R + E+L+ ++ KK
Sbjct: 232 SLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-32
Identities = 73/249 (29%), Positives = 123/249 (49%), Gaps = 11/249 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ IG+G+F V A+K +D K + + E+ E + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSY 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSR 130
++R YE K K+ IV+E+ G+L + + ED+ R+F Q++ + + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+K NL LDAY N+K+ D G++ LS +T GTP Y++PE+ D+
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGTPYYLSPELCEDKP 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR--KLIAR 247
Y+ +D+W+ GV+L+ G PFD +N L KI F P ++ + +LI +
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQ 235
Query: 248 ILDPNPMTR 256
L + R
Sbjct: 236 CLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 71/189 (37%), Positives = 103/189 (54%), Gaps = 10/189 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
IGEGT+ V ARN TGE VALK LD E + RE++ +K + HPN+V+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 64
Query: 77 YEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
+V+ ++ K+++V EF+ + F + + Y QL+ + +CHS V HR
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 136 DLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
DLKP+NLL++ G +K++DFGL+ A VR H T Y APE+L Y +
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYSTA 181
Query: 195 ADLWSCGVI 203
D+WS G I
Sbjct: 182 VDIWSLGCI 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 68/216 (31%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+++ +GEG++ V A + ETG+ VA+K++ E+ L ++I +E++ +K P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-----QEIIKEISILKQCDSPY 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+V+ Y T ++IV+E+ G + D KI N + E+E Q + ++Y HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL+ G K++DFG+S Q +T GTP ++APEV+ + GY
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + AD+WS G+ + G P+ D + M I
Sbjct: 177 N-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 96/295 (32%), Positives = 141/295 (47%), Gaps = 49/295 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKL 67
KYE IGEGT+ V A+N ET E VALK + D E V + RE+ +K
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKE 55
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVD 125
+KH N+VRLY+V+ S K+ +V E+ + FD +G + + + + QL+ +
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLA 113
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV 184
+CHS V HRDLKP+NLL++ G LK++DFGL+ A VR T Y P+V
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDV 170
Query: 185 L-NDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKI-----SAAEFTCP--- 234
L + Y S D+WS G I L P F +++ + K+I + E + P
Sbjct: 171 LFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229
Query: 235 ---------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268
P L+ T R L+ +L NP+ RI+ E L+ +F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 67/200 (33%), Positives = 108/200 (54%), Gaps = 6/200 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + TG+ A K LDK+++ K K + E ++ V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYHRD 136
+K + +V+ + GG+L I N G EAR F Q+I +++ H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LKPEN+LLD +GN+++SD GL+ +++ + GTP Y+APEVL YD + D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176
Query: 197 LWSCGVILFVLLAGYLPFDD 216
++ G L+ ++AG PF
Sbjct: 177 WFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 84/332 (25%), Positives = 139/332 (41%), Gaps = 69/332 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+ + IG G + V A + TG VA+K I + L A++I RE+ ++ ++H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID--AKRILREIKLLRHLRH 58
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFD----KIVNHGRMKEDEARRYFQ-QL 120
N++ L +++ + ++IV E L + K++ + D+ +YF Q+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS V HRDLKP N+L+++ +LK+ DFGL A +D T YV
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL-ARGVDPDEDEKGFLT----EYV 167
Query: 181 ------APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------- 226
APE+ L+ Y + D+WS G I LL F + ++ I
Sbjct: 168 VTRWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226
Query: 227 -----------SAAEF-----TCPPWLSFT---------ARKLIARILDPNPMTRITIPE 261
A + P + A L+ ++L +P RIT E
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPK-KPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285
Query: 262 ILEDEWFKKDYKP---PVFEEK-KDTNLDDVE 289
L + + + P PV + DD E
Sbjct: 286 ALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDE 317
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 80/243 (32%), Positives = 113/243 (46%), Gaps = 46/243 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+T+G G F +V AR +T A+K L K+ VL +K E + + VVRL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y K ++ V++++ GG++ ++ G ED AR Y +L AV+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGL---------SALSQ---QVRDDG---------------- 168
+KP+N+L+D G++K++DFGL S Q VR D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL GY D WS GVIL+ +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 212 LPF 214
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKLV 68
YE IGEG + V AR+ TG VALK KV E I RE+A +K +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK-----KVRVPLSEEGIPLSTLREIALLKQL 55
Query: 69 K---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQ 118
+ HPN+VRL +V + K+ +V E V K G + + + +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMR 114
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTP 177
QL+ VD+ HS + HRDLKP+N+L+ + G +K++DFGL+ ++ + T+ T
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA----RIYSFEMALTSVVVTL 170
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL 207
Y APEVL Y + D+WS G I L
Sbjct: 171 WYRAPEVLLQSSY-ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 71/214 (33%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVAT 64
V KYE IG+GTF +V AR+ +T + VALK +++ EK A RE+
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA---LREIKI 64
Query: 65 MKLVKHPNVVRLYEVMGSKTK--------IFIVLEFVT---GGELFDKIVNHGRMKEDEA 113
++L+KH NVV L E+ +K ++V EF G L +K V + E
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEI 121
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHT 172
++ + L+N + Y H + HRD+K N+L+ G LK++DFGL+ A S +T
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 173 T-CGTPNYVAPEV-LNDRGYDGSTADLWSCGVIL 204
T Y PE+ L +R Y G D+W G I+
Sbjct: 182 NRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 81/252 (32%), Positives = 138/252 (54%), Gaps = 16/252 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V AR +G VA+K++D + K + E + EV M+ +H NVV +Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++++EF+ GG L D IV+ R+ E++ + ++ A+ Y HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
+++LL G +K+SDFG A Q +D + GTP ++APEV++ Y G+ D+W
Sbjct: 145 SDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIW 201
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKLIARILDPN 252
S G+++ ++ G P+ + + K++ + PP L S R + R+L
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKNAHKISPVLRDFLERMLTRE 258
Query: 253 PMTRITIPEILE 264
P R T E+L+
Sbjct: 259 PQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 87/308 (28%), Positives = 130/308 (42%), Gaps = 63/308 (20%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-------R 60
R V +YE I EGT+ V AR+ +TGE VALK K KM ++ + R
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLR 53
Query: 61 EVATMKLVKHPNVVRLYE-VMGSK-TKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYF 117
E+ + ++HPN+V + E V+GS KI++V+E+V +L + + E +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
QL++ V + H + HRDLK NLLL+ G LK+ DFGL+ T
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-------YTQ 165
Query: 178 N-----YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------ 226
Y APE+L + D+WS G I LL F + ++ KI
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT 225
Query: 227 ---------------SAAEFTCPPW-----------LSFTARKLIARILDPNPMTRITIP 260
FT P+ LS L+ R+L +P RI+
Sbjct: 226 PTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE 285
Query: 261 EILEDEWF 268
+ L+ +F
Sbjct: 286 DALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 87/281 (30%), Positives = 133/281 (47%), Gaps = 34/281 (12%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLV 68
G +E+ IGEGT+ KV AR+ +TG+ VA+KI+D + E+IK E + K
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 69 KHPNVVRLYEV------MGSKTKIFIVLEFVTGG---ELFDKIVNHG-RMKEDEARRYFQ 118
HPN+ Y G+ ++++V+E GG +L + G R+KE+ +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + + Y H V HRD+K +N+LL +K+ DFG+SA Q G +T GTP
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPY 178
Query: 179 YVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFT 232
++APEV+ D YD + +D+WS G+ L G P D + M L+K
Sbjct: 179 WMAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--- 234
Query: 233 CPPWLSFTAR------KLIARILDPNPMTRITIPEILEDEW 267
PP L I+ L N R + E+LE +
Sbjct: 235 -PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 83/258 (32%), Positives = 137/258 (53%), Gaps = 18/258 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A TG+ VA+K +D + K + E + EV M+ H NVV +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ Y H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
+++LL + G +K+SDFG A +S++V L GTP ++APEV++ Y G+ D+
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---VGTPYWMAPEVISRLPY-GTEVDI 201
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKLIARILDP 251
WS G+++ ++ G P+ + + ++I PP + S R + +L
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDLMLVR 258
Query: 252 NPMTRITIPEILEDEWFK 269
P R T E+L+ + K
Sbjct: 259 EPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 75/243 (30%), Positives = 112/243 (46%), Gaps = 46/243 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+T+G G F +V A +T A+K L K+ VL +K E + + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y K ++ V++++ GG++ ++ E AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGL---------SALSQQ---VRDDG---------------- 168
+KP+N+L+D G++K++DFGL S Q+ +R D
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL +GY D WS GVILF +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 212 LPF 214
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 74/266 (27%), Positives = 124/266 (46%), Gaps = 24/266 (9%)
Query: 14 EVGRTIGEGTFAKVK----FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
E+G+ +GEG F +V T VA+K L + + + E+ E + MK +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER--EEFLEEASIMKKLS 59
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+VRL V ++IV E++ GG+L D + HG + + + Q+ ++Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVL 185
S+ HRDL N L+ +K+SDFG LS+ + +D G ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFG---LSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 186 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-----AAEFTCPPWLSF 239
D + S +D+WS GV+L+ + G P+ + + + + CP L
Sbjct: 177 KDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL-- 233
Query: 240 TARKLIARILDPNPMTRITIPEILED 265
+L+ + +P R T E++ED
Sbjct: 234 --YELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 84/272 (30%), Positives = 138/272 (50%), Gaps = 25/272 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKH 70
+E+ +G+G F KV A+N ETG A K+++ E+ L+ M E + + H
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE-----IEILATCNH 68
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHS 129
P +V+L K++I++EF GG + ++ R + E + + +Q++ A+ Y HS
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQVRDDGLLHTTCGTPNYVAPEV-- 184
+ HRDLK N+LL G++K++DFG+SA + Q RD + GTP ++APEV
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVM 183
Query: 185 ---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLS 238
+ D YD AD+WS G+ L + P + N M + KI+ +E + P S
Sbjct: 184 CETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242
Query: 239 FTARKLIARILDPNPMTRITIPEILEDEWFKK 270
R + LD +P TR + ++LE +
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 74/243 (30%), Positives = 126/243 (51%), Gaps = 12/243 (4%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKHPNV 73
G+ +G+G F +V + +TG +A K + D E K ++ E+ +K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 74 VRLYEVM---GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
V+ Y + KT + I +E++ GG + D++ +G + E R+Y +Q++ + Y HS
Sbjct: 67 VQYYGCLRDRAEKT-LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLNDRG 189
+ HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT---ARKLIA 246
Y G AD+WS G + +L P+ + M KI A + T P S AR +
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-ATQPTNPQLPSHISEHARDFLG 243
Query: 247 RIL 249
I
Sbjct: 244 CIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 94/308 (30%), Positives = 139/308 (45%), Gaps = 53/308 (17%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R V ++E IGEGT+ V AR++ +GE VALK + + + + RE+ +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLN 62
Query: 68 VKHPNVVRLYEVMGSK--TKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
++HPN+V L EV+ K IF+V+E+ L D + E + + QL+
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQVKCLMLQLLRG 120
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----- 178
+ Y H + HRDLK NLLL G LK++DFGL+ L TP
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG-------LPAKPMTPKVVTLW 173
Query: 179 YVAPEVL-NDRGYDGSTADLWSCGVILFVLLAG--YLP----FDDSNLM---------NL 222
Y APE+L Y + D+W+ G IL LLA LP + +L+ ++
Sbjct: 174 YRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232
Query: 223 YKKIS----AAEFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEW 267
+ S +FT P PWLS +L+ +L +P R T E LE +
Sbjct: 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292
Query: 268 FKKDYKPP 275
FK+ KP
Sbjct: 293 FKE--KPL 298
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 22/201 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL---DKEKVLKHKMAEQIKREVATMKLV 68
YE+ + IG GT+ V AR+ TGE VA+K++ + E I++E++ +K
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF------EIIQQEISMLKEC 57
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYC 127
+HPN+V + + K++IV+E+ GG L D V G + E + ++ + + Y
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL---SQQVRDDGLLHTTCGTPNYVAPEV 184
H G HRD+K N+LL G++K++DFG+SA + R + GTP ++APEV
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK-----SFIGTPYWMAPEV 172
Query: 185 LNDR---GYDGSTADLWSCGV 202
GYDG D+W+ G+
Sbjct: 173 AAVERKGGYDGK-CDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 72/244 (29%), Positives = 129/244 (52%), Gaps = 8/244 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKH 70
+ +G+ +G+G F +V +++TG +A+K + D E K ++ E+ +K + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 71 PNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+V+ Y + + + I +E + GG + D++ ++G + E+ R+Y +Q++ V Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLND 187
S + HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPPWLSFTARKLI 245
GY G AD+WS G + +L P+ + M KI+ PP +S R +
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 246 ARIL 249
RI
Sbjct: 243 KRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 77/255 (30%), Positives = 128/255 (50%), Gaps = 8/255 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y V R +GEG+F + ++ + + A+K + K E ++E + +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRM-KEDEARRYFQQLINAVDYCHS 129
N+V E + ++IV+E+ GG+L KI + G++ ED ++F Q+ V + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ V HRD+K +N+ L G +K+ DFG + L T GTP YV PE+ +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248
Y+ + +D+WS G IL+ L PF ++ NL K+ + P S+ R LI ++
Sbjct: 177 YN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 249 LDPNPMTRITIPEIL 263
NP +R + IL
Sbjct: 236 FKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 5e-30
Identities = 66/220 (30%), Positives = 120/220 (54%), Gaps = 6/220 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKH 70
+ +G+ +G G F +V +++TG +A+K + D + K ++ E+ +K ++H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 71 PNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+V+ Y + K+ I +E++ GG + D++ +G + E+ RRY +Q++ V Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLND 187
S + HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
GY G AD+WS + +L P+ + M KI+
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 73/201 (36%), Positives = 114/201 (56%), Gaps = 11/201 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REVATMKLVKH---PNVV 74
IG G F +V R ++TG+ A+K LDK+++ K K E + E + LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ + K+ +L+ + GG+L + HG E E R Y ++I +++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-RGYDGS 193
RDLKP N+LLD +G++++SD GL+ + + H + GT Y+APEVL YD S
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-S 175
Query: 194 TADLWSCGVILFVLLAGYLPF 214
+AD +S G +LF LL G+ PF
Sbjct: 176 SADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 76/221 (34%), Positives = 119/221 (53%), Gaps = 18/221 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKI-LDKEKVLKHKMAEQIK-REVATMKLVK 69
KYE +GEG++ V ++ ETG+ VA+K L+ E KM ++I RE+ +K ++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED---DKMVKKIAMREIRMLKQLR 58
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H N+V L EV K ++++V EFV L D + E R+Y Q++ +++CHS
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVL- 185
+ HRD+KPEN+L+ G +K+ DFG + A +V D + T Y APE+L
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELLV 173
Query: 186 NDRGYDGSTADLWSCGVILFVLLAG--YLPFDDSNLMNLYK 224
D Y G D+W+ G ++ +L G P DS++ LY
Sbjct: 174 GDTKY-GRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 81/256 (31%), Positives = 137/256 (53%), Gaps = 29/256 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-----L 67
+E+ + IG G F +V + TG+ A+KIL+K ++LK + E A + L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK-------RAETACFREERDVL 55
Query: 68 VKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAV 124
V + L+ + +++V+++ GG+L + R+ ED AR Y +++ A+
Sbjct: 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAP 182
D H G HRD+KP+N+LLD G+++++DFG S L ++ DG + + GTP+Y++P
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISP 172
Query: 183 EVL----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW 236
E+L + +G G D WS GV ++ +L G PF +L+ Y KI + F PP
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232
Query: 237 ---LSFTARKLIARIL 249
+S A+ LI R++
Sbjct: 233 VTDVSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 71/200 (35%), Positives = 112/200 (56%), Gaps = 9/200 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REVATMKLVKH---PNVV 74
IG G F +V R ++TG+ A+K LDK+++ K K E + E + LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ + K+ +L+ + GG+L + HG E E R Y ++I +++ H+R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKP N+LLD +G++++SD GL+ + + H + GT Y+APEVL S+
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSS 176
Query: 195 ADLWSCGVILFVLLAGYLPF 214
AD +S G +LF LL G+ PF
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 73/212 (34%), Positives = 119/212 (56%), Gaps = 12/212 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEGT+ V RN +TG+ VA+K + E + + I RE++ +K ++HPN+V L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-REISLLKELQHPNIVCLQD 66
Query: 79 VMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
V+ +++++++ EF++ + D + M + + Y Q++ + +CHSR V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHT-TCGTPNYVAPEVLNDRGYDGST 194
LKP+NLL+D G +K++DFGL+ A VR ++T T Y APEVL +
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 195 ADLWSCGVILFVLLAGYLPF--DDSNLMNLYK 224
D+WS G I F +A P DS + L++
Sbjct: 183 VDIWSIGTI-FAEMATKKPLFHGDSEIDQLFR 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 78/266 (29%), Positives = 137/266 (51%), Gaps = 13/266 (4%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K++ ++E IG+G V A + TG+ VA+K ++ ++ K E I E+ M+
Sbjct: 18 KKKYTRFE---KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMR 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
KHPN+V + ++++V+E++ GG L D +V M E + ++ + A+++
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HS V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---AEFTCPPWLSFTARK 243
+ Y G D+WS G++ ++ G P+ + N + I+ E P LS R
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247
Query: 244 LIARILDPNPMTRITIPEILEDEWFK 269
+ R L+ + R + E+L+ + K
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 18/263 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A +G+ VA+K +D + K + E + EV M+ +H NVV +Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
+++LL G +K+SDFG A +S++V L GTP ++APE+++ Y G D+
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPELISRLPY-GPEVDI 199
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKLIARILDP 251
WS G+++ ++ G P+ + + K I PP L S + + + R+L
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPKLKNLHKVSPSLKGFLDRLLVR 256
Query: 252 NPMTRITIPEILEDEWFKKDYKP 274
+P R T E+L+ + K P
Sbjct: 257 DPAQRATAAELLKHPFLAKAGPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 25/263 (9%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
G+ +GEG F +V + + VA+K L ++ + E+ RE M+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
NVV+L V + ++IV+E++ GG+L + + ++ + + Q+ ++Y S+
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL N L+ +K+SDFG LS+ + DD G P ++APE L +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFG---LSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 189 GYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-----TCPPWLSFTA 241
+ ++ D+WS GV+L+ + G P+ + + + + CPP L
Sbjct: 179 KF--TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPEL---- 232
Query: 242 RKLIARILDPNPMTRITIPEILE 264
L+ + +P R T E++E
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 25/266 (9%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +GEG F +V + VA+K L ++ + + + +E MK + HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNV 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLI-------NAV 124
VRL V + +++VLE++ GG+L D + + + + L+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---A 181
+Y S+ HRDL N L+ +K+SDFG LS+ V DD G + A
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFG---LSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 182 PEVLNDRGYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLS 238
PE L D + ++ D+WS GV+L+ + G P+ + + + + P +
Sbjct: 176 PESLKDGIF--TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCP 233
Query: 239 FTARKLIARILDPNPMTRITIPEILE 264
+L+ +P R T E++E
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 81/263 (30%), Positives = 132/263 (50%), Gaps = 18/263 (6%)
Query: 31 RNSETGEPVALKILD-KEKVL-------KHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82
RN T VA + D KEKV+ + A + E+ + H +V+ ++ S
Sbjct: 77 RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136
Query: 83 KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K+ +++E+ +GG+L +I H +E E F Q++ A+D HSR + HRDLK
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
N+ L G +K+ DFG S S V D + + CGTP Y+APE+ + Y AD+
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPELWERKRYS-KKADM 254
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTR 256
WS GVIL+ LL + PF + + +++ ++ P +S + L+ +L NP R
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALR 314
Query: 257 ITIPEILEDEWFKKDYKPPVFEE 279
T ++L E+ K Y +F++
Sbjct: 315 PTTQQLLHTEFLK--YVANLFQD 335
|
Length = 478 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 73/249 (29%), Positives = 132/249 (53%), Gaps = 15/249 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + + A+KIL+K ++LK + E + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ + +++V+++ GG+L + R+ ED AR Y +++ A+D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVL---- 185
HRD+KP+N+L+D G+++++DFG S L ++ +DG + ++ GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPW---LSFT 240
+ +G G D WS GV ++ +L G PF +L+ Y KI F P +S
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 241 ARKLIARIL 249
A+ LI R++
Sbjct: 240 AKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 82/262 (31%), Positives = 130/262 (49%), Gaps = 23/262 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR----EVATMKL 67
KY + R +G G V A+ GEP A+K++D E M+E K EV +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-----MSEADKNRAQAEVCCLLN 87
Query: 68 VKHPNVVRLYEVMGSKTK--------IFIVLEFVTGGELFDKIVNHGR----MKEDEARR 115
++V+ +E K I +VL++ G+L +I + + +E EA
Sbjct: 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
F Q++ AV + HS+ + HRD+K N+LL + G +K+ DFG S + D + T CG
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CP 234
TP YVAPE+ + Y AD++S GV+L+ LL PFD N+ + K A + P
Sbjct: 208 TPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266
Query: 235 PWLSFTARKLIARILDPNPMTR 256
P +S ++++ +L +P R
Sbjct: 267 PSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 70/264 (26%), Positives = 122/264 (46%), Gaps = 26/264 (9%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
G+ +GEG F +V VA+K L ++ + E+ RE M+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
N+V+L V + + IV+E++ GG+L D + + + + + Q+ ++Y S
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLND 187
+ HRDL N L+ +K+SDFG LS+ + DD G P ++APE L +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFG---LSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 188 RGYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-----TCPPWLSFT 240
+ ++ D+WS GV+L+ + G P+ + + + + CPP L
Sbjct: 179 GKF--TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL--- 233
Query: 241 ARKLIARILDPNPMTRITIPEILE 264
KL+ + +P R T E++E
Sbjct: 234 -YKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 75/249 (30%), Positives = 129/249 (51%), Gaps = 15/249 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + T A+KIL+K ++LK + E +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ + +++V+++ GG+L + R+ ED AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVL---- 185
HRD+KP+N+LLD G+++++DFG S L ++ DG + ++ GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCL--KMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPWL---SFT 240
+ G G D WS GV ++ +L G PF +L+ Y KI E F P + S
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 241 ARKLIARIL 249
A+ LI R++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 79/266 (29%), Positives = 139/266 (52%), Gaps = 13/266 (4%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K++ +YE IG+G V A + TG+ VA+K ++ +K K ++ I E+ MK
Sbjct: 18 KKKYTRYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMK 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+K+PN+V + ++F+V+E++ GG L D +V M E + ++ + A+++
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEF 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H+ V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARK 243
+ Y G D+WS G++ ++ G P+ + N + I+ E P LS R
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247
Query: 244 LIARILDPNPMTRITIPEILEDEWFK 269
+ R L+ + R + E+L+ + K
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 5e-28
Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 10/261 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA+K ++ ++ K ++ I E+ M+ K+P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKNP 76
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+D+ HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIARI 248
G D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252
Query: 249 LDPNPMTRITIPEILEDEWFK 269
L+ + R + E+L+ + K
Sbjct: 253 LEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 85/282 (30%), Positives = 144/282 (51%), Gaps = 29/282 (10%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKH 70
+E+ +G+G F KV A+N ETG A K++D E+ L+ M E + + H
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVE-----IDILASCDH 61
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHS 129
PN+V+L + + ++I++EF GG + ++ R + E + R +Q + A++Y H
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV--RDDGLLHTTCGTPNYVAPEVL-- 185
+ HRDLK N+L G++K++DFG+SA + + R D + GTP ++APEV+
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMC 177
Query: 186 ---NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
DR YD AD+WS G+ L + P + N M + KI+ +E PP L+ +R
Sbjct: 178 ETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTLAQPSR 233
Query: 243 ------KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
+ + L+ N R T ++L+ + + P+ E
Sbjct: 234 WSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRE 275
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-27
Identities = 73/263 (27%), Positives = 126/263 (47%), Gaps = 11/263 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVK 69
+Y + + +G+G+F V ++ + LK+L + V L Q +E + +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVD 125
HP +V+ + + I+ E+ G +L K+ + E++ +F QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H R + HRDLK +N+ L LK+ DFG+S L D L T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEAL 177
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKL 244
+GYD S +D+WS G IL+ + F+ N +++ +I + P S +
Sbjct: 178 KHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236
Query: 245 IARILDPNPMTRITIPEILEDEW 267
+ +L+ +P R + EIL + +
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 81/303 (26%), Positives = 135/303 (44%), Gaps = 68/303 (22%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK-LVK 69
Y++ IGEGTF++V A++ +TG+ A+K + K K EQ+ RE+ ++ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 70 HPNVVRLYEVM-----GSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINA 123
HPN++RL EV+ G +F +++ L++ I R + E + Y QL+ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV--- 180
+D+ H G++HRD+KPEN+L+ LK++DFG S P Y
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SC-----------RGIYSKPPYTEYI 159
Query: 181 ------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---------------- 218
APE L GY G D+W+ G + F +L+ + F +N
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD 219
Query: 219 --LMNLYKKISAAEFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILED 265
++ ++K + P P S L+ ++L +P RIT + L
Sbjct: 220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279
Query: 266 EWF 268
+F
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 10/261 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA++ ++ ++ K E I E+ M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIARI 248
G D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 249 LDPNPMTRITIPEILEDEWFK 269
LD + R + E+L+ ++ K
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-27
Identities = 79/264 (29%), Positives = 134/264 (50%), Gaps = 15/264 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T E VA+KI+D E+ E I++E+ + P + R Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G ++E ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADL 197
N+LL G++K++DFG++ Q+ D + T GTP ++APEV+ YD AD+
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPNP 253
WS G+ L G P D + M + I PP L S ++ + L+ +P
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVLFLIPK---NSPPTLEGQYSKPFKEFVEACLNKDP 241
Query: 254 MTRITIPEILEDEWFKKDYKPPVF 277
R T E+L+ ++ + K F
Sbjct: 242 RFRPTAKELLKHKFITRYTKKTSF 265
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 69/227 (30%), Positives = 113/227 (49%), Gaps = 9/227 (3%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLK-HKMAEQIKREVATMKLVKHPN 72
G +G+G + V + + G+ +A+K LD VL K E+++ EV +K +KH N
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V+ I I +EFV GG + + G + E +Y +Q+++ V Y H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 133 YHRDLKPENLLLDAYGNLKVSDFG----LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
HRD+K N++L G +K+ DFG L+ + +L + GTP ++APEV+N+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
GY G +D+WS G +F + G P + + I A P
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 76/267 (28%), Positives = 122/267 (45%), Gaps = 24/267 (8%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G V + TG+ +A+K + E + + +QI RE+ + P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI--VNHGRMKEDEARRYFQQLINAVDYCHS-RGVY 133
Y + I I +E++ GG L DKI GR+ E + ++ + Y H +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
HRD+KP N+L+++ G +K+ DFG+S Q V + L T GT +Y+APE + Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS--GQLV--NSLAKTFVGTSSYMAPERIQGNDYSVK 179
Query: 194 TADLWSCGVILFVLLAGYLPFDDSN-----LMNLYKKISAAEFTCPPWL-----SFTARK 243
+D+WS G+ L L G P+ N + L + I PP L S +
Sbjct: 180 -SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLPSGKFSPDFQD 235
Query: 244 LIARILDPNPMTRITIPEILEDEWFKK 270
+ L +P R + E+LE + KK
Sbjct: 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 80/260 (30%), Positives = 134/260 (51%), Gaps = 15/260 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADL 197
N+LL G++K++DFG++ Q+ D + T GTP ++APEV+ YD S AD+
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPNP 253
WS G+ L G P D + M + I PP L S ++ I L+ +P
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFIDACLNKDP 241
Query: 254 MTRITIPEILEDEWFKKDYK 273
R T E+L+ ++ K+ K
Sbjct: 242 SFRPTAKELLKHKFIVKNAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 93/296 (31%), Positives = 140/296 (47%), Gaps = 48/296 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YE IGEGT+ V AR+ T E +ALK + E+ + + I RE++ +K ++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHG 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR------YFQQLINAVD 125
N+VRL +V+ S+ ++++V E+ L + H D A+ Y Q++ +
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 126 YCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPE 183
YCHS V HRDLKP+NLL+D N LK++DFGL+ A VR H T Y APE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVV-TLWYRAPE 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKI--------------- 226
+L + + D+WS G I F + P DS + L+K
Sbjct: 174 ILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 227 SAAEF--TCPPW-----------LSFTARKLIARILDPNPMTRITIPEILEDEWFK 269
S ++ P W L L++++L +P RIT LE E+FK
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-27
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 15/216 (6%)
Query: 34 ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY-EVMGSKTKIFIVLEF 92
TG VA+K+L + + + +RE A + HPN+V L +F V E+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---N 149
V G L + + G + E R Q+++A+ H++G+ HRDLKP+N+++ G +
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 150 LKVSDFGLSALSQQVRDDGLLHTT-----CGTPNYVAPEVLNDRGYDGSTA--DLWSCGV 202
KV DFG+ L VRD + T GTP Y APE L RG + T DL++ G+
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL--RG-EPVTPNSDLYAWGL 177
Query: 203 ILFVLLAGYLPFDDSNLMN-LYKKISAAEFTCPPWL 237
I L G +++ LY+++S + + PPW+
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI 213
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 75/261 (28%), Positives = 133/261 (50%), Gaps = 17/261 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G + E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
N+LL +G +K++DFG++ Q++ + + GTP ++APEV+ YD S AD
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAYD-SKAD 183
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPN 252
+WS G+ L G P + + M + I PP L S ++ + L+
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNKE 240
Query: 253 PMTRITIPEILEDEWFKKDYK 273
P R T E+L+ ++ + K
Sbjct: 241 PSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 72/203 (35%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE IGEG++ V RN ETG+ VA+K + ++ + K+A RE+ +K +K
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA---LREIRMLKQLK 58
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPN+V L EV K K+ +V E+ L + N + E ++ Q + AV++CH
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVL-ND 187
HRD+KPEN+L+ G +K+ DFG + + DD +T T Y APE+L D
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRWYRAPELLVGD 175
Query: 188 RGYDGSTADLWSCGVILFVLLAG 210
Y G D+W+ G + LL G
Sbjct: 176 TQY-GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-26
Identities = 37/58 (63%), Positives = 46/58 (79%), Gaps = 1/58 (1%)
Query: 315 MNAFELISLSKGLNLGNLFDAEQDFKR-ETRFTSRCPANEIINKIEEAAKPLGFDVHK 371
+NAF+LISLS GL+L LF+ E+ K+ ETRFTSR PA+EII+K+EE AK LGF V K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 71/214 (33%), Positives = 110/214 (51%), Gaps = 24/214 (11%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVAT 64
KR V K+++ IGEGT+ +V AR+ +TGE VALK LD EK RE+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKI 59
Query: 65 MKLVKHPNVVRLYEVMGSKTK----------IFIVLEFVTG---GELFDKIVNHGRMKED 111
++ + H N+V L E++ K ++V E++ G L +V+ ED
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSED 116
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171
+ + +QL+ ++YCH + HRD+K N+LL+ G +K++DFGL+ L ++ +
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPY 174
Query: 172 TT-CGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 204
T T Y PE+L G D+WSCG IL
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 23/268 (8%)
Query: 13 YEVGRTIGEGTFAKV-KFARNSETGEPVALK-------ILDKEKVLKHKMAEQIKREVAT 64
Y V +G G F V K + + +ALK K+K + K I EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIV-NHGRMKEDEARRYFQQ 119
+K ++HPN+VR Y+ +++IV++ + G GE F+ + R E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 120 LINAVDYCH-SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ A+ Y H + + HRDL P N++L + ++DFG L++Q + + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG---LAKQKQPESKLTSVVGTIL 178
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y PE++ + Y G AD+W+ G IL+ + PF +N+++L KI A + P
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 239 FT--ARKLIARILDPNPMTRITIPEILE 264
++ +I L P+ R P+I++
Sbjct: 238 YSEDVTDVITSCLTPDAEAR---PDIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 78/260 (30%), Positives = 125/260 (48%), Gaps = 14/260 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG GT+ V ARN TGE A+K++ E + +Q E+ MK KH N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V + + K++I +EF GG L D G + E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV--LNDRGY 190
HRD+K N+LL G++K++DFG+SA Q + GTP ++APEV + +G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKL 244
D+W+ G+ L P D + M ++ + F PP L S +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PPKLKDKMKWSNSFHHF 244
Query: 245 IARILDPNPMTRITIPEILE 264
+ L NP R T ++L+
Sbjct: 245 VKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G DE R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD YG++++SD GL+ ++ + + GT Y+APEV+ + Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 78/238 (32%), Positives = 120/238 (50%), Gaps = 27/238 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMK-LVK 69
KYE+ + +G+G + V A + T E VALK I D + A++ RE+ ++ L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD--AQRTFREIMFLQELGD 65
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFD----KIVNHGRMKEDEARRYFQQLINAVD 125
HPN+V+L V+ ++ I L F E + ++ +++ R QL+ A+
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIMYQLLKALK 121
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTT--CGTPNYVAP 182
Y HS V HRDLKP N+LL++ +K++DFGL+ +LS+ + T T Y AP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 183 EVLNDRGYDGSTA-----DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
E+L GST D+WS G IL +L G F ++ +N +KI E PP
Sbjct: 182 EILL-----GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI--IEVIGPP 232
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 87/302 (28%), Positives = 134/302 (44%), Gaps = 54/302 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
YE IGEGT+ KV AR+ TG+ VALK K E I RE++ +++
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALK-----KTRLEMDEEGIPPTALREISLLQM 56
Query: 68 VKH-PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGR-----MKEDEARRY 116
+ +VRL +V + K +++V E++ +L + ++GR + + +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLS-ALSQQVRDDGLLHTTC 174
QL+ V +CH GV HRDLKP+NLL+D LK++D GL A S V+ H
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIV 173
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDS---NLMNLYKKI-SAA 229
T Y APEVL + + D+WS G I + F DS L++++K + +
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232
Query: 230 EFTCP-----------------------PWLSFTARKLIARILDPNPMTRITIPEILEDE 266
E P P LS L+ ++L +P RI+ L
Sbjct: 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292
Query: 267 WF 268
+F
Sbjct: 293 YF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 51/170 (30%), Positives = 92/170 (54%), Gaps = 2/170 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
I G F KV R + A+K++ K ++ M Q++ E + L K P +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+ S +++V+E++ GG++ + +G E+ A +Y ++ A+DY H G+ HRDLK
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
P+N+L+ G++K++DFGLS ++ + + + TP+ P+ R
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKVT--LNRELNMMDILTTPSMAKPKNDYSR 179
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G +E+ A Y +++ ++ H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD YG++++SD GL+ ++ + + GT Y+APEVLN++ Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY-TLS 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 8/201 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR-EVATMKLVKHPNVVRLY 77
+G+G F +V + TG+ A K LDK++ LK K E++ E ++ V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR-LKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRGVYHR 135
SKT + +V+ + GG+L I N G + R Y Q+ + + HS + +R
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
D+KPEN+LLD GN ++SD GL+ +++D + GT Y+APE+L + Y
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV- 175
Query: 196 DLWSCGVILFVLLAGYLPFDD 216
D ++ G ++ ++AG PF D
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 91/325 (28%), Positives = 151/325 (46%), Gaps = 50/325 (15%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKHP 71
Y+ IGEG + V A + TG VA+K K +H+ ++ RE+ ++ KH
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK---KISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 72 NVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ + +++ + ++IV E + +L+ K++ + D + + Q++ + Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKY 121
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEV- 184
HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D G L T Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 185 LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF---DDSNLMNLYKKI----SAAEFTC--- 233
LN +GY + A D+WS G IL +L+ F D + +NL + S + C
Sbjct: 182 LNSKGY--TKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239
Query: 234 ----------P-----PWLSF------TARKLIARILDPNPMTRITIPEILEDEWFKKDY 272
P PW A L+ ++L NP RIT+ E L + ++ +
Sbjct: 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299
Query: 273 KP---PVFEEKKDTNLDDVEAVFKD 294
P PV EE + + + + K+
Sbjct: 300 DPSDEPVAEEPFPFDFELFDDLPKE 324
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 67/196 (34%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
K+EV +GEG + V R+ ET E VA+K K+ ++ E RE+ ++ +K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
N+V L E + K+++V E+V EL +++ N + ++ R Y QLI A+ +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRD+KPENLL+ LK+ DFG + LS+ + T Y +PE+L
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG--SNANYTEYVATRWYRSPELLLGA 176
Query: 189 GYDGSTADLWSCGVIL 204
Y G D+WS G IL
Sbjct: 177 PY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 76/229 (33%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHP 71
+E+ TIG+GT+ KV N + G A+KILD H + E+I+ E +K L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP----IHDIDEEIEAEYNILKALSDHP 75
Query: 72 NVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKI---VNHG-RMKEDEARRYFQQLIN 122
NVV+ Y + K ++++VLE GG + D + + G RM+E + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ + H HRD+K N+LL G +K+ DFG+SA R +T+ GTP ++AP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAP 193
Query: 183 EVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
EV+ D YD + D+WS G+ L G P D + M KI
Sbjct: 194 EVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 20/200 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEG++A V R+ TG+ VALK E L+H+ RE + +K +KH N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK----EIRLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ +K + +V E++ +L + + G + R + QL+ + YCH R V HR
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL+ G LK++DFGL A ++ V + T Y P+VL GST
Sbjct: 128 DLKPQNLLISERGELKLADFGL-ARAKSVPSKTYSNEVV-TLWYRPPDVLL-----GSTE 180
Query: 196 -----DLWSCGVILFVLLAG 210
D+W G I + + G
Sbjct: 181 YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 83/332 (25%), Positives = 149/332 (44%), Gaps = 52/332 (15%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + +V A +++TG VA+K L + + H A++ RE+ +K + H
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH--AKRTYRELRLLKHMDH 73
Query: 71 PNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V + +++V + G +L + IV ++ +D + Q++ +
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGL 131
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y HS G+ HRDLKP N+ ++ LK+ DFGL+ + D + T Y APE+
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEI 186
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------------------ 226
+ + + T D+WS G I+ LL G F S+ ++ K+I
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246
Query: 227 SAAEF--TCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273
SA + + P + A L+ ++L +P RIT E L + + +
Sbjct: 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306
Query: 274 P---PVFEEKKDTNLDDVE-AVFKDSEVCWME 301
P PV D + + + V + E+ + E
Sbjct: 307 PEDEPV-APPYDQSFESRDLTVDEWKELVYKE 337
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 86/293 (29%), Positives = 127/293 (43%), Gaps = 35/293 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMKLVK 69
K +GEG V R TG ALK I K QI RE+ K K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK---QILRELEINKSCK 57
Query: 70 HPNVVRLYE--VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-------RYFQQL 120
P +V+ Y + S + I I +E+ GG L D I + ++K+ R + + +
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSI--YKKVKKRGGRIGEKVLGKIAESV 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HSR + HRD+KP N+LL G +K+ DFG+S + V + L T GT Y+
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELV--NSLAGTFTGTSFYM 170
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--------NLMNLYKKISAAEFT 232
APE + + Y T+D+WS G+ L + PF L++ + E
Sbjct: 171 APERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229
Query: 233 CPP-----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEK 280
P W S + I + L+ +P R T ++LE W K K V K
Sbjct: 230 DEPGNGIKW-SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAK 281
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 3e-23
Identities = 78/267 (29%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 19 IGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+GT+ V AR+ T +A+K D V + + E+A +KH N+V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV------QPLHEEIALHSYLKHRNIVQ 69
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEA--RRYFQQLINAVDYCHSRGV 132
I +E V GG L + + G +K++E Y +Q++ + Y H +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 133 YHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RG 189
HRD+K +N+L++ Y G +K+SDFG S + + T GT Y+APEV++ RG
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTS--KRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC---------PPWLSFT 240
Y G+ AD+WS G + + G PF + + AA F P LS
Sbjct: 188 Y-GAPADIWSLGCTIVEMATGKPPFIE------LGEPQAAMFKVGMFKIHPEIPESLSAE 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEW 267
A+ I R +P+P R + ++L+D +
Sbjct: 241 AKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-23
Identities = 79/260 (30%), Positives = 126/260 (48%), Gaps = 16/260 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ + +G GT+ V ARN TGE A+KI+ E + I++E+ +K KH N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKHCN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V + S+ K++I +E+ GG L D G + E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL---NDRG 189
HRD+K N+LL G++K++DFG++A + + GTP ++APEV + G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARK 243
Y+ D+W+ G+ L P D + M +S + F PP L S T
Sbjct: 186 YN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-PPKLKDKTKWSSTFHN 243
Query: 244 LIARILDPNPMTRITIPEIL 263
+ L NP R T +L
Sbjct: 244 FVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-23
Identities = 75/242 (30%), Positives = 121/242 (50%), Gaps = 37/242 (15%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R+ +YEV + IG G F +V ++ T E K + + LK + Q+ EV M+ +
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMREL 69
Query: 69 KHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLIN 122
KH N+VR + +K K++I++EF G+L I G+++E +QL++
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 123 AVDYCHS-------RGVYHRDLKPENLLLDA-----------YGNL------KVSDFGLS 158
A+ YCH+ V HRDLKP+N+ L NL K+ DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+ + + + H+ GTP Y +PE+L + YD +D+W+ G I++ L +G PF
Sbjct: 190 ---KNIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPFHK 245
Query: 217 SN 218
+N
Sbjct: 246 AN 247
|
Length = 1021 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 8e-23
Identities = 75/249 (30%), Positives = 122/249 (48%), Gaps = 15/249 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + TG+ A K L+K+++ K K E E + V +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+KT + +V+ + GG+L I N + E A Y Q+I+ +++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
RDLKPEN+LLD GN+++SD GL+ Q + G GTP ++APE+L YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY----AGTPGFMAPELLQGEEYDF 176
Query: 193 STADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248
S D ++ GV L+ ++A PF + L ++I T P S ++ +
Sbjct: 177 SV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235
Query: 249 LDPNPMTRI 257
L +P R+
Sbjct: 236 LAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKL 67
+Y+ IG G + V A ++ +G+ VA+K K+ +A++ RE+ ++
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFV---TGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
KH N++ + +++ F + V +L I + + E+ R + QL+ +
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL--SALSQQVRDDGLLHTTCGTPNYVAP 182
Y HS V HRDLKP NLL++ L++ DFG+ S + T Y AP
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 183 EVLNDRGYDGSTA-DLWSCGVIL 204
E+L + +TA D+WS G I
Sbjct: 181 ELLLSLP-EYTTAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 74/273 (27%), Positives = 126/273 (46%), Gaps = 22/273 (8%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ T E VA+K + ++ + I +EV ++ ++HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 77 YEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ ++V+E+ G ++ + V+ ++E E + + Y HS H
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG-YD 191
RD+K N+LL G +K++DFG ++L ++ GTP ++APEV+ D G YD
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYD 192
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA-----RKLIA 246
G D+WS G+ L P + N M+ I+ + P LS R +
Sbjct: 193 GK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLSSNDWSDYFRNFVD 248
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L P R + E+L+ + ++ P V +
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVLRERPPTVIID 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 3e-22
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I + G +E R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD +G++++SD GL+ V + + GT Y+APEV+ + Y S
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W+ G +L+ ++AG PF
Sbjct: 182 PDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 67/224 (29%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK E+ +K
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 70 HPNVVRLYEVM------GSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D + N +KED ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H+ V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 189
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
PEV+ D YD +D+WS G+ + G P D + M
Sbjct: 190 PEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 75/232 (32%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+E+ TIG+GT+ KV N + G A+KILD + E+I+ E ++ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77
Query: 70 HPNVVRLYEVMGSKTK-----IFIVLEFVTGG---ELFDKIVNHG-RMKEDEARRYFQQL 120
HPNVV+ Y + K +++VLE GG EL ++ G R+ E
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPN 178
+ + + H+ + HRD+K N+LL G +K+ DFG+SA S ++R + T+ GTP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPF 193
Query: 179 YVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYK 224
++APEV+ D YD + D+WS G+ L G P FD + L+K
Sbjct: 194 WMAPEVIACEQQYDYSYD-ARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 84/318 (26%), Positives = 144/318 (45%), Gaps = 53/318 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKL 67
+Y + +G G F V AR+ TG+ VA+K K++K +A++ RE+ +K
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-----KIMKPFSTPVLAKRTYRELKLLKH 65
Query: 68 VKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
++H N++ L ++ S I+ V E + G +++ +++ + + Q++ + Y
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKY 123
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-L 185
HS GV HRDLKP N+L++ +LK+ DFGL+ + Q + G + T Y APE+ L
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLKICDFGLARI-QDPQMTGYVSTR----YYRAPEIML 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----------- 234
+ YD D+WS G I +L G F + +N + I+ T P
Sbjct: 179 TWQKYD-VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237
Query: 235 --------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
+A L+ ++L +P RI+ E L + + P
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297
Query: 275 ---PVFEEKKDTNLDDVE 289
PV EEK D + +D +
Sbjct: 298 TDEPVAEEKFDWSFNDAD 315
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 77/312 (24%), Positives = 127/312 (40%), Gaps = 54/312 (17%)
Query: 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-----------REVA 63
G +GEGT+ KV+ A ++ TG+ VA+K + ++ ++ RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLIN 122
M +KH N++ L +V I +V++ + K+V+ R+ E + + Q++N
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILN 130
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPN- 178
++ H HRDL P N+ +++ G K++DFGL+ T
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 179 --------YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKI 226
Y APE+L D+WS G I LL G F N L +++ +
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250
Query: 227 SAAEFT-------CPPWLSFTARK-----------------LIARILDPNPMTRITIPEI 262
P + FT RK L+ +L NP+ RI+ E
Sbjct: 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310
Query: 263 LEDEWFKKDYKP 274
L+ E+FK D P
Sbjct: 311 LKHEYFKSDPLP 322
|
Length = 335 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 5e-22
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQ----IKREVATMKLV 68
+ +GEG F KV+ R TGE VA+K L H EQ +RE+ ++ +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFEREIEILRTL 63
Query: 69 KHPNVVRL----YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLIN 122
H N+V+ + G ++ ++E++ G L D + H R + + R + Q+
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRL--IMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICK 120
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
+DY S+ HRDL N+L+++ +K+SDFGL+ + + +D + +P + A
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLL 208
PE L + S +D+WS GV L+ L
Sbjct: 181 PECLRTSKFS-SASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 80/319 (25%), Positives = 132/319 (41%), Gaps = 58/319 (18%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLV 68
+Y R +G G+ V A +S+ + VA+K +L + +KH + RE+ ++ +
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-----REIKIIRRL 59
Query: 69 KHPNVVRLYEVMGSKTK--------------IFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
H N+V++YEV+G ++IV E++ ++ G + E+ AR
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHAR 117
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLS-ALSQQVRDDGLLHT 172
+ QL+ + Y HS V HRDLKP N+ ++ LK+ DFGL+ + G L
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 173 TCGTPNYVAPE-VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNL------ 222
T Y +P +L+ Y D+W+ G I +L G F ++ M L
Sbjct: 178 GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236
Query: 223 ----------------YKKISAAEFTCP-----PWLSFTARKLIARILDPNPMTRITIPE 261
+ + E P P ++ A + +IL NPM R+T E
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296
Query: 262 ILEDEWFKKDYKPPVFEEK 280
L + Y P E
Sbjct: 297 ALMHPYM-SCYSCPFDEPV 314
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 7e-22
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 19/276 (6%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
EV +G+G + V + TG +A+K + E L QI E+ + P +
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYI 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
V Y + +++ +E++ G +L+ V + ED RR ++ + +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 131 -GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL---- 185
+ HRD+KP N+L++ G +K+ DFG+S V L T G +Y+APE +
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVAS--LAKTNIGCQSYMAPERIKSGG 177
Query: 186 -NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFT 240
N +D+WS G+ + + G P+ N++ ++SA PP L S
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
A+ +A+ L+ P R T ++LE W K V
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV 273
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G DE R F +L ++ + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD G++++SD GL+ Q+ + + GT Y+APEV+N+ Y S
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKYTFS- 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-22
Identities = 71/253 (28%), Positives = 129/253 (50%), Gaps = 12/253 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNVV 74
R +G+G++ +V R+ G+ +K L+ + K AEQ E + +KHPN+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNIV 62
Query: 75 RLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRM-KEDEARRYFQQLINAVDYCHSRG 131
E G ++IV+ F GG+L+ K+ G++ E++ +F Q+ A+ Y H +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLK +N+ L +KV D G++ + + D + T GTP Y++PE+ +++ Y+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYN 180
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNL-YKKISAAEFTCPPWLSFTARKLIARILD 250
+D+W+ G ++ + F+ ++ +L Y+ I P S +LIA +L
Sbjct: 181 -YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239
Query: 251 PNPMTRITIPEIL 263
P R ++ IL
Sbjct: 240 KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVAT 64
++ YE+ +GEGTF +V AR +TG VALK K+L H + RE+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKI 60
Query: 65 MKLVKHPNVVRLYEVMGSKTK--------IFIVLEFVT---GGELFDKIVNHGRMKEDEA 113
+K +KHPNVV L ++ + +++V ++ G L + V + E +
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQI 117
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173
+ Y QL+ ++Y H + HRD+K N+L+D G LK++DFG L++
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG---LARPYDGPPPNPKG 174
Query: 174 CGTPN------------YVAPE-VLNDRGYDGSTADLWSCGVIL 204
G Y PE +L +R Y + D+W G +
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F +V R PVA+K + L + + +E +K HPN+VRL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V K I+IV+E V GG+ + G R+K E + + ++Y S+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YVAPEVLNDRGYDGS 193
N L+ LK+SDFG+S + +DG+ +T G + APE LN Y S
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNYGRYS-S 175
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMN 221
+D+WS G++L+ + G +P+ +NL N
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPY--ANLSN 202
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 4e-21
Identities = 68/224 (30%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK+E+ +K
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 70 HPNVVRLYEVM------GSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D I N +KE+ ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 179
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
PEV+ D YD +DLWS G+ + G P D + M
Sbjct: 180 PEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 14/265 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G+F V FA NS T E VA+K + ++ + I +EV ++ +KHPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+ ++V+E+ G V+ ++E E + + Y HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV---LNDRGYDGSTA 195
N+LL G +K++DFG ++ S ++ GTP ++APEV +++ YDG
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKV- 201
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPN 252
D+WS G+ L P + N M+ I+ + W + + R + L
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW-TDSFRGFVDYCLQKI 260
Query: 253 PMTRITIPEILEDEWFKKDYKPPVF 277
P R E+L ++ ++D V
Sbjct: 261 PQERPASAELLRHDFVRRDRPARVL 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 7e-21
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 48 KVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG 106
K++K K I+ V MK +PN ++LY + + ++++++ G+LFD + G
Sbjct: 47 KIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG 104
Query: 107 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSAL--SQQ 163
++ E E ++ +QL+ A++ H + H D+K EN+L D + + D+GL + +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164
Query: 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----- 218
D GT +Y +PE + YD S D W+ GV+ + LL G PF +
Sbjct: 165 CYD--------GTLDYFSPEKIKGHNYDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELD 215
Query: 219 ---LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258
L+ +K + +S A + +L N R+T
Sbjct: 216 LESLLKRQQK----KLPFIKNVSKNANDFVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-21
Identities = 65/195 (33%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALK----EIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ ++ + +V E++ +L + N G M + + QL+ + YCH R + HR
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL++ G LK++DFGL A ++ V + T Y P+VL +
Sbjct: 128 DLKPQNLLINEKGELKLADFGL-ARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPI 185
Query: 196 DLWSCGVILFVLLAG 210
D+W G IL+ + G
Sbjct: 186 DMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 9e-21
Identities = 86/338 (25%), Positives = 140/338 (41%), Gaps = 77/338 (22%)
Query: 13 YEVGRTIGEGTFAKVKFARNSET--GEPVALK----ILDKEKVLKHKMAEQIKREVATMK 66
YE+ + +G+G + V ARN+ET E VA+K + K+ + K + RE+ ++
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLLR 56
Query: 67 LVK-HPNVVRLYEVMGSKTKIFIVLEFVTGG---------ELFD----KIVNHGRMKEDE 112
+ H N+ LY+ ++ V G EL + +I+ G+ D
Sbjct: 57 HFRGHKNITCLYD-----------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDA 105
Query: 113 ARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ--QVRDDGL 169
+ F Q++ + Y HS V HRDLKP NLL++A LK+ DFGL+ + G
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 170 LHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAG------------------ 210
+ T Y APE+ L+ + Y + D+WS G IL LL
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224
Query: 211 YLPFDDSNLMNLYKKISAAEFT----CPPWLSFT---------ARKLIARILDPNPMTRI 257
L D ++ A + P F A L+ ++L +P RI
Sbjct: 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284
Query: 258 TIPEILE----DEWFKKDYKPPVFEEKKDTNLDDVEAV 291
++ E LE W D PV ++ D + + +++
Sbjct: 285 SVEEALEHPYLAIWHDPD-DEPVCQKPFDFSFESEDSM 321
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 73/205 (35%), Positives = 109/205 (53%), Gaps = 19/205 (9%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
+YE IGEG + KV AR+ + G VALK + + + + M REVA ++ ++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 70 --HPNVVRLYEV-----MGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQL 120
HPNVVRL++V +TK+ +V E V DK+ G + + + QL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQL 119
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-SQQVRDDGLLHTTCGTPNY 179
+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+ + S Q+ L + T Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWY 175
Query: 180 VAPEVLNDRGYDGSTADLWSCGVIL 204
APEVL Y + DLWS G I
Sbjct: 176 RAPEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 84/308 (27%), Positives = 134/308 (43%), Gaps = 58/308 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
KY + IG G + V A+NSET E VA+K + +++ A++ RE+ ++ + H
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN--AFDNRIDAKRTLREIKLLRHLDH 63
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFD----KIVNHGRMKEDEARRYF-QQL 120
NV+ + ++M + ++IV E L D +I+ + D+ +YF QL
Sbjct: 64 ENVIAIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLSDDHCQYFLYQL 117
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS V HRDLKP NLLL+A +LK+ DFGL+ + + + T Y
Sbjct: 118 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVTRWYR 175
Query: 181 APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPF-------------------DDSNLM 220
APE+ LN Y + D+WS G I LL F + +L
Sbjct: 176 APELLLNCSEY-TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234
Query: 221 NL--------------YKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 266
+ + S A P + A L+ ++L +P RIT+ E L
Sbjct: 235 FIRNEKARRYIRSLPYTPRQSFARLF--PHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292
Query: 267 WFKKDYKP 274
+ + P
Sbjct: 293 YLASLHDP 300
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 11/207 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-KMAEQIKREVATMKLVKH 70
+Y++ IG+G++ V A ++ TGE VA+K ++ V +H A +I RE+ ++L++H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND--VFEHVSDATRILREIKLLRLLRH 58
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
P++V + +M ++ I++V E + +L I + + + + + QL+ A+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEV 184
Y H+ V+HRDLKP+N+L +A LK+ DFGL+ ++ + T T Y APE+
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 185 LNDRGYDGSTA-DLWSCGVILFVLLAG 210
+ A D+WS G I +L G
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ YE +GEG++A V ++ G+ VALK++ ++ + RE + +K +
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGL 60
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
KH N+V L++++ +K + +V E+V + DK + G + + + + QL+ + Y
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSY 118
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG---TPNYVAPE 183
H R + HRDLKP+NLL+ G LK++DFGL A ++ V HT T Y P+
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGL-ARAKSVPS----HTYSNEVVTLWYRPPD 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
VL + D+W G I ++ G F
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 12/220 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + V A ++ + VA+K L + + L H A + RE+ +K +KH
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH--ARRTYRELRLLKHMKH 73
Query: 71 PNVVRLYEVMGSKTKI--FIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
NV+ L +V T I F + VT G + IV ++ ++ + QL+ + Y
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HS G+ HRDLKP N+ ++ L++ DFG L++Q D+ + T Y APE++
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFG---LARQADDE--MTGYVATRWYRAPEIML 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + T D+WS G I+ LL G F ++ ++ K+I
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 77/285 (27%), Positives = 130/285 (45%), Gaps = 22/285 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ T E VA+K + ++ + I +EV ++ +KHPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++V+E+ G V+ ++E E + + Y HS + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV---LNDRGYDGS 193
+K N+LL G +K++DFG ++++ ++ GTP ++APEV +++ YDG
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILD 250
D+WS G+ L P + N M+ I+ E W + R + L
Sbjct: 205 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF-RNFVDSCLQ 262
Query: 251 PNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDS 295
P R T E+L+ + V E+ +T L D+ KD+
Sbjct: 263 KIPQDRPTSEELLKHMF--------VLRERPETVLIDLIQRTKDA 299
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-20
Identities = 67/244 (27%), Positives = 107/244 (43%), Gaps = 34/244 (13%)
Query: 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81
G KV ++ T + LK L K + I V PN+V L++ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCV--------PNMVCLHKYIV 55
Query: 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141
S+ +F+VL+ GG+L+ I + E+ +R+ +++ A+D H G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 142 LLLDAYGNLKVSDFG-LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA--DLW 198
+LLD G+++++ F S + + + + C APEV G T D W
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEV---GGISEETEACDWW 166
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAA-----EFTCPPWLSFTARKLIARILDPNP 253
S G ILF LL G L + + P W+S AR L+ ++L NP
Sbjct: 167 SLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNP 217
Query: 254 MTRI 257
R+
Sbjct: 218 TERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-20
Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 16/237 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G G + V A + TG VA+K L + A++ RE+ +K +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHE 74
Query: 72 NVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V + ++V+ F+ G K++ H ++ ED + Q++ +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVI 187
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
+ + T D+WS G I+ +L G F + ++ +I + T P F +
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI--MKVTGTPSKEFVQK 242
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-- 69
+YE IG G + V AR+ +G VALK + + + + + REVA +K ++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 70 -HPNVVRLYEVMGS-----KTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLI 121
HPN+VRL +V + +TK+ +V E V DK+ G + + + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFL 118
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-SQQVRDDGLLHTTCGTPNYV 180
+D+ H+ + HRDLKPEN+L+ + G +K++DFGL+ + S Q+ ++ T Y
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YR 174
Query: 181 APEVLNDRGYDGSTADLWSCGVIL 204
APEVL Y + D+WS G I
Sbjct: 175 APEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ + + +V E++ +L + + G M + + Q++ + YCH R V HR
Sbjct: 70 HDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL++ G LK++DFGL A ++ V + T Y P+VL +
Sbjct: 129 DLKPQNLLINERGELKLADFGL-ARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQI 186
Query: 196 DLWSCGVILFVLLAGYLPFDDSNL 219
D+W G I F + +G F S +
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 71/265 (26%), Positives = 123/265 (46%), Gaps = 36/265 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++G TIG+G F V G+ VA+K L + A+ E + M ++HPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNL 62
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI-------NAVDY 126
V+L V+ ++IV E++ G L D + + GR A Q + ++Y
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEY 117
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVL 185
+ HRDL N+L+ KVSDFGL+ + Q +D G L P + APE L
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTAPEAL 171
Query: 186 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-----AEFTCPPWLSF 239
++ + + +D+WS G++L+ + + G +P+ L ++ + A CPP +
Sbjct: 172 REKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEV-- 228
Query: 240 TARKLIARILDPNPMTRITIPEILE 264
K++ + +P R T ++ E
Sbjct: 229 --YKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 57/232 (24%), Positives = 109/232 (46%), Gaps = 17/232 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + R +G G F +V VA+KIL + +LK + ++EV +K ++H +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQ-QLINAVDYCHSR 130
++ L+ V ++I+ E + G L + + G++ + Q+ + Y +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRG 189
HRDL N+L+ KV+DFGL+ L +++D L + P + APE +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA-----AEFTCPP 235
+ + +D+WS G++L+ + G +P+ N +Y +I+A CP
Sbjct: 181 FS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQ 231
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+GEG++A V + G+ VALK++ + + + RE + +K +KH N+V L++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
++ +K + V E++ +L ++ H G + R + QL+ + Y H + + HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 138 KPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
KP+NLL+ G LK++DFGL+ ++ Q ++ T Y P+VL S
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-----TLWYRPPDVLLGATDYSSA 184
Query: 195 ADLWSCGVILFVLLAG 210
D+W G I +L G
Sbjct: 185 LDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 77 YEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
++++ ++ + +V E++ + D N M + + QL+ ++YCH R V H
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--VKLFLFQLLRGLNYCHRRKVLH 127
Query: 135 RDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
RDLKP+NLL++ G LK++DFGL+ ++ + + ++ T Y P++L
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILLGSTDY 182
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNL 219
+ D+W G I + + G F S +
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 22/198 (11%)
Query: 19 IGEGTFAKVKFAR-NSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+G+F V+ ++ G+ PVA+K L +K+ + + +E A M + H N++R
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIR 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--------RYFQQLINAVDYC 127
LY V+ + + +V E G L D R+++D Y Q+ N + Y
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLD------RLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLN 186
S+ HRDL N+LL + +K+ DFGL Q D ++ P + APE L
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 187 DRGYDGSTADLWSCGVIL 204
R + +D+W GV L
Sbjct: 174 TRTFS-HASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 83/335 (24%), Positives = 146/335 (43%), Gaps = 56/335 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + V A +++TG VA+K L + + + H A++ RE+ +K +KH
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYRELRLLKHMKH 75
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V +++V + G + IV ++ +D + Q++ +
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y HS + HRDLKP NL ++ LK+ DFGL+ D + T Y APE+
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEI 188
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----SF 239
+ + + T D+WS G I+ LL G F ++ ++ K I T L S
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248
Query: 240 TARKLIARI------------LDPNPMT--------------RITIPEILEDEWFKKDYK 273
+AR I + + NP+ RIT + L +F + +
Sbjct: 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308
Query: 274 P---PVFE------EKKDTNLDDVEAVFKDSEVCW 299
P PV + E +D +D+ +++ D + +
Sbjct: 309 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISF 343
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 71/308 (23%), Positives = 135/308 (43%), Gaps = 53/308 (17%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +Y++ R IG+G +V A + VALK + ++ + ++ RE +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR------------RYF 117
HP +V +Y + ++ + ++ G L ++ KE ++ F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD---------G 168
++ ++Y HS+GV HRDLKP+N+LL +G + + D+G + + +D
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 169 LLHTT-------CGTPNYVAPEVLNDRGYDGS-TADLWSCGVILFVLLAGYLPF---DDS 217
+ +++ GTP+Y+APE L G S + D+++ GVIL+ +L P+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237
Query: 218 NLMNLYKKISAAEFT----CPPWLSFTARKLIARILDPNPMTRI-TIPEILED------- 265
+ +S E PP+LS ++ + L +P R ++ E+ +D
Sbjct: 238 KISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAERYSSVQELKQDLEPHLQG 293
Query: 266 --EWFKKD 271
EW K
Sbjct: 294 SPEWTVKA 301
|
Length = 932 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 10/217 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ E VA+K + ++ + I +EV ++ ++HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++V+E+ G V+ ++E E + + Y HS + HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV---LNDRGYDGS 193
+K N+LL G +K+ DFG +++ + GTP ++APEV +++ YDG
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230
D+WS G+ L P + N M+ I+ E
Sbjct: 195 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 15/221 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G G + V A + TGE VA+K L + A++ RE+ +K ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHE 74
Query: 72 NVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V S ++V+ ++ KI+ H + ED+ + Q++ +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGLK 131
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y HS G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTGYVVTRWYRAPEVI 186
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + T D+WS G I+ +L G F + ++ +I
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 72/260 (27%), Positives = 122/260 (46%), Gaps = 28/260 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V F + PVA+K ++ L ++ + E +K HPN+V+L
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD------YCHSRG 131
V + I+IV+E V GG+ + R K+DE + +QL+ A+D Y S+
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESKN 113
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YVAPEVLND 187
HRDL N L+ LK+SDFG+S ++D ++++ G + APE LN
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 188 RGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245
Y S +D+WS G++L+ + G P+ +++ +CP K++
Sbjct: 169 GRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVM 227
Query: 246 ARILDPNPMTRITIPEILED 265
R D P R E+ ++
Sbjct: 228 QRCWDYKPENRPKFSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA-EQIKREVATMKLVKHPNVVR 75
R IG G F V + G+ VALK + V ++ ++ +++ RE+ + KH NV+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKM--PNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 76 LYEVM-----GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+++ +I++V E + +L IV+ + D + + Q++ + Y HS
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA 122
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVLNDR 188
G+ HRD+KP NLL+++ LK+ DFGL+ + + D H T T Y APE+L
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP---DESKHMTQEVVTQYYRAPEILMGS 179
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSN 218
+ S D+WS G I LL + F +
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 73/273 (26%), Positives = 115/273 (42%), Gaps = 51/273 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKIL-------DKEKVLKHKMAEQIKREVATMKLVK 69
IG+G F V E VA+K K K L+ E +K
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQ---------EAEILKQYD 50
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDE--ARRYFQQLINA---V 124
HPN+V+L V K I+IV+E V GG L + R K++ ++ Q ++A +
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSL----LTFLRKKKNRLTVKKLLQMSLDAAAGM 106
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YV 180
+Y S+ HRDL N L+ LK+SDFG+S + + G+ + G +
Sbjct: 107 EYLESKNCIHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWT 162
Query: 181 APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYK--------KISAAEF 231
APE LN Y S +D+WS G++L+ G P+ + N ++ A +
Sbjct: 163 APEALNYGRYT-SESDVWSYGILLWETFSLGDTPY--PGMSNQQTRERIESGYRMPAPQL 219
Query: 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CP + +L+ + +P R + EI
Sbjct: 220 -CPEEI----YRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 58/194 (29%), Positives = 88/194 (45%), Gaps = 12/194 (6%)
Query: 17 RTIGEGTFAKVK---FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G F V + S VA+K L +E + K ++ RE + M + HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
VRL V + + +V+E G L + + + + Q+ + Y S+
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDRGY 190
HRDL N+LL K+SDFG+S AL D TT G P + APE +N +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALG--AGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 191 DGSTADLWSCGVIL 204
S +D+WS GV L
Sbjct: 176 S-SKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
K +G IGEG F V + TG+ VA+K + + A+ E A M + H
Sbjct: 7 KLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHK 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHS 129
N+VRL V+ ++IV+E ++ G L + + GR + ++ + ++Y S
Sbjct: 60 NLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ + HRDL N+L+ G KVSDFGL+ + D+ L + APE L +
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKK 173
Query: 190 YDGSTADLWSCGVILF 205
+ S +D+WS GV+L+
Sbjct: 174 FS-SKSDVWSYGVLLW 188
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 37/223 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE+ IG GT+ +V A+ N + G+ A+K +K +++ RE+A ++ +K
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 70 HPNVVRLYEVMGSKT--KIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQ------- 118
H NVV L EV ++++ ++ D +I+ R R
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQA---KRVSIPPSMVKSL 113
Query: 119 --QLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGL-----SALSQQVRDD 167
Q++N V Y HS V HRDLKP N+L+ G +K+ D GL + L D
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 168 GLLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLA 209
++ T Y APE+ L R Y D+W+ G I LL
Sbjct: 174 PVVVTIW----YRAPELLLGARHYT-KAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 76/313 (24%), Positives = 135/313 (43%), Gaps = 60/313 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ G VA+K L + A++ RE+ +K V H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVNHK 80
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + +++V+E + ++ ++H RM Q++
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS-----YLLYQMLCG 135
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ + ++ T Y APE
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTACTNFMMTPYVVTRYYRAPE 192
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------SAAEFTCP--- 234
V+ GY D+WS G I+ L+ G + F ++ ++ + K+ +AEF
Sbjct: 193 VILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 235 ------------PWLSFT---------------------ARKLIARILDPNPMTRITIPE 261
P +SF AR L++++L +P RI++ E
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311
Query: 262 ILEDEWFKKDYKP 274
L + Y P
Sbjct: 312 ALRHPYITVWYDP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 5e-17
Identities = 71/254 (27%), Positives = 119/254 (46%), Gaps = 16/254 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G G F V + + VA+K +++ + + E+ K MKL HP +V+L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAK---VMMKL-SHPKLVQL 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
Y V + ++IV EF+ G L + + G++ +D Q + ++Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYDG 192
DL N L+ + G +KVSDFG +++ V DD ++ G + PEV N Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFG---MTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 193 STADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-SFTARKLIARILD 250
S +D+WS GV+++ V G +PF+ + + + IS P L S T +++
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWH 239
Query: 251 PNPMTRITIPEILE 264
P R T E+L
Sbjct: 240 EKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 87/359 (24%), Positives = 147/359 (40%), Gaps = 87/359 (24%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDK--EKVLKHKMAEQIKREVATMKLVK 69
+Y+ + IG G V A ++ TG+ VA+K L + + V K A RE+ MKLV
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRA---YRELVLMKLVN 73
Query: 70 HPNVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYF-QQL 120
H N++ L V + +++V+E + ++ ++H RM Y Q+
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS------YLLYQM 127
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYR 184
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----- 235
APEV+ GY D+WS G I+ ++ G + F ++ ++ + KI T
Sbjct: 185 APEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243
Query: 236 ----------------WLSFT----------------------ARKLIARILDPNPMTRI 257
SF AR L++++L +P RI
Sbjct: 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI 303
Query: 258 TIPEILEDE----WFKKD--YKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHVTEQKEE 310
++ + L+ W+ PP D ++D+ EH V E KE
Sbjct: 304 SVDDALQHPYINVWYDPSEVEAPP--PAPYDHSIDER------------EHTVEEWKEL 348
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y V +T+ G+ +V A +PV LKI K L M ++ V HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM---------LLQNVNHPS 118
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
V+R+ + + S +VL + +L+ + + D+A +Q++ + Y H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+K EN+ ++ + + D G + GL GT APEVL Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233
Query: 191 DGSTADLWSCGVILFVLLA 209
+ S AD+WS G++LF +LA
Sbjct: 234 N-SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 16 GRTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G F V R VA+K++ +E + + E M + HPN+
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID---VAIKMI-REGAMSE---DDFIEEAKVMMKLSHPNL 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 132
V+LY V + IFIV E++ G L + + G++ + + A++Y S G
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL N L+ +KVSDFG L++ V DD + GT + PEV D
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFG---LARYVLDDQYTSSQ-GTKFPVKWAPPEVF-DYS 176
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFD 215
S +D+WS GV+++ V G +P++
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 13 YEVGRT-------IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+E+ RT +G G + +V + VA+K L KE ++ E+ +E A M
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAVM 56
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ--QLINA 123
K +KHPN+V+L V + +I+ EF+T G L D + R + + + Q+ +A
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAP 182
++Y + HRDL N L+ +KV+DFGLS L D H P + AP
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAP 174
Query: 183 EVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
E L + +D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 175 ESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 35/276 (12%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
R +GEG F KV+ R TGE VA+K L E H +K+E+ ++ + H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 67
Query: 73 VVRLYEVM--GSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+V+ + I +++EF+ G E + N +K+ +Y Q+ +DY
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQ--QLKYAVQICKGMDYL 125
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-VAPEVL- 185
SR HRDL N+L+++ +K+ DFGL+ + ++ + +P + APE L
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------------- 230
+ Y S D+WS GV L+ LL Y + S + K I
Sbjct: 186 QSKFYIAS--DVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242
Query: 231 --FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
PP +L+ + + P R T ++E
Sbjct: 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
E +G G V ++ TG +A K++ K + +QI RE+ M + P +
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYI 65
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR-G 131
V Y ++ I + +EF+ G L D+I G + + + ++ + Y ++
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S L + D T GT Y++PE + Y
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGKY 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSN 218
+D+WS G+ + L G PF SN
Sbjct: 180 T-VKSDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
R +GEG F KV N TGE VA+K L +E ++ K+E+ +K + H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHEN 67
Query: 73 VVRLY---EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+V+ G K + +++E+V G L D + H ++ + + QQ+ + Y HS
Sbjct: 68 IVKYKGCCSEQGGKG-LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHS 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA------LSQQVRDDGLLHTTCGTPNY-VAP 182
+ HRDL N+LLD +K+ DFGL+ +VR+DG +P + A
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAV 179
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLL 208
E L + + ++ D+WS GV L+ LL
Sbjct: 180 ECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE-QIKREVATMKLVKHPNVVR 75
+ +G G F VK+ + VA+K++ KE M+E + E M + H +V+
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMI-KEG----SMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYH 134
LY V + I+IV E+++ G L + + HG R + + + + + Y S+ H
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYD 191
RDL N L+D G +KVSDFG LS+ V DD ++ G+ + PEVL +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFG---LSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS 179
Query: 192 GSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
S +D+W+ GV+++ V G +P++ N +K+S
Sbjct: 180 -SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 24/212 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV--KH--PNVV 74
IG GT +V R +TG +A+K ++ + E+ KR + + +V H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSR-G 131
+ Y + + +FI +E + DK++ G + ED + ++ A+ Y + G
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT-TCGTPNYVAPEVLN---- 186
V HRD+KP N+LLDA GN+K+ DFG+S + V D T + G Y+APE ++
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG--RLV--DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSN 218
+ YD AD+WS G+ L L G P+ +
Sbjct: 192 NPKYD-IRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G V ++ +G +A K++ E +K + QI RE+ + P +V Y
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG------- 131
S +I I +E + GG L D+++ EA+R ++++ V RG
Sbjct: 71 AFYSDGEISICMEHMDGGSL-DQVLK-------EAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 132 --VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTH 178
Query: 190 YDGSTADLWSCGVILFVLLAGYLP 213
Y +D+WS G+ L L G P
Sbjct: 179 YS-VQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMK 66
+ E + +G G F V GE PVA+K+L +E K ++I E M
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
V HP+VVRL + S + ++ + + G L D + NH + + Q+ +
Sbjct: 65 SVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPE 183
Y + + HRDL N+L+ ++K++DFGL+ L D+ H G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALE 181
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216
+ R Y +D+WS GV ++ L+ G P++
Sbjct: 182 SILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 19 IGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQI---KREVATMKLVKHP 71
+G+G F V+ R TGE VA+K L+H AE + +RE+ +K ++H
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVK------KLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 72 NVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYC 127
N+V+ V S + + +V+E++ G L D + H R + D + Y Q+ ++Y
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYL 124
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-VAPEVLN 186
S+ HRDL N+L+++ +K+ DFGL+ + Q ++ + +P + APE L
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 187 DRGYDGSTADLWSCGVILFVL 207
+ + +D+WS GV+L+ L
Sbjct: 185 ESKFS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 36/219 (16%)
Query: 17 RTIGEGTFAKVKFARNSETGEP---VALKIL-----DKEKVLKHKMAEQIKREVATMKLV 68
+ IG G F +V R G+ VA+K L DK+++ E + M
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-------DFLTEASIMGQF 62
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN------ 122
HPN++RL V+ + I+ E++ G L DK ++E++ + QL+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIA 116
Query: 123 -AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--TP-N 178
+ Y HRDL N+L+++ KVSDFG LS+++ D +TT G P
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKGGKIPIR 173
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 216
+ APE + R + S +D+WS G++++ V+ G P+ D
Sbjct: 174 WTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 14 EVGRTIGEGTFAKV-KFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+GR IGEG F V + S E VA+K + E+ +E M+ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDH 66
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHS 129
P++V+L V+ ++ ++IV+E GEL + VN + Y QL A+ Y S
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLND 187
+ HRD+ N+L+ + +K+ DFGLS + D+ + G P ++APE +N
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESINF 182
Query: 188 RGYDGSTADLWSCGVILF-VLLAGYLPF 214
R + S +D+W GV ++ +L+ G PF
Sbjct: 183 RRFT-SASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 35/204 (17%)
Query: 16 GRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
R +G G F +V N T VA+K L K + E +E MK ++H +V
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTT--KVAVKTL-KPGTMS---PEAFLQEAQIMKKLRHDKLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR-YFQQLI-------NAVDY 126
+LY V + I+IV E+++ G L D +K E ++ QL+ + Y
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTP---NYVAP 182
SR HRDL N+L+ K++DFGL+ L + DD +T G + AP
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDD--EYTAREGAKFPIKWTAP 173
Query: 183 EVLNDRGYDGST--ADLWSCGVIL 204
E N Y T +D+WS G++L
Sbjct: 174 EAAN---YGRFTIKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 62/228 (27%), Positives = 110/228 (48%), Gaps = 22/228 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+TIG+G F V G VA+K + + A+ E + M ++H N+V+L
Sbjct: 12 QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQL 64
Query: 77 YEVM-GSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVY 133
V+ K ++IV E++ G L D + + GR + D ++ + A++Y +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
HRDL N+L+ KVSDFGL+ + +D G L + APE L ++ + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFS-T 178
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-----AEFTCPP 235
+D+WS G++L+ + + G +P+ L ++ ++ A CPP
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 65/269 (24%), Positives = 120/269 (44%), Gaps = 19/269 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 76
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + +++V+E + ++ ++H RM Q++
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 131
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPE 188
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTAR 242
V+ GY D+WS G I+ ++ + F + ++ + K+ T CP ++
Sbjct: 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271
+ + + +T P++ D F D
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPAD 276
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 47/300 (15%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI-----KREV----AT 64
EV +G G + V R+ TG +A+K ++ + KR + +
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVK----------RIRATVNSQEQKRLLMDLDIS 53
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHG-RMKEDEARRYFQQLI 121
M+ V P V Y + + ++I +E + + + K+ + G + ED + ++
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 122 NAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
A++Y HS+ V HRD+KP N+L++ G +K+ DFG+S + D G Y+
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYM 170
Query: 181 APE----VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236
APE LN +GYD +D+WS G+ + L G P+D + ++++ P
Sbjct: 171 APERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYD--SWKTPFQQLKQVVEEPSPQ 227
Query: 237 L---SFTA--RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAV 291
L F+ + + + L N R PE+L+ P FE N D V
Sbjct: 228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH---------PFFELHLSKNTDVASFV 278
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY 77
+G G V A + T +A+K++ + ++ + +QI E+ + P ++ Y
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFY 65
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +I I EF+ GG L D + ++ E R ++ + Y S + HRD+
Sbjct: 66 GAFFVENRISICTEFMDGGSL-DV---YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
KP N+L++ G +K+ DFG+S +Q V + + T GT Y+APE ++ Y G +D+
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVS--TQLV--NSIAKTYVGTNAYMAPERISGEQY-GIHSDV 176
Query: 198 WSCGVILFVLLAGYLPF 214
WS G+ L G P+
Sbjct: 177 WSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 18/223 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 83
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + ++IV+E + ++ ++H RM Q++
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 138
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
V+ GY D+WS G I+ ++ G + F ++ ++ + K+
Sbjct: 196 VILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 32/216 (14%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V A+ GE VA+K +++ ++ ++ + E + MK
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--------RYFQ 118
+VVRL V+ + +V+E + G+L + + R + + ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQ 123
Query: 119 ---QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL---SQQVRDDG--LL 170
++ + + Y ++ HRDL N ++ +K+ DFG++ + R G LL
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 171 HTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILF 205
P ++APE L D G + +D+WS GV+L+
Sbjct: 184 ------PVRWMAPESLKD-GVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 63/266 (23%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 1 MSQPKIKRR---VGKYEVGRTIGEGTFAKV---------------KFARNSETGEPVALK 42
++Q K+K + + V + G F K+ + ++ G+P +
Sbjct: 135 LAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCER 194
Query: 43 ILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV---LEFVTGGELF 99
++ K + A Q++ E+ + + H N++++ E++ S+ +++ +F ++
Sbjct: 195 LIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMY 254
Query: 100 DKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
D+ + R + R +QL+ AV+Y H + + HRD+K EN+ L+ G + + DFG +
Sbjct: 255 DEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDS 217
++ R + + GT +PE+L GY T D+WSCG+IL +L+ + P D
Sbjct: 315 MPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEIT-DIWSCGLILLDMLSHDFCPIGDG 372
Query: 218 ------NLMNLYKKISAA--EFTCPP 235
L+ + +S EF PP
Sbjct: 373 GGKPGKQLLKIIDSLSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 64
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-G 131
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L Y
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS 180
Query: 192 GSTADLWSCGVILFVLLAGYLP 213
+D+WS G+ L + G P
Sbjct: 181 -VQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 50/223 (22%), Positives = 102/223 (45%), Gaps = 19/223 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+ + V A++ T VA+K ++ + + + +++E+ T + ++HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHS 129
++ +++++V + G D + H G + E + ++NA+DY HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-------NYVAP 182
+G HR +K ++LL G + +S GL ++ P +++P
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 183 EVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223
EVL N +GY+ +D++S G+ L G++PF D +
Sbjct: 178 EVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 19 IGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
IG G V AR TGE V ++ ++ E ++M ++ E+ KL HPN+V
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ ++++V F+ G D I H M E Q ++ A+DY H G H
Sbjct: 65 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVH 124
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-------VAPEVL-- 185
R +K ++L+ G + +S GL + + L P Y ++PEVL
Sbjct: 125 RSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ 182
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
N +GYD + +D++S G+ L G++PF D
Sbjct: 183 NLQGYD-AKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ IG G F +V R G+ PVA+K L K + E + M HPN+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHPNI 67
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 132
+ L V+ + IV E++ G L + H G+ + + + + + Y G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL N+L+++ KVSDFGLS + + D +TT G + APE + R
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS-----AAEFTCP 234
+ S +D+WS G++++ V+ G P+ + + ++ K I A CP
Sbjct: 186 FT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 19 IGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKR----EVATMKLVKHP 71
IG G F +V R G+ VA+K LK E+ +R E + M HP
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIK------TLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHS 129
N++ L V+ + I+ EF+ G L D + N G+ + + + + Y
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLN 186
HRDL N+L+++ KVSDFGLS + D ++ G + APE +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 187 DRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE--FTCPP 235
R + S +D+WS G++++ V+ G P+ D M+ I+A E + PP
Sbjct: 185 YRKFT-SASDVWSYGIVMWEVMSYGERPYWD---MSNQDVINAIEQDYRLPP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 26/222 (11%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +GR +G+G F V+ A+ + + VA+K+L K + E+ RE A MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 70 HPNVVRLYEV-MGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI-- 121
HPNV++L V + S+ K ++L F+ G+L ++ R+ E+ Q L+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRF 118
Query: 122 -----NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
+ ++Y S+ HRDL N +L+ + V+DFG LS+++ C +
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG---LSKKIYSGDYYRQGCAS 175
Query: 177 P---NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++A E L D Y + +D+W+ GV ++ ++ G P+
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 19 IGEGTFAKVKFARNSETGEPVALK----ILDKEKVLKHKMAEQIKREV-ATMKLVKHPNV 73
IG G F V + +G +A+K +D+ K +++ ++ M+ P +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE------KEQKRLLMDLDVVMRSSDCPYI 65
Query: 74 VRLYEVMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG- 131
V+ Y + + +I +E + + F K V + +K ++++ + +
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYV-YEVLK----SVIPEEILGKIAVATVKAL 120
Query: 132 --------VYHRDLKPENLLLDAYGNLKVSDFGLSALSQ----QVRDDGLLHTTCGTPNY 179
+ HRD+KP N+LLD GN+K+ DFG+S + RD G C P Y
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG-----C-RP-Y 173
Query: 180 VAPEVLNDRGYDGS--TADLWSCGVILFVLLAGYLPFDDSN 218
+APE ++ DG +D+WS G+ L+ + G P+ N
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G V + +G +A K++ E +K + QI RE+ + P +V Y
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG------- 131
S +I I +E + GG L D+++ +A R + ++ + RG
Sbjct: 67 AFYSDGEISICMEHMDGGSL-DQVLK-------KAGRIPENILGKISIAVLRGLTYLREK 118
Query: 132 --VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTH 174
Query: 190 YDGSTADLWSCGVILFVLLAGYLP 213
Y + D+WS G+ L + G P
Sbjct: 175 YTVQS-DIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 15/228 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F V E + VA+K + +E + E E M + HP +V+LY
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTI-REGAMSE---EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 79 VMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V ++ I +V EF+ G L D + G+ ++ + + Y S V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYDGST 194
N L+ +KVSDFG++ V DD +T GT + +PEV + Y S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRF---VLDDQYTSST-GTKFPVKWSSPEVFSFSKYS-SK 181
Query: 195 ADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
+D+WS GV+++ V G P+++ + + + I+A P L+ +
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS 229
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 39/223 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEP-----VALKILDKEKVLKHKMAEQIKREVATMK 66
+ +G+ +GEG F +V A P VA+K+L K+ + +++ + E+ MK
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS-EMEMMK 70
Query: 67 LV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ------- 118
++ KH N++ L V + +++V+E+ G L D + R + A
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETL 129
Query: 119 ----------QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-- 166
Q+ +++ S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA------RDIH 183
Query: 167 --DGLLHTTCG-TP-NYVAPEVLNDRGYDGSTADLWSCGVILF 205
D TT G P ++APE L DR Y + D+WS GV+L+
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 15 VGRTIGEGTFAKVKFAR-NSETGEP--VALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+G+ +GEG F V + + + G VA+K + K + + E+ E A MK HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 72 NVVRLYEV---MGSKTKI---FIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLIN- 122
NV++L V S KI ++L F+ G+L ++ + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLKF 118
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
VD Y +R HRDL N +L + V+DFG LS+++
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG---LSKKIYSGDYYRQGRIA 175
Query: 177 P---NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++A E L DR Y S +D+W+ GV ++ + G P+
Sbjct: 176 KMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 1/88 (1%)
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
+QL++A+DY H G+ HRD+K EN+L++ ++ + DFG + ++ + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILF 205
+ APEVL Y + D+WS G+++F
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-12
Identities = 22/90 (24%), Positives = 35/90 (38%), Gaps = 4/90 (4%)
Query: 339 FKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKM----RLENMKAGRKGNLNVATE 394
K E SR +EI I + + G ++ + +L N + E
Sbjct: 2 KKWELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIE 61
Query: 395 VFQVAPSLHMVEVRKAKGDTLEFHKFYKNL 424
V++V P L MV+ +K G T F K +
Sbjct: 62 VYEVGPGLFMVDFKKKTGSTKTFTKLATKI 91
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 17 RTIGEGTFAKV--KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F +V + NS VA+K L + E E MK ++H +V
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTK---VAVKTLKPGTMSVQAFLE----EANLMKTLQHDKLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RLY V+ + I+I+ E++ G L D K G++ + + Q+ + Y +
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL+ N+L+ K++DFGL+ +V +D G + APE +N G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAIN-FG 179
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPF 214
+D+WS G++L+ ++ G +P+
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 1 MSQPKIKRRVGK-YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
M I R K Y++G IG G+F V A +T E VA+K KVL+ +
Sbjct: 55 MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK-----KVLQDPQYKN-- 107
Query: 60 REVATMKLVKHPNVVRLYE------VMGSKTKIF--IVLEFVTGGELFDKIVNHGRMKED 111
RE+ MK + H N++ L + ++ IF +V+EF+ + K + H
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNH 165
Query: 112 E-----ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVR 165
+ Y QL A+ Y HS+ + HRDLKP+NLL+D + LK+ DFG + +
Sbjct: 166 ALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLA 223
Query: 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
+ C + Y APE++ + DLWS G I+ ++ GY F
Sbjct: 224 GQRSVSYIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 54/246 (21%), Positives = 102/246 (41%), Gaps = 30/246 (12%)
Query: 19 IGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+GEG F KV + VA+K L + + K+ ++ ++E M ++HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ--------------- 118
V L V + ++ E++ G+L + +V + + A +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
Q+ ++Y S HRDL N L+ +K+SDFGLS + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLYKK--ISAAEF 231
++ PE + G + +D+WS GV+L+ + L Y F + ++ + + +
Sbjct: 191 RWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPE 249
Query: 232 TCPPWL 237
CP +
Sbjct: 250 DCPARV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 40/248 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSE-TGEP----VALKILDKEKVLKHKMAEQIKREVATMK 66
+G+T+GEG F KV A G VA+K+L + + E +K
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD--LLSEFNLLK 58
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL----------------FDKIVNHGRMKE 110
V HP+V++LY + +++E+ G L D N +
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 111 DEAR--------RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ R + Q+ + Y + HRDL N+L+ +K+SDFGLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RD 176
Query: 163 QVRDDGLLHTTCG-TP-NYVAPEVLNDRGYDGSTADLWSCGVILF--VLLAG--YLPFDD 216
+D + + G P ++A E L D Y + +D+WS GV+L+ V L G Y
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 217 SNLMNLYK 224
L NL K
Sbjct: 236 ERLFNLLK 243
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 17 RTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
R +G G F +V N+ T PVA+K L K + + E MK ++HP +++
Sbjct: 12 RKLGAGQFGEVWEGLWNNTT--PVAVKTL-KPGTMD---PKDFLAEAQIMKKLRHPKLIQ 65
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVY 133
LY V + I+IV E + G L + + +K + Q+ + + Y ++
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGY 190
HRDL N+L+ KV+DFGL+ +V + + G + APE Y
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLA----RVIKEDIYEAREGAKFPIKWTAPEAAL---Y 178
Query: 191 DGST--ADLWSCGVILFVLLA-GYLPF 214
+ + +D+WS G++L ++ G +P+
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
+YE G +G GT+ V A+ + + +KE LK I RE+A ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKD-------EKEYALKQIEGTGISMSACREIALLRE 54
Query: 68 VKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDE---------ARRY 116
+KHPNV+ L +V S + K++++ ++ +L+ I H K ++ +
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSAL-SQQVRDDGLLH 171
Q+++ + Y H+ V HRDLKP N+L+ G +K++D G + L + ++ L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208
T Y APE+L + D+W+ G I LL
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 15 VGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
+G+ +GEG F +V A + VA+K+L K+ +A+ I E+ MKL
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EMELMKL 73
Query: 68 V-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI---------VNHGRMKEDEARRYF 117
+ KH N++ L V + +++++E+ G L + + K E + F
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 118 QQLINAV-------DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170
+ L++ +Y SR HRDL N+L+ +K++DFGL+ + D
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI--DYYK 191
Query: 171 HTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
T+ G ++APE L DR Y +D+WS G++++
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
+YE G +G GT+ V A+ + + D++ LK I RE+A ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKD-------DRDYALKQIEGTGISMSACREIALLRE 54
Query: 68 VKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDE---------ARRY 116
+KHPNV+ L +V S K++++ ++ +L+ I H K ++ +
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSAL-SQQVRDDGLLH 171
Q+++ + Y H+ V HRDLKP N+L+ G +K++D G + L + ++ L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208
T Y APE+L + D+W+ G I LL
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 63/252 (25%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEP--VALKILDKEKVLKHKM 54
+ PK + + +G+ +GEG F +V A + +P VA+K+L + K
Sbjct: 3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKD 60
Query: 55 AEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------FDKI 102
+ E+ MK++ KH N++ L +++++E+ + G L D
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120
Query: 103 VNHGRMKEDEARRYFQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155
+ ++ E++ F+ L++ ++Y S+ HRDL N+L+ +K++DF
Sbjct: 121 FDTCKLPEEQLT--FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178
Query: 156 GLSALSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYL 212
GL+ + D TT G ++APE L DR Y +D+WS GV+L+ + G
Sbjct: 179 GLARDVHNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGS 235
Query: 213 PFDDSNLMNLYK 224
P+ + L+K
Sbjct: 236 PYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+K L + K ++I E M V +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ----QLINAVDYCH 128
V RL + + T + ++ + + G L D + H K++ +Y Q+ ++Y
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLN 186
R + HRDL N+L+ ++K++DFGL+ L D+ H G P ++A E +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESIL 184
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFD 215
R Y +D+WS GV ++ L+ G P+D
Sbjct: 185 HRIYT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 2/155 (1%)
Query: 60 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
RE+ +K + H ++ L K+ + +V+ +LF + G + ++A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
L+ A+ Y H RG+ HRD+K EN+ LD N + DFG + D + GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
+PE+L Y T D+WS G++LF + +
Sbjct: 254 NSPELLALDPYCAKT-DIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V AR + G L++ K +K ++ R+ A KL HPN+
Sbjct: 3 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA----------------RRYF 117
+ L + +++ +E+ G L D + ++ D A +
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+ +DY + HRDL N+L+ K++DFGLS + + T G
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 174 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 66/267 (24%), Positives = 107/267 (40%), Gaps = 29/267 (10%)
Query: 18 TIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
T+G G F +V A+ E V +K L K K + +RE+ + + H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE--FRRELDMFRKLSHKN 69
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGEL--FDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
VVRL + +++LE+ G+L F + K +Q + A+ +
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV-ALCTQIAL 128
Query: 131 GV--------YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
G+ HRDL N L+ + +KVS LS + P ++A
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVYNSEYYKLRNALIPLRWLA 186
Query: 182 PEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF----DDSNLMNLYKKISAAEFTCPPW 236
PE + + + + D+WS GV+++ V G LPF D+ L L + E P
Sbjct: 187 PEAVQEDDFSTKS-DVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL--QAGKLELPVPEG 243
Query: 237 LSFTARKLIARILDPNPMTRITIPEIL 263
KL+ R NP R + E++
Sbjct: 244 CPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
E+GR G V AR++ TG V ++I D E + + + ++ EV +HPN+
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+ + V + + ++++ F+ G L G M E + ++Y H
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-------VAPE 183
G HR++K ++L+ G + +S GLS L VR+ P + ++PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 184 VLND--RGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+L GY+ +D++S G+ L G +PF D
Sbjct: 179 LLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 68/281 (24%), Positives = 111/281 (39%), Gaps = 48/281 (17%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKLVKHPN 72
R +GEG F KV F EP K L K LK + + RE + +H N
Sbjct: 11 RELGEGAFGKV-FLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-------MKEDEAR-------RYFQ 118
+V+ Y V +V E++ G+L + +HG +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT----- 173
Q+ + + Y S+ HRDL N L+ +K+ DFG+S RD ++TT
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RD---VYTTDYYRV 180
Query: 174 CGTP----NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 228
G ++ PE + R + + +D+WS GV+L+ + G P+ + + + I+
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239
Query: 229 AEF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
TCP ++ +P RI I +I E
Sbjct: 240 GRLLQRPRTCPS----EVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 24/234 (10%)
Query: 17 RTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ IG G F +V K E VA+K L K + + E + M H
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEV--AVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHH 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHS 129
N++RL V+ I+ E++ G L DK + + G + + + + Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLN 186
HRDL N+L+++ KVSDFGLS + + D +TT G + APE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED--DPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 187 DRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS-----AAEFTCP 234
R + S +D+WS G++++ V+ G P+ D + + K I+ A CP
Sbjct: 184 YRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 17 RTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+ +G G F +V A N T VA+K + + E E MK ++H +V+
Sbjct: 12 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVK 65
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR--------YFQQLINAVDYC 127
L+ V+ +K I+I+ EF+ G L D +K DE + + Q+ + +
Sbjct: 66 LHAVV-TKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLN 186
R HRDL+ N+L+ A K++DFGL+ + + ++ P + APE +N
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAIN 176
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPF 214
G +D+WS G++L ++ G +P+
Sbjct: 177 -FGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 6/190 (3%)
Query: 19 IGEGTFAKVK--FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F VK + ++ + VA+KIL K + +++ RE M+ + +P +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ +++ +V+E G L + + + E Q+ + Y HRD
Sbjct: 62 IGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGSTA 195
L N+LL K+SDFGLS + T P + APE +N + S +
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS-SKS 179
Query: 196 DLWSCGVILF 205
D+WS GV+++
Sbjct: 180 DVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 15 VGRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+T+GEG F V + ++ VA+K + + +M E E MK HPN
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPN 61
Query: 73 VVRLYEV--MGSKTKIF----IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI----- 121
V+RL V +++ + ++L F+ G+L ++ + R+ + Q L+
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTD 120
Query: 122 --NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA------LSQQVRDDGLLHTT 173
+ ++Y S+ HRDL N +L+ N+ V+DFGLS +Q R +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM---- 176
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
++A E L DR Y + +D+WS GV ++
Sbjct: 177 --PVKWIAIESLADRVYT-TKSDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 40/241 (16%)
Query: 15 VGRTIGEGTFAKVKFAR--NSETGEP-----VALKILDKEKVLKHKMAEQIKREVATMKL 67
+G+ +GEG F +V A + +P VA+K+L K + +++ I E+ MK+
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 79
Query: 68 V-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------- 116
+ KH N++ L +++++E+ + G L + + R + Y
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYCYNPTQVPEE 135
Query: 117 ---FQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
F+ L++ ++Y S+ HRDL N+L+ +K++DFGL+ +
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-- 193
Query: 167 DGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLY 223
D TT G ++APE L DR Y +D+WS GV+L+ + G P+ + L+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
Query: 224 K 224
K
Sbjct: 253 K 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 60/248 (24%), Positives = 113/248 (45%), Gaps = 32/248 (12%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAE 56
P+ + K +G+ +GEG F +V A + VA+K+L K+ + +++
Sbjct: 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSD 66
Query: 57 QIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI------------- 102
+ E+ MK++ KH N++ L +++++E+ + G L + +
Sbjct: 67 LVS-EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 103 ---VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159
V +M + Q+ ++Y S+ HRDL N+L+ +K++DFGL+
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 160 LSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 216
+ D TT G ++APE L DR Y +D+WS GV+++ + G P+
Sbjct: 186 DVNNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPG 242
Query: 217 SNLMNLYK 224
+ L+K
Sbjct: 243 IPVEELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V A + G + I K+LK +E R+ A KL HPN+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA----------------RRYF 117
+ L ++ ++I +E+ G L D + ++ D A ++
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+ + Y + HRDL N+L+ K++DFGLS ++ + T G
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRL 180
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 181 PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 56/221 (25%), Positives = 86/221 (38%), Gaps = 27/221 (12%)
Query: 14 EVGRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ R +G G F +V VA+K L + + E M
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIMSKF 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY-FQQLIN-AVD- 125
H N+VRL V + FI+LE + GG+L + R + + + L+ A D
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 126 -----YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSA---LSQQVRDDGLLHTTC 174
Y HRD+ N LL G K++DFG++ + R G
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG---RAM 182
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++ PE D G S D+WS GV+L+ + GY+P+
Sbjct: 183 LPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 17 RTIGEGTFAKV--KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F +V + VA+K L K+ + E E MK ++HP +V
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTK---VAIKSL-KQGSMS---PEAFLAEANLMKQLQHPRLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RLY V+ ++ I+I+ E++ G L D K ++ ++ Q+ + + +
Sbjct: 65 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYD 191
HRDL+ N+L+ K++DFGL+ L + ++ P + APE +N G
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAIN-YGTF 180
Query: 192 GSTADLWSCGVIL 204
+D+WS G++L
Sbjct: 181 TIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREV 62
IKRR + R +GEG F KV F P K+L K LK + +RE
Sbjct: 2 IKRR--DIVLKRELGEGAFGKV-FLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREA 58
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---------------- 106
+ ++H ++V+ Y V G + +V E++ G+L + HG
Sbjct: 59 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 107 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQ 163
+ + Q+ + + Y S+ HRDL N L+ A +K+ DFG+S +
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
R G HT ++ PE + R + + +D+WS GVIL+
Sbjct: 179 YRVGG--HTMLPI-RWMPPESIMYRKFT-TESDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V AR + G L++ K +K ++ R+ A KL HPN+
Sbjct: 15 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA---------RRYFQQLIN-- 122
+ L + +++ +E+ G L D + ++ D A QQL++
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 123 -----AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+DY + HRDL N+L+ K++DFGLS Q+V + T G
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV----YVKKTMGRL 185
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 186 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
IG G F KV + G A +++ KE EQ+ +EV + + HPNV++
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQL----INAVDYCHSRG 131
+VLEF G+L + + N G + + + Q++ + + + H
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGY 190
H DL N L A ++K+ D+GL AL Q D + P ++APE++ RG
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGL-ALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 191 DGSTAD------LWSCGVILFVLL-AGYLPFDD 216
D D +WS GV ++ L A P+ D
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 42/241 (17%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++++ +GEGTF KV A + + E A+KI+ V K+ +I E+ M+ V+
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV--RNVPKYTRDAKI--EIQFMEKVRQ 184
Query: 71 PNVVRLYEVMG------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI--- 121
+ + +M ++T ++ G L D I+ HG R+ Q+I
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH----RHLAQIIFQT 240
Query: 122 -NAVDYCHSR-GVYHRDLKPENLLLDAYGN----------------LKVSDFGLSALSQQ 163
A+DY H+ + H DLKPEN+L++ +++ D G +
Sbjct: 241 GVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH 300
Query: 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNL 222
R T +Y +PEV+ G+ ST D+WS G I++ L G L +D NL +L
Sbjct: 301 SRT-----AIVSTRHYRSPEVVLGLGWMYST-DMWSMGCIIYELYTGKLLYDTHDNLEHL 354
Query: 223 Y 223
+
Sbjct: 355 H 355
|
Length = 467 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 49/175 (28%), Positives = 70/175 (40%), Gaps = 29/175 (16%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSE--TGEP---VALKILDKEKVLKHKMAEQIKREVATM 65
E R IG+G F +V AR EP VA+K+L +E M +RE A M
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 62
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-------KIVNHGRMKEDEARRYFQ 118
HPN+V+L V + ++ E++ G+L + + AR+
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 119 ---------QLINAVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
QL A Y R HRDL N L+ +K++DFGLS
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+KIL++ K + + E M + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+VRL V S T I +V + + G L D + H + + Q+ + Y R
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP--NYVAPEVLNDRG 189
+ HRDL N+L+ + ++K++DFGL+ L + D+ + G ++A E ++ R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEG--DEKEYNADGGKMPIKWMALECIHYRK 187
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFD 215
+ +D+WS GV ++ L+ G P+D
Sbjct: 188 FT-HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 22/235 (9%)
Query: 17 RTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +G G F ++ K E PVA+ L K + E T+ H
Sbjct: 11 RILGTGRFGELCRGCLKLPSKREL--PVAIHTLRAGCSDKQRRG--FLAEALTLGQFDHS 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
N+VRL V+ + IV E+++ G L + H G++ + L + + Y
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN--YVAPEVLNDR 188
G H+ L +L+++ K+S F Q+ + + + T G + APE +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ-Y 182
Query: 189 GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-----AAEFTCPPWL 237
+ S +D+WS G++++ +++ G P+ D + ++ K + A CP L
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL 237
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNV 73
R +GEG F KV A P KIL K LK + RE + ++H ++
Sbjct: 11 RELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------------RMKEDEARRYFQQL 120
V+ Y V + +V E++ G+L + HG + + + QQ+
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQVRDDGLLHTTCGTP 177
+ Y S+ HRDL N L+ +K+ DFG+S + R G HT
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTMLPI- 186
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILF 205
++ PE + R + + +D+WS GV+L+
Sbjct: 187 RWMPPESIMYRKFT-TESDVWSLGVVLW 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+K+L + K ++I E M V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPY 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
V RL + + T + +V + + G L D + + R+ + + Q+ + Y
Sbjct: 71 VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLNDRG 189
+ HRDL N+L+ + ++K++DFGL+ L D+ H G P ++A E + R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESILHRR 187
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFD 215
+ +D+WS GV ++ L+ G P+D
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 67/261 (25%), Positives = 117/261 (44%), Gaps = 17/261 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G G F +V + + VA+K L + E E MK ++H +V+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVN-HGR-MKEDEARRYFQQLINAVDYCHSRGVYH 134
Y V+ S+ I+IV E+++ G L D + + GR +K Q+ + Y H
Sbjct: 67 YAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGS 193
RDL+ N+L+ K++DFGL+ L + ++ P + APE G
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTI 182
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDP 251
+D+WS G++L L+ G +P+ N + +++ CP + +L+ +
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKK 242
Query: 252 NPMTRITIPEILEDEWFKKDY 272
+P R T E L+ F +DY
Sbjct: 243 DPEERPTF-EYLQS--FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 83/315 (26%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGEP---VALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V AR+ GE VA+K +++ L+ ++ + E + MK
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELF--------DKIVNHGRMKE--DEARRY 116
+VVRL V+ +V+E + G+L + N GR E +
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
++ + + Y +++ HRDL N ++ +K+ DFG++ RD
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIYETDYYRKG 178
Query: 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL--------------------- 204
GLL ++APE L D G +++D+WS GV+L
Sbjct: 179 GKGLLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232
Query: 205 FVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
FV+ GYL D+ CP ++ L+ NP R T EI+
Sbjct: 233 FVMDGGYLDQPDN---------------CPERVT----DLMRMCWQFNPKMRPTFLEIV- 272
Query: 265 DEWFKKDYKPPVFEE 279
K D P F E
Sbjct: 273 -NLLKDDLHPS-FPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + T + VA+K L + M E +E MK ++H +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 79 VMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
V+ S+ I+IV EF+ G L D K + +K + Q+ + + Y HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGSTA 195
L+ N+L+ K++DFGL+ L + ++ P + APE G +
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTIKS 184
Query: 196 DLWSCGVILFVLLA-GYLPF 214
D+WS G++L L+ G +P+
Sbjct: 185 DVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 40/249 (16%)
Query: 19 IGEGTFAKVK----FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+GE F K+ + + + VA+K L + + ++E + M + HPN+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ--WGEFQQEASLMAELHHPNIV 70
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIV-------------NHGRMKEDEARRYFQ--- 118
L V+ + + ++ E++ G+L + ++ G +K F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-----SALSQQVRDDGLLHT 172
Q+ ++Y S H+DL N+L+ ++K+SD GL SA +V+ LL
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLYKK--I 226
++ PE + G S +D+WS GV+L+ + L Y F + ++ + +K +
Sbjct: 191 -----RWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244
Query: 227 SAAEFTCPP 235
CPP
Sbjct: 245 LPCSEDCPP 253
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 36/155 (23%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 61 EVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 116
E ++ + HP++++L G+ K I+ + T +L+ + + +
Sbjct: 133 EAHILRAINHPSIIQL---KGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAI 187
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
+ ++ A+ Y H + HRD+K EN+ ++ G++ + DFG + + + + GT
Sbjct: 188 ERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGT 246
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
APE+L Y G D+WS G++LF + +
Sbjct: 247 IATNAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 17 RTIGEGTFAKV------KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+G G F +V VA+K L K + K E +K E M H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLK-EAHLMSNFNH 58
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVDYCHS 129
PN+V+L V +I++E + GG+L + + + ++L++ +D
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 130 RGVY-------HRDLKPENLLLDAYGN-----LKVSDFGL-----SALSQQVRDDGLLHT 172
VY HRDL N L+ G +K+ DFGL + + +GLL
Sbjct: 119 -CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++APE L D G + +D+WS GV+++ +L G P+
Sbjct: 178 -----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
+I R + EV +G+G F +V + T VA+K L + E +E
Sbjct: 2 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQV 54
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLIN 122
MK ++H +V+LY V+ S+ I+IV E+++ G L D K ++ + Q+ +
Sbjct: 55 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
+ Y HRDL+ N+L+ KV+DFGL+ L + ++ P + A
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTA 171
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 214
PE G +D+WS G++L L G +P+
Sbjct: 172 PEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 22/198 (11%)
Query: 19 IGEGTFAKVK--FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F VK + + VA+K+L E + + +++ RE M + +P +VR+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-----RYFQQLINAVDYCHSRG 131
V ++ + +V+E +GG L + K+DE Q+ + Y +
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTP---NYVAPEVLND 187
HRDL N+LL K+SDFGLS AL DD + APE +N
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINF 172
Query: 188 RGYDGSTADLWSCGVILF 205
R + S +D+WS G+ ++
Sbjct: 173 RKFS-SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 17 RTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
R IG+G F V + A+K L++ L+ EQ +E MK HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE--VEQFLKEGIIMKDFSHPNV 58
Query: 74 VRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAVDYCHSRG 131
+ L + S+ +VL ++ G+L + I + + F Q+ ++Y S+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL----HTTCGTP-NYVAPEVLN 186
HRDL N +LD +KV+DFG L++ + D HT P ++A E L
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFG---LARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLY------KKISAAEFTCPPWLSF 239
+ + + +D+WS GV+L+ L+ G P+ D + ++ +++ E+ CP L
Sbjct: 176 TQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY-CPDPLY- 232
Query: 240 TARKLIARILDPNPMTRITIPEILED 265
+++ P P R T E++
Sbjct: 233 ---EVMLSCWHPKPEMRPTFSELVSR 255
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 21 EGTFAKVKFAR-NSETG---EPVALKILDKEKVLKHKMAEQIKR---EVATMKLVKHPNV 73
EGTF ++ + E E V +K V H Q+ E + + H N+
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVK-----TVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 74 VRLYEVMGSKT-KIFIVLEFVTGGEL--FDKIVNHGRMKEDEARRYFQ------QLINAV 124
+ + V F++ ++ G L F + G +A Q Q+ +
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN------ 178
Y H RGV H+D+ N ++D +K++D +ALS RD + C N
Sbjct: 131 SYLHKRGVIHKDIAARNCVIDEELQVKITD---NALS---RDLFPMDYHCLGDNENRPVK 184
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216
++A E L ++ Y S +D+WS GV+L+ L+ G P+ +
Sbjct: 185 WMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 6 IKRR--VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK---HKMAEQIKR 60
IKRR V K+E +GEG F KV A P K+L K LK + +R
Sbjct: 2 IKRRDIVLKWE----LGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQR 56
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRY 116
E + +++H ++VR Y V + +V E++ G+L + +HG + E
Sbjct: 57 EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116
Query: 117 FQ-----------QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQ 162
Q Q+ + + Y S HRDL N L+ +K+ DFG+S +
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
R G T ++ PE + R + + +D+WS GV+L+
Sbjct: 177 YYRVGG---RTMLPIRWMPPESILYRKFT-TESDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 32/168 (19%)
Query: 19 IGEGTFAKVKFAR------------NSETGEP--VALKIL--DKEKVLKHKMAEQIKREV 62
+GEG F +V G+P VA+K+L D K ++ ++IK
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK--- 69
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL------------FDKIVNHGRMKE 110
M +K+PN++RL V S + ++ E++ G+L F N +
Sbjct: 70 -IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 111 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
Q+ + + Y S HRDL N L+ + +K++DFG+S
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 56/246 (22%), Positives = 109/246 (44%), Gaps = 30/246 (12%)
Query: 19 IGEGTFAKVKFAR--NSETGEP---VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+GE F KV + GE VA+K L K+K + + E+ K E ++HPN+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIV------NHGRMKED-------EARRYFQ-- 118
V L V+ + + ++ + + +L + +V + G +D E +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
Q+ +++ S V H+DL N+L+ N+K+SD GL L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLY--KKISAAEF 231
+++PE + G +D+WS GV+L+ + L Y + + +++ + +++
Sbjct: 191 RWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD 249
Query: 232 TCPPWL 237
CP W+
Sbjct: 250 DCPAWV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 54/243 (22%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KL 67
G+T+G G F KV A S+ VA+K+L + E + E+ M L
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHL 95
Query: 68 VKHPNVVRLYEVMGSKTK---IFIVLEFVTGGELFDKIVNHGRMKE------DEARRYFQ 118
H N+V L +G+ T I ++ E+ G+L +N R K ++ +
Sbjct: 96 GNHENIVNL---LGACTIGGPILVITEYCCYGDL----LNFLRRKRESFLTLEDLLSFSY 148
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ + + S+ HRDL N+LL +K+ DFGL+ RD +++ + N
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA------RD--IMNDS----N 196
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMN 221
YV APE + + Y +D+WS G++L+ + + G P+ DS
Sbjct: 197 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255
Query: 222 LYK 224
L K
Sbjct: 256 LIK 258
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 40/213 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGE----------PVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+GTF + + V LK+L H+ + + M
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS----DHRDSLAFFETASLMS 56
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF----QQLIN 122
+ H ++V+LY V I +V E+V G L D ++ R K + + + +QL +
Sbjct: 57 QLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL-DVFLH--REKNNVSLHWKLDVAKQLAS 112
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGN-------LKVSDFG--LSALSQQVRDDGLLHTT 173
A+ Y + + H ++ +N+L+ YG +K+SD G ++ LS++ R + +
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI---- 168
Query: 174 CGTPNYVAPEVL-NDRGYDGSTADLWSCGVILF 205
P ++APE + N + AD WS G L
Sbjct: 169 ---P-WIAPECIRNGQASLTIAADKWSFGTTLL 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 52/220 (23%), Positives = 99/220 (45%), Gaps = 40/220 (18%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGEP---VALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V A+ EP VA+K +++ ++ ++ + E + MK
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-------KIVNHGRMKEDEARRYFQ- 118
+VVRL V+ +++E +T G+L ++ N+ ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 119 --QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
++ + + Y ++ HRDL N ++ +K+ DFG++ RD
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKG 178
Query: 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
GLL +++PE L D G + +D+WS GV+L+
Sbjct: 179 GKGLLPV-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 35/124 (28%), Positives = 55/124 (44%), Gaps = 16/124 (12%)
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 234
GTP+Y+APE+L + + G D W+ GV LF L G PF+D +++ I +
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI--- 597
Query: 235 PW------LSFTARKLIARILDPNPMTRITIPEILED------EWFKKDYKPPVFEEKKD 282
PW LS A+ I +L +P R + E+ + +W + F + D
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPD 657
Query: 283 TNLD 286
D
Sbjct: 658 DETD 661
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 29/175 (16%)
Query: 11 GKYEVGRTIGEGTFAKV--------------KFARNSETGEP--VALKILDKEKVLKHKM 54
+GEG F +V FA N P VA+K+L + +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAR 63
Query: 55 AEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL---------FDKIVNH 105
+ +K EV + + PN+ RL V + +++E++ G+L +
Sbjct: 64 EDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 106 G-RMKEDEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
+ Y Q+ + + Y S HRDL N L+ +K++DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 44/201 (21%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA----TMKLVKHP 71
+ +G G F V G+ ++KI K ++ + Q +E+ M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGD--SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 72 NVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
+VRL + G+ ++ V + G L D + H + + Q+ + Y
Sbjct: 70 YIVRLLGICPGASLQL--VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDR 188
+ HR+L N+LL + ++++DFG++ L D ++ TP ++A E +
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP-DDKKYFYSEHKTPIKWMALESILFG 186
Query: 189 GYDGSTADLWSCGVILFVLLA 209
Y +D+WS GV ++ +++
Sbjct: 187 RYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR---RYFQQLINAVDYCHSRGV 132
L ++M SK + V + L K+ + + E E + +Q++ A+D HS G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276
Query: 133 YHRDLKPENLLLD-AYGNLKVSDFGLSA 159
HRD+KP+N++ G+ K+ D G +A
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 25/102 (24%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y Q+ +++ SR HRDL N+LL +K+ DFGL+ RD
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYK 225
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
P+YV APE + D+ Y + +D+WS GV+L+
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 26/163 (15%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLL 170
Y Q+ +++ SR HRDL N+LL +K+ DFGL+ RD D +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RDIYKDPDYVR 232
Query: 171 HTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMNLYK 224
+ P ++APE + D+ Y + +D+WS GV+L+ + + G P+ + K
Sbjct: 233 KGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
Query: 225 ---KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
++ A E P +++ +P R T ++E
Sbjct: 292 DGTRMRAPENATP-----EIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 39/176 (22%)
Query: 19 IGEGTFAKV--------------KFARNSETGEP--VALKILDKEKVLKHKMAEQIKREV 62
+GEG F +V +F N G P VA+KIL + K+ + +K EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLK-EV 70
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-------- 114
+ +K PN++RL V + + ++ E++ G+L ++ ++ + + E
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129
Query: 115 ------------RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
Q+ + + Y S HRDL N L+ +K++DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 26/112 (23%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y Q+ +++ SR HRDL N+LL +K+ DFG L++ + D
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG---LARDIYKD-------- 232
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 214
P+YV APE + DR Y +D+WS GV+L+ + + G P+
Sbjct: 233 -PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 19 IGEGTFAKV---------KFARNSETGEP-------VALKILDKEKVLKHKMAEQIKREV 62
+GEG F +V KF + + VA+K+L +E K+ + +K E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANKNARNDFLK-EI 70
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQ 118
M +K PN++RL V + + ++ E++ G+L + H K D +
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 119 QLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
LI + Y S HRDL N L+ +K++DFG+S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 20/66 (30%), Positives = 35/66 (53%)
Query: 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150
EF+ G+ + + + + +Q++ + H G+ HRD+KPENLL+ G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348
Query: 151 KVSDFG 156
K+ DFG
Sbjct: 349 KIIDFG 354
|
Length = 507 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 27/136 (19%), Positives = 49/136 (36%), Gaps = 23/136 (16%)
Query: 33 SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-----PNVVRLYEVMGSKTKIF 87
E LKI + +REVA ++L+ P V+ E S +
Sbjct: 18 GTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGE---SDGWSY 69
Query: 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY---HRDLKPENLLL 144
+++E++ G L + ++ +L H + H DL P N+L+
Sbjct: 70 LLMEWIEGETLDEVSEEEKEDIAEQLAELLAKL-------HQLPLLVLCHGDLHPGNILV 122
Query: 145 DAYGNLKVSDFGLSAL 160
D L + D+ +
Sbjct: 123 DDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 39 VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98
V LK+LD +A + M V H ++ ++ V ++ +V EFV G L
Sbjct: 47 VVLKVLDPSH---RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 99 FDKIV--NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-------N 149
D + GR+ QQL +A+ Y + + H ++ +N+LL G
Sbjct: 104 -DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPF 162
Query: 150 LKVSDFGLS--ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF-V 206
+K+SD G+S ALS++ R + + ++APE + + AD WS G L +
Sbjct: 163 IKLSDPGVSFTALSREERVERI--------PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
Query: 207 LLAGYLPFDD---SNLMNLY-KKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEI 262
G +P + S Y KK E +C + LI++ L P R + I
Sbjct: 215 CFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELAT-----LISQCLTYEPTQRPSFRTI 269
Query: 263 LED 265
L D
Sbjct: 270 LRD 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 39 VALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGE 97
V LK+LD H+ E A+M + V H ++V LY V + +V EFV G
Sbjct: 35 VILKVLDP----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 98 LFDKIVNHGRMKEDEARRYFQ---QLINAVDYCHSRGVYHRDLKPENLLLDAYG------ 148
L + H + F+ QL +A+ Y + + H ++ +N+LL G
Sbjct: 91 L--DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECG 148
Query: 149 -NLKVSDFG--LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
+K+SD G ++ LS+Q + + ++APE + D AD WS G L+
Sbjct: 149 PFIKLSDPGIPITVLSRQECVERI--------PWIAPECVEDSKNLSIAADKWSFGTTLW 200
Query: 206 -VLLAGYLPFDDSNL 219
+ G +P D L
Sbjct: 201 EICYNGEIPLKDKTL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 63/288 (21%), Positives = 121/288 (42%), Gaps = 52/288 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVV 74
+ IG G F KV +G A +++ KE + + EQ+K E + ++H N++
Sbjct: 1 KEIGNGWFGKV-ILGEVNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA------RRYFQQLINAVDYCH 128
+ T +V+EF G+L + R E +R ++ + + H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDL-KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-------YVA 181
H DL N LL A +K+ D+GLS + ++D + TP+ ++A
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYV-----TPDQLWVPLRWIA 170
Query: 182 PEVLNDRGYDGSTAD------LWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCP 234
PE++++ + D +WS GV ++ L G P Y+ +S +
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP---------YRHLSDEQV--- 218
Query: 235 PWLSFTARKLIARILDPNPMTRITIP----EILEDEWFKKDYKPPVFE 278
L++T R+ ++ P P ++ + E+++ W + + +P E
Sbjct: 219 --LTYTVREQQLKL--PKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEE 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.002
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NV +Y V I V+E++ G L D ++N M+E E R +L+ + HS G
Sbjct: 62 NVPAVYFVDPENFII--VMEYIEGEPLKD-LINSNGMEELELSREIGRLVGKL---HSAG 115
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
+ H DL N++L G + + DFGL+ S+ + D
Sbjct: 116 IIHGDLTTSNMILSG-GKIYLIDFGLAEFSKDLED 149
|
Length = 211 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 30/123 (24%)
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ +++ S+ HRDL N+LL +K+ DFGL+ RD ++H + N
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA------RD--IMHDS----N 292
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMN 221
YV APE + D Y + +D+WS G++L+ + + G P+ DS N
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351
Query: 222 LYK 224
K
Sbjct: 352 KIK 354
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 443 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.61 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.53 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.94 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.75 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.72 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.71 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.58 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.56 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.4 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.3 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.2 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.13 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 98.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.03 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.01 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.97 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.91 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.81 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.77 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.68 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.63 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.58 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.43 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.32 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.28 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.1 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.04 | |
| PLN02236 | 344 | choline kinase | 97.03 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.88 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.61 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.47 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.43 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.34 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.98 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.9 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.81 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.51 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.0 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.81 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.61 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.53 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-65 Score=486.21 Aligned_cols=259 Identities=41% Similarity=0.735 Sum_probs=234.2
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHH----HHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK----MAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
.-+.|.+.++||+|+||.|.+|..+.+|+.||||++++....... ....+++|++||++|+|||||+++++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456799999999999999999999999999999999987754422 2345789999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC---CCeEEeecCccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALS 161 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~~kl~DFGla~~~ 161 (443)
..|+||||+.||+|++++..++.+.|+..+.+++||+.|+.|||++||+||||||+|||++.+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999876 67999999999975
Q ss_pred ccccCCCccccccCCCcccchhhhccCC--CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHH-HHHHhhcCccCCCC--C
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFTCPP--W 236 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~~~~~~--~ 236 (443)
+ ....+.+.||||.|.|||++.+.+ ++..++||||+|||||.+|+|.+||.+..... +.+.|..+.+.+-| |
T Consensus 330 g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 330 G---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred c---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 4 456788999999999999997765 44568999999999999999999998876554 88999999886643 4
Q ss_pred --CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 237 --LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 237 --~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+|.++++||.+||..||++|||++|+|+||||+.
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 8999999999999999999999999999999984
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-63 Score=492.23 Aligned_cols=262 Identities=61% Similarity=1.067 Sum_probs=247.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh--HHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK 83 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 83 (443)
....++|++++.||+|+||+|++|.+..+|..||+|+++++.... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 367889999999999999999999999999999999888763321 135678889999999998 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC-CCeEEeecCcccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~~kl~DFGla~~~~ 162 (443)
..+|+||||+.||+|+++|...++++|.+++.+|+||++|++|||++||+||||||||||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999 999999999998764
Q ss_pred cccCCCccccccCCCcccchhhhccCC-CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCC-CHH
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-SFT 240 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~ 240 (443)
.....+.+.||||.|+|||++.+.. |++.++|||||||+||.|++|..||++.+...++.+|..+.+.+|.|+ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3567789999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+++|+++||.+||.+|+|+.+|+.||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-63 Score=492.84 Aligned_cols=268 Identities=37% Similarity=0.695 Sum_probs=252.3
Q ss_pred cccccccc-----EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 013407 5 KIKRRVGK-----YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV 79 (443)
Q Consensus 5 ~~~~~~~~-----y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 79 (443)
.++..+.+ |+.++.||+|+|+.||.+++..+|+.||+|++.+....+....+.+.+||+|++.|+|||||+++++
T Consensus 7 ~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~ 86 (592)
T KOG0575|consen 7 EIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF 86 (592)
T ss_pred CCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence 34444444 9999999999999999999999999999999999888888888999999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 80 MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 80 ~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
|++.+++|||+|+|..++|..+++..+.++|.+|+.+++||+.||.|||++||+|||||..|+|++++.++||+|||||+
T Consensus 87 FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 87 FEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred eecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCH
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF 239 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 239 (443)
.... .+....+.||||.|+|||++...++ +..+||||+|||||.||.|++||+..+..+.|.+|...++.+|..+|.
T Consensus 167 ~le~--~~Erk~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~ 243 (592)
T KOG0575|consen 167 QLEY--DGERKKTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSA 243 (592)
T ss_pred eecC--cccccceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCH
Confidence 7654 3455678999999999999998777 599999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCccccccCCCC
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~~ 275 (443)
++++||.+||++||.+|||++++|.|+||+..+.|.
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence 999999999999999999999999999998777654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-63 Score=499.03 Aligned_cols=264 Identities=45% Similarity=0.851 Sum_probs=250.2
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
...+|-|+++++||.|+.|.|.+|++..||+.+|||++.+..-........+.+||.||+.+.||||+++|++|++...+
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 45789999999999999999999999999999999999987444444567899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+|.||++||+||+++...|+++|.+++++|+||+.|+.|||..+|+||||||||+|||..+++||+|||+|.+- ..
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~ 164 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VP 164 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---cC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999863 24
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 246 (443)
+..+.+.||+|.|.|||++.+.+|+|.++||||||||||+||+|.+||++.+...++.++..|.|..|..+|+++++||+
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLR 244 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHH
Confidence 66789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCChhhhhcCccccccCC
Q 013407 247 RILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
+||+.||.+|+|.+||++|||+.....
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCCC
Confidence 999999999999999999999986443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-60 Score=447.50 Aligned_cols=260 Identities=38% Similarity=0.724 Sum_probs=243.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...+.|++.+.||+|+||+|++++.+++++.||+|++++..+......+.+.+|..||..++||.||+++..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 56789999999999999999999999999999999999999887777899999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+|+||+.||+|+..|++.+.++|+.++.|+..|+.||.|||++||+||||||||||||.+|+++|+||||++..-. .+
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999985322 34
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC-CCCHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-WLSFTARKLIA 246 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~s~~~~~li~ 246 (443)
....+.|||+.|||||++.+.+|+ ..+|.||||+++|+||+|.+||.+.+...++++|..+....++ .+|.++++||+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 456678999999999999999986 8999999999999999999999999999999999999855555 49999999999
Q ss_pred HhcCCCCCCCC----ChhhhhcCccccc
Q 013407 247 RILDPNPMTRI----TIPEILEDEWFKK 270 (443)
Q Consensus 247 ~mL~~dP~~R~----t~~eil~hp~~~~ 270 (443)
++|..||.+|. .+.+|.+||||..
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999996 6889999999974
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-59 Score=430.54 Aligned_cols=257 Identities=38% Similarity=0.747 Sum_probs=245.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..+++|+++++||.|+||.|.+++++.+|..+|+|++++..+.+....+...+|.++|+.+.||.++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56889999999999999999999999999999999999999988888899999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+||||++||+||.++++.+++++..|++|+.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998532
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 247 (443)
+...+.||||.|+|||++..++|. .++|.|||||++|||++|.+||.+.+...+|++|..++..+|+.+++++++||.+
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 336789999999999999999986 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCC-----ChhhhhcCccccc
Q 013407 248 ILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 248 mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
+|+.|-.+|. ...+|..||||+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999995 4789999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-59 Score=456.87 Aligned_cols=263 Identities=35% Similarity=0.671 Sum_probs=246.3
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (443)
.+...+|.+++.||.|+|++|++|+++.+++.||||++.++.+.++...+.+.+|-.+|.+| .||.|++||-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45678999999999999999999999999999999999999998888889999999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+|+||+++|+|+++|.+.+.+++..++.|..||+.||+|||++|||||||||||||+|++|++||+|||.|+++....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999865432
Q ss_pred CC-------Cc----cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC
Q 013407 166 DD-------GL----LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 234 (443)
Q Consensus 166 ~~-------~~----~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~ 234 (443)
.. .. ..+.+||..|++||++..... ++.+|||+||||||+|++|.+||.+.+....+++|....+.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 11 11 145789999999999987554 6899999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 235 ~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+.+++.+++||+++|..||.+|+|+++|.+||||..
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 999999999999999999999999999999999974
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=429.19 Aligned_cols=261 Identities=38% Similarity=0.677 Sum_probs=239.0
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
....+++|.+.+.||.|+||+||+|+++.++..||||.+.+.+. .....+.+..||.+|+.++|||||+++++..+++.
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 34678999999999999999999999999999999999998765 34457889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC------CCeEEeecCccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY------GNLKVSDFGLSA 159 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~------~~~kl~DFGla~ 159 (443)
+|+|||||.||+|.++|...+.++|..++.++.||+.||++||+++|+||||||+||||+.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999875 358999999999
Q ss_pred ccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc---CCCCC
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPW 236 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~ 236 (443)
... ......+.||||.|||||++....|+ .|+|+||+|+|||+|++|++||+..+..+++..+..+.. ..+.+
T Consensus 164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred hCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhh
Confidence 765 45667899999999999999888887 889999999999999999999999999999888877653 33456
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+....+|+...|..+|..|.+..+-+.|++....
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 88999999999999999999999999999998754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=434.11 Aligned_cols=261 Identities=41% Similarity=0.762 Sum_probs=247.2
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
.+|++.++||+|+||+|.+|....+|+.||||.|.+..+.++...-.+++||+||+.|+||||+.+|++|++.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 58999999999999999999999999999999999999988888889999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||..+|+|+|+|...+.++|.+++.+|+||++|+.|||.++++|||||.+|||+|.++|+||+|||++.++. ....+
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DKKFL 209 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---cccHH
Confidence 999999999999999999999999999999999999999999999999999999999999999999998765 45678
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~ 250 (443)
.+.||+|.|.+||++.+.+|.|+.+|-|||||+||.|..|..||++.+...+...|..+.+.-|+ -+.++.-||+.||.
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWMLM 288 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999886655 55688999999999
Q ss_pred CCCCCCCChhhhhcCccccccCCCC
Q 013407 251 PNPMTRITIPEILEDEWFKKDYKPP 275 (443)
Q Consensus 251 ~dP~~R~t~~eil~hp~~~~~~~~~ 275 (443)
.||.+|.|+++|-.|=|+.-.+.-+
T Consensus 289 VNP~RRATieDiAsHWWvNwgy~~~ 313 (668)
T KOG0611|consen 289 VNPERRATIEDIASHWWVNWGYNMP 313 (668)
T ss_pred cCcccchhHHHHhhhheeecccccc
Confidence 9999999999999998887665543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-56 Score=435.73 Aligned_cols=262 Identities=37% Similarity=0.656 Sum_probs=238.4
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
...+++|++++.||+||||+||+|+.+.||+.+|+|++.+......+.++.++.|-.+|...++|+||++|..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45788999999999999999999999999999999999999888888889999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc--
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV-- 164 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 164 (443)
||||||++||++..+|.+.+.++|+.+++|+.+++.|+.-+|+.|++||||||+|+|||..|++||+||||++.....
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998643210
Q ss_pred ------------------cCCC-------------------------ccccccCCCcccchhhhccCCCCCCchhhhhhh
Q 013407 165 ------------------RDDG-------------------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 201 (443)
Q Consensus 165 ------------------~~~~-------------------------~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 201 (443)
..+. .....+|||.|+|||++.+.+|. ..+|.||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHH
Confidence 0000 01245799999999999999985 999999999
Q ss_pred HHHHHHhhCCCCCCCCcHHHHHHHhhcCc--cCCCCC--CCHHHHHHHHHhcCCCCCCCCC---hhhhhcCccccc
Q 013407 202 VILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (443)
Q Consensus 202 vil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~--~s~~~~~li~~mL~~dP~~R~t---~~eil~hp~~~~ 270 (443)
||+||||.|.+||.+.++.+.+++|..-. +.+|.. +++++++||.++|. ||.+|.. ++||.+||||+.
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 99999999999999999999999997654 555554 78999999999999 9999995 999999999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-55 Score=415.43 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=231.2
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE-EE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-IF 87 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~ 87 (443)
..+..+.++.||+|+.|+||+++|+.|++.+|+|++.... ++...+++.+|+++++.++|||||++|+.|.+... ++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 3446777899999999999999999999999999995432 34567899999999999999999999999999994 99
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||.||+|.+.+...++++|.....++.++++||.|||+ ++|+||||||+|||++..|.+||||||.|+..-.
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--- 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--- 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---
Confidence 999999999999999988999999999999999999999995 9999999999999999999999999999986533
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC-----cHHHHHHHhhcCc-cCCCCC-CCH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-----NLMNLYKKISAAE-FTCPPW-LSF 239 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~s~ 239 (443)
....+..||..|||||.+.+..|. .++||||||+.+.|+.+|+.||..+ +..+++..|..+. +..|.. +|+
T Consensus 232 -S~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 232 -SIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred -hhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 255788999999999999998885 8899999999999999999999875 5667888887754 456665 999
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
++++||..||++||.+|||+.|+++|||+++..
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999999999999999998643
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=403.06 Aligned_cols=258 Identities=39% Similarity=0.728 Sum_probs=235.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.-+.|.+.+.||+|+|+.||++.+..+|+.+|+|+++..++... ..+.+.+|++|-+.|+||||+++.+.+.+....|+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 44678999999999999999999999999999999998776544 56889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC---CCeEEeecCccccccccc
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~ 165 (443)
|+|++.|++|+.-|...-.++|..+-.+++||++||.|||.+||+|||+||+|+|+... .-+||+|||+|....
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--- 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--- 164 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence 99999999998888776778999999999999999999999999999999999999544 359999999998544
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC--C--CCHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--W--LSFTA 241 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s~~~ 241 (443)
.........|||.|||||++...+| +.++|||+||||||.||.|.+||.+.+...+|+.|..+.+.+|+ | +++++
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 4555677889999999999998888 48899999999999999999999999999999999999877664 3 89999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
++|+++||..||.+|+|+.|+|+|||+...
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=421.80 Aligned_cols=268 Identities=37% Similarity=0.678 Sum_probs=236.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHH-----------HHHHHHHHHHHHhcCCCCCcce
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-----------MAEQIKREVATMKLVKHPNVVR 75 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~ 75 (443)
.+.+++|++++.||+|.||.|.+|++..+++.||||++++....... -.+++++||.||++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 46789999999999999999999999999999999999876543221 1368999999999999999999
Q ss_pred EEEEEEe--CCEEEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEE
Q 013407 76 LYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (443)
Q Consensus 76 l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl 152 (443)
|+++..+ .+.+|+|+|||..|.+.. ....+. +++.+|++|+++++.||+|||.+||+||||||.|+||+++|++||
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 9999976 468999999999998744 334445 999999999999999999999999999999999999999999999
Q ss_pred eecCcccccccc---cCCCccccccCCCcccchhhhcc---CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHh
Q 013407 153 SDFGLSALSQQV---RDDGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226 (443)
Q Consensus 153 ~DFGla~~~~~~---~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i 226 (443)
+|||.+..+... ..+..+....|||.|+|||.+.+ ..|.+.+.||||+||+||+|+.|+.||-+....+++.+|
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 999998765332 12223455789999999999876 457889999999999999999999999999999999999
Q ss_pred hcCccCCCCC--CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCCC
Q 013407 227 SAAEFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (443)
Q Consensus 227 ~~~~~~~~~~--~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~~ 275 (443)
....+.+|.. +.+.+++||.+||.+||.+|+++.+|..|||...+...+
T Consensus 332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 9988877765 799999999999999999999999999999999876544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-55 Score=402.93 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=221.9
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|+.+..+|+|+||.|++|++++||+.||||.+-.+. .++...+-..|||++|++|+|||+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 478999999999999999999999999999999986433 3344557788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
+|||...-|.+.-....+++++.++.|++|++.|+.|||+++++||||||||||++.+|.+||||||+|+.... .+..
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~ 157 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN 157 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence 99998744444334456899999999999999999999999999999999999999999999999999997654 3455
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--------------------
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------- 229 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------- 229 (443)
.+.++.|.+|+|||.+.+...+|.++||||+||++.||++|++.|++.++.++...|...
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 677889999999999998776789999999999999999999999998877665544211
Q ss_pred -ccCCC----------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 230 -EFTCP----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 230 -~~~~~----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
.++-| +.++..+.+|+++||..||++|++.+|+|.||||.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 11111 23577899999999999999999999999999995
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-55 Score=390.30 Aligned_cols=258 Identities=37% Similarity=0.716 Sum_probs=244.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
-.+++|++++.||+|-||.||+|+.+.++..||+|++.++.+...+...++++|++|.+.|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 36789999999999999999999999999999999999998887777889999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~--~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+++||+.+|+|+..+. ...++++..++.|+.|++.||.|||.++|+||||||+|+|++.+|.+||+|||-+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 9999999999999998 66789999999999999999999999999999999999999999999999999986432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
.+...+.|||..|.|||...+.+++ ..+|+|++|++.|+++.|.+||...+..+.|++|...++.+|+.++.++++||
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI 253 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLI 253 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHH
Confidence 4456789999999999999999997 88999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCChhhhhcCccccc
Q 013407 246 ARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.+||..+|.+|.+..|++.|||+..
T Consensus 254 ~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 254 SRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999999865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=403.58 Aligned_cols=248 Identities=32% Similarity=0.567 Sum_probs=222.5
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEE-EE-EeCCE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE-VM-GSKTK 85 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~-~~~~~ 85 (443)
..+..|++.+.||+|+||+||++.+..+|..||.|.++-... +....+.+..|+.+|++|+|||||++++ .+ ++..-
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 456679999999999999999999999999999999985443 3445678999999999999999999998 34 44445
Q ss_pred EEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--cEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 86 IFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHS--RG--VYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~--~g--ivHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
++||||||.+|+|...|+. .+.++|..+|++|.||+.||..||+ .. |.||||||.||+++.+|.+||+||||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 9999999999999998864 4579999999999999999999999 44 99999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC-CC-C
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CP-P 235 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~-~ 235 (443)
++.+.. .....++.+|||+||+||++.+.+|+ .++||||+||++|||++-++||.+.+...+.++|..++++ .| .
T Consensus 175 ~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~ 251 (375)
T KOG0591|consen 175 GRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDE 251 (375)
T ss_pred HhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHH
Confidence 998765 34456788999999999999999997 9999999999999999999999999999999999999886 55 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCh
Q 013407 236 WLSFTARKLIARILDPNPMTRITI 259 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~ 259 (443)
.+|.++..||..|+.+||..||+.
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCc
Confidence 689999999999999999999987
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-54 Score=418.30 Aligned_cols=265 Identities=41% Similarity=0.733 Sum_probs=245.9
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
++..|-|.+.++||+|-|+.|.+|++..+|+.||||++++.+.... ....+..|++.|+.++|||||++|++..+...+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 3566789999999999999999999999999999999999876543 356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc-cCCCeEEeecCcccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~ 164 (443)
|+|+|+-.||+|+|+|.++ .+++|+.+++||.||+.|+.|||+..++||||||||+.+- .-|-+||.|||++..+.+
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P- 171 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP- 171 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence 9999999999999999876 5799999999999999999999999999999999998875 458999999999986654
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 244 (443)
...+.+.||+..|.|||++.+..|+.+++||||||||||-|.+|++||...+..+..-.|....+..|..+|.++++|
T Consensus 172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL 249 (864)
T KOG4717|consen 172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL 249 (864)
T ss_pred --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence 456889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCChhhhhcCccccccCCCC
Q 013407 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~~~~~~~~ 275 (443)
|..||..||.+|.+.++|..|+|++....++
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 9999999999999999999999999765443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-54 Score=423.60 Aligned_cols=258 Identities=33% Similarity=0.591 Sum_probs=241.4
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.+++..-. +...+.+++|++|++.++|||||.+++.|++...+|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 46899999999999999999999999999999999986543 33578899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
.|||.| +|+..+..++.++|+.++.+..|+++||.|||+++|.|||+||.|||++..|.+|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 9999999999999999999999999999999999999999999999999999999999999987554 3445
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL 249 (443)
+....|||.|||||++.+.+|+ ..+|+||||||+|||.+|++||...+..++.+.|.......|+..|..+.+||..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6677899999999999998887 889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhcCccccccC
Q 013407 250 DPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 250 ~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.+||.+|+|..+++.|||++...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999998643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-53 Score=407.86 Aligned_cols=260 Identities=31% Similarity=0.557 Sum_probs=223.3
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--EEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--KIF 87 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 87 (443)
..+|..++.||+|+||.||++.+..+|...|||.+...... ..+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 45699999999999999999999999999999999876322 2677999999999999999999999754444 799
Q ss_pred EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-CCCeEEeecCccccccc-c
Q 013407 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQ-V 164 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~~kl~DFGla~~~~~-~ 164 (443)
++|||++||+|.+.+...+ .++|..++.|.+||++||.|||++||+||||||+|||++. ++.+||+|||++..... .
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999887 7999999999999999999999999999999999999999 79999999999986553 1
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCC-CcHHHHHHHhhcC--ccCCCCCCCHHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAA--EFTCPPWLSFTA 241 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~--~~~~~~~~s~~~ 241 (443)
..........|||.|||||++......+.++||||+||++.+|+||..||.. .......-.+... .+.+|.++|.++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1223344678999999999998633334589999999999999999999987 4444444444333 357788899999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
+++|.+|+..||.+|||+.++|.|||.+...
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999999999999999997644
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-52 Score=411.19 Aligned_cols=259 Identities=36% Similarity=0.707 Sum_probs=237.4
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
....+++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 34568999999999999999999999999999999999987655444456788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999875422
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....++.+..+...+|.+++..+++||
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 171 ---RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLV 246 (329)
T ss_pred ---CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHH
Confidence 22356899999999999887764 88999999999999999999999988888888998888889999999999999
Q ss_pred HHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
.+||+.||.+|++ +++++.||||..
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999999997 799999999975
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=424.10 Aligned_cols=260 Identities=32% Similarity=0.592 Sum_probs=242.4
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 85 (443)
...+++|++.+.||+|+||+|++|..+.+++.+|||++.|..+...+.++.++.|.+|+...+ ||.++.++..|++.+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 456789999999999999999999999999999999999998888788899999999999885 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||+.||++ ..+...+.+++..++.|+..++.||.|||++||||||||.+|||||.+|++||+|||+++- ...
T Consensus 444 l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe--~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE--GMG 520 (694)
T ss_pred EEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc--cCC
Confidence 9999999999994 4455568899999999999999999999999999999999999999999999999999874 233
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
.+....+.||||.|+|||++.+..|. ..+|.|||||+||+||.|+.||.+.+..+++..|...++.+|.|+|.++.+++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence 45567899999999999999998885 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
+++|..||.+|.. +++|.+||||+.
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999996 578999999984
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=394.99 Aligned_cols=262 Identities=29% Similarity=0.468 Sum_probs=224.6
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----CCE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-----KTK 85 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~ 85 (443)
.+|...+.||+|+||.|+.|.++.+|+.||||.+.. .+.+.-..++..||+++|++++|+||+.+++++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456667999999999999999999999999999974 34445567899999999999999999999999865 467
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+|+|++ +.+|...|+.+..++++.++.+++||+.||+|+||.||+||||||.|+|++.++.+||||||+|+......
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999999 45888888877779999999999999999999999999999999999999999999999999999875544
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC----------------
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---------------- 229 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 229 (443)
....++.++-|.+|.|||++.....++..+||||+|||+.||++|++.|.|.+..+..+.|...
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 4556677889999999999876655569999999999999999999999998866555443211
Q ss_pred -------ccCCC--------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 230 -------EFTCP--------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 230 -------~~~~~--------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
....| +..++.+.+|+.+||..||.+|+|++|+|+|||+..-..|
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 01111 3478999999999999999999999999999999875544
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=411.59 Aligned_cols=257 Identities=41% Similarity=0.753 Sum_probs=235.4
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 88 (443)
-..|++.+.||+|.||.||.|+++.+|+.+|+|++.+...........+.+|+.+|+++. |||||.+++++++...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 357999999999999999999999999999999999887665545678999999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC----CCeEEeecCcccccccc
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY----GNLKVSDFGLSALSQQV 164 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~----~~~kl~DFGla~~~~~~ 164 (443)
|||+|.||+|++.|... .++|..+..++.|++.|++|||+.||+||||||||+|+... +.+|++|||+|.....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~- 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP- 191 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence 99999999999999876 49999999999999999999999999999999999999644 4799999999986543
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC--CC--CCHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--PW--LSFT 240 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~--~s~~ 240 (443)
.......||||.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+....+..+..+++.++ +| +|..
T Consensus 192 --~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 192 --GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred --CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 5567889999999999999887885 899999999999999999999999999888889988876544 44 7999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
++++|++||..||.+|+|+.++|+|||++..
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=401.55 Aligned_cols=254 Identities=33% Similarity=0.665 Sum_probs=232.3
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998765444445567899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875432 12
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~ 250 (443)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....++.+..+...+|..+++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 346799999999999887764 8899999999999999999999999888888898888888888999999999999999
Q ss_pred CCCCCCCC-----hhhhhcCccccc
Q 013407 251 PNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 251 ~dP~~R~t-----~~eil~hp~~~~ 270 (443)
.||.+|++ +++++.||||+.
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=418.54 Aligned_cols=263 Identities=43% Similarity=0.798 Sum_probs=248.6
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
...++.|.+.++||+|.|++|.+|++..++..||||++++...... ..+.+.+|+.+|+.|+|||||+++.+..+...+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 4678999999999999999999999999999999999998765544 445599999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+.||++++++.+++++.+..++.+|.|+++|++|||+++|+|||||++||||+.+.++||+|||++..+. .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999775 3
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 246 (443)
...+.+.||+|+|.|||++.+..|+++.+|+||+|++||.|+.|.+||++.+...+..+...+.+..|-.++.++.+||+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 56788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCChhhhhcCccccccCC
Q 013407 247 RILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
++|..+|.+|+++++++.|+|....+.
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhh
Confidence 999999999999999999999876543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=408.16 Aligned_cols=262 Identities=32% Similarity=0.519 Sum_probs=227.8
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--C
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--T 84 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~ 84 (443)
....+.|+.++.||+|+||.||+|++..+|+.||+|.+..+.. +++......|||.||++|+||||+++.++..+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 3566789999999999999999999999999999999976543 345667788999999999999999999998876 7
Q ss_pred EEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
.+|+|+|||+. +|.-++.. .-.|++.++..|++||+.||+|||++||.|||||.+|||||.+|++||+|||||+++..
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 89999999987 77777765 34799999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--c--------cCC
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--E--------FTC 233 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~--------~~~ 233 (443)
... ..++..+-|.+|.|||.+.+...++..+|+||+||||.||++|++.|.+.+..++..+|... . ..+
T Consensus 271 ~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 271 SGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 433 34667778999999999999887789999999999999999999999999988877776321 0 011
Q ss_pred C-------------------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 234 P-------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 234 ~-------------------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
| ..++..+.+|+..||..||.+|.|+.++|.|+||+..
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 1 1257889999999999999999999999999999543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-53 Score=410.16 Aligned_cols=259 Identities=32% Similarity=0.511 Sum_probs=225.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC-E
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT-K 85 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-~ 85 (443)
..+++|.+++.||.|+||.||+|+.+.+|+.||||.+.+....-+ .. .=.||+..|++|+ |||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~-~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-EC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 457899999999999999999999999999999999977543322 22 2348999999998 999999999998877 9
Q ss_pred EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
+|+||||++ .+|++.++.. ..+++..++.|+.||++||+|+|.+|++|||+||||||+..+..+||+|||+|+..
T Consensus 85 L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev--- 160 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV--- 160 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc---
Confidence 999999997 4999998654 56999999999999999999999999999999999999999999999999999854
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc----------------
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---------------- 228 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---------------- 228 (443)
......+.++.|.+|+|||++...++++.++|||++|||++|+.+-++.|+|.+..+...+|..
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 3445567788999999999999999999999999999999999999999999998877666521
Q ss_pred ---CccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 229 ---AEFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 229 ---~~~~~~-----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
-.+.+| +..+.++.+||.+||..||++|||+.++|+||||+...
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 122232 23688999999999999999999999999999998644
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=403.07 Aligned_cols=251 Identities=35% Similarity=0.627 Sum_probs=227.7
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 96 (443)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544445667889999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCC
Q 013407 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (443)
Q Consensus 97 ~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 176 (443)
+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 9999999888999999999999999999999999999999999999999999999999999864221 22234456899
Q ss_pred CcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 013407 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (443)
Q Consensus 177 ~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R 256 (443)
+.|+|||++.+..|. .++||||+||++|+|++|..||...+.......+......+|..+++++.+||.+||..||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999877774 8899999999999999999999998888888888888888888999999999999999999999
Q ss_pred C-----ChhhhhcCccccc
Q 013407 257 I-----TIPEILEDEWFKK 270 (443)
Q Consensus 257 ~-----t~~eil~hp~~~~ 270 (443)
| ++.++++||||..
T Consensus 238 ~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-53 Score=383.79 Aligned_cols=258 Identities=36% Similarity=0.654 Sum_probs=232.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh-----hhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (443)
-..+|...+.||.|..+.|.++.++.+|..+|+|++..... ....+.+.-.+|+.||+++ .||||+++.+++++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 35678888999999999999999999999999999964221 1234567788999999999 69999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
+..+++|+|.|+.|+|||++.....++|..++.+++||++|+.|||.++|+||||||+|||+|++.++||+|||+|+...
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998554
Q ss_pred cccCCCccccccCCCcccchhhhccC-----CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC--CCC
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPP 235 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~ 235 (443)
.+..+...||||.|.|||.+... +.++..+|+|+||||+|-||.|.+||-.....-+...|..|.+. .|.
T Consensus 175 ---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 175 ---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred ---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 35567889999999999998643 23357899999999999999999999999888899999999765 466
Q ss_pred C--CCHHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 236 W--LSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 236 ~--~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
| +|.++++||+++|+.||.+|+|++|+|+||||.
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 6 789999999999999999999999999999995
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=403.80 Aligned_cols=258 Identities=33% Similarity=0.619 Sum_probs=234.3
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCC-ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
...+++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 456789999999999999999999976654 6899999987665445556788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
.|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+....++.+..+...+|+.+++.++++|
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred ---CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 2245689999999999987666 488999999999999999999999988888888888888888999999999999
Q ss_pred HHhcCCCCCCCC-----ChhhhhcCccccc
Q 013407 246 ARILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
++||+.||.+|+ |++++++||||..
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999996 8999999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-51 Score=370.54 Aligned_cols=257 Identities=32% Similarity=0.505 Sum_probs=222.8
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
.+|...+.||+|+||.||+|++..+|+.||||.+...+.. .+......|||+.|+.++||||+.++++|.+.+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 5789999999999999999999999999999999876543 233456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||++. +|...|+.. ..++..++..|+.++++||+|||++.|.||||||.|+|++.+|.+||+|||+|+.+.... ..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~--~~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN--RI 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC--cc
Confidence 99985 888888654 468999999999999999999999999999999999999999999999999999876532 23
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-------------------
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------- 230 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------- 230 (443)
....+-|.+|.|||.+.+...++..+||||.|||+.||+-|.+-|.|.++-++...|-+.-
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 3344789999999999988777899999999999999999999999998877666653210
Q ss_pred ---cCCC------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 231 ---FTCP------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 231 ---~~~~------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
++.| +..+.++.+|+.+||..||.+|+|+.|+|+|+||+..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 1111 1257789999999999999999999999999999873
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=395.22 Aligned_cols=250 Identities=36% Similarity=0.621 Sum_probs=226.2
Q ss_pred eeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013407 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (443)
Q Consensus 19 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 98 (443)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++.+.+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876544444567788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCc
Q 013407 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (443)
Q Consensus 99 ~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 178 (443)
.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 99999888999999999999999999999999999999999999999999999999999875322 1223345689999
Q ss_pred ccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-
Q 013407 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI- 257 (443)
Q Consensus 179 y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~- 257 (443)
|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+......+|..+++.+++||.+||..||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999887774 88999999999999999999999988888888888888888889999999999999999999997
Q ss_pred --ChhhhhcCcccccc
Q 013407 258 --TIPEILEDEWFKKD 271 (443)
Q Consensus 258 --t~~eil~hp~~~~~ 271 (443)
++.+++.||||...
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57899999999853
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=401.27 Aligned_cols=258 Identities=32% Similarity=0.592 Sum_probs=224.6
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+++|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544555678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC----
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 166 (443)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875322100
Q ss_pred -----------------------------CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC
Q 013407 167 -----------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (443)
Q Consensus 167 -----------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~ 217 (443)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0011346899999999999887775 8899999999999999999999998
Q ss_pred cHHHHHHHhhcC--ccCCCCC--CCHHHHHHHHHhcCCCCC---CCCChhhhhcCccccc
Q 013407 218 NLMNLYKKISAA--EFTCPPW--LSFTARKLIARILDPNPM---TRITIPEILEDEWFKK 270 (443)
Q Consensus 218 ~~~~~~~~i~~~--~~~~~~~--~s~~~~~li~~mL~~dP~---~R~t~~eil~hp~~~~ 270 (443)
+....+.++... ...+|+. +++++++||.+|+. +|. .||+++|+++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 888888777653 3445543 78999999999875 444 4689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=395.86 Aligned_cols=251 Identities=35% Similarity=0.635 Sum_probs=226.8
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 96 (443)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544555678889999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCC
Q 013407 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (443)
Q Consensus 97 ~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 176 (443)
+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999999864221 12233456899
Q ss_pred CcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 013407 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (443)
Q Consensus 177 ~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R 256 (443)
+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||++||..||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999987766 48899999999999999999999988888888888778888888999999999999999999999
Q ss_pred C-----ChhhhhcCccccc
Q 013407 257 I-----TIPEILEDEWFKK 270 (443)
Q Consensus 257 ~-----t~~eil~hp~~~~ 270 (443)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-50 Score=384.88 Aligned_cols=263 Identities=33% Similarity=0.519 Sum_probs=228.5
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....+.|++...||.|..++||+|+...+++.||||+++.+++... .+.+++|+..|+.++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 4567899999999999999999999999999999999999887664 78999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
|+||.|+.+|++++.+... .+++|..+..++++++.||.|||.+|.+|||||+.||||+.+|.+||+|||.+......
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999999999764 46999999999999999999999999999999999999999999999999988765443
Q ss_pred cCCC-cc-ccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC------
Q 013407 165 RDDG-LL-HTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP------ 234 (443)
Q Consensus 165 ~~~~-~~-~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 234 (443)
+... .. .+..|||+|||||++.. .+|+ .|+||||+|+...||.+|..||....++++.-.-..+.++.+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 3211 11 56789999999999533 3565 999999999999999999999998877765433333333322
Q ss_pred ----CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 235 ----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 235 ----~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
..++..++.+|..||+.||.+|||+.++|+|+||++..
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 12677899999999999999999999999999998654
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=392.79 Aligned_cols=251 Identities=35% Similarity=0.646 Sum_probs=225.9
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876544444556777888888876 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 99999998888999999999999999999999999999999999999999999999999999864321 1223345689
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+..+....|.+++.++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999877664 889999999999999999999999998888889888888889999999999999999999999
Q ss_pred CCCh------hhhhcCccccc
Q 013407 256 RITI------PEILEDEWFKK 270 (443)
Q Consensus 256 R~t~------~eil~hp~~~~ 270 (443)
||++ ++++.||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 89999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=393.35 Aligned_cols=251 Identities=35% Similarity=0.631 Sum_probs=226.5
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 96 (443)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544445667889999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCC
Q 013407 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (443)
Q Consensus 97 ~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 176 (443)
+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999999864211 12223456799
Q ss_pred CcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 013407 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (443)
Q Consensus 177 ~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R 256 (443)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999877664 8899999999999999999999998888888888878888888899999999999999999999
Q ss_pred C-----ChhhhhcCccccc
Q 013407 257 I-----TIPEILEDEWFKK 270 (443)
Q Consensus 257 ~-----t~~eil~hp~~~~ 270 (443)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=398.27 Aligned_cols=258 Identities=34% Similarity=0.627 Sum_probs=225.1
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444455677899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC---
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--- 167 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 167 (443)
||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998653221100
Q ss_pred ---------------------------------CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCC
Q 013407 168 ---------------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (443)
Q Consensus 168 ---------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf 214 (443)
....+.+||+.|+|||++.+..+. .++|||||||++|+|++|.+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011235799999999999877774 8899999999999999999999
Q ss_pred CCCcHHHHHHHhhcCc--cCCCC--CCCHHHHHHHHHhcCCCCCCCCC---hhhhhcCccccc
Q 013407 215 DDSNLMNLYKKISAAE--FTCPP--WLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (443)
Q Consensus 215 ~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~mL~~dP~~R~t---~~eil~hp~~~~ 270 (443)
.+.+....+..+.... +.+|. .+++++++||++||. +|.+|++ ++++++||||..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9888777776665432 33343 368999999999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=393.03 Aligned_cols=254 Identities=32% Similarity=0.574 Sum_probs=226.1
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765544445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875432 23
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--cCCCC------CCCHHHH
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP------WLSFTAR 242 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~------~~s~~~~ 242 (443)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+.... ...|. .++.++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 456799999999999887665 88999999999999999999999888777666654322 22222 3589999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 243 KLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+||.+||..+|.+||+++++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=390.49 Aligned_cols=256 Identities=31% Similarity=0.564 Sum_probs=229.6
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCEEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~ 90 (443)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544444567788899999999764 6888999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 9999999999998888999999999999999999999999999999999999999999999999999864221 12233
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~ 250 (443)
...+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+....+..+......+|..++.++.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999887774 8899999999999999999999999888888888888888888999999999999999
Q ss_pred CCCCCCCCh-----hhhhcCccccc
Q 013407 251 PNPMTRITI-----PEILEDEWFKK 270 (443)
Q Consensus 251 ~dP~~R~t~-----~eil~hp~~~~ 270 (443)
.||.+|++. +++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999987 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=384.41 Aligned_cols=264 Identities=28% Similarity=0.475 Sum_probs=235.9
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
...-+.+|++++.||+|.-|+||+|....++..+|+|+++++.........+++.|-.||+.++||.++.||..++++..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 34556789999999999999999999999999999999999888777778899999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
.|++||||+||+|....++ .+.+++..+++|+..++-||+|||..|||+||||||||||-++|++-|+||.|+....-
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999988865 45799999999999999999999999999999999999999999999999998743210
Q ss_pred -----------------------------c---c-C---------------------CCccccccCCCcccchhhhccCC
Q 013407 164 -----------------------------V---R-D---------------------DGLLHTTCGTPNYVAPEVLNDRG 189 (443)
Q Consensus 164 -----------------------------~---~-~---------------------~~~~~~~~gt~~y~APEvl~~~~ 189 (443)
. . . +......+||-.|+|||++.+.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0 00112357899999999999988
Q ss_pred CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC--CCCHHHHHHHHHhcCCCCCCCCC----hhhhh
Q 013407 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--WLSFTARKLIARILDPNPMTRIT----IPEIL 263 (443)
Q Consensus 190 ~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~li~~mL~~dP~~R~t----~~eil 263 (443)
.. .++|.|+|||.+||||.|..||.+.+..+.+.+|......+|. .++..+++||+++|.+||.+|.. +.||.
T Consensus 312 Hg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 312 HG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 85 8999999999999999999999999999999999888777664 57899999999999999999998 99999
Q ss_pred cCccccc
Q 013407 264 EDEWFKK 270 (443)
Q Consensus 264 ~hp~~~~ 270 (443)
+||||+.
T Consensus 391 ~HpFF~g 397 (459)
T KOG0610|consen 391 RHPFFEG 397 (459)
T ss_pred cCccccC
Confidence 9999985
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=391.21 Aligned_cols=251 Identities=33% Similarity=0.594 Sum_probs=226.4
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876554444556777899998866 799999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 99999998888999999999999999999999999999999999999999999999999999874322 2223345679
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....++.+.......|.+++.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999877774 889999999999999999999999998899999988888889999999999999999999999
Q ss_pred CC-------ChhhhhcCccccc
Q 013407 256 RI-------TIPEILEDEWFKK 270 (443)
Q Consensus 256 R~-------t~~eil~hp~~~~ 270 (443)
|+ +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 8999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=401.33 Aligned_cols=257 Identities=29% Similarity=0.518 Sum_probs=228.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
....+|.....||+|+.|.||.|....+++.||||.++...... .+.+.+|+.+|+..+|+|||.+++.|.-.+.+|
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 34567888999999999999999999999999999999876544 457899999999999999999999998889999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+||||++||+|.|.+.. ..++|.++..+++++++||+|||.+||+|||||.+|||++.+|.+||+|||++...... .
T Consensus 347 VVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~ 423 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--Q 423 (550)
T ss_pred EEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc--c
Confidence 99999999999887765 45999999999999999999999999999999999999999999999999998865542 2
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHh-hcC--ccCCCCCCCHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-SAA--EFTCPPWLSFTARKL 244 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i-~~~--~~~~~~~~s~~~~~l 244 (443)
....+..|||+|||||++..+.| |+++||||||++++||+.|++||-..++......| ..+ .+..|..+|+.+++|
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred CccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 24567899999999999998888 59999999999999999999999877766544444 333 456677899999999
Q ss_pred HHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 245 IARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
|.+||+.||.+|+++.|+|+||||+..
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 999999999999999999999999643
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=398.59 Aligned_cols=259 Identities=32% Similarity=0.535 Sum_probs=222.6
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
..|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999998766555556678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC----
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 166 (443)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999754311000
Q ss_pred -----------------------------------------CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHH
Q 013407 167 -----------------------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205 (443)
Q Consensus 167 -----------------------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~ 205 (443)
.....+.+||+.|+|||++.+..|. .++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHH
Confidence 0011345799999999999887775 8899999999999
Q ss_pred HHhhCCCCCCCCcHHHHHHHhhc--CccCCCC--CCCHHHHHHHHHhc--CCCCCCCCChhhhhcCccccc
Q 013407 206 VLLAGYLPFDDSNLMNLYKKISA--AEFTCPP--WLSFTARKLIARIL--DPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 206 ~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~~~~li~~mL--~~dP~~R~t~~eil~hp~~~~ 270 (443)
+|++|.+||...+.......+.. .....|. .+++++.+||.+|+ ..+|..|++++++++||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 99999999998877665555543 2334444 47999999999966 455556999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=392.54 Aligned_cols=251 Identities=35% Similarity=0.629 Sum_probs=226.3
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 96 (443)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998766544445667788999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 97 ~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
+|.+.+...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 999999888889999999999999999999998 7999999999999999999999999999864221 1223345679
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999877764 889999999999999999999999888888888888888888889999999999999999999
Q ss_pred CC-----ChhhhhcCccccc
Q 013407 256 RI-----TIPEILEDEWFKK 270 (443)
Q Consensus 256 R~-----t~~eil~hp~~~~ 270 (443)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=398.54 Aligned_cols=258 Identities=33% Similarity=0.589 Sum_probs=222.7
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++++.||+|+||.||+|.+..+++.||||++.+.........+.+++|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765544555678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC---
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--- 167 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 167 (443)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHH
Q 013407 168 ------------------------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205 (443)
Q Consensus 168 ------------------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~ 205 (443)
......+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 000135799999999999877774 8899999999999
Q ss_pred HHhhCCCCCCCCcHHHHHHHhhcC--ccCCCC--CCCHHHHHHHHHhcCCCCCCC---CChhhhhcCccccc
Q 013407 206 VLLAGYLPFDDSNLMNLYKKISAA--EFTCPP--WLSFTARKLIARILDPNPMTR---ITIPEILEDEWFKK 270 (443)
Q Consensus 206 ~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~mL~~dP~~R---~t~~eil~hp~~~~ 270 (443)
+|++|.+||.+.+....+..+... ...+|. .++.++++||.+||. +|.+| +|+.+++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877777766542 334444 478999999999998 66665 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=398.32 Aligned_cols=258 Identities=34% Similarity=0.567 Sum_probs=223.1
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
.+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765544556678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc-----
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR----- 165 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----- 165 (443)
||++||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHH
Q 013407 166 ----------------------------------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205 (443)
Q Consensus 166 ----------------------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~ 205 (443)
......+.+||+.|+|||++.+..|+ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00011235799999999999888775 8899999999999
Q ss_pred HHhhCCCCCCCCcHHHHHHHhhcC--ccCCC--CCCCHHHHHHHHHhcCCCCCCCCC---hhhhhcCccccc
Q 013407 206 VLLAGYLPFDDSNLMNLYKKISAA--EFTCP--PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (443)
Q Consensus 206 ~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~~~li~~mL~~dP~~R~t---~~eil~hp~~~~ 270 (443)
+|++|++||.+.+......++... ....| ..+++++.++|.+|+ .+|.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999988776665555432 23333 357999999999987 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=387.64 Aligned_cols=251 Identities=31% Similarity=0.612 Sum_probs=222.8
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||.||+|.+..+|+.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999876543333455677788888754 899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 99999998888899999999999999999999999999999999999999999999999999863211 1223456789
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.....+.+.......|.+++.++++||++||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887774 889999999999999999999999888888888887778888899999999999999999999
Q ss_pred CCCh-hhhhcCccccc
Q 013407 256 RITI-PEILEDEWFKK 270 (443)
Q Consensus 256 R~t~-~eil~hp~~~~ 270 (443)
||++ +++++||||..
T Consensus 238 R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 238 RLGVVGNIRGHPFFKT 253 (316)
T ss_pred cCCChHHHHcCCCcCC
Confidence 9998 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=388.06 Aligned_cols=254 Identities=30% Similarity=0.545 Sum_probs=225.0
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHH---hcCCCCCcceEEEEEEeCCEEEEE
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM---KLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|++++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999876544444456777777665 566799999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|||++|++|...+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence 999999999888754 5799999999999999999999999999999999999999999999999999864222 2223
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL 249 (443)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|..++..+.++|.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred ccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 345789999999999987766 4889999999999999999999999988888888888888888889999999999999
Q ss_pred CCCCCCCC-----ChhhhhcCccccc
Q 013407 250 DPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 250 ~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
+.||.+|| ++.++++||||..
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 99999999 6999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=382.10 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=214.0
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
++++|++.+.||.|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 578899999999999999999999999999999999754321 123467789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||||+.| +|.+.+...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~ 157 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PT 157 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CC
Confidence 9999985 8988887644 579999999999999999999999999999999999999999999999999875332 12
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------------------
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------ 229 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 229 (443)
.......||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 22344578999999999876544468999999999999999999999887765444332110
Q ss_pred -ccCC-----------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 230 -EFTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 230 -~~~~-----------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
...+ .+.++.++++||++||+.||.+|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0011 12367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=381.31 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=220.1
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987655444444567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|+.+|+|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 99999998887543 4689999999999999999999999999999999999999999999999999875422 122
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH----HHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
.....||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+.. .....+.......+..++.++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 3456799999999999877775 8899999999999999999999875432 2333344445566777999999999
Q ss_pred HHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
++||+.||.+||+ ++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=397.61 Aligned_cols=258 Identities=34% Similarity=0.557 Sum_probs=222.5
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC----
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 166 (443)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999753311000
Q ss_pred -------------------------------------CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh
Q 013407 167 -------------------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 209 (443)
Q Consensus 167 -------------------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~ 209 (443)
.......+||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 0011235799999999999887775 88999999999999999
Q ss_pred CCCCCCCCcHHHHHHHhhcC--ccCCCC--CCCHHHHHHHHHhcCCCCCCCC---ChhhhhcCccccc
Q 013407 210 GYLPFDDSNLMNLYKKISAA--EFTCPP--WLSFTARKLIARILDPNPMTRI---TIPEILEDEWFKK 270 (443)
Q Consensus 210 G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~mL~~dP~~R~---t~~eil~hp~~~~ 270 (443)
|..||.+.+.......+... ....|. .+++++.++|.+|+ .+|.+|+ |+.++++||||..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999988877665555432 223333 47999999999987 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=393.49 Aligned_cols=258 Identities=34% Similarity=0.644 Sum_probs=228.0
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544445678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc-----
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR----- 165 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----- 165 (443)
||+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999987543322
Q ss_pred ----------------------CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHH
Q 013407 166 ----------------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223 (443)
Q Consensus 166 ----------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~ 223 (443)
.........||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 00123345799999999999887664 8999999999999999999999998877777
Q ss_pred HHhhc--CccCCCCC--CCHHHHHHHHHhcCCCCCCCCC-hhhhhcCccccc
Q 013407 224 KKISA--AEFTCPPW--LSFTARKLIARILDPNPMTRIT-IPEILEDEWFKK 270 (443)
Q Consensus 224 ~~i~~--~~~~~~~~--~s~~~~~li~~mL~~dP~~R~t-~~eil~hp~~~~ 270 (443)
.++.. .....|.. +++++.+||.+||. ||.+|++ ++++++||||..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77765 34444443 59999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=386.51 Aligned_cols=256 Identities=31% Similarity=0.559 Sum_probs=229.3
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
+|++.+.||+|+||.||+|.+..+++.||+|++.+..............|..++..+ +||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 488999999999999999999999999999999876544444456677888888877 5899999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999864321 12233
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~ 250 (443)
...+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+......+|..++.++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 456899999999999887775 8899999999999999999999999888888888888888888999999999999999
Q ss_pred CCCCCCCCh-----hhhhcCccccc
Q 013407 251 PNPMTRITI-----PEILEDEWFKK 270 (443)
Q Consensus 251 ~dP~~R~t~-----~eil~hp~~~~ 270 (443)
.||.+|++. .++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999985 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=387.98 Aligned_cols=251 Identities=32% Similarity=0.592 Sum_probs=220.5
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555567788999999988 799999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999864211 2233445789
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC---------cHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------NLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 246 (443)
|+.|+|||++.+..++ .++||||+||++|+|++|..||+.. .....++.+.......|..++..+.++|+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887765 8899999999999999999999631 12234556666777888899999999999
Q ss_pred HhcCCCCCCCCC------hhhhhcCccccc
Q 013407 247 RILDPNPMTRIT------IPEILEDEWFKK 270 (443)
Q Consensus 247 ~mL~~dP~~R~t------~~eil~hp~~~~ 270 (443)
+||+.||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=385.21 Aligned_cols=251 Identities=33% Similarity=0.650 Sum_probs=222.0
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||.||+|.+..+++.||+|++.+.........+....|..++..+ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876544444455666777777654 899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874322 1233445689
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+.......|.+++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999877764 889999999999999999999999888888888877777888899999999999999999999
Q ss_pred CCChh-hhhcCccccc
Q 013407 256 RITIP-EILEDEWFKK 270 (443)
Q Consensus 256 R~t~~-eil~hp~~~~ 270 (443)
||++. +++.||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99875 8889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=386.29 Aligned_cols=251 Identities=35% Similarity=0.647 Sum_probs=224.0
Q ss_pred eEeeccCcEEEEEEEEC---CCCceEEEEEeechhhhh-HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 17 RTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
+.||+|+||.||+|.+. .+++.||+|++.+..... ......+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999874 478899999998754322 23345678999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcccc
Q 013407 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (443)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 172 (443)
+.|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~ 159 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTHT 159 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCcccc
Confidence 99999999999888999999999999999999999999999999999999999999999999999864322 2223345
Q ss_pred ccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCC
Q 013407 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252 (443)
Q Consensus 173 ~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~d 252 (443)
.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+..+....|+.+++.+.+||.+||+.|
T Consensus 160 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred cCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 6799999999999877664 889999999999999999999999888888888888888889999999999999999999
Q ss_pred CCCCC-----ChhhhhcCccccc
Q 013407 253 PMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 253 P~~R~-----t~~eil~hp~~~~ 270 (443)
|.+|| +++++++||||..
T Consensus 239 p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HhHcCCCCCCCHHHHhcCCCcCC
Confidence 99999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=392.01 Aligned_cols=262 Identities=32% Similarity=0.544 Sum_probs=227.2
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45678999999999999999999999999999999999875544444456688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||++||+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~- 196 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG- 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-
Confidence 999999999999998865 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCccccccCCCcccchhhhccCC---CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--cCCCC--CCCH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP--WLSF 239 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~ 239 (443)
.......+||+.|+|||++.+.. +.+.++|||||||++|+|++|.+||.+.+....+.++.... ..+|. .+|.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 11223567999999999986532 34688999999999999999999999988888888776542 44454 4799
Q ss_pred HHHHHHHHhcCCCCCC--CCChhhhhcCccccc
Q 013407 240 TARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~--R~t~~eil~hp~~~~ 270 (443)
++++||++||+.+|.+ |+|++++++||||+.
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 9999999999999988 999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-49 Score=392.38 Aligned_cols=258 Identities=33% Similarity=0.619 Sum_probs=225.0
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
+.|++.+.||+|+||.||+|.+..+++.||+|++.+...........+++|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544555678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC----
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 166 (443)
||++||+|.+.+...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864321100
Q ss_pred -----------------------------CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC
Q 013407 167 -----------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (443)
Q Consensus 167 -----------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~ 217 (443)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0011245799999999999887775 8899999999999999999999998
Q ss_pred cHHHHHHHhhcC--ccCCCCC--CCHHHHHHHHHhcCCCCCCCCC---hhhhhcCccccc
Q 013407 218 NLMNLYKKISAA--EFTCPPW--LSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (443)
Q Consensus 218 ~~~~~~~~i~~~--~~~~~~~--~s~~~~~li~~mL~~dP~~R~t---~~eil~hp~~~~ 270 (443)
+....+.++... ...+|+. ++.++++||.+|+. ||.+|++ ++++++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 888777776543 3344443 78999999999874 9999994 799999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=385.86 Aligned_cols=251 Identities=36% Similarity=0.619 Sum_probs=221.9
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++.+.+.+..|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765444333445555555 56889999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999864221 2223345679
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+.......++.++..+.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999887765 889999999999999999999999888888888888877788889999999999999999999
Q ss_pred CCCh----hhhhcCccccc
Q 013407 256 RITI----PEILEDEWFKK 270 (443)
Q Consensus 256 R~t~----~eil~hp~~~~ 270 (443)
||++ .+++.||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9998 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=384.64 Aligned_cols=251 Identities=34% Similarity=0.642 Sum_probs=226.1
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876554444566778899999888 799999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 99999998888999999999999999999999999999999999999999999999999999864221 1222345679
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+.......|..++..+.+||++||..||.+
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 889999999999999999999999888888888888888888889999999999999999999
Q ss_pred CCCh-----hhhhcCccccc
Q 013407 256 RITI-----PEILEDEWFKK 270 (443)
Q Consensus 256 R~t~-----~eil~hp~~~~ 270 (443)
|||+ .+++.||||..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCC
Confidence 9999 99999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=376.13 Aligned_cols=260 Identities=33% Similarity=0.620 Sum_probs=244.6
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..+++|..++.||+|.||+|-+++.+.+++.+|||++.++-+...+....-..|-++|+..+||.+..+...|++.+.++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 46788999999999999999999999999999999999988777777788889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+||||+.||+|+-.+.+...++|+.++.|-..|++||.|||+++|++||||.+|+|+|.+|++||+|||+++- .....
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~~g 322 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIKYG 322 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--ccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999873 33455
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 247 (443)
....+.||||.|.|||++....| +.++|.|.+||++|+|++|++||...+...++..|...+..+|..+|++++.|+..
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSG 401 (516)
T ss_pred ceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHH
Confidence 66788999999999999998888 59999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCC-----hhhhhcCccccc
Q 013407 248 ILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 248 mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
+|..||.+|.. +.||.+|+||..
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 99999999984 889999999974
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=378.59 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=213.7
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999999764322 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||+.++.+.........+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 999998776655555679999999999999999999999999999999999999999999999999987643211 1223
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-------------------c
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------------------F 231 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 231 (443)
....||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+..+....+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 345789999999999877764 88999999999999999999998766543322221100 0
Q ss_pred CCC-------------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 232 TCP-------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 232 ~~~-------------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
..| ..+|..+.+||++||+.||.+|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 011 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=381.06 Aligned_cols=257 Identities=27% Similarity=0.466 Sum_probs=210.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 357899999999999999999999999999999999754321 123457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||||+. ++|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 157 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PS 157 (303)
T ss_pred EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CC
Confidence 999996 5777777654 5789999999999999999999999999999999999999999999999999874322 12
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhc--Cc--------------
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISA--AE-------------- 230 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~--~~-------------- 230 (443)
......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.... .....+.. +.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22345678999999999876555568899999999999999999999875432 22222110 00
Q ss_pred -----c--CCC---------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 231 -----F--TCP---------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 231 -----~--~~~---------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+ ..+ ...+..+.+||++||+.||.+|||+.++++||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 0 000 013567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=391.49 Aligned_cols=262 Identities=33% Similarity=0.576 Sum_probs=225.3
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34567999999999999999999999999999999999875544444456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~- 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG- 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-
Confidence 999999999999998865 468999999999999999999999999999999999999999999999999987643211
Q ss_pred CCccccccCCCcccchhhhccCC---CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCCC--CCCH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPP--WLSF 239 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~ 239 (443)
.....+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||.+.+....+..+... .+.+|. .++.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 276 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence 11224568999999999997543 3468899999999999999999999998887777777653 244444 4699
Q ss_pred HHHHHHHHhcCCCCCC--CCChhhhhcCccccc
Q 013407 240 TARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~--R~t~~eil~hp~~~~ 270 (443)
.+++++.+||..+|.+ |+|++++++||||+.
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 9999999999866544 899999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=383.04 Aligned_cols=251 Identities=31% Similarity=0.609 Sum_probs=222.0
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||.||+|.+..+++.||||++.+..............|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876543333445667788888764 899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 99999998888899999999999999999999999999999999999999999999999999864221 1222345679
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....++.+.......|.+++.+++++|.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999877764 889999999999999999999999888888888877777788899999999999999999999
Q ss_pred CCChh-hhhcCccccc
Q 013407 256 RITIP-EILEDEWFKK 270 (443)
Q Consensus 256 R~t~~-eil~hp~~~~ 270 (443)
||++. ++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 238 RLGVKGDIRQHPFFRE 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99996 8999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=386.66 Aligned_cols=258 Identities=29% Similarity=0.522 Sum_probs=223.8
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766544455678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 999999999999876 6899999999999999999999999999999999999999999999999999875432111 12
Q ss_pred cccccCCCcccchhhhcc-----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc----cCCCCCCCHH
Q 013407 170 LHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----FTCPPWLSFT 240 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----~~~~~~~s~~ 240 (443)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ++..+.++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2233588999999999999999999999888777777665432 2233458999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+.+||++||. +|.+|||++++++||||..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=382.84 Aligned_cols=256 Identities=31% Similarity=0.565 Sum_probs=228.2
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~ 90 (443)
.|+..+.||+|+||.||+|.+..+|+.||+|++.+.........+.+..|..+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998765444445567888999998885 578889999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999874321 12223
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~ 250 (443)
...+||+.|+|||++.+..++ .++||||+||++|+|++|.+||.+.+.....+.+.......|..++.++.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999877764 8899999999999999999999999888888888888888888899999999999999
Q ss_pred CCCCCCCCh-----hhhhcCccccc
Q 013407 251 PNPMTRITI-----PEILEDEWFKK 270 (443)
Q Consensus 251 ~dP~~R~t~-----~eil~hp~~~~ 270 (443)
.||.+|++. +++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 999999984 78999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=383.91 Aligned_cols=258 Identities=31% Similarity=0.583 Sum_probs=222.0
Q ss_pred cEEEEeEeeccCcEEEEEEEEC---CCCceEEEEEeechhhh-hHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (443)
+|++++.||+|+||.||+|.+. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998874 47899999999865432 223456788999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+.||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC----cHHHHHHHhhcCccCCCCCCCHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWLSFTAR 242 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~ 242 (443)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+.......|..+++.++
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 122335679999999999987654568899999999999999999999643 2334455566666677778999999
Q ss_pred HHHHHhcCCCCCCCC-----ChhhhhcCccccc
Q 013407 243 KLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 243 ~li~~mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
++|.+||+.||++|| +++++++||||+.
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999 7889999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=384.88 Aligned_cols=251 Identities=32% Similarity=0.596 Sum_probs=219.4
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555567788999998777 899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|...+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874322 1223345689
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC---------cHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------NLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 246 (443)
|+.|+|||++.+..++ .++|||||||++|+|++|..||... ......+.+......+|..++..+.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887764 8899999999999999999999521 12234555666777888889999999999
Q ss_pred HhcCCCCCCCCC------hhhhhcCccccc
Q 013407 247 RILDPNPMTRIT------IPEILEDEWFKK 270 (443)
Q Consensus 247 ~mL~~dP~~R~t------~~eil~hp~~~~ 270 (443)
+||+.||.+||| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=369.00 Aligned_cols=261 Identities=31% Similarity=0.402 Sum_probs=223.4
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCCE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--SKTK 85 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~ 85 (443)
..++.|+.+..|++|+||.||+|+++.|++.||+|.++.+. ...+..-.-.|||.+|.+++|||||.+-++.. +-+.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 35678999999999999999999999999999999997755 33334445679999999999999999999874 4567
Q ss_pred EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
+|+|||||+. +|...+..-+ +++..+++.+..|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+...
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999999986 8888887754 8999999999999999999999999999999999999999999999999999976542
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---------------
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------- 229 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------- 229 (443)
-...+..+-|.+|+|||.+.+...++.++|+||+|||+.+|+++.+.|.+.+..+...+|...
T Consensus 231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 233556678999999999998877779999999999999999999999999887776665210
Q ss_pred ----ccCCCC-----------C--CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 230 ----EFTCPP-----------W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 230 ----~~~~~~-----------~--~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
...++. + ++....+|++.+|..||.+|.|+.|.|+|+||....
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 011111 1 458899999999999999999999999999998643
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=383.08 Aligned_cols=251 Identities=36% Similarity=0.608 Sum_probs=221.2
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765433333445555655 57789999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.......++..+..+.++|++||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999887775 889999999999999999999999888888888887777777889999999999999999999
Q ss_pred CCCh----hhhhcCccccc
Q 013407 256 RITI----PEILEDEWFKK 270 (443)
Q Consensus 256 R~t~----~eil~hp~~~~ 270 (443)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9987 58999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=385.28 Aligned_cols=250 Identities=33% Similarity=0.585 Sum_probs=219.4
Q ss_pred eeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 19 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
||+|+||+||+|++..+++.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876544443445566677777665 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 99999999888999999999999999999999999999999999999999999999999999864322 2223446789
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCC-CCHHHHHHHHHhcCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW-LSFTARKLIARILDPNPM 254 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-~s~~~~~li~~mL~~dP~ 254 (443)
|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+..+...+|.. ++.++++||++||..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 9999999999765544688999999999999999999999988888888888777766654 799999999999999999
Q ss_pred CCC----ChhhhhcCccccc
Q 013407 255 TRI----TIPEILEDEWFKK 270 (443)
Q Consensus 255 ~R~----t~~eil~hp~~~~ 270 (443)
+|| ++.++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=380.36 Aligned_cols=251 Identities=35% Similarity=0.592 Sum_probs=221.5
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765444334445555554 67889999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 99999998888899999999999999999999999999999999999999999999999999874221 2223345689
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+.......|+..+..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999877775 789999999999999999999999888888888888888888889999999999999999999
Q ss_pred CCCh----hhhhcCccccc
Q 013407 256 RITI----PEILEDEWFKK 270 (443)
Q Consensus 256 R~t~----~eil~hp~~~~ 270 (443)
|+++ .++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9976 49999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=371.21 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=221.1
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCC----
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKT---- 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 84 (443)
+..|+.++.||+|+||+||+|+++.+|+.||+|.+..+.-. +.......+|+.+++.|+|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 55677888899999999999999999999999999875432 334456789999999999999 999999998877
Q ss_pred --EEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 85 --KIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 85 --~~~lv~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
.+|+|+||+.. +|..++.... +++...++.+++||+.||+|||++||+||||||+|||+++.|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999975 8988887654 6888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc----------
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---------- 228 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---------- 228 (443)
+.+.. .........+|.+|+|||++.+..+++..+||||+|||++||+++++.|++.+..++...|-.
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 86543 223356678999999999999987777999999999999999999999999888776665521
Q ss_pred --------CccCCCCC------------CCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 229 --------AEFTCPPW------------LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 229 --------~~~~~~~~------------~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
....++.| .+++..+++.+||+.+|.+|.|+..+|.||||...
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11122222 23589999999999999999999999999999864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=379.87 Aligned_cols=251 Identities=36% Similarity=0.621 Sum_probs=219.9
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHH-HHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV-ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|. .+++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999875543333333444444 457889999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 99999999888899999999999999999999999999999999999999999999999999874322 2223446689
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.+....+..+.......++.++..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887765 889999999999999999999999888888888877777777889999999999999999999
Q ss_pred CCChh----hhhcCccccc
Q 013407 256 RITIP----EILEDEWFKK 270 (443)
Q Consensus 256 R~t~~----eil~hp~~~~ 270 (443)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=380.71 Aligned_cols=257 Identities=30% Similarity=0.492 Sum_probs=210.4
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----CEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----TKI 86 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 86 (443)
+|++.+.||+|+||.||+|.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999875322 222345788999999999999999999987543 358
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 68999998888899999999999999999999999999999999999999999999999999875432211
Q ss_pred -CCccccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc---------------
Q 013407 167 -DGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--------------- 228 (443)
Q Consensus 167 -~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 228 (443)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|++||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 122345679999999999865 344 5889999999999999999999987654332211100
Q ss_pred -----------CccCC-----CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 229 -----------AEFTC-----PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 229 -----------~~~~~-----~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
...+. -+.+++.+.++|.+||+.||++|||++++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00000 12367889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=381.32 Aligned_cols=250 Identities=35% Similarity=0.630 Sum_probs=222.5
Q ss_pred eEeeccCcEEEEEEEE---CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 013407 17 RTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 93 (443)
+.||+|+||.||++.+ ..+|+.||+|++.+..... .....+.+|+.++++++||||+++++++.+.+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 6799999999999886 3578999999998754332 23456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccc
Q 013407 94 TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173 (443)
Q Consensus 94 ~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 173 (443)
.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceecc
Confidence 9999999998888899999999999999999999999999999999999999999999999999875332 11233456
Q ss_pred cCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCC
Q 013407 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253 (443)
Q Consensus 174 ~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP 253 (443)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......|..+++.+.+||++||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 89999999999987766 48899999999999999999999998888888888888888888899999999999999999
Q ss_pred CCCCC-----hhhhhcCccccc
Q 013407 254 MTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 254 ~~R~t-----~~eil~hp~~~~ 270 (443)
.+||+ +++++.||||..
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCC
Confidence 99999 777999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=379.47 Aligned_cols=251 Identities=31% Similarity=0.589 Sum_probs=220.1
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999887655555667889999999888 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
|+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874221 2223446789
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC-------cHHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-------NLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~m 248 (443)
|+.|+|||++.+..++ .++|||||||++|+|++|..||... .....++.+.......|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999877774 8999999999999999999999632 2234455566666778888999999999999
Q ss_pred cCCCCCCCCCh------hhhhcCccccc
Q 013407 249 LDPNPMTRITI------PEILEDEWFKK 270 (443)
Q Consensus 249 L~~dP~~R~t~------~eil~hp~~~~ 270 (443)
|+.||.+|+++ ++++.||||..
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 99999999984 69999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=384.68 Aligned_cols=262 Identities=34% Similarity=0.573 Sum_probs=224.7
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45568999999999999999999999999999999999875544444456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~- 196 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG- 196 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-
Confidence 999999999999998865 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCccccccCCCcccchhhhccCC---CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--cCCC--CCCCH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP--PWLSF 239 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~ 239 (443)
.......+||+.|+|||++.... +.+.++|||||||++|+|++|.+||.+.+....+.++.... ..+| ..++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 11224568999999999997543 34688999999999999999999999988888888776532 3334 35899
Q ss_pred HHHHHHHHhcCCCCCC--CCChhhhhcCccccc
Q 013407 240 TARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~--R~t~~eil~hp~~~~ 270 (443)
.+++||.+||..+|.+ |++++++++||||+.
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 9999999999854443 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=386.51 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=228.6
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
..|+..+.||+|+||.||+|.+..+++.||+|+++.+.... ..+.++.|+.++..++++||.++|+.+..+..+|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 45788899999999999999999999999999999876543 4788999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
|||.||++.+.++....+.|..+..++++++.||.|||+++.+|||||+.|||+..+|++|++|||.+...... ....
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKRR 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech--hhcc
Confidence 99999999999998888899999999999999999999999999999999999999999999999998755432 2233
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHHhc
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARIL 249 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL 249 (443)
.+..|||.|||||++.+.+|+ .++||||||++.++|++|.+||....++.....|....+ .....+|+.+++|+..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 788999999999999988887 899999999999999999999998887655555544432 222358999999999999
Q ss_pred CCCCCCCCChhhhhcCcccccc
Q 013407 250 DPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 250 ~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+.||+.||++.++|+|+|++..
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHhc
Confidence 9999999999999999999873
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=362.94 Aligned_cols=253 Identities=37% Similarity=0.672 Sum_probs=221.6
Q ss_pred ccccEEEE-eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe----
Q 013407 9 RVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS---- 82 (443)
Q Consensus 9 ~~~~y~~~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~---- 82 (443)
..++|.+. +.||-|-.|+|..+.++.||+.+|+|++.- ....++|+++.-.. .|||||.++++|++
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 56678875 479999999999999999999999999742 24678899987666 69999999999854
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC---CCeEEeecCc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGL 157 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~~kl~DFGl 157 (443)
...+.+|||.++||+||+.|+..+. ++|.+|..+++||..|+.|||+.+|+||||||||+|.... ..+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 5678899999999999999988765 9999999999999999999999999999999999999754 4699999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc----HHHHHHHhhcCccCC
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTC 233 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~ 233 (443)
|+... ....+.+.|-||+|+|||++....|+ ..+|+||+|||+|.||+|++||.... ...+..+|..+.+.|
T Consensus 211 AK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 211 AKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 98543 35667899999999999999887886 88999999999999999999997643 346778888888777
Q ss_pred CC--C--CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 234 PP--W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 234 ~~--~--~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
|. | +|..++++|+.+|..+|.+|.|+.+++.|||+.....
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 64 5 7999999999999999999999999999999987543
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=369.30 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=213.9
Q ss_pred eeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013407 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (443)
Q Consensus 19 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 98 (443)
||+|+||+||+|.+..+++.||+|.+.+.........+.+..|+.+++.++||||+++.+++.+....|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876554444456778899999999999999999999999999999999999999
Q ss_pred HHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcccccc
Q 013407 99 FDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (443)
Q Consensus 99 ~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 174 (443)
.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 887742 356999999999999999999999999999999999999999999999999998754331 12233457
Q ss_pred CCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH----HHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 013407 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (443)
Q Consensus 175 gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~ 250 (443)
||+.|+|||++.+..++ .++||||+||++|+|++|+.||..... ......+.......|+.++..+.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999887775 889999999999999999999976532 2333444444556667789999999999999
Q ss_pred CCCCCCC-----ChhhhhcCccccc
Q 013407 251 PNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 251 ~dP~~R~-----t~~eil~hp~~~~ 270 (443)
.||.+|| |++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 7899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=375.24 Aligned_cols=259 Identities=29% Similarity=0.534 Sum_probs=220.0
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998755444445667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||+.||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence 99999999999976 4579999999999999999999999999999999999999999999999999986543211 111
Q ss_pred cccccCCCcccchhhhcc----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--cCCC---CCCCHH
Q 013407 170 LHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP---PWLSFT 240 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~ 240 (443)
....+||+.|+|||++.. ....+.++||||+||++|+|++|..||.+.+..+.+..+.... +..| +.++..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223579999999999863 2344578999999999999999999999888777776665432 3333 347999
Q ss_pred HHHHHHHhcCCCCCC--CCChhhhhcCccccc
Q 013407 241 ARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (443)
Q Consensus 241 ~~~li~~mL~~dP~~--R~t~~eil~hp~~~~ 270 (443)
+++||++||..++.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999999764444 889999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=367.27 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=219.4
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+++..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999998999999999976554443344567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|+.||+|.+.+... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 99999998887653 4699999999999999999999999999999999999999999999999999875432 122
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHH----HHHhhcCccCCCCCCCHHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----YKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~li 245 (443)
....+|++.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.... ...+.......+..++..+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 2345799999999999876664 789999999999999999999987655332 23333444455667899999999
Q ss_pred HHhcCCCCCCCC-----ChhhhhcCccccc
Q 013407 246 ARILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
.+||..||.+|| +++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=373.10 Aligned_cols=256 Identities=23% Similarity=0.406 Sum_probs=218.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|+||.||+|.+..++..+|+|++..+. .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999997642 23345679999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||||++||+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 999999999999998888899999999999999999999986 699999999999999999999999999875422
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc-------------------
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------------- 228 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------- 228 (443)
.......||+.|+|||++.+..+. .++||||+||++|+|++|+.||...+..++...+..
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 223455799999999999877664 889999999999999999999987665443222110
Q ss_pred ---------------------------Cc-cCC-CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 229 ---------------------------AE-FTC-PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 229 ---------------------------~~-~~~-~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.. ... ...+++++++||.+||..||++|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00 001 11367899999999999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=375.22 Aligned_cols=251 Identities=27% Similarity=0.473 Sum_probs=216.2
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCce-EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-E
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEP-VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-K 85 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~ 85 (443)
.......+.+.||.|+||+||+|.+. |+. ||||++......... .+.+.+|+.+|++++|||||++++++.+.. .
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 33445566677999999999999985 445 999999876654443 779999999999999999999999999887 7
Q ss_pred EEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeeeCCCCcEEEccCC-CeEEeecCccccc
Q 013407 86 IFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRG-VYHRDLKPENLLLDAYG-NLKVSDFGLSALS 161 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NILl~~~~-~~kl~DFGla~~~ 161 (443)
..+||||+++|+|.+++.. .+.++...+..++.||+.||.|||+++ |+||||||+|||++.++ ++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999999987 678999999999999999999999999 99999999999999997 9999999999865
Q ss_pred ccccCCCccccccCCCcccchhhhc--cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhh--cCccCCCCCC
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS--AAEFTCPPWL 237 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~--~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~ 237 (443)
.... .......||+.|||||++. ...|+ .++||||+|++||||+||..||.+.........+. .....+|..+
T Consensus 195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred cccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 4321 2233467999999999999 45675 99999999999999999999999988765555443 2345566779
Q ss_pred CHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 238 SFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
++.+..|+.+||..||.+||++.+|+.
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 999999999999999999999999875
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=391.52 Aligned_cols=265 Identities=31% Similarity=0.504 Sum_probs=229.0
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
+......++|++.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..++|+||+++++.+...
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 34456678999999999999999999999999999999999765432 33456788999999999999999998876433
Q ss_pred C--------EEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeE
Q 013407 84 T--------KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (443)
Q Consensus 84 ~--------~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~k 151 (443)
. .+++||||+.+|+|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 2 47899999999999998864 34689999999999999999999999999999999999999999999
Q ss_pred EeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc
Q 013407 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (443)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 231 (443)
|+|||+++............+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+..+..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999998765433233334567899999999999887775 899999999999999999999999888777777666544
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 232 -TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 232 -~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+.|+.+++++.+|+.+||..||.+||++.++++|||++.
T Consensus 263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 467779999999999999999999999999999999874
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=381.12 Aligned_cols=258 Identities=30% Similarity=0.507 Sum_probs=236.4
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE-EE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-IF 87 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~ 87 (443)
.+++|..++.+|+|+||.+++++++.+++.+++|.+........ .......|+.++++++|||||.+.+.|..++. .+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 46899999999999999999999999999999999988765443 34578899999999999999999999988887 99
Q ss_pred EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|||+||+||+|.+.|...+ -++|+.+..||.|++.|+.|||+++|.|||||+.||+++.++.+||+|||+|+....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~-- 158 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP-- 158 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--
Confidence 9999999999999997654 589999999999999999999999999999999999999999999999999997654
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 244 (443)
......+..|||.|+.||++.+.+|. .++|||||||++|+|++-+++|.+.+...+..+|..+. .+.|..++.+++.|
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 23466788999999999999999996 99999999999999999999999999999999998886 57788899999999
Q ss_pred HHHhcCCCCCCCCChhhhhcCccccc
Q 013407 245 IARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
|..||..+|..||++.++|.+|....
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999999988763
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=371.49 Aligned_cols=259 Identities=27% Similarity=0.510 Sum_probs=220.7
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998655444444566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998643221 1112
Q ss_pred cccccCCCcccchhhhcc----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--cCCCC---CCCHH
Q 013407 170 LHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP---WLSFT 240 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 240 (443)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ..+|. .++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234679999999999863 2334588999999999999999999999988888777775543 33333 47999
Q ss_pred HHHHHHHhcCCCCCC--CCChhhhhcCccccc
Q 013407 241 ARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (443)
Q Consensus 241 ~~~li~~mL~~dP~~--R~t~~eil~hp~~~~ 270 (443)
+++||++||..+|.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765554 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=368.18 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=214.4
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 467899999999999999999999999999999999754322 123457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 158 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--T 158 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--c
Confidence 9999986 788877654 45899999999999999999999999999999999999999999999999998753221 1
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------------------
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------ 229 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 229 (443)
.......+|+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22234568999999999876554568999999999999999999999887654433322110
Q ss_pred -ccCC-----------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 230 -EFTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 230 -~~~~-----------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.... .+.+++++++||.+||..||.+|||++|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0111 12368899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=364.28 Aligned_cols=250 Identities=33% Similarity=0.487 Sum_probs=211.8
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----EE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 86 (443)
.|.-.+.+|.|+||.||.|...++++.||||.+-.++- --.+|+.+|+.++|||||++..+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 58889999999999999999999999999999865432 2347999999999999999998885422 34
Q ss_pred EEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC-CCeEEeecCccccc
Q 013407 87 FIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALS 161 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~~kl~DFGla~~~ 161 (443)
.+||||++. +|.+.++. +.+++.-.++-|.+||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 589999985 88888874 5789999999999999999999999999999999999999977 89999999999976
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc-------------
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------- 228 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------- 228 (443)
... ....++..|.+|+|||.+.+...++.+.||||+|||+.||+-|++.|.|.+..++...|..
T Consensus 177 ~~~---epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKG---EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccC---CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 542 3335677899999999999887778999999999999999999999999887665544311
Q ss_pred ----CccCCC------------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 229 ----AEFTCP------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 229 ----~~~~~~------------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.+..+| ...++++.+|+.++|..+|.+|.++.|++.||||..-.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 011111 23689999999999999999999999999999998643
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=387.63 Aligned_cols=252 Identities=28% Similarity=0.390 Sum_probs=206.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (443)
..++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3457999999999999999999999999999999886432 2345799999999999999999886432
Q ss_pred ---CEEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-CeEEeec
Q 013407 84 ---TKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDF 155 (443)
Q Consensus 84 ---~~~~lv~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~~kl~DF 155 (443)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 257799999986 6666654 346799999999999999999999999999999999999999765 6999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------ 229 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------ 229 (443)
|+|+.... .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 216 Gla~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99975432 222335678999999999876554468999999999999999999999987665444333210
Q ss_pred -----------cc------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 230 -----------EF------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 230 -----------~~------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.. .+|...+.++.+||.+||..||.+|||+.|+++||||..-
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 01 1233467899999999999999999999999999999753
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=362.09 Aligned_cols=254 Identities=37% Similarity=0.724 Sum_probs=230.8
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|++|.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998766555555678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||+++++|.+.+...+.+++..+..++.||+.||.|||++|++||||+|.||+++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999988889999999999999999999999999999999999999999999999999998754321 3
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~ 250 (443)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.....+.+..+....|..++..++++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 34578999999999877655 48899999999999999999999988877777777777888888899999999999999
Q ss_pred CCCCCCC-----ChhhhhcCccccc
Q 013407 251 PNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 251 ~dP~~R~-----t~~eil~hp~~~~ 270 (443)
.||.+|+ +++++++||||..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 8999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=358.55 Aligned_cols=257 Identities=32% Similarity=0.611 Sum_probs=224.3
Q ss_pred cEEEE-eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEE
Q 013407 12 KYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 12 ~y~~~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv 89 (443)
-|++. +.||+|+||.|-.+.+..+|..||||++++.. .....++.+|++++.++ .|+||++++++|+++..+|+|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 35553 57999999999999999999999999998863 23467899999999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC---CeEEeecCcccccccc--
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQV-- 164 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~-- 164 (443)
||-+.||.|...|.+...++|.+|.++.++|+.||.|||.+||+||||||+|||..... -+|||||.+..-....
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999999999999999999999999999999999999999999999999999997654 4899999987543221
Q ss_pred ---cCCCccccccCCCcccchhhhc----cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc---------------HHHH
Q 013407 165 ---RDDGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---------------LMNL 222 (443)
Q Consensus 165 ---~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---------------~~~~ 222 (443)
-....+.+.||+..|||||+.. ...++..++|.||||||||.||+|++||.+.- ...+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 1223456789999999999963 33455589999999999999999999996531 4578
Q ss_pred HHHhhcCccCCCC--C--CCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 223 YKKISAAEFTCPP--W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 223 ~~~i~~~~~~~~~--~--~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
++.|+.+.+.+|. | +|.++++|++.+|..|+.+|.++.++++|||++.-
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 9999999999985 3 89999999999999999999999999999999863
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=370.57 Aligned_cols=259 Identities=29% Similarity=0.496 Sum_probs=220.6
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998754444444567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||+.||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999977 4679999999999999999999999999999999999999999999999999987543211 111
Q ss_pred cccccCCCcccchhhhccC----CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--cCCCC---CCCHH
Q 013407 170 LHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP---WLSFT 240 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 240 (443)
....+||+.|+|||++.+. +..+.++||||+||++|+|++|..||...+....+..+.... +.+|+ .++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998652 223578999999999999999999999888777777765533 33443 36899
Q ss_pred HHHHHHHhcCCCCCC--CCChhhhhcCccccc
Q 013407 241 ARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (443)
Q Consensus 241 ~~~li~~mL~~dP~~--R~t~~eil~hp~~~~ 270 (443)
++++|.+||..++.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 568999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=378.33 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=215.5
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----EE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 86 (443)
.|++++.||+|+||.||+|.+..+|+.||||.+.... ......+.+.+|+.+++.++||||+++++++.+.. ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999999999999999986532 22233567889999999999999999999998776 79
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 99999997 588888888888999999999999999999999999999999999999999999999999998754322 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc------------------
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------------ 228 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------ 228 (443)
........+|+.|+|||++.+....+.++||||+||++|+|++|++||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 12233456899999999998765556889999999999999999999988776554443321
Q ss_pred -----Ccc---------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 229 -----AEF---------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 229 -----~~~---------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
... ......++++.+||.+||+.||.+|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 000 1223357899999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=378.88 Aligned_cols=253 Identities=19% Similarity=0.299 Sum_probs=208.8
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
+...++|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.++++++||||+++++++......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3455789999999999999999999999999999997532 3467899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
++|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... .
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~ 236 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N 236 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence 99999995 689999988888999999999999999999999999999999999999999999999999998653221 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc-------HHHHHHHh-------------
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKI------------- 226 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i------------- 226 (443)
.......+||+.|+|||++.+..| +.++||||+||++|+|++|..||.... .......+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 122345689999999999987776 489999999999999999998874321 00111110
Q ss_pred -------------hcCc----cCCCC-----CCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 227 -------------SAAE----FTCPP-----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 227 -------------~~~~----~~~~~-----~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.... ...|. .++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0000 01111 146689999999999999999999999999999863
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=387.12 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=224.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCC-CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
....|.+.+.||+|++|.||+|.+..+ +..||+|.+.... ......+++|+.+++.++||||+++++++.+.+.+|
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 345599999999999999999998877 7889999875432 233457889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 88 IVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
+||||++||+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999999887743 45689999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTAR 242 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~ 242 (443)
..........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+..+.. +.|..++.+++
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 222223456789999999999987766 4889999999999999999999999888777777766554 35566899999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 243 KLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
++|.+||..||++||++.+++.|||++.
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999999999864
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=357.87 Aligned_cols=253 Identities=35% Similarity=0.656 Sum_probs=215.1
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
|++++.||+|+||+||+|.+..+++.||+|++......... .....+|+.++++++||||+++++++.+....+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999886544332 33445699999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcccc
Q 013407 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (443)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 172 (443)
+.+++|.+++...+.+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||++... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 999999999997889999999999999999999999999999999999999999999999999998753 112334456
Q ss_pred ccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc---HHHHHHHhhcCccCCCC----CCCHHHHHHH
Q 013407 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPP----WLSFTARKLI 245 (443)
Q Consensus 173 ~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~~----~~s~~~~~li 245 (443)
..+|+.|+|||++......+.++||||||+++|+|++|..||...+ ...............+. ..+..+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 7789999999998833444699999999999999999999999873 22333333322221111 1248999999
Q ss_pred HHhcCCCCCCCCChhhhhcCccc
Q 013407 246 ARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=374.01 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=211.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--- 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 84 (443)
..+++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 357899999999999999999999999999999999976432 2334567889999999999999999999986543
Q ss_pred ---EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 85 ---KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 85 ---~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
.+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999976 5666653 35899999999999999999999999999999999999999999999999998743
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc-------------
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------- 228 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------- 228 (443)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..
T Consensus 174 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 174 CT---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cc---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 22 2233456789999999999887775 789999999999999999999987765433222110
Q ss_pred ---------CccC---------CCC-----------CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 229 ---------AEFT---------CPP-----------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 229 ---------~~~~---------~~~-----------~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
.... ++. ..+..+++||.+||..||++|||+.|+++||||...+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 0000 011 135789999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=362.44 Aligned_cols=252 Identities=32% Similarity=0.457 Sum_probs=206.5
Q ss_pred ccEEEEeEeeccCcEEEEEEEECC-CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCcceEEEEEE-----
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMG----- 81 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----- 81 (443)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+....... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 56889999987543222 2234556777777666 6999999999875
Q ss_pred eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
....+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999997 5888888653 458999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc--------
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-------- 231 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------- 231 (443)
.... ........||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+..+....+.....
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 5432 2233456799999999999877664 789999999999999999999998877665555432110
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 232 -------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 232 -------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
...+.++..+++||.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=374.55 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=215.0
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
...++.|+.++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 445788999999999999999999999999999999996543 223456789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+.+|+|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-- 221 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--
Confidence 999999999998643 34678888999999999999999999999999999999999999999999998765332
Q ss_pred CCccccccCCCcccchhhhcc----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH---HHHHHhh-cCccCCCCCCC
Q 013407 167 DGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKKIS-AAEFTCPPWLS 238 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~-~~~~~~~~~~s 238 (443)
........||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||...... .....+. ......+..++
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence 112234579999999999743 245567899999999999999999999743322 2222222 22334456689
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.++++||.+||..||++|||+.|+++||||.+..
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999999999999999999999999998754
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=354.00 Aligned_cols=257 Identities=28% Similarity=0.517 Sum_probs=221.4
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh--HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
+.|++.+.||+|++|.||.|.+..+++.||+|.+....... ......+.+|+.++++++||||+++++++.+....|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543221 2234678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC-
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD- 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 167 (443)
++||++|++|.+.+...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998754332111
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLI 245 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li 245 (443)
.......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||...+.......+... ....|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 11134568899999999987665 48999999999999999999999877665544444332 3456667899999999
Q ss_pred HHhcCCCCCCCCChhhhhcCccc
Q 013407 246 ARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=371.84 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=212.2
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK---- 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 83 (443)
..+++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 357899999999999999999999999999999999976432 223356788999999999999999999987543
Q ss_pred --CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 84 --TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 84 --~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
..+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 457999999976 6777664 35889999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc----------
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------- 231 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------- 231 (443)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+.++.....
T Consensus 177 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 177 GT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred CC---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 22 2223456789999999999887775 889999999999999999999988776554444321100
Q ss_pred ------------C--------------C------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 232 ------------T--------------C------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 232 ------------~--------------~------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
. . +...+..+++||.+||..||.+|||++++|+||||...+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 0 0 0013467899999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=366.34 Aligned_cols=256 Identities=24% Similarity=0.417 Sum_probs=216.6
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.-++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+++++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3478999999999999999999999999999999987642 22345678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||||+.||+|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence 999999999999998888899999999999999999999985 799999999999999999999999999875422
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHh---------------------
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--------------------- 226 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i--------------------- 226 (443)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...........+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 12234579999999999987666 48899999999999999999999866543322111
Q ss_pred -----------------------hcC-ccCCC-CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 227 -----------------------SAA-EFTCP-PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 227 -----------------------~~~-~~~~~-~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
... ....+ ..++.++++||.+||+.||++|||+.|++.||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 01111 1257889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=360.33 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=214.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
++++|++.+.||.|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 5789999999999999999999999999999999987543221 23457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~ 158 (301)
T cd07873 82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T 158 (301)
T ss_pred EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--C
Confidence 9999974 88888765 356899999999999999999999999999999999999999999999999998753321 1
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------------------
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------ 229 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 229 (443)
.......+++.|+|||++.+....+.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22234467899999999876555568899999999999999999999887765444332110
Q ss_pred -ccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 230 -EFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 230 -~~~~~-----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
....| +.+++.+++||.+||..||.+|||++++++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00111 246888999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=358.11 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=215.6
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+.+.+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999987554444444567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|+.|++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 99999999888543 3589999999999999999999999999999999999999999999999999864322 122
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH----HHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
.....||+.|+|||++.+..+. .++||||+||++|+|++|.+||...... .............+..+++++++|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 2345799999999999877664 8899999999999999999999865321 1111112222334566889999999
Q ss_pred HHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
.+||+.||.+||| ++++++||||..
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=369.68 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=211.6
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK---- 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 83 (443)
..+++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 367899999999999999999999999999999999976432 233456788999999999999999999988543
Q ss_pred --CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 84 --TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 84 --~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
...|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999976 6666664 35899999999999999999999999999999999999999999999999998753
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------------
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------ 229 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------ 229 (443)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+...
T Consensus 170 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 170 GT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred CC---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 22 2223456799999999999887775 8899999999999999999999887654433221100
Q ss_pred ---------------ccC---------------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 230 ---------------EFT---------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 230 ---------------~~~---------------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
... .+...+..+++||.+||..||.+|||+.|+++||||...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 000 01113567899999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=382.75 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=203.6
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC------CCcceEEEEEEe
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH------PNVVRLYEVMGS 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~ 82 (443)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3478999999999999999999999999999999996422 123345567777766654 568899998876
Q ss_pred C-CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCC------------
Q 013407 83 K-TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYG------------ 148 (443)
Q Consensus 83 ~-~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~------------ 148 (443)
. ..+|+|||++ |++|.+++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 5788999988 77899999888899999999999999999999998 5999999999999998765
Q ss_pred ----CeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHH
Q 013407 149 ----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK 224 (443)
Q Consensus 149 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~ 224 (443)
.+||+|||++.... ......+||+.|+|||++.+..|. .++|||||||++|+|++|++||++.+..+...
T Consensus 282 ~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999875321 223456899999999999887775 88999999999999999999998876544333
Q ss_pred HhhcCccCCC-----------------------C-------------------CCCHHHHHHHHHhcCCCCCCCCChhhh
Q 013407 225 KISAAEFTCP-----------------------P-------------------WLSFTARKLIARILDPNPMTRITIPEI 262 (443)
Q Consensus 225 ~i~~~~~~~~-----------------------~-------------------~~s~~~~~li~~mL~~dP~~R~t~~ei 262 (443)
.+......+| + ..++.+.+||.+||..||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 2211100000 0 013557799999999999999999999
Q ss_pred hcCccccccC
Q 013407 263 LEDEWFKKDY 272 (443)
Q Consensus 263 l~hp~~~~~~ 272 (443)
|+||||.+.+
T Consensus 436 L~Hp~~~~~~ 445 (467)
T PTZ00284 436 TTHPYVLKYY 445 (467)
T ss_pred hcCccccccC
Confidence 9999998644
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=377.84 Aligned_cols=249 Identities=31% Similarity=0.488 Sum_probs=214.7
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-C-----CCcceEEEEEEeCC
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-H-----PNVVRLYEVMGSKT 84 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~~~~ 84 (443)
.+|++.+.||+|+||+|.+|.+..|++.||||+++... ....+...|+.+|.+|+ | -|+|+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 38999999999999999999999999999999997643 35678889999999997 4 48999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC--CCeEEeecCcccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSAL 160 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~--~~~kl~DFGla~~ 160 (443)
++|||+|... -+|+++|+.+. +++...++.+.+||+.||.+||+.||||+|||||||||... ..+||+|||+|..
T Consensus 262 HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999999996 59999998764 69999999999999999999999999999999999999764 3699999999986
Q ss_pred cccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC-----------
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA----------- 229 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------- 229 (443)
.. ....+++.+..|+|||++.+.+|+ .+.||||||||++||++|.+.|.|.+..+++..|...
T Consensus 341 ~~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 341 ES-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cC-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 33 334488899999999999999997 8899999999999999999999999887766654210
Q ss_pred -----------------------------------------ccCCCCC-----------CCHHHHHHHHHhcCCCCCCCC
Q 013407 230 -----------------------------------------EFTCPPW-----------LSFTARKLIARILDPNPMTRI 257 (443)
Q Consensus 230 -----------------------------------------~~~~~~~-----------~s~~~~~li~~mL~~dP~~R~ 257 (443)
+...|+. -...+.++|.+||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0001100 123468999999999999999
Q ss_pred ChhhhhcCccccc
Q 013407 258 TIPEILEDEWFKK 270 (443)
Q Consensus 258 t~~eil~hp~~~~ 270 (443)
|..++|+||||+.
T Consensus 495 tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 495 TPAQALNHPFLTG 507 (586)
T ss_pred CHHHHhcCccccc
Confidence 9999999999984
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=369.52 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=211.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (443)
..++|++.+.||+|+||.||+|.+..+++.||||++.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 457899999999999999999999999999999999764322 22345677899999999999999999987543
Q ss_pred -CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
..+|+++|++ |++|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999988 678877664 4679999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc------------
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 230 (443)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 23456799999999999775555689999999999999999999998766544333321100
Q ss_pred -----------cCCC--------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 231 -----------FTCP--------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 231 -----------~~~~--------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
...+ ...++.+.+||.+||..||.+|||+.++++||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0001 12466789999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=355.33 Aligned_cols=248 Identities=28% Similarity=0.443 Sum_probs=208.3
Q ss_pred eeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013407 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (443)
Q Consensus 19 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 98 (443)
||+|+||.||++.+..+|+.||+|.+.............+..|+.+++.++||||+++++++.++..+|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765544333344566799999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCC
Q 013407 99 FDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (443)
Q Consensus 99 ~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 176 (443)
.+.+.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..... ........||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 88885533 588999999999999999999999999999999999999999999999999875432 1222345789
Q ss_pred CcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH----HHHHHHhhcCccCCC-CCCCHHHHHHHHHhcCC
Q 013407 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCP-PWLSFTARKLIARILDP 251 (443)
Q Consensus 177 ~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~-~~~s~~~~~li~~mL~~ 251 (443)
+.|+|||++.+..+ +.++||||+||++|+|++|..||..... ..............+ ..++.++++||++||+.
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999987775 4889999999999999999999976432 233333333333332 35799999999999999
Q ss_pred CCCCCCCh----hhhhcCccccc
Q 013407 252 NPMTRITI----PEILEDEWFKK 270 (443)
Q Consensus 252 dP~~R~t~----~eil~hp~~~~ 270 (443)
||.+||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=357.26 Aligned_cols=251 Identities=30% Similarity=0.469 Sum_probs=204.9
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEe-----C
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGS-----K 83 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 83 (443)
+|++.+.||+|+||.||+|.+..+++.||+|.+....... .......+|+.+++.+ +||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6999999999999999999999999999999987543221 1223455677777665 79999999998754 3
Q ss_pred CEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
..++++|||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999985 888888653 35899999999999999999999999999999999999999999999999998764
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------------
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------ 229 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------ 229 (443)
.. ........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+......++...
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cC---cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 32 122334578999999999987666 48899999999999999999999877665444433210
Q ss_pred ------cc---------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 230 ------EF---------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 230 ------~~---------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.+ ...+.++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0112367789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=353.80 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=219.2
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
.|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+.+++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999987655444445667889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|+.+++|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 99999998887543 4699999999999999999999999999999999999999999999999999865322 122
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHH----HHHhhcCccCCCCCCCHHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----YKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~li 245 (443)
.....|++.|+|||.+.+..+. .++|+||+||++|+|++|..||.+...... ...+.......++.++..+.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 2345799999999999876664 889999999999999999999987655432 23333444455667889999999
Q ss_pred HHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
.+||+.||.+||| +.+++.||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 9999999999999 889999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=345.31 Aligned_cols=253 Identities=25% Similarity=0.505 Sum_probs=218.7
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCEEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVL 90 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv~ 90 (443)
+|++.+.||.|++|.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999999764432 2235678899999999999999999998764 45689999
Q ss_pred eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 91 EFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 91 E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||+++++|.+.+... ..+++.+++.++.|++.||.+||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--CC
Confidence 999999999998763 45899999999999999999999999999999999999999999999999998765331 22
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIAR 247 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 247 (443)
......|++.|+|||++.+..+. .++|+||+|+++|+|++|..||...+.......+..+.. ..+..+++.+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 33456789999999999877664 789999999999999999999998777666666555544 4556689999999999
Q ss_pred hcCCCCCCCCChhhhhcCccc
Q 013407 248 ILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~ 268 (443)
||+.||.+|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=348.95 Aligned_cols=256 Identities=30% Similarity=0.524 Sum_probs=220.3
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhh------hHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL------KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
+|.+...||+|++|.||+|.+..+++.||+|.+...... .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588999999999999999999889999999988654322 22345678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
.+++|||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987654211
Q ss_pred C----CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHH
Q 013407 166 D----DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (443)
Q Consensus 166 ~----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (443)
. ........|++.|+|||.+.+..+. .++|+||+||++|+|++|+.||.+.+.......+... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 1112235688999999999876664 7899999999999999999999887665554444333 33456668999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+.++|++||+.||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=364.41 Aligned_cols=252 Identities=22% Similarity=0.386 Sum_probs=204.7
Q ss_pred cccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (443)
-++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999752 345789999986532 222346788999999999 899999999988654
Q ss_pred -CEEEEEEeccCCCchHHHHHhC---------------------------------------------------------
Q 013407 84 -TKIFIVLEFVTGGELFDKIVNH--------------------------------------------------------- 105 (443)
Q Consensus 84 -~~~~lv~E~~~gg~L~~~i~~~--------------------------------------------------------- 105 (443)
..+|++|||++||+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999998652
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCccc
Q 013407 106 -----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180 (443)
Q Consensus 106 -----~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 180 (443)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 237788889999999999999999999999999999999999999999999987543211111122334667899
Q ss_pred chhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHH-HHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 013407 181 APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRI 257 (443)
Q Consensus 181 APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~ 257 (443)
|||++.+..++ .++|||||||++|+|++ |..||.+.... .....+..+ ....|..+++.+.+|+.+||..||.+||
T Consensus 244 aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999877664 88999999999999997 99999876543 333334333 3345666899999999999999999999
Q ss_pred Chhhhhc
Q 013407 258 TIPEILE 264 (443)
Q Consensus 258 t~~eil~ 264 (443)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=348.15 Aligned_cols=253 Identities=28% Similarity=0.557 Sum_probs=223.9
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987665554567789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
|+.|++|.+.+.....+++..+..++.||++||.|||++|++|+||+|+||++++++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC---cccc
Confidence 9999999999988778999999999999999999999999999999999999999999999999998754322 1234
Q ss_pred cccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH---HHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 013407 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCPPWLSFTARKLIARI 248 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~m 248 (443)
...|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+. ..............|+.++..+.++|++|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5668899999999987665 4889999999999999999999987663 33333333355667777899999999999
Q ss_pred cCCCCCCCCCh--hhhhcCccc
Q 013407 249 LDPNPMTRITI--PEILEDEWF 268 (443)
Q Consensus 249 L~~dP~~R~t~--~eil~hp~~ 268 (443)
|..||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=397.54 Aligned_cols=261 Identities=31% Similarity=0.536 Sum_probs=233.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..-++|++++.||+|+||.|.+++++.+++.||+|++++-...+.....-++.|-.+|..-+.+-|+.++..|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 45678999999999999999999999999999999998855444444567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+||||++||+|...+.+.+.+||+.|++|+..|+.||+.+|+.|+|||||||+|||||..|++||+|||.+-.+...+ .
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~ 230 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-T 230 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-c
Confidence 999999999999999998899999999999999999999999999999999999999999999999999876544321 1
Q ss_pred CccccccCCCcccchhhhcc----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCC--CCCCH
Q 013407 168 GLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP--PWLSF 239 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~ 239 (443)
-.....+|||.|+|||++.. .+.+|..+|.||+||++|+|+.|..||...+....|.+|... .+.|| ..+|.
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence 23456789999999999953 356689999999999999999999999999999999999765 67788 45899
Q ss_pred HHHHHHHHhcCCCCCCCCC---hhhhhcCccccc
Q 013407 240 TARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t---~~eil~hp~~~~ 270 (443)
++++||.+++. +|..|.. ++++..||||..
T Consensus 311 eakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 311 EAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 99999999885 6888888 999999999985
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=350.29 Aligned_cols=253 Identities=29% Similarity=0.459 Sum_probs=208.8
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999865432 22234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 92 FVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 92 ~~~gg~L~~~i~~~---~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|+. ++|.+.+... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 998 5888877542 46899999999999999999999999999999999999999999999999998754321 12
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc--------------------
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA-------------------- 228 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------------- 228 (443)
......+++.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 223446789999999987655445889999999999999999999987654322211100
Q ss_pred --------Cc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 229 --------AE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 229 --------~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.. ......+++++.++|++||+.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00 00112368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=352.28 Aligned_cols=259 Identities=32% Similarity=0.619 Sum_probs=223.2
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999998765444445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC----
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 166 (443)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998864211000
Q ss_pred ---------CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC--
Q 013407 167 ---------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-- 235 (443)
Q Consensus 167 ---------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-- 235 (443)
........|+..|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..+....+..+....|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 001123467889999999877666 58899999999999999999999988877777776665443332
Q ss_pred -CCCHHHHHHHHHhcCCCCCCCCC---hhhhhcCccccc
Q 013407 236 -WLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (443)
Q Consensus 236 -~~s~~~~~li~~mL~~dP~~R~t---~~eil~hp~~~~ 270 (443)
.++.++.++|.+||+.||.+||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 47899999999999999999998 789999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=358.17 Aligned_cols=247 Identities=27% Similarity=0.430 Sum_probs=194.3
Q ss_pred EeEeeccCcEEEEEEEEC--CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEEEEEEe
Q 013407 16 GRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLE 91 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E 91 (443)
++.||+|+||.||+|.+. .+++.||+|.+..... ...+.+|+.++++++||||+++++++.+ ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999975 3678899999865432 2356789999999999999999998854 567899999
Q ss_pred ccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE----ccCCCeEEeecCcc
Q 013407 92 FVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (443)
Q Consensus 92 ~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~~~~kl~DFGla 158 (443)
|+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9964 888877532 258999999999999999999999999999999999999 45678999999999
Q ss_pred ccccccc-CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH---------HHHHHhhc
Q 013407 159 ALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------NLYKKISA 228 (443)
Q Consensus 159 ~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~i~~ 228 (443)
....... ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7654321 1122345678999999999987655568999999999999999999999653310 11111100
Q ss_pred ----------------------------CccCC----------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 229 ----------------------------AEFTC----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 229 ----------------------------~~~~~----------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
..... ....+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 01135678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.23 Aligned_cols=254 Identities=25% Similarity=0.424 Sum_probs=215.5
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... ......++.+|+.++++++||||+++++.+.+++.+|++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999987532 2334567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||++|++|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 999999999999888889999999999999999999998 5999999999999999999999999999864322 22
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--------------------
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------- 229 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------- 229 (443)
....+|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345678999999999877665 48899999999999999999999765544333222111
Q ss_pred -----------------ccCCCC-CCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 230 -----------------EFTCPP-WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 230 -----------------~~~~~~-~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
....|. .++.++++|+.+||..||++|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 001111 257789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=341.14 Aligned_cols=253 Identities=29% Similarity=0.480 Sum_probs=221.8
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
.|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999999765433 3345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 99999999998764 57899999999999999999999999999999999999999999999999998754332 222
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC-CCCCCCHHHHHHHHHh
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~m 248 (443)
....+|++.|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+..+..+ .+..++..+.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3445789999999999877664 8899999999999999999999988877777776665543 3346889999999999
Q ss_pred cCCCCCCCCChhhhhcCccc
Q 013407 249 LDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 249 L~~dP~~R~t~~eil~hp~~ 268 (443)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=354.04 Aligned_cols=259 Identities=32% Similarity=0.558 Sum_probs=224.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
.+|++.+.||+|++|.||+|.+..+++.||+|.+.+.........+.+.+|+.+++.++||||+++++.+.+....|++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765544345678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC-
Q 013407 91 EFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD- 167 (443)
Q Consensus 91 E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 167 (443)
||+.|++|.+.+... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998753 56999999999999999999999999999999999999999999999999998654221100
Q ss_pred --------------------------CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHH
Q 013407 168 --------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221 (443)
Q Consensus 168 --------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~ 221 (443)
.......||..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468899999999987666 488999999999999999999999888777
Q ss_pred HHHHhhcCccCCCCC--CCHHHHHHHHHhcCCCCCCCCC----hhhhhcCccccc
Q 013407 222 LYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRIT----IPEILEDEWFKK 270 (443)
Q Consensus 222 ~~~~i~~~~~~~~~~--~s~~~~~li~~mL~~dP~~R~t----~~eil~hp~~~~ 270 (443)
.+..+.......+.. ++..++++|.+||..||++||| +++++.||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 777666555555444 6899999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=344.27 Aligned_cols=255 Identities=27% Similarity=0.473 Sum_probs=216.6
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh---hhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV---LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+..... ........+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999987 4788999999875432 122334678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc---
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR--- 165 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 165 (443)
+|||++|++|.+.+...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred -CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHH
Q 013407 166 -DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTA 241 (443)
Q Consensus 166 -~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~ 241 (443)
.........|+..|+|||.+.+..+. .++|+|||||++|+|++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11223345689999999999876664 8899999999999999999999876655443333322 234556689999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.++|++||..+|.+|||+.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=352.82 Aligned_cols=253 Identities=33% Similarity=0.529 Sum_probs=208.5
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 68999999999999999999999999999999975432 22233567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 92 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
|+.+ +|.+.+.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence 9975 77777754 567999999999999999999999999999999999999999999999999998754321 1222
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCC-CCCcHHHHHHHhhcC----------------c---
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA----------------E--- 230 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~----------------~--- 230 (443)
....+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+....+..+... .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877555568999999999999999988885 444444333332110 0
Q ss_pred c----------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 231 F----------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 231 ~----------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+ ...+.+++++++||.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=346.92 Aligned_cols=255 Identities=30% Similarity=0.472 Sum_probs=212.8
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|++|.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 5799999999999999999999999999999998754321 122356789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||++++.|...+.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence 999998888877777789999999999999999999999999999999999999999999999999987653321 122
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---------------c----c
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---------------E----F 231 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------~----~ 231 (443)
....++..|+|||.+.+....+.++||||+|+++|+|++|.+||.+.+..+....+... . .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 33457889999999876554468899999999999999999999876654333222110 0 0
Q ss_pred CCC------------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 232 TCP------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 232 ~~~------------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
..| +.++..+.+||.+||+.||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 2357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.48 Aligned_cols=257 Identities=32% Similarity=0.467 Sum_probs=220.2
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
.++|++.+.||.|+||.||+|.+..++..+|+|++.... ....+.+.+|+.+++.++||||+++++.+.++...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 457999999999999999999998899999999986532 23456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||+++++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence 9999999999988764 56999999999999999999999999999999999999999999999999987654321 11
Q ss_pred ccccccCCCcccchhhhccC----CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTA 241 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~ 241 (443)
......|++.|+|||.+... ...+.++|+||+||++|+|++|.+||...+......++..+. +..|..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 22345689999999998532 222468999999999999999999999887766666665543 23455688999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.++|.+||..+|.+||++.++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=366.50 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=207.5
Q ss_pred cccEEEEeEeeccCcEEEEEEEEC--CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
-.+|++++.||.|+||.||+|... .++..||+|.+.... ...+|+.+++.++||||+++++++......|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 347999999999999999999764 356789999886432 3457999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
++||++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9999996 589999977788999999999999999999999999999999999999999999999999998754432222
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH---HHHHHhhc----------------
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKKISA---------------- 228 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~~---------------- 228 (443)
.......||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.... ..+..+..
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 223356799999999999877775 8899999999999999999999764321 11111100
Q ss_pred -------------CccCCCC-----CCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 229 -------------AEFTCPP-----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 229 -------------~~~~~~~-----~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
..+..|. .++.++.++|.+||..||.+|||+.++|.||||.+.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0011111 246788999999999999999999999999999863
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.72 Aligned_cols=254 Identities=30% Similarity=0.421 Sum_probs=212.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+++|+.+++.++||||+++++.+..+..+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 34679999999999999999999999999999999975432 123568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||||+++++|.+.+...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IA 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--cc
Confidence 9999999999999988788999999999999999999999999999999999999999999999999998754321 11
Q ss_pred ccccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC-----CCCCHHH
Q 013407 169 LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-----PWLSFTA 241 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~~ 241 (443)
......|++.|+|||.+.. ....+.++|+||+||++|+|++|..||...........+....+..+ ..++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 1234568999999999853 22224789999999999999999999976554433333322222222 2367899
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEW 267 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~ 267 (443)
.+||++||..||.+|||++++++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=374.48 Aligned_cols=254 Identities=29% Similarity=0.478 Sum_probs=225.4
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
+.|+|++.||.|+||+||+|.++.++-..|.|+|... ..+.++.+.-||.||..++||+||++++.|..++.+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 4688999999999999999999999888899998653 3455788889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|||.||-....+.. ...+++++++.+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.+..... .-..
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence 99999988666544 56799999999999999999999999999999999999999999999999999864221 2223
Q ss_pred cccccCCCcccchhhhc-----cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC---CCCCCCHHH
Q 013407 170 LHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---CPPWLSFTA 241 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~-----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~ 241 (443)
..+..|||+|||||++. ..+|+ .++||||||+.|.+|..+.+|....+++...-+|...+++ -|..++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 46788999999999974 45676 8999999999999999999999999999988888777653 466789999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.++|.+||..||..||++.++|+||||+.
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 99999999999999999999999999985
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=343.76 Aligned_cols=248 Identities=35% Similarity=0.688 Sum_probs=220.0
Q ss_pred eeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013407 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (443)
Q Consensus 19 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 98 (443)
||.|++|.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++...|++|||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999989999999999876554445567899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCc
Q 013407 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (443)
Q Consensus 99 ~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 178 (443)
.+.+.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 9999888889999999999999999999999999999999999999999999999999987543321 2234578999
Q ss_pred ccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc--HHHHHHHhh--cCccCCCCCCCHHHHHHHHHhcCCCCC
Q 013407 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKIS--AAEFTCPPWLSFTARKLIARILDPNPM 254 (443)
Q Consensus 179 y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~--~~~~~~~~~~s~~~~~li~~mL~~dP~ 254 (443)
|+|||.+.+..++ .++|+||+|+++|+|++|..||.... ....+..+. ......|...+.++.++|.+||..||.
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998776664 88999999999999999999998776 566666665 345667777899999999999999999
Q ss_pred CCCC-----hhhhhcCccccc
Q 013407 255 TRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 255 ~R~t-----~~eil~hp~~~~ 270 (443)
+||+ ++|+++||||+.
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=349.30 Aligned_cols=260 Identities=28% Similarity=0.486 Sum_probs=221.1
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
.++....+|++.+.||+|++|.||+|.+..++..||+|.+...... ..+.+.+|+.+++.++||||+++++.+....
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 3456678999999999999999999999999999999999764432 2467889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
..|+||||++|++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999999999998864 56899999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc-C--ccCCCCCCCHHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA-A--EFTCPPWLSFTA 241 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-~--~~~~~~~~s~~~ 241 (443)
........|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+.. . ....+..++..+
T Consensus 170 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (296)
T cd06654 170 --QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (296)
T ss_pred --ccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence 122234578999999999987665 4889999999999999999999987765433322222 2 223345688999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+++.+||..||.+|||+.+++.||||...
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=346.94 Aligned_cols=253 Identities=30% Similarity=0.457 Sum_probs=213.0
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+...+..|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 34689999999999999999999999999999999875432 224567889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
+|||+++++|.+.+...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA 161 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999998654321 12
Q ss_pred ccccccCCCcccchhhhc---cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC-----CCCCHH
Q 013407 169 LLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-----PWLSFT 240 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~ 240 (443)
......|++.|+|||++. ...+ +.++|+||+||++|+|++|..||...................+ ..++..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred ccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 223457899999999974 2234 4789999999999999999999976554333322222222221 236788
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCcc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEW 267 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~ 267 (443)
+.++|.+||..||++|||++++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=342.01 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=219.1
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+......|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999997644322 4578999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 91 EFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 91 E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
|++.|++|.+.+... ..+++..++.++.||+.||.|||+.|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999998765443222
Q ss_pred --CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC-CC-----CCCCH
Q 013407 168 --GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CP-----PWLSF 239 (443)
Q Consensus 168 --~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~-----~~~s~ 239 (443)
.......|++.|+|||++......+.++|+||+||++|+|++|..||...+....+.++...... .+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12344578999999999876634468899999999999999999999887766555554433221 11 24678
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.+.+++.+||..||++|||+.+++.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=343.67 Aligned_cols=257 Identities=31% Similarity=0.518 Sum_probs=215.6
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh-------HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6899999999999999999998899999999986432211 123457889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
..++||||+.|++|.+.+...+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++++|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCccccccCCCcccchhhhccCC-CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCCC----CC
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPP----WL 237 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~----~~ 237 (443)
..........|+..|+|||.+.... ..+.++|+||||+++|+|++|..||...+.......+... ....+. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222234456899999999987654 2358899999999999999999999766554433333222 222232 35
Q ss_pred CHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 238 SFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+..+.++|.+||.++|.+|||++++++|||+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=356.30 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=206.3
Q ss_pred EEeEeecc--CcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 15 VGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 15 ~~~~LG~G--~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
++++||+| +|++||++.++.+|+.||+|.+...... ....+.+++|+.+++.++||||+++++++.+++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 7899999999999999999999765432 23456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC----
Q 013407 93 VTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (443)
Q Consensus 93 ~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 166 (443)
+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999998653 4689999999999999999999999999999999999999999999999986543211110
Q ss_pred -CCccccccCCCcccchhhhccC--CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC-----------
Q 013407 167 -DGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----------- 232 (443)
Q Consensus 167 -~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~----------- 232 (443)
........++..|+|||++.+. .| +.++||||+||++|+|++|..||..............+..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1111234577889999999753 34 58899999999999999999999865544332222111100
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 233 -----------------------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 233 -----------------------------------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
....+++.+.+||.+||+.||++|||++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 01124678999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=346.06 Aligned_cols=255 Identities=31% Similarity=0.498 Sum_probs=215.0
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||+|++|.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999999999999999765432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 92 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
|+ |++|.+.+.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999998865 45699999999999999999999999999999999999999999999999999876543211 223
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC-------------------cc
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------EF 231 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~ 231 (443)
....|+..|+|||.+.+....+.++||||+||++|+|++|.+||.+.+....+..+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 44578999999999876555568999999999999999999999877655444333211 00
Q ss_pred C-----------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 232 T-----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 232 ~-----------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
. ..+..+..+.+||++||..||.+|||++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0123568899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=348.44 Aligned_cols=258 Identities=30% Similarity=0.498 Sum_probs=221.1
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
++....+|++.+.||.|++|.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 44556789999999999999999999999999999999975432 234678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+|+||+.|++|...+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~- 168 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE- 168 (296)
T ss_pred EEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc-
Confidence 9999999999999998865 46899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTAR 242 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~ 242 (443)
........|++.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+.......+... ....+..+++.+.
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06655 169 -QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246 (296)
T ss_pred -cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 112234568999999999987666 48899999999999999999999987765544444322 2234456889999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 243 KLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
++|++||..||.+|||+.+++.||||..
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 9999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=345.51 Aligned_cols=254 Identities=29% Similarity=0.490 Sum_probs=216.1
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 778899999999999999999999999999986533 23356788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 93 VTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 93 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
+.+++|...+.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... .....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence 999999887754 467999999999999999999999999999999999999999999999999998653221 12233
Q ss_pred cccCCCcccchhhhcc-----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHHHH
Q 013407 172 TTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARK 243 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~ 243 (443)
...|++.|+|||++.. ..+ +.++||||+||++|+|++|.+||...+.......+.... ...|..++.++.+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred cccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 4568999999999842 223 478999999999999999999998877665555554332 2345568899999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 244 LIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
+|.+||+.||.+|||++++++||||....
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 99999999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=345.90 Aligned_cols=257 Identities=34% Similarity=0.657 Sum_probs=228.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 89 (443)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++ ||||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765544445577889999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC--
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-- 167 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 167 (443)
|||+.+++|.+.+...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.+++++++|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999998765432211
Q ss_pred ----------------CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc
Q 013407 168 ----------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (443)
Q Consensus 168 ----------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 231 (443)
.......|+..|+|||++....+ +.++||||||++++++++|..||...+....++.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 12233467899999999876555 4889999999999999999999998887777777777777
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCh----hhhhcCccc
Q 013407 232 TCPPWLSFTARKLIARILDPNPMTRITI----PEILEDEWF 268 (443)
Q Consensus 232 ~~~~~~s~~~~~li~~mL~~dP~~R~t~----~eil~hp~~ 268 (443)
..|..+++.+.++|.+||+.||.+|||+ .++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 7888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=346.82 Aligned_cols=240 Identities=16% Similarity=0.244 Sum_probs=209.1
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCEEEEEEec
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEF 92 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~ 92 (443)
..||+|++|.||+|.. +|+.||||.+...........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5689999999999997 688999999987554444456788899999999999999999999876 4578999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
++||+|.+.+...+.+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cc
Confidence 99999999999888899999999999999999999985 9999999999999999999999999998754321 12
Q ss_pred cccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHHHHHH
Q 013407 172 TTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~ 247 (443)
...||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..+.+..+... .+..|...++.+.+++.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999975 445 58999999999999999999999988877777776433 445565789999999999
Q ss_pred hcCCCCCCCCChhhhhc
Q 013407 248 ILDPNPMTRITIPEILE 264 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~ 264 (443)
||+.||++|||++++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999985
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=348.30 Aligned_cols=255 Identities=29% Similarity=0.459 Sum_probs=214.6
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+.... ....+.+.+|+.+++.++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999989999999998654332 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||+.++.|.........+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999988887776667999999999999999999999999999999999999999999999999998754332 1223
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-------------------c
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------------------F 231 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 231 (443)
....|+..|+|||++.+....+.++||||+|+++|+|++|.+||...+..+....+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345688999999998765555688999999999999999999998766544333322100 0
Q ss_pred ------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 232 ------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 232 ------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
...+.++..+.+|+.+||+.+|.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=338.38 Aligned_cols=253 Identities=30% Similarity=0.594 Sum_probs=220.2
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||+|+||.||.+.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 6999999999999999999999999999999997654322 234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|+.+++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 999999999987643 58999999999999999999999999999999999999999999999999987543311 11
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHHh
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARI 248 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~m 248 (443)
.....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..+.. ..+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 223458899999999877665 4789999999999999999999988877777766655544 35566899999999999
Q ss_pred cCCCCCCCCChhhhhcCccc
Q 013407 249 LDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 249 L~~dP~~R~t~~eil~hp~~ 268 (443)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=343.33 Aligned_cols=257 Identities=26% Similarity=0.474 Sum_probs=216.2
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh---hhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV---LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
+|+..+.||+|++|.||+|.+..+++.||+|++..... ......+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 48889999999999999999999999999999975432 112245788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-CeEEeecCcccccccccC-
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRD- 166 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~- 166 (443)
||||+.|++|.+.+...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998876 599999999875433211
Q ss_pred -CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHh---h--cCccCCCCCCCHH
Q 013407 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI---S--AAEFTCPPWLSFT 240 (443)
Q Consensus 167 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---~--~~~~~~~~~~s~~ 240 (443)
........||..|+|||.+.+..+. .++|+||+|+++|+|++|..||...........+ . ......|+.++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1112234688999999999776664 8899999999999999999999765433222222 1 2234455668899
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
+.+++.+||..+|.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=347.61 Aligned_cols=261 Identities=33% Similarity=0.479 Sum_probs=217.8
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhh--hHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+|++.+.||+|++|.||+|.+..+|+.||||.+...... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765433 122345677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||+ +++|.+++.... .+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence 9999 889999998765 7999999999999999999999999999999999999999999999999998754332 12
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-----------------
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------------- 231 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------------- 231 (443)
......+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+....+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345688999999986554556889999999999999999999987776554444321100
Q ss_pred ------C-----CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCCC
Q 013407 232 ------T-----CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (443)
Q Consensus 232 ------~-----~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~~ 275 (443)
. .....+..+.++|.+||..||++|||+.+++.||||+....+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 0 0122467899999999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=338.71 Aligned_cols=251 Identities=31% Similarity=0.479 Sum_probs=216.4
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++.+.+...+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 679999999999999999999998999999999976432 24578899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 999999999988776 789999999999999999999999999999999999999999999999999987543321 12
Q ss_pred cccccCCCcccchhhhccC---CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC-----CCCCCCHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-----CPPWLSFTA 241 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~---~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~~ 241 (443)
.....|+..|+|||.+... .++ .++|+||||+++|+|++|.+||...+.......+....+. .+..++.++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 2345688999999998765 554 7899999999999999999999887655544444333222 223357889
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEW 267 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~ 267 (443)
.+++.+||..+|..|||+.+++.|+|
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=345.76 Aligned_cols=249 Identities=30% Similarity=0.464 Sum_probs=204.8
Q ss_pred EeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHH---hcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013407 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM---KLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 18 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 94 (443)
.||+|+||.||+|.+..+++.+|+|.+.+.............+|..++ ...+||||+.+++.+...+..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999999765443222223334444443 34479999999999999999999999999
Q ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcccccc
Q 013407 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (443)
Q Consensus 95 gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 174 (443)
|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999999988888999999999999999999999999999999999999999999999999998644321 123457
Q ss_pred CCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH---HHHHHHhhcCccCCCCCCCHHHHHHHHHhcCC
Q 013407 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (443)
Q Consensus 175 gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~ 251 (443)
||+.|+|||.+......+.++||||+||++|+|++|..||..... ..............|+.++.++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 999999999986433335889999999999999999999975432 22222222334456677899999999999999
Q ss_pred CCCCCC-----ChhhhhcCccccc
Q 013407 252 NPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 252 dP~~R~-----t~~eil~hp~~~~ 270 (443)
||.+|+ |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=353.23 Aligned_cols=261 Identities=31% Similarity=0.474 Sum_probs=232.2
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
+....+.|..-+.||+|+||.||-++.+.||+-||.|.+.+..+..........+|-.||++++.+.||.+-..|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34556778888999999999999999999999999999999888766666678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
+++||..|+||+|.-+|.+.+ +++|..+++|+.+|+.||.+||+.+|++|||||+|||+|+.|+++|+|+|||.-+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~- 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP- 338 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC-
Confidence 999999999999988887766 89999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH----HHHHHhhcCccCCCCCCCH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAEFTCPPWLSF 239 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s~ 239 (443)
.........||..|||||++.+..|+ ..+|.|||||+||+|+.|+.||...... +.-+.+......+|..+|+
T Consensus 339 --~g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 339 --EGKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred --CCCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence 34445566999999999999988875 8889999999999999999999765432 4445556666677888999
Q ss_pred HHHHHHHHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 240 TARKLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
+++++.+.+|..||.+|.. ++++.+||||+.
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 9999999999999999984 779999999985
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=340.46 Aligned_cols=256 Identities=27% Similarity=0.504 Sum_probs=214.8
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhh--hHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIF 87 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 87 (443)
.|+..+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.+ ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 689999999999999999999999999999998754321 22345678999999999999999999998865 46789
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc-C
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR-D 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 166 (443)
+++||+++++|.+.+...+.+++...+.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999999999887889999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKL 244 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~l 244 (443)
........|+..|+|||.+.+..+ +.++||||+||++|+|++|+.||...........+... ....|..+++.++++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 112234568899999999987665 47899999999999999999999876655444333222 344566688999999
Q ss_pred HHHhcCCCCCCCCChhhhhcCcccc
Q 013407 245 IARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
| +||..+|++|||++++++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.01 Aligned_cols=257 Identities=28% Similarity=0.534 Sum_probs=215.6
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh--hhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKI 86 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 86 (443)
..|++.+.||+|+||.||.|.+..+|..||||.+..... ......+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999999864321 122345688999999999999999999998866 3578
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc-
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR- 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 165 (443)
|++|||++|++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 8999999999999999887889999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ 243 (443)
.........|+..|+|||++.+..+ +.++|||||||++|+|++|..||...........+... ....|+.++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 1112234568999999999987666 48899999999999999999999876555444443322 23345567889999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 244 LIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
+|++|+. +|++||+++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=345.39 Aligned_cols=255 Identities=30% Similarity=0.485 Sum_probs=216.4
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
-+.|++++.||.|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+..++..|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 367999999999999999999999999999999987542 33457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||++|++|...+.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++...... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence 999999999887754 457899999999999999999999999999999999999999999999999987643221 11
Q ss_pred ccccccCCCcccchhhhcc-----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHH
Q 013407 169 LLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFT 240 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~ 240 (443)
......|++.|+|||++.+ ..+ +.++|+|||||++|+|++|.+||...+......++.... ...+..++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred ccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 2234568899999999853 223 478999999999999999999998776655555544332 2334557889
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+.++|.+||..||++||+++++++||||..
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 999999999999999999999999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=348.11 Aligned_cols=258 Identities=29% Similarity=0.482 Sum_probs=219.0
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
+....+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++......
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 44568999999999999999999999999999999999754322 245688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~-- 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 168 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC--
Confidence 999999999999998865 56899999999999999999999999999999999999999999999999998754321
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc-C--ccCCCCCCCHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA-A--EFTCPPWLSFTARK 243 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-~--~~~~~~~~s~~~~~ 243 (443)
........|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.+.......+.. + ....|..++..+++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 112234578999999999987666 4889999999999999999999987665433222221 1 12234557889999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 244 LIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
|+.+||..||++||++++++.||||...
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhccc
Confidence 9999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=366.23 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=204.9
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+.++++++|||||++++++...+..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 2356899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99996 6888887654 469999999999999999999999999999999999999999999999999997654322222
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCC--------CcHHHHHHHhhcCcc---------
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD--------SNLMNLYKKISAAEF--------- 231 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~--------~~~~~~~~~i~~~~~--------- 231 (443)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..|+.. .....+.+.+.....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 23346799999999999887775 889999999999999998765422 112222222222111
Q ss_pred --------------------CCCCC-----CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 232 --------------------TCPPW-----LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 232 --------------------~~~~~-----~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..+.| ++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11111 4568999999999999999999999999999974
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.89 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=210.1
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++.+......++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999987542 2234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||+++++|... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..... ...
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccc
Confidence 99999988544 4578999999999999999999999999999999999999999999999999875432 223
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH-------HHHHHHhhcCcc-CC-CCCCCHHH
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-------MNLYKKISAAEF-TC-PPWLSFTA 241 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-------~~~~~~i~~~~~-~~-~~~~s~~~ 241 (443)
...+||+.|+|||++.+..+ +.++|+||+||++|+|++|..||..... ......+..... .. ....++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 45679999999999987766 4889999999999999999999965321 122222222221 11 23478899
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
++++.+||+.||.+||++++++.||||...
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=343.93 Aligned_cols=248 Identities=31% Similarity=0.479 Sum_probs=212.2
Q ss_pred eeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013407 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (443)
Q Consensus 19 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 98 (443)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999875544333455667899999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCC
Q 013407 99 FDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (443)
Q Consensus 99 ~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 176 (443)
.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ........|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 99997765 799999999999999999999999999999999999999999999999999875432 2222345678
Q ss_pred CcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH----HHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCC
Q 013407 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252 (443)
Q Consensus 177 ~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~d 252 (443)
..|+|||++.+..+ +.++||||+||++|+|++|..||..... ......+.......++.+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999877665 4889999999999999999999987544 223333333344556668999999999999999
Q ss_pred CCCCC-----ChhhhhcCccccc
Q 013407 253 PMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 253 P~~R~-----t~~eil~hp~~~~ 270 (443)
|.+|| ++.+++.||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=342.84 Aligned_cols=255 Identities=27% Similarity=0.488 Sum_probs=221.0
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+....|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 478999999999999999999999999999999976432 223467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||+++++|.+++... .+++..++.++.|++.|+.|||+.|++||||+|+||+++.++.++|+|||++....... ...
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 999999999998765 89999999999999999999999999999999999999999999999999987654321 122
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCC-CCHHHHHHHHHh
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW-LSFTARKLIARI 248 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~~~~~li~~m 248 (443)
....|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+..... ..+.. ++.++.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 34568899999999987765 4889999999999999999999988776655555544432 33334 788999999999
Q ss_pred cCCCCCCCCChhhhhcCcccccc
Q 013407 249 LDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 249 L~~dP~~R~t~~eil~hp~~~~~ 271 (443)
|..||++|||++++++||||...
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=341.99 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=211.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe-----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS----- 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----- 82 (443)
.-+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45789999999999999999999999999999999875431 235678899999998 79999999999865
Q ss_pred -CCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 83 -KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 83 -~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
...+|++|||+.+++|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 35689999999999999998763 468999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCccccccCCCcccchhhhcc-----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc--C
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--T 232 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~ 232 (443)
..... ........|++.|+|||++.. ..+ +.++||||+||++|+|++|..||...........+..... .
T Consensus 160 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 160 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred ecccc--cccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 54321 122345679999999999863 234 4789999999999999999999987655544433332221 1
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 233 CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 233 ~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.+..++..+.+|+.+||..||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 223478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=365.48 Aligned_cols=263 Identities=32% Similarity=0.588 Sum_probs=244.4
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
+.....+.+.+.+.+||-|+||.|-++........+|+|++++..+.+....+.+..|-+||..++.|.||++|-.|.+.
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 44456788889999999999999999988766667999999998888877889999999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
.++|++||-|-||+|+..+...+.+.+..+++|...+++|++|||++||++|||||||++++.+|-+||.|||+|+...
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~- 571 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG- 571 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTA 241 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~ 241 (443)
.+...-+.||||.|+|||++.+++++ ..+|.||||+++||||+|.+||.+.+++..|..|..+ ...+|..++..+
T Consensus 572 --~g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a 648 (732)
T KOG0614|consen 572 --SGRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTA 648 (732)
T ss_pred --cCCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhH
Confidence 34556789999999999999999997 8899999999999999999999999999999999877 467889999999
Q ss_pred HHHHHHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 242 RKLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
.+||+++...+|.+|.. +.+|.+|.||..
T Consensus 649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 99999999999999996 899999999974
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=344.11 Aligned_cols=249 Identities=30% Similarity=0.464 Sum_probs=208.1
Q ss_pred EeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHH---HHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013407 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE---VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 18 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E---i~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 94 (443)
.||+|+||.||+|.+..+++.||+|++.+..............| +.+++...||||+++++.+.+.+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999986543322212222333 344555689999999999999999999999999
Q ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcccccc
Q 013407 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (443)
Q Consensus 95 gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 174 (443)
|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... .....+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcC
Confidence 9999999988888999999999999999999999999999999999999999999999999998754321 223457
Q ss_pred CCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC---cHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCC
Q 013407 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (443)
Q Consensus 175 gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~ 251 (443)
|++.|+|||++.+....+.++||||+||++|+|++|..||.+. ........+.......|..++..+.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875433358899999999999999999999876 3333344444445566667899999999999999
Q ss_pred CCCCCC-----ChhhhhcCccccc
Q 013407 252 NPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 252 dP~~R~-----t~~eil~hp~~~~ 270 (443)
+|.+|| ++.++++||||..
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccC
Confidence 999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=335.18 Aligned_cols=253 Identities=30% Similarity=0.541 Sum_probs=222.0
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+....+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|+++++|.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 99999999999764 468999999999999999999999999999999999999999999999999987543322 12
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC-CCCCCCHHHHHHHHHh
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~m 248 (443)
.....|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+..+....+..+.+. .++.++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3455789999999998876654 7899999999999999999999988877777776665443 3455789999999999
Q ss_pred cCCCCCCCCChhhhhcCccc
Q 013407 249 LDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 249 L~~dP~~R~t~~eil~hp~~ 268 (443)
|..+|.+||++.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=383.54 Aligned_cols=262 Identities=29% Similarity=0.463 Sum_probs=216.8
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--C
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--K 83 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 83 (443)
....+++|++++.||.|+||.||+|.+..++..||+|++...... ......+.+|+.+++.|+|||||++++++.+ .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 356788999999999999999999999999999999999765433 2345678899999999999999999998854 4
Q ss_pred CEEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CcEeeeCCCCcEEEcc------
Q 013407 84 TKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR-------GVYHRDLKPENLLLDA------ 146 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-------givHrDlkp~NILl~~------ 146 (443)
..+|+||||+.+|+|.+.|.. .+.+++..++.++.||+.||.|||+. +|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 679999999999999998865 35799999999999999999999984 4999999999999964
Q ss_pred -----------CCCeEEeecCcccccccccCCCccccccCCCcccchhhhccC-CCCCCchhhhhhhHHHHHHhhCCCCC
Q 013407 147 -----------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPF 214 (443)
Q Consensus 147 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf 214 (443)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++|..||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 23489999999875432 2223456799999999998643 23358899999999999999999999
Q ss_pred CCCcHH-HHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 215 DDSNLM-NLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 215 ~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
...+.. .+...+........+..+.++.+||.+||..+|.+||++.|+|.|||+...
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 865543 444444433222224578999999999999999999999999999999753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=358.93 Aligned_cols=247 Identities=32% Similarity=0.673 Sum_probs=217.4
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
.+.||+|.||+||-|+++.+|+.||||+|++.++...+ ..++++|+.||+.+.||.||.+--.+++.+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 36899999999999999999999999999998876543 47899999999999999999999999999999999999976
Q ss_pred CchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC---CeEEeecCcccccccccCCCcc
Q 013407 96 GELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 96 g~L~~~i~--~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~~ 170 (443)
++...|. ..+++++...++++.||+.||.|||-+||+|+||||||||+.... .+||||||+|++..+ ....
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksFR 723 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSFR 723 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---hhhh
Confidence 6666664 357899999999999999999999999999999999999997654 599999999997654 3445
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC--CC--CCHHHHHHHH
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--PW--LSFTARKLIA 246 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~--~s~~~~~li~ 246 (443)
.+..|||.|.|||++..++|+ ...|+||.|||+|.-|+|..||.... ++-..|+...+-+| || +++.+.+||+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLIN 800 (888)
T ss_pred hhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHH
Confidence 678899999999999999997 77899999999999999999997543 33445555555444 55 8999999999
Q ss_pred HhcCCCCCCCCChhhhhcCccccc
Q 013407 247 RILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.+|+..-.+|+|++..+.|||++.
T Consensus 801 ~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 801 NLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHHhcchHhhccchhhhc
Confidence 999999999999999999999875
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=335.90 Aligned_cols=254 Identities=28% Similarity=0.494 Sum_probs=218.6
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh--hhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+|+..+.||+|++|.||+|.+..+++.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58888999999999999999988999999999875432 1233457789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
+||++|++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987543321 2
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc--CccCCCCCCCHHHHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li~~ 247 (443)
.....|++.|+|||.+......+.++|+||+||++|+|++|..||...........+.. .....++.+++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34566899999999987655235889999999999999999999987665444444333 2234556789999999999
Q ss_pred hcCCCCCCCCChhhhhcCccc
Q 013407 248 ILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~ 268 (443)
||..+|.+||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=343.80 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=216.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCC-----ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETG-----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
.+++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4678999999999999999999876554 679999986433 233456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~ 147 (443)
...|++|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999764 457889999999999999999999999999999999999999
Q ss_pred CCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHh
Q 013407 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (443)
Q Consensus 148 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i 226 (443)
+.++|+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999998754322111223344678899999998776664 88999999999999998 99999988888877777
Q ss_pred hcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 227 SAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 227 ~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..... ..|..++.++.+|+.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65543 4566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.37 Aligned_cols=260 Identities=33% Similarity=0.462 Sum_probs=214.4
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 86 (443)
.+++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.++++++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 5789999999999999999999999999999999987543221 2233466899999999999999999998654 578
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||+.+ +|.+.+.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999975 78777765 3678999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC----------------
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---------------- 229 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 229 (443)
.......+++.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+.+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 12233346788999999876554468899999999999999999999988776665544321
Q ss_pred ---ccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 230 ---EFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 230 ---~~~~~-----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.+..+ .+.++.+.+||.+||+.||.+|||+.+++.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 11111 23588899999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=343.05 Aligned_cols=255 Identities=29% Similarity=0.488 Sum_probs=207.2
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.+++|++.+.||+|++|.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 4689999999999999999999999899999999987543211 12346689999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||||+.+ +|.+.+... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~ 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--S 157 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--C
Confidence 9999985 898888654 46899999999999999999999999999999999999999999999999998643221 1
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc-HHHHHHHhhcC-----------------
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAA----------------- 229 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~----------------- 229 (443)
.......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.. ..+....+...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 112233568899999998764444588999999999999999999997665 22222211100
Q ss_pred --c--cCC---------CCCCC--HHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 230 --E--FTC---------PPWLS--FTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 230 --~--~~~---------~~~~s--~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
. ... .+.++ ..+.++|.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000 01233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.11 Aligned_cols=256 Identities=31% Similarity=0.464 Sum_probs=213.5
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC-
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT- 84 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~- 84 (443)
....++|++.+.||+|++|.||+|.+..+++.+|+|++..... ..+.+.+|+.+++++ +||||+++++++.+..
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 3456899999999999999999999998999999999876432 235788999999999 7999999999986544
Q ss_pred -----EEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeec
Q 013407 85 -----KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 85 -----~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DF 155 (443)
.+|+||||+.+++|.+.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 58999999999999988765 357999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccCC----CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 231 (443)
|++...... ........|++.|+|||++.... ..+.++|||||||++|+|++|.+||...........+.....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 235 (275)
T cd06608 158 GVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP 235 (275)
T ss_pred ccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence 998754321 12233456899999999985422 224789999999999999999999987665554444443322
Q ss_pred ---CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 232 ---TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 232 ---~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
..+..++..+++||.+||..||.+|||+.++++|||+
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2223367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=350.47 Aligned_cols=261 Identities=31% Similarity=0.567 Sum_probs=238.7
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (443)
..+..+|..+..||+|+||+|-+|..+.+.+.+|||++.+.-+...+..+--..|-++|... +-|.+++++..|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45678899999999999999999999999999999999887665555555566788888777 57899999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||+.||+|--.|+.-+.+.|..|..|+..|+-||-+||++||++||||.+||++|.+|++||+|||+++. ...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999863 233
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
......+.||||.|+|||++...+| +..+|.||+||+|||||+|++||++.+..++++.|......+|..+|.++.++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 4455678999999999999998888 589999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
...|...|.+|.. -.+|..||||+.
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhh
Confidence 9999999999985 468999999974
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=334.63 Aligned_cols=249 Identities=31% Similarity=0.552 Sum_probs=216.5
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+.+.+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2245678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 92 FVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++++|||++...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 9999999998865 345899999999999999999999999999999999999999999999999998754332 112
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHHh
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARI 248 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~m 248 (443)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234568999999999987666 4889999999999999999999998887777666655544 35566889999999999
Q ss_pred cCCCCCCCCChhhhhcC
Q 013407 249 LDPNPMTRITIPEILED 265 (443)
Q Consensus 249 L~~dP~~R~t~~eil~h 265 (443)
|+.||.+|||+.+++.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=353.24 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=211.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (443)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 46789999999999999999999999999999999865432 223345677899999999999999999988543
Q ss_pred -CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
...|+||||+.+ +|.+.+... +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 888877643 8999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc------------
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 230 (443)
. ........|++.|+|||.+.+..+. .++|||||||++|+|++|..||...+....+.++....
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 1223345689999999999887775 88999999999999999999998766544333321100
Q ss_pred ----------c--------------CC-------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 231 ----------F--------------TC-------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 231 ----------~--------------~~-------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
. .. +...+..++++|.+||+.||++|||+.|+|.||||+.++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0 00 11235578999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=338.04 Aligned_cols=251 Identities=34% Similarity=0.649 Sum_probs=221.3
Q ss_pred eeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013407 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (443)
Q Consensus 19 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 98 (443)
||.|+||.||+|.+..+|+.+|+|++...........+.+.+|+.++++++||||+++++.+.+....|++|||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999876554445667899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC------CCcccc
Q 013407 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------DGLLHT 172 (443)
Q Consensus 99 ~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~------~~~~~~ 172 (443)
.+.+...+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998878899999999999999999999999999999999999999999999999999875432211 112234
Q ss_pred ccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCC--CHHHHHHHHHhcC
Q 013407 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL--SFTARKLIARILD 250 (443)
Q Consensus 173 ~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--s~~~~~li~~mL~ 250 (443)
..+++.|+|||.+....+ +.++|+||||+++|+|++|..||........+..+..+....|... +..+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999877665 4889999999999999999999998888888888777666666555 8999999999999
Q ss_pred CCCCCCCCh---hhhhcCccccc
Q 013407 251 PNPMTRITI---PEILEDEWFKK 270 (443)
Q Consensus 251 ~dP~~R~t~---~eil~hp~~~~ 270 (443)
.+|.+|||+ .++++||||+.
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999973
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=333.78 Aligned_cols=252 Identities=30% Similarity=0.510 Sum_probs=218.9
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||+|++|.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999998654332 345788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-CeEEeecCcccccccccCCC
Q 013407 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~ 168 (443)
|++|++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 99999999999763 3589999999999999999999999999999999999998654 5799999998754322 2
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIAR 247 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 247 (443)
......|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+.... ...+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2234568999999999987655 478999999999999999999999887776666655443 34566689999999999
Q ss_pred hcCCCCCCCCChhhhhcCccc
Q 013407 248 ILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~ 268 (443)
||..||++|||+.++++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.82 Aligned_cols=256 Identities=32% Similarity=0.510 Sum_probs=215.3
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+++..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999875432 2334578899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||+.++.+.........+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 9999877777676667799999999999999999999999999999999999999999999999999876543221 123
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---------------------
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------------- 229 (443)
....|++.|+|||++.+....+.++||||+|+++|+|++|.+||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 34578899999999987734458999999999999999999999876554332221110
Q ss_pred cc-----------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 230 EF-----------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 230 ~~-----------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.+ ..+..++.++.+||++||..+|++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1223358899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=356.58 Aligned_cols=247 Identities=28% Similarity=0.409 Sum_probs=199.9
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
-.+|++++.||+|+||.||+|.+..+++.||+|+..+. ....|+.++++++||||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34699999999999999999999999999999986432 234689999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 99996 478887754 46799999999999999999999999999999999999999999999999999874322 12
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCC-CCCCCCcH----------HHHHHHhhcCc---cCCC
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNL----------MNLYKKISAAE---FTCP 234 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~-~Pf~~~~~----------~~~~~~i~~~~---~~~~ 234 (443)
......||+.|+|||++.+..+. .++||||+||++|+|+++. ++|..... ..+...+.... ..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 23346799999999999887774 8899999999999999854 44443211 01111111000 0011
Q ss_pred ------------------------------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 235 ------------------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 235 ------------------------------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667888999999999999999999999999974
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=334.85 Aligned_cols=253 Identities=34% Similarity=0.577 Sum_probs=219.4
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCCEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIV 89 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv 89 (443)
+|++.+.||.|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++. .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998764432 334567889999999999999999999775 35678999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCH-----SRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH-----~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
|||+++++|.+.+.. ...+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998865 367899999999999999999999 89999999999999999999999999999886
Q ss_pred cccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCH
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSF 239 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~ 239 (443)
..... .......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.....+.+..+.. ..+..++.
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 54321 11334578999999999987665 4889999999999999999999998887777777766654 45567889
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.+.+++.+||..+|++|||+.++++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=345.20 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=204.2
Q ss_pred cccEEEEeEeeccCcEEEEEEEECC----------------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCc
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSE----------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 73 (443)
-++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998532 34479999987543 22345678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 013407 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------------------RMKEDEARRYFQQLINAVDYCHSRGVYH 134 (443)
Q Consensus 74 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-------------------~l~e~~~~~~~~qi~~aL~~LH~~givH 134 (443)
+++++++.+.+..++||||+.+|+|.+++.... .++...+..++.||+.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999886532 3677888999999999999999999999
Q ss_pred eeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh--CCC
Q 013407 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYL 212 (443)
Q Consensus 135 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~--G~~ 212 (443)
|||||+|||++.++.+||+|||++................++..|+|||++....+ +.++|||||||++|+|++ |..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999875432211112223456788999999877666 489999999999999986 678
Q ss_pred CCCCCcHHHHHHHhhc--------CccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhh
Q 013407 213 PFDDSNLMNLYKKISA--------AEFTCPPWLSFTARKLIARILDPNPMTRITIPEIL 263 (443)
Q Consensus 213 Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil 263 (443)
||...+..+....+.. .....|+.++..+.+|+.+||..||.+|||+.+|.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 8887665554433211 11234566889999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=335.52 Aligned_cols=250 Identities=28% Similarity=0.487 Sum_probs=215.8
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .+.+.+|+.+++.++||||+++++.+.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 579999999999999999999998899999999875432 568899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||+.+++|.+.+.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cc
Confidence 99999999999875 4568999999999999999999999999999999999999999999999999987644321 12
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIA 246 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~ 246 (443)
.....|+..|+|||++.+..++ .++||||+|+++|+|++|..||...+.......+... ....+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 2344588999999999877664 8899999999999999999999876655443333222 22334457889999999
Q ss_pred HhcCCCCCCCCChhhhhcCccc
Q 013407 247 RILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+||+.||.+|||+.+++.||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=340.38 Aligned_cols=260 Identities=28% Similarity=0.423 Sum_probs=215.4
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (443)
..++...++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++++ +|||++++++++..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4556678999999999999999999999999999999999865321 235677899999999 89999999999865
Q ss_pred C-----CEEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEe
Q 013407 83 K-----TKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (443)
Q Consensus 83 ~-----~~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~ 153 (443)
. ...|+||||++|++|.+.+.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3 468999999999999988753 4578999999999999999999999999999999999999999999999
Q ss_pred ecCcccccccccCCCccccccCCCcccchhhhccCC----CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC
Q 013407 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (443)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~ 229 (443)
|||++....... .......|+..|+|||++.... ..+.++||||+||++|+|++|++||...+.......+...
T Consensus 171 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 171 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred ecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 999987543211 1123456899999999985432 1257899999999999999999999877655444444333
Q ss_pred c---cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 230 E---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 230 ~---~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
. ...+...+..+.+||.+||+.||++||++.++++||||+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2 223445678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.45 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=215.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++||||+++++.+...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999999899999999986532 2223467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 91 EFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 91 E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
||++|++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999998888763 379999999999999999999997 5999999999999999999999999999865422
Q ss_pred CCccccccCCCcccchhhhccCCC-----CCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHH---HhhcC-ccCCCCCC
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISAA-EFTCPPWL 237 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i~~~-~~~~~~~~ 237 (443)
.......|++.|+|||.+.+... .+.++||||+||++|+|++|..||........+. .+..+ ....|+.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 22334568899999999854332 2578999999999999999999997655444333 23222 23456668
Q ss_pred CHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
+.++.++|.+||..+|++||++++++.||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.75 Aligned_cols=253 Identities=30% Similarity=0.486 Sum_probs=209.6
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
.|++.+.||.|++|.||+|.+..+|+.||||.+..... .......+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999875432 22233578899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 92 FVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|+. ++|.+++.. ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 588888755 356899999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------------------cc
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------EF 231 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~ 231 (443)
.....+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+......++... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 234457889999999876655568899999999999999999999876654332222110 00
Q ss_pred C-----------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 232 T-----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 232 ~-----------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
. ..+.++++++++|.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=344.77 Aligned_cols=262 Identities=28% Similarity=0.404 Sum_probs=210.1
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
.....+++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred cccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 3556789999999999999999999999999999999998654321 222345678999999999999999999986543
Q ss_pred --------EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeec
Q 013407 85 --------KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 85 --------~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DF 155 (443)
..|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence 46999999975 777777654 37899999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCC--CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc---
Q 013407 156 GLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--- 230 (443)
Q Consensus 156 Gla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--- 230 (443)
|++......... .......++..|+|||.+.+....+.++||||+|+++|+|++|.+||.+.+.......+....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 998765432211 122345678899999998765444588999999999999999999998776543332221100
Q ss_pred ----------------cCCC-------------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 231 ----------------FTCP-------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 231 ----------------~~~~-------------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
...| ...+..+.+||.+||..||.+|||++++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0001 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=334.26 Aligned_cols=256 Identities=32% Similarity=0.561 Sum_probs=217.5
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++...+.+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999889999999999765433 3456789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC-c-
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-L- 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~- 169 (443)
|+.+++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999887789999999999999999999999999999999999999999999999999987654321111 1
Q ss_pred cccccCCCcccchhhhccCC--CCCCchhhhhhhHHHHHHhhCCCCCCCCc-HHHHHHHhhcC-ccCCCCCC--CHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAA-EFTCPPWL--SFTARK 243 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~-~~~~~~~~--s~~~~~ 243 (443)
.....+++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||.... .......+... ....|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22456889999999987654 13588999999999999999999997653 22322223222 33445554 899999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCccc
Q 013407 244 LIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+|.+||+.+|.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=358.67 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=206.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCC-----CceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (443)
..++|++++.||+|+||.||+|++..+ +..||+|++..... ......+.+|+.+++.+ +||||+++++.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345799999999999999999986443 35799999975432 22356788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhC---------------------------------------------------------
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNH--------------------------------------------------------- 105 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~--------------------------------------------------------- 105 (443)
....|+||||+++|+|.+++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999988542
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcccc
Q 013407 106 -------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (443)
Q Consensus 106 -------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 172 (443)
.++++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 2478888999999999999999999999999999999999999999999999875432211111122
Q ss_pred ccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHH-HHhhcC-ccCCCCCCCHHHHHHHHHhc
Q 013407 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLY-KKISAA-EFTCPPWLSFTARKLIARIL 249 (443)
Q Consensus 173 ~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~s~~~~~li~~mL 249 (443)
..+++.|+|||++.+..+ +.++||||+||++|+|++ |..||........+ ..+..+ ....|...++++.+++.+||
T Consensus 274 ~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 274 ARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 335667999999977666 489999999999999997 99999876544333 333322 34456678999999999999
Q ss_pred CCCCCCCCChhhhhc
Q 013407 250 DPNPMTRITIPEILE 264 (443)
Q Consensus 250 ~~dP~~R~t~~eil~ 264 (443)
+.||.+|||+.++++
T Consensus 353 ~~dp~~RPs~~~l~~ 367 (374)
T cd05106 353 NLEPTERPTFSQISQ 367 (374)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=348.05 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=193.1
Q ss_pred EeEeeccCcEEEEEEEECC--CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCCEEEEEEe
Q 013407 16 GRTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLE 91 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv~E 91 (443)
+..||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. ....+|++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4679999999999999754 567899999865432 235778999999999999999999884 4568899999
Q ss_pred ccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE----ccCCCeEEeecCcc
Q 013407 92 FVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (443)
Q Consensus 92 ~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~~~~kl~DFGla 158 (443)
|+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9875 777776421 258899999999999999999999999999999999999 55678999999999
Q ss_pred cccccccC-CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH---------HHHHHhhc
Q 013407 159 ALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------NLYKKISA 228 (443)
Q Consensus 159 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~i~~ 228 (443)
........ ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 76543211 112344578999999999977555568999999999999999999999753211 00000000
Q ss_pred ----------------------------Ccc----------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 229 ----------------------------AEF----------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 229 ----------------------------~~~----------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
... ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=336.04 Aligned_cols=247 Identities=34% Similarity=0.607 Sum_probs=210.7
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHH-HhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
+.||.|+||.||+|.+..+++.||+|++.+...........+..|..+ ....+||||+++++++.+.+..|++|||+.|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 569999999999999999999999999976543333333344555554 4455899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 99999998888899999999999999999999999999999999999999999999999998874322 234468
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHHHHHHHHHhcCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDP 251 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~ 251 (443)
++.|+|||.+.+..+ +.++||||+|+++|+|++|.+||...+....+..+.......+ ..+++.+.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999987665 5899999999999999999999998888777777665543322 34789999999999999
Q ss_pred CCCCCCC---hhhhhcCccccc
Q 013407 252 NPMTRIT---IPEILEDEWFKK 270 (443)
Q Consensus 252 dP~~R~t---~~eil~hp~~~~ 270 (443)
||++||+ ++|++.||||..
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 9999995 579999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=344.17 Aligned_cols=256 Identities=32% Similarity=0.420 Sum_probs=213.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 86 (443)
.+++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... ...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 457899999999999999999999999999999999754332 22345677899999999999999999998777 899
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999999975 8888886643 58999999999999999999999999999999999999999999999999987544321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc---------------
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------------- 230 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------- 230 (443)
.......+++.|+|||.+.+....+.++||||+|+++|+|++|.+||...+......++....
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 222345678899999998765545688999999999999999999998877655444432110
Q ss_pred ----------------cCCCCC-CCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 231 ----------------FTCPPW-LSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 231 ----------------~~~~~~-~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
..++.. +++.+.++|++||+.||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011222 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=338.89 Aligned_cols=249 Identities=31% Similarity=0.528 Sum_probs=205.5
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--CEEEEE
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK--TKIFIV 89 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lv 89 (443)
|++.+.||+|+||.||+|.+..+++.||+|.+.+..... . .....+|+.+++++. ||||+++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999999999999986542211 1 223457888888885 99999999999887 899999
Q ss_pred EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---P 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---C
Confidence 999975 78888765 357899999999999999999999999999999999999999 99999999998754321 2
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------------------c
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------E 230 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~ 230 (443)
......+++.|+|||.+....+.+.++||||+||++|+|++|.+||.+.+..+....+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2234568899999998766566668999999999999999999999887765544433211 1
Q ss_pred cCCC-----------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 231 FTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 231 ~~~~-----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+.+| +.++..+.++|.+||++||.+|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=338.86 Aligned_cols=256 Identities=29% Similarity=0.528 Sum_probs=217.1
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 88 (443)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++ |||++++++++.+....|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58888999999999999999999999999999875422 223567889999999996 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
+|||+.|++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--S 156 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--c
Confidence 9999999999998865 579999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCC-CCHHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW-LSFTARKLIA 246 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~~~~~li~ 246 (443)
......|+..|+|||.+.+....+.++|+||+||++|+|++|..||.+.+.......+..... ..+.. ++.++.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 223456899999999987544446889999999999999999999988776555444433322 22222 7789999999
Q ss_pred HhcCCCCCCCCChhhhhcCccccccC
Q 013407 247 RILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
+||+.||++||++.+++.||||+...
T Consensus 237 ~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 237 ACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=340.04 Aligned_cols=255 Identities=28% Similarity=0.430 Sum_probs=205.5
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.+++.++|+||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 357899999999999999999999999999999998654322 123456789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||||+. ++|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 157 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--S 157 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--C
Confidence 999996 577666654 456889999999999999999999999999999999999999999999999998753321 1
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhcC-----------------
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAA----------------- 229 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~----------------- 229 (443)
.......+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+.. +....+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 12234467899999999876544457899999999999999999999865432 211111100
Q ss_pred ---c-c--CCCC---------CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 230 ---E-F--TCPP---------WLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 230 ---~-~--~~~~---------~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
. . ..+. ..+..+.+++.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 0000 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=335.37 Aligned_cols=251 Identities=20% Similarity=0.295 Sum_probs=211.1
Q ss_pred cccEEEEeEeeccCcEEEEEEEEC---CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 467999999999999999999764 3466899999876432 22346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+|++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999998764 578999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
........++..|+|||.+.+..+. .++||||+||++|++++ |..||.+.+.....+.+..+ ..+.|..++..+.+
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 162 -IYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred -hhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 0111123356789999999876664 89999999999999775 99999988877777776655 33556668899999
Q ss_pred HHHHhcCCCCCCCCChhhhhc
Q 013407 244 LIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~ 264 (443)
++.+||+.+|.+|||+++|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=339.03 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=211.2
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE----
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG---- 81 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~---- 81 (443)
....+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 345689999999999999999999999999999999986543 1235678899999998 7999999999984
Q ss_pred --eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 82 --SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 82 --~~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
....+|++|||+.+|+|.+.+... ..+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 356889999999999999988653 4588999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhcc-----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~- 231 (443)
+...... ........|++.|+|||.+.. ..+ +.++|+|||||++|+|++|..||...........+.....
T Consensus 168 ~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 244 (282)
T cd06636 168 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 244 (282)
T ss_pred hhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCC
Confidence 8754321 122344678999999999852 234 4789999999999999999999987655443333332211
Q ss_pred C-CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 232 T-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 232 ~-~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
. .+..++.++.+||++||..||.+|||+.++++||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 1 122478899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=356.29 Aligned_cols=253 Identities=22% Similarity=0.382 Sum_probs=206.8
Q ss_pred cccEEEEeEeeccCcEEEEEEEE-----CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (443)
.++|++.+.||+|+||.||+|.+ ..++..||||++..... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 34799999999999999999974 34667899999865332 22346788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC---------------------------------------------------------
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHG--------------------------------------------------------- 106 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~--------------------------------------------------------- 106 (443)
+..|+||||++||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886422
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 107 ------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 107 ------------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 36788899999999999999999999999999999999999999999999987543321111
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHH-HHHHHhhcC-ccCCCCCCCHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISAA-EFTCPPWLSFTARKLI 245 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li 245 (443)
......++..|+|||++.+..+. .++|||||||++|+|++ |..||...... ...+.+..+ ....|...+.++++|+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 11223356679999999877664 89999999999999998 99999876543 334444433 2334556788999999
Q ss_pred HHhcCCCCCCCCChhhhhcC
Q 013407 246 ARILDPNPMTRITIPEILED 265 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~h 265 (443)
.+||+.||++|||+.++++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=347.48 Aligned_cols=260 Identities=28% Similarity=0.477 Sum_probs=209.9
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----C
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 84 (443)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 368999999999999999999999999999999986422 222346678899999999999999999887544 3
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
..|+++||+.+ +|.+.+. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 58999999975 8877774 467999999999999999999999999999999999999999999999999998754322
Q ss_pred cC-CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc---------------
Q 013407 165 RD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--------------- 228 (443)
Q Consensus 165 ~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 228 (443)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 11223457899999999976544446899999999999999999999987654332221100
Q ss_pred ---------Ccc-------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 229 ---------AEF-------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 229 ---------~~~-------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
... ...+..+..+.++|.+||+.||.+|||+.++++||||.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000 011346788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=339.88 Aligned_cols=255 Identities=30% Similarity=0.436 Sum_probs=207.8
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE----
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK---- 85 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 85 (443)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999865432 2223456788999999995 6999999999877665
Q ss_pred -EEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-CCCeEEeecCcc
Q 013407 86 -IFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLS 158 (443)
Q Consensus 86 -~~lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~~kl~DFGla 158 (443)
.|++|||+.+ +|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 788887642 35799999999999999999999999999999999999998 889999999998
Q ss_pred cccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--------
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------- 230 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------- 230 (443)
...... ........+++.|+|||++.+....+.++||||+|+++|+|++|.+||.+.+......++....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 754221 1112234578899999998664444589999999999999999999998876554443332110
Q ss_pred -----------c-C--------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 231 -----------F-T--------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 231 -----------~-~--------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
+ . ..+.++..+.++|.+||..||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 0 0124788899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=343.84 Aligned_cols=257 Identities=29% Similarity=0.485 Sum_probs=217.4
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 44556678999999999999999899999999986533 223567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... ....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKR 175 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cccC
Confidence 99999999888754 57999999999999999999999999999999999999999999999999998654321 1222
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHHHHHHHH
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIAR 247 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~ 247 (443)
....|++.|+|||.+.+..+. .++||||+|+++|+|++|..||...+.......+.... ......++..+.+++.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 345789999999999776664 78999999999999999999998877665555443321 22223478899999999
Q ss_pred hcCCCCCCCCChhhhhcCccccccCCC
Q 013407 248 ILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
||..||.+|||++++++||||.....|
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCCc
Confidence 999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=339.00 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=214.6
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECC-----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .+..+.+.+|+++++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998753 357899999875432 22457889999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHG--------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~--------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~ 149 (443)
...|++|||++|++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997643 4788999999999999999999999999999999999999999
Q ss_pred eEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhc
Q 013407 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA 228 (443)
Q Consensus 150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 228 (443)
+||+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 999999998753221111112234467889999999877764 88999999999999998 9999988887777777776
Q ss_pred CccC-CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 229 AEFT-CPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 229 ~~~~-~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
+... .+..++..+++++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6553 34568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=337.81 Aligned_cols=256 Identities=30% Similarity=0.457 Sum_probs=211.5
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE---
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG--- 81 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~--- 81 (443)
.....++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 44577899999999999999999999999999999999864221 235678899999999 6999999999873
Q ss_pred --eCCEEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeec
Q 013407 82 --SKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 82 --~~~~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DF 155 (443)
+....|+||||++|++|.+.+.. ...+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 45679999999999999887752 356899999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhcc-----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 230 (443)
|++...... ........|++.|+|||++.. ..+ +.++||||+||++|+|++|..||...+.......+....
T Consensus 169 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 169 GVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred CceeecccC--CCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 998754321 112234568999999999853 224 478999999999999999999998776544443332221
Q ss_pred ---cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 231 ---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 231 ---~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
...|..++..+.+||.+||+.||++|||+.++++|+||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22344467899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=333.77 Aligned_cols=253 Identities=30% Similarity=0.531 Sum_probs=213.2
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 47899999999999999999999999999999998754444444556788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|||+++++|.+.+.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~- 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence 999999999888753 345899999999999999999999999999999999999999999999999998764321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc--HHHHHHHhhcCccC-CC-CCCCHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISAAEFT-CP-PWLSFTA 241 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~~-~~-~~~s~~~ 241 (443)
........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.... .......+.....+ .+ ..++..+
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred -hHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 1122345688999999999877664 88999999999999999999996543 23444554443322 22 2477899
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcC
Q 013407 242 RKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+++.+||..+|++||++.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=337.89 Aligned_cols=252 Identities=32% Similarity=0.512 Sum_probs=210.4
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||.|++|.||+|.+..+|+.||||.+...... .....+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999999764321 123567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 92 FVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 92 ~~~gg~L~~~i~~~---~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|+.+ +|.+.+... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++...... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence 9985 888887654 35899999999999999999999999999999999999999999999999998754331 11
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------------------c
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------E 230 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~ 230 (443)
......+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 2234567899999999876555568999999999999999999999887655444332110 0
Q ss_pred cC-----------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 231 FT-----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 231 ~~-----------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.. ..+..+..+.++|.+||+.||.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=336.92 Aligned_cols=253 Identities=27% Similarity=0.450 Sum_probs=216.7
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+.+.+..|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468889999999999999999999999999999876532 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||+.+++|.+.+... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999876 789999999999999999999999 999999999999999999999999999987543221
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC-----cHHHHHHHhhcC-ccCCCCC-CCHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-----NLMNLYKKISAA-EFTCPPW-LSFTA 241 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~-~~~~~~~-~s~~~ 241 (443)
.....|+..|+|||.+.+..+. .++||||+|+++|+|++|..||... ...+..+.+... ....+.. ++.++
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred -hhcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 1126789999999999877664 8899999999999999999999754 223334443333 2233333 78899
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+++|.+||..||.+|||+.+++.||||++
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=339.58 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=217.6
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++.+.+...+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3568999999999999999999999999999999987543 23345788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||||+++++|.+.+...+.+++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~---- 156 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---- 156 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence 99999999999999888889999999999999999999997 5999999999999999999999999999864322
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-----------HHHHHhhcCc-cCCCC
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-----------NLYKKISAAE-FTCPP 235 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-----------~~~~~i~~~~-~~~~~ 235 (443)
......+|+..|+|||++.+..+ +.++||||+||++|+|++|..||...... .....+.... ..++.
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred hccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 11234578999999999877655 47899999999999999999999865431 2223332222 22222
Q ss_pred C-CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 236 W-LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 236 ~-~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
. ++..+.+|+.+||+.||.+|||+.++++||||.+..
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 2 778999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=338.08 Aligned_cols=255 Identities=29% Similarity=0.478 Sum_probs=218.2
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
+.|+..+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468888999999999999999998999999999875432 234578899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||+.|++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--cccc
Confidence 99999999998865 57899999999999999999999999999999999999999999999999998754321 1122
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhc
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARIL 249 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL 249 (443)
....++..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.... ...+..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 33468889999999977665 488999999999999999999998877665555443332 2333457889999999999
Q ss_pred CCCCCCCCChhhhhcCcccccc
Q 013407 250 DPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 250 ~~dP~~R~t~~eil~hp~~~~~ 271 (443)
..+|++||++.+++.||||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=343.49 Aligned_cols=256 Identities=29% Similarity=0.428 Sum_probs=206.2
Q ss_pred cEEEEeEeeccCcEEEEEEEECC--CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIF 87 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 87 (443)
+|++.+.||+|++|.||+|.+.. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999999864322233346778899999999999999999999888 8899
Q ss_pred EEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc----CCCeEEeecCcc
Q 013407 88 IVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA----YGNLKVSDFGLS 158 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~----~~~~kl~DFGla 158 (443)
+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 676666432 36899999999999999999999999999999999999999 899999999998
Q ss_pred cccccccC-CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHH---------HHHHh--
Q 013407 159 ALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---------LYKKI-- 226 (443)
Q Consensus 159 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~---------~~~~i-- 226 (443)
........ .......++|+.|+|||++.+....+.++|||||||++|+|++|.+||.+..... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86543222 1122345789999999998765544588999999999999999999997544221 00000
Q ss_pred ------------------------hcCccCCC---------C--CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 227 ------------------------SAAEFTCP---------P--WLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 227 ------------------------~~~~~~~~---------~--~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.......+ . ..+..+.++|.+||+.||.+|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00001111 1 456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=331.18 Aligned_cols=253 Identities=32% Similarity=0.589 Sum_probs=217.3
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||+|+||.||+|.+..+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+.+....|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5899999999999999999999999999999997654322 234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC-eEEeecCcccccccccCCC
Q 013407 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~-~kl~DFGla~~~~~~~~~~ 168 (443)
|+++++|.+.+.... .+++..+..++.|++.||.|||+.|++|+||||+||++++++. +||+|||.+..... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--Ccc
Confidence 999999999987643 4799999999999999999999999999999999999998864 69999999876432 112
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIAR 247 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 247 (443)
......|++.|+|||++.+..+. .++|+||+|+++|+|++|..||...+.......+..... ..++.++.+++++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 22345689999999998776664 889999999999999999999988776666555544433 3455678999999999
Q ss_pred hcCCCCCCCCChhhhhcCccc
Q 013407 248 ILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~ 268 (443)
||..+|++|||+.++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=351.96 Aligned_cols=263 Identities=27% Similarity=0.416 Sum_probs=215.2
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (443)
..+..+-..|++++.||+|+.+.||++...+.+ .||+|.+.... .+...+.-+.+||..|.+| .|.+||+++++-..
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 445566778999999999999999999986544 46666654433 3455678899999999999 59999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGRM-KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~l-~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
++.+|+||||-. .+|...+.+.... +...++.|..|++.|++++|..||||.||||.|+|+-. |.+||+|||+|...
T Consensus 432 d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 432 DGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred CceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 999999999875 5898888876654 44688999999999999999999999999999999965 99999999999877
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCC----------CCchhhhhhhHHHHHHhhCCCCCCCCc-HHHHHHHhhcC-
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAA- 229 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~----------~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~- 229 (443)
......-...+.+||+.|||||.+....+. +.++||||||||||+|+.|++||..-. ...-+..|...
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 665555566788999999999998654332 578999999999999999999997532 33333444433
Q ss_pred -ccCCCCCCCHH-HHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 230 -EFTCPPWLSFT-ARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 230 -~~~~~~~~s~~-~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
++.+|..-+.. +.++++.||..||++|||+.++|+|||++.
T Consensus 590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 33555543333 999999999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=351.98 Aligned_cols=241 Identities=27% Similarity=0.452 Sum_probs=210.4
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
+++++.||+|.||+|++|.... ...||+|.+...... .+.+.+|+.+|++|+|+|||++++++..+..+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 3456789999999999999954 346999999764322 24567999999999999999999999998899999999
Q ss_pred cCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 93 VTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 93 ~~gg~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
++.|+|.+++.. ...++..+...++.||++|++||+++++|||||-..|||++++..+||+|||||+.... +..
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d----~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD----DEY 358 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC----Cce
Confidence 999999999987 45689999999999999999999999999999999999999999999999999994321 222
Q ss_pred ccccC---CCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 013407 171 HTTCG---TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (443)
Q Consensus 171 ~~~~g---t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 245 (443)
....| ..-|.|||.+....++ .++||||+||+||||+| |+.|+.+.+..+..+.+..| +.+.|+.+|+++.+++
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELM 437 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHH
Confidence 22222 3469999999887775 89999999999999998 99999999999999999888 5788999999999999
Q ss_pred HHhcCCCCCCCCChhhhh
Q 013407 246 ARILDPNPMTRITIPEIL 263 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil 263 (443)
..||..+|++|||++.+.
T Consensus 438 ~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHhhCCcccCCCHHHHH
Confidence 999999999999998654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=360.13 Aligned_cols=244 Identities=34% Similarity=0.604 Sum_probs=216.0
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 87 (443)
....|++...+|.|+|+.|..+.+..+++.+++|++.++. ....+|+.++... +||||+++.+++.+....|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 4678999999999999999999999999999999998762 2345678666555 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE-ccCCCeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-DAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+|||++.|+.|.+.+.....+. .++..|+.||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.+......
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999999998876666 7888999999999999999999999999999999 58899999999998754321
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
..+.|-|..|.|||++...+|+ ..+|+||||++||+||+|+.||...... ++...+..+.+. .++|..+++||
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred ---hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 4566788999999999988886 9999999999999999999999865444 667777665554 88999999999
Q ss_pred HHhcCCCCCCCCChhhhhcCccc
Q 013407 246 ARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
++||++||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=334.98 Aligned_cols=246 Identities=25% Similarity=0.472 Sum_probs=205.8
Q ss_pred cccccEEEEeEe--eccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 013407 8 RRVGKYEVGRTI--GEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (443)
Q Consensus 8 ~~~~~y~~~~~L--G~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (443)
...++|++.+.+ |+|+||.||++.++.++..+|+|++....... .|+.....+ +||||+++++.+...+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 345678887776 99999999999999999999999987643221 122222222 7999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-CeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 163 (443)
.+|+||||++|++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999999999999998888999999999999999999999999999999999999999998 999999999875322
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHH-----HHHHhhcCccCCCCCCC
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-----LYKKISAAEFTCPPWLS 238 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~s 238 (443)
.....|++.|+|||++.+..+. .++||||+|+++|+|++|..||....... ..... ......++.++
T Consensus 163 ------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (267)
T PHA03390 163 ------PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVS 234 (267)
T ss_pred ------CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccC
Confidence 1234689999999999877764 88999999999999999999998654322 22222 33345555689
Q ss_pred HHHHHHHHHhcCCCCCCCCC-hhhhhcCcccc
Q 013407 239 FTARKLIARILDPNPMTRIT-IPEILEDEWFK 269 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t-~~eil~hp~~~ 269 (443)
+.+.++|.+||+.||.+||+ ++++++||||.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 99999999999999999996 69999999996
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=337.66 Aligned_cols=252 Identities=32% Similarity=0.480 Sum_probs=209.6
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
|++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.++|||++++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999999764322 22345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 93 VTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 93 ~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
+. ++|.+.+.... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 58999887665 7899999999999999999999999999999999999999999999999998754321 1122
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---------------------
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------------- 229 (443)
....+++.|+|||++.+....+.++||||+|+++|+|++|.+||...+......++...
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 33457889999999876544458899999999999999999999877654433222110
Q ss_pred --c------cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 230 --E------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 230 --~------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
. ....+.++..+.++|.+||++||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 01123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=347.17 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=214.5
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE----eCCEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG----SKTKI 86 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~ 86 (443)
++|++.+.||+|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++. .....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999976432 2234567788999999999999999998875 34578
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 58999988778899999999999999999999999999999999999999999999999999875432211
Q ss_pred --CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc----------------
Q 013407 167 --DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---------------- 228 (443)
Q Consensus 167 --~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---------------- 228 (443)
........|+..|+|||.+.+....+.++||||+||++|+|++|..||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 11223457899999999987644446889999999999999999999987654432221110
Q ss_pred ---------Cc-cCC-----CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 229 ---------AE-FTC-----PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 229 ---------~~-~~~-----~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
.. ... .+..+.++.++|.+||+.||.+|||+.+++.||||.+...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 00 001 13368899999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=326.47 Aligned_cols=255 Identities=30% Similarity=0.552 Sum_probs=220.0
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIV 89 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv 89 (443)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+.+. ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999989999999999765432 33467899999999999999999999999988 899999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
+||+.+++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998878999999999999999999999999999999999999999999999999999886544322112
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc-HHHHHHHhhc--CccCCCCCCCHHHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISA--AEFTCPPWLSFTARKLIA 246 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~--~~~~~~~~~s~~~~~li~ 246 (443)
.....++..|+|||.+....+ +.++||||+|+++|+|++|..||.... .......+.. .....|...+..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999877665 588999999999999999999998765 2233333332 233456667999999999
Q ss_pred HhcCCCCCCCCChhhhhcCccc
Q 013407 247 RILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+||..||++||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=331.35 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=209.2
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
.+.......||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3334445689999999999999998999999999875432 2356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-CCCeEEeecCccccccccc
Q 013407 90 LEFVTGGELFDKIVNH-GRM--KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 165 (443)
+||+++++|.+.+... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 162 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI- 162 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC-
Confidence 9999999999999764 445 88889999999999999999999999999999999986 679999999998754321
Q ss_pred CCCccccccCCCcccchhhhccCC-CCCCchhhhhhhHHHHHHhhCCCCCCCCcHH--HHHHH-hhcCccCCCCCCCHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLM--NLYKK-ISAAEFTCPPWLSFTA 241 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~~~~-i~~~~~~~~~~~s~~~ 241 (443)
........|++.|+|||.+.... ..+.++|+||+|+++|+|++|..||...... ..+.. ........|..+++++
T Consensus 163 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd06624 163 -NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA 241 (268)
T ss_pred -CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHH
Confidence 12223346899999999986533 2358899999999999999999999754322 22221 1222344566789999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
++++.+||+.+|.+|||+.+++.||||
T Consensus 242 ~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 242 KNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=336.79 Aligned_cols=257 Identities=31% Similarity=0.483 Sum_probs=210.3
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++.+.||.|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999865432 222345788899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-CCCeEEeecCcccccccccC
Q 013407 90 LEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~ 166 (443)
|||+. ++|.+.+.... .+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 99996 47888776544 3588889999999999999999999999999999999985 456999999998754321
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC-----------------
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA----------------- 229 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------- 229 (443)
........|++.|+|||.+.+....+.++||||+||++|+|++|.+||...+..+...++...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112234467899999999876544458899999999999999999999876655443332110
Q ss_pred ------cc------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 230 ------EF------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 230 ------~~------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.. ...+.+++.+.+++.+||+.+|.+||++.++++||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00 012346888999999999999999999999999999975
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=325.94 Aligned_cols=253 Identities=30% Similarity=0.530 Sum_probs=221.4
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|++++++++|||++++++++.+....|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999989999999999775432 2345789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
|+++++|.+.+.....+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc--cccc
Confidence 99999999999888899999999999999999999999999999999999999999999999999987654322 1133
Q ss_pred cccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHh-hcCccCCCCCCCHHHHHHHHHhcC
Q 013407 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIARILD 250 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~s~~~~~li~~mL~ 250 (443)
...|+..|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+ .......++.++..+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4568999999999877664 58899999999999999999999876654433333 344455667789999999999999
Q ss_pred CCCCCCCChhhhhcCccc
Q 013407 251 PNPMTRITIPEILEDEWF 268 (443)
Q Consensus 251 ~dP~~R~t~~eil~hp~~ 268 (443)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.02 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=211.5
Q ss_pred ccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.+|.+.+.||+|+||.||++.+. .++..+|+|.+.... ......+.+|+.++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 57999999999999999999852 345679999986532 2345678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEE
Q 013407 86 IFIVLEFVTGGELFDKIVNHG-------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~-------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl 152 (443)
.|++|||+++++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||++++++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999987543 4899999999999999999999999999999999999999999999
Q ss_pred eecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCcc
Q 013407 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF 231 (443)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~ 231 (443)
+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+.......+..+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999875432111111223445778999999987665 488999999999999998 9999998887777777776653
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 232 -TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 232 -~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
..+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 345568899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=329.61 Aligned_cols=255 Identities=30% Similarity=0.513 Sum_probs=220.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
.+|++.+.||.|++|.||+|.+..+++.||+|++...... .....+.+|+..++.++||||+++++++......|++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765422 34577899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||+++++|.+.+.....+++..+..++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence 999999999999888889999999999999999999999 999999999999999999999999999987653321 11
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC---cHHHHHHHhhcC-ccCCCCC-CCHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAA-EFTCPPW-LSFTARKL 244 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~-~~~~~~~-~s~~~~~l 244 (443)
.....++..|+|||.+....+ +.++|+||||+++|+|++|..||... ...+....+... ....+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 234568899999999877655 58899999999999999999999876 344555554433 2334445 78999999
Q ss_pred HHHhcCCCCCCCCChhhhhcCccccc
Q 013407 245 IARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
|.+||..+|++|||+.++++|||++.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=356.55 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=220.7
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
|.-++.||.|+||-||.|++..+.+.||||.++...-...+-.+.+..|++.|++++|||+|.+.++|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55668899999999999999999999999999876655555678899999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 93 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
|-| +-.|.+.-+ +++.+.++..+..+.+.||.||||.+.||||||..|||+++.|.|||+|||.|.+..+ ..
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN 180 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence 975 667777543 5799999999999999999999999999999999999999999999999999987543 35
Q ss_pred cccCCCcccchhhhcc---CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC-ccCCC-CCCCHHHHHHHH
Q 013407 172 TTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCP-PWLSFTARKLIA 246 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~~-~~~s~~~~~li~ 246 (443)
+.+|||+||||||+.. ..|+ -++|||||||+..+|...++|+-..+.+.....|... .+..+ +.+|..+++|+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 6789999999999853 3455 7899999999999999999998888877555555444 33333 337889999999
Q ss_pred HhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 247 RILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
.||++-|..|||.+++|.|+|+...-.+
T Consensus 260 ~CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred HHHhhCcccCCcHHHHhhcchhccCCCc
Confidence 9999999999999999999999876543
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=338.94 Aligned_cols=257 Identities=26% Similarity=0.387 Sum_probs=215.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
...+|.+.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34569999999999999999999998999999999875443344445678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||||+.| +|.+.+.. ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---- 167 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---- 167 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC----
Confidence 9999975 66666653 45799999999999999999999999999999999999999999999999999865322
Q ss_pred CccccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-cCC-CCCCCHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTC-PPWLSFTARK 243 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~-~~~~s~~~~~ 243 (443)
.....|++.|+|||++.+ ....+.++||||+|+++|+|++|..||.+.+.......+.... ... +..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred --CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 123468889999998742 2233578999999999999999999998877665444443332 222 2236789999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 244 LIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
+|.+||..||++||++.+++.||||....
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.85 Aligned_cols=253 Identities=22% Similarity=0.358 Sum_probs=210.5
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCce----EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEP----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
...+|++.+.||+|+||.||+|.+..+++. ||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 345799999999999999999998666654 8999986432 223456788999999999999999999998764
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..++++||+.+|+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 578999999999999999774 4689999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (443)
...........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+....+....+..+ ..+.++.++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2211112223346789999999877664 88999999999999997 99999987766655444433 345567789999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcC
Q 013407 242 RKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+++.+||..||.+|||+.+++.+
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=328.28 Aligned_cols=247 Identities=40% Similarity=0.721 Sum_probs=222.2
Q ss_pred eeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013407 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (443)
Q Consensus 19 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 98 (443)
||.|+||.||++.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+.++...|++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999877655555567899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCc
Q 013407 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (443)
Q Consensus 99 ~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 178 (443)
.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .......|+..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 9999888889999999999999999999999999999999999999999999999999987643321 22345568899
Q ss_pred ccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 013407 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258 (443)
Q Consensus 179 y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t 258 (443)
|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+.......|...+..+.++|++||..||++|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999876655 4789999999999999999999988887777777777777888888999999999999999999999
Q ss_pred h---hhhhcCccc
Q 013407 259 I---PEILEDEWF 268 (443)
Q Consensus 259 ~---~eil~hp~~ 268 (443)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=326.25 Aligned_cols=253 Identities=35% Similarity=0.630 Sum_probs=222.0
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||.|+||.||++.+..+++.||+|++...... ......+.+|+++++.++|||++++.+.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999989999999999764432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 92 FVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 92 ~~~gg~L~~~i~~~----~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
|+++++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+++++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999998763 679999999999999999999999999999999999999999999999999987654322
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 246 (443)
.......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+............. ..|..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 233445789999999998776654 789999999999999999999988877776666555433 445568899999999
Q ss_pred HhcCCCCCCCCChhhhhcCccc
Q 013407 247 RILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+||..+|++|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=344.28 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=213.7
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-- 84 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 84 (443)
....++|++.+.||+|+||.||+|.+..+|..||||.+.+... .......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3456789999999999999999999999999999999865432 2233457889999999999999999999987653
Q ss_pred ----EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 85 ----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 85 ----~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
.+++||||+ |++|.+.+. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 468999999 678877765 46799999999999999999999999999999999999999999999999999875
Q ss_pred cccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc---------
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--------- 231 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--------- 231 (443)
... ......+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+....+..+.....
T Consensus 168 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 168 TDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 322 123446789999999987644456889999999999999999999987765544333221110
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 232 ----------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 232 ----------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
...+.+++.+.++|.+||..||.+|||+.+++.||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 112356788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=333.79 Aligned_cols=254 Identities=30% Similarity=0.490 Sum_probs=216.9
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
.|...+.||+|++|.||++.+..+++.+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 45555799999999999999988999999999864332 234568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
|+.|++|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Ccccc
Confidence 9999999998877 67999999999999999999999999999999999999999999999999987643321 11223
Q ss_pred cccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC---CCCCCHHHHHHHHHh
Q 013407 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC---PPWLSFTARKLIARI 248 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~s~~~~~li~~m 248 (443)
...|++.|+|||.+.+..+. .++||||+||++|+|++|..||...+.......+....... +..++..+.+++++|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 45689999999999876664 88999999999999999999998877766666655443222 233788999999999
Q ss_pred cCCCCCCCCChhhhhcCccccccC
Q 013407 249 LDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 249 L~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
|..+|.+|||+.++++||||.+..
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=328.61 Aligned_cols=256 Identities=28% Similarity=0.499 Sum_probs=216.2
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh--hhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 86 (443)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+++|+.++++++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999864321 1233456889999999999999999999998664 568
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+++|||+++++|.+.+...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999875432211
Q ss_pred -CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHH
Q 013407 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARK 243 (443)
Q Consensus 167 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ 243 (443)
........|+..|+|||.+.+..+ +.++|+|||||++|+|++|.+||...........+... ....|+.++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 112234568999999999987665 48899999999999999999999877655544444322 23456778999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCccc
Q 013407 244 LIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+|.+||. +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=335.36 Aligned_cols=259 Identities=21% Similarity=0.289 Sum_probs=212.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECC-----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
.-++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 35789999999999999999997642 345799999865432 22234678899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEe
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~ 153 (443)
...|+||||+.+|+|.+++...+ .++...+..++.||+.||.|||++||+||||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999997532 24567888999999999999999999999999999999999999999
Q ss_pred ecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-cc
Q 013407 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EF 231 (443)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~ 231 (443)
|||+++...............++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+....+..+ ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999875332111111122345678999999887666 488999999999999998 89999988877766666544 33
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc------Cccccc
Q 013407 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE------DEWFKK 270 (443)
Q Consensus 232 ~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~------hp~~~~ 270 (443)
..+...++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 455667899999999999999999999999986 888863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=333.68 Aligned_cols=255 Identities=28% Similarity=0.472 Sum_probs=218.4
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
-|++.+.||.|+||.||+|.+..++..||+|++...... .....+.+|+.+++.++||||+++++.+.++...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 377888999999999999999889999999998654322 235678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
|+++++|.+++.+ ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRN 159 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hhhhc
Confidence 9999999988865 56899999999999999999999999999999999999999999999999998654321 11123
Q ss_pred cccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcC
Q 013407 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILD 250 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~ 250 (443)
...|+..|+|||.+.+...+ .++|+||+||++|+|++|..||...+.......+.... ...+..++.++.+++.+||.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 35688999999998766554 78999999999999999999998877666555554433 23455688999999999999
Q ss_pred CCCCCCCChhhhhcCccccccC
Q 013407 251 PNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 251 ~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.+|.+||++.++++||||.+..
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred CChhhCcCHHHHHhCHHHhhhh
Confidence 9999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.29 Aligned_cols=259 Identities=30% Similarity=0.437 Sum_probs=213.0
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----C
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 84 (443)
..+|.+.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 35899999999999999999999999999999998754322 22345677899999999999999999987644 3
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
..|+++||+. ++|.+.+...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999996 689999988888999999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc----------------
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---------------- 228 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~---------------- 228 (443)
........|+..|+|||.+......+.++||||+||++|+|++|.+||.+.+.......+..
T Consensus 162 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 162 --GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred --cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 12234556899999999987544456899999999999999999999987654332221110
Q ss_pred ---------C---cc---CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 229 ---------A---EF---TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 229 ---------~---~~---~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
. .. ...+.+++.+.+||++||+.||.+|||++++++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0 00 01234788999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=328.49 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=214.8
Q ss_pred eEeeccCcEEEEEEEECCC---CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 013407 17 RTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 93 (443)
+.||+|+||.||+|.+... +..||+|.+....... ..+.+.+|+.+++.++|+||+++++++.+...++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8899999997654322 4678999999999999999999999999999999999999
Q ss_pred CCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 94 TGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 94 ~gg~L~~~i~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 77999999999999999999999999999999999999999999999999998865443
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (443)
..........+++.|+|||.+....+ +.++||||||+++|+|++ |..||...+.....+.+..+ ....|..++.++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 22122344567889999999877655 488999999999999999 69999998887777777654 3456777899999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcC
Q 013407 243 KLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~h 265 (443)
+++.+||..||.+|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.57 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=209.6
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCce--EEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEP--VALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (443)
..+++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4577899999999999999999999877765 466665432 2233456788999999999 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC
Q 013407 85 KIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~ 148 (443)
.+|+||||+++++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999987542 478999999999999999999999999999999999999999
Q ss_pred CeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhh
Q 013407 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS 227 (443)
Q Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 227 (443)
.+||+|||++....... ......++..|+|||.+.+..+ +.++||||+||++|+|++ |.+||.+.+..+....+.
T Consensus 162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 99999999986322111 1111234567999999877665 488999999999999998 999998877777666665
Q ss_pred cCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 228 AAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 228 ~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+. ...+..+++.+.+|+.+||+.+|++||++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 442 23445578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=333.94 Aligned_cols=254 Identities=19% Similarity=0.333 Sum_probs=212.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEEC----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNS----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
.+..|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4678999999999999999999853 356789999986432 2233467889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC
Q 013407 85 KIFIVLEFVTGGELFDKIVNH-----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~-----------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~ 147 (443)
..|++|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999988532 237888899999999999999999999999999999999999
Q ss_pred CCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHh
Q 013407 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (443)
Q Consensus 148 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i 226 (443)
+.+||+|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||.+.+.....+.+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875433222222234456778999999977666 489999999999999998 99999887766666655
Q ss_pred hcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 227 SAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 227 ~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.... ...+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 4443 44566689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=328.73 Aligned_cols=245 Identities=27% Similarity=0.451 Sum_probs=204.0
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 96 (443)
+.||+|+||.||+|.+..+++.||+|.+.... ..+....+.+|+.+++.++||||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999886432 2334567899999999999999999999999999999999999999
Q ss_pred chHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 97 ELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 97 ~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
+|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999987644 589999999999999999999999999999999999999999999999999875332111000111123
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNP 253 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP 253 (443)
+..|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+... ....+..++..+.+|+.+||+.||
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999877666 488999999999999997 99999877665555554433 345566688999999999999999
Q ss_pred CCCCChhhhhc
Q 013407 254 MTRITIPEILE 264 (443)
Q Consensus 254 ~~R~t~~eil~ 264 (443)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=333.53 Aligned_cols=254 Identities=19% Similarity=0.276 Sum_probs=209.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECC-----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
.-++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34689999999999999999998642 356799999864322 12345688999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEe
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~ 153 (443)
...++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||++++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999986532 35677889999999999999999999999999999999999999999
Q ss_pred ecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-c
Q 013407 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-F 231 (443)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~ 231 (443)
|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999874322111111122345788999999987666 488999999999999999 799999887777666655543 3
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 232 ~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4566688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=339.23 Aligned_cols=254 Identities=29% Similarity=0.482 Sum_probs=215.0
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
+.|+..+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++.+......|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 346677889999999999999998999999999875432 224567899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||+++++|.+.+.. +.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++++|||++...... ....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence 99999999988864 57899999999999999999999999999999999999999999999999998754321 1112
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhc
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARIL 249 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL 249 (443)
....|+..|+|||.+.+..+. .++|+||+||++|+|++|..||...........+.... ...+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 234688999999999877664 88999999999999999999998765554444443332 2233447889999999999
Q ss_pred CCCCCCCCChhhhhcCccccc
Q 013407 250 DPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 250 ~~dP~~R~t~~eil~hp~~~~ 270 (443)
..+|++|||+.++++||||..
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHH
Confidence 999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=388.89 Aligned_cols=259 Identities=32% Similarity=0.531 Sum_probs=226.5
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
-+|.-+.+||.|.||.||.|.+.++|+..|+|-+...... ......+.+|..++..++|||+|++|++-.+.+..||.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3688888999999999999999999999999988765443 345678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc--CCC
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR--DDG 168 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--~~~ 168 (443)
|||+||+|.+.++..+-.+|...+.|..|++.|+.|||+.|||||||||+||+++.+|.+|++|||.|....... -.+
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999999999888888999999999999999999999999999999999999999999999999997654321 123
Q ss_pred ccccccCCCcccchhhhccCC--CCCCchhhhhhhHHHHHHhhCCCCCCCCc-HHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAA-EFTCPPWLSFTARKL 244 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (443)
.+....|||.|||||++.+.. ..+-++||||||||+.||.||+.||...+ ...+..++..+ .+++|..+|++.+++
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dF 1473 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDF 1473 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHH
Confidence 456778999999999997643 33567899999999999999999997644 34666666665 567888899999999
Q ss_pred HHHhcCCCCCCCCChhhhhcCccccc
Q 013407 245 IARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
|.+||..||++|+++.|+++|.|-+.
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHHhhcccc
Confidence 99999999999999999999988653
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=333.25 Aligned_cols=253 Identities=22% Similarity=0.327 Sum_probs=211.0
Q ss_pred cccEEEEeEeeccCcEEEEEEEECC-----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
-++|.+.+.||+|++|.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4679999999999999999999977 678899998864322 223456888999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC---CeEEee
Q 013407 85 KIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSD 154 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~~kl~D 154 (443)
..|++|||+.|++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999987653 488999999999999999999999999999999999998765 599999
Q ss_pred cCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccC
Q 013407 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFT 232 (443)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~ 232 (443)
||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999875422111111112233567999999987666 489999999999999997 99999988777766655443 345
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 233 CPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 233 ~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.|..++..+.+++.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 567789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=332.36 Aligned_cols=256 Identities=24% Similarity=0.402 Sum_probs=205.5
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHH-HhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
++|++.+.||+|+||.||+|.+..+|+.||+|.+....... . ...+..|+.+ ++.++||||+++++++...+..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-E-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-H-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987643222 1 2344456654 6777999999999999999999999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
|||++ |+|.+.+.. ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99997 477666543 34689999999999999999999998 999999999999999999999999999875432
Q ss_pred cCCCccccccCCCcccchhhhccC---CCCCCchhhhhhhHHHHHHhhCCCCCCCCc-H-HHHHHHhhcCccCCC-CCCC
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSN-L-MNLYKKISAAEFTCP-PWLS 238 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~---~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~-~~~~~~i~~~~~~~~-~~~s 238 (443)
........|+..|+|||.+.+. ...+.++|+||+||++|+|++|..||.... . ......+.......| ..+|
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 157 --SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred --ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 1112335688999999998642 122578999999999999999999997532 2 222222322233333 3478
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.++.++|.+||..+|.+|||+.++++||||.+..
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.00 Aligned_cols=260 Identities=28% Similarity=0.479 Sum_probs=218.9
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
++...++|++.+.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++.+.....
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDE 90 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence 35567899999999999999999999988999999999864322 224678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
.|+|+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~- 168 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 168 (293)
T ss_pred EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc-
Confidence 9999999999999998865 46889999999999999999999999999999999999999999999999988654332
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC-c--cCCCCCCCHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-E--FTCPPWLSFTAR 242 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~--~~~~~~~s~~~~ 242 (443)
........|++.|+|||.+....+ +.++|+||+||++|++++|..||...+.......+... . ...+..++..++
T Consensus 169 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (293)
T cd06647 169 -QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246 (293)
T ss_pred -ccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence 122234568999999999877666 47899999999999999999999876654433322221 1 222334678899
Q ss_pred HHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 243 KLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
++|++||..+|.+||++.+++.||||+...
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=331.43 Aligned_cols=252 Identities=31% Similarity=0.547 Sum_probs=212.8
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++.+.||+|++|.||+|.+..+++.+|||.+.............+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 46899999999999999999999989999999998765444444456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|||+.|++|.+.+.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence 999999999988863 356899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH--HHHHHHhhcCccC-C-CCCCCHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL--MNLYKKISAAEFT-C-PPWLSFTA 241 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~~~~~~-~-~~~~s~~~ 241 (443)
.......+|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||.+... ......+.....+ . +..++..+
T Consensus 160 -~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred -CcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 1223345789999999999877664 789999999999999999999976543 3444444433322 2 23478899
Q ss_pred HHHHHHhcCCCCCCCCChhhhhc
Q 013407 242 RKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~ 264 (443)
++++.+||..||.+|||+.++++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.78 Aligned_cols=255 Identities=29% Similarity=0.510 Sum_probs=215.9
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
-|.....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+..++..|++||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 35556689999999999999998999999999865432 224568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
|+++++|.+.+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~ 175 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRK 175 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--ccccc
Confidence 9999999887654 67899999999999999999999999999999999999999999999999998654321 11223
Q ss_pred cccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHHHHHHHHh
Q 013407 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARI 248 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~m 248 (443)
..+|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+.... ...+..++..+.++|++|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 4678999999999987666 488999999999999999999998777665555544332 222345788999999999
Q ss_pred cCCCCCCCCChhhhhcCccccccCC
Q 013407 249 LDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 249 L~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
|+.+|.+||+++++++||||.+..-
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccCCC
Confidence 9999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=340.29 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=219.0
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
|.++++||+|+||.||+|+++++|+.+|||.+..+. ..+.+..||.||++++.|+||++|+.+-....+||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 667889999999999999999999999999987643 367788999999999999999999999888999999999
Q ss_pred cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 93 VTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 93 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
|..|+..|.++. ++.++|+++..+++..+.||+|||...-+|||||..|||++.+|+.||+|||.|...... -....
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhC
Confidence 999999999864 568999999999999999999999999999999999999999999999999998643321 11235
Q ss_pred cccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHHHHHHHh
Q 013407 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARI 248 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~m 248 (443)
+..|||.|||||++..-+|+ .++||||||+...+|..|++||.+-.++....-|... .+.-|...|.++.+++++|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 67899999999999999997 7899999999999999999999876665443333222 1223444788999999999
Q ss_pred cCCCCCCCCChhhhhcCccccccC
Q 013407 249 LDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 249 L~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
|..+|++|-|+-++++|||++...
T Consensus 267 LiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred hcCCHHHHHHHHHHhhhhhhcCCC
Confidence 999999999999999999998653
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=365.86 Aligned_cols=246 Identities=31% Similarity=0.520 Sum_probs=206.6
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEE-EEe------C
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEV-MGS------K 83 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~~------~ 83 (443)
++++.+.|.+|+|+.||+|.+...|..||+|.+-.. ++...+.+++||.+|++|. |+|||.+++. ... .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 577889999999999999999888899999998543 5667899999999999996 9999999993 211 1
Q ss_pred CEEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
-.++|.||||.||.|.|++.. ..+|+|.++.+||.|+++||.+||... |||||||-|||||+.+|+.||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 347899999999999999974 456999999999999999999999998 9999999999999999999999999987
Q ss_pred ccccccC--CCc-----cccccCCCcccchhhh---ccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC
Q 013407 160 LSQQVRD--DGL-----LHTTCGTPNYVAPEVL---NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (443)
Q Consensus 160 ~~~~~~~--~~~-----~~~~~gt~~y~APEvl---~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~ 229 (443)
-.-.... .+. --....|+.|+|||++ .+.+. +.|+|||+|||+||-|+....||++.... .|..+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNG 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEec
Confidence 4322111 000 0123469999999997 34444 59999999999999999999999876432 46677
Q ss_pred ccCCCC--CCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 230 EFTCPP--WLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 230 ~~~~~~--~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+.+|+ .++..+.+||+.||++||.+||+|-|++.+
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 887776 589999999999999999999999999854
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=328.50 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=213.3
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCC---CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
.++|++.+.||+|+||.||+|.+..+ ...||||.+.... .......+.+|+.+++.++||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 35799999999999999999998654 4579999986543 223356788899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|++|||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999998764 478999999999999999999999999999999999999999999999999998654211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
.........+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...........+..+ ..+.+...+..+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11111223346789999999876664 88999999999999998 99999887777777666554 33455668999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcC
Q 013407 244 LIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~h 265 (443)
++.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=344.46 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=215.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE--
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-- 85 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 85 (443)
..-++|++.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++.+++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 356789999999999999999999999999999999875432 22334667889999999999999999988765554
Q ss_pred ----EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 86 ----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 86 ----~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
.|+|+||+ |++|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 5699888865 57999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc----------
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------- 231 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------- 231 (443)
.. ......+++.|+|||.+.+....+.++||||+||++|+|++|+.||.+.+....+..+.....
T Consensus 169 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 32 133456889999999987644456899999999999999999999988776554444322110
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 232 ---------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 232 ---------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
......++.+.++|.+||+.||.+|||+.++++||||.+...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0012358899999999999999999999999999999875544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=335.02 Aligned_cols=259 Identities=24% Similarity=0.421 Sum_probs=216.5
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCC-----CceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEE
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 77 (443)
+.....-++|++.+.||+|+||.||++.+... ...+|+|.+..... ......+.+|+.+++++ +||||++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 44556678999999999999999999987643 36799999875432 22346688999999999 899999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCc
Q 013407 78 EVMGSKTKIFIVLEFVTGGELFDKIVN----------------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (443)
Q Consensus 78 ~~~~~~~~~~lv~E~~~gg~L~~~i~~----------------~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 141 (443)
+++...+.+|++|||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N 162 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence 999999999999999999999999854 2458899999999999999999999999999999999
Q ss_pred EEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHH
Q 013407 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM 220 (443)
Q Consensus 142 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~ 220 (443)
|+++.++.+||+|||++................++..|+|||++.+..++ .++||||+||++|+|++ |..||.+.+..
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999998764432111111223356789999998776664 88999999999999997 99999988877
Q ss_pred HHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 221 NLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 221 ~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+.+..+..+. ...|...+..+.+|+.+||..||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 7777665553 34566688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=371.03 Aligned_cols=254 Identities=22% Similarity=0.403 Sum_probs=208.0
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+++.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 58999999999999999999999999999999999765444444567889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 90 LEFVTGGELFDKIVNH-----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-----------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
|||++||+|.+.+... ..++...+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999988641 23556678899999999999999999999999999999999999999999999
Q ss_pred cccccccC----------------CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHH
Q 013407 159 ALSQQVRD----------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL 222 (443)
Q Consensus 159 ~~~~~~~~----------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~ 222 (443)
........ .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 76521100 001123479999999999987776 4899999999999999999999987654433
Q ss_pred HHHhhc-CccCC--CCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 223 YKKISA-AEFTC--PPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 223 ~~~i~~-~~~~~--~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
...... ..... ...+++.+.+++.+||..||++|++..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222111 11111 1347889999999999999999988666554
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=333.03 Aligned_cols=259 Identities=30% Similarity=0.560 Sum_probs=217.8
Q ss_pred cEEEEeEeeccCcEEEEEEEEC---CCCceEEEEEeechhhhh-HHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (443)
.|++.+.||.|+||.||+|.+. .+|+.||+|++....... ....+.+.+|+.+++.+ +||||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999874 478999999997644322 22346788999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred CCccccccCCCcccchhhhccC-CCCCCchhhhhhhHHHHHHhhCCCCCCCCc----HHHHHHHhhcCccCCCCCCCHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLSFTA 241 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 241 (443)
........|+..|+|||.+... ...+.++||||+|+++|+|++|..||.... .......+.....+.|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1222345789999999998643 233578999999999999999999997432 23344444445556667789999
Q ss_pred HHHHHHhcCCCCCCCC-----ChhhhhcCcccccc
Q 013407 242 RKLIARILDPNPMTRI-----TIPEILEDEWFKKD 271 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~-----t~~eil~hp~~~~~ 271 (443)
.+++++||+.||++|| ++++++.||||.+.
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=336.95 Aligned_cols=257 Identities=23% Similarity=0.399 Sum_probs=213.4
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECC-------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 77 (443)
.....++|.+++.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 34456899999999999999999998643 23469999997542 222346788899999999 799999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCc
Q 013407 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (443)
Q Consensus 78 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 141 (443)
+++...+..|+||||+.+|+|.+++.... .++...+..++.|++.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999999999999997542 47888999999999999999999999999999999
Q ss_pred EEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHH
Q 013407 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM 220 (443)
Q Consensus 142 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~ 220 (443)
|+++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999999875432111111112234578999999987666 488999999999999998 99999888777
Q ss_pred HHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 221 NLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 221 ~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+....+.... ...|..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7777665554 35566789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=326.26 Aligned_cols=252 Identities=31% Similarity=0.554 Sum_probs=213.5
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.++++++|+||+++++.+.+.+..+++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 36899999999999999999999989999999998764444444467889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|||+++++|.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~- 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC-
Confidence 999999999998864 345899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc--HHHHHHHhhcCcc-CCCC-CCCHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISAAEF-TCPP-WLSFTA 241 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~s~~~ 241 (443)
........|++.|+|||.+.+..+. .++|+||+||++|+|++|..||.... .......+..+.. +.|. .++..+
T Consensus 160 -~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred -CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 1222345689999999999877764 78999999999999999999996543 2344444444433 2333 578899
Q ss_pred HHHHHHhcCCCCCCCCChhhhhc
Q 013407 242 RKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.++|.+||..+|++|||+.++++
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=342.07 Aligned_cols=263 Identities=29% Similarity=0.388 Sum_probs=214.9
Q ss_pred cccEEE-EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHH-----------HHHHHHHHHHHHhcCCCCCcceEE
Q 013407 10 VGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-----------MAEQIKREVATMKLVKHPNVVRLY 77 (443)
Q Consensus 10 ~~~y~~-~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~l~ 77 (443)
-++|.. .+.||.|+||.||+|.+..+++.||||++......... ....+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 457764 57799999999999999999999999998654322100 112477899999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 78 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
+++...+..|++|||+. |+|.+.+.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999999997 58999998888899999999999999999999999999999999999999999999999999
Q ss_pred cccccccc------------CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHH
Q 013407 158 SALSQQVR------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK 225 (443)
Q Consensus 158 a~~~~~~~------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 225 (443)
+....... .........+++.|+|||.+.+....+.++|+|||||++|+|++|.+||.+.+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 87544110 111223345788999999987655556899999999999999999999998776655443
Q ss_pred hhcCc--c--------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 226 ISAAE--F--------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 226 i~~~~--~--------------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
+.... . ...+..+..+.++|.+||+.+|++|||+++++.||||+....
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 32100 0 001235788999999999999999999999999999987544
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=343.02 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=208.0
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 83 (443)
-++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 3789999999999999999999999999999999876443 2346788999999999999999999876543
Q ss_pred --------CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-CCCeEEee
Q 013407 84 --------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSD 154 (443)
Q Consensus 84 --------~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~~kl~D 154 (443)
...|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||+.|++||||||+||+++. ++.+|++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35899999997 488877754 57999999999999999999999999999999999999974 45789999
Q ss_pred cCcccccccccC-CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC----
Q 013407 155 FGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---- 229 (443)
Q Consensus 155 FGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---- 229 (443)
||++........ ........|+..|+|||.+.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875432211 112233467899999998765444568899999999999999999999876654433322111
Q ss_pred ---------------------cc-----CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 230 ---------------------EF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 230 ---------------------~~-----~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.. ...+.++.++.+||.+||+.||.+|||+.+++.||||+.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 0113467889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=330.09 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=212.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCC-----CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
..++|++.+.||+|+||.||+|.+... +..||+|.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 456899999999999999999988643 47899999865432 22345688999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEe
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~ 153 (443)
...|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999999986432 36788999999999999999999999999999999999999999999
Q ss_pred ecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-cc
Q 013407 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EF 231 (443)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~ 231 (443)
|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 9999875433221122234457789999999876665 488999999999999998 99999988777766666544 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 232 ~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
..|..++..+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 566678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=337.80 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=208.0
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 82 (443)
.+++|++.+.||.|+||.||+|.+..+++.+|+|.+....... .......+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 3789999999999999999999999999999999987543222 123456789999999999999999988743
Q ss_pred --CCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 83 --KTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 83 --~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
...+|+||||+.+ +|...+.. ...+++..+..++.||++||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 3357999999975 66666654 4579999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCC---------CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc
Q 013407 160 LSQQVRDD---------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (443)
Q Consensus 160 ~~~~~~~~---------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 230 (443)
........ .......|++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54332111 111234578899999998765444688999999999999999999999877765544432110
Q ss_pred c-----------------------CCC-------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 231 F-----------------------TCP-------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 231 ~-----------------------~~~-------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
. ..+ ..+++.+.++|.+||..||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 000 1244678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=329.93 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=208.2
Q ss_pred EEEEeEeeccCcEEEEEEEECC---CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE----
Q 013407 13 YEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK---- 85 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 85 (443)
|++++.||+|+||.||.|.... ++..||+|.+...... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5788999999999999998764 3478999998754332 3345678999999999999999999998765443
Q ss_pred --EEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 86 --IFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 86 --~~lv~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
.+++|||+++|+|...+... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999998887432 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCC
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPP 235 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 235 (443)
+................++..|+|||.+.+..+ +.++||||+||++|+|++ |.+||.+.+..+.+..+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 875433221111222345678999999876666 488999999999999999 99999888777776666554 345667
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.++..+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.16 Aligned_cols=254 Identities=30% Similarity=0.446 Sum_probs=209.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFI 88 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 88 (443)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|++++++++||||+++++++.+ .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999875432 2345678999999999999999999998854 457899
Q ss_pred EEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 89 VLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
||||++|++|.+.+.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887643 356899999999999999999999999999999999999999999999999998643321
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc-----HHHHHHHhhcCc-cCCC----
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-----LMNLYKKISAAE-FTCP---- 234 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-----~~~~~~~i~~~~-~~~~---- 234 (443)
......++..|+|||.+.+..++ .++|||||||++|+|++|..||.... ..+....+.... ...+
T Consensus 159 ----~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 ----LAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ----ccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 12244678899999999877665 78999999999999999999998652 223333333211 1111
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 235 --PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 235 --~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
...++.+.++|.+||..||.+|||+.|++.||||++.
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1246789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=326.32 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=213.6
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
....|.+.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++...+.+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 34569999999999999999999999999999999865321 24568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999999998653 3589999999999999999999999999999999999999999999999999875432111
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (443)
. ......+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..+.+..+... ....|..++..+.++
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL 237 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 1 11122345679999998776664 78999999999999998 99999988877777776654 445666789999999
Q ss_pred HHHhcCCCCCCCCChhhhhc
Q 013407 245 IARILDPNPMTRITIPEILE 264 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~ 264 (443)
|.+||+.||++|||+.++++
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=342.43 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=218.4
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----EE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 86 (443)
+|++.+.||.|++|.||+|.+..+++.||||.+.... ......+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999999899999999987643 22334567899999999999999999999987765 78
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|++|||+.+ +|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999984 8999998878899999999999999999999999999999999999999999999999999886543221
Q ss_pred -CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC-------------
Q 013407 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT------------- 232 (443)
Q Consensus 167 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------------- 232 (443)
........+++.|+|||++.+....+.++|+||+|+++|+|++|.+||.+.+..+.+..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 112334568999999999987734468999999999999999999999988766655544321100
Q ss_pred ------------------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 233 ------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 233 ------------------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
..+.++..+.++|.+||+.||.+|||+++++.||||.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 11236788999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=354.70 Aligned_cols=252 Identities=28% Similarity=0.488 Sum_probs=215.9
Q ss_pred EeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 013407 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGE 97 (443)
Q Consensus 18 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~ 97 (443)
.||+|+||+||-|++..+.-..|||-+.... ....+-+..||.+.++|+|.|||++.|.+..++.+-|+||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 5999999999999999999999999997543 2346778999999999999999999999999999999999999999
Q ss_pred hHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-CCCeEEeecCcccccccccCCCccccc
Q 013407 98 LFDKIVNH-GRM--KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTT 173 (443)
Q Consensus 98 L~~~i~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 173 (443)
|.+.++.. |++ +|..+-+|-+||++||.|||.+.|+|||||-+|+|++. .|.+||+|||-++.... -+....+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 99999876 456 88999999999999999999999999999999999975 58999999998875432 34445678
Q ss_pred cCCCcccchhhhccC-CCCCCchhhhhhhHHHHHHhhCCCCCCCCc--HHHHHHH-hhcCccCCCCCCCHHHHHHHHHhc
Q 013407 174 CGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKK-ISAAEFTCPPWLSFTARKLIARIL 249 (443)
Q Consensus 174 ~gt~~y~APEvl~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~-i~~~~~~~~~~~s~~~~~li~~mL 249 (443)
.||..|||||++... ..+|.++|||||||.+.||.||++||-... ...+++- ..+..++.|..+|.+++.+|.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 899999999999532 234799999999999999999999997533 2233332 233456778889999999999999
Q ss_pred CCCCCCCCChhhhhcCccccccCCC
Q 013407 250 DPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 250 ~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
.+||..||++.++|.+||++...+.
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred CCCcccCccHHHhccCcccccCCCC
Confidence 9999999999999999999876443
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=340.19 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=210.5
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK---- 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 83 (443)
..-++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 3458999999999999999999999999999999999764322 22345688899999999999999999988543
Q ss_pred --CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 84 --TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 84 --~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
...|++++++ |++|.+.+.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478888887 7788777654 56999999999999999999999999999999999999999999999999998753
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc----------
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------- 231 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------- 231 (443)
.. ......|++.|+|||++.+....+.++||||+||++|+|++|.+||...+.......+.....
T Consensus 171 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 171 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 22 223456899999999987644445889999999999999999999987655443332211000
Q ss_pred -------------CCC--------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 232 -------------TCP--------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 232 -------------~~~--------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
..| ...++.+.++|.+||+.||.+|||+.+++.||||.+...+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 000 1257889999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=349.08 Aligned_cols=257 Identities=33% Similarity=0.551 Sum_probs=222.5
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
-|..+++||-|+||+|.++...+|...||+|.+.+..+...+....++.|-.||..-+.+-||+||..|.+++.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47888999999999999999999999999999999888777778899999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC---
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG--- 168 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--- 168 (443)
|++||++-.++.+-+-|+|+.|++|+..+..|+++.|..|+|||||||+|||||.+|++||.||||++-++-.....
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999987543211000
Q ss_pred -------------------------------------ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCC
Q 013407 169 -------------------------------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211 (443)
Q Consensus 169 -------------------------------------~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~ 211 (443)
..+..+||+.|+|||++...+|. ..+|.||.|||||+|+.|+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCC
Confidence 01245799999999999998886 8899999999999999999
Q ss_pred CCCCCCcHHHHHHHhhc--CccCCC--CCCCHHHHHHHHHhcCCCCCCCCC---hhhhhcCccccc
Q 013407 212 LPFDDSNLMNLYKKISA--AEFTCP--PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (443)
Q Consensus 212 ~Pf~~~~~~~~~~~i~~--~~~~~~--~~~s~~~~~li~~mL~~dP~~R~t---~~eil~hp~~~~ 270 (443)
+||-..+......++.. ..+.++ -.+|.++.+||.++. -+++.|.. .+++..||||+.
T Consensus 869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 99987766554444322 222333 458999999999866 56788884 778999999984
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=329.11 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=206.0
Q ss_pred EEEeEeeccCcEEEEEEEECCCCc--eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------CCE
Q 013407 14 EVGRTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------KTK 85 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~ 85 (443)
.+++.||+|+||.||+|.+..++. .||+|.+..... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 467899999999999999877665 589999865432 23345778899999999999999999997632 235
Q ss_pred EEEEEeccCCCchHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 86 IFIVLEFVTGGELFDKIVN------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~------~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
.+++|||+.+|+|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 7899999999999888743 2348899999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCC
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWL 237 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~ 237 (443)
...............+++.|+|||.+.+..+ +.++||||+||++|+|++ |.+||.+......+..+..+. ...++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 6433211111123346778999999987666 488999999999999999 899999887777777776654 3456668
Q ss_pred CHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 238 SFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+..+.++|.+||+.||.+|||+++++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=333.70 Aligned_cols=259 Identities=24% Similarity=0.419 Sum_probs=217.0
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEEC-------CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcce
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 75 (443)
+......++|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.+++.+ +||||++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchh
Confidence 556677889999999999999999999752 2345799999865322 22356789999999999 8999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCC
Q 013407 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (443)
Q Consensus 76 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp 139 (443)
+++++......|++|||+.+|+|.+++... ..++...+..++.||+.||.|||++|++||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999998753 2467788999999999999999999999999999
Q ss_pred CcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCc
Q 013407 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (443)
Q Consensus 140 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~ 218 (443)
+||+++.++.+||+|||++................+++.|+|||++.+..++ .++||||||+++|+|++ |..||.+.+
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999998755332222222334567789999999876664 88999999999999998 899999888
Q ss_pred HHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 219 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 219 ~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..+....+..+. ...+..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 888777776543 34456688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=331.78 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=212.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
+.++|.+.+.||+|+||.||+|.+. .++..+++|.+..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4678999999999999999999853 2455689999865332 2345788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~ 147 (443)
...++||||+++++|.+++...+ .+++..++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997542 38899999999999999999999999999999999999999
Q ss_pred CCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHh
Q 013407 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (443)
Q Consensus 148 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i 226 (443)
+.++|+|||++................|++.|+|||.+.+..+. .++||||+||++|+|++ |..||...+.......+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999998754322111122334568899999999876664 78999999999999998 99999888877777766
Q ss_pred hcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 227 SAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 227 ~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
..+.. ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 66544 334557889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=333.19 Aligned_cols=254 Identities=21% Similarity=0.337 Sum_probs=214.0
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCC-----CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
.+.+|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 456788999999999999999987543 5789999997543 223456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~ 147 (443)
...++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 247888899999999999999999999999999999999999
Q ss_pred CCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHh
Q 013407 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (443)
Q Consensus 148 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i 226 (443)
+.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875433221122233456789999999876666 488999999999999998 99999988887777777
Q ss_pred hcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 227 SAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 227 ~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..... ..+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 66653 4566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=335.35 Aligned_cols=259 Identities=30% Similarity=0.506 Sum_probs=211.0
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-- 84 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 84 (443)
...+++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 34678999999999999999999999999999999999754321 222356778999999999999999999887654
Q ss_pred --------EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeec
Q 013407 85 --------KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 85 --------~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DF 155 (443)
.+|+++||+.+ +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 89999999986 666666653 46999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---cc-
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EF- 231 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~- 231 (443)
|++........ .......++..|+|||.+.+....+.++||||+||++|+|++|++||...+.......+... ..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99876533211 11222346788999999875544468899999999999999999999877665544333221 00
Q ss_pred --------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 232 --------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 232 --------------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.....++..+.++|.+||..||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0011367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=330.87 Aligned_cols=253 Identities=33% Similarity=0.500 Sum_probs=211.0
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEEEEEE
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVL 90 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv~ 90 (443)
|++.+.||.|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++.+. +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998653 2233446688899999999999999999999888 8999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||+.+ +|.+.+... ..+++..++.++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 888888665 5799999999999999999999999999999999999999999999999999876543221 12
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc------------------
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------------ 231 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------------ 231 (443)
.....++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23446788999999877654446899999999999999999999988776554443322100
Q ss_pred -----CC-------CCC-CCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 232 -----TC-------PPW-LSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 232 -----~~-------~~~-~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.. ... ++..+.+++++||..+|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=366.47 Aligned_cols=151 Identities=31% Similarity=0.629 Sum_probs=141.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.+++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 47899999999999999999999999999999999987655555566789999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=333.25 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=212.3
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
.|...+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++|||++++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 36777889999999999999999999999999976544444455678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 92 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
|+.| +|.+.+.. ...+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.... ..
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~ 174 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PA 174 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------CC
Confidence 9965 77777754 4568999999999999999999999999999999999999999999999999875321 12
Q ss_pred ccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC--CCCCCCHHHHHHHH
Q 013407 171 HTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPPWLSFTARKLIA 246 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~ 246 (443)
....|+..|+|||.+.. ....+.++|||||||++|+|++|..||...+.......+.....+ ..+.++..+++|+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 34578999999999842 233357899999999999999999999887765554444433221 12346788999999
Q ss_pred HhcCCCCCCCCChhhhhcCcccccc
Q 013407 247 RILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+||+.+|.+||++.+++.||||...
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 255 YCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=343.02 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=204.7
Q ss_pred ccEEEEeEeeccCcEEEEEEEECC-----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe-C
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS-K 83 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-~ 83 (443)
++|++.+.||+|+||.||+|.+.. +++.||+|++..... ....+.+.+|+.+++++ +||||+++++++.. +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 589999999999999999997533 457899999865332 22346778899999999 89999999998754 4
Q ss_pred CEEEEEEeccCCCchHHHHHhC----------------------------------------------------------
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH---------------------------------------------------------- 105 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~---------------------------------------------------------- 105 (443)
..++++|||+++++|.+.+...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 6789999999999999988542
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccch
Q 013407 106 ---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182 (443)
Q Consensus 106 ---~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 182 (443)
..++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++................++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 25788999999999999999999999999999999999999999999999999764322111112234456789999
Q ss_pred hhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHH-HHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 013407 183 EVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN-LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITI 259 (443)
Q Consensus 183 Evl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~ 259 (443)
|++.+..+. .++||||+||++|+|++ |..||.+....+ ....+..+ ....|...++++.+++.+||+.+|++||++
T Consensus 245 E~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999887775 88999999999999998 999998754333 33333333 234455678999999999999999999999
Q ss_pred hhhhcC
Q 013407 260 PEILED 265 (443)
Q Consensus 260 ~eil~h 265 (443)
.++++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=332.05 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=211.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCC----------------ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETG----------------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 72 (443)
..++|++++.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 4578999999999999999999876543 4589999875432 234578899999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCc
Q 013407 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (443)
Q Consensus 73 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 141 (443)
|+++++++..+...+++|||+.+++|.+++.... .+++..++.++.|++.||.|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997765 68999999999999999999999999999999999
Q ss_pred EEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh--CCCCCCCCcH
Q 013407 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNL 219 (443)
Q Consensus 142 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~--G~~Pf~~~~~ 219 (443)
|+++.++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999875433222222234456788999999877555 488999999999999998 7889987766
Q ss_pred HHHHHHhhcC--------ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 220 MNLYKKISAA--------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 220 ~~~~~~i~~~--------~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
...+..+... ....++.++.++.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6555544322 12344567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=319.00 Aligned_cols=249 Identities=33% Similarity=0.565 Sum_probs=214.1
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
.|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999998999999999976543 245688899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 92 FVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 92 ~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
|+.|++|.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998775 5799999999999999999999999999999999999999999999999999875443211 3
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC-ccCC--CCCCCHHHHHHHHH
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTC--PPWLSFTARKLIAR 247 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~--~~~~s~~~~~li~~ 247 (443)
....|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+........... .... +..++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999976654 58899999999999999999999887544433333222 1122 22348899999999
Q ss_pred hcCCCCCCCCChhhhhcCcc
Q 013407 248 ILDPNPMTRITIPEILEDEW 267 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~ 267 (443)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=327.25 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=209.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCc----eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
...+|++.+.||+|+||.||+|.+..+++ .||+|++..... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 35689999999999999999999877766 489999865332 2335678899999999999999999999875 4
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..++++||+++|+|.+.+... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 578999999999999999764 5699999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTA 241 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 241 (443)
...........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+..+. .+.++..+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 2111111223356789999999877665 88999999999999998 999998877666655555543 34556689999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhc
Q 013407 242 RKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+++.+||..||++||++.+++.
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=323.50 Aligned_cols=248 Identities=25% Similarity=0.434 Sum_probs=209.2
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
..+|++.+.||+|+||.||+|.... +..+|+|.+...... ...+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 4679999999999999999998754 567999988654321 34678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||++||+|.+.+... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-e
Confidence 9999999999998753 5689999999999999999999999999999999999999999999999998875322111 1
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 246 (443)
......++..|+|||++.+..+. .++||||+|+++|+|++ |+.||...+..+....+..+. ...|...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11122345689999999876664 88999999999999999 999999888777777776653 3345557889999999
Q ss_pred HhcCCCCCCCCChhhhhc
Q 013407 247 RILDPNPMTRITIPEILE 264 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~ 264 (443)
+||..||.+|||++++++
T Consensus 236 ~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 SCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=317.46 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=209.8
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE---
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--- 81 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--- 81 (443)
.+...-.||++.+.||.|+|+.||++.+..++..||+|.+.... .+..+...+|+...++++||||++++++..
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 34556679999999999999999999999999999999996544 345678999999999999999999987753
Q ss_pred --eCCEEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeeCCCCcEEEccCCCeEEe
Q 013407 82 --SKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVS 153 (443)
Q Consensus 82 --~~~~~~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kl~ 153 (443)
.....|+++.|...|+|.+.|+.. ..++|.++..||.+|++||++||+.. .+||||||.|||+++.+..++.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 334599999999999999998652 36999999999999999999999999 9999999999999999999999
Q ss_pred ecCcccccccccCCC-------ccccccCCCcccchhhhccCCC--CCCchhhhhhhHHHHHHhhCCCCCCCCcHH--HH
Q 013407 154 DFGLSALSQQVRDDG-------LLHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAGYLPFDDSNLM--NL 222 (443)
Q Consensus 154 DFGla~~~~~~~~~~-------~~~~~~gt~~y~APEvl~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~ 222 (443)
|||.++.....-.+. .......|.+|+|||.+.-+.+ .+.++|||||||+||+|+.|..||+..-.. .+
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 999987643321111 0122346899999999864432 258899999999999999999999632110 11
Q ss_pred HHHhhcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 223 YKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 223 ~~~i~~~~~~~~--~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.-.+..+.+.+| +.+|..+.+||+.||++||.+||++.+++.+
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 112334455444 3489999999999999999999999999875
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=326.77 Aligned_cols=249 Identities=22% Similarity=0.401 Sum_probs=213.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.-.+|++++.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34579999999999999999999987 88899999876442 224578899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 99999999999999753 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (443)
.......++..|+|||.+....+. .++||||||+++|+|++ |..||.+.+..+.+..+..+ ..+.+...++.+.++
T Consensus 159 -~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 159 -YLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred -ccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHH
Confidence 111233456789999999876664 78999999999999998 89999988777777766544 345566789999999
Q ss_pred HHHhcCCCCCCCCChhhhhc
Q 013407 245 IARILDPNPMTRITIPEILE 264 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~ 264 (443)
+.+||+.||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 237 MLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.01 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=204.8
Q ss_pred EeeccCcEEEEEEEE--CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 18 TIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 18 ~LG~G~~g~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
.||+|+||.||+|.+ ..++..+|+|++.... ......+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 4577899999986543 23345677899999999999999999999875 4567899999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC-Ccccccc
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTC 174 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~ 174 (443)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++......... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999988888999999999999999999999999999999999999999999999999998754322110 0112233
Q ss_pred CCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCC
Q 013407 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPN 252 (443)
Q Consensus 175 gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~d 252 (443)
+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+. ...|..+++++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4678999999876555 478999999999999998 999999887777777666553 4566779999999999999999
Q ss_pred CCCCCChhhhhc
Q 013407 253 PMTRITIPEILE 264 (443)
Q Consensus 253 P~~R~t~~eil~ 264 (443)
|++||++++|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=341.59 Aligned_cols=261 Identities=31% Similarity=0.438 Sum_probs=213.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe--CC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS--KT 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~~ 84 (443)
...++|++.+.||+|+||.||+|.+..+|+.+|+|.+..... .......+.+|+.+++++ +||||+++++++.. ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 346789999999999999999999998999999999865322 222345677899999999 99999999998864 34
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
..|+||||+.+ +|...+... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 68999999974 898888765 7899999999999999999999999999999999999999999999999998765432
Q ss_pred cCC---CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-----------
Q 013407 165 RDD---GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------- 230 (443)
Q Consensus 165 ~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------- 230 (443)
... .......||+.|+|||.+.+....+.++||||||+++|+|++|++||.+........++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 211 223345689999999998765555688999999999999999999998766544333321110
Q ss_pred ----------------c----CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 231 ----------------F----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 231 ----------------~----~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
. ...+.++.++.++|.+||+.||++|||+.++++|||++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0112368899999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=346.63 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=207.5
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCC-----CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVM 80 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 80 (443)
...-++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.++++++ ||||+++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34456788999999999999999987433 3469999996543 2233567899999999996 99999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhC-------------------------------------------------------
Q 013407 81 GSKTKIFIVLEFVTGGELFDKIVNH------------------------------------------------------- 105 (443)
Q Consensus 81 ~~~~~~~lv~E~~~gg~L~~~i~~~------------------------------------------------------- 105 (443)
.+....|+||||+++|+|.+++...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999999887542
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE
Q 013407 106 -----------------------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL 144 (443)
Q Consensus 106 -----------------------------------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl 144 (443)
..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 236778889999999999999999999999999999999
Q ss_pred ccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHH-HH
Q 013407 145 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NL 222 (443)
Q Consensus 145 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~-~~ 222 (443)
+.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... ..
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 9999999999999875433221112223456788999999987666 489999999999999997 99999875443 33
Q ss_pred HHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 223 YKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 223 ~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
+..+..+ ....+..++..+.+++.+||+.||++|||+.++.+
T Consensus 350 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3444433 33455668899999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=332.97 Aligned_cols=255 Identities=24% Similarity=0.403 Sum_probs=211.7
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECC-------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 78 (443)
...-++|.+.+.||+|+||.||+|.+.. .+..+|+|.+..... ......+.+|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3445789999999999999999998632 345699999875322 22356788999999999 6999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcE
Q 013407 79 VMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (443)
Q Consensus 79 ~~~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 142 (443)
++.+.+.+|++|||+.+|+|.+++... ..++...+..++.||+.||.|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999999653 3478889999999999999999999999999999999
Q ss_pred EEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHH
Q 013407 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (443)
Q Consensus 143 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~ 221 (443)
|++.++.+||+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999875433211111222334568999999987666 488999999999999999 999999888777
Q ss_pred HHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 222 LYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 222 ~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+..+..+. ...+..++.++.+++.+||..||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 245 LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 777766553 3455667889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.18 Aligned_cols=257 Identities=29% Similarity=0.491 Sum_probs=220.0
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..-..|+..+.||+|++|.||+|.+..++..||+|++..... ..+.+.+|+.+++.++|+||+++++.+......|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 345678999999999999999999988899999999975432 3457889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+++||+.|++|.+.+.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 9999999999999998876 89999999999999999999999999999999999999999999999999876543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARK 243 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~ 243 (443)
.......+++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+..... ..+..++..+.+
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 122344578899999999876664 889999999999999999999988766554444433222 222337889999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 244 LIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+|.+||+.+|.+|||+.+++.||||.+.
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 9999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.85 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=208.0
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCc--eEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 87 (443)
++|++.+.||+|+||.||+|....++. .+++|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+..|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877765 46888875321 222356788999999999 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeE
Q 013407 88 IVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~k 151 (443)
++|||+++++|.+++.... .+++..++.++.||+.||+|||++|++||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 488899999999999999999999999999999999999999999
Q ss_pred EeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc
Q 013407 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE 230 (443)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 230 (443)
|+|||++........ ......+..|+|||.+.+..+. .++|||||||++|+|++ |.+||.+.+..+....+..+.
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999863221100 1112234579999999876664 88999999999999997 999999888877777765543
Q ss_pred -cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 231 -FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 231 -~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
...|..++..+.+|+.+||..+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34455689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=301.58 Aligned_cols=256 Identities=34% Similarity=0.531 Sum_probs=215.1
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
.+|.-.++||+|+||+|++|++.++++.||+|.+..... ++.......+||.+++.++|.|||+++++..++..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 456677899999999999999999999999999976543 2334456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|||.. +|..+... ++.++.+.++.++.|++.||.|||++++.||||||.|+|++.+|.+|++|||+|+.+.-.- .-
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Ee
Confidence 99964 77666654 5779999999999999999999999999999999999999999999999999998665321 11
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC--c--------------c-
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA--E--------------F- 231 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~--------------~- 231 (443)
.....-|.+|.+|.++.+...++...|+||.|||+.|+.. |.+.|++.+..+...+|... . +
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 2233468999999999988777788999999999999985 89999999888777665221 0 0
Q ss_pred C---CC---------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 232 T---CP---------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 232 ~---~~---------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
. +| |.++..-++|++++|.-+|.+|++++.+++||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 0 11 123456799999999999999999999999999975
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=320.72 Aligned_cols=251 Identities=29% Similarity=0.483 Sum_probs=219.7
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++.+.||.|++|.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999997644322 234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 92 FVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 92 ~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998866 356899999999999999999999999999999999999999999999999998765432
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 246 (443)
......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+....+ ..+..++.++++++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 23345689999999999877664 789999999999999999999998887776666655544 344568899999999
Q ss_pred HhcCCCCCCCCChhhhhcCccc
Q 013407 247 RILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+||..+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=338.43 Aligned_cols=254 Identities=20% Similarity=0.328 Sum_probs=202.8
Q ss_pred eEeecc--CcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013407 17 RTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 17 ~~LG~G--~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 94 (443)
..||.| +||+||+|.+..+|+.||+|++....... ...+.+++|+.+++.++||||+++++++..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 99999999999999999999987644322 345789999999999999999999999999999999999999
Q ss_pred CCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC----
Q 013407 95 GGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG---- 168 (443)
Q Consensus 95 gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~---- 168 (443)
+++|.+.+... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999988764 358999999999999999999999999999999999999999999999998654322111110
Q ss_pred -ccccccCCCcccchhhhccCC-CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc---------------
Q 013407 169 -LLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--------------- 231 (443)
Q Consensus 169 -~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--------------- 231 (443)
......++..|+|||++.+.. ..+.++||||+||++|+|++|.+||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011223567799999987532 235889999999999999999999987654433222211100
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 232 --------------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 232 --------------------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+.+..++..+.+||++||..||.+|||+.++++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0111256789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=327.82 Aligned_cols=265 Identities=29% Similarity=0.430 Sum_probs=213.2
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCc----eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-C
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-K 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~ 83 (443)
.+..|++++.||+|+||.||+|..++++. .+|||.+..++.. .+.....-||+.+++.++||||+.+..++.+ +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 35679999999999999999997665433 6899998765321 2234567899999999999999999999877 8
Q ss_pred CEEEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC----CCeEEee
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY----GNLKVSD 154 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~----~~~kl~D 154 (443)
..+|+++||++. +|...|.-+ ..++...++.++.||+.|+.|||++=|.||||||.|||+..+ |.+||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999986 888888643 368999999999999999999999999999999999999887 8999999
Q ss_pred cCcccccccccCCC-ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH---------HHHHH
Q 013407 155 FGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---------MNLYK 224 (443)
Q Consensus 155 FGla~~~~~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---------~~~~~ 224 (443)
||+|+++...-..- .....+-|.+|.|||.+.+...++++.|||+.|||+.|||+-++.|.+... .+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999876532211 233456688999999999988888999999999999999999999865421 12222
Q ss_pred HhhcC--cc---------CCC--------------------CC------CCHHHHHHHHHhcCCCCCCCCChhhhhcCcc
Q 013407 225 KISAA--EF---------TCP--------------------PW------LSFTARKLIARILDPNPMTRITIPEILEDEW 267 (443)
Q Consensus 225 ~i~~~--~~---------~~~--------------------~~------~s~~~~~li~~mL~~dP~~R~t~~eil~hp~ 267 (443)
+|... .+ ..| .| -++.+.+|+.+||+.||.+|+|++++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 22110 00 011 11 2456899999999999999999999999999
Q ss_pred ccccCCCC
Q 013407 268 FKKDYKPP 275 (443)
Q Consensus 268 ~~~~~~~~ 275 (443)
|+.+..|+
T Consensus 340 F~~d~lpp 347 (438)
T KOG0666|consen 340 FTEDPLPP 347 (438)
T ss_pred cccCCCCC
Confidence 99876654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=347.22 Aligned_cols=238 Identities=23% Similarity=0.405 Sum_probs=208.0
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
..-++.||.|+.|-||+|+. .++.||||.+.. .-..+|+-|++|+|||||.+.++|.....++|||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 33457899999999999997 467899998742 223578899999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcccc
Q 013407 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (443)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 172 (443)
|..|.|...++....+.......|..+|+.|++|||.+.|||||||.-||||+.+..+||+|||-++.... ......
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STkMS 270 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTKMS 270 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh---hhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999998875433 234457
Q ss_pred ccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHHHHHHhcC
Q 013407 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARILD 250 (443)
Q Consensus 173 ~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~mL~ 250 (443)
.+||..|||||++...+.. .|+||||+||||||||||..||.+-+...++--+... .++.|..++..++-||++||+
T Consensus 271 FaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 8999999999999987775 9999999999999999999999876655443333322 456778899999999999999
Q ss_pred CCCCCCCChhhhhcCc
Q 013407 251 PNPMTRITIPEILEDE 266 (443)
Q Consensus 251 ~dP~~R~t~~eil~hp 266 (443)
-.|..||++.+||.|=
T Consensus 350 sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLHL 365 (904)
T ss_pred cCCCCCccHHHHHHHH
Confidence 9999999999999883
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=357.49 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=195.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCC-CceEEEEE--------------eechhhhhHHHHHHHHHHHHHHhcCCCCCc
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKI--------------LDKEKVLKHKMAEQIKREVATMKLVKHPNV 73 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~-~~~vAiK~--------------i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 73 (443)
..++|++++.||+|+||+||+|..+.. +...+.|. +.+...........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 357899999999999999999876432 22223321 111111122245678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC
Q 013407 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (443)
Q Consensus 74 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~ 148 (443)
+++++++.+.+..|+++|++. ++|++++... .......++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999995 4777776432 2345677889999999999999999999999999999999999
Q ss_pred CeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCC-CCCCC--cH-HHHHH
Q 013407 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDDS--NL-MNLYK 224 (443)
Q Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~-Pf~~~--~~-~~~~~ 224 (443)
.+||+|||++....... .......+||+.|+|||++.+..|. .++|||||||++|+|++|.. ||... +. ..+.+
T Consensus 305 ~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 305 KIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999997653321 1122346799999999999887775 88999999999999999875 44322 11 12211
Q ss_pred Hhhc---------------------Ccc-----CCC-----CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 225 KISA---------------------AEF-----TCP-----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 225 ~i~~---------------------~~~-----~~~-----~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+.. ..+ ..+ ..++.++.++|.+||..||.+|||+.|+|.||||...
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 1110 000 000 1245677888999999999999999999999999763
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.89 Aligned_cols=249 Identities=24% Similarity=0.417 Sum_probs=208.5
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
..+|++.+.||+|+||.||+|.+. ++..+|+|++.+.... ...+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 346889999999999999999886 4667999998653322 23577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~ 156 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T 156 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence 9999999999998763 4689999999999999999999999999999999999999999999999999875422110 0
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 246 (443)
......++..|+|||.+.+..+. .++||||+|+++|+|++ |..||...+.......+..+ ....|...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 01111234579999999876664 78999999999999998 89999887777766666554 34556668999999999
Q ss_pred HhcCCCCCCCCChhhhhcC
Q 013407 247 RILDPNPMTRITIPEILED 265 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~h 265 (443)
+||..+|++|||+.++++.
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHhcCChhhCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=322.48 Aligned_cols=248 Identities=22% Similarity=0.370 Sum_probs=209.2
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
-++|++.+.||+|++|.||+|.+. +++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 467999999999999999999975 456799999875432 135678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 90 LEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
|||+.|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999999997644 6899999999999999999999999999999999999999999999999998765421111
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 245 (443)
......++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ....+...+..+.+++
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred -ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 1111223457999999877665 488999999999999999 99999988877777666544 2345566889999999
Q ss_pred HHhcCCCCCCCCChhhhhc
Q 013407 246 ARILDPNPMTRITIPEILE 264 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~ 264 (443)
.+||+.+|.+||++.++++
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.75 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=207.4
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 83 (443)
.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 4799999999999999999999999999999999876432 222345678999999999999999999998654
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..+|+|+||+.+ +|...+ ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 357999999964 666554 34689999999999999999999999999999999999999999999999999874321
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-------------
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------- 230 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 230 (443)
......|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+....
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 12345678999999998764444588999999999999999999999876554433322100
Q ss_pred ----------cCC--------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 231 ----------FTC--------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 231 ----------~~~--------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
... .+..+..+.+||.+||+.||.+||++++++.||||..-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 12367789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=323.00 Aligned_cols=249 Identities=20% Similarity=0.352 Sum_probs=209.6
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+.+..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 4578999999999999999999975 556799999865332 24678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+|||+++++|.+++... ..++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999998653 4688999999999999999999999999999999999999999999999999976432111
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (443)
.......++..|+|||.+....+ +.++|||||||++|+|++ |..||...........+... ..+.+..++.++.++
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 159 -TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred -eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11122335678999999877665 478999999999999998 99999887777666666544 233344578999999
Q ss_pred HHHhcCCCCCCCCChhhhhc
Q 013407 245 IARILDPNPMTRITIPEILE 264 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~ 264 (443)
+.+||..+|++|||++++.+
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=327.36 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=209.7
Q ss_pred cccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
-.+|.+.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 457888999999999999999743 356689999876432 234568999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC
Q 013407 85 KIFIVLEFVTGGELFDKIVNHG---------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~---------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~ 149 (443)
..|++|||+.+++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999987643 4789999999999999999999999999999999999999999
Q ss_pred eEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhc
Q 013407 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA 228 (443)
Q Consensus 150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 228 (443)
+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999998754321111112233456789999999877764 88999999999999998 9999988776666665554
Q ss_pred C-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 229 A-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 229 ~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
+ ....+..+++.+.++|.+||..||.+||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4 34455668999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=332.00 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=214.8
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
.|...+.||+|+||.||+|.+..++..||+|.+........+....+.+|+.+++.++|||++++++++.+....|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 47888999999999999999999999999999976544444456788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 92 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
|+.| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..... .
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~ 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------A 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------c
Confidence 9975 77776654 45689999999999999999999999999999999999999999999999998764322 2
Q ss_pred ccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CC-CCCCCHHHHHHHH
Q 013407 171 HTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TC-PPWLSFTARKLIA 246 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~s~~~~~li~ 246 (443)
....|++.|+|||.+.. .+..+.++||||+||++|+|++|..||...+.......+..... .. +..++..+++++.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 34568999999999742 23335789999999999999999999988776655555544432 22 2347889999999
Q ss_pred HhcCCCCCCCCChhhhhcCccccccC
Q 013407 247 RILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
+||+.+|.+||++.++++|+|+....
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhccC
Confidence 99999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=322.28 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=208.7
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+...... .+.+.+|+.++++++||||+++++++.+....|++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998754 446999998654321 34678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........ .
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 9999999999998764 4689999999999999999999999999999999999999999999999999875422111 1
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 246 (443)
......++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+..+.. ..+...+..+++++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 11122345679999999776664 78999999999999998 9999988777766666655533 334557899999999
Q ss_pred HhcCCCCCCCCChhhhhcC
Q 013407 247 RILDPNPMTRITIPEILED 265 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~h 265 (443)
+||..||.+|||+.+++.+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=335.11 Aligned_cols=259 Identities=28% Similarity=0.416 Sum_probs=208.5
Q ss_pred cEEEEeEeeccCcEEEEEEEECCC--CceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe----CC
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSET--GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS----KT 84 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 84 (443)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999887 8899999986432 2222346778899999999 59999999987432 35
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.+|+++||+. ++|.+.+.....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999986 589999988888999999999999999999999999999999999999999999999999998754332
Q ss_pred cC--CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC-------------
Q 013407 165 RD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------- 229 (443)
Q Consensus 165 ~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 229 (443)
.. ........||+.|+|||.+.+....+.++||||+||++|+|++|.+||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112234578999999998865433358899999999999999999999876543322221110
Q ss_pred ------------c---cC---CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 230 ------------E---FT---CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 230 ------------~---~~---~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
. .. ..+..+..+.+|+.+||+.||.+|||+.+++.|||+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0 00 1123578999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=330.77 Aligned_cols=252 Identities=30% Similarity=0.493 Sum_probs=213.0
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
...||+|+||.||++.+..+|+.||||.+.... ......+.+|+.+++.++||||+++++.+...+..|++|||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 357999999999999999999999999985432 22356788999999999999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
++|.+.+. .+.+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... ........|
T Consensus 102 ~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~ 178 (292)
T cd06657 102 GALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVG 178 (292)
T ss_pred CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--ccccccccc
Confidence 99988764 457899999999999999999999999999999999999999999999999987643221 112234568
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHHHHHHHHhcCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPN 252 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~mL~~d 252 (443)
++.|+|||.+.+..+ +.++|+||+|+++|+|++|.+||.+.+.......+.... ......+++.+.+++.+||..|
T Consensus 179 ~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 179 TPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred CccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 999999999876665 488999999999999999999998876665544443322 2223447889999999999999
Q ss_pred CCCCCChhhhhcCccccccCCC
Q 013407 253 PMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 253 P~~R~t~~eil~hp~~~~~~~~ 274 (443)
|.+||++.+++.||||.+...+
T Consensus 258 P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 258 PAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred cccCcCHHHHhcChHHhccCCC
Confidence 9999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=329.06 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=208.8
Q ss_pred cEEEEeEeeccCcEEEEEEEECC-----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235689998865432 22346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcE
Q 013407 87 FIVLEFVTGGELFDKIVNH------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 142 (443)
|++|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999987642 2478889999999999999999999999999999999
Q ss_pred EEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHH
Q 013407 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (443)
Q Consensus 143 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~ 221 (443)
|+++++.+||+|||++...............+++..|+|||.+.+..++ .++||||||+++|+|++ |.+||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999998754322111112234567789999998776664 88999999999999998 999999888777
Q ss_pred HHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 222 LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 222 ~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+..+... ....|..++.++.+++.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76666543 33456668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=330.91 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=208.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEE-----CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 81 (443)
...++|.+.+.||+|+||.||+|.+ ..++..||+|.+..... ....+.+.+|+.+++++ +||||+++++.+.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 3446899999999999999999975 23456799999875432 23356789999999999 7999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
..+..|++|||+.+|+|.+++.... .+++..+..++.|++.||.|||++|++|+||||+|||++.++.++++|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999999987543 38999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHH-hhcC-ccCCCCC
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKK-ISAA-EFTCPPW 236 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~-i~~~-~~~~~~~ 236 (443)
...............+++.|+|||.+.+..+. .++||||+||++|+|++ |..||........+.+ +..+ ....+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence 54322111111223467889999999876664 88999999999999998 9999987665544333 3323 2334556
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.++.+.+++.+||+.+|++|||+.++++
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 8899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=327.18 Aligned_cols=258 Identities=32% Similarity=0.565 Sum_probs=215.5
Q ss_pred cEEEEeEeeccCcEEEEEEEEC---CCCceEEEEEeechhhhh-HHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (443)
.|++.+.||+|++|.||+|.+. .+++.||||++.+..... ......+.+|+.+++++ +||||+++++.+.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 467889999997644322 23346788999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+.+++|.+.+.....+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987543321
Q ss_pred CCccccccCCCcccchhhhccCC-CCCCchhhhhhhHHHHHHhhCCCCCCCCc----HHHHHHHhhcCccCCCCCCCHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLSFTA 241 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 241 (443)
.......+|++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||.... .....+.+.......|..++..+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11123356899999999986543 23578999999999999999999996432 22334444455566677789999
Q ss_pred HHHHHHhcCCCCCCCCC---hhhhhcCccccc
Q 013407 242 RKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t---~~eil~hp~~~~ 270 (443)
.++|.+||+.||++||| +.++++||||+.
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 99999999999999998 567799999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=330.17 Aligned_cols=254 Identities=22% Similarity=0.333 Sum_probs=205.5
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 89 (443)
++|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...|++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677788999999999999999999999999998764322 33567889999999996 99999999999999999999
Q ss_pred EeccCCCchHH---HHH--hCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 90 LEFVTGGELFD---KIV--NHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 90 ~E~~~gg~L~~---~i~--~~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
|||+.+ ++.+ .+. ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 4433 322 246799999999999999999999985 999999999999999999999999999874322
Q ss_pred ccCCCccccccCCCcccchhhhccC--CCCCCchhhhhhhHHHHHHhhCCCCCCCCcH-HHHHHHhhcCcc-CC----CC
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEF-TC----PP 235 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~-~~----~~ 235 (443)
........|++.|+|||++.+. ...+.++||||+||++|+|++|.+||...+. ......+..+.. .. +.
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 ---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred ---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1222344689999999999765 2345889999999999999999999976542 122222222221 11 12
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.++.++.+||.+||+.||++|||+++++.||||+.
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 37889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=322.64 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=211.6
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCc---eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.++.|++.+.||+|+||.||+|.+..+++ .||||.+.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 35679999999999999999999877665 59999987542 23345778999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.++||||+.+++|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999998875 356899999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCcccccc---CCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCH
Q 013407 165 RDDGLLHTTC---GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (443)
Q Consensus 165 ~~~~~~~~~~---gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 239 (443)
.......... ++..|+|||.+.+..++ .++||||+||++|+|++ |..||...+.......+... ..+.++.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence 2211111111 24579999999877764 78999999999999886 99999887777666666443 3344556788
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 240 TARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+.+++.+||..+|++||++++++.
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=325.10 Aligned_cols=252 Identities=18% Similarity=0.309 Sum_probs=207.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCce----EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEP----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
..++|++.+.||+|+||.||+|.+..++.. +++|.+.... .......+..|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 346899999999999999999999777764 6777765322 1223467788999999999999999999875 45
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..++++||+++|+|.+.+... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 578999999999999999764 5689999999999999999999999999999999999999999999999999975433
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTA 241 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~ 241 (443)
...........|+..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.......+.+..+.. ..+...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 222222234456778999999977666 488999999999999998 9999988776665555554443 3344577899
Q ss_pred HHHHHHhcCCCCCCCCChhhhhc
Q 013407 242 RKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+++.+|+..||++|||+.++++
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=326.08 Aligned_cols=248 Identities=31% Similarity=0.518 Sum_probs=204.4
Q ss_pred EEEeEeeccCcEEEEEEEEC----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 14 EVGRTIGEGTFAKVKFARNS----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
++.+.||.|+||.||+|... ..+..|+||.+... ......+.+.+|++++++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999987 34678999999542 2233467899999999999999999999999988889999
Q ss_pred EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
|||+++|+|.+++... ..++......++.||+.||.|||+++++|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 67999999999999999999999999999999999999999999999999998765221111
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLI 245 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 245 (443)
.......+...|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+..+....+..+. ...+..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 12233446778999999987666 489999999999999999 789999888887777775554 345667899999999
Q ss_pred HHhcCCCCCCCCChhhhhc
Q 013407 246 ARILDPNPMTRITIPEILE 264 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~ 264 (443)
.+||..||.+|||+.++++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=333.83 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=213.6
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCC-------CceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcce
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSET-------GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 75 (443)
++-...-.+|++++.||+|+||.||+|.+... +..||+|.+.... .....+.+.+|+.+++++ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34445556899999999999999999986432 2368999886432 223456788999999999 7999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCC
Q 013407 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (443)
Q Consensus 76 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp 139 (443)
+++++...+..|++|||+++|+|.+++.... .++...+..++.|++.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999987532 367788899999999999999999999999999
Q ss_pred CcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCc
Q 013407 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (443)
Q Consensus 140 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~ 218 (443)
+|||++.++.+||+|||+++...............++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999998754332111112223345679999999877665 78999999999999998 899999888
Q ss_pred HHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 219 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 219 ~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..+....+.... ...+..++..+.+++.+||+.+|.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 777777765543 34556678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=321.61 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=206.8
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
.++|++.+.||+|+||.||+|.+..+ ..||+|++...... .+.+.+|+.+++.++||||+++++.+. ....|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 46899999999999999999998665 45999999754321 246789999999999999999999875 4568999
Q ss_pred EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
|||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~- 157 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 157 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence 9999999999999753 3588999999999999999999999999999999999999999999999999875433211
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 245 (443)
.......++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.........+..+ ....+..++..+.+++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 236 (262)
T ss_pred ccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 11123346678999999877666 488999999999999999 99999887776666666544 2344556889999999
Q ss_pred HHhcCCCCCCCCChhhhhc
Q 013407 246 ARILDPNPMTRITIPEILE 264 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~ 264 (443)
.+||++||++|||+.++++
T Consensus 237 ~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 237 CQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=325.07 Aligned_cols=250 Identities=31% Similarity=0.465 Sum_probs=206.1
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCE----
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGSKTK---- 85 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 85 (443)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999988899999999975432 222334566788777666 59999999999988776
Q ss_pred -EEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 86 -IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 86 -~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
+|++|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 7888887643 58999999999999999999999999999999999999999999999999987653
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-----cC-----
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-----FT----- 232 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-----~~----- 232 (443)
.. .......+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||.+.+..+...++.... ..
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 32 22233457889999999987666 488999999999999999999999887766555443210 00
Q ss_pred -----------------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 233 -----------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 233 -----------------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
..+.++..+.++|.+||+.||.+||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 001245778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=319.52 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=204.6
Q ss_pred eEeeccCcEEEEEEEECCCC---ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 013407 17 RTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 93 (443)
+.||+|+||.||+|....++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. ....+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876544 78999999765433 34567889999999999999999999876 45689999999
Q ss_pred CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC-cccc
Q 013407 94 TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHT 172 (443)
Q Consensus 94 ~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 172 (443)
.+|+|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999888889999999999999999999999999999999999999999999999999987553321110 0111
Q ss_pred ccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcC
Q 013407 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILD 250 (443)
Q Consensus 173 ~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~ 250 (443)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+....+.... ...|..++..++++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 223467999999977666 488999999999999998 999998877776666665543 35566789999999999999
Q ss_pred CCCCCCCChhhhhc
Q 013407 251 PNPMTRITIPEILE 264 (443)
Q Consensus 251 ~dP~~R~t~~eil~ 264 (443)
.||++||++.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.24 Aligned_cols=252 Identities=33% Similarity=0.508 Sum_probs=211.2
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
|++.+.||+|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++++.+++..|+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67789999999999999999989999999998764432 23456788899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 93 VTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 93 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
+.+ +|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 88887766 4589999999999999999999999999999999999999999999999999987654322 1223
Q ss_pred cccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC-------------------ccC
Q 013407 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------EFT 232 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~~ 232 (443)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+.+.++... ...
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 3457889999999877634468999999999999999999999887765554443211 000
Q ss_pred -----------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 233 -----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 233 -----------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
..+.++..+.++|.+||.+||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=323.22 Aligned_cols=261 Identities=31% Similarity=0.582 Sum_probs=236.0
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (443)
.+.-+.+|.+++.||+|+|++|.+++.+.+.+.||+|++.++-....+....++.|-.+...- +||.+|.++..|++++
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 345678999999999999999999999999999999999998887777788889998887766 7999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.+++|.||++||+|--.+.+...+||+.|+.|...|+.||.|||++||++||||..|+|+|..|++|+.|+|+++. ..
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~l 402 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GL 402 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--CC
Confidence 9999999999999988888889999999999999999999999999999999999999999999999999999863 33
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCC-------CcH-HHHHHHhhcCccCCCCC
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-------SNL-MNLYKKISAAEFTCPPW 236 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-------~~~-~~~~~~i~~~~~~~~~~ 236 (443)
.......+.||||.|+|||++.+..| +..+|.|+|||++++|++|+.||+- .+. .-+++-|....+..|..
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs 481 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS 481 (593)
T ss_pred CCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence 45567788999999999999999888 5999999999999999999999962 222 24567777888899999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCC------hhhhhcCcccc
Q 013407 237 LSFTARKLIARILDPNPMTRIT------IPEILEDEWFK 269 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t------~~eil~hp~~~ 269 (443)
+|-.+..+++..|++||.+|.. ..++..|+||+
T Consensus 482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR 520 (593)
T ss_pred eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence 9999999999999999999984 67899999997
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=325.61 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=211.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECC-----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45689999999999999999998743 678899999875432 23456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHG----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~----------------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 141 (443)
...|++|||+.+|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986432 36788899999999999999999999999999999
Q ss_pred EEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHH
Q 013407 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM 220 (443)
Q Consensus 142 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~ 220 (443)
|+++.++.++|+|||++................++..|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998754322111112223346679999998877664 88999999999999997 88999887777
Q ss_pred HHHHHhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 221 NLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 221 ~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
+....+..+.. ..|..++..+.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77776665543 445668899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=337.56 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=204.0
Q ss_pred cccEEEEeEeeccCcEEEEEEEE-----CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe-
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS- 82 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 82 (443)
-++|++.+.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 46899999999999999999984 34678899999975432 22356788999999999 68999999998754
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC--------------------------------------------------------
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHG-------------------------------------------------------- 106 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~-------------------------------------------------------- 106 (443)
...++++|||+.+|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 456899999999999999886421
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 107 -----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 107 -----------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
.++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 357778889999999999999999999999999999999999999999999875432111111122345
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHH-HHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISAA-EFTCPPWLSFTARKLIARILDPN 252 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~d 252 (443)
++.|+|||.+.+..+. .++||||||+++|+|++ |..||...... .....+..+ ....|.+.++.+.+++.+||..|
T Consensus 244 ~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 6789999999876664 88999999999999997 99999875433 223333332 34556678899999999999999
Q ss_pred CCCCCChhhhhcC
Q 013407 253 PMTRITIPEILED 265 (443)
Q Consensus 253 P~~R~t~~eil~h 265 (443)
|.+|||+.++++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=329.64 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=211.8
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
..|...+.||+|+||.||+|++..+++.+|+|.+.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45788899999999999999999999999999987543333344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||+. |+|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------ 167 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC------
Confidence 9997 477776643 45689999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CC-CCCCCHHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TC-PPWLSFTARKLI 245 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~s~~~~~li 245 (443)
.....|++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+..... .. +..++..+.+||
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 224568899999999752 22235789999999999999999999987665544444433322 22 234788999999
Q ss_pred HHhcCCCCCCCCChhhhhcCcccccc
Q 013407 246 ARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+||..+|.+||++++++.|||+...
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=321.18 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=209.8
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCc---eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999865443 699999865432 22356789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||++|++|.+++... +.++...+..++.|++.||.|||++|++||||||+||+++.++.++++|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCc-cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 013407 166 DDGL-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (443)
Q Consensus 166 ~~~~-~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (443)
.... .....++..|+|||.+.+..+ +.++|+|||||++|++++ |..||.+.+..+....+..+ ..+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1111 111223567999999987666 488999999999999886 99999887766666666544 2344455788999
Q ss_pred HHHHHhcCCCCCCCCChhhhhc
Q 013407 243 KLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~ 264 (443)
+++.+||+.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=322.11 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=212.4
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCc----eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
..++|++.+.||+|+||.||+|.+..+|+ .+|+|.+..... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45789999999999999999999876665 589998875532 2345678899999999999999999999887 7
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..+++|||+.+|+|.+.+... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 899999999999999998764 4689999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTA 241 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 241 (443)
...........++..|+|||.+....+. .++|+||+||++|++++ |..||.+....+..+.+..+. .+.|...+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2111111122245689999998766664 88999999999999998 999999888777777666553 45566688999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhc
Q 013407 242 RKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+++.+||..||..|||+.++++
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=327.89 Aligned_cols=252 Identities=20% Similarity=0.288 Sum_probs=204.5
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCC--------------ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcce
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETG--------------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~--------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 75 (443)
-.+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 358999999999999999999875432 358999987542 2234567899999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEE
Q 013407 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (443)
Q Consensus 76 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIL 143 (443)
+++++...+..|+||||+.+++|.+.+.... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886432 3688889999999999999999999999999999999
Q ss_pred EccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh--CCCCCCCCcHHH
Q 013407 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNLMN 221 (443)
Q Consensus 144 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~--G~~Pf~~~~~~~ 221 (443)
++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999875432111111222345678999999877666 589999999999999988 778998766555
Q ss_pred HHHHhhc--------CccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 222 LYKKISA--------AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 222 ~~~~i~~--------~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
....+.. .....++..++.+.+|+.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4443311 112334557899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=331.30 Aligned_cols=258 Identities=27% Similarity=0.437 Sum_probs=210.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIF 87 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 87 (443)
.-++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45789999999999999999999999999999999865432 22234678899999999999999999998865 56789
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
++|||+ +++|.+.+.. ..+++..+..++.||++||.|||++||+||||+|.||+++.++.++|+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 999998 5688777653 5689999999999999999999999999999999999999999999999999874322
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc-------------------
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------------- 228 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------- 228 (443)
......+++.|+|||.+.+....+.++||||+||++|+|++|.+||...+....+..+..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 223456788999999986634445899999999999999999999987654322211110
Q ss_pred -----C--ccCC-----CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 229 -----A--EFTC-----PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 229 -----~--~~~~-----~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
. .... .+.++..++++|++||+.+|.+|||+++++.||||.....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 0 0011 13467899999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=315.11 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=211.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 86 (443)
..++..+.+..||.|+.|.|++++.+.+|...|||.+.+.. +.+..+++.+.+.++...+ +|+||+.+++|-.+..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 34556667788999999999999999999999999998654 3445678888888887775 89999999999999999
Q ss_pred EEEEeccCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 87 FIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~--~~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
+|.||.+.. -++++. -.++++|..+-++...+++||.||..+ ||+|||+||+|||+|+.|++|+||||+|...-.
T Consensus 167 ~IcMelMs~--C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELMST--CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHH--HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 999999854 233332 246799999999999999999999865 899999999999999999999999999875432
Q ss_pred ccCCCccccccCCCcccchhhhcc---CCCCCCchhhhhhhHHHHHHhhCCCCCCCCc-HHHHHHHhhcCccCC-CC--C
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAAEFTC-PP--W 236 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~~~-~~--~ 236 (443)
........|.+.|||||.+.- ..|+ .++||||||+.|++|.||+.||.+-+ ..+...++...+.+. |. .
T Consensus 245 ---SkAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~g 320 (391)
T KOG0983|consen 245 ---SKAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMG 320 (391)
T ss_pred ---ccccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccC
Confidence 233445679999999999853 3465 88999999999999999999999844 345566666554432 22 3
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+|+.+.+|+..||.+|+.+||...++|+|||+..
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 8999999999999999999999999999999875
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=317.66 Aligned_cols=244 Identities=25% Similarity=0.458 Sum_probs=210.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
...+|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 3568999999999999999999874 78899999975432 35678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-- 155 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-- 155 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc--
Confidence 999999999999997765 6999999999999999999999999999999999999999999999999998754221
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (443)
.....++..|+|||.+....+ +.++||||||+++|+|++ |..||...+.......+... ....|..+++.+.++
T Consensus 156 ---~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05039 156 ---QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV 231 (256)
T ss_pred ---cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHH
Confidence 112334567999999876655 478999999999999997 99999888777766665544 334556688999999
Q ss_pred HHHhcCCCCCCCCChhhhhc
Q 013407 245 IARILDPNPMTRITIPEILE 264 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~ 264 (443)
|.+||..+|++|||+.++++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=322.06 Aligned_cols=253 Identities=28% Similarity=0.503 Sum_probs=212.9
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhh--hHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+|.+.+.||+|+||.||++.+..++..+++|++...... .......+.+|+.+++.++||||+++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999887777778776543221 122234677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|||+++++|.+.+.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999888753 356999999999999999999999999999999999999975 6799999999875432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKL 244 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~l 244 (443)
.........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+..+.. ..+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 12223345688999999998776665 789999999999999999999988777666666655433 3455688999999
Q ss_pred HHHhcCCCCCCCCChhhhhcCccc
Q 013407 245 IARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=325.92 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=203.7
Q ss_pred ccEEEEeEeeccCcEEEEEEEECC----------------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcc
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSE----------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv 74 (443)
++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 579999999999999999986432 34469999987542 233456789999999999999999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEE
Q 013407 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (443)
Q Consensus 75 ~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIL 143 (443)
++++++.+.+..|++|||+.+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999987642 3667789999999999999999999999999999999
Q ss_pred EccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh--CCCCCCCCcHHH
Q 013407 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNLMN 221 (443)
Q Consensus 144 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~--G~~Pf~~~~~~~ 221 (443)
++.++.++|+|||++................+++.|+|||......+ +.++|||||||++|+|++ |..||...+..+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999875432211111222344678999998876665 589999999999999998 789998766555
Q ss_pred HHHHhh--------cCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 222 LYKKIS--------AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 222 ~~~~i~--------~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
...... ....+.+..++..+.+|+.+||+.||.+|||+.++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 443321 1123345567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.54 Aligned_cols=243 Identities=24% Similarity=0.452 Sum_probs=206.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEE-EeCCEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM-GSKTKIF 87 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~ 87 (443)
...+|++.+.||+|+||.||++... |..||+|.+.... ..+.+.+|+.++++++||||+++++++ ...+..|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 4568999999999999999999864 7789999986432 245688999999999999999999875 4567899
Q ss_pred EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
++|||+++++|.+.+...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 155 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence 9999999999999987644 4889999999999999999999999999999999999999999999999998743221
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
.....++..|+|||++.+..+. .++|||||||++|+|++ |.+||...+.......+..+ ....++.+++.+.+
T Consensus 156 ----~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05082 156 ----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYD 230 (256)
T ss_pred ----CCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 1233456789999999876664 78999999999999997 99999988777776666554 23445668999999
Q ss_pred HHHHhcCCCCCCCCChhhhhc
Q 013407 244 LIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~ 264 (443)
++.+||..+|++|||+.++++
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=319.62 Aligned_cols=248 Identities=23% Similarity=0.377 Sum_probs=206.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.++++++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 3468999999999999999999875 5567999998764432 246889999999999999999999885 456899
Q ss_pred EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+|||+.+++|.+.+... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999998753 4589999999999999999999999999999999999999999999999999875432111
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (443)
.......++..|+|||.+.+..+ +.++||||||+++|+|++ |.+||.+.+..+....+... ..+.+...+..+.+|
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 11112235567999999876665 488999999999999999 99999887777766666544 344566688999999
Q ss_pred HHHhcCCCCCCCCChhhhhc
Q 013407 245 IARILDPNPMTRITIPEILE 264 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~ 264 (443)
+.+||..||++|||++++.+
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=324.99 Aligned_cols=252 Identities=32% Similarity=0.519 Sum_probs=210.9
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998654 2223346778899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 93 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
+.+ +|.+.+... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++...... .....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence 984 899999876 57999999999999999999999999999999999999999999999999998754332 11223
Q ss_pred cccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------------------ccCC
Q 013407 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------EFTC 233 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~~~ 233 (443)
...++..|+|||.+.+....+.++||||+||++|+|++|.+||...+......++... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 3456788999999876634468899999999999999999999887655444333210 0001
Q ss_pred C-----------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 234 P-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 234 ~-----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+ +.++..+.++|++||..||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=324.25 Aligned_cols=250 Identities=32% Similarity=0.480 Sum_probs=207.0
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEe
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 91 (443)
|++.+.||+|++|.||+|....+++.||||.+....... ......+|+..+++++ ||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 688999999999999999999899999999986543211 1223457899999998 9999999999999999999999
Q ss_pred ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|+ +|+|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---CC
Confidence 99 789999887754 7899999999999999999999999999999999999999999999999998754321 22
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC-------------------c
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------E 230 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 230 (443)
.....|+..|+|||++.+....+.++|+||+|+++++|++|.+||...+..+...++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999999865444458899999999999999999999877655444332110 0
Q ss_pred cC-----------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 231 FT-----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 231 ~~-----------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
.. ..+..+..+.++|++||..||.+|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 012236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=340.22 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=208.9
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVM 80 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 80 (443)
....++|.+++.||+|+||.||+|++. .+++.||+|++..... ....+.+.+|+.++.++. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 345567889999999999999999864 3456899999975432 223457889999999997 99999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhCC------------------------------------------------------
Q 013407 81 GSKTKIFIVLEFVTGGELFDKIVNHG------------------------------------------------------ 106 (443)
Q Consensus 81 ~~~~~~~lv~E~~~gg~L~~~i~~~~------------------------------------------------------ 106 (443)
.+.+..|+||||+.+|+|.+++...+
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999986432
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcE
Q 013407 107 --------------------------------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (443)
Q Consensus 107 --------------------------------------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 142 (443)
.++...++.++.||+.||.|||+.|++||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256677888999999999999999999999999999
Q ss_pred EEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHH
Q 013407 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (443)
Q Consensus 143 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~ 221 (443)
|++.++.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999999875432111111223457889999999987666 488999999999999998 899998755444
Q ss_pred H-HHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 222 L-YKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 222 ~-~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
. ...+..+ ....|..++.++.+|+.+||..+|.+||++.+|+..
T Consensus 350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 3334333 344566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=317.09 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=210.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|+||.||+|.+. ++..||||.+...... .+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 4578999999999999999999975 4577999998754322 3568899999999999999999999999899999
Q ss_pred EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+|||+++++|.+.+.... .++...+..++.|++.|+.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999999997643 689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (443)
.......++..|+|||.+.+..+ +.++||||+|+++|+|++ |+.||.+.+.......+..+ ....+...+..+.++
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11112234568999999987665 588999999999999998 99999888777777776554 334556678999999
Q ss_pred HHHhcCCCCCCCCChhhhhc
Q 013407 245 IARILDPNPMTRITIPEILE 264 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~ 264 (443)
+.+||..+|.+||+++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=316.86 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=206.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 346899999999999999999998655 4599998865432 2356788999999999999999999885 456899
Q ss_pred EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999999999754 3478999999999999999999999999999999999999999999999999875432111
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (443)
.......++..|+|||.+.+..+ +.++||||+|+++|+|++ |.+||.+.........+... ....+...+..+.++
T Consensus 158 -~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 158 -TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred -cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 11122345678999999876665 488999999999999999 99999988777666666544 234456688999999
Q ss_pred HHHhcCCCCCCCCChhhhhc
Q 013407 245 IARILDPNPMTRITIPEILE 264 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~ 264 (443)
+++||..||.+||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.42 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=205.7
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 96 (443)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.++++++||||+++++++.+....|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999977 999999998764432 24567899999999999999999999999999999999999999
Q ss_pred chHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 97 ELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 97 ~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999865 35689999999999999999999999999999999999999999999999999875432111111112234
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNP 253 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP 253 (443)
+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+... ....|...+..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999877665 488999999999999998 89999887776666666544 334556688999999999999999
Q ss_pred CCCCChhhhhc
Q 013407 254 MTRITIPEILE 264 (443)
Q Consensus 254 ~~R~t~~eil~ 264 (443)
.+|||+.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=315.60 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=210.8
Q ss_pred EEEeEeeccCcEEEEEEEECCCC----ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 14 EVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
++.+.||.|+||.||+|.+..++ ..||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 56789999999999999998766 8899999965432 22457889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 90 LEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
|||+++++|.+.+..... +++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999999876544 999999999999999999999999999999999999999999999999998765432111
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLI 245 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 245 (443)
. .....+++.|+|||.+.+..+ +.++||||+|+++|+|++ |.+||...+.....+.+.... ...+...+..+.+++
T Consensus 160 ~-~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (258)
T smart00219 160 K-KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM 237 (258)
T ss_pred c-cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 1 111236789999999866555 489999999999999998 899999888777777766554 345566899999999
Q ss_pred HHhcCCCCCCCCChhhhhc
Q 013407 246 ARILDPNPMTRITIPEILE 264 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~ 264 (443)
.+||..||.+|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHCcCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=320.32 Aligned_cols=254 Identities=19% Similarity=0.281 Sum_probs=210.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECC----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSE----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS- 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 82 (443)
..-++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999876 35789999886432 23345778899999999999999999998755
Q ss_pred CCEEEEEEeccCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEee
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNH--------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSD 154 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~D 154 (443)
....++++||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 57789999999999999998653 3589999999999999999999999999999999999999999999999
Q ss_pred cCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cC
Q 013407 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FT 232 (443)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~ 232 (443)
||+++...............++..|+|||.+.+..+. .++|||||||++|++++ |.+||...+..+....+..+. ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 9998754321111111223456789999999876664 88999999999999998 999999887777766665542 34
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 233 CPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 233 ~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+..+++.+.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 45567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=317.12 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=209.8
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCc---eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
...|+..+.||+|+||.||+|.+..++. .+|+|.+..... ....+.+.+|+++++.++||||+++.+++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4578999999999999999999876654 699999865422 22356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999998653 578999999999999999999999999999999999999999999999999987543321
Q ss_pred CCCcc-ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHH
Q 013407 166 DDGLL-HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTAR 242 (443)
Q Consensus 166 ~~~~~-~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 242 (443)
..... .....++.|+|||.+....+ +.++||||+||++|+|++ |..||...+.......+..+. .+.+...+..+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 11223457999999987666 488999999999999997 999998877777777665542 233344788999
Q ss_pred HHHHHhcCCCCCCCCChhhhhc
Q 013407 243 KLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~ 264 (443)
+++.+||..+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.66 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=201.0
Q ss_pred eEeeccCcEEEEEEEECCCCc--eEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEecc
Q 013407 17 RTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFV 93 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 93 (443)
+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++...+..|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988775 46888876422 223356788999999999 8999999999999999999999999
Q ss_pred CCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 94 TGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 94 ~gg~L~~~i~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999987543 478899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCC
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPP 235 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~ 235 (443)
+....... .......+..|+|||++....+ +.++|||||||++|+|++ |..||.+.+....+..+.... ...+.
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 85322110 1112234567999999877665 488999999999999997 999998887777776665542 34455
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
..+.++.+|+.+||..||.+|||+++++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 57899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.99 Aligned_cols=243 Identities=23% Similarity=0.355 Sum_probs=201.5
Q ss_pred EeeccCcEEEEEEEEC--CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013407 18 TIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (443)
Q Consensus 18 ~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 95 (443)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999875 345679999986543 2334567899999999999999999999886 4578999999999
Q ss_pred CchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC-ccccc
Q 013407 96 GELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTT 173 (443)
Q Consensus 96 g~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 173 (443)
++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999998874 4578999999999999999999999999999999999999999999999999987543221111 11112
Q ss_pred cCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCC
Q 013407 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDP 251 (443)
Q Consensus 174 ~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~ 251 (443)
.+++.|+|||.+....+ +.++|||||||++|+|++ |..||.+.........+..+ ....|+..++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23578999999877665 478999999999999996 99999988777766666554 3556777899999999999999
Q ss_pred CCCCCCChhhhhc
Q 013407 252 NPMTRITIPEILE 264 (443)
Q Consensus 252 dP~~R~t~~eil~ 264 (443)
||++||++.++.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=317.15 Aligned_cols=247 Identities=22% Similarity=0.364 Sum_probs=207.0
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
-+.|++++.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++||||+++++++. .+..|++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 467999999999999999999875 5678999998754432 346888999999999999999999874 5578999
Q ss_pred EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
|||+.+++|.+.+... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-Y 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-c
Confidence 9999999999998653 468999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 245 (443)
.......++..|+|||.+....+ +.++||||+|+++|+|++ |.+||.+.+.......+..+ ....+...+.++.+++
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM 236 (260)
T ss_pred ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11122345678999999877665 488999999999999998 99999988777776666544 2344556788999999
Q ss_pred HHhcCCCCCCCCChhhhhc
Q 013407 246 ARILDPNPMTRITIPEILE 264 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~ 264 (443)
.+||..+|++|||+++++.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHccCChhhCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=316.11 Aligned_cols=244 Identities=27% Similarity=0.446 Sum_probs=205.4
Q ss_pred eEeeccCcEEEEEEEECC-CCc--eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 013407 17 RTIGEGTFAKVKFARNSE-TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 93 (443)
+.||+|++|.||+|.+.. .++ .||||.+...... ...+.+.+|+.++++++||||+++++++.+ ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999875543 456789999999999999999999999988 8999999999
Q ss_pred CCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC-Ccc
Q 013407 94 TGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLL 170 (443)
Q Consensus 94 ~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~ 170 (443)
++++|.+.+.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999997754 6899999999999999999999999999999999999999999999999998765432111 111
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHHHHHH
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~ 247 (443)
....++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+..+....+... ....+...+..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234577899999998876664 78999999999999998 99999887777666655432 233445578999999999
Q ss_pred hcCCCCCCCCChhhhhc
Q 013407 248 ILDPNPMTRITIPEILE 264 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~ 264 (443)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=321.47 Aligned_cols=239 Identities=23% Similarity=0.316 Sum_probs=197.6
Q ss_pred eEeeccCcEEEEEEEECCCCc-------eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 17 RTIGEGTFAKVKFARNSETGE-------PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~-------~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+.||+|+||.||+|.+...+. .+|+|.+.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999866544 38888876432 23456788899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC--------eEEeecCcccc
Q 013407 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--------LKVSDFGLSAL 160 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~--------~kl~DFGla~~ 160 (443)
|||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987765 69999998764
Q ss_pred cccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhC-CCCCCCCcHHHHHHHhhcCccCCCCCCCH
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAEFTCPPWLSF 239 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 239 (443)
... .....+++.|+|||++.+....+.++||||+||++|+|++| .+||...+...... ........|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcH
Confidence 321 23456889999999998655446889999999999999998 57776655443322 23344556666778
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 240 TARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
++.+|+.+||+.||++|||++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=342.70 Aligned_cols=254 Identities=27% Similarity=0.516 Sum_probs=220.7
Q ss_pred ccEEE-EeEeeccCcEEEEEEEECCCCceEEEEEeechhh-hhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE--E
Q 013407 11 GKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK--I 86 (443)
Q Consensus 11 ~~y~~-~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--~ 86 (443)
++|-- ...||+|+|-+||+|.|..+|-.||---+....+ ..+...+++..|+.+|+.|+|||||++|+.|.+..+ +
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 44433 3579999999999999999999998655544333 344567899999999999999999999999987655 8
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeeCCCCcEEEccC-CCeEEeecCccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQ 163 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 163 (443)
.+|+|++.+|+|..++.+.+.++...++.|++||+.||.|||++. |+|||||-+||+|+.+ |.+||+|+|||++.+.
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 899999999999999999999999999999999999999999995 9999999999999876 8999999999998654
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCC-CcHHHHHHHhhcCccCC--CCCCCHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTC--PPWLSFT 240 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~--~~~~s~~ 240 (443)
. ......|||.|||||++. ..|+ ..+||||||+.+.||.|+..||.. .+..++|+++..|..+- ..--.++
T Consensus 199 s----~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 199 S----HAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred c----ccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 2 233478999999999997 4676 899999999999999999999974 67789999998885432 2224789
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
++++|.+||.. .+.|+|+.|+|.||||..+
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999999 9999999999999999975
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=317.42 Aligned_cols=229 Identities=29% Similarity=0.429 Sum_probs=194.0
Q ss_pred cCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHH
Q 013407 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK 101 (443)
Q Consensus 22 G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 101 (443)
|++|.||+|.+..+++.||+|.+.+... ..+|...+....||||+++++++.+....|++|||++||+|.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976431 22344445556799999999999999999999999999999999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccc
Q 013407 102 IVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181 (443)
Q Consensus 102 i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 181 (443)
+.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+..... ......++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 98888899999999999999999999999999999999999999999999999998764332 1223456788999
Q ss_pred hhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCh--
Q 013407 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI-- 259 (443)
Q Consensus 182 PEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~-- 259 (443)
||.+....+ +.++|+||+|+++|+|++|..||....... -.......|+++++.++++|.+||+.||++||++
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876666 478999999999999999999886432210 0112345678899999999999999999999996
Q ss_pred ---hhhhcCccc
Q 013407 260 ---PEILEDEWF 268 (443)
Q Consensus 260 ---~eil~hp~~ 268 (443)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=319.45 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=211.5
Q ss_pred ccEEEEeEeeccCcEEEEEEEECC-----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.+|++.+.||.|+||.||+|+.+. +.+.||+|.+.... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 679999999999999999999754 34679999886533 22245678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecC
Q 013407 86 IFIVLEFVTGGELFDKIVNHG---------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~---------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFG 156 (443)
.|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999997655 68999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCcc--CC
Q 013407 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF--TC 233 (443)
Q Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~ 233 (443)
++...... .........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+.. ..
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 97643211 1112223456778999999876665 488999999999999998 8999988777777666665543 33
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 234 PPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 234 ~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+..++..+.+++.+||..||.+|||+.+++.+
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 45588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=322.51 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=209.9
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (443)
......++.|++.+.||+|++|.||+|.+..+++.||||.+.+.... .....+.+|+.++... .||||+++++++.+
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 34456788999999999999999999999988999999999754322 2234556677766666 59999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
....|++|||+.+ .|.+.+.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 86 DSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred CCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999999999864 66666554 4578999999999999999999997 5999999999999999999999999999865
Q ss_pred cccccCCCccccccCCCcccchhhhccCC---CCCCchhhhhhhHHHHHHhhCCCCCCCCcH-HHHHHHhhcCc-cCCCC
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAE-FTCPP 235 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~-~~~~~ 235 (443)
.... .......|++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... .+....+.... ...+.
T Consensus 165 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 165 LVDS---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241 (296)
T ss_pred ccCC---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence 4321 1122345788999999986542 234789999999999999999999976432 23343433332 22222
Q ss_pred --CCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 236 --WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 236 --~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.++.++.+|+.+||..||.+|||+++++.||||...
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 368899999999999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=341.06 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=216.0
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...+...++..||+|.||+||+|++-. .||||+++...... +..+.+++|+..+++-+|.||+-+.|++..... .
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 455667888999999999999999865 39999998766544 478999999999999999999999999987776 9
Q ss_pred EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
||+-+|+|-+|+.++.- ...+.....+.|++||++|+.|||.++|+|||||..||++.+++.|||+||||++.......
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999999999854 34688889999999999999999999999999999999999999999999999987665555
Q ss_pred CCccccccCCCcccchhhhccC--CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC-----CCCCH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-----PWLSF 239 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~ 239 (443)
........|...|||||++... ..+++.+||||+|||+|||++|.+||...+..+++-.+..|..... ...+.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence 5566777899999999998632 2335899999999999999999999997776666555555533221 23567
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 240 TARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
++++|+..||..+|++||++.+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999999986
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=319.60 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=199.7
Q ss_pred ccE-EEEeEeeccCcEEEEEEE----ECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--C
Q 013407 11 GKY-EVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--K 83 (443)
Q Consensus 11 ~~y-~~~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 83 (443)
++| ++.+.||+|+||+||++. ...++..||+|++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 566 899999999999998865 345678899999875422 2234567889999999999999999998765 3
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..+|++|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 468999999999999999876 4699999999999999999999999999999999999999999999999999876433
Q ss_pred ccCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH--HH-------------HHHhh
Q 013407 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM--NL-------------YKKIS 227 (443)
Q Consensus 164 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~-------------~~~i~ 227 (443)
.... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... .. ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 2111 11122345678999999877666 48899999999999999999998654311 11 11111
Q ss_pred cC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 228 AA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 228 ~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+ ..+.+..++..+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 22345567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=311.13 Aligned_cols=243 Identities=25% Similarity=0.429 Sum_probs=203.2
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 96 (443)
+.||+|+||.||+|... ++..+|+|.+..... ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999864 678899999875432 223456889999999999999999999999999999999999999
Q ss_pred chHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccC
Q 013407 97 ELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (443)
Q Consensus 97 ~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (443)
+|.+++... ..+++..+..++.|++.||.|+|++|++||||||+||+++.++.+||+|||++....... ........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 999988653 468999999999999999999999999999999999999999999999999986432211 111112234
Q ss_pred CCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCC
Q 013407 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNP 253 (443)
Q Consensus 176 t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP 253 (443)
+..|+|||++.+..+ +.++||||+|+++|++++ |..||.+.........+..+ ....+..++..+.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 667999999876655 478999999999999998 99999887776666666544 335566789999999999999999
Q ss_pred CCCCChhhhhc
Q 013407 254 MTRITIPEILE 264 (443)
Q Consensus 254 ~~R~t~~eil~ 264 (443)
.+||++.++++
T Consensus 236 ~~Rp~~~~l~~ 246 (250)
T cd05085 236 ENRPKFSELQK 246 (250)
T ss_pred ccCCCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=315.81 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=208.5
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCC---CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.-.+|.+.+.||+|+||.||+|.+... ...||||....... ....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 345799999999999999999987543 34689998865432 2345678999999999999999999999875 45
Q ss_pred EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999997644 5899999999999999999999999999999999999999999999999998754322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (443)
.. .......+++.|+|||.+....+. .++||||||+++|+|++ |..||.+.+..+....+..+ ....|+.++..+.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 11 111122345689999998776664 88999999999999986 99999988777666666554 3455677899999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcC
Q 013407 243 KLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~h 265 (443)
+++.+|+..+|.+|||+.+++..
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.81 Aligned_cols=247 Identities=21% Similarity=0.393 Sum_probs=197.3
Q ss_pred CcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHH
Q 013407 23 TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI 102 (443)
Q Consensus 23 ~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i 102 (443)
++|.||.+++..+++.||||++..... .......+.+|+.+++.++||||+++++++.+....|++|||+.+|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445566666667899999999976532 2334678999999999999999999999999999999999999999999998
Q ss_pred HhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC-----CCccccccC
Q 013407 103 VNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLLHTTCG 175 (443)
Q Consensus 103 ~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-----~~~~~~~~g 175 (443)
... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+........ ........+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 753 4689999999999999999999999999999999999999999999999998764322111 111233457
Q ss_pred CCcccchhhhccC--CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHH-HHHhhcCc----------------------
Q 013407 176 TPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL-YKKISAAE---------------------- 230 (443)
Q Consensus 176 t~~y~APEvl~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~-~~~i~~~~---------------------- 230 (443)
+..|+|||++... .+ +.++|+||+||++|+|++|..||........ .+++....
T Consensus 171 ~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 171 NLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred cccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 8899999998653 34 4789999999999999999999987554322 22221100
Q ss_pred -----------cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 231 -----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 231 -----------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
...+..++.++.+|+.+||..||++|||++++++||||+.-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00011235678999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=312.74 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=209.8
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
..+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 468999999999999999999885 4678999998754332 24678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||+.+++|.+++... +.++++.++.++.|++.|+.|||+.|++||||||+||+++.++.++|+|||++........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence 9999999999998764 4689999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 246 (443)
......++..|+|||.+.+..+. .++||||||+++|+|++ |..||.........+.+..+. ...|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 11122345689999999876664 78999999999999998 999999888777777766553 3345557899999999
Q ss_pred HhcCCCCCCCCChhhhhcC
Q 013407 247 RILDPNPMTRITIPEILED 265 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~h 265 (443)
+||..+|++|||+.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=316.06 Aligned_cols=239 Identities=22% Similarity=0.291 Sum_probs=194.2
Q ss_pred eEeeccCcEEEEEEEECCC------------CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 17 RTIGEGTFAKVKFARNSET------------GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~------------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
+.||+|+||.||+|..... ...||+|++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999985322 2358899876532 234567888999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC-------eEEeecC
Q 013407 85 KIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-------LKVSDFG 156 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~-------~kl~DFG 156 (443)
..+++|||+.+|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888865 356899999999999999999999999999999999999987664 8999999
Q ss_pred cccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHh-hCCCCCCCCcHHHHHHHhhcCccCCCC
Q 013407 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKISAAEFTCPP 235 (443)
Q Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 235 (443)
++..... .....|+..|+|||.+......+.++||||+||++|+|+ .|..||......+.. ...........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 8764321 123457889999999875444468899999999999997 599999876544332 22333333334
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..+.++.+||.+||+.||.+||++.+|+.+
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=322.63 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=207.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCc----eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
..++|+..+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 34678999999999999999999877776 468888865332 22334688999999999999999999998754
Q ss_pred EEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..++++||+++|+|.+.+.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4679999999999999987654 689999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (443)
...........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+ .+..++..+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 222112223445778999999877666 488999999999999997 99999887655554444433 234455678999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcC
Q 013407 242 RKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+++.+|+..+|++||++.++++.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=319.03 Aligned_cols=238 Identities=24% Similarity=0.292 Sum_probs=193.3
Q ss_pred EeeccCcEEEEEEEECC------------------------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCc
Q 013407 18 TIGEGTFAKVKFARNSE------------------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73 (443)
Q Consensus 18 ~LG~G~~g~V~~a~~~~------------------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 73 (443)
.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 59999999999987432 12358999986543 2234578889999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC----
Q 013407 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---- 148 (443)
Q Consensus 74 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---- 148 (443)
+++++++.+....|+||||+++|+|...+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999988865 46789999999999999999999999999999999999998654
Q ss_pred ---CeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHh-hCCCCCCCCcHHHHHH
Q 013407 149 ---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYK 224 (443)
Q Consensus 149 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll-~G~~Pf~~~~~~~~~~ 224 (443)
.+|++|||++..... .....++..|+|||.+.+....+.++||||+||++|+|+ +|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998753211 122357889999999876444468999999999999985 7999998766544322
Q ss_pred HhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 225 KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 225 ~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.. ......|...++.+.++|.+||+.+|.+|||+.+++++
T Consensus 233 ~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FY-EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22 22334445567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=317.33 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=202.9
Q ss_pred eEeeccCcEEEEEEEECCCC------ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 17 RTIGEGTFAKVKFARNSETG------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
+.||+|+||.||+|.+.... ..+|+|.+.+... ......+.+|+.+++.++||||+++++++.+....|++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986543 6799998865321 223457888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-----CeEEeecCcc
Q 013407 91 EFVTGGELFDKIVNH-------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-----NLKVSDFGLS 158 (443)
Q Consensus 91 E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-----~~kl~DFGla 158 (443)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++++|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 3478899999999999999999999999999999999999887 8999999998
Q ss_pred cccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCC
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPW 236 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 236 (443)
................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 75432211111223345788999999987666 589999999999999998 99999887776666665443 3455667
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
++..+.++|.+||..+|.+||+++++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=359.19 Aligned_cols=257 Identities=32% Similarity=0.534 Sum_probs=208.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEE-------
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM------- 80 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~------- 80 (443)
+-...|+.++.||+||||.||+++++-+|..||||.|.... .......+.+|+..+.+|+|||||++|..|
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 35567788899999999999999999999999999998765 333467899999999999999999998532
Q ss_pred --------------------------------------------------E---------------------e-------
Q 013407 81 --------------------------------------------------G---------------------S------- 82 (443)
Q Consensus 81 --------------------------------------------------~---------------------~------- 82 (443)
. +
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0 0
Q ss_pred --------------------------C--------CEEEEEEeccCCCchHHHHHhCCCC-CHHHHHHHHHHHHHHHHHH
Q 013407 83 --------------------------K--------TKIFIVLEFVTGGELFDKIVNHGRM-KEDEARRYFQQLINAVDYC 127 (443)
Q Consensus 83 --------------------------~--------~~~~lv~E~~~gg~L~~~i~~~~~l-~e~~~~~~~~qi~~aL~~L 127 (443)
+ ..+||-||||+...|.+.|..+... ..+.++++|+||++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 2379999999987777777665544 4788999999999999999
Q ss_pred HHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc----c------------ccCCCccccccCCCcccchhhhccCC--
Q 013407 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ----Q------------VRDDGLLHTTCGTPNYVAPEVLNDRG-- 189 (443)
Q Consensus 128 H~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~APEvl~~~~-- 189 (443)
|+.|++||||||.||++|+++++||+|||+|+... . .......+...||..|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999998621 0 01122445678999999999997665
Q ss_pred -CCCCchhhhhhhHHHHHHhhCCCCCCC-CcHHHHHHHhhcCccCCCCC----CCHHHHHHHHHhcCCCCCCCCChhhhh
Q 013407 190 -YDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW----LSFTARKLIARILDPNPMTRITIPEIL 263 (443)
Q Consensus 190 -~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~----~s~~~~~li~~mL~~dP~~R~t~~eil 263 (443)
|+ .|+|+|||||||+||+. ||.- .........+..+.++.|+. --+....+|+.||+.||++|||+.|+|
T Consensus 794 ~Yn-~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 794 KYN-SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccc-chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 65 99999999999999984 5643 23334556666677766632 235678999999999999999999999
Q ss_pred cCccccc
Q 013407 264 EDEWFKK 270 (443)
Q Consensus 264 ~hp~~~~ 270 (443)
++.||..
T Consensus 870 ~s~llpp 876 (1351)
T KOG1035|consen 870 NSELLPP 876 (1351)
T ss_pred hccCCCc
Confidence 9999863
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=315.21 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=192.0
Q ss_pred eEeeccCcEEEEEEEECC--CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013407 17 RTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 94 (443)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 369999999999996533 44578888875432 22234567889999999999999999999999999999999999
Q ss_pred CCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 95 GGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 95 gg~L~~~i~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
+|+|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999987643 246788899999999999999999999999999999999999999999999864322111111
Q ss_pred cccccCCCcccchhhhccC------CCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHh-hcCccC-----CCCC
Q 013407 170 LHTTCGTPNYVAPEVLNDR------GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFT-----CPPW 236 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~------~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i-~~~~~~-----~~~~ 236 (443)
.....+++.|+|||++... ...+.++||||+||++|+|++ |.+||......+..... ...... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233456789999997532 233578999999999999999 88999877655544433 333222 2234
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
++....+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888899999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=318.14 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=201.5
Q ss_pred cEEEEeEeeccCcEEEEEEEE----CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CE
Q 013407 12 KYEVGRTIGEGTFAKVKFARN----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TK 85 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 85 (443)
-|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 368899999999999999974 4578899999986543 223356799999999999999999999998775 67
Q ss_pred EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.|+||||++|++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999998664 35899999999999999999999999999999999999999999999999998765332
Q ss_pred cCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH---------------HHHHHHhhc
Q 013407 165 RDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---------------MNLYKKISA 228 (443)
Q Consensus 165 ~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---------------~~~~~~i~~ 228 (443)
... .......|+..|+|||++.+..+. .++||||+||++|+|+++..|+..+.. ......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 111 112234567789999998876664 889999999999999998776532210 111111222
Q ss_pred C-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 229 A-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 229 ~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+ ..+.+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2 233445588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=335.32 Aligned_cols=249 Identities=27% Similarity=0.429 Sum_probs=212.9
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCc---e-EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGE---P-VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~---~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
+-.+.+.||+|+||.||+|..+..+. . ||||....+..........+.+|.++|++++|||||++||+...+..+|
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 44556899999999999998765322 3 8999987644445556788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+|||+|+||+|.+++.+.+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+|+.....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~-- 315 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY-- 315 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce--
Confidence 9999999999999999887 4999999999999999999999999999999999999999999999999998743211
Q ss_pred CCcccccc-CCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc--cCCCCCCCHHHH
Q 013407 167 DGLLHTTC-GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTAR 242 (443)
Q Consensus 167 ~~~~~~~~-gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~ 242 (443)
......+ -...|+|||.+....| +.++||||+||++||+++ |..||.+....+...+|.... .+.|+..+..+.
T Consensus 316 -~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 316 -VMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred -eeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 1111111 3457999999987766 599999999999999998 899999999999999985443 355666888999
Q ss_pred HHHHHhcCCCCCCCCChhhhhc
Q 013407 243 KLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~ 264 (443)
.++.+|+..||+.|||+.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 9999999999999999999865
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=311.10 Aligned_cols=242 Identities=26% Similarity=0.452 Sum_probs=204.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.+++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 457899999999999999999864 67889999986432 235688999999999999999999998654 4799
Q ss_pred EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+|||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997643 5899999999999999999999999999999999999999999999999998753221
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 244 (443)
......+..|+|||.+.+..+ +.++|+||+||++|+|++ |.+||...+.......+..+. ...+..++..+.++
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 122334568999999876665 488999999999999997 999999888777666665542 33445578999999
Q ss_pred HHHhcCCCCCCCCChhhhhc
Q 013407 245 IARILDPNPMTRITIPEILE 264 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~ 264 (443)
+.+||+.+|.+||++++++.
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=310.17 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=207.2
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.+++.++|+||+++++++.+ ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 34678999999999999999999865 456699998865321 24578899999999999999999999887 7889
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
++|||+++++|.+++... ..++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999763 357888899999999999999999999999999999999999999999999987543211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 243 (443)
........++..|+|||++....+ +.++|+|||||++|++++ |..||.+.+.......+..+. ...+...+.++.+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 157 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234 (260)
T ss_pred -cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence 111122335667999999976655 478999999999999998 999999887776666665442 3445568899999
Q ss_pred HHHHhcCCCCCCCCChhhhhc
Q 013407 244 LIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~ 264 (443)
++.+||+.+|++||++.++++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=313.99 Aligned_cols=245 Identities=20% Similarity=0.243 Sum_probs=192.8
Q ss_pred eEeeccCcEEEEEEEEC--CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013407 17 RTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 94 (443)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 3556799998865432 1223568889999999999999999999999999999999999
Q ss_pred CCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 95 GGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 95 gg~L~~~i~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
+|+|.+++.... ..++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999986532 456778889999999999999999999999999999999999999999999864322111111
Q ss_pred cccccCCCcccchhhhccCC------CCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHH-hhcCccCC--C---CC
Q 013407 170 LHTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKK-ISAAEFTC--P---PW 236 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~------~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~-i~~~~~~~--~---~~ 236 (443)
.....|++.|+|||++.+.. ..+.++||||+|+++|+|++ |..||......+.... +....... | ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22346788899999986432 12578999999999999996 9999987665544332 22222211 1 23
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+..+.+++++|+ .+|++|||+++++.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=314.52 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=204.7
Q ss_pred EEEEeEeeccCcEEEEEEEECC---CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----
Q 013407 13 YEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----- 84 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 84 (443)
|++.+.||+|+||.||+|.... ++..||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998643 578899999965432 2334567889999999999999999999875432
Q ss_pred -EEEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 85 -KIFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 85 -~~~lv~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
..++++||+.+|+|.+.+... ..++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347899999999998876432 2478999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCC
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPP 235 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 235 (443)
+................+++.|++||.+....+. .++|||||||++|+|++ |.+||.+.+..+.+..+... ....++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8754321111111233456789999999876664 78999999999999999 99999888777766665544 345566
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..+..+.+++.+||+.+|+.|||+.+++.+
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=314.51 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=199.7
Q ss_pred ccEEEEeEeeccCcEEEEEEE----ECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 013407 11 GKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KT 84 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 84 (443)
.+|++.+.||+|+||.||+|. +..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 478999999999999999997 34578899999986543 2335678899999999999999999998643 45
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
.+|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 789999999999999998764 4689999999999999999999999999999999999999999999999999886432
Q ss_pred ccCCCc-cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHH----------------HHHHh
Q 013407 164 VRDDGL-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----------------LYKKI 226 (443)
Q Consensus 164 ~~~~~~-~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~----------------~~~~i 226 (443)
...... .....++..|+|||.+.+..+ +.++||||+||++|+|++|..|+....... +...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 211100 111223456999999987666 488999999999999999987765432211 11111
Q ss_pred hcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 227 SAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 227 ~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
... .++.+..++.++.+|+.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 23344568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=310.11 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=198.4
Q ss_pred eEeeccCcEEEEEEEECC---CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCCEEEEEEec
Q 013407 17 RTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-SKTKIFIVLEF 92 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lv~E~ 92 (443)
+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998753 34579999985422 2234567889999999999999999999765 45678999999
Q ss_pred cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC--CCc
Q 013407 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGL 169 (443)
Q Consensus 93 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--~~~ 169 (443)
+.+|+|.+++... ...+...+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++........ ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999998764 3467788889999999999999999999999999999999999999999999874322110 011
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIAR 247 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 247 (443)
.....+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+....+..+. ...+..++..+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 123345778999999877666 488999999999999999 577888777666666655543 33445578899999999
Q ss_pred hcCCCCCCCCChhhhhcC
Q 013407 248 ILDPNPMTRITIPEILED 265 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~h 265 (443)
||..+|++||++.+++..
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.08 Aligned_cols=236 Identities=21% Similarity=0.269 Sum_probs=193.4
Q ss_pred eEeeccCcEEEEEEEECCCC----------ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 17 RTIGEGTFAKVKFARNSETG----------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~----------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999998766 3478887754321 14678899999999999999999999887 778
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-------CeEEeecCcc
Q 013407 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-------NLKVSDFGLS 158 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-------~~kl~DFGla 158 (443)
++||||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 799999999999999999999999999999999999999888 7999999998
Q ss_pred cccccccCCCccccccCCCcccchhhhccC-CCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCccCCCCC
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCPPW 236 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (443)
..... .....++..|+|||++.+. ...+.++|||||||++|+|++ |..||...+.......... ....+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCCC
Confidence 75322 2234577889999998765 244588999999999999999 6888877654333222221 1122222
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+..+.++|.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=320.42 Aligned_cols=252 Identities=31% Similarity=0.498 Sum_probs=206.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CC----cceEEEEEEe
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PN----VVRLYEVMGS 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pn----Iv~l~~~~~~ 82 (443)
.-++|++..++|+|+||.|-.+.+..++..||||++.. + ....+..+-|+++++++++ |+ +|++.++|+-
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~--V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN--V--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHH--H--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 35799999999999999999999999999999999853 2 2245667789999999942 33 7788888999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc--------------
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------------- 146 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-------------- 146 (443)
.+..+||+|.+ |-++++++.++. +++.+.++.+.+||+++++|||+.+++|.||||||||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999998 559999998754 6899999999999999999999999999999999999932
Q ss_pred ------CCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH
Q 013407 147 ------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220 (443)
Q Consensus 147 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~ 220 (443)
+..++++|||.|+.-.+ ...+.+.|..|.|||++.+-++. .++||||+||||+|+.+|...|+..+..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred eeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcH
Confidence 23589999999986433 23567789999999999999996 8899999999999999999999875533
Q ss_pred H---HHHHhhcC------------------ccCCCC-------------------------CCCHHHHHHHHHhcCCCCC
Q 013407 221 N---LYKKISAA------------------EFTCPP-------------------------WLSFTARKLIARILDPNPM 254 (443)
Q Consensus 221 ~---~~~~i~~~------------------~~~~~~-------------------------~~s~~~~~li~~mL~~dP~ 254 (443)
+ +.+.|... .+..|. ....++.+||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 3 44443210 111010 0112478999999999999
Q ss_pred CCCChhhhhcCcccccc
Q 013407 255 TRITIPEILEDEWFKKD 271 (443)
Q Consensus 255 ~R~t~~eil~hp~~~~~ 271 (443)
+|+|+.|+|.||||+..
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999853
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=312.79 Aligned_cols=265 Identities=30% Similarity=0.462 Sum_probs=217.5
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----- 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 82 (443)
..++.|+-..+||+|.||+|++|+.+.+|+.||+|++--+. .+++.-....+|+.+|..|+|+|++.+++++.+
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 35678888899999999999999999999999998764322 233445567899999999999999999987743
Q ss_pred ---CCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 83 ---KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 83 ---~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
...+|+||.+|+. +|+-.+... .+++..++..+++++.+||.|+|+..|+|||+||+|+||+.+|.+||+|||++
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 4569999999986 888887654 67999999999999999999999999999999999999999999999999999
Q ss_pred cccccccC--CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc--CccC--
Q 013407 159 ALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFT-- 232 (443)
Q Consensus 159 ~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~-- 232 (443)
+.+..... ....+..+-|.+|.+||.+.+...++++.|||..|||+.+|.+|.+.+.+.+..+....|.. +.+.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 76544221 12234456699999999998877778999999999999999999999998877665554421 1110
Q ss_pred ------------------CC------------CC-CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 233 ------------------CP------------PW-LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 233 ------------------~~------------~~-~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
.| ++ -++++.+|+.+||..||.+|+++++++.|.||.++..|
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 11 01 24578999999999999999999999999999987654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=309.10 Aligned_cols=250 Identities=29% Similarity=0.513 Sum_probs=209.3
Q ss_pred cEEEEeEeeccCcEEEEEEEECC-CCceEEEEEeechhh-------hhHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKV-------LKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGS 82 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 82 (443)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 688999998864321 122334567788888865 799999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
.+..|++|||++|++|.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999887743 3568999999999999999999996 7899999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC-CC-
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PP- 235 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-~~- 235 (443)
+...... .......|+..|+|||.+.+..+ +.++|+||||+++|+|++|.+||...+.......+....... +.
T Consensus 161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 8754332 13345678999999999987665 589999999999999999999998877766666665554332 22
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+++.+.++|.+||+.||++||++.|+.++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=311.59 Aligned_cols=254 Identities=16% Similarity=0.194 Sum_probs=193.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCC---CceEEEEEeechhhh--hHHH------HHHHHHHHHHHhcCCCCCcceE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVL--KHKM------AEQIKREVATMKLVKHPNVVRL 76 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~--~~~~------~~~~~~Ei~il~~l~hpnIv~l 76 (443)
..-++|++.+.||+|+||.||+|.+..+ +..+|+|+....... .+.. ......+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3346899999999999999999998877 667888865432211 0000 0112234445667789999999
Q ss_pred EEEEEeCC----EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEE
Q 013407 77 YEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (443)
Q Consensus 77 ~~~~~~~~----~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl 152 (443)
++.+.... ..++++|++.. ++.+.+......++..+..++.|++.||.|||++||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765443 45788888754 66666665556789999999999999999999999999999999999999999999
Q ss_pred eecCcccccccccC-----CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH-HH-----
Q 013407 153 SDFGLSALSQQVRD-----DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MN----- 221 (443)
Q Consensus 153 ~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~----- 221 (443)
+|||+|+....... ........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+. ..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999976532111 112233579999999999987777 4899999999999999999999987632 11
Q ss_pred ---HHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 222 ---LYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 222 ---~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
....+..+.... +..+..+.+++..|+..+|.+||+++++++
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223333333332 346789999999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=311.14 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=203.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECC----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSE----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KT 84 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 84 (443)
..|++.+.||+|+||.||+|.... +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 568888999999999999998643 4789999999765432 245689999999999999999999999877 66
Q ss_pred EEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..+++|||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 8999999999999999997654 689999999999999999999999999999999999999999999999999886542
Q ss_pred ccCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHH---------------HHHHhh
Q 013407 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---------------LYKKIS 227 (443)
Q Consensus 164 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~---------------~~~~i~ 227 (443)
.... .......++..|+|||.+.+..+ +.++||||+|+++|+|++|..||....... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1111 11112344567999999877665 478999999999999999999987543221 122222
Q ss_pred cC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 228 AA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 228 ~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.. ..+.+..++..+.+++.+||..+|.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 23344557889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.35 Aligned_cols=258 Identities=29% Similarity=0.483 Sum_probs=215.3
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK---- 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 83 (443)
....+|.-++.+|.|+. .|..|.+.-++++||+|.+..+. ......++..+|..++..++|+||++++.++...
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34568999999999999 88899999999999999998774 3344568899999999999999999999998654
Q ss_pred --CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 84 --TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 84 --~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
...|+|||++.. +|...+. -.++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+..
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 458999999975 7777765 45777889999999999999999999999999999999999999999999999753
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------------
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------ 229 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------ 229 (443)
+. +-..+.+..|.+|.|||++.+.+| ...+||||+|||+.+|++|...|.|.+.-+.+.++...
T Consensus 169 ~~---~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 169 DT---DFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred Cc---ccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 32 235667889999999999999886 48899999999999999999999988766655544110
Q ss_pred ------------c---cC----CCC-----------CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 230 ------------E---FT----CPP-----------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 230 ------------~---~~----~~~-----------~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
+ +. +|. .-+..+++|+.+||..||++|++++++|.|||++-++.+
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~ 319 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP 319 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc
Confidence 0 01 111 123468999999999999999999999999999865543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=307.23 Aligned_cols=245 Identities=18% Similarity=0.248 Sum_probs=192.0
Q ss_pred eEeeccCcEEEEEEEECCC--CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013407 17 RTIGEGTFAKVKFARNSET--GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 94 (443)
+.||+|+||.||+|..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 33466777654332 2235678999999999999999999999999999999999999
Q ss_pred CCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 95 GGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 95 gg~L~~~i~~~----~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
+|+|.+++... ...++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999998753 34667788899999999999999999999999999999999999999999987532111111112
Q ss_pred ccccCCCcccchhhhccCC------CCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc------cCCCCCC
Q 013407 171 HTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE------FTCPPWL 237 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~------~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~------~~~~~~~ 237 (443)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+.... ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999985321 12468999999999999996 678998776666555443221 1223347
Q ss_pred CHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 238 SFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
++.+.+++..|+ .+|.+||+++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 888999999999 67999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=338.47 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=213.2
Q ss_pred ccEEEEeEeeccCcEEEEEEEECC-----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
..-+..+.||+|+||+||+|+... ....||||.++... +.++.+.++||++++..++|||||+++|++..++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 445677899999999999998643 34579999997543 33367899999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeE
Q 013407 86 IFIVLEFVTGGELFDKIVNHG----------R----MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~----------~----l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~k 151 (443)
+|+|+||+..|||..++...+ . ++..+...++.||+.|+.||-++.++||||-..|+|+.++..||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 999999999999999987532 2 77888999999999999999999999999999999999999999
Q ss_pred EeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc
Q 013407 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE 230 (443)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 230 (443)
|+||||++-.-....-.......-...|||||.+....|. .++||||+||+|||+++ |..||.+.+..+..+.|..+.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 9999999743211100011011123579999999988885 88999999999999998 999999999999999998886
Q ss_pred -cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhh
Q 013407 231 -FTCPPWLSFTARKLIARILDPNPMTRITIPEIL 263 (443)
Q Consensus 231 -~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil 263 (443)
.+.|..++.++.+|+..||+.+|++||++.||-
T Consensus 723 lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 723 LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 477888999999999999999999999999983
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=342.77 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=213.1
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCC-Cc----eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSET-GE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~-~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
..-++.+.||+|+||.||.|..... |. .||||.+.+. .+.+....+.+|..+|+.++|||||+++|++-+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3567889999999999999987653 32 3888887653 345567889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 86 IFIVLEFVTGGELFDKIVNH-------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
.+|++|||.||+|..+|++. ..++..+...++.||++|++||+++++|||||...|+||++...+||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999999876 35888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccC--CCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHH-HhhcCccCCC
Q 013407 159 ALSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYK-KISAAEFTCP 234 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~g--t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~-~i~~~~~~~~ 234 (443)
+.... .+.......+ ...|||||.+....+ +.++||||+||+|||+++ |..||.+.+..+... -...+++..|
T Consensus 850 rDiy~--~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P 926 (1025)
T KOG1095|consen 850 RDIYD--KDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP 926 (1025)
T ss_pred Hhhhh--chheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence 83211 1111111112 246999999988666 589999999999999998 999999988887776 4456688899
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 235 PWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 235 ~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
+.++..+.+++..||+.+|+.||++..|++
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 999999999999999999999999999987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=317.75 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=199.4
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
..+....+.|.-...||+|+||.||+|...+ |..||||.+....... ...+.+|+.++.+++|||+|+++|+|.+.
T Consensus 68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 68 DELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEG 143 (361)
T ss_pred HHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence 3445566778888899999999999999864 4889999876543221 34599999999999999999999999998
Q ss_pred C-EEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 84 T-KIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG---VYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 84 ~-~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
+ ..++|+||++.|+|.+.+.... .+++....+|+.+++.||+|||... |+||||||+|||||++.+.||+|||+
T Consensus 144 ~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGL 223 (361)
T KOG1187|consen 144 GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGL 223 (361)
T ss_pred CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccC
Confidence 8 5999999999999999997654 8899999999999999999999864 99999999999999999999999999
Q ss_pred ccccccccCCCccccc-cCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc------HHHHH-HHhhcC
Q 013407 158 SALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN------LMNLY-KKISAA 229 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~-~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~------~~~~~-~~i~~~ 229 (443)
|...... .....+. .||..|+|||.+.... .+.++||||+||+|.||++|+.|.+... ...+. ..+..+
T Consensus 224 a~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 224 AKLGPEG--DTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred cccCCcc--ccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 9643221 2222222 8999999999987643 4589999999999999999999887532 11111 112221
Q ss_pred cc------CCC-CCCC-----HHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 230 EF------TCP-PWLS-----FTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 230 ~~------~~~-~~~s-----~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.. ... ...+ ..+..+..+|++.+|..||++.|+..
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11 111 1122 12556778999999999999999754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=315.19 Aligned_cols=263 Identities=29% Similarity=0.452 Sum_probs=219.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh----HHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKLVKHPNVVRLYEVMG-SK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~ 83 (443)
.-++|-++.+||+|+|++||+|.+...+++||+|+-...+... ++..+...+|.+|.+.|+||.||++|+++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3468889999999999999999999999999999976654433 345677889999999999999999999985 55
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--CcEeeeCCCCcEEEcc---CCCeEEeecCcc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--GVYHRDLKPENLLLDA---YGNLKVSDFGLS 158 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NILl~~---~~~~kl~DFGla 158 (443)
+.++-|+|||+|.+|.-++..+..++|.+|+.|+-||+.||.||... .|+|-||||.|||+-. .|.+||.||||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 67889999999999998999999999999999999999999999976 5999999999999943 478999999999
Q ss_pred cccccccCCC-----ccccccCCCcccchhhhcc---CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHH---h
Q 013407 159 ALSQQVRDDG-----LLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKK---I 226 (443)
Q Consensus 159 ~~~~~~~~~~-----~~~~~~gt~~y~APEvl~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~---i 226 (443)
++++....+. ......||.+|++||.+.- .+-.+.++||||+|||+|.++.|+.||...... ++.+. +
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 9987543321 2344679999999998742 334468899999999999999999999765432 33221 2
Q ss_pred hcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 227 SAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 227 ~~~~~~~~--~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+.+..|| |-++++++++|++||..--..|+.+.++-.||||...
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 33344555 5699999999999999999999999999999999753
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=328.99 Aligned_cols=202 Identities=34% Similarity=0.565 Sum_probs=176.4
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 84 (443)
.-+-|...+.||+||||.||+++++.+|+.||||.+++..... ..++.-+|+++|++++|||||+++++-++..
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 3466888899999999999999999999999999998755333 3578889999999999999999999866544
Q ss_pred --EEEEEEeccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc--CC--CeEEeec
Q 013407 85 --KIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YG--NLKVSDF 155 (443)
Q Consensus 85 --~~~lv~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~~--~~kl~DF 155 (443)
.-.+|||||.||+|+..++. ..+++|.+...++..+..||.|||.+||+||||||+||++-. +| ..||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 45699999999999999964 458999999999999999999999999999999999999843 23 3799999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCC
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~ 215 (443)
|.|+-.+ ++....+..||+.|.+||++....+++..+|.||+||++|++.||..||.
T Consensus 169 G~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 169 GAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9998554 34577888999999999999865666799999999999999999999995
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=331.91 Aligned_cols=256 Identities=18% Similarity=0.260 Sum_probs=179.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCC----CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEE----
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSET----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV---- 79 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~---- 79 (443)
...++|++.+.||+|+||.||+|.+..+ +..||+|.+...... +....| .++...+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 4678999999999999999999999888 899999988643211 111111 1111222222222211
Q ss_pred --EEeCCEEEEEEeccCCCchHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCcEeeeC
Q 013407 80 --MGSKTKIFIVLEFVTGGELFDKIVNHGR--------------------MKEDEARRYFQQLINAVDYCHSRGVYHRDL 137 (443)
Q Consensus 80 --~~~~~~~~lv~E~~~gg~L~~~i~~~~~--------------------l~e~~~~~~~~qi~~aL~~LH~~givHrDl 137 (443)
......+|+||||+.+++|.+.+..... ..+..+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456789999999999999998865321 123456789999999999999999999999
Q ss_pred CCCcEEEcc-CCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCC---------------------CCch
Q 013407 138 KPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD---------------------GSTA 195 (443)
Q Consensus 138 kp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~---------------------~~~~ 195 (443)
||+|||++. ++.+||+|||+|+..... ........+||+.|+|||.+....+. ..++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 579999999999754322 12233456899999999976432211 2456
Q ss_pred hhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC-------C--------------CCCCHHHHHHHHHhcCCCCC
Q 013407 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-------P--------------PWLSFTARKLIARILDPNPM 254 (443)
Q Consensus 196 DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-------~--------------~~~s~~~~~li~~mL~~dP~ 254 (443)
||||+||+||+|+++..|++... ......+....... + ...+....+||.+||+.||.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999999877754321 11111111111100 0 11123455899999999999
Q ss_pred CCCChhhhhcCccccccC
Q 013407 255 TRITIPEILEDEWFKKDY 272 (443)
Q Consensus 255 ~R~t~~eil~hp~~~~~~ 272 (443)
+|||+.++|+||||+...
T Consensus 440 kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 440 QRISAKAALAHPYFDREG 457 (566)
T ss_pred cCCCHHHHhCCcCcCCCC
Confidence 999999999999998643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=288.35 Aligned_cols=250 Identities=26% Similarity=0.502 Sum_probs=204.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--CE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK--TK 85 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~ 85 (443)
..++|++.+.+|+|.|++|+.|++..+++.++||++.+-+ .+.+++|+.||+.|. ||||++++++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 5678999999999999999999999999999999996532 467999999999997 99999999998765 34
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC-CCeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 164 (443)
..+++||+...+..... ..++...++.|+.||+.||.||||.||.|||+||.|+++|.. ..++|+|+|+|.+..+.
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 67999999886644333 568899999999999999999999999999999999999864 57999999999876543
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCC-CCcHHHHHHHhh-------------c--
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKIS-------------A-- 228 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~-~~~~~~~~~~i~-------------~-- 228 (443)
. .......+.+|--||.+..-..+....|+||+||+|..|+..+-||- |.+..+..-+|. .
T Consensus 187 ~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 187 K---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred c---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 2 23456678899999999876655688999999999999999999984 433333222221 0
Q ss_pred -----------CccCCCCC-----------CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 229 -----------AEFTCPPW-----------LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 229 -----------~~~~~~~~-----------~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+...--+| +++++.+||.++|..|..+|+|+.|++.||||..
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 01111111 5799999999999999999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=288.62 Aligned_cols=240 Identities=47% Similarity=0.833 Sum_probs=208.4
Q ss_pred CcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHH
Q 013407 23 TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI 102 (443)
Q Consensus 23 ~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i 102 (443)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..+++++|+||+++++.+......++++||+.+++|.+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998999999999976543221 578899999999999999999999999999999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccch
Q 013407 103 VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182 (443)
Q Consensus 103 ~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 182 (443)
.....++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+...... .......|+..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence 87666999999999999999999999999999999999999999999999999998764432 133456688999999
Q ss_pred hhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCC-CcHHHHHHHhhcCccCCCCC---CCHHHHHHHHHhcCCCCCCCCC
Q 013407 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW---LSFTARKLIARILDPNPMTRIT 258 (443)
Q Consensus 183 Evl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~s~~~~~li~~mL~~dP~~R~t 258 (443)
|.+....++ .++||||+|+++++|++|..||.. .+.....+.+.......+.. ++.++.+++.+||..+|++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999866665 799999999999999999999987 55556666665554443332 8889999999999999999999
Q ss_pred hhhhhcCccc
Q 013407 259 IPEILEDEWF 268 (443)
Q Consensus 259 ~~eil~hp~~ 268 (443)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=322.32 Aligned_cols=257 Identities=30% Similarity=0.451 Sum_probs=220.7
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE----
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG---- 81 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~---- 81 (443)
+-.-+.|++.++||.|.+|.||+++++.+++..|+|+.+.... .-+.+..|.++++.+ .|||++.+|+++.
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3456789999999999999999999999999999999876432 345678899999888 6999999999984
Q ss_pred -eCCEEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 82 -SKTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 82 -~~~~~~lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
.++.+|+|||||.||+.-|+++. ..++.|+.+..+++.++.|+.+||.+.++|||||-.|||++.+|.+|++|||.+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 35789999999999999999875 457999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccchhhhccC-----CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc--
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-- 231 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-- 231 (443)
..... .-+...+..|||+|||||++... .|+ ..+|+||||++..||..|.+|+-+..++.....|.....
T Consensus 171 aQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 171 AQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeeec--ccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 75543 22344678899999999999543 354 779999999999999999999998888766656544322
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 232 -TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 232 -~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.-|...+.++.++|..||..|-.+||+..+++.|||++.
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 123447899999999999999999999999999999984
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=293.51 Aligned_cols=247 Identities=26% Similarity=0.456 Sum_probs=202.8
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 94 (443)
...||.|+||+|++-.++.+|+..|||.|....... ..+++..|.... +.-+.||||++|+..-.++..||.||++.
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k--eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK--EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH--HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 457999999999999999999999999998765432 356777777764 45579999999999999999999999995
Q ss_pred CCchHHHH------HhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 95 GGELFDKI------VNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 95 gg~L~~~i------~~~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
- +| |++ .....++|+..-.+..-.+.||.||... .|+|||+||+|||++..|.+||||||++..... .
T Consensus 147 ~-Sl-DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---S 221 (361)
T KOG1006|consen 147 I-SL-DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---S 221 (361)
T ss_pred h-hH-HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH---H
Confidence 3 43 222 2346799999999999999999999865 899999999999999999999999999864322 2
Q ss_pred CccccccCCCcccchhhhc--cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH-HHHHHHhhcCccCC---CC---CCC
Q 013407 168 GLLHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTC---PP---WLS 238 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~--~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~---~~---~~s 238 (443)
-..+...|..+|||||.+. +.+|+ -++|+||||+.|||+.||..|+.+.+. .+....+..+.++. +. .+|
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 2234457899999999995 34576 899999999999999999999987654 35555555555432 22 278
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 239 FTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..+..+|..||.+|-+.||...+++++||++.
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 99999999999999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=313.03 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=212.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC------CCcceEEEEEEe
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH------PNVVRLYEVMGS 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~ 82 (443)
.-++|.+....|+|-|++|..|.+...|+.||||+|..+. -+.+.=.+|++||++|+. -|.++++-.|..
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3468999999999999999999999999999999997643 355667789999999963 489999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-CeEEeecCcc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLS 158 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~~kl~DFGla 158 (443)
.+++|+|+|.+. -+|.+.+.+.| ++....++.|.+||+.||..|-..||+|.||||.|||+++.. .+||||||.|
T Consensus 506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 999999999886 48888887754 688999999999999999999999999999999999999865 5899999998
Q ss_pred cccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---- 234 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---- 234 (443)
.... .+..+.+.-+..|.|||++.+.+|+ ...|+||.||.||||.||+..|+|.+..+++.........+|
T Consensus 585 ~~~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 585 SFAS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccc----cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 7543 2334556667889999999999997 889999999999999999999999887766554322222222
Q ss_pred -------------------------------------C------------CC-------CHHHHHHHHHhcCCCCCCCCC
Q 013407 235 -------------------------------------P------------WL-------SFTARKLIARILDPNPMTRIT 258 (443)
Q Consensus 235 -------------------------------------~------------~~-------s~~~~~li~~mL~~dP~~R~t 258 (443)
| .+ -..+++||.+||..||++|+|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 0 01 124789999999999999999
Q ss_pred hhhhhcCccccc
Q 013407 259 IPEILEDEWFKK 270 (443)
Q Consensus 259 ~~eil~hp~~~~ 270 (443)
+.++|.||||+.
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.91 Aligned_cols=263 Identities=19% Similarity=0.265 Sum_probs=190.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEEC----------------CCCceEEEEEeechhhhh-HH----------HHHHHHH
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNS----------------ETGEPVALKILDKEKVLK-HK----------MAEQIKR 60 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~----------------~~~~~vAiK~i~~~~~~~-~~----------~~~~~~~ 60 (443)
...++|++.+.||+|+||.||+|... ..++.||||.+....... .+ ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34679999999999999999999752 235679999986432110 00 1122334
Q ss_pred HHHHHhcCCCCCc-----ceEEEEEEe--------CCEEEEEEeccCCCchHHHHHhCC---------------------
Q 013407 61 EVATMKLVKHPNV-----VRLYEVMGS--------KTKIFIVLEFVTGGELFDKIVNHG--------------------- 106 (443)
Q Consensus 61 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~i~~~~--------------------- 106 (443)
|+.++.+++|.++ +++++++.. ++..|+||||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766544 666666542 456899999999999998886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchh
Q 013407 107 ---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183 (443)
Q Consensus 107 ---~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 183 (443)
.++...++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....... ........+|+.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChh
Confidence 23556788999999999999999999999999999999999999999999986533211 11111233589999999
Q ss_pred hhccCC--------------------CC-CCchhhhhhhHHHHHHhhCCC-CCCCCc-----------HHHHHHHhhcCc
Q 013407 184 VLNDRG--------------------YD-GSTADLWSCGVILFVLLAGYL-PFDDSN-----------LMNLYKKISAAE 230 (443)
Q Consensus 184 vl~~~~--------------------~~-~~~~DIwSlGvil~~ll~G~~-Pf~~~~-----------~~~~~~~i~~~~ 230 (443)
++.... |. ..+.||||+||++|+|++|.+ ||.+.. ....+..+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 985322 11 124799999999999999986 775422 112223333344
Q ss_pred cCCC--CCCCHHHHHHHHHhcCCCC---CCCCChhhhhcCcccccc
Q 013407 231 FTCP--PWLSFTARKLIARILDPNP---MTRITIPEILEDEWFKKD 271 (443)
Q Consensus 231 ~~~~--~~~s~~~~~li~~mL~~dP---~~R~t~~eil~hp~~~~~ 271 (443)
+.++ ...++.+.+|+.+||..+| .+|+|++|+|+||||...
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 4444 3478999999999999866 689999999999999753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=309.04 Aligned_cols=243 Identities=26% Similarity=0.463 Sum_probs=206.4
Q ss_pred EEEeEeeccCcEEEEEEEECCC--C--ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 14 EVGRTIGEGTFAKVKFARNSET--G--EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~~~--~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
++.+.||.|.||.||.|....- | -.||||..+.+. ..+..+.+..|..+|+.++|||||+++|++. ....|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEE
Confidence 4457899999999999987542 3 358999987643 2334788999999999999999999999997 4578999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||+++-|+|..+++.+ ..++......|+.||+.||.||||++++||||-..|||+.....+||+|||+++.... +.
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed---~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED---DA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc---cc
Confidence 9999999999999865 4689999999999999999999999999999999999999999999999999986543 22
Q ss_pred ccccccCC--CcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 013407 169 LLHTTCGT--PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (443)
Q Consensus 169 ~~~~~~gt--~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (443)
..+...|. .-|||||-+.-..+. .++|||-|||.+||++. |..||.+-...+..-.+..| +++.|+.+++.+..|
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYsl 624 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSL 624 (974)
T ss_pred hhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHH
Confidence 22333343 359999999877664 88999999999999886 99999998777766666665 578999999999999
Q ss_pred HHHhcCCCCCCCCChhhhh
Q 013407 245 IARILDPNPMTRITIPEIL 263 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil 263 (443)
+.+||..+|.+||++.+|.
T Consensus 625 mskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 625 MSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHhccCcccCCcHHHHH
Confidence 9999999999999988764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=289.83 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=210.1
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----EEE
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KIF 87 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~ 87 (443)
.+..+.||-|+||.||.+.+..+|+.||+|.+.. ...+-...+++-+|+++|..++|.||+...++..... .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3456889999999999999999999999999853 3333334578999999999999999999999886543 478
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+++|++.. +|...|.....++.+.+.-+++||++||+|||+.||.||||||.|+|++.+..+||||||+++..+... .
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~ 211 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-R 211 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh-h
Confidence 88999865 787778888899999999999999999999999999999999999999999999999999998754432 2
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhh--------------------
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS-------------------- 227 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-------------------- 227 (443)
...+...-|.+|.|||++.+...++..+||||.|||+.|||..+..|...++.+..+.|.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 233444568899999999988777799999999999999999999998877665544431
Q ss_pred ---cCccCCCC-----------CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 228 ---AAEFTCPP-----------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 228 ---~~~~~~~~-----------~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
++....|. .-..+...++.+||.+||++|++.++++.|+|...
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 11111111 12346889999999999999999999999999764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=306.13 Aligned_cols=205 Identities=30% Similarity=0.568 Sum_probs=187.4
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHH-----HHHHHHHHHHhcCC---CCCcceEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA-----EQIKREVATMKLVK---HPNVVRLYE 78 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~-----~~~~~Ei~il~~l~---hpnIv~l~~ 78 (443)
..++..|...+.+|.|+||.|++|.++.+...|+||.|.++++...... -.+-.||.||..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 3567789999999999999999999999999999999999876543222 34667999999997 999999999
Q ss_pred EEEeCCEEEEEEecc-CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 79 VMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 79 ~~~~~~~~~lv~E~~-~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
+|++++++||+||-- +|-+||++|+.+..++|.++..+|+|++.|+++||+.||+|||||-||+.++.+|.+||+|||.
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 999999999999976 5789999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCC
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~ 215 (443)
|... ..+......||..|.|||++.+..|-|..-|||++|++||-+...+-||.
T Consensus 717 aa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 8754 45667889999999999999999999999999999999999999888885
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=305.12 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=215.3
Q ss_pred ccEEEEeEeeccCcEEEEEEEECC-CCc--eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSE-TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
++..+.++||+|+||.|++|.+.. +|+ .||||++....... ....+.+|+.+|-+|+|||+|+||++..+ ....
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 455667899999999999998865 444 58999997655432 46789999999999999999999999987 7788
Q ss_pred EEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|||++++|+|.+.+.+ ...|.......|+.||+.|+.||.++++|||||-..|+|+-....+|||||||.+-+....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999987 3468888999999999999999999999999999999999999999999999998665422
Q ss_pred CCCccc-cccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 013407 166 DDGLLH-TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (443)
Q Consensus 166 ~~~~~~-~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (443)
+-..+. ...-...|+|||.+....+. .++|+|++||.+|||++ |+.||.+-...++.++|..+ .++-|+.++.++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 211111 11123479999999887775 88999999999999998 89999999999999998766 4677888999999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 243 KLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+++..||..+|..|||+..|.+.-+.
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHH
Confidence 99999999999999999998754443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=305.89 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=219.2
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCc---eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
...-.+.+.||.|.||+|++|+.+..|+ .||||.++.... +.....+..|..||-+++||||++|.++......+
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 3456788999999999999999877664 699999975443 33467899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
.||.|||++|+|..+++. +++++..+...+++.|+.|++||-+.|.+||||-..|||++.+-.+|++||||++......
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999999999976 4679999999999999999999999999999999999999999999999999999775533
Q ss_pred CCCccccccC--CCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 013407 166 DDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (443)
Q Consensus 166 ~~~~~~~~~g--t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (443)
+....+.-| ...|.|||.+....+. .++||||+||++||.++ |+.||-+.+..+....|..+ .++.|..++..+
T Consensus 786 -~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL 863 (996)
T KOG0196|consen 786 -EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL 863 (996)
T ss_pred -CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence 222333333 2479999999888875 88999999999998775 99999998888888888776 566777899999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcC
Q 013407 242 RKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..|+..||++|-.+||++.||+.+
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.85 Aligned_cols=249 Identities=20% Similarity=0.313 Sum_probs=204.5
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+..+++.||+|-||+|.+|.-. .+..||||.++.... ......+.+||++|.+|+||||++++++|..++.+++++|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 4567899999999999999863 368899999986543 3346789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 92 FVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~--l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|++.|+|.+++..+.. .......+++.||++|++||.+.+++||||.|.|+|++.++++||+|||+|+-.-....-..
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999999999988743 34455667999999999999999999999999999999999999999999984322111111
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHh--hCCCCCCCCcHHHHHHHhhc--------CccCCCCCCCH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL--AGYLPFDDSNLMNLYKKISA--------AEFTCPPWLSF 239 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll--~G~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~ 239 (443)
.....-...|||||.+....+. .++|+|++|+.+||++ +.+.||...+..+..++... ..+..|+-++.
T Consensus 696 qgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~ 774 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ 774 (807)
T ss_pred ecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence 1112234689999998876664 8999999999999875 58999998877766655422 12355677899
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 240 TARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+.+|+-+|+..|-.+||+++++-.
T Consensus 775 ~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 775 GLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHHHhchhhhcCCCHHHHHH
Confidence 9999999999999999999999843
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=286.36 Aligned_cols=129 Identities=29% Similarity=0.517 Sum_probs=114.8
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----C---CCcceEEEEEEe
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----H---PNVVRLYEVMGS 82 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~~~~~ 82 (443)
++|.+.++||-|-|++||+|.+..+.+.||+|++... +.+.+....||++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 7999999999999999999999999999999998653 345678889999999984 3 369999999854
Q ss_pred ----CCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEE
Q 013407 83 ----KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLL 144 (443)
Q Consensus 83 ----~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl 144 (443)
+.++++|+|+. |..|+.+|... ++++...++.|++|++.||.|||.. ||+|.||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 56899999999 67898888764 6899999999999999999999975 99999999999999
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=292.88 Aligned_cols=241 Identities=26% Similarity=0.417 Sum_probs=210.7
Q ss_pred EEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 013407 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 93 (443)
++..+||-|.||.||.|.++.-.-.||||.+..... ..+.+..|..+|+.++|||+|+++++|..+..+|||+|||
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 445689999999999999998888899999865332 2567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 94 TGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 94 ~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
..|+|+++++... .++.-....++.||.+|+.||..+++|||||-..|+|+.++..+|++||||++++.. ...+
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg----DTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG----DTYT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC----Ccee
Confidence 9999999998754 467777888899999999999999999999999999999999999999999998643 2222
Q ss_pred cccC---CCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHH
Q 013407 172 TTCG---TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (443)
Q Consensus 172 ~~~g---t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 246 (443)
...| ..-|.|||-+....+ +.++|||+|||+|||+.| |-.||.+-+..+.|..+..+ ...-|..+++.+.+|++
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred cccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence 2233 346999999987666 489999999999999998 99999999999888887766 56778889999999999
Q ss_pred HhcCCCCCCCCChhhhh
Q 013407 247 RILDPNPMTRITIPEIL 263 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil 263 (443)
.||+.+|..||++.||-
T Consensus 501 aCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHhcCCcccCccHHHHH
Confidence 99999999999999873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=307.42 Aligned_cols=244 Identities=30% Similarity=0.458 Sum_probs=195.3
Q ss_pred EeEeeccCcEE-EEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEecc
Q 013407 16 GRTIGEGTFAK-VKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFV 93 (443)
Q Consensus 16 ~~~LG~G~~g~-V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 93 (443)
.+.+|.|+-|+ ||+|.. .|+.||||.+-.+ ....+++||..|+.- +|||||++|+.-.++...||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35689999986 688886 5789999987543 345788999999998 5999999999999999999999999
Q ss_pred CCCchHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc---CC--CeEEeecCcccccccc
Q 013407 94 TGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YG--NLKVSDFGLSALSQQV 164 (443)
Q Consensus 94 ~gg~L~~~i~~~~~----l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~--~~kl~DFGla~~~~~~ 164 (443)
. .+|.++++..+. ......+..+.|+++||++||+.+|+||||||.||||+. ++ .++|+|||+++.....
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 7 599999987521 111456889999999999999999999999999999976 34 5899999999876543
Q ss_pred cCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhC-CCCCCCCcHHHHHHHhhcCccCCC---CCCCH
Q 013407 165 RDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAEFTCP---PWLSF 239 (443)
Q Consensus 165 ~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~~---~~~s~ 239 (443)
... ....+..||-+|+|||++...... .++||+|+|||+|+.++| ..||.+.-. ...+|..+.+... +....
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeeccCchH
Confidence 221 224566799999999999876553 689999999999998885 999976432 2234555544322 11222
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
++.+||.+||++||..||++.++|.||+|-..
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 89999999999999999999999999999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.80 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=223.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.-++|+++..+|.|+||.||+|+++.+++..|+|+++.+... ...-++.||-+++.++|||||-+++.+......|+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 346899999999999999999999999999999999876543 35678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
.||||.||+|.+.-.-.+.++|.++....+..++||+|||+.|=+|||||-.|||+++.|.+|++|||.+..... .-.
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~ 167 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIA 167 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hhh
Confidence 999999999999887788999999999999999999999999999999999999999999999999998764332 112
Q ss_pred ccccccCCCcccchhhh--c-cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC-----CCCHH
Q 013407 169 LLHTTCGTPNYVAPEVL--N-DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-----WLSFT 240 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl--~-~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-----~~s~~ 240 (443)
......|||+|||||+- . ..+| ...+|||++|+...++-.-++|-.+..++..........+..|. ..++.
T Consensus 168 KrksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 23467899999999985 2 3345 49999999999999999889997777766666666666555443 37889
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+.+|++.+|..+|++|||++.+|.|||....
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999999999998753
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=327.34 Aligned_cols=237 Identities=19% Similarity=0.300 Sum_probs=187.1
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
..|...+.||+|+||.||+|.+..++..||||.+..... ...+|+.++++++|||||++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 445666789999999999999988999999999864321 1234688999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH---SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||+++|+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999999999985 3889999999999999999999 6799999999999999998888776 665442211
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH-----HHHHHHhh---------cCcc--
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-----MNLYKKIS---------AAEF-- 231 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-----~~~~~~i~---------~~~~-- 231 (443)
.....||+.|+|||++.+..|. .++||||+||++|||++|+.||+.... ........ ....
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1233688999999999877764 899999999999999999999964211 11111100 0000
Q ss_pred --CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 232 --TCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 232 --~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..+.....++.+++.+||+.||.+|||+.|+++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0011122356789999999999999999999874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=293.46 Aligned_cols=246 Identities=26% Similarity=0.439 Sum_probs=206.9
Q ss_pred EEEeEeeccCcEEEEEEEECC-------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 013407 14 EVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (443)
.+.+.||+|+||.|++|.-.. ....||||.+...... ...+.+..|+.+|+.+ .||||+.+.+.+...+.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 456689999999999986421 1456999998754433 4567899999999999 69999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC
Q 013407 86 IFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~ 149 (443)
+++|+||+..|+|.++++..+ .++..+...+..||+.|++||++.+++||||-..|||+..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998765 3888999999999999999999999999999999999999999
Q ss_pred eEEeecCcccccccccCCCcc-ccccCCCc--ccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCc-HHHHHH
Q 013407 150 LKVSDFGLSALSQQVRDDGLL-HTTCGTPN--YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN-LMNLYK 224 (443)
Q Consensus 150 ~kl~DFGla~~~~~~~~~~~~-~~~~gt~~--y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~-~~~~~~ 224 (443)
+||+|||+|+.... .+... ....|+.+ |||||.+....| +.++||||+||+|||+++ |..||.+-. ..++++
T Consensus 457 ~kIaDFGlar~~~~--~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 457 IKIADFGLARDHYN--KDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred EEEccccceeccCC--CCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 99999999984322 11111 12223344 999999998666 488999999999999998 999999854 566677
Q ss_pred HhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 225 KISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 225 ~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+..|. ...|.+++.++.++++.||+.+|.+||++.++.+
T Consensus 534 ~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 777774 5788889999999999999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=274.22 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=202.0
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECC---CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (443)
.....|.++.+||.|+|++||+|.+.. .++.||+|.+..... ..++.+|+++|..+ .+.||+++.+.+..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 445678999999999999999999877 788999999875432 45799999999999 589999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC-CCeEEeecCcccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~~kl~DFGla~~~~ 162 (443)
+...+||||.+..+..++.. .++-.+++.|++.++.||.++|++||+||||||.|+|.+.. +.-.|+|||+|...+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 99999999999887766663 47789999999999999999999999999999999999864 678999999987211
Q ss_pred ccc------C-------------------------CC-----------ccccccCCCcccchhhhccCCCCCCchhhhhh
Q 013407 163 QVR------D-------------------------DG-----------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSC 200 (443)
Q Consensus 163 ~~~------~-------------------------~~-----------~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSl 200 (443)
... . .+ ......||++|.|||++...+-.++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0 00 00124599999999999887777889999999
Q ss_pred hHHHHHHhhCCCCCCCCcHH-----HH---------------------HH---------------Hhh-----cCcc---
Q 013407 201 GVILFVLLAGYLPFDDSNLM-----NL---------------------YK---------------KIS-----AAEF--- 231 (443)
Q Consensus 201 Gvil~~ll~G~~Pf~~~~~~-----~~---------------------~~---------------~i~-----~~~~--- 231 (443)
|||+..++++..||-..... ++ ++ .+. ..+.
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 99999999999999432210 00 00 000 0000
Q ss_pred CC---CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 232 TC---PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 232 ~~---~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.. ....+..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00 0114558999999999999999999999999999973
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=274.30 Aligned_cols=245 Identities=23% Similarity=0.329 Sum_probs=196.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC--CCCCcceEEEEEEeCC--
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV--KHPNVVRLYEVMGSKT-- 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~~-- 84 (443)
.+...++.+.||+|.||.||+|.. .++.||||++.... .+.+++|-+|.+.. .|+||+++++.-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 455677889999999999999997 45899999997533 45667777776655 7999999998765444
Q ss_pred --EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------CCcEeeeCCCCcEEEccCCCeEEe
Q 013407 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS---------RGVYHRDLKPENLLLDAYGNLKVS 153 (443)
Q Consensus 85 --~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~---------~givHrDlkp~NILl~~~~~~kl~ 153 (443)
.++||+||.+.|+|.+++..+ .++.....+++..+++||+|||+ -.|+|||||..|||+..|+..-|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 899999999999999999874 58999999999999999999996 359999999999999999999999
Q ss_pred ecCcccccccccCCCccccccCCCcccchhhhccCCCCC-----CchhhhhhhHHHHHHhhCC------------CCCC-
Q 013407 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG-----STADLWSCGVILFVLLAGY------------LPFD- 215 (443)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~-----~~~DIwSlGvil~~ll~G~------------~Pf~- 215 (443)
|||||-.+......+.....+||..|||||++.+..... .+.||||+|.|||||++.- +||.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999999888776667777789999999999997653321 3589999999999999852 3443
Q ss_pred ----CCcHHHHHHHhh--cCccCCCCC-----CCHHHHHHHHHhcCCCCCCCCChhhh
Q 013407 216 ----DSNLMNLYKKIS--AAEFTCPPW-----LSFTARKLIARILDPNPMTRITIPEI 262 (443)
Q Consensus 216 ----~~~~~~~~~~i~--~~~~~~~~~-----~s~~~~~li~~mL~~dP~~R~t~~ei 262 (443)
.++..++...+. +.++.+|.. .-..+++.+..||+.||+.|.|+.=+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 233444444443 334444432 23568899999999999999998644
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=286.01 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=210.0
Q ss_pred EEEeEeeccCcEEEEEEEECCCCc----eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 14 EVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+..+.||+|+||+||+|.+...|+ +||||++...... .....+.+|.-+|..++|||++++++++.... .-||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 345789999999999998865554 6889988764433 34567899999999999999999999997665 8899
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
++|+++|.|.|+++.+ ..+.......|..||++|+.|||.++++||||-..|+|+.+..++||.|||+|++......+-
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999999875 468889999999999999999999999999999999999999999999999999876543322
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 246 (443)
......-.+.|||=|.+....|. .++||||+||.+||++| |..|+++....++-..+..+ +++.|+-.+.++.-++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 22222224579999999887775 89999999999999998 99999998887776666555 57888999999999999
Q ss_pred HhcCCCCCCCCChhhhhc
Q 013407 247 RILDPNPMTRITIPEILE 264 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~ 264 (443)
+||..|+..||++.++-.
T Consensus 935 kCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhccCcccCccHHHHHH
Confidence 999999999999988754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=245.22 Aligned_cols=213 Identities=43% Similarity=0.786 Sum_probs=186.8
Q ss_pred eeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013407 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (443)
Q Consensus 19 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 98 (443)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654321 346789999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-CCCeEEeecCcccccccccCCCccccccCC
Q 013407 99 FDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (443)
Q Consensus 99 ~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 176 (443)
.+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9998775 57899999999999999999999999999999999999999 89999999999875433211 23345578
Q ss_pred CcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 013407 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (443)
Q Consensus 177 ~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R 256 (443)
..|++||.+......+.+.|+||+|+++++| ..+.+++.+|+..||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987652445889999999999998 678999999999999999
Q ss_pred CChhhhhcCc
Q 013407 257 ITIPEILEDE 266 (443)
Q Consensus 257 ~t~~eil~hp 266 (443)
|++.++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=245.18 Aligned_cols=209 Identities=23% Similarity=0.443 Sum_probs=168.6
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
...-+..||+|++|.|-+.++..+|...|+|.+... ..++ ..+++.+|+.+..+. .+|.+|.+|+.+-....+||.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344456799999999999999999999999998653 3333 356777888875555 7999999999999999999999
Q ss_pred eccCCCchHH----HHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 91 EFVTGGELFD----KIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 91 E~~~gg~L~~----~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|.+.. +|.. .+...+.++|..+-+++..++.||.|||++ .++|||+||+|||++.+|.+|+||||.+.....
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d-- 201 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD-- 201 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh--
Confidence 99964 5532 234567899999999999999999999987 899999999999999999999999999875432
Q ss_pred CCCccccccCCCcccchhhhc----cCCCCCCchhhhhhhHHHHHHhhCCCCCCCC-cHHHHHHHhh
Q 013407 166 DDGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKIS 227 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~ 227 (443)
.-..+...|..+|||||.+. .++|+ -++||||||+.++||.+++.||+.. ++.++...+.
T Consensus 202 -SiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 202 -SIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred -hhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 11222356889999999984 34564 8999999999999999999999753 3444444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=248.19 Aligned_cols=219 Identities=44% Similarity=0.744 Sum_probs=187.0
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999865432 2457889999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 93 VTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 93 ~~gg~L~~~i~~~~~-l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
+.+++|.+.+..... +++..+..++.|++.++.+||+.|++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 999999999987766 8999999999999999999999999999999999999999999999999988654422 11234
Q ss_pred cccCCCcccchhhh-ccCCCCCCchhhhhhhHHHHHHhhCCCCCCC-Cc-HHHHHHHhhcCccCCCC
Q 013407 172 TTCGTPNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SN-LMNLYKKISAAEFTCPP 235 (443)
Q Consensus 172 ~~~gt~~y~APEvl-~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~-~~~~~~~i~~~~~~~~~ 235 (443)
...++..|++||.+ ....+. .++|+||||+++++|++|+.||.. .+ ...+.+.+..+.....+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 55788899999998 444454 689999999999999999999987 34 44677777776644433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=264.80 Aligned_cols=246 Identities=25% Similarity=0.425 Sum_probs=188.7
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEe----C
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGS----K 83 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~----~ 83 (443)
-.+-++.+.||+|-||+||+|.++ |+.||||++.... .....||.+|.+. |+|+||+.+++.--. -
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 346788999999999999999984 7889999997532 2345566666654 599999999875321 2
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeeeCCCCcEEEccCCCeEEeec
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NILl~~~~~~kl~DF 155 (443)
..+|+|.+|.+.|+|+|++.. ..++.+.+.+++..+++||++||.. .|+|||||..|||+..+|.+-|+|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 368999999999999999988 6799999999999999999999953 4999999999999999999999999
Q ss_pred CcccccccccC--CCccccccCCCcccchhhhccCC----CCC-CchhhhhhhHHHHHHhhC----------CCCCCC--
Q 013407 156 GLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRG----YDG-STADLWSCGVILFVLLAG----------YLPFDD-- 216 (443)
Q Consensus 156 Gla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~----~~~-~~~DIwSlGvil~~ll~G----------~~Pf~~-- 216 (443)
|||-....... +-.....+||..|||||++...- +.+ ..+||||+|.|+||++.. ++||.+
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 99976554321 22346789999999999985431 111 458999999999998753 688864
Q ss_pred ---CcHHHHHHHh--hcCccCCCC-CCCHH----HHHHHHHhcCCCCCCCCChhhhhc
Q 013407 217 ---SNLMNLYKKI--SAAEFTCPP-WLSFT----ARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 217 ---~~~~~~~~~i--~~~~~~~~~-~~s~~----~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
++.+++.+-+ ....+..|. |-|.+ +..+++.||..||..|.|+--|.+
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 3444444333 222344443 44433 456889999999999999865543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-33 Score=295.09 Aligned_cols=260 Identities=30% Similarity=0.520 Sum_probs=212.1
Q ss_pred ccE-EEEeEeeccCcEEEEEEEECCCCceEEEEEeec---hhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 11 GKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDK---EKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 11 ~~y-~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
.+| .....+|.|++|.|+.+......+.++.|.... ...........+..|+.+-..+.|||++.....+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 445 346789999999888888776666666665432 1111222334488899999999999998888777777777
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+..||||++ +|+..+...+.++..++..+++||+.||+|+|+.||.|||+||+|++++.+|.+||+|||.+..+.....
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 777999999 9999999888999999999999999999999999999999999999999999999999999998876655
Q ss_pred C--CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHH--HHHhh-------cCccCCCC
Q 013407 167 D--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL--YKKIS-------AAEFTCPP 235 (443)
Q Consensus 167 ~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~--~~~i~-------~~~~~~~~ 235 (443)
. ......+|+.+|+|||++.+..|+...+||||+|++++.|.+|+.||......+. +.... .+....-.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 5 4556789999999999999999999999999999999999999999976554322 11111 11111112
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.++...+.+|.+||++||.+|+|+++|++++||+.-
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 367889999999999999999999999999999853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-33 Score=253.02 Aligned_cols=252 Identities=25% Similarity=0.448 Sum_probs=200.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEE-EEeCCEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV-MGSKTKI 86 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~~~ 86 (443)
..+.|.+.+.||+|-||.+.+|.|+.+++.+++|.++++.. ..+.+.+|...--.| .|.||+.-|++ |++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 45789999999999999999999999999999999987653 246788888876666 58999998876 6888899
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc--CCCeEEeecCcccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 164 (443)
.+++||++.|+|.+.+.. .++.|.....++.|+++|+.|+|+++++|||||.+||||-. .-.+||||||+++..+
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 999999999999998876 56999999999999999999999999999999999999943 2479999999876432
Q ss_pred cCCCccccccCCCcccchhhhccCC----CCCCchhhhhhhHHHHHHhhCCCCCCCCcHH----HHHHHhhcC-ccCCCC
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAA-EFTCPP 235 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~-~~~~~~ 235 (443)
......--+..|.|||+..... ...+.+|||.+|+|+|.+|+|.+||...... -.+.++..+ ....|.
T Consensus 175 ---~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 175 ---TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred ---ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 2222333466899999874321 1135689999999999999999999854322 223333333 333443
Q ss_pred ---CCCHHHHHHHHHhcCCCCCCC---CChhhhhcCccccc
Q 013407 236 ---WLSFTARKLIARILDPNPMTR---ITIPEILEDEWFKK 270 (443)
Q Consensus 236 ---~~s~~~~~li~~mL~~dP~~R---~t~~eil~hp~~~~ 270 (443)
.+|+.+..+.++-|.++|++| .++.......|...
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 379999999999999999999 66666677777654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=293.24 Aligned_cols=200 Identities=18% Similarity=0.253 Sum_probs=146.8
Q ss_pred CCC-CCcceEEEEE-------EeCCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCC
Q 013407 68 VKH-PNVVRLYEVM-------GSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138 (443)
Q Consensus 68 l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlk 138 (443)
++| +||.++++.+ .....++.+||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5777777766 2234677888987 5699999965 4569999999999999999999999999999999
Q ss_pred CCcEEEccC-------------------CCeEEeecCcccccccccC--------------CCccccccCCCcccchhhh
Q 013407 139 PENLLLDAY-------------------GNLKVSDFGLSALSQQVRD--------------DGLLHTTCGTPNYVAPEVL 185 (443)
Q Consensus 139 p~NILl~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APEvl 185 (443)
|+||||+.. +.+|++|||+++....... .......+||+.|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999653 4556666666643211000 0001124689999999999
Q ss_pred ccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC-CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 186 ~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+..| +.++|||||||+||||++|.+|+..... ....+.....+ .+....+...+++.+||.+||.+|||+.|+++
T Consensus 188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88777 5899999999999999999998764321 11222111111 11123566789999999999999999999999
Q ss_pred Ccccccc
Q 013407 265 DEWFKKD 271 (443)
Q Consensus 265 hp~~~~~ 271 (443)
||||...
T Consensus 265 h~~~~~~ 271 (793)
T PLN00181 265 SEFINEP 271 (793)
T ss_pred chhhhhh
Confidence 9999753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=231.26 Aligned_cols=256 Identities=36% Similarity=0.621 Sum_probs=213.2
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCEEEEEEe
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~E 91 (443)
|.+.+.||.|+||.||.+.+. ..+|+|.+.............+.+|+.+++.+.|+ +|+++.+++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 77999999876655444567899999999999988 79999999988888999999
Q ss_pred ccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-CeEEeecCcccccccccCC
Q 013407 92 FVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~---~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 167 (443)
++.++++.+.+.... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997777665 799999999999999999999999999999999999999988 6999999998754432221
Q ss_pred C----ccccccCCCcccchhhhccC--CCCCCchhhhhhhHHHHHHhhCCCCCCCCcH----HHHHHHhhcCccC-CCCC
Q 013407 168 G----LLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFT-CPPW 236 (443)
Q Consensus 168 ~----~~~~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~-~~~~ 236 (443)
. .....+||+.|+|||.+.+. .+.....|+||+|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 34677899999999999874 4556889999999999999999999987763 4444444444332 2222
Q ss_pred CC--------HHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 237 LS--------FTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 237 ~s--------~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 21 478999999999999999999999988776543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=223.83 Aligned_cols=158 Identities=22% Similarity=0.254 Sum_probs=128.3
Q ss_pred CchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcccccc
Q 013407 96 GELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (443)
Q Consensus 96 g~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 174 (443)
|+|.+.+... ..+++..++.++.|++.||.|||++| ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 6899999764 56999999999999999999999999 999999999999999 9998764331 226
Q ss_pred CCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhcCccC-------CCCCCCH--HHHHH
Q 013407 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFT-------CPPWLSF--TARKL 244 (443)
Q Consensus 175 gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~-------~~~~~s~--~~~~l 244 (443)
||+.|+|||++.+..|+ .++||||+||++|+|++|..||...... .....+...... .+..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999887775 8999999999999999999999765432 223332221111 1112333 69999
Q ss_pred HHHhcCCCCCCCCChhhhhcCcccc
Q 013407 245 IARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
|.+||..||.+|||+.++++|+|+.
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=238.80 Aligned_cols=171 Identities=22% Similarity=0.227 Sum_probs=135.7
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECC-CCceEEEEEeechhh--hhHHHHHHHHHHHHHHhcCCCCCcce-EEEEEE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVR-LYEVMG 81 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~ 81 (443)
.+...++|++.+.||+|+||+||+|.+.. +++.||||++..... ........+.+|+.+|+.++|+||+. +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 35677899999999999999999999876 678889998753311 12234567999999999999999985 5442
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeC-CCCcEEEccCCCeEEeecCcccc
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL-KPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDl-kp~NILl~~~~~~kl~DFGla~~ 160 (443)
+..|+||||+.|++|.. +.. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 45899999999999963 211 11 1468899999999999999999999 99999999999999999999987
Q ss_pred cccccCCCc------cccccCCCcccchhhhcc
Q 013407 161 SQQVRDDGL------LHTTCGTPNYVAPEVLND 187 (443)
Q Consensus 161 ~~~~~~~~~------~~~~~gt~~y~APEvl~~ 187 (443)
......... ..+.++++.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 654332222 245678999999999853
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=230.22 Aligned_cols=251 Identities=19% Similarity=0.247 Sum_probs=204.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCC-----ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCC
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETG-----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-SKT 84 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~ 84 (443)
.|+++...+-+|+||.||.|++++.. +.|-+|.+.... ++-....+..|-..+..+.|||+..+.++.. +..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 46777788999999999999776532 345666654321 2334567888999999999999999999874 456
Q ss_pred EEEEEEeccCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecC
Q 013407 85 KIFIVLEFVTGGELFDKIVNH--------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFG 156 (443)
.-++++.+...|+|..++... +.++..+...+..|++.|++|||+.||+|.||-..|++||+.-.+||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 677888888889999988721 247777888899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCC
Q 013407 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCP 234 (443)
Q Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~ 234 (443)
+++-..+......-........|||||.+....|. ..+|+|||||+||||+| |+.|+-.-++.++..-++.| +..-|
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP 520 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP 520 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence 98865443222222222345679999999988885 88999999999999998 99999999999998888877 45667
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 235 PWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 235 ~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
-.++.++..++.-||..+|++||+.+|+..
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 779999999999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=253.90 Aligned_cols=239 Identities=35% Similarity=0.606 Sum_probs=209.7
Q ss_pred EeeccCcEEEEEEEE---CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEecc
Q 013407 18 TIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFV 93 (443)
Q Consensus 18 ~LG~G~~g~V~~a~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 93 (443)
.+|+|+||.|++++. .+.|..+|+|+..+......... .-+.|-.++..++ ||.+|++...+++++..|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999988643 45688899999987665433222 5667888888886 999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccc
Q 013407 94 TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173 (443)
Q Consensus 94 ~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 173 (443)
.||+|+..+.....+.+...+.+...++-|++++|+.||+|||+|++||+++.+|++++.|||+++..-.. ...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------KIA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh------hhc
Confidence 99999999998889999999999999999999999999999999999999999999999999998854321 122
Q ss_pred cCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCC
Q 013407 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253 (443)
Q Consensus 174 ~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP 253 (443)
|||..|||||++. ++. ..+|.||+|++.++|++|..||.. +....|...++..|..++..+++++..|+..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999997 444 778999999999999999999988 667778888899999999999999999999999
Q ss_pred CCCCC-----hhhhhcCccccc
Q 013407 254 MTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 254 ~~R~t-----~~eil~hp~~~~ 270 (443)
.+|.- +.++++|++|..
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHhccCcchhHHHhccchhee
Confidence 99985 579999999974
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-28 Score=256.91 Aligned_cols=260 Identities=35% Similarity=0.618 Sum_probs=223.6
Q ss_pred cccEEEEeEeeccCcEEEEEEEECC-CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 87 (443)
...|.+.+.||+|+|+.|-++.... +...+|+|.+.... .......++..|..+.+.+. |+|++.+++...+....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5679999999999999999888744 44567888776543 23445678888999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCcEeeeCCCCcEEEccCC-CeEEeecCccccccc
Q 013407 88 IVLEFVTGGELFDKI-VNHG-RMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQ 163 (443)
Q Consensus 88 lv~E~~~gg~L~~~i-~~~~-~l~e~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 163 (443)
++++|..|+++++.+ ..+. ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ +++++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 7776 7899999999999999999999 99999999999999999999 999999999998776
Q ss_pred -ccCCCccccccC-CCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHH-HHHhhc--CccCCCCC--
Q 013407 164 -VRDDGLLHTTCG-TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL-YKKISA--AEFTCPPW-- 236 (443)
Q Consensus 164 -~~~~~~~~~~~g-t~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~-~~~i~~--~~~~~~~~-- 236 (443)
.+........|| ++.|+|||...+..|.++..|+||+|+++..+++|.+||........ +..... ..+...+|
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 566667778899 99999999999888999999999999999999999999987665432 222222 22223333
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
++..+.+++.++|..+|..|.+++++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7889999999999999999999999999999987
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=220.74 Aligned_cols=249 Identities=27% Similarity=0.334 Sum_probs=192.3
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCC-ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC----CCcceEEEEE-EeCCE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVKH----PNVVRLYEVM-GSKTK 85 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 85 (443)
+|++.+.||+|+||.||.|.+..++ ..+|+|+......... ..+..|+.++..+.. +++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997764 6789998875432211 267889999988863 6999999999 58889
Q ss_pred EEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC-----CCeEEeecCcc
Q 013407 86 IFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-----GNLKVSDFGLS 158 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-----~~~kl~DFGla 158 (443)
.|+||+.+ |.+|.+..... +.++...+..++.|++.+|+++|+.|++||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 67998877443 589999999999999999999999999999999999999765 35999999999
Q ss_pred cccccccCCC-------c-cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH---HHHHHhh
Q 013407 159 ALSQQVRDDG-------L-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKKIS 227 (443)
Q Consensus 159 ~~~~~~~~~~-------~-~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~ 227 (443)
+.+......+ . .....||..|+++....+... +.+.|+||++.++.+|+.|.+||.+.... ..+....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8433211111 1 123459999999999988766 58999999999999999999999776533 2222222
Q ss_pred cCccC--CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 228 AAEFT--CPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 228 ~~~~~--~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..... .....+.....+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22211 223345667777777777888888887776553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=197.03 Aligned_cols=244 Identities=22% Similarity=0.313 Sum_probs=192.0
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCCEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSKTKI 86 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 86 (443)
...++|+++++||+|+||.+|+|.+..+|+.||||+=... .. -.++..|.++.+.|++ ..|..+..+..+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CC----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 4678999999999999999999999999999999986432 22 2367789999999975 7888888888888899
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC---CCeEEeecCcccccc
Q 013407 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQ 162 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~~kl~DFGla~~~~ 162 (443)
.+||+.. |.+|.+...- ...++...+.-++-|++.-++|+|.++++||||||+|+|..-+ ..+-++|||+|+.+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 6677666643 4579999999999999999999999999999999999999654 358999999998765
Q ss_pred cccCCCc-----cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH---HHHHHHhhcCccCCC
Q 013407 163 QVRDDGL-----LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCP 234 (443)
Q Consensus 163 ~~~~~~~-----~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~~ 234 (443)
....... -....||..|.+--...+... +..-|+=|+|.+|.++.-|.+||.+-.. .+-+++|.......|
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 4332221 134568999998777665544 4778999999999999999999998543 345667766665554
Q ss_pred C-----CCCHHHHHHHHHhcCCCCCCCCC
Q 013407 235 P-----WLSFTARKLIARILDPNPMTRIT 258 (443)
Q Consensus 235 ~-----~~s~~~~~li~~mL~~dP~~R~t 258 (443)
. .++.+..-.+.-|-..-=.+-|.
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 3 46777777777775554444444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=237.09 Aligned_cols=220 Identities=32% Similarity=0.617 Sum_probs=176.2
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
=..|..+++|..|+||-||+++|+.+.+.+|+ .+++++.. +++ |+..-..|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-------lRn---ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-------LRN---ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh-------hhc---cccccCCccee---------------
Confidence 45789999999999999999999999999999 55554321 111 34444455544
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC--
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-- 167 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 167 (443)
|+-...+..-+.++.+. +.+++|+|+.||+|||+||+|.+|+.-|++|+.|||++...-.....
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 45555666656666654 78999999999999999999999999999999999998642111000
Q ss_pred ----------C-ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCC
Q 013407 168 ----------G-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236 (443)
Q Consensus 168 ----------~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (443)
. .-...||||.|+|||++...+| |..+|.|++|+|+|+++.|..||.+.+.++++..........|..
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 0 1123599999999999998888 599999999999999999999999999999998887776655543
Q ss_pred ---CCHHHHHHHHHhcCCCCCCCCC---hhhhhcCccccc
Q 013407 237 ---LSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (443)
Q Consensus 237 ---~s~~~~~li~~mL~~dP~~R~t---~~eil~hp~~~~ 270 (443)
++++++++|.++|+.+|..|.- +-++.+|+||+.
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 7899999999999999999984 667889999974
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-25 Score=202.23 Aligned_cols=173 Identities=14% Similarity=0.200 Sum_probs=135.8
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHH------HHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQ------IKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
-++|++.+.||.|+||.||++.. ++..+|||++..+....+..... +.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999655 46689999998665544444444 68999999999999999999886543
Q ss_pred --------CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeec
Q 013407 84 --------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 84 --------~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DF 155 (443)
+..+++|||++|.+|.+.. .+++ ....+++.++..||+.|++|||+||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 3588999999999997763 2333 2466999999999999999999999999999988 999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHh
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll 208 (443)
|.+......... ..+.....|+ .++|+||||+.+..+.
T Consensus 179 g~~~~~~e~~a~--------------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK--------------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH--------------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 987643221110 1134455676 7899999999887543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=199.82 Aligned_cols=142 Identities=21% Similarity=0.274 Sum_probs=113.7
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHH-----------------------HHHHHHHHHHHHhcCCCCC
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-----------------------MAEQIKREVATMKLVKHPN 72 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn 72 (443)
.+.||+|++|.||+|.+. +|+.||||++......... ......+|+.+++++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999764321100 0123456999999998887
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEeeeCCCCcEEEccCCCeE
Q 013407 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC-HSRGVYHRDLKPENLLLDAYGNLK 151 (443)
Q Consensus 73 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~L-H~~givHrDlkp~NILl~~~~~~k 151 (443)
+.....+... ..++||||+.|+++...+...+.+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7544433222 2389999999988766655567899999999999999999999 799999999999999998 48899
Q ss_pred EeecCccccc
Q 013407 152 VSDFGLSALS 161 (443)
Q Consensus 152 l~DFGla~~~ 161 (443)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-24 Score=199.82 Aligned_cols=244 Identities=23% Similarity=0.353 Sum_probs=191.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 86 (443)
..--.|+++++||+|+||..+.|.+.-++++||||.=.... .+.+++.|.+..+.|. .++|...|.+...+.+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 44458999999999999999999999999999999865422 2568999999999995 69999999998888888
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-----CeEEeecCcccc
Q 013407 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-----NLKVSDFGLSAL 160 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-----~~kl~DFGla~~ 160 (443)
.+|||+. |-+|.|+..- ...++...+..++.|++.-++|+|++.+|.|||||+|+||...+ .+-++|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8999998 5566665543 45799999999999999999999999999999999999997544 489999999987
Q ss_pred cccccCCC-----ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC---cHHHHHHHhhcCccC
Q 013407 161 SQQVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFT 232 (443)
Q Consensus 161 ~~~~~~~~-----~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~ 232 (443)
+....... ...+..||..||+--...+.... .+-|+=|||-+++++|-|.+||.+. +..+-|++|....-.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 65543222 12456799999998888887764 7889999999999999999999874 455677887554433
Q ss_pred CC-----CCCCHHHHHHHHHhcCCCCCCCCC
Q 013407 233 CP-----PWLSFTARKLIARILDPNPMTRIT 258 (443)
Q Consensus 233 ~~-----~~~s~~~~~li~~mL~~dP~~R~t 258 (443)
.| ..++.++..-++-.-..+=.+-|.
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 33 224555544444443333334344
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=192.22 Aligned_cols=142 Identities=21% Similarity=0.259 Sum_probs=115.4
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh-----------------------HHHHHHHHHHHHHHhcCCCCC
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----------------------HKMAEQIKREVATMKLVKHPN 72 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~~~~Ei~il~~l~hpn 72 (443)
.+.||+|++|+||+|.+. +|+.||||++....... .......++|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999998642110 001234578999999999998
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeE
Q 013407 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLK 151 (443)
Q Consensus 73 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~k 151 (443)
|.....+.... .|+||||++|+++.........+++..+..++.|++.++.++|+ .||+||||||+||+++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 86555444333 48999999998665544445678899999999999999999999 9999999999999999 79999
Q ss_pred EeecCccccc
Q 013407 152 VSDFGLSALS 161 (443)
Q Consensus 152 l~DFGla~~~ 161 (443)
|+|||+|...
T Consensus 158 liDFG~a~~~ 167 (190)
T cd05145 158 IIDVSQAVEL 167 (190)
T ss_pred EEEcccceec
Confidence 9999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=200.13 Aligned_cols=236 Identities=26% Similarity=0.325 Sum_probs=154.1
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC----------CCcceEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH----------PNVVRLYEVM 80 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~~ 80 (443)
-....++.||.|+++.||.+.+..||+.+|+|++...........+.+++|.-....+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 356778899999999999999999999999999976654444456788888766666433 1233333332
Q ss_pred E---------e---CC-----EEEEEEeccCCCchHHHHH---hCCCC---CHHHH-HHHHHHHHHHHHHHHHCCcEeee
Q 013407 81 G---------S---KT-----KIFIVLEFVTGGELFDKIV---NHGRM---KEDEA-RRYFQQLINAVDYCHSRGVYHRD 136 (443)
Q Consensus 81 ~---------~---~~-----~~~lv~E~~~gg~L~~~i~---~~~~l---~e~~~-~~~~~qi~~aL~~LH~~givHrD 136 (443)
. . .+ +.+++|+-+. ++|.+.+. ..... ....| ..+..|+++.+++||+.|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 1 1 11 2367777775 47877654 22222 12223 34458999999999999999999
Q ss_pred CCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCC-------CCCCchhhhhhhHHHHHHhh
Q 013407 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-------YDGSTADLWSCGVILFVLLA 209 (443)
Q Consensus 137 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-------~~~~~~DIwSlGvil~~ll~ 209 (443)
|+|+|++++.+|.+.|+||+.....+. .......+..|.+||...... ..+.+.|.|+||+++|.|.+
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999987653222 111134567899999875421 12477899999999999999
Q ss_pred CCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 013407 210 GYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (443)
Q Consensus 210 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R 256 (443)
|.+||+.......... .+.....++..++.||+.||+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999987654321110 222222688999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=235.74 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=185.9
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh-hhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
.|...+-||++-|=+|.+|++.+ |. |+||++-+..- ..-....+...|++ ....+|||.+.+.-+..+....|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78889999999999999999854 44 99999976541 11112233334555 56679999999998888888899999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC--C
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--G 168 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~ 168 (443)
+|... +|+|++....-+..-+.+.|+.||+.||.-||..||+|||||.||||++..+.+.|+||..-+..-...++ .
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99976 99999988777888999999999999999999999999999999999999999999999865432111111 1
Q ss_pred ---ccccccCCCcccchhhhccCC----------CCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHh-hcCccCC
Q 013407 169 ---LLHTTCGTPNYVAPEVLNDRG----------YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTC 233 (443)
Q Consensus 169 ---~~~~~~gt~~y~APEvl~~~~----------~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i-~~~~~~~ 233 (443)
...+...-.+|+|||.+.... .-.++.||||+||+++||++ |++||.-.....+...- ...+...
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~L 259 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLL 259 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHH
Confidence 223444556899999985421 12467899999999999987 89999643221111000 0000000
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 234 PPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 234 ~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..--+..+++||..|++.||++|.++++.|+.
T Consensus 260 e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 260 EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 01124578999999999999999999999874
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=180.68 Aligned_cols=191 Identities=17% Similarity=0.201 Sum_probs=142.1
Q ss_pred EEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHH-HHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEe
Q 013407 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-MAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 91 (443)
-+...|++|+||+|+++.. .+..++.+.+......... ....+.+|+++|++|. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3567899999999997775 5677887777654432111 1235889999999995 5889999886 44799999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeC-CCCcEEEccCCCeEEeecCcccccccccCC---
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL-KPENLLLDAYGNLKVSDFGLSALSQQVRDD--- 167 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 167 (443)
|+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9999998654321 1 1357899999999999999999999 799999999999999999999854432210
Q ss_pred -C-------ccccccCCCcccchhhhccC-CCCCCchhhhhhhHHHHHHhhCCCCCCCC
Q 013407 168 -G-------LLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (443)
Q Consensus 168 -~-------~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~ 217 (443)
. .......++.|++|+.-.-. ...-...+.++.|+-+|.++|+..|+-+.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 01122368889999864322 11124578899999999999999887543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.1e-23 Score=195.59 Aligned_cols=190 Identities=25% Similarity=0.383 Sum_probs=142.0
Q ss_pred CCCCcceEEEEEE---------------------------eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHH
Q 013407 69 KHPNVVRLYEVMG---------------------------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121 (443)
Q Consensus 69 ~hpnIv~l~~~~~---------------------------~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~ 121 (443)
+|||||+++..|. ....+|+||..+.. +|..++-. ...+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHHHH
Confidence 5999999987652 24568999998864 88888765 4467778888999999
Q ss_pred HHHHHHHHCCcEeeeCCCCcEEEc--cCC--CeEEeecCccccccccc----CCCccccccCCCcccchhhhccCC----
Q 013407 122 NAVDYCHSRGVYHRDLKPENLLLD--AYG--NLKVSDFGLSALSQQVR----DDGLLHTTCGTPNYVAPEVLNDRG---- 189 (443)
Q Consensus 122 ~aL~~LH~~givHrDlkp~NILl~--~~~--~~kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~APEvl~~~~---- 189 (443)
+|+.|||.+||.|||+|.+|||+. +++ .+.|+|||++---+..+ ........-|...-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999994 333 48999999864221110 011112345788899999985432
Q ss_pred -CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHH-HHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChh
Q 013407 190 -YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY-KKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIP 260 (443)
Q Consensus 190 -~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~ 260 (443)
.+-.++|.|++|.+.||++...-||.+...+.+- ...... -...|..+++.+++|+..+|++||++|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 2236899999999999999999999875433221 111122 3456777999999999999999999999854
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=180.61 Aligned_cols=133 Identities=20% Similarity=0.265 Sum_probs=107.5
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-----CCCCcceEEEEEEeCC---EEE
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-----KHPNVVRLYEVMGSKT---KIF 87 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 87 (443)
.+.||+|+||.||. ++.++.. +||++...... ..+.+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 7666665 79998764321 346789999999999 5799999999998874 434
Q ss_pred -EEEec--cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCcEeeeCCCCcEEEccC----CCeEEeecCc
Q 013407 88 -IVLEF--VTGGELFDKIVNHGRMKEDEARRYFQQLINAV-DYCHSRGVYHRDLKPENLLLDAY----GNLKVSDFGL 157 (443)
Q Consensus 88 -lv~E~--~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL-~~LH~~givHrDlkp~NILl~~~----~~~kl~DFGl 157 (443)
+|||| +.+|+|.+++.. +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 557999999976 456666 35678888777 99999999999999999999743 3799999553
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-21 Score=181.73 Aligned_cols=144 Identities=19% Similarity=0.247 Sum_probs=116.1
Q ss_pred cEEEEeEeeccCcEEEEEEE-ECCCCceEEEEEeechhhhh---------------------HHHHHHHHHHHHHHhcCC
Q 013407 12 KYEVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLK---------------------HKMAEQIKREVATMKLVK 69 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~-~~~~~~~vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 69 (443)
-|.+.+.||+|++|.||+|. +..+|+.||+|++....... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999999 66789999999997543110 011235678999999997
Q ss_pred CC--CcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeeeCCCCcEEEcc
Q 013407 70 HP--NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG-VYHRDLKPENLLLDA 146 (443)
Q Consensus 70 hp--nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NILl~~ 146 (443)
+. .+.++++. ...|+||||+.|++|.........+....+..++.||+.++.+||+.| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34455543 235899999999888766545556777778899999999999999999 99999999999999
Q ss_pred CCCeEEeecCcccc
Q 013407 147 YGNLKVSDFGLSAL 160 (443)
Q Consensus 147 ~~~~kl~DFGla~~ 160 (443)
++.++|+|||.|..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999998874
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=179.80 Aligned_cols=244 Identities=21% Similarity=0.362 Sum_probs=194.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..++...+..+|...-.|+.|+|++. |..+++|++...... ......+..|.-.|+-+.||||+.+++.+.+..+..
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 44556667778899999999999985 445788888664432 223467888999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCC--cEeeeCCCCcEEEccCCCeEEe--ecCccccc
Q 013407 88 IVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVS--DFGLSALS 161 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kl~--DFGla~~~ 161 (443)
++..|++.|+|+..+..... ++..++.++..+++.|+.|||+.. |----|....+++|++-..+|+ |--++ +
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--f 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--F 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--e
Confidence 99999999999999976543 677889999999999999999974 3334588889999998776664 32111 1
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCC--CCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHh--hcCccCCCCCC
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYD--GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPWL 237 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~--~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~ 237 (443)
+. ....-+|.|||||.+..++.+ -..+|+||+++++|||-|.+.||.+.++++---+| .......||.+
T Consensus 342 qe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi 414 (448)
T KOG0195|consen 342 QE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI 414 (448)
T ss_pred ec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc
Confidence 11 112347899999999876544 35689999999999999999999998877654444 34467899999
Q ss_pred CHHHHHHHHHhcCCCCCCCCChhhhh
Q 013407 238 SFTARKLIARILDPNPMTRITIPEIL 263 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~t~~eil 263 (443)
+.....|++-|++.||.+||.++.|.
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999999988764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=202.48 Aligned_cols=197 Identities=25% Similarity=0.343 Sum_probs=160.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKT 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~ 84 (443)
.-..+|.|-+.||+|+||+||.|.+.. |+.||+|+=.......--...++ +.+|+ -+.|+.+...+.-.+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~------~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQV------MERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHH------HHhhchhhhcchHHHHHHHccCC
Confidence 445689999999999999999999977 99999999766543321111222 23333 234555555555566
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-------CCCeEEeecCc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------YGNLKVSDFGL 157 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-------~~~~kl~DFGl 157 (443)
.-++|+||.+.|+|.+++...+.+++..+..+..|++..|+.||..||||+||||+|.+|.. ..-++|+|||.
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 77899999999999999999899999999999999999999999999999999999999942 23499999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCC
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 212 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~ 212 (443)
|--+............++|-.+-.+|+..++++. ..+|.|.++.+++.||.|+.
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHH
Confidence 8766555555566778899999999999999996 88999999999999999853
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-19 Score=167.06 Aligned_cols=137 Identities=24% Similarity=0.330 Sum_probs=115.5
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhh-----HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+.||+|++|.||+|.+ .|..+++|+........ ......+.+|+.++..+.|++|.....++.+....+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 67789999865432211 1123568899999999999999887777777788999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998865332 7889999999999999999999999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=162.94 Aligned_cols=133 Identities=20% Similarity=0.249 Sum_probs=108.1
Q ss_pred EeeccCcEEEEEEEECCCCceEEEEEeechhhh-----hHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 18 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
.||+|++|.||+|.. +|..+++|........ ......++.+|+.+++.+.|+++....-+.......+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 5678999986543211 111236788999999999988765555555566677999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
++|++|.+.+..... .++.|++.+|.++|+.|++|||++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999888754321 7899999999999999999999999999999 79999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-19 Score=178.75 Aligned_cols=200 Identities=23% Similarity=0.360 Sum_probs=157.8
Q ss_pred HhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCc-EeeeCCCCcE
Q 013407 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGV-YHRDLKPENL 142 (443)
Q Consensus 65 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~gi-vHrDlkp~NI 142 (443)
|+.+.|.|+.++++.+-++...++|.+||..|+|.|.+.. ...++..-...++++|+.||.|+|+..| +|+.+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999987 4567777888899999999999999876 9999999999
Q ss_pred EEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCC------CCCchhhhhhhHHHHHHhhCCCCCCC
Q 013407 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY------DGSTADLWSCGVILFVLLAGYLPFDD 216 (443)
Q Consensus 143 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~------~~~~~DIwSlGvil~~ll~G~~Pf~~ 216 (443)
++|..-.+|++|||+..+..............-...|.|||.+..... -+.+.||||+|++++++++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876532111111112223456999999976422 24668999999999999999999976
Q ss_pred Cc----HHHHHHHhhc-CccCCCCC------CCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 217 SN----LMNLYKKISA-AEFTCPPW------LSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 217 ~~----~~~~~~~i~~-~~~~~~~~------~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.. ..+....+.. +...+-|. ..+++..++++|+..+|..||+++++..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2344444544 33222222 3457899999999999999999999854
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-19 Score=162.72 Aligned_cols=138 Identities=22% Similarity=0.333 Sum_probs=109.5
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH-------------------HHHHHHHHHHHHHhcCCCC--
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-------------------KMAEQIKREVATMKLVKHP-- 71 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hp-- 71 (443)
|.+.+.||+|+||.||+|... +|+.||||++........ .......+|+.++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888899999999999999875 799999999765321000 0112467899999999877
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeE
Q 013407 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (443)
Q Consensus 72 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~k 151 (443)
.++..++ ....+++|||+.|++|...... .....++.+++.++.++|+.|++||||||+||++++++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4555544 2456899999999988654321 34567889999999999999999999999999999999999
Q ss_pred EeecCccccc
Q 013407 152 VSDFGLSALS 161 (443)
Q Consensus 152 l~DFGla~~~ 161 (443)
|+|||++...
T Consensus 166 liDfg~~~~~ 175 (198)
T cd05144 166 IIDWPQMVST 175 (198)
T ss_pred EEECCccccC
Confidence 9999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.1e-20 Score=182.33 Aligned_cols=206 Identities=24% Similarity=0.359 Sum_probs=148.7
Q ss_pred HHHHHHHHHHhcCCCCCcceEEE-------EE-----EeCCEEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHH
Q 013407 56 EQIKREVATMKLVKHPNVVRLYE-------VM-----GSKTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQL 120 (443)
Q Consensus 56 ~~~~~Ei~il~~l~hpnIv~l~~-------~~-----~~~~~~~lv~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qi 120 (443)
....+++-.+....|.+..-+.+ .+ ....+.||.|++|.-.+|.++|.... ..+......++.|+
T Consensus 289 ~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~ 368 (516)
T KOG1033|consen 289 KYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQI 368 (516)
T ss_pred hhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhh
Confidence 34455555555554444433333 11 12346899999999999999997543 35667889999999
Q ss_pred HHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc----CCCccccccCCCcccchhhhccCCCCCCchh
Q 013407 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR----DDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196 (443)
Q Consensus 121 ~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~APEvl~~~~~~~~~~D 196 (443)
..|++| +|.+|||+||.||+...++.+||.|||+.+-..... .........||+.||+||.+.+..|. .++|
T Consensus 369 ~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvd 444 (516)
T KOG1033|consen 369 APAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVD 444 (516)
T ss_pred ccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcc
Confidence 999999 999999999999999999999999999987544432 11123456799999999999998885 9999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCccCCCCCC-CHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 197 LWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCPPWL-SFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 197 IwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
|||||+||++++. =..+|.. ......+..+.++...+. .+....|+.+||.+.|.+||++.+.--|+|.
T Consensus 445 IyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 445 IYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 9999999999997 2233221 122223333433311222 3456799999999999999987777777664
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=180.76 Aligned_cols=138 Identities=20% Similarity=0.227 Sum_probs=112.4
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh-----hhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
.|...+.||+|+||.||++.+.. ..+++|+...... ......+++.+|+.+++.++|++++....+..+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44567899999999999998754 3445554322111 1112246788999999999999999888777777788
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
++||||++|++|.+.+. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998875 356789999999999999999999999999999 678999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-18 Score=156.30 Aligned_cols=138 Identities=24% Similarity=0.391 Sum_probs=101.2
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHH---------------------HHHHHHHHHhcCCCC--C
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE---------------------QIKREVATMKLVKHP--N 72 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hp--n 72 (443)
.+.||+|+||.||+|.+. +|+.||||++............ ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 7899999998754321111111 124677777777543 3
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCe
Q 013407 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNL 150 (443)
Q Consensus 73 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~-~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~ 150 (443)
+.+.++. ...+++|||++|+.+.. .+.. .... ..++.++.+++.++.++|+ .||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKD-VRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhh-hhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 5555553 23589999999854321 1111 1111 6788999999999999999 9999999999999999 8999
Q ss_pred EEeecCccccc
Q 013407 151 KVSDFGLSALS 161 (443)
Q Consensus 151 kl~DFGla~~~ 161 (443)
+++|||.+...
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.8e-17 Score=151.79 Aligned_cols=137 Identities=20% Similarity=0.295 Sum_probs=104.3
Q ss_pred eEee-ccCcEEEEEEEECCCCceEEEEEeechhh----h------hHHHHHHHHHHHHHHhcCCCCCc--ceEEEEEEeC
Q 013407 17 RTIG-EGTFAKVKFARNSETGEPVALKILDKEKV----L------KHKMAEQIKREVATMKLVKHPNV--VRLYEVMGSK 83 (443)
Q Consensus 17 ~~LG-~G~~g~V~~a~~~~~~~~vAiK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~ 83 (443)
..|| .|+.|+||.+... +..++||.+..... . ......++.+|+.++.+|+|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3566 7778888877763 67899998864321 1 11223578899999999998775 6777664332
Q ss_pred -CE---EEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 84 -TK---IFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 84 -~~---~~lv~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
.. .++|||+++| .+|.+.+.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 2599999997 688887754 4566543 578999999999999999999999999999899999999987
Q ss_pred cc
Q 013407 159 AL 160 (443)
Q Consensus 159 ~~ 160 (443)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.7e-18 Score=182.19 Aligned_cols=264 Identities=27% Similarity=0.452 Sum_probs=212.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
...++.+.+.+.+-+|+++.+..+.-..+|...++|+..+.........+.+..+-.++-...+|-++...-.+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 45677888999999999999999988888877777766443221111223344444444334557777666556667889
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc--
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV-- 164 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 164 (443)
+++++|+.|++|..++...+..+++-++.++..+..+++|||+..+.|||++|.|+|...+|+.+++|||........
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999999999999999899999999999999999999999999999999999999999999999999843211100
Q ss_pred --------c------------C-----C--CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC
Q 013407 165 --------R------------D-----D--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (443)
Q Consensus 165 --------~------------~-----~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~ 217 (443)
. . + .......||+.|.+||.+.+... +..+|.|+.|+++++.++|.+||+..
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 0 0 11223568999999999988776 48899999999999999999999999
Q ss_pred cHHHHHHHhhcCccCCCC---CCCHHHHHHHHHhcCCCCCCCCChh---hhhcCcccccc
Q 013407 218 NLMNLYKKISAAEFTCPP---WLSFTARKLIARILDPNPMTRITIP---EILEDEWFKKD 271 (443)
Q Consensus 218 ~~~~~~~~i~~~~~~~~~---~~s~~~~~li~~mL~~dP~~R~t~~---eil~hp~~~~~ 271 (443)
...+.++.|.....+.|. ..+..+++++.+.|..+|.+|..+. +...||+|+..
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 999999999888776554 3789999999999999999999988 88999999853
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.6e-17 Score=139.85 Aligned_cols=132 Identities=23% Similarity=0.305 Sum_probs=112.4
Q ss_pred EEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCEEEEEEec
Q 013407 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~ 92 (443)
+++.||.|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.| +++++++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999843 6799999865432 3568889999999976 5899999988888899999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR---GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
+.|+.+... +......++.+++.++.++|.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998776543 5566678899999999999985 799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.6e-16 Score=157.89 Aligned_cols=254 Identities=19% Similarity=0.205 Sum_probs=192.6
Q ss_pred cEEEEeEeec--cCcEEEEEEEE--CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 013407 12 KYEVGRTIGE--GTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 12 ~y~~~~~LG~--G~~g~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (443)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... .......-.+|+.....+ .|+|.++.+..++..+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCCcc
Confidence 4566778999 99999999998 88999999998432221 111223445677777777 499999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHCCcEeeeCCCCcEEEccC-CCeEEeecCcccc
Q 013407 87 FIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLIN----AVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSAL 160 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qi~~----aL~~LH~~givHrDlkp~NILl~~~-~~~kl~DFGla~~ 160 (443)
|+-+|+|. .+|..+...... +++..++..+.+..+ ||.++|+.+++|-|+||.||++..+ ...+++|||+...
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 99999996 688887766544 899999999999999 9999999999999999999999999 8999999999876
Q ss_pred cccccCCCc---cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC--cHHHHHHHhhcCccCCCC
Q 013407 161 SQQVRDDGL---LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--NLMNLYKKISAAEFTCPP 235 (443)
Q Consensus 161 ~~~~~~~~~---~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~~~ 235 (443)
.....-... .....|..-|++||...+. .+...||+|+|.++.+-.+|..++... +.......+. ....+-.
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~~~ 349 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEFCE 349 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchhhhc
Confidence 544321111 1222577889999998653 357899999999999888877665433 1111111111 0111222
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..+..+...+..|++.+|..|++.+.+++|+++..
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 34667777999999999999999999999999874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-15 Score=158.16 Aligned_cols=146 Identities=21% Similarity=0.394 Sum_probs=101.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh-------------------------------HHHHHH
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------------------HKMAEQ 57 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-------------------------------~~~~~~ 57 (443)
.+..|+. +.||+|++|+||.|+.+.+|+.||||++.+.-... .+..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 78999999999999998889999999997542100 012223
Q ss_pred H------HHHHHHHhcCC----CCCcceEEEEEEe-CCEEEEEEeccCCCchHHH--HHhCC----CCCHHHHHHHHHHH
Q 013407 58 I------KREVATMKLVK----HPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDK--IVNHG----RMKEDEARRYFQQL 120 (443)
Q Consensus 58 ~------~~Ei~il~~l~----hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--i~~~~----~l~e~~~~~~~~qi 120 (443)
+ .+|...+.++. +.+.+.+-.++.+ .+..++||||+.|+.+.+. +...+ .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 3 33444444442 3333333333322 4567899999999999764 33333 25555666677776
Q ss_pred HHHHHHHHHCCcEeeeCCCCcEEEccCC----CeEEeecCcccccc
Q 013407 121 INAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQ 162 (443)
Q Consensus 121 ~~aL~~LH~~givHrDlkp~NILl~~~~----~~kl~DFGla~~~~ 162 (443)
+ ..|++|+|+||.||+++.+| .++++|||++....
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 5 58999999999999999988 89999999987543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.8e-14 Score=145.17 Aligned_cols=140 Identities=21% Similarity=0.365 Sum_probs=96.8
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhh-------------------------------HHHHH------HHH
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------------------HKMAE------QIK 59 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-------------------------------~~~~~------~~~ 59 (443)
+.||.|++|+||+|+.. +|+.||||+..+.-... .+... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999975 68999999986531100 00001 234
Q ss_pred HHHHHHhcCC-----CCCc--ceEEEEEEeCCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHC
Q 013407 60 REVATMKLVK-----HPNV--VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLIN-AVDYCHSR 130 (443)
Q Consensus 60 ~Ei~il~~l~-----hpnI--v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~-aL~~LH~~ 130 (443)
+|...+.++. +++| .+++. ...+..++||||++|++|.+..... .... ...+..+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555552 3332 23332 2234578999999999998766432 1222 2345555555 46789999
Q ss_pred CcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 131 givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
|++|+|++|.||+++.+|.++++|||++....
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.3e-13 Score=141.52 Aligned_cols=170 Identities=17% Similarity=0.327 Sum_probs=131.3
Q ss_pred EEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCC
Q 013407 29 FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM 108 (443)
Q Consensus 29 ~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l 108 (443)
.|..+.++.+|.|.....+.. .....+++-++-|+.++||||+++++.++.++..|+|+|.+. -|-.++.+ +
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---L 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---h
Confidence 456667888999999876543 345678888999999999999999999999999999999984 45555654 3
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhcc
Q 013407 109 KEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 187 (443)
Q Consensus 109 ~e~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~ 187 (443)
+......-+.||+.||.||| ..+++|++|.-..|+++..|..||++|.++........ ......---.|..|+.+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence 37777888999999999998 56899999999999999999999999998764433221 1111111223667776543
Q ss_pred CCCCCCchhhhhhhHHHHHHhhCC
Q 013407 188 RGYDGSTADLWSCGVILFVLLAGY 211 (443)
Q Consensus 188 ~~~~~~~~DIwSlGvil~~ll~G~ 211 (443)
.. -..|.|-|||++++++.|.
T Consensus 180 s~---~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SE---WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cc---cchhhhhHHHHHHHHhCcc
Confidence 33 3469999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=2e-13 Score=124.01 Aligned_cols=142 Identities=15% Similarity=0.224 Sum_probs=105.7
Q ss_pred EeEeeccCcEEEEEEEECC------CCceEEEEEeechhh---------------h----hHHHHH----HHHHHHHHHh
Q 013407 16 GRTIGEGTFAKVKFARNSE------TGEPVALKILDKEKV---------------L----KHKMAE----QIKREVATMK 66 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~------~~~~vAiK~i~~~~~---------------~----~~~~~~----~~~~Ei~il~ 66 (443)
...||.|--+.||.|.... .+..+|||+...... . +.+... ..++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998653 357899998853211 0 011122 3448999999
Q ss_pred cCCC--CCcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEeeeCCCCcEE
Q 013407 67 LVKH--PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC-HSRGVYHRDLKPENLL 143 (443)
Q Consensus 67 ~l~h--pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~L-H~~givHrDlkp~NIL 143 (443)
++.. -++.+++++ ...++||||+.++.+.....++..+++..+..++.|++.+|..+ |+.|++|+||+|.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9953 567777765 45789999998765533223334566677788899999999999 8999999999999999
Q ss_pred EccCCCeEEeecCcccccc
Q 013407 144 LDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 144 l~~~~~~kl~DFGla~~~~ 162 (443)
++ ++.+.|+|||.|...+
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 4789999999876443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-14 Score=146.91 Aligned_cols=252 Identities=21% Similarity=0.168 Sum_probs=190.4
Q ss_pred cccccEEEEeEeeccCcEEEEEEEEC-CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (443)
...++|..+..||.|.|+.|+..... .++..|++|-.........+.. .-..|+.+...+ .|.|+++++..|.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 45678899999999999999987755 5778899998765443332222 223455555555 59999999999988888
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC-CCeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 164 (443)
.|+-.|||.++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.++.+.-
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~- 419 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF- 419 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-
Confidence 88999999999988777655678999999999999999999999999999999999999886 7889999998763111
Q ss_pred cCCCcccccc-CCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCC-CCCCcHHHHHHHhhcCccCCCCCCCHHHH
Q 013407 165 RDDGLLHTTC-GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAAEFTCPPWLSFTAR 242 (443)
Q Consensus 165 ~~~~~~~~~~-gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~P-f~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 242 (443)
...... ++..|-.+|++........++|++|||.-+++.++|... +.+ ..+..+..+..+..+..+..+.
T Consensus 420 ----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----~~~~~i~~~~~p~~~~~~~~~q 491 (524)
T KOG0601|consen 420 ----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----VQSLTIRSGDTPNLPGLKLQLQ 491 (524)
T ss_pred ----ecccccccccccccchhhccccccccccccccccccccccccCcccCccc----ccceeeecccccCCCchHHhhh
Confidence 001111 233342345544433345889999999999999988643 222 2344556666666666668899
Q ss_pred HHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 243 KLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
.+...|+.+++..|+.+.++..|+=|.
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccchhh
Confidence 999999999999999999988876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.2e-13 Score=120.16 Aligned_cols=127 Identities=20% Similarity=0.291 Sum_probs=96.7
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEeccC
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~ 94 (443)
++.|+.|.++.||++... +..|++|+...... ......+|+.+++.+.+.++ .+++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999864 77899999765321 12245789999998865444 45555443 33579999999
Q ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----EeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV-----YHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 95 gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~gi-----vHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
|.++.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887542 11123467899999999999985 9999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.6e-13 Score=99.28 Aligned_cols=61 Identities=57% Similarity=0.928 Sum_probs=48.4
Q ss_pred CCcccchhhhhhcCCCCCCcccCccccc--ccccceEEecCCHHHHHHHHHHHhccCCcEEEe
Q 013407 311 QPVAMNAFELISLSKGLNLGNLFDAEQD--FKRETRFTSRCPANEIINKIEEAAKPLGFDVHK 371 (443)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~ 371 (443)
+|..+|||++||+|+|+||++||+..+. +++.+||+|..+++.|+++||++++.+|+.|++
T Consensus 1 ~p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 1 KPKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp --EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CCccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 3678999999999999999999986543 578899999999999999999999999999874
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=123.87 Aligned_cols=202 Identities=15% Similarity=0.260 Sum_probs=141.6
Q ss_pred HHhcCCCCCcceEEEEEEeC-----CEEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--c
Q 013407 64 TMKLVKHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG--V 132 (443)
Q Consensus 64 il~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g--i 132 (443)
.+-.+-|.|+|+++.++.+. ....++.||+..|+|..++++. ..+......+|+.||++||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34455699999999998654 4478999999999999998753 46888889999999999999999984 9
Q ss_pred EeeeCCCCcEEEccCCCeEEeecCcccccccccC--CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhC
Q 013407 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 210 (443)
Q Consensus 133 vHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G 210 (443)
+|+++.-..|++..+|-+|+.--.-......... ........|-++|.|||.=..... ..++|||++|....+|..|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHh
Confidence 9999999999999988888753221111000000 011122346788999996433333 3578999999999999888
Q ss_pred CCCC-CCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 211 YLPF-DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 211 ~~Pf-~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
..-- .+.+....-..+...-+.. -...-+.++.+||+..|..||++.+++.||..-
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred eeccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 6542 2222222222222211111 122346788999999999999999999999754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.5e-11 Score=107.21 Aligned_cols=134 Identities=21% Similarity=0.273 Sum_probs=100.8
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHH-----HHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-----MAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
..+++|+-+.+|.+.. -|..+++|.=.+.....++ ...+..+|.+++.++.--.|.-.+=+.-+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578999999999865 3445777764433332222 23567889999999975555444444455677789999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
|++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||.+... ++.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 99998888888765 24567777778888999999999999999999874 499999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7e-11 Score=103.96 Aligned_cols=145 Identities=23% Similarity=0.254 Sum_probs=108.7
Q ss_pred EEeEeeccCcEEEEEEEECCCCceEEEEEeechhh-----hhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
....|-+|+-+.|+.+.. .|+...||.=..... ...-...+.++|++++.++.--.|.-..=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567899999999999986 678878886433322 2222346788999999998755555544456666677899
Q ss_pred EeccCC-CchHHHHHhCC-CCCHHH-HHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC---eEEeecCccccc
Q 013407 90 LEFVTG-GELFDKIVNHG-RMKEDE-ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALS 161 (443)
Q Consensus 90 ~E~~~g-g~L~~~i~~~~-~l~e~~-~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~---~kl~DFGla~~~ 161 (443)
|||++| .++.+++.... .-.++. ...++++|-+.+.-||.++++|+||..+||++..+|+ +-++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 46677776543 223333 3688999999999999999999999999999977664 589999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=116.43 Aligned_cols=211 Identities=20% Similarity=0.248 Sum_probs=157.0
Q ss_pred cEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCEEEEEEeccCC-Cch
Q 013407 24 FAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTG-GEL 98 (443)
Q Consensus 24 ~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~~~g-g~L 98 (443)
-.+.|+|....+|..|++|.++..+.... .....-+++++++.|+|||++.+++.+ +..+.+|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 46789999999999999999965443322 233445778899999999999999863 4578999999986 667
Q ss_pred HHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 99 FDKIVN---------------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 99 ~~~i~~---------------~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
.++.-. +...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+..++|+..|...+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 665422 22478999999999999999999999999999999999999988888887776554332
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCC-CCCCcHHHH-HHHhhcCccCCCCCCCHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNL-YKKISAAEFTCPPWLSFTA 241 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~P-f~~~~~~~~-~~~i~~~~~~~~~~~s~~~ 241 (443)
.. + |.+.+. .+-|.=-||.++..|.+|..- |........ ...|. +.+|.++
T Consensus 446 d~---------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------~~yS~D~ 498 (655)
T KOG3741|consen 446 DP---------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------TTYSTDL 498 (655)
T ss_pred CC---------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------hhhhHHH
Confidence 11 0 122221 345999999999999999543 222222222 22222 3478899
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcC
Q 013407 242 RKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+++|.-+...++.. -++.+++.+
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999999887 688888865
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.7e-11 Score=111.41 Aligned_cols=140 Identities=21% Similarity=0.314 Sum_probs=107.4
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeC---CEEEEEEe
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSK---TKIFIVLE 91 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lv~E 91 (443)
+.||.|..+.||++...+ |+.+++|+....... .....+.+|..+++.+.+ .++.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 678999999999998743 678999997654321 123568899999999975 4467777776654 36789999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS------------------------------------------ 129 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~------------------------------------------ 129 (443)
|++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888665432 356777777788888888888873
Q ss_pred --------------CCcEeeeCCCCcEEEcc--CCCeEEeecCcccc
Q 013407 130 --------------RGVYHRDLKPENLLLDA--YGNLKVSDFGLSAL 160 (443)
Q Consensus 130 --------------~givHrDlkp~NILl~~--~~~~kl~DFGla~~ 160 (443)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.4e-11 Score=122.92 Aligned_cols=152 Identities=20% Similarity=0.357 Sum_probs=114.6
Q ss_pred HHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCcccccccccC-------CCccccccCCCcccchhhhccCCC
Q 013407 119 QLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-------DGLLHTTCGTPNYVAPEVLNDRGY 190 (443)
Q Consensus 119 qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-------~~~~~~~~gt~~y~APEvl~~~~~ 190 (443)
+.+.|+.|+|.. +++|++|.|++|.++.+|.+||+.|+++........ ........-...|.|||.+... .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-T 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-c
Confidence 444899999965 899999999999999999999999998764333111 1111122345689999999874 4
Q ss_pred CCCchhhhhhhHHHHHHh-hCCCCCCCCcHHHHHHH----hhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 191 DGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKK----ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 191 ~~~~~DIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+.++|++|+||++|.+. .|+.-+...+....+.. ...+.+..+..+++++++-|.++|..++..||++..++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 468899999999999998 56666665543332222 1222344456689999999999999999999999999999
Q ss_pred cccccc
Q 013407 266 EWFKKD 271 (443)
Q Consensus 266 p~~~~~ 271 (443)
|||...
T Consensus 266 ~ff~D~ 271 (700)
T KOG2137|consen 266 PFFSDP 271 (700)
T ss_pred cccCCc
Confidence 999854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.3e-10 Score=99.94 Aligned_cols=127 Identities=24% Similarity=0.388 Sum_probs=84.2
Q ss_pred EEEEEEECCCCceEEEEEeechh-----------------------hhhHHHHHHHHHHHHHHhcCCCC--CcceEEEEE
Q 013407 26 KVKFARNSETGEPVALKILDKEK-----------------------VLKHKMAEQIKREVATMKLVKHP--NVVRLYEVM 80 (443)
Q Consensus 26 ~V~~a~~~~~~~~vAiK~i~~~~-----------------------~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~ 80 (443)
.||.|... .|..+|+|+..... ....-.....++|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48889874 57789999884311 01111235788999999999765 577777653
Q ss_pred EeCCEEEEEEeccC--CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCcEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 81 GSKTKIFIVLEFVT--GGELFDKIVNHGRMKEDEARRYFQQLINAVDY-CHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 81 ~~~~~~~lv~E~~~--gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~-LH~~givHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
...|||||+. |..+.. +.. ..++.+....++.+++..+.. +|+.||+|+||.+.||+++++ .+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~-~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKD-VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHH-CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhh-HHh-ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3469999998 655533 322 122245567788888885555 579999999999999999886 999999998
Q ss_pred ccc
Q 013407 158 SAL 160 (443)
Q Consensus 158 a~~ 160 (443)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.1e-08 Score=97.97 Aligned_cols=132 Identities=17% Similarity=0.091 Sum_probs=93.4
Q ss_pred EEEEEEECCCCceEEEEEeechhhhh---H-----HHHHHHHHHHHHHhcCCCCC--cceEEEEEEe-----CCEEEEEE
Q 013407 26 KVKFARNSETGEPVALKILDKEKVLK---H-----KMAEQIKREVATMKLVKHPN--VVRLYEVMGS-----KTKIFIVL 90 (443)
Q Consensus 26 ~V~~a~~~~~~~~vAiK~i~~~~~~~---~-----~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~-----~~~~~lv~ 90 (443)
.|..+.. .|+.|.||......... . .-.....+|...+.+|..-+ ++.++.+... ...-++||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3445443 56789999764322110 0 00114778999988884333 3444444432 23578999
Q ss_pred eccCCC-chHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-------CCCeEEeecCccc
Q 013407 91 EFVTGG-ELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------YGNLKVSDFGLSA 159 (443)
Q Consensus 91 E~~~gg-~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-------~~~~kl~DFGla~ 159 (443)
|++++. +|.+.+.. ....++.....++.+++..+.-||..||+|+|++|.|||++. +..+.++||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999986 78887753 345667788899999999999999999999999999999975 4679999999775
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.8e-09 Score=96.72 Aligned_cols=136 Identities=22% Similarity=0.348 Sum_probs=103.6
Q ss_pred EEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh-----------------hh--HHHHHHHHHHHHHHhcCCCC--C
Q 013407 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----------------LK--HKMAEQIKREVATMKLVKHP--N 72 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-----------------~~--~~~~~~~~~Ei~il~~l~hp--n 72 (443)
.++..||-|--|.||.|.+. .|..+|||.=..... .+ .-.....++|..+|.+|... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46688999999999999986 688899996421100 00 11234678999999999654 7
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEE
Q 013407 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (443)
Q Consensus 73 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl 152 (443)
|.+.+++ +...+||||+.|-.|... +++.+.+..++..|+.-+.-+-..|++|+|+++-||+++++|.+.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 8888764 567799999999777542 2235556667777777777777999999999999999999999999
Q ss_pred eecCccc
Q 013407 153 SDFGLSA 159 (443)
Q Consensus 153 ~DFGla~ 159 (443)
+||--+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9998654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.1e-08 Score=90.67 Aligned_cols=105 Identities=19% Similarity=0.357 Sum_probs=84.9
Q ss_pred HHHHHHHHHHhcCCC--CCcceEEEEEEeC----CEEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 013407 56 EQIKREVATMKLVKH--PNVVRLYEVMGSK----TKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128 (443)
Q Consensus 56 ~~~~~Ei~il~~l~h--pnIv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH 128 (443)
.+..+|...+..|.. =.+.+.+.+.... ...++|+|+++|. +|.+.+......+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 467889988888853 2345555555442 2458999999984 78888876555778888999999999999999
Q ss_pred HCCcEeeeCCCCcEEEccCC---CeEEeecCcccc
Q 013407 129 SRGVYHRDLKPENLLLDAYG---NLKVSDFGLSAL 160 (443)
Q Consensus 129 ~~givHrDlkp~NILl~~~~---~~kl~DFGla~~ 160 (443)
..||+|+|++|.|||++.++ .+.++||+.+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 799999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.3e-07 Score=87.80 Aligned_cols=139 Identities=19% Similarity=0.229 Sum_probs=100.5
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHH---------------------HHHHHHHHHHHHhcCC--CCCc
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK---------------------MAEQIKREVATMKLVK--HPNV 73 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~---------------------~~~~~~~Ei~il~~l~--hpnI 73 (443)
..|++|--+.||+|.. .++..+|+|+.......-.. ......+|+..|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4677888889999986 45788999998643321111 1234667888888884 4556
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCc-hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeE
Q 013407 74 VRLYEVMGSKTKIFIVLEFVTGGE-LFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLK 151 (443)
Q Consensus 74 v~l~~~~~~~~~~~lv~E~~~gg~-L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~k 151 (443)
.+.+.+.. -.+||||+.... -.-.+. +.++..+++..+..++++.+.-|-. .|++|+||+.-|||+. ++.+.
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 67776553 459999996531 111221 2234444789999999999998877 8999999999999999 78999
Q ss_pred EeecCcccccc
Q 013407 152 VSDFGLSALSQ 162 (443)
Q Consensus 152 l~DFGla~~~~ 162 (443)
|+|||-|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999876544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.7e-10 Score=113.80 Aligned_cols=246 Identities=19% Similarity=0.200 Sum_probs=169.3
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeC
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSK 83 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~ 83 (443)
...-+...|....-+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-++.+
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E 306 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGE 306 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcc
Confidence 33445556667778899999999999887665544 6666542 24556889999999999 77777778888
Q ss_pred CEEEEEEeccCCC-chHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 84 TKIFIVLEFVTGG-ELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 84 ~~~~lv~E~~~gg-~L~~~i-~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
...++.|+++.++ +-..-+ ...-.+.+-+.....+.-+.+++++|+.-=+||| ||+..+ +..|..||+....+
T Consensus 307 ~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 307 DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc
Confidence 8999999999887 211111 1111233334445566667889999998778998 888766 78899999987644
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--cCC---CCC
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTC---PPW 236 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~---~~~ 236 (443)
... ....+..+|+.++|||+.....++ .+.|.||+|+--.+|.-|.+|-..+... ...+..+. +.. ..|
T Consensus 382 ~~~---~~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~p~s~~L~~~~aw 455 (829)
T KOG0576|consen 382 TRT---MKPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNGPNSPMLTDKSAW 455 (829)
T ss_pred Ccc---cccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCCCCccccchhhhc
Confidence 322 134567799999999999888887 6789999999877888888876542110 00010000 000 012
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
-...-+++...|+..-|..|+....++.|.+|..
T Consensus 456 ~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 456 SPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 2222234777899999999999999998888864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.7e-07 Score=90.84 Aligned_cols=233 Identities=21% Similarity=0.246 Sum_probs=149.0
Q ss_pred EEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEE------EEEeCCE-E
Q 013407 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE------VMGSKTK-I 86 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~------~~~~~~~-~ 86 (443)
.++.||+|+-+.+|-.-... ..+.|+.+....... .+ .+..|... .||-+-.=+. +..+.+. +
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~---aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ---AQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHH---HH---HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 46789999999998654321 246788876543211 11 12223333 5664433111 1122333 6
Q ss_pred EEEEeccCCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 87 FIVLEFVTGGELFDKIVN-------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-------~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
-++|..++|..--..+-+ ......+-+.+..+.|+.+...||..|.+-+|+.++|+|+++++.+.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 788888887543222211 1235667788899999999999999999999999999999999999999854322
Q ss_pred ccccccCCCccccccCCCcccchhhhc-----cCCCCCCchhhhhhhHHHHHHhhC-CCCCCCCcH----HHHHH-Hhhc
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNL----MNLYK-KISA 228 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~----~~~~~-~i~~ 228 (443)
+. ..+......+|.+.|.+||.-. +-+- ....|.|.||++++++|.| +.||.+-.. ...++ .|..
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 11 1222334567999999999854 2222 3568999999999999886 999975210 01111 2222
Q ss_pred Ccc-----------CCC---CC--CCHHHHHHHHHhcCCC--CCCCCChh
Q 013407 229 AEF-----------TCP---PW--LSFTARKLIARILDPN--PMTRITIP 260 (443)
Q Consensus 229 ~~~-----------~~~---~~--~s~~~~~li~~mL~~d--P~~R~t~~ 260 (443)
+.+ +.| || ++++++.|..+|+... +.-|||++
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 211 111 22 6889999999999653 56899865
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.7e-07 Score=86.12 Aligned_cols=139 Identities=18% Similarity=0.294 Sum_probs=91.6
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHH------HHHHHHHHHhcCCC---CCcceEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE------QIKREVATMKLVKH---PNVVRLYEVM 80 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~------~~~~Ei~il~~l~h---pnIv~l~~~~ 80 (443)
-++|.+.+.+-......|.+..- +|+.+++|....+....+.... ...+++..+..+.. .....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 35788888888888887876654 5788999987654322222111 13344444444432 2233322222
Q ss_pred -----EeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeec
Q 013407 81 -----GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 81 -----~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DF 155 (443)
.-....+++|||++|..|.+.. .++++ +...|.+++.-+|+.|++|+|..|.|++++.+ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch----hcCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 1234567899999998876543 13332 44667788999999999999999999999864 5999999
Q ss_pred Cccc
Q 013407 156 GLSA 159 (443)
Q Consensus 156 Gla~ 159 (443)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.1e-07 Score=85.15 Aligned_cols=133 Identities=16% Similarity=0.188 Sum_probs=84.4
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC--cceEEEEEEeCCEEEEEEeccC
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~ 94 (443)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+++..+.+...++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999974 24568899876422 1245789999999986433 5778888888888899999999
Q ss_pred CCc-hHHH--------------HHh-----C----CCCCHHH-HHHHHHHH----------HHH-HHHHH----HCCcEe
Q 013407 95 GGE-LFDK--------------IVN-----H----GRMKEDE-ARRYFQQL----------INA-VDYCH----SRGVYH 134 (443)
Q Consensus 95 gg~-L~~~--------------i~~-----~----~~l~e~~-~~~~~~qi----------~~a-L~~LH----~~givH 134 (443)
|.. +... +.. + ...+... ...+..++ ... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 1111 100 0 0111000 00111111 111 11222 124789
Q ss_pred eeCCCCcEEEccCCCeEEeecCccc
Q 013407 135 RDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 135 rDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
+|+.|.||++++++ +.++||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.3e-07 Score=97.98 Aligned_cols=136 Identities=24% Similarity=0.389 Sum_probs=90.1
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhh-------------------------------HHHHH------HHH
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------------------HKMAE------QIK 59 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-------------------------------~~~~~------~~~ 59 (443)
..|+.++-|+||.|+.+. |+.||||+..+.-... .+..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 679999999999999864 9999999986421000 01111 234
Q ss_pred HHHHHHhcCC-----CCCcceEEEEEEeCCEEEEEEeccCCCchHHH--HHhCCCCCHHH-----HHHHHHHHHHHHHHH
Q 013407 60 REVATMKLVK-----HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK--IVNHGRMKEDE-----ARRYFQQLINAVDYC 127 (443)
Q Consensus 60 ~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~--i~~~~~l~e~~-----~~~~~~qi~~aL~~L 127 (443)
+|...+.+++ .|+|.=..=+++-.+.-.++|||+.|-.+.+. +.. .+.+... +..++.|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~------- 281 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQL------- 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHH-------
Confidence 4555555542 23332222233345667899999999888766 444 4455332 33333333
Q ss_pred HHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 128 H~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
-..|++|.|..|.||+++.+|.+.+.|||+....
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 3489999999999999999999999999987654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.5e-07 Score=81.92 Aligned_cols=138 Identities=16% Similarity=0.139 Sum_probs=97.9
Q ss_pred eccCcEEEEEEEECCCCceEEEEEeechhhhh---HHHHHHHHHHHHHHhcCCC--CCcceEEEE--EEeC--CEEEEEE
Q 013407 20 GEGTFAKVKFARNSETGEPVALKILDKEKVLK---HKMAEQIKREVATMKLVKH--PNVVRLYEV--MGSK--TKIFIVL 90 (443)
Q Consensus 20 G~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~h--pnIv~l~~~--~~~~--~~~~lv~ 90 (443)
|+|+-+.|+.... .|+.+-+|.-....... +.-...+.+|+..+++|.. -.+.+.... .... -.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688888988665 34467788654111000 1124678999999999853 224554421 1111 2367999
Q ss_pred eccCC-CchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC--eEEeecCccc
Q 013407 91 EFVTG-GELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSA 159 (443)
Q Consensus 91 E~~~g-g~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~--~kl~DFGla~ 159 (443)
|-+.| .+|.+.+... .+.++.....++.+++.++.-||+.|+.|+|+-|.||+++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 6777777553 34577778899999999999999999999999999999987777 9999998654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.3e-06 Score=81.14 Aligned_cols=137 Identities=20% Similarity=0.320 Sum_probs=82.5
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CcceEEEEE---EeCCEEEEEE
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEVM---GSKTKIFIVL 90 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lv~ 90 (443)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+... -+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4789999999999999855 48999997654 2356778899998888533 356666643 2344679999
Q ss_pred eccCCCchHH----------------HHH---hC----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 013407 91 EFVTGGELFD----------------KIV---NH----GRMKEDE------ARRY---------------FQQLIN-AVD 125 (443)
Q Consensus 91 E~~~gg~L~~----------------~i~---~~----~~l~e~~------~~~~---------------~~qi~~-aL~ 125 (443)
++++|..+.. .+. .. ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 110 11 0111000 0000 111222 233
Q ss_pred HHHH-------CCcEeeeCCCCcEEEc-cCCCeEEeecCccc
Q 013407 126 YCHS-------RGVYHRDLKPENLLLD-AYGNLKVSDFGLSA 159 (443)
Q Consensus 126 ~LH~-------~givHrDlkp~NILl~-~~~~~kl~DFGla~ 159 (443)
.+++ .+++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 3599999999999999 55666799999765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.7e-06 Score=94.69 Aligned_cols=203 Identities=18% Similarity=0.209 Sum_probs=145.0
Q ss_pred HHHHHHHHHHhcCCCCCcceEEEEEEeCCE----EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013407 56 EQIKREVATMKLVKHPNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131 (443)
Q Consensus 56 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~g 131 (443)
....-|+..+..+.|+|++.++.+...... ..+..|+++..++...+..-+..+.+.++.+..+++.|+.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 344557777888899999999988654332 3355689999999999999999999999999999999999999997
Q ss_pred cEeeeCCCC---cEEEccCCCeEEe--ecCcccccccccCCCccccccCCCcccchhhhccCCCC-CCchhhhhhhHHHH
Q 013407 132 VYHRDLKPE---NLLLDAYGNLKVS--DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD-GSTADLWSCGVILF 205 (443)
Q Consensus 132 ivHrDlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~-~~~~DIwSlGvil~ 205 (443)
..|.-+... +-..+..+...++ ||+.+...... .......-+.-+.|||....+.+. +...|+|++|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~---~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN---EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCc---ccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 666665555 4444556667776 88876643322 222233345668888887665553 12369999999999
Q ss_pred HHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 206 VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 206 ~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.+..|..+-....... .. .+........+++.+|+..++++|+++.+++.|||.+.
T Consensus 384 ~~~~~~~i~~~~~~~~---~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVPV---SL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhcCcccccccchh---hh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 9988765532111100 00 00111126788999999999999999999999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.30 E-value=5.3e-06 Score=78.40 Aligned_cols=134 Identities=16% Similarity=0.117 Sum_probs=82.6
Q ss_pred eeccCc-EEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 013407 19 IGEGTF-AKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (443)
Q Consensus 19 LG~G~~-g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~gg 96 (443)
|..|.. +.||++... +..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444444 789988753 4678899875432 235677898888883 444667888777777789999999997
Q ss_pred chHHHHH----------------hCCCCCH-----H-HHHHHHHH-----------------------HHHHHHHHH---
Q 013407 97 ELFDKIV----------------NHGRMKE-----D-EARRYFQQ-----------------------LINAVDYCH--- 128 (443)
Q Consensus 97 ~L~~~i~----------------~~~~l~e-----~-~~~~~~~q-----------------------i~~aL~~LH--- 128 (443)
.|..... .-..++. . .....+.+ +...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 6643210 0000100 0 00000000 111112221
Q ss_pred ----HCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 129 ----SRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 129 ----~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
...++|+|+.|.||++++++.+.|+||+.+..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 13489999999999999977788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.26 E-value=1e-05 Score=89.75 Aligned_cols=80 Identities=19% Similarity=0.336 Sum_probs=57.6
Q ss_pred EeEeeccCcEEEEEEEECCCC--ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCc--ceEEEEEEeC---CEEE
Q 013407 16 GRTIGEGTFAKVKFARNSETG--EPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNV--VRLYEVMGSK---TKIF 87 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~~ 87 (443)
++.|+.|.+..+|+......+ ..+++|+........ ....+.+|..+|+.+. |++| .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 567899999999998765432 467888765432211 1346889999999995 6665 7888877664 4678
Q ss_pred EEEeccCCCc
Q 013407 88 IVLEFVTGGE 97 (443)
Q Consensus 88 lv~E~~~gg~ 97 (443)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.9e-05 Score=70.92 Aligned_cols=133 Identities=20% Similarity=0.307 Sum_probs=94.5
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechh-------------hhhHHHHHHHHHHHHHHhcCC------CCCcceEE
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEK-------------VLKHKMAEQIKREVATMKLVK------HPNVVRLY 77 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~-------------~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~ 77 (443)
..||+|+.-.||.- + .+....||++.... ........+..+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999998843 2 34457999997755 001112355667777766665 78999999
Q ss_pred EEEEeCCEEEEEEeccCC------CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC---
Q 013407 78 EVMGSKTKIFIVLEFVTG------GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG--- 148 (443)
Q Consensus 78 ~~~~~~~~~~lv~E~~~g------g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~--- 148 (443)
|+.+++.-.-+|+|.+.. -+|.+++.. +.+++ . +...+-+-..||-+.+|+.+|++|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998753 346666643 45666 3 333444556688999999999999999996543
Q ss_pred -CeEEee-cCc
Q 013407 149 -NLKVSD-FGL 157 (443)
Q Consensus 149 -~~kl~D-FGl 157 (443)
.+.|+| ||-
T Consensus 159 ~~lvlIDG~G~ 169 (199)
T PF10707_consen 159 FRLVLIDGLGE 169 (199)
T ss_pred eEEEEEeCCCC
Confidence 477887 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.5e-07 Score=102.98 Aligned_cols=256 Identities=16% Similarity=0.077 Sum_probs=164.5
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh--HHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KT 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 84 (443)
.+..|++.=.+|.|.++.-..-+.+..+ +.+|+...-...+ +...+-+..|..-++...|+++...+.-..+ ..
T Consensus 1227 ~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred HhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 3445666555666665543222222222 3455443211111 1122334445556667789988877665543 34
Q ss_pred EEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeeeCCCCcEEEccCCCeEEeec
Q 013407 85 KIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NILl~~~~~~kl~DF 155 (443)
..|..++|+.+|.+++.|.+. ..+.+.-+....++.+.+..-+|+.. .+|+++|+-|.+|..+-++|++++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 578999999999999999764 23445555555566688888888652 689999999999999999999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCC
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCP 234 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~ 234 (443)
|+.++..+ .........+++.|++|++...-.+. .++|+|..|+-+|....|..||-.-....+...+..+.+ ..+
T Consensus 1385 gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe 1461 (2724)
T KOG1826|consen 1385 GLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIE 1461 (2724)
T ss_pred ccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCccccccccccc
Confidence 99884322 12233456788999999998777775 569999999999999999888754333333333333322 233
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 235 ~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
...|.++-.....+|-..-..||.-...+.-+.|.
T Consensus 1462 ~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1462 KLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred ccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 33445555555556666667778777777666553
|
|
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.2e-05 Score=55.27 Aligned_cols=43 Identities=16% Similarity=0.321 Sum_probs=37.9
Q ss_pred cceEEEEEEEEEc-CCeeEEEEEecCCCchHHHHHHHHHHHhcc
Q 013407 387 GNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHKFYKNLSTCLE 429 (443)
Q Consensus 387 ~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~~~~~~~l~ 429 (443)
..+.|.++|+++. .+++.|+|+|.+||.+.|+++|.+|...|+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR 46 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence 4689999999998 899999999999999999999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.2e-05 Score=73.87 Aligned_cols=73 Identities=10% Similarity=0.059 Sum_probs=46.3
Q ss_pred EeEeeccCcE-EEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC---CcceEEEEEEeC---CEEEE
Q 013407 16 GRTIGEGTFA-KVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP---NVVRLYEVMGSK---TKIFI 88 (443)
Q Consensus 16 ~~~LG~G~~g-~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~l 88 (443)
++.|+.|+.. .||... ..+++|+..... ....+.+|..+++.+... -+.+.++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567777666 488752 347888754321 234788999999888532 345555544332 24588
Q ss_pred EEeccCCCch
Q 013407 89 VLEFVTGGEL 98 (443)
Q Consensus 89 v~E~~~gg~L 98 (443)
+|++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.8e-05 Score=67.90 Aligned_cols=127 Identities=19% Similarity=0.308 Sum_probs=92.1
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcc-eEEEEEEeCCEEEEEEeccC
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV-RLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lv~E~~~ 94 (443)
.+.||+|.+|.||++... |..+|+|+-..+. ....+..|.++|..+...++. ++|.+.. .++.|||+.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~ 95 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID 95 (201)
T ss_pred hhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence 467999999999999984 5589999865432 246788999999999876664 4444433 335699999
Q ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCC-CCcEEEccCCCeEEeecCcccc
Q 013407 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK-PENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 95 gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlk-p~NILl~~~~~~kl~DFGla~~ 160 (443)
|-.|.+.-... . ++-+..++++---|-..||-|..|. |..+++-.++.+.|+||..|+.
T Consensus 96 G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 97776544321 1 3334456666556778899999987 6666666667999999998874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.8e-05 Score=79.76 Aligned_cols=139 Identities=24% Similarity=0.355 Sum_probs=85.9
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhh----------------------------HHHHHHH------HHHH
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----------------------------HKMAEQI------KREV 62 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~----------------------------~~~~~~~------~~Ei 62 (443)
+.||..+.|+|++|+.+. |+.||||+-++.--.. .+..+.+ .+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999876 9999999875421000 0111122 2233
Q ss_pred HHH----hcCCCCC------cceEEEEEEeCCEEEEEEeccCCCchH--HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013407 63 ATM----KLVKHPN------VVRLYEVMGSKTKIFIVLEFVTGGELF--DKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130 (443)
Q Consensus 63 ~il----~~l~hpn------Iv~l~~~~~~~~~~~lv~E~~~gg~L~--~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~ 130 (443)
+.. +.+.|-+ |.++|- .-.....++|||+.|.-+. +.|.+.+ ++...+...+.+.. +.-+=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHH--HHHHHhc
Confidence 322 2223444 444433 2245678999999997664 4455544 44443322222221 1223357
Q ss_pred CcEeeeCCCCcEEEcc----CCCeEEeecCccccc
Q 013407 131 GVYHRDLKPENLLLDA----YGNLKVSDFGLSALS 161 (443)
Q Consensus 131 givHrDlkp~NILl~~----~~~~kl~DFGla~~~ 161 (443)
|++|+|=.|.||+++. ++.+.+-|||+....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 8999999999999984 567999999987643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00011 Score=66.85 Aligned_cols=128 Identities=23% Similarity=0.272 Sum_probs=91.0
Q ss_pred ccEEEEeEeeccCc-EEEEEEEECCCCceEEEEEeec---h-------hhhh--------HHHHHHHHHHHHHHhcCC--
Q 013407 11 GKYEVGRTIGEGTF-AKVKFARNSETGEPVALKILDK---E-------KVLK--------HKMAEQIKREVATMKLVK-- 69 (443)
Q Consensus 11 ~~y~~~~~LG~G~~-g~V~~a~~~~~~~~vAiK~i~~---~-------~~~~--------~~~~~~~~~Ei~il~~l~-- 69 (443)
..++.++.||.|+- |.|+++.. .|+.||+|++.. . .... .....-+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 99999986 577999999321 0 0000 012345677888877774
Q ss_pred -CCCc--ceEEEEEEeC------------------CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 013407 70 -HPNV--VRLYEVMGSK------------------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128 (443)
Q Consensus 70 -hpnI--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH 128 (443)
+.++ |+++++..-. ....||.||++... .++. .=+.+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 4566 9999987211 12457888876643 2222 34567778888999
Q ss_pred HCCcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 129 ~~givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
..||+-+|+++.|.. +-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 3489999964
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00014 Score=68.22 Aligned_cols=75 Identities=20% Similarity=0.313 Sum_probs=48.9
Q ss_pred EeEeeccCcEEEEEEEECC-CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCEEEEEEecc
Q 013407 16 GRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVLEFV 93 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~E~~ 93 (443)
++.|..|-...+|++.... .++.|++|+...... ..-...+|+.+++.+... -..+++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4668889899999987543 356789997754221 112345788888888533 3445544432 2 3799999
Q ss_pred CCCch
Q 013407 94 TGGEL 98 (443)
Q Consensus 94 ~gg~L 98 (443)
+|..+
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00028 Score=71.29 Aligned_cols=80 Identities=19% Similarity=0.243 Sum_probs=55.7
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhh--h--HHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEE
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--K--HKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 88 (443)
.+.||.|.+..||++.....++.++||.-...... . .-..++...|.+.|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999998654468999985321100 0 112457778888888863 3567888776 4466789
Q ss_pred EEeccCCCc
Q 013407 89 VLEFVTGGE 97 (443)
Q Consensus 89 v~E~~~gg~ 97 (443)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.81 E-value=7.5e-05 Score=67.78 Aligned_cols=99 Identities=20% Similarity=0.309 Sum_probs=80.1
Q ss_pred HHHHHHHhcCCC-CCcceEEEEEEeCCEEEEEEeccCCCchHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 013407 59 KREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDK---IVNHGRMKEDEARRYFQQLINAVDYCHS---RG 131 (443)
Q Consensus 59 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~---i~~~~~l~e~~~~~~~~qi~~aL~~LH~---~g 131 (443)
..|.-+++.+++ +++++++|++.. +++.||...+++... +..-...+.....+++.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 799999999853 578999987766421 2222346888999999999999999997 35
Q ss_pred cEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 132 ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
+.-.|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 788999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00013 Score=71.02 Aligned_cols=136 Identities=21% Similarity=0.195 Sum_probs=82.8
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CcceEEEE------EEeCCEEE
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEV------MGSKTKIF 87 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~------~~~~~~~~ 87 (443)
.+.|..|....+|+... .+..+++|+.... . ...+..|+.+++.+.+. .+.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56788888889998864 3346899987641 1 24567788888888432 24555432 23345678
Q ss_pred EEEeccCCCchHH--------------HHHh-CCCCCH--------HHHH------------HHHHHHHHHHHHHHH---
Q 013407 88 IVLEFVTGGELFD--------------KIVN-HGRMKE--------DEAR------------RYFQQLINAVDYCHS--- 129 (443)
Q Consensus 88 lv~E~~~gg~L~~--------------~i~~-~~~l~e--------~~~~------------~~~~qi~~aL~~LH~--- 129 (443)
+++++++|..+.. .+.. ...+.. .... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866411 0000 000000 0000 011112233444443
Q ss_pred ----CCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 130 ----RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 130 ----~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999987777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.77 E-value=8.1e-05 Score=70.93 Aligned_cols=133 Identities=14% Similarity=0.185 Sum_probs=77.9
Q ss_pred EeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEeccCCC
Q 013407 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVTGG 96 (443)
Q Consensus 18 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~gg 96 (443)
.+..|-.+.+|+.. .+++.+++|+...... ...-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45678888999887 3566788997643211 110134678999988864333 44444432 36899999986
Q ss_pred chHH----------HH----H---hCC----CCC-HHHHHHHHHHHH---------HHHHHHHH--------CCcEeeeC
Q 013407 97 ELFD----------KI----V---NHG----RMK-EDEARRYFQQLI---------NAVDYCHS--------RGVYHRDL 137 (443)
Q Consensus 97 ~L~~----------~i----~---~~~----~l~-e~~~~~~~~qi~---------~aL~~LH~--------~givHrDl 137 (443)
.+.. .+ . ... .++ ...+..+..++. ..+..+-+ ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5421 11 1 000 111 122223332221 11222211 25899999
Q ss_pred CCCcEEEccCCCeEEeecCcccc
Q 013407 138 KPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 138 kp~NILl~~~~~~kl~DFGla~~ 160 (443)
.|.||++++++ +.++||+.|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00048 Score=67.52 Aligned_cols=139 Identities=24% Similarity=0.247 Sum_probs=81.4
Q ss_pred EEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CcceEEEE------EEeCCE
Q 013407 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEV------MGSKTK 85 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~------~~~~~~ 85 (443)
..++.++.|....+|++.. .+| .+++|+..... . ...+..|+.++..|... .+.+++.. ....+.
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eeccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 3356778888889998864 334 58889875421 1 23455677777777422 24444432 122456
Q ss_pred EEEEEeccCCCchH-----------HH---HHh-CCCCCH-------HHHH----------------HHHHHHHHHHHHH
Q 013407 86 IFIVLEFVTGGELF-----------DK---IVN-HGRMKE-------DEAR----------------RYFQQLINAVDYC 127 (443)
Q Consensus 86 ~~lv~E~~~gg~L~-----------~~---i~~-~~~l~e-------~~~~----------------~~~~qi~~aL~~L 127 (443)
.++++||++|..+. .. +.. ...++. ...+ .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999985431 00 110 011100 0000 0011233345555
Q ss_pred HH-------CCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 128 HS-------RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 128 H~-------~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
.. .+++|+|+.+.||+++.++...|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 42 689999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00072 Score=66.04 Aligned_cols=77 Identities=16% Similarity=0.163 Sum_probs=54.8
Q ss_pred EEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC---CCcceEEEEEEe---CCEEEE
Q 013407 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH---PNVVRLYEVMGS---KTKIFI 88 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~l 88 (443)
-.+.||.|..+.||.....+ + .+.+|.. +... ....+.+|...|+.|.. ..|.++++++.. .+..++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ-G-NPMPLMA-RSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcCC-C-CEEEEEe-cccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 35679999999999986432 3 4677774 3210 12467889999988843 367888887754 366899
Q ss_pred EEeccCCCch
Q 013407 89 VLEFVTGGEL 98 (443)
Q Consensus 89 v~E~~~gg~L 98 (443)
|||++.|+.+
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00042 Score=68.01 Aligned_cols=142 Identities=21% Similarity=0.275 Sum_probs=99.4
Q ss_pred EEeEeeccCcEEEEEEEECCCCceEEEEEeechhh----------------------hhHHHH-HHHHHHHHHHhcCCCC
Q 013407 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV----------------------LKHKMA-EQIKREVATMKLVKHP 71 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~----------------------~~~~~~-~~~~~Ei~il~~l~hp 71 (443)
+...|..|--+.||.|... +|..+|||+...+-. ....+. -....|++.|.+++..
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4567888999999999874 577799999853211 011122 3466788889888755
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeeeCCCCcEEEccCCCe
Q 013407 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYGNL 150 (443)
Q Consensus 72 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NILl~~~~~~ 150 (443)
.|.-.--+.. ....|||+++.+..-..-..++..++...+..+.+|++.-+.-|- ..++||.||+--|+|+.+ |.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEE
Confidence 5432221111 234699999964332222223457888899999999999988875 569999999999999976 899
Q ss_pred EEeecCcccc
Q 013407 151 KVSDFGLSAL 160 (443)
Q Consensus 151 kl~DFGla~~ 160 (443)
.|+|.+-|.-
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999987654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0011 Score=65.21 Aligned_cols=136 Identities=18% Similarity=0.185 Sum_probs=74.3
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CcceEEE------EEEeCCEEE
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYE------VMGSKTKIF 87 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~ 87 (443)
.+.|+.|....+|..... +| .+++|++.. . . .+.+..|+.+++.|... .+.+.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~-~--~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER-L--T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEecc-C--C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 355777888899988753 33 689998752 1 1 12334455666555311 1333332 123356689
Q ss_pred EEEeccCCCchH-----------HHHH---h-CCCC--------C--H--HHHH-----------HHHHHHH-HHHHHHH
Q 013407 88 IVLEFVTGGELF-----------DKIV---N-HGRM--------K--E--DEAR-----------RYFQQLI-NAVDYCH 128 (443)
Q Consensus 88 lv~E~~~gg~L~-----------~~i~---~-~~~l--------~--e--~~~~-----------~~~~qi~-~aL~~LH 128 (443)
++++|++|..+. ..+. . ...+ . . .... ..+.+.+ ..+..+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999986431 1110 0 0001 0 0 0000 1111111 1122222
Q ss_pred -------HCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 129 -------SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 129 -------~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
..|++|+|+.|.||+++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2489999999999999866556899999764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0012 Score=64.68 Aligned_cols=139 Identities=22% Similarity=0.290 Sum_probs=88.6
Q ss_pred EEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCC--EEEEEE
Q 013407 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSKT--KIFIVL 90 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~--~~~lv~ 90 (443)
+++.+..|..-.+|..... ++.+++. .+. ............+|..+++.+.- .-+...++++.++. ..|.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 4444444444455655543 7788888 332 12222345678889999988853 23444555565554 679999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHH-HHHHHHHHHHHH----------------------------------------
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYF-QQLINAVDYCHS---------------------------------------- 129 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~-~qi~~aL~~LH~---------------------------------------- 129 (443)
+|++|..+.+.. .+......+. ..+...|.-||+
T Consensus 105 ~~veGe~~~~~~-----~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 105 EWVEGEVVWSAL-----PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred EEecceeccCcC-----CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 999985443222 1111112222 366666666664
Q ss_pred ------------------CCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 130 ------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 130 ------------------~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
..++|+|+.+.|++++..+-+=+.||+++.+-+
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 358999999999999999889999999987643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0017 Score=63.41 Aligned_cols=75 Identities=17% Similarity=0.199 Sum_probs=48.9
Q ss_pred EeEeeccCcEEEEEEEECC------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCEEEE
Q 013407 16 GRTIGEGTFAKVKFARNSE------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKIFI 88 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~l 88 (443)
++.|..|-...+|++.... +++.+++|+...... ......+|..+++.+...+ ..+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3567778888999887543 257899999654321 1235678888888885333 3455555532 35
Q ss_pred EEeccCCCch
Q 013407 89 VLEFVTGGEL 98 (443)
Q Consensus 89 v~E~~~gg~L 98 (443)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00035 Score=67.56 Aligned_cols=134 Identities=20% Similarity=0.282 Sum_probs=95.4
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhh-----------------hHH--HHHHHHHHHHHHhcCCC--C
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----------------KHK--MAEQIKREVATMKLVKH--P 71 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----------------~~~--~~~~~~~Ei~il~~l~h--p 71 (443)
|.++..||-|.-+.||.+-+. .|++.++|+=...... +.- ..-...+|...|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 557789999999999999884 5788898864221110 000 01235678999988842 3
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeE
Q 013407 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (443)
Q Consensus 72 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~k 151 (443)
-|.+.+++ +..++|||++.|-.|...-. ...+..+...+..-+--|-.+|+||+|..--||++++++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 35566553 56789999999876643211 123345666777777788899999999999999999999999
Q ss_pred EeecCc
Q 013407 152 VSDFGL 157 (443)
Q Consensus 152 l~DFGl 157 (443)
++||--
T Consensus 243 vIDFPQ 248 (465)
T KOG2268|consen 243 VIDFPQ 248 (465)
T ss_pred EeechH
Confidence 999974
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0057 Score=60.79 Aligned_cols=76 Identities=14% Similarity=0.156 Sum_probs=50.4
Q ss_pred EeeccCcEEEEEEEECCCCceEEEEEeechhhh-h---HHHHHHHHHHHHHHhcCC--CC-CcceEEEEEEeCCEEEEEE
Q 013407 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVL-K---HKMAEQIKREVATMKLVK--HP-NVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 18 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-~---~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv~ 90 (443)
.||.|....||++.+...++.|+||.-..--.. . +-...+..-|...|+... .| ++.++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998644468999965321110 0 112456778888887764 24 56666553 455667999
Q ss_pred eccCC
Q 013407 91 EFVTG 95 (443)
Q Consensus 91 E~~~g 95 (443)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0055 Score=59.15 Aligned_cols=30 Identities=23% Similarity=0.407 Sum_probs=25.3
Q ss_pred CcEeeeCCCCcEEEccCCC-eEEeecCcccc
Q 013407 131 GVYHRDLKPENLLLDAYGN-LKVSDFGLSAL 160 (443)
Q Consensus 131 givHrDlkp~NILl~~~~~-~kl~DFGla~~ 160 (443)
.++|+|++|.||+++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0068 Score=61.31 Aligned_cols=77 Identities=14% Similarity=0.139 Sum_probs=52.4
Q ss_pred EEeEeeccCcEEEEEEEECCCCceEEEEEeechhh-hhH---HHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEE
Q 013407 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-LKH---KMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 87 (443)
-.+.||.|....||+..+. +..++||.-..... ..+ ....+...|...|+.+. ..++.+++.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3577999999999998873 45689997652111 011 12455666777777664 357888888776 4467
Q ss_pred EEEeccCC
Q 013407 88 IVLEFVTG 95 (443)
Q Consensus 88 lv~E~~~g 95 (443)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.004 Score=62.14 Aligned_cols=136 Identities=17% Similarity=0.246 Sum_probs=79.6
Q ss_pred EeEeeccCcEEEEEEEECC----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEE
Q 013407 16 GRTIGEGTFAKVKFARNSE----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~ 90 (443)
+..|-.|-.-.+|++.... +++.|++|+..... .....+ .+|..+++.+..-++ .++++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3456568888999987432 34679999876532 112233 678999888854333 3556665432 578
Q ss_pred eccCCCchHHH----------H----H---hC---C---CCCHHHHHHHHHHH-----------------HHHHHHH---
Q 013407 91 EFVTGGELFDK----------I----V---NH---G---RMKEDEARRYFQQL-----------------INAVDYC--- 127 (443)
Q Consensus 91 E~~~gg~L~~~----------i----~---~~---~---~l~e~~~~~~~~qi-----------------~~aL~~L--- 127 (443)
||++|..|... + . .- + ....+.+..++.++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99887665211 1 0 00 0 01112233333222 1111112
Q ss_pred -H----HCCcEeeeCCCCcEEEcc-CCCeEEeecCccc
Q 013407 128 -H----SRGVYHRDLKPENLLLDA-YGNLKVSDFGLSA 159 (443)
Q Consensus 128 -H----~~givHrDlkp~NILl~~-~~~~kl~DFGla~ 159 (443)
. ...++|+|+++.||++++ ++.+.++||..|.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 235899999999999986 4679999999875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0039 Score=63.85 Aligned_cols=163 Identities=21% Similarity=0.291 Sum_probs=104.8
Q ss_pred HHHHHHHHHHhcCCCCCcceEEEEEEeC-CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 013407 56 EQIKREVATMKLVKHPNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134 (443)
Q Consensus 56 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givH 134 (443)
.++.-...+++.+.|+|...++++.... ....+|||++. .+|.+...... +-.... . .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~---~-----------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESL---L-----------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhh---c-----------ccccce
Confidence 3455667889999999999999987543 34789999995 58888776543 211110 0 222222
Q ss_pred eeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCC
Q 013407 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (443)
Q Consensus 135 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf 214 (443)
-|+ ++.+| .+++ . | |- ..++++||||+|.++.++.-|...|
T Consensus 91 -----~~~-------~~~td-~~~t-------~-----------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 91 -----LNI-------IYITD-HFLT-------K-----------Y--PS------PIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred -----ehh-------hhccc-cccc-------c-----------C--CC------CCCcchhhhhHHHHHHHHHHhhHHH
Confidence 122 22333 1110 0 0 11 1125899999999999999998888
Q ss_pred CCCcHHHHHHHhhcCccCCC------------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 215 DDSNLMNLYKKISAAEFTCP------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 215 ~~~~~~~~~~~i~~~~~~~~------------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
......+....+.+-..... -.++.....++.+|+...|..||...++++++-|...+.
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 76555554444432211111 114667788999999999999999999999999886543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.053 Score=52.91 Aligned_cols=29 Identities=34% Similarity=0.574 Sum_probs=25.4
Q ss_pred CCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 130 ~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999988 678999999643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.016 Score=58.31 Aligned_cols=78 Identities=18% Similarity=0.242 Sum_probs=52.9
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh---HHHHHHHHHHHHHHhcCC--CC-CcceEEEEEEeCCEEEEE
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK---HKMAEQIKREVATMKLVK--HP-NVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv 89 (443)
.+.||.|.-.-||++.+...++.|+||--..--... +-..++..-|..+|+... .| ++.++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 567999999999999985445679998643211111 112467788889888774 34 56667553 45667789
Q ss_pred EeccCC
Q 013407 90 LEFVTG 95 (443)
Q Consensus 90 ~E~~~g 95 (443)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.018 Score=57.17 Aligned_cols=136 Identities=18% Similarity=0.282 Sum_probs=77.7
Q ss_pred eEeeccCcEEEEEEEECCC---CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEec
Q 013407 17 RTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~ 92 (443)
+.|..|-...+|++..... +..|++|+...... ..-.-.+|..+++.+..-++ .++++++..+ +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehh
Confidence 4555588888998875432 34789998754321 11123578888888865444 4556555322 58899
Q ss_pred cCCCchHH----------HHH----h-C-CC------C-CHHHHHHHHHHH----------------------HHHHHHH
Q 013407 93 VTGGELFD----------KIV----N-H-GR------M-KEDEARRYFQQL----------------------INAVDYC 127 (443)
Q Consensus 93 ~~gg~L~~----------~i~----~-~-~~------l-~e~~~~~~~~qi----------------------~~aL~~L 127 (443)
++|..|.. .+. + + .. . ....+..|+.++ ..-+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 88765411 111 0 0 01 1 112233333222 1112111
Q ss_pred ----HHCC----cEeeeCCCCcEEEcc-CCCeEEeecCcccc
Q 013407 128 ----HSRG----VYHRDLKPENLLLDA-YGNLKVSDFGLSAL 160 (443)
Q Consensus 128 ----H~~g----ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 160 (443)
.+.+ ++|+|+.|.||++++ ++.++++||..|..
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1222 799999999999975 47899999998753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.052 Score=53.18 Aligned_cols=29 Identities=17% Similarity=0.170 Sum_probs=26.9
Q ss_pred CcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 131 givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
+++|+|+.+.|+|+++++.+-++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.044 Score=55.41 Aligned_cols=76 Identities=16% Similarity=0.193 Sum_probs=45.4
Q ss_pred EEeEeeccCcEEEEEEEECCC-Cce-----EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCEEE
Q 013407 15 VGRTIGEGTFAKVKFARNSET-GEP-----VALKILDKEKVLKHKMAEQIKREVATMKLVKHP-NVVRLYEVMGSKTKIF 87 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~-~~~-----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~ 87 (443)
-++.|..|-...+|++..... +.. |.+++... ..+..-.-.+|+.+++.+... .-.++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 345666688899999875432 222 44443211 111112235689999999644 44566666642 5
Q ss_pred EEEeccCCCch
Q 013407 88 IVLEFVTGGEL 98 (443)
Q Consensus 88 lv~E~~~gg~L 98 (443)
++.||++|..|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 99999998665
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.015 Score=53.49 Aligned_cols=30 Identities=33% Similarity=0.626 Sum_probs=21.6
Q ss_pred CcEeeeCCCCcEEE-ccCCCeEEeecCcccc
Q 013407 131 GVYHRDLKPENLLL-DAYGNLKVSDFGLSAL 160 (443)
Q Consensus 131 givHrDlkp~NILl-~~~~~~kl~DFGla~~ 160 (443)
.++|+|+.|.||++ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.069 Score=51.81 Aligned_cols=74 Identities=15% Similarity=0.198 Sum_probs=47.3
Q ss_pred EEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEEEEe
Q 013407 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~E 91 (443)
-.+.++.|....+|... .+++.+.||+-.... ...+..|..-|+.|. .-.+.+.+.+....+.-|++||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 35678999999999887 567889999876321 235667777777773 4567889988887777899999
Q ss_pred ccCCC
Q 013407 92 FVTGG 96 (443)
Q Consensus 92 ~~~gg 96 (443)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.046 Score=54.06 Aligned_cols=85 Identities=25% Similarity=0.362 Sum_probs=60.8
Q ss_pred CCCcceEEEEE-EeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccC
Q 013407 70 HPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAY 147 (443)
Q Consensus 70 hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~ 147 (443)
.++..+.+-+- ....+.|++|++- |+.+ ..+ ..-..+++..+|.+.+..++-+..+ ..-|||+...||||+ +
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~i-s~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~ 357 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPI-SII---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E 357 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Ccee-eee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence 34444444333 3345667888876 3333 222 2245667888999998888777765 689999999999999 8
Q ss_pred CCeEEeecCcccc
Q 013407 148 GNLKVSDFGLSAL 160 (443)
Q Consensus 148 ~~~kl~DFGla~~ 160 (443)
|++.|+||-+++.
T Consensus 358 GnvtLIDfklsRl 370 (488)
T COG5072 358 GNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEeeeeec
Confidence 9999999999884
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.69 Score=45.68 Aligned_cols=71 Identities=20% Similarity=0.098 Sum_probs=42.2
Q ss_pred cCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CcceEE---E--EEEeCCEEEEEEeccC
Q 013407 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLY---E--VMGSKTKIFIVLEFVT 94 (443)
Q Consensus 22 G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~---~--~~~~~~~~~lv~E~~~ 94 (443)
+.-..||.... .+|..+++|+...... ....+..|+..+..|... .|+... + +...++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34556888765 3466799998754321 134566788887777321 122221 1 1233567888999998
Q ss_pred CCc
Q 013407 95 GGE 97 (443)
Q Consensus 95 gg~ 97 (443)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 753
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.1 Score=52.40 Aligned_cols=61 Identities=18% Similarity=0.188 Sum_probs=42.3
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCcEeeeCCCCcEEEccC
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY-CHSRGVYHRDLKPENLLLDAY 147 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~-LH~~givHrDlkp~NILl~~~ 147 (443)
..++-+|..|-.+..++.. ...+|.....+..--+.|+-- +---+++|.|+.|.||++--+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4466678888777777654 445666666666655565443 345689999999999999543
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.21 Score=48.40 Aligned_cols=75 Identities=11% Similarity=0.077 Sum_probs=45.0
Q ss_pred eccCcEEEEEEEECC----C----CceEEEEEeechhhhhH--HHHHHHHHHHHHHhcCC---------C----CCcceE
Q 013407 20 GEGTFAKVKFARNSE----T----GEPVALKILDKEKVLKH--KMAEQIKREVATMKLVK---------H----PNVVRL 76 (443)
Q Consensus 20 G~G~~g~V~~a~~~~----~----~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~---------h----pnIv~l 76 (443)
|.|-.|.+|++.-.. + ...+.||.......... .....+.+|+.+.+.+- + ..+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 667778888765422 2 23588998763222211 12356788888777652 1 234666
Q ss_pred EEEEEeCCEEEEEEeccC
Q 013407 77 YEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 77 ~~~~~~~~~~~lv~E~~~ 94 (443)
+....+.....||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 666555556889998663
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.51 Score=53.95 Aligned_cols=30 Identities=33% Similarity=0.488 Sum_probs=25.7
Q ss_pred CCcEeeeCCCCcEEEccCC--CeE-EeecCccc
Q 013407 130 RGVYHRDLKPENLLLDAYG--NLK-VSDFGLSA 159 (443)
Q Consensus 130 ~givHrDlkp~NILl~~~~--~~k-l~DFGla~ 159 (443)
.+++|+|+.+.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999999875 555 99999765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 443 | ||||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-77 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-76 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-75 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-75 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-75 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-75 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-74 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-74 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-65 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-65 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-64 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-64 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-64 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-63 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-63 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-63 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-62 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-61 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-60 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-57 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-57 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-56 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-56 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-56 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-53 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-51 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-51 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-51 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-51 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-51 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-51 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-51 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-51 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-50 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-50 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-50 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-50 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-50 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-50 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-50 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-50 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-50 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-50 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-50 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-50 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-50 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-50 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-50 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-50 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-50 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-50 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-50 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-50 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-50 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-50 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-50 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-50 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-50 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-50 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-50 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-50 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-50 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-50 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-50 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-50 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-50 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-50 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-50 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-50 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-50 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-50 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-50 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-50 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-49 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-49 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-49 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-49 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-49 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-49 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-49 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-48 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-47 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-47 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-47 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-47 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-47 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-46 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-46 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-46 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-46 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-46 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-46 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-45 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-45 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-45 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-45 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-45 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-45 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-45 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-45 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-45 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-44 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-44 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-44 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-44 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-44 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-43 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-43 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-42 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-42 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-42 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-42 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-42 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-42 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-42 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-42 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-41 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-41 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-41 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-41 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-41 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-41 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-41 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-41 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-41 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-41 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-41 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-41 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-41 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-41 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-41 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-41 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-41 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-41 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-41 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-41 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-41 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-41 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-41 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-41 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-41 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-41 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-41 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-41 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-41 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-41 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-41 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-41 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-41 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-41 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-41 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-41 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-41 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-41 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-41 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-41 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-41 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-41 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-41 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-40 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-40 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-40 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-40 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-40 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-40 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-40 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-40 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-40 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-40 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-40 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-40 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-40 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-40 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-40 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-40 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-40 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-40 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-40 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-40 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-40 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-40 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-39 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-39 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-39 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-39 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-39 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-39 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-39 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-39 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-39 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-39 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-39 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-39 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-39 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-39 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-39 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-39 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-39 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-39 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-39 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-39 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-39 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-39 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-39 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-39 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-39 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-38 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-38 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-38 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-38 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-38 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-38 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-38 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-38 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-38 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-38 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-38 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-38 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-38 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-38 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-37 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-37 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-37 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-37 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-37 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-37 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-37 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-37 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-37 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-37 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-37 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-37 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-37 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-37 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-37 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-37 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-37 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-37 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-36 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-36 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-36 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 2e-36 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-36 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-36 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-36 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-36 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-36 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-36 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-36 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-35 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-35 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-35 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-35 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-35 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-35 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-35 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-35 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-35 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-35 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-35 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-34 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-34 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-34 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-34 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-34 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-34 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-33 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-33 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-33 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-33 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-33 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-33 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-33 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-32 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-32 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-32 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-31 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-31 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-31 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-31 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-31 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-31 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-31 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-31 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-31 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-31 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-31 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-31 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-30 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-30 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-30 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-30 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-30 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-30 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-30 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-29 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-29 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-29 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-29 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-29 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-28 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-28 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-28 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-28 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-28 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-28 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-28 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-27 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-27 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-27 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-27 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-27 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-27 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-27 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-27 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-27 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-27 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-27 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-26 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-26 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-26 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-26 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-26 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-26 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-26 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-25 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-25 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-25 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-25 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-25 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-25 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-25 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-24 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-24 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-24 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-24 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-24 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-24 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-24 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-24 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-24 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-24 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-24 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-24 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-24 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-24 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-24 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-24 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-24 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-24 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-24 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-24 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-24 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-24 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-24 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-24 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-24 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-24 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-24 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-24 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-24 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-24 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-24 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-24 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-24 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-24 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-24 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-24 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-24 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-24 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-24 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-24 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-24 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-24 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-24 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-24 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-23 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-23 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-23 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-23 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-23 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-23 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-23 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-23 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-23 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-23 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-23 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-23 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-23 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-23 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-23 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-23 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-23 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-23 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-22 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-22 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-22 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-22 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-21 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-20 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-19 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-19 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-19 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-19 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-18 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-18 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-18 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-18 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-18 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-18 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-18 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-18 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-18 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-18 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-18 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-18 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-18 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-18 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-18 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-18 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-17 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-17 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-17 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-17 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-16 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-16 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-16 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-16 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-16 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-16 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-16 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-15 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-13 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-12 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 2zfd_B | 123 | The Crystal Structure Of Plant Specific Calcium Bin | 3e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 9e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 9e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-09 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 |
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2ZFD|B Chain B, The Crystal Structure Of Plant Specific Calcium Binding Protein Atcbl2 In Complex With The Regulatory Domain Of Atcipk14 Length = 123 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 564 bits (1454), Expect = 0.0
Identities = 152/472 (32%), Positives = 243/472 (51%), Gaps = 59/472 (12%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++G Y +G T+G GTF KVK ++ TG VA+KIL+++K+ + +I+RE
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ +KL +HP++++LY+V+ + + IF+V+E+V+GGELFD I +GR+ E E+RR FQQ++
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ VDYCH V HRDLKPEN+LLDA+ N K++DFGLS + + D L T+CG+PNY A
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAA 183
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEV++ R Y G D+WS GVIL+ LL G LPFDD ++ L+KKI F P +L+ +
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD--DVEAVFK------ 293
L+ +L +PM R TI +I E EWFK+D +F E + D EA+ +
Sbjct: 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFE 303
Query: 294 --------------------------------------------DSEVCWMEHHVTEQKE 309
+ +HH+T
Sbjct: 304 CSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHP 363
Query: 310 EQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETR---FTSRCPANEIINKIEEAAKPLG 366
E+ + A + L Q ++ S+ N+I+ ++ A K L
Sbjct: 364 ERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLD 423
Query: 367 FDVHKKN-YKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEF 417
++ N Y +R+ ++ +++QV ++++ R + LE
Sbjct: 424 YEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 515 bits (1330), Expect = 0.0
Identities = 133/278 (47%), Positives = 191/278 (68%), Gaps = 3/278 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S+ + ++G Y +G T+G GTF KVK + TG VA+KIL+++K+ + +IKRE
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ +KL +HP++++LY+V+ + T F+V+E+V+GGELFD I HGR++E EARR FQQ++
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+AVDYCH V HRDLKPEN+LLDA+ N K++DFGLS + + D L T+CG+PNY A
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAA 178
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEV++ R Y G D+WSCGVIL+ LL G LPFDD ++ L+KKI F P +L+ +
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSV 238
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L+ +L +P+ R TI +I E EWFK+D +F E
Sbjct: 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 509 bits (1312), Expect = 0.0
Identities = 108/322 (33%), Positives = 165/322 (51%), Gaps = 9/322 (2%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ P + +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+
Sbjct: 1 MAVPFV----EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKK 54
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ K++ H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ V Y H G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW--L 237
APE+L R + D+WSCG++L +LAG LP+D S+ Y + PW +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEV 297
L+ +IL NP RITIP+I +D W+ K K + + +
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHI 294
Query: 298 CWMEHHVTEQKEEQPVAMNAFE 319
+ +
Sbjct: 295 QSNLDFSPVNSASRTPGSGWSK 316
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 505 bits (1303), Expect = 0.0
Identities = 108/276 (39%), Positives = 160/276 (57%), Gaps = 9/276 (3%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ P + +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+
Sbjct: 1 MAVPFV----EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKK 54
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ K++ H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ V Y H G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW--L 237
APE+L R + D+WSCG++L +LAG LP+D S+ Y + PW +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273
L+ +IL NP RITIP+I +D W+ K K
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 507 bits (1308), Expect = 0.0
Identities = 136/326 (41%), Positives = 208/326 (63%), Gaps = 8/326 (2%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
KR +G Y + T+GEG+F KVK A + +T + VALK + ++ + K M +++RE++
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
+KL++HP++++LY+V+ + T I +V+E+ GGELFD IV RM EDE RR+FQQ+I A
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
++YCH + HRDLKPENLLLD N+K++DFGLS + + D L T+CG+PNY APE
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPE 177
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V+N + Y G D+WSCG++L+V+L G LPFDD + NL+KK+++ + P +LS A+
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVF-EEKKDTNLDDVEAVFKDSEV-CWME 301
LI R++ +PM RITI EI D WF + + E+ + D V K E + E
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSE 297
Query: 302 HHVTE--QKEEQPVAMNAFELISLSK 325
++ E + +E A+ L+ ++
Sbjct: 298 DYIVEALRSDENNEVKEAYNLLHENQ 323
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 505 bits (1302), Expect = e-180
Identities = 121/355 (34%), Positives = 181/355 (50%), Gaps = 21/355 (5%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
I +Y+ + IG G F + R+ T E VA+K +++ + E ++RE
Sbjct: 11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQRE 66
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ + ++HPN+VR EV+ + T + I++E+ +GGEL+++I N GR EDEAR +FQQL+
Sbjct: 67 IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL 126
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ V YCHS + HRDLK EN LLD LK+ DFG S S +T GTP Y
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAY 183
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK----ISAAEFTCPP 235
+APEVL + YDG AD+WSCGV L+V+L G PF+D Y+K I + +++ P
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243
Query: 236 --WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT-NLDDVEAVF 292
+S LI+RI +P TRI+IPEI WF K+ + E + E
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPM 303
Query: 293 KDSEVCWMEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTS 347
+ + + P N ++ L+L + D + D + E S
Sbjct: 304 QSLD----TIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMD-DFDSESEIDIDS 353
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 497 bits (1283), Expect = e-178
Identities = 89/288 (30%), Positives = 152/288 (52%), Gaps = 7/288 (2%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-MAEQIKREVATMK 66
+ +GKY +G +GEG++ KVK +SET A+KIL K+K+ + +K+E+ ++
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 67 LVKHPNVVRLYEVMG--SKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLIN 122
++H NV++L +V+ K K+++V+E+ G E+ D + R +A YF QLI+
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLID 120
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
++Y HS+G+ H+D+KP NLLL G LK+S G++ D T+ G+P + P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 183 EVLND-RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
E+ N + G D+WS GV L+ + G PF+ N+ L++ I + P
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 289
L+ +L+ P R +I +I + WF+K + P + D +
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 481 bits (1240), Expect = e-171
Identities = 93/271 (34%), Positives = 139/271 (51%), Gaps = 3/271 (1%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +Y GR +G+G FAK +++T E A KI+ K +LK E++ E++ +
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ H +VV + +F+VLE L + + E EAR Y +Q++ Y
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H V HRDLK NL L+ +K+ DFGL+ + D CGTPNY+APEVL+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLS 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
+G+ D+WS G I++ LL G PF+ S L Y +I E++ P ++ A LI
Sbjct: 189 KKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVF 277
++L +P R TI E+L DE+F Y P
Sbjct: 248 KMLQTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 479 bits (1236), Expect = e-170
Identities = 93/269 (34%), Positives = 139/269 (51%), Gaps = 3/269 (1%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +Y GR +G+G FAK +++T E A KI+ K +LK E++ E++ +
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ H +VV + +F+VLE L + + E EAR Y +Q++ Y
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H V HRDLK NL L+ +K+ DFGL+ + D CGTPNY+APEVL+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLS 214
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
+G+ D+WS G I++ LL G PF+ S L Y +I E++ P ++ A LI
Sbjct: 215 KKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPP 275
++L +P R TI E+L DE+F Y P
Sbjct: 274 KMLQTDPTARPTINELLNDEFFTSGYIPA 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 476 bits (1228), Expect = e-170
Identities = 90/277 (32%), Positives = 152/277 (54%), Gaps = 4/277 (1%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
I ++ ++VG +G+G+FA V A + TG VA+K++DK+ + K M ++++ EV
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLIN 122
+KHP+++ LY +++VLE GE+ + N E+EAR + Q+I
Sbjct: 64 IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ Y HS G+ HRDL NLLL N+K++DFGL+ + +T CGTPNY++P
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISP 181
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
E+ + G +D+WS G + + LL G PFD + N K+ A++ P +LS A+
Sbjct: 182 EIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK 240
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
LI ++L NP R+++ +L+ + ++ +E
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 469 bits (1209), Expect = e-166
Identities = 119/293 (40%), Positives = 182/293 (62%), Gaps = 4/293 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S + +G Y + +TIG+G FAKVK AR+ TG VA+KI+DK + L +++ RE
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFRE 64
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
V MK++ HPN+V+L+EV+ ++ +++++E+ +GGE+FD +V HGRMKE EAR F+Q++
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+AV YCH + + HRDLK ENLLLDA N+K++DFG S + G L CG P Y A
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAFCGAPPYAA 181
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE+ + YDG D+WS GVIL+ L++G LPFD NL L +++ ++ P ++S
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 241
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKD 294
L+ R L NP+ R T+ +I++D W ++ + + LD + D
Sbjct: 242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRID 294
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 462 bits (1191), Expect = e-164
Identities = 94/283 (33%), Positives = 163/283 (57%), Gaps = 8/283 (2%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
PK K + +++GR +G+G F V AR + +ALK+L K ++ K + Q++RE
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ ++HPN++R+Y + +I+++LEF GEL+ ++ HGR E + + ++L
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA 124
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A+ YCH R V HRD+KPENLL+ G LK++DFG S + +R T CGT +Y+
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLP 180
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ + +D DLW GV+ + L G PFD + +++I + PP+LS +
Sbjct: 181 PEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYK---PPVFEEKK 281
+ LI+++L +P R+ + ++E W K + + PPV++ +
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQ 282
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 461 bits (1189), Expect = e-163
Identities = 95/298 (31%), Positives = 157/298 (52%), Gaps = 32/298 (10%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-------- 53
++ +Y + IG+G++ VK A N A+K+L K+K+++
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 54 ---------------MAEQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEFVTGG 96
EQ+ +E+A +K + HPNVV+L EV+ ++ +++V E V G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156
+ + + + ED+AR YFQ LI ++Y H + + HRD+KP NLL+ G++K++DFG
Sbjct: 124 PVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPF 214
+S + D LL T GTP ++APE L++ + + G D+W+ GV L+ + G PF
Sbjct: 183 VSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 215 DDSNLMNLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
D +M L+ KI + P P ++ + LI R+LD NP +RI +PEI W +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 453 bits (1168), Expect = e-161
Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 5/280 (1%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
K + + +E+GR +G+G F V AR ++ +ALK+L K ++ K + Q++REV
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
++HPN++RLY T+++++LE+ G ++ ++ + E Y +L NA
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ YCHS+ V HRD+KPENLLL + G LK++DFG S + R CGT +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
++ R +D DLWS GV+ + L G PF+ + YK+IS EFT P +++ AR
Sbjct: 178 MIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
LI+R+L NP R + E+LE W + P + K++
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 445 bits (1146), Expect = e-156
Identities = 82/322 (25%), Positives = 145/322 (45%), Gaps = 15/322 (4%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE----- 56
KY +G G F V A + E + V +K + KEKVL+ E
Sbjct: 15 LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 57 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDEARR 115
++ E+A + V+H N++++ ++ ++ +V+E +G +LF I H R+ E A
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
F+QL++AV Y + + HRD+K EN+++ +K+ DFG +A + L +T CG
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCG 191
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
T Y APEVL Y G ++WS GV L+ L+ PF + ++ A P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY 245
Query: 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDS 295
+S L++ +L P P R T+ +++ D W + + ++ ++ E+ +
Sbjct: 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSA 305
Query: 296 EVCWMEHHVTEQKEEQPVAMNA 317
M + +
Sbjct: 306 ASLEMGNRSLSDVAQAQELCGG 327
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 436 bits (1122), Expect = e-153
Identities = 83/297 (27%), Positives = 134/297 (45%), Gaps = 17/297 (5%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQ 57
+ + +Y+VG +G G F V PVA+K ++K+++ +
Sbjct: 33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR 92
Query: 58 IKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEFVTG-GELFDKIVNHGRMKEDEAR 114
+ EV +K V V+RL + ++LE +LFD I G ++E+ AR
Sbjct: 93 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 152
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTT 173
+F Q++ AV +CH+ GV HRD+K EN+L+D G LK+ DFG AL + D +
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDF 208
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233
GT Y PE + Y G +A +WS G++L+ ++ G +PF+ ++I +
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFF 262
Query: 234 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEA 290
+S + LI L P R T EI W + P E +L +
Sbjct: 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 435 bits (1120), Expect = e-153
Identities = 86/287 (29%), Positives = 133/287 (46%), Gaps = 19/287 (6%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQ--- 57
+ +Y +G +G+G F V VA+K++ + +VL
Sbjct: 21 PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT 80
Query: 58 IKREVATMKLV----KHPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDE 112
EVA + V HP V+RL + ++ +VLE + +LFD I G + E
Sbjct: 81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLH 171
+R +F Q++ A+ +CHSRGV HRD+K EN+L+D G K+ DFG AL D
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYT 196
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231
GT Y PE ++ Y A +WS G++L+ ++ G +PF+ ++I AE
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAEL 250
Query: 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
P +S LI R L P P +R ++ EIL D W + +
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 409 bits (1054), Expect = e-142
Identities = 66/325 (20%), Positives = 130/325 (40%), Gaps = 50/325 (15%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-------- 53
+ + + Y + RT+ +G F K+ + + ALK +K + K +
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 54 ------MAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR 107
+ K E+ + +K+ + ++ + +++I+ E++ +
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 108 MK--------EDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
+ + + ++N+ Y H+ + + HRD+KP N+L+D G +K+SDFG S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDD- 216
D + + GT ++ PE ++ Y+G+ D+WS G+ L+V+ +PF
Sbjct: 200 EYMV----DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
Query: 217 SNLMNLYKKISAAEFTCP-------------------PWLSFTARKLIARILDPNPMTRI 257
+L+ L+ I P +LS + L NP RI
Sbjct: 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 258 TIPEILEDEWFKKDYKPPVFEEKKD 282
T + L+ EW + E K+
Sbjct: 316 TSEDALKHEWLADTNIEDLREFSKE 340
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-117
Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 36/303 (11%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R +E +G+G F +V ARN+ A+K + + + I EV +
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLAS 58
Query: 68 VKHPNVVRLYEV-------------MGSKTKIFIVLEFVTGGELFDKIVNHGRMK-EDEA 113
+ H VVR Y + K+ +FI +E+ G L+D I + + DE
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ---------- 163
R F+Q++ A+ Y HS+G+ HRDLKP N+ +D N+K+ DFGL+ +
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 164 --VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221
L + GT YVA EVL+ G+ D++S G+I F ++ Y +N
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVN 236
Query: 222 LYKKISAAEFTCPPWL----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF 277
+ KK+ + PP +K+I ++D +P R +L W ++ V
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296
Query: 278 EEK 280
+E
Sbjct: 297 KEA 299
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-113
Identities = 97/275 (35%), Positives = 152/275 (55%), Gaps = 19/275 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMK 66
+Y + +T+G G +VK A +T + VA+KI+ K K + A ++ E+ +K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ HP ++++ ++ +IVLE + GGELFDK+V + R+KE + YF Q++ AV Y
Sbjct: 71 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 127 CHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
H G+ HRDLKPEN+LL + +K++DFG S + + + L+ T CGTP Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 186
Query: 184 VLNDRGYD--GSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW-- 236
VL G D WS GVILF+ L+GY PF + ++L +I++ F W
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271
+S A L+ ++L +P R T E L W + +
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-109
Identities = 103/271 (38%), Positives = 145/271 (53%), Gaps = 15/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + TIG G++ +VK A T A K + K V + ++ K+E+ MK + HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++RLYE T I++V+E TGGELF+++V+ +E +A R + +++AV YCH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
V HRDLKPEN L LK+ DFGL+A + ++ T GTP YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVLE-G 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y G D WS GV+++VLL GY PF + KI F W +S A L
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I R+L +P RIT + LE EWF+K
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 322 bits (829), Expect = e-109
Identities = 100/279 (35%), Positives = 159/279 (56%), Gaps = 12/279 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+V +G+G F+ V+ + TG A KI++ +K L + ++++RE + ++HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 65
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + ++ ++V + VTGGELF+ IV E +A QQ++ ++ YCHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 132 VYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LKPENLLL + +K++DFG L+ +V D H GTP Y++PEVL
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFG---LAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+W+CGVIL++LL GY PF D + LY +I A ++ P W ++ A+ L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
I +L NP RIT + L+ W + ++DT
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 280
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 335 bits (860), Expect = e-109
Identities = 89/454 (19%), Positives = 156/454 (34%), Gaps = 59/454 (12%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S + G +E+ +G G F V + +TGE VA+K +E K++ E+ E
Sbjct: 5 SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLE 62
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHGR---MKEDE 112
+ MK + HPNVV EV K+ + +E+ GG+L + +KE
Sbjct: 63 IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGL 169
R + +A+ Y H + HRDLKPEN++L K+ D G ++++ L
Sbjct: 123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG---YAKELDQGEL 179
Query: 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISA 228
GT Y+APE+L + Y T D WS G + F + G+ PF + + + K+
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238
Query: 229 AEFTCPPWLSFT-----------------------ARKLIARILDPNPMTRITIPEILED 265
+ + +L + R T P+
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298
Query: 266 EWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHVTEQKEEQPVAMNAFELISLSK 325
F+ + +V + VTE + Q N +
Sbjct: 299 GCFQ---------ALDSILSLKLLSVMNMVSGRVHTYPVTENENLQ----NLKSWLQQDT 345
Query: 326 GLNLGN--LFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMKA 383
G+ L A + ++ + + + L F + E +
Sbjct: 346 GIPEEEQELLQASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRK--TVYEPQIS 403
Query: 384 GRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEF 417
+V+ + L +R+ G +
Sbjct: 404 LPAHPESVSIVLQDPKRPLTYTHLRRVWGQIWQT 437
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 327 bits (840), Expect = e-109
Identities = 97/276 (35%), Positives = 153/276 (55%), Gaps = 21/276 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMK 66
+Y + +T+G G +VK A +T + VA++I+ K K + A ++ E+ +K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ HP ++++ ++ +IVLE + GGELFDK+V + R+KE + YF Q++ AV Y
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 127 CHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
H G+ HRDLKPEN+LL + +K++DFG S + + + L+ T CGTP Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 311
Query: 184 VLND---RGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW- 236
VL GY D WS GVILF+ L+GY PF + ++L +I++ F W
Sbjct: 312 VLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370
Query: 237 -LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271
+S A L+ ++L +P R T E L W + +
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-108
Identities = 92/275 (33%), Positives = 143/275 (52%), Gaps = 20/275 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMK 66
KY+ IG G + V+ + TG A+KI++ ++ E +RE ++
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 67 LVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
V HP+++ L + S + +F+V + + GELFD + + E E R + L+ AV
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ H+ + HRDLKPEN+LLD +++SDFG S + L CGTP Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271
Query: 186 ------NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW- 236
GY G DLW+CGVILF LLAG PF + + + I +F+ P W
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 237 -LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
S T + LI+R+L +P R+T + L+ +F++
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-108
Identities = 69/289 (23%), Positives = 128/289 (44%), Gaps = 19/289 (6%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + Y + + IG G +KV N E + A+K ++ E+ ++ + +
Sbjct: 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRN 75
Query: 61 EVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E+A + ++ + ++RLY+ + I++V+E +L + + E + Y++
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWK 134
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ AV H G+ H DLKP N L+ G LK+ DFG++ Q + + GT N
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 179 YVAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKI 226
Y+ PE + D +D+WS G IL+ + G PF + + L+ I
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 227 -SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
E P + ++ L +P RI+IPE+L + + P
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-108
Identities = 91/282 (32%), Positives = 140/282 (49%), Gaps = 21/282 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK------HKMAEQIKREVATM 65
YE +G G + V+ + T + A+KI+D ++ E +EV +
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 66 KLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
+ V HPN+++L + + T F+V + + GELFD + + E E R+ + L+ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + HRDLKPEN+LLD N+K++DFG S Q+ L CGTP+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFG---FSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 185 L------NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW 236
+ N GY G D+WS GVI++ LLAG PF M + + I + +F P W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 237 --LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
S T + L++R L P R T E L +F++ V
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-105
Identities = 98/271 (36%), Positives = 155/271 (57%), Gaps = 12/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+V +G+G F+ V+ + TG A KI++ +K L + ++++RE + ++HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 88
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + ++ ++V + VTGGELF+ IV E +A QQ++ ++ YCHS G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 132 VYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LKPENLLL + +K++DFGL+ +V D H GTP Y++PEVL
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+W+CGVIL++LL GY PF D + LY +I A ++ P W ++ A+ L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I +L NP RIT + L+ W +
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 312 bits (803), Expect = e-105
Identities = 96/270 (35%), Positives = 147/270 (54%), Gaps = 15/270 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F++V + TG+ ALK + K + ++ E+A +K +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKHE 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V L ++ S T ++V++ V+GGELFD+I+ G E +A QQ+++AV Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL + + ++DFGLS ++ +G++ T CGTP YVAPEVL +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQK 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D WS GVI ++LL GY PF + L++KI EF P W +S +A+
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKP 274
I +L+ +P R T + L W +
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTAL 271
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-104
Identities = 83/269 (30%), Positives = 138/269 (51%), Gaps = 17/269 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ R +G G F V +G +K ++K++ EQI+ E+ +K + HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYC 127
N+++++EV ++IV+E GGEL ++IV + E +Q++NA+ Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
HS+ V H+DLKPEN+L + +K+ DFGL+ L + D GT Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEV 197
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW-LSFTA 241
R D+WS GV+++ LL G LPF ++L + +K + E + L+ A
Sbjct: 198 FK-RDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270
L+ ++L +P R + ++L EWFK+
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-104
Identities = 59/307 (19%), Positives = 114/307 (37%), Gaps = 50/307 (16%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + +G+G A V R+ +TG+ A+K+ + L+ + RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68
Query: 73 VVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
+V+L+ + T +++EF G L+ + + E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 128 HSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
G+ HR++KP N++ D K++DFG + ++ DD + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185
Query: 184 VLNDRGYD-------GSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFT 232
+ G+T DLWS GV + G LPF + KI + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 233 C-------------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267
L ++A IL+ + + +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 268 FKKDYKP 274
Sbjct: 306 DILHRGN 312
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-104
Identities = 94/267 (35%), Positives = 150/267 (56%), Gaps = 13/267 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G+G+F +V ++ T + A+K+++K K+K I REV +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L+E++ + +IV E TGGELFD+I+ R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPEN+LL + ++K+ DFGLS + + + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF N ++ K++ F P W +S A+ L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 245 IARILDPNPMTRITIPEILEDEWFKKD 271
I ++L +P RIT + LE W +K
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 314 bits (805), Expect = e-104
Identities = 71/298 (23%), Positives = 129/298 (43%), Gaps = 19/298 (6%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ I + Y + + IG G +KV N E + A+K ++ E+ ++ + + E
Sbjct: 47 ANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNE 104
Query: 62 VATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
+A + ++ + ++RLY+ + I++V+E +L + + E + Y++
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKN 163
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
++ AV H G+ H DLKP N L+ G LK+ DFG++ Q + + G NY
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 180 VAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKI- 226
+ PE + D +D+WS G IL+ + G PF + + L+ I
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282
Query: 227 SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTN 284
E P + ++ L +P RI+IPE+L + + P K T
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 340
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 312 bits (800), Expect = e-104
Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 19/288 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + + IG G +KV N E + A+K ++ E+ ++ + + E+A + ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 67
Query: 72 N--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ ++RLY+ + I++V+E +L + + E + Y++ ++ AV H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ H DLKP N L+ G LK+ DFG++ Q + + GT NY+ PE + D
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 190 YD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKISA-AEFTCPPW 236
+D+WS G IL+ + G PF + + L+ I E P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTN 284
+ ++ L +P RI+IPE+L + + P K T
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 293
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-101
Identities = 67/362 (18%), Positives = 132/362 (36%), Gaps = 54/362 (14%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + +G+G A V R+ +TG+ A+K+ + L+ + RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68
Query: 73 VVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
+V+L+ + T +++EF G L+ + + E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 128 HSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
G+ HR++KP N++ D K++DFG + ++ DD + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185
Query: 184 VLNDRGYD-------GSTADLWSCGVILFVLLAGYLPFDD----SNLMNLYKKISAAEFT 232
+ G+T DLWS GV + G LPF + KI + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 233 -------------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267
L ++A IL+ + + +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 268 FKKDYKPPVFEEKKDTNLDDVEAVFKDSEVCWMEHHVTEQKEEQPVAMNAFELISLSKGL 327
+ + ++ + E V +Q + + + ELI + L
Sbjct: 306 DILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHE-LVYKQTK---IISSNQELIYEGRRL 361
Query: 328 NL 329
L
Sbjct: 362 VL 363
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-100
Identities = 97/271 (35%), Positives = 151/271 (55%), Gaps = 11/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y++ +G+G F+ V+ G+ A I++ +K+ ++++RE +L+KHP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + + +++ + VTGGELF+ IV E +A QQ++ AV +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
V HR+LKPENLLL +K++DFGL+ + + GTP Y++PEVL
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKD 188
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y G DLW+CGVIL++LL GY PF D + LY++I A +F P W ++ A+ L
Sbjct: 189 PY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I ++L NP RIT E L+ W
Sbjct: 248 INKMLTINPSKRITAAEALKHPWISHRSTVA 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-100
Identities = 93/278 (33%), Positives = 147/278 (52%), Gaps = 19/278 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVK 69
YE+ IG+G F+ V+ N ETG+ A+KI+D K E +KRE + ++K
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HP++V L E S +++V EF+ G +L +IV E A Y +Q++ A+
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 126 YCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVA 181
YCH + HRD+KP +LL + +K+ FG++ Q+ + G + GTP+++A
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMA 201
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--L 237
PEV+ Y G D+W CGVILF+LL+G LPF + L++ I + W +
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 259
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
S +A+ L+ R+L +P RIT+ E L W K+ +
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = 1e-99
Identities = 96/268 (35%), Positives = 146/268 (54%), Gaps = 17/268 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+EV +G G + V + T +P ALK+L K + ++ E+ + + HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHP 108
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L E+ + T+I +VLE VTGGELFD+IV G E +A +Q++ AV Y H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL LK++DFG LS+ V L+ T CGTP Y APE+L
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFG---LSKIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW--LSFTARK 243
Y G D+WS G+I ++LL G+ PF D+ ++++I F P W +S A+
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKD 271
L+ +++ +P R+T + L+ W
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVTGK 312
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 2e-98
Identities = 88/276 (31%), Positives = 141/276 (51%), Gaps = 22/276 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKH 70
YEV IG G+++ K + T A+KI+DK K E+ + + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQH 75
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN++ L +V +++V E + GGEL DKI+ E EA + V+Y H++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 131 GVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
GV HRDLKP N+L ++++ DFG + + ++GLL T C T N+VAPEVL
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVLE 193
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKISAA--EFTCPPW--LSF 239
+GYD + D+WS GV+L+ +L GY PF + + +I + + W +S
Sbjct: 194 RQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
TA+ L++++L +P R+T +L W + P
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 297 bits (761), Expect = 3e-98
Identities = 94/312 (30%), Positives = 142/312 (45%), Gaps = 53/312 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVK 69
KY + IG+G++ V+ A ++T A+KI++K K+ + K E+IK EV MK +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK-------------------- 109
HPN+ RLYEV + I +V+E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 110 --------------------EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL--DAY 147
E +Q+ +A+ Y H++G+ HRD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 148 GNLKVSDFGLSAL--SQQVRDDGLLHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVI 203
+K+ DFGLS + + T GTP +VAPEVLN + Y G D WS GV+
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVL 265
Query: 204 LFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKLIARILDPNPMTRITI 259
L +LL G +PF N + ++ + F P + LS AR L++ +L+ N R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 260 PEILEDEWFKKD 271
L+ W +
Sbjct: 326 MRALQHPWISQF 337
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 5e-98
Identities = 94/276 (34%), Positives = 151/276 (54%), Gaps = 15/276 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
YE+G +G G FA V+ R TG+ A K + K ++ + E+I+REV ++ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPN++ L+++ +KT + ++LE V+GGELFD + + EDEA ++ +Q+++ V Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S+ + H DLKPEN++L +K+ DFG ++ ++ GTP +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG---IAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF ISA +F + S
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
A+ I R+L +P R+TI + LE W K + V
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 4e-97
Identities = 97/289 (33%), Positives = 158/289 (54%), Gaps = 17/289 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G+G+F +V ++ T + A+K+++K K+K I REV +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L+E++ + +IV E TGGELFD+I+ R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPEN+LL + ++K+ DFG LS + + + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFG---LSTCFQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF N ++ K++ + F P W +S A+ L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 293
I ++L +P RIT + LE W +K E ++L +E+
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSS----ETPTISDLPSLESAMT 301
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 6e-97
Identities = 98/283 (34%), Positives = 144/283 (50%), Gaps = 15/283 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y+ G +G G FA VK R TG A K + K + + E I+REV+ +K +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPNV+ L+EV +KT + ++LE V GGELFD + + E+EA + +Q++N V Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S + H DLKPEN++L +K+ DFG L+ ++ GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF +SA EF + S
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
A+ I R+L +P R+TI + L+ W K K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASA 290
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 2e-96
Identities = 97/272 (35%), Positives = 155/272 (56%), Gaps = 12/272 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ R +G+G+F +V ++ TG+ A+K++ K +V + E + REV +K + HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++LYE K ++V E TGGELFD+I++ R E +A R +Q+++ + Y H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLLL N+++ DFG LS + GT Y+APEVL+
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFG---LSTHFEASKKMKDKIGTAYYIAPEVLH-G 202
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF+ +N ++ KK+ + F P W +S +A+ L
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
I ++L P RI+ + L+ EW + K +
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 4e-96
Identities = 89/283 (31%), Positives = 146/283 (51%), Gaps = 15/283 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y++G +G G FA VK R TG A K + K + + E+I+REV+ ++ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
H NV+ L++V ++T + ++LE V+GGELFD + + E+EA + +Q+++ V+Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
++ + H DLKPEN++L ++K+ DFG L+ ++ D GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF I++ +F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
A+ I ++L R+TI E L W ++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 2e-95
Identities = 97/331 (29%), Positives = 158/331 (47%), Gaps = 39/331 (11%)
Query: 12 KYEVG---RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
Y++ + +GEG+F+ + + ++ + A+KI+ K ++E+ +KL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLC 62
Query: 69 K-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ HPN+V+L+EV + F+V+E + GGELF++I E EA ++L++AV +
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H GV HRDLKPENLL + +K+ DFG + L D+ L T C T +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKISAA--EFTCPP 235
LN GYD S DLWS GVIL+ +L+G +PF + + + KKI F
Sbjct: 181 LNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 236 W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 293
W +S A+ LI +L +P R+ + + +EW + + L + +
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS------SNPLMTPDILGS 293
Query: 294 DSEVCWMEHHVTEQKEEQPVAMNAFELISLS 324
V + A N ++
Sbjct: 294 SG------AAVHTCVKATFHAFNKYKREGFC 318
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 2e-95
Identities = 90/283 (31%), Positives = 147/283 (51%), Gaps = 15/283 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y++G +G G FA VK R TG A K + K + + E+I+REV+ ++ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
HPN++ L++V ++T + ++LE V+GGELFD + + E+EA + +Q+++ V+Y H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
++ + H DLKPEN++L ++K+ DFG L+ ++ D GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF I+A +F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
A+ I ++L R+TI E L W ++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 2e-94
Identities = 92/287 (32%), Positives = 148/287 (51%), Gaps = 22/287 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA----------EQIKRE 61
Y R +G G + +V + A+K++ K + K + + E+I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ +K + HPN+++L++V K ++V EF GGELF++I+N + E +A +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 122 NAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + Y H + HRD+KPEN+LL ++ N+K+ DFG LS D L GT
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG---LSSFFSKDYKLRDRLGTAY 213
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW 236
Y+APEVL + Y D+WSCGVI+++LL GY PF N ++ KK+ + F W
Sbjct: 214 YIAPEVLK-KKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 237 --LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKK 281
+S A++LI +L + R T E L W KK ++K
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 2e-94
Identities = 93/271 (34%), Positives = 145/271 (53%), Gaps = 13/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ + +G G + +V R+ T A+KI+ K + ++ EVA +KL+ HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDHP 96
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++LY+ K ++V+E GGELFD+I++ + E +A +Q+++ V Y H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLLL + +K+ DFGLSA+ + + GT Y+APEVL +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVLR-K 212
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVILF+LLAGY PF + +K+ + F P W +S A+ L
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I ++L + RI+ + LE W K+
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 285 bits (730), Expect = 4e-93
Identities = 49/311 (15%), Positives = 102/311 (32%), Gaps = 53/311 (17%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ ++ R G +G+ A + ETGE + + + +Q+K EV
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 63 ATMKL----------------------VKHPNVVRLYEVMGSKTKIFIVLEFV------- 93
++L VK P ++ V + ++++ F
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 94 ----TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149
G L H + + Q+I + H G+ H L+P +++LD G
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244
Query: 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----------YDGSTADLWS 199
+ ++ F DG + + + PE+ R + D W+
Sbjct: 245 VFLTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 200 CGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI 259
G++++ + LP + + I F + R L+ L R+
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLP 354
Query: 260 PEILEDEWFKK 270
+ +E +++
Sbjct: 355 LQAMETPEYEQ 365
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 1e-92
Identities = 64/271 (23%), Positives = 126/271 (46%), Gaps = 15/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + +G G F V + + + K + + + +K+E++ + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
N++ L+E S ++ ++ EF++G ++F++I + E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 131 GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D++PEN++ + +K+ +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFG---QARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
+ D+WS G +++VLL+G PF + + I A F + +S A
Sbjct: 179 VV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+ R+L +R+T E L+ W K+ +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 2e-92
Identities = 81/286 (28%), Positives = 140/286 (48%), Gaps = 16/286 (5%)
Query: 12 KYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
Y + + +G G FA V+ + TG+ A K L K + +I E+A ++L K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKS 87
Query: 71 -PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYC 127
P V+ L+EV + ++I ++LE+ GGE+F + + E++ R +Q++ V Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + H DLKP+N+LL G++K+ DFG +S+++ L GTP Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG---MSRKIGHACELREIMGTPEYLAPEI 204
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
LN + D+W+ G+I ++LL PF + Y IS +++ + +S
Sbjct: 205 LNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD 286
A I +L NP R T L W ++ +F ++ ++
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 5e-91
Identities = 84/294 (28%), Positives = 139/294 (47%), Gaps = 38/294 (12%)
Query: 12 KYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
Y++ +GEG A+V+ N T + A+KI++K+ + ++ REV + +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQG 69
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H NV+ L E + + ++V E + GG + I E EA Q + +A+D+ H+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 130 RGVYHRDLKPENLLL---DAYGNLKVSDFGLSAL-----SQQVRDDGLLHTTCGTPNYVA 181
+G+ HRDLKPEN+L + +K+ DF L + L T CG+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN--------------- 221
PEV+ YD DLWS GVIL++LL+GY PF +
Sbjct: 190 PEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 222 LYKKISAA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271
L++ I EF W +S A+ LI+++L + R++ ++L+ W +
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 6e-91
Identities = 109/349 (31%), Positives = 158/349 (45%), Gaps = 41/349 (11%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
Q K + Y+V + +G G KV N T E ALK+L + +RE
Sbjct: 53 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARRE 104
Query: 62 VATMK-LVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEAR 114
V + P++VR+ +V + + IV+E + GGELF +I + G E EA
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLH 171
+ + A+ Y HS + HRD+KPENLL LK++DFG +++ L
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKETTSHNSLT 221
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKIS 227
T C TP YVAPEVL YD S D+WS GVI+++LL GY PF ++ + + +I
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 228 AA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
EF P W +S + LI +L P R+TI E + W + K P T
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP------QT 334
Query: 284 NLDDVEAVFKDSEVCWMEHHVTEQKEEQPVAMNA-FELISLSKGLNLGN 331
L V K+ + W V E+ M +E I + K + N
Sbjct: 335 PLHTSR-VLKEDKERWE--DVKEEMTSALATMRVDYEQIKIKKIEDASN 380
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 1e-90
Identities = 89/294 (30%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 12 KYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVK 69
Y++ + +G G KV + TG+ ALK+L + ++EV +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 70 HPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINA 123
P++V + +V K + I++E + GGELF +I G E EA + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 124 VDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + HS + HRD+KPENLL + LK++DFG + + L T C TP YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQTPCYTPYYV 196
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAA--EFTCP 234
APEVL YD S D+WS GVI+++LL G+ PF + + ++I F P
Sbjct: 197 APEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 235 PW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD 286
W +S A++LI +L +P R+TI + + W + P T L
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP------QTPLH 303
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-89
Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 14/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++ +G G F V TG K ++ L +K E++ M + HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHP 108
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
++ L++ K ++ ++LEF++GGELFD+I +M E E Y +Q + + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 131 GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D+KPEN++ + +K+ DFG L+ ++ D ++ T T + APE+++
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
G D+W+ GV+ +VLL+G PF + + + + EF + +S A+
Sbjct: 226 PV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I +L P R+T+ + LE W K D+
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 4e-88
Identities = 84/282 (29%), Positives = 140/282 (49%), Gaps = 16/282 (5%)
Query: 12 KYEVGRT--IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
Y V +T +G G F +V + TG +A KI+ + K E++K E++ M +
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLD 144
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCH 128
H N+++LY+ SK I +V+E+V GGELFD+I++ + E + + +Q+ + + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 129 SRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
+ H DLKPEN+L +K+ DFG L+++ + L GTP ++APEV+N
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFG---LARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTAR 242
+ D+WS GVI ++LL+G PF N I A + + +S A+
Sbjct: 262 -YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTN 284
+ I+++L RI+ E L+ W +K N
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKN 362
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 5e-88
Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 34/291 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
+ V R + EG FA V A++ +G ALK L + + I +EV MK L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGH 85
Query: 71 PNVVRLY-------EVMGSKTKIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQL 120
PN+V+ E + F++L + G+L + + G + D + F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 121 INAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSA-------LSQQVRDDGLLH 171
AV + H + + HRDLK ENLLL G +K+ DFG + S + L+
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 172 ---TTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
T TP Y PE+++ G D+W+ G IL++L PF+D + +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RI 261
Query: 227 SAAEFTCPPWLSFTA--RKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+++ PP + LI +L NP R++I E++ +
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 5e-88
Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 14/289 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++ +G G F V TG A K + E +++E+ TM +++HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHP 214
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR 130
+V L++ ++ ++ EF++GGELF+K+ + H +M EDEA Y +Q+ + + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 131 GVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
H DLKPEN++ LK+ DFG L+ + + T GT + APEV +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFG---LTAHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
G D+WS GV+ ++LL+G PF N + + + + +S +
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 293
I ++L +P TR+TI + LE W P + + + K
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 439
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 6e-87
Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 23/284 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + +GEG F+ V G ALK + + + E+ +RE +L HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHP 86
Query: 72 NVVRLYEV----MGSKTKIFIVLEFVTGGELFDKI----VNHGRMKEDEARRYFQQLINA 123
N++RL G+K + +++L F G L+++I + ED+ +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHTTCGT 176
++ H++G HRDLKP N+LL G + D G S+Q T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 177 PNYVAPEVLNDRGYD--GSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTC 233
+Y APE+ + + + D+WS G +L+ ++ G P+D + + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 234 PPWLSFT--ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
P + +L+ ++ +P R IP +L + P
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 7e-87
Identities = 82/289 (28%), Positives = 140/289 (48%), Gaps = 14/289 (4%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
K+R ++ G+ +GEG+F+ V AR T A+KIL+K ++K + RE
Sbjct: 21 PPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 80
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
M + HP V+LY K++ L + GEL I G E R Y +++
Sbjct: 81 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A++Y H +G+ HRDLKPEN+LL+ +++++DFG + + ++ GT YV+
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE+L ++ ++DLW+ G I++ L+AG PF N +++KI E+ P A
Sbjct: 201 PELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259
Query: 242 RKLIARILDPNPMTRITIP------EILEDEWFKK-------DYKPPVF 277
R L+ ++L + R+ + +F+ PP
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 1e-84
Identities = 87/274 (31%), Positives = 135/274 (49%), Gaps = 16/274 (5%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R YEV TIG G++ + + R G+ + K LD + + + EV ++ +
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLREL 62
Query: 69 KHPNVVRLYE--VMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLIN 122
KHPN+VR Y+ + + T ++IV+E+ GG+L I + + E+ R QL
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 123 AVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
A+ CH R V HRDLKP N+ LD N+K+ DFGL+ + D T GTP
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPW 236
Y++PE +N Y+ +D+WS G +L+ L A PF + L KI +F P
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
S ++I R+L+ R ++ EILE+ +
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 5e-83
Identities = 74/312 (23%), Positives = 123/312 (39%), Gaps = 44/312 (14%)
Query: 2 SQPKIKRRVGK-YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ P ++ + + +G G+ V F S G PVA+K + + +
Sbjct: 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALM 57
Query: 61 EVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMKEDE 112
E+ + + HPNV+R Y + ++I LE L D + + KE
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-------------AYGNLKVSDFGLSA 159
+Q+ + V + HS + HRDLKP+N+L+ + +SDFGL
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 160 L--SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD------GSTADLWSCGVILFVLL-AG 210
S Q L+ GT + APE+L + + D++S G + + +L G
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 211 YLPFDDSNLMN---LYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRITIPEILED 265
PF D + S E C L A LI++++D +P+ R T ++L
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 266 EWFKKDYKPPVF 277
F K F
Sbjct: 297 PLFWPKSKKLEF 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-81
Identities = 76/262 (29%), Positives = 139/262 (53%), Gaps = 7/262 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + IGEG+F K +++E G +K ++ + + K E+ +REVA + +KHP
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI--VNHGRMKEDEARRYFQQLINAVDYCHS 129
N+V+ E ++IV+++ GG+LF +I +ED+ +F Q+ A+ + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R + HRD+K +N+ L G +++ DFG++ + L GTP Y++PE+ ++
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKP 201
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSFTARKLIARI 248
Y+ + +D+W+ G +L+ L F+ ++ NL KI + F S+ R L++++
Sbjct: 202 YN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 249 LDPNPMTRITIPEILEDEWFKK 270
NP R ++ ILE + K
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAK 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 2e-80
Identities = 67/282 (23%), Positives = 114/282 (40%), Gaps = 33/282 (11%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
KR ++ IG G F +V A++ G+ +K + E+ +REV +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALA 59
Query: 67 LVKHPNVVRLYE----------------VMGSKTKIFIVLEFVTGGELFDKIV--NHGRM 108
+ H N+V +FI +EF G L I ++
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168
+ A F+Q+ VDY HS+ + +RDLKP N+ L +K+ DFGL +++DG
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDG 176
Query: 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA 228
+ GT Y++PE ++ + Y DL++ G+IL LL +++ + +
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD 233
Query: 229 AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
+ L+ ++L P R EIL K
Sbjct: 234 GII--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 4e-80
Identities = 45/310 (14%), Positives = 87/310 (28%), Gaps = 47/310 (15%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ + K ++ + G + V R+ E E ALK+ E++
Sbjct: 54 DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEAT 113
Query: 63 ATMKLVKHPNVVRLYEVMG--------------------------SKTKIFIVLEFVTG- 95
+ + + + +++ +
Sbjct: 114 FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVD 173
Query: 96 ----GELFDKIVNHGRMKEDEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150
D + + A QLI S+G+ H P+NL + G L
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRL 233
Query: 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD-GSTADLWSCGVILFVLLA 209
+ D + + Y E LN + W G+ ++ +
Sbjct: 234 MLGDVSAL-----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 210 GYLPFDDSN--LMNLYKKISAAE-------FTCPPWLSFTARKLIARILDPNPMTRITIP 260
+LPF + +K+ S F L + LI R L+ + R+
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348
Query: 261 EILEDEWFKK 270
E +E F +
Sbjct: 349 EAMETPEFLQ 358
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 9e-79
Identities = 48/302 (15%), Positives = 98/302 (32%), Gaps = 42/302 (13%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+ R G +G+ A + ETGE + + + +Q+K EV +
Sbjct: 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132
Query: 66 KL----------------------VKHPNVVRLYEVMGSKTKIFIVLEFVT--------- 94
+L VK P ++ V + ++++ F
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192
Query: 95 --GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152
G L H + + Q+I + H G+ H L+P +++LD G + +
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 252
Query: 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST----ADLWSCGVILFVLL 208
+ F + + P A +L + + D W+ G+ ++ +
Sbjct: 253 TGFEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 209 AGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268
LP D + + I + P R L+ L R+ + +E +
Sbjct: 312 CADLPNTDDAALGGSEWIFRSCKNIPQP----VRALLEGFLRYPKEDRLLPLQAMETPEY 367
Query: 269 KK 270
++
Sbjct: 368 EQ 369
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 1e-78
Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 24/287 (8%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
VGK + +G G + + R VA+K + E REV
Sbjct: 18 VVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQL 70
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM-KEDEARRYFQQLIN 122
++ +HPNV+R + + +I +E L + + E QQ +
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTS 129
Query: 123 AVDYCHSRGVYHRDLKPENLLL-----DAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGT 176
+ + HS + HRDLKP N+L+ +SDFGL L+ GT
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 177 PNYVAPEVLNDRGYDGST--ADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTC 233
++APE+L++ + T D++S G + + +++ G PF S + A C
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249
Query: 234 PPW---LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF 277
AR+LI +++ +P R + +L+ +F K F
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQF 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 2e-78
Identities = 85/295 (28%), Positives = 124/295 (42%), Gaps = 57/295 (19%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
+ +G G KV N T E ALK+L + +REV + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 72 NVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVD 125
++VR+ +V + + IV+E + GGELF +I + G E EA + + A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 126 YCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
Y HS + HRD+KPENLL LK++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAA--EFTCPPW 236
E YD S D+WS GVI+++LL GY PF ++ + + +I EF P W
Sbjct: 169 ETTG-EKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 237 --LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 289
+S + LI +L P R+TI E + W + K P T L
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP------QTPLHTSR 275
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 4e-78
Identities = 88/288 (30%), Positives = 150/288 (52%), Gaps = 20/288 (6%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++ +++ +T+G G+F +V ++ E+G A+KILDK+KV+K K E E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ V P +V+L + +++V+E+V GGE+F + GR E AR Y Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+Y HS + +RDLKPENLL+D G ++V+DFG + R G T CGTP +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALA 206
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ +GY D W+ GV+++ + AGY PF + +Y+KI + + P S
Sbjct: 207 PEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 242 RKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 275
+ L+ +L + R + +I +WF + + P
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 5e-78
Identities = 96/303 (31%), Positives = 167/303 (55%), Gaps = 27/303 (8%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
PK + +++ RT+G G+F +V R+ G A+K+L KE V++ K E E
Sbjct: 1 PKYS--LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
+ +V HP ++R++ +IF++++++ GGELF + R A+ Y ++ A
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
++Y HS+ + +RDLKPEN+LLD G++K++DFG + + +T CGTP+Y+APE
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V++ + Y + D WS G++++ +LAGY PF DSN M Y+KI AE PP+ + +
Sbjct: 174 VVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 232
Query: 244 LIARILDPNPMTRI-----TIPEILEDEWFK---------KD----YKPPVFEEKKDT-N 284
L++R++ + R+ ++ WFK ++ Y+PP+ + + DT
Sbjct: 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQ 292
Query: 285 LDD 287
D
Sbjct: 293 FDK 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 1e-76
Identities = 64/261 (24%), Positives = 111/261 (42%), Gaps = 10/261 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ +G G++ +V R+ E G A+K A ++ + K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
VRL + +++ E G L G + E + Y + + A+ + HS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
G+ H D+KP N+ L G K+ DFGL ++ G G P Y+APE+L Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232
Query: 191 DGSTADLWSCGVILFVLLAGY-LPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
+ AD++S G+ + + LP L + EF LS R ++ +L
Sbjct: 233 G-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289
Query: 250 DPNPMTRITIPEILEDEWFKK 270
+P+P R T +L ++
Sbjct: 290 EPDPKLRATAEALLALPVLRQ 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-76
Identities = 82/289 (28%), Positives = 137/289 (47%), Gaps = 15/289 (5%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + + + IG G F++V A G PVALK + ++ K +
Sbjct: 22 LRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK 81
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRY 116
E+ +K + HPNV++ Y ++ IVLE G+L I + + + E +Y
Sbjct: 82 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
F QL +A+++ HSR V HRD+KP N+ + A G +K+ D GL H+ GT
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGT 199
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCP 234
P Y++PE +++ GY+ +D+WS G +L+ + A PF D NL +L KKI ++ P
Sbjct: 200 PYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--P 256
Query: 235 PW----LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
P S R+L+ ++P+P R + + + E
Sbjct: 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-73
Identities = 67/294 (22%), Positives = 114/294 (38%), Gaps = 31/294 (10%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R + +E + +G G F V A+N A+K + + E++ REV +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAK 59
Query: 68 VKHPNVVRLYEV------------MGSKTKIFIVLEFVTGGELFDKIVNHGRMK---EDE 112
++HP +VR + K ++I ++ L D + ++
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL----------SQ 162
F Q+ AV++ HS+G+ HRDLKP N+ +KV DFGL
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL 222
+ GT Y++PE ++ Y D++S G+ILF LL Y +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--YPFSTQMERVRT 236
Query: 223 YKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+ +F ++ +L P+PM R I+E+ F+ P
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 9e-73
Identities = 75/289 (25%), Positives = 142/289 (49%), Gaps = 21/289 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG+G+F KV + ++T + A+K ++K+K ++ + +E+ M+ ++HP +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ + +F+V++ + GG+L + + KE+ + + +L+ A+DY ++ + HRD
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR---GYDGS 193
+KP+N+LLD +G++ ++DF ++A + + + T GT Y+APE+ + R GY
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY-SF 196
Query: 194 TADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
D WS GV + LL G P+ ++ + T P S L+ ++L+
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLE 256
Query: 251 PNPMTRI-TIPEILEDEWFK---------KDYKPPVFEEKKDTNLDDVE 289
PNP R + ++ + K P F K D
Sbjct: 257 PNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPG-FIPNKGRLNCDPT 304
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 5e-71
Identities = 47/298 (15%), Positives = 106/298 (35%), Gaps = 36/298 (12%)
Query: 3 QPKIKRRVG--KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMA 55
+PK + ++G V +GEG FA+V A +++ + LK+ + +
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 56 EQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-----NHGRMKE 110
Q+ +K ++ Y + +V E + G L + I M +
Sbjct: 115 TQLMER---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 111 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-----------DAYGNLKVSDFGLSA 159
+ +++ ++ H + H D+KP+N +L D L + D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSN 218
+ + C T + E+L+++ ++ D + ++ +L G Y+ +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 219 LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE---DEWFKKDYK 273
+ + W + +L+ + ++L + F++ Y
Sbjct: 291 GECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 7e-68
Identities = 91/273 (33%), Positives = 140/273 (51%), Gaps = 17/273 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV AR+ A+K+L K+ +LK K + I E + K VKHP +V
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL+++ GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + + T CGTP Y+APEVL+ + Y T
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTV 220
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF N +Y I P ++ +AR L+ +L +
Sbjct: 221 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 280
Query: 256 RITIP----EILEDEWFK---------KDYKPP 275
R+ EI +F K PP
Sbjct: 281 RLGAKDDFMEIKSHVFFSLINWDDLINKKITPP 313
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 9e-68
Identities = 91/273 (33%), Positives = 142/273 (52%), Gaps = 17/273 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG A+KIL KE ++ E ++ +HP + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + E+ AR Y ++++A++Y HSR V +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 257 I-----TIPEILEDEWFK---------KDYKPP 275
+ E++E +F K PP
Sbjct: 248 LGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-67
Identities = 82/287 (28%), Positives = 146/287 (50%), Gaps = 16/287 (5%)
Query: 2 SQPKIKRRVG--KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
+P ++ ++ + + + +G+G+F KV A +T + A+K L K+ VL E
Sbjct: 6 ERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM 65
Query: 60 REVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + L +HP + ++ +K +F V+E++ GG+L I + + A Y
Sbjct: 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++I + + HS+G+ +RDLK +N+LLD G++K++DFG+ + + D +T CGTP+
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPD 183
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y+APE+L + Y + D WS GV+L+ +L G PF + L+ I P WL
Sbjct: 184 YIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 242
Query: 239 FTARKLIARILDPNPMTRI-TIPEILEDEWFK---------KDYKPP 275
A+ L+ ++ P R+ +I + F+ K+ PP
Sbjct: 243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP 289
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 7e-67
Identities = 88/277 (31%), Positives = 146/277 (52%), Gaps = 21/277 (7%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKHPN 72
R +G+G + KV R + TG+ A+K+L K ++ K K E ++ VKHP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L + K++++LE+++GGELF ++ G ED A Y ++ A+ + H +G+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN++L+ G++K++DFGL S + D + HT CGT Y+APE+L G+
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGTVTHTFCGTIEYMAPEILMRSGH-N 199
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D WS G +++ +L G PF N KI + PP+L+ AR L+ ++L N
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRN 259
Query: 253 PMTRI-----TIPEILEDEWFK---------KDYKPP 275
+R+ E+ +F+ + +PP
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPP 296
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-66
Identities = 88/276 (31%), Positives = 148/276 (53%), Gaps = 21/276 (7%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G+F KV + S+ + A+K+L K + K E + V HP +
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVNHPFI 88
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+L+ ++ K++++L+F+ GG+LF ++ E++ + Y +L A+D+ HS G+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
+RDLKPEN+LLD G++K++DFGLS S + + ++ CGT Y+APEV+N RG+
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAPEVVNRRGH-TQ 205
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
+AD WS GV++F +L G LPF + I A+ P +LS A+ L+ + NP
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265
Query: 254 MTRI-----TIPEILEDEWFK---------KDYKPP 275
R+ + EI +F ++ PP
Sbjct: 266 ANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 301
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 6e-66
Identities = 97/302 (32%), Positives = 154/302 (50%), Gaps = 30/302 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YEV + IG G F +V+ R+ T + A+K+L K +++K + E M P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+L+ +++V+E++ GG+L ++++ + E AR Y +++ A+D HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 189
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVAPEVLNDRGY 190
HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PEVL +G
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 191 D---GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----FTCPPWLSFTARK 243
D G D WS GV L+ +L G PF +L+ Y KI + F +S A+
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306
Query: 244 LIARILDPNPMTRIT---IPEILEDEWFK---------KDYKPPV---FEEKKDT-NLDD 287
LI L + R+ + EI +FK +D PV DT N DD
Sbjct: 307 LICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDD 365
Query: 288 VE 289
+E
Sbjct: 366 LE 367
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 9e-66
Identities = 91/275 (33%), Positives = 146/275 (53%), Gaps = 19/275 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R +G+G+F KV AR ETG+ A+K+L K+ +L+ E E + L HP + +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + ++F V+EFV GG+L I R E AR Y ++I+A+ + H +G+ +R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAV 205
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +L G+ PF+ N +L++ I E P WL A ++ + NP
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTM 265
Query: 256 RI------TIPEILEDEWFK---------KDYKPP 275
R+ IL +FK + +PP
Sbjct: 266 RLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPP 300
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 5e-65
Identities = 81/274 (29%), Positives = 143/274 (52%), Gaps = 18/274 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+G+G+F KV + T E A+KIL K+ V++ E E + L K P + +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++ V+E+V GG+L I GR KE A Y ++ + + S+G+ +R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G +
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 202
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 262
Query: 256 RI-----TIPEILEDEWFK---------KDYKPP 275
R+ +I E +F+ K+ +PP
Sbjct: 263 RLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 7e-65
Identities = 93/289 (32%), Positives = 151/289 (52%), Gaps = 18/289 (6%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
++PK + + ++E + +G+GTF KV + TG A+KIL KE ++ E
Sbjct: 139 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ +HP + L + ++ V+E+ GGELF + ED AR Y +++
Sbjct: 199 NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 122 NAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+A+DY HS + V +RDLK ENL+LD G++K++DFGL + ++D + T CGTP Y+
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYL 316
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D Y G D W GV+++ ++ G LPF + + L++ I E P L
Sbjct: 317 APEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 375
Query: 241 ARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 275
A+ L++ +L +P R+ EI++ +F K PP
Sbjct: 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 424
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-64
Identities = 85/284 (29%), Positives = 147/284 (51%), Gaps = 28/284 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV R +T A+K++ KE V + + ++ E + HP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+E+V GG+L + ++ E+ AR Y ++ A++Y H RG+ +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++D+G+ + +R T CGTPNY+APE+L Y G +
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 191
Query: 196 DLWSCGVILFVLLAGYLPF---------DDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PF D + L++ I + P LS A ++
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251
Query: 247 RILDPNPMTRI------TIPEILEDEWFK---------KDYKPP 275
L+ +P R+ +I +F+ K PP
Sbjct: 252 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPP 295
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 9e-64
Identities = 78/304 (25%), Positives = 140/304 (46%), Gaps = 32/304 (10%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + + A+KIL+K ++LK + E +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ +++V+++ GG+L + R+ E+ AR Y +++ A+D H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVAPEVLND-- 187
HRD+KP+N+L+D G+++++DFG ++ +DG + GTP+Y++PE+L
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 188 ---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPW---LSF 239
Y G D WS GV ++ +L G PF +L+ Y KI F P +S
Sbjct: 253 GGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 240 TARKLIARILDPNPMTRIT---IPEILEDEWFK-------KDYKPPV---FEEKKDT-NL 285
A+ LI R++ R+ I + + +F ++ + P DT N
Sbjct: 312 NAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNF 370
Query: 286 DDVE 289
D +
Sbjct: 371 DVDD 374
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 1e-63
Identities = 87/313 (27%), Positives = 147/313 (46%), Gaps = 34/313 (10%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
+ R+ + +E+ + IG G F++V + +TG+ A+KI++K +LK + E
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINA 123
+ + +L+ + +++V+E+ GG+L + G R+ + AR Y +++ A
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVA 181
+D H G HRD+KP+N+LLD G+++++DFG ++R DG + GTP+Y++
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLS 231
Query: 182 PEVLNDRGYD------GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTC 233
PE+L G G D W+ GV + + G PF + Y KI +
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291
Query: 234 P---PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFK-------KDYKPPV---F 277
P + AR I R+L P TR+ + +F +D PP F
Sbjct: 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDF 350
Query: 278 EEKKDT-NLDDVE 289
E DT N D VE
Sbjct: 351 EGATDTCNFDLVE 363
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-62
Identities = 86/301 (28%), Positives = 153/301 (50%), Gaps = 30/301 (9%)
Query: 2 SQPKIKRRVG--KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
K +G +++ R IG G++AKV R +T A++++ KE V + + ++
Sbjct: 41 ESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ 100
Query: 60 REVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + HP +V L+ +++++F V+E+V GG+L + ++ E+ AR Y
Sbjct: 101 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 160
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ A++Y H RG+ +RDLK +N+LLD+ G++K++D+G+ + +R T CGTPN
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPN 218
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF---------DDSNLMNLYKKISAA 229
Y+APE+L Y G + D W+ GV++F ++AG PF D + L++ I
Sbjct: 219 YIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
Query: 230 EFTCPPWLSFTARKLIARILDPNPMTRI------TIPEILEDEWFK---------KDYKP 274
+ P LS A ++ L+ +P R+ +I +F+ K P
Sbjct: 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 337
Query: 275 P 275
P
Sbjct: 338 P 338
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 4e-62
Identities = 83/284 (29%), Positives = 149/284 (52%), Gaps = 27/284 (9%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKH-P 71
+ +G G + KV R +TG+ A+K+L K ++ K K E + E ++ ++ P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V L+ ++TK+ ++L+++ GGELF + R E E + Y +++ A+++ H G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG 189
+ +RD+K EN+LLD+ G++ ++DFGLS + + CGT Y+AP+++ D G
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSG 238
Query: 190 YDGSTADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245
+D + D WS GV+++ LL G PF + ++ + ++I +E P +S A+ LI
Sbjct: 239 HDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 297
Query: 246 ARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 275
R+L +P R+ EI E +F+ K P
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 341
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 7e-62
Identities = 81/274 (29%), Positives = 143/274 (52%), Gaps = 18/274 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+G+G+F KV + T E A+KIL K+ V++ E E + L K P + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++ V+E+V GG+L I GR KE A Y ++ + + S+G+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G +
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 523
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 583
Query: 256 RI-----TIPEILEDEWFK---------KDYKPP 275
R+ +I E +F+ K+ +PP
Sbjct: 584 RLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 617
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-62
Identities = 74/298 (24%), Positives = 129/298 (43%), Gaps = 28/298 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G G F +V + TG+ A K L+K+++ K K + E + V +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGV 132
+KT + +V+ + GG++ I N + +E A Y Q+++ +++ H R +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLD GN+++SD GL+ + GTP ++APE+L Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEY-D 367
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFTCPPWLSFTARKLIARI 248
+ D ++ GV L+ ++A PF L +++ T P S ++ +
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427
Query: 249 LDPNPMTRI-----TIPEILEDEWFK---------KDYKPPVF---EEKKDTNLDDVE 289
L +P R+ + + F+ PP N+ DV
Sbjct: 428 LQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVG 485
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-61
Identities = 81/314 (25%), Positives = 141/314 (44%), Gaps = 33/314 (10%)
Query: 3 QPKIKRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMA 55
++ + + V R IG G F +V R ++TG+ A+K LDK+++ +
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN 238
Query: 56 EQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 115
E + ++ + P +V + + K+ +L+ + GG+L + HG E + R
Sbjct: 239 E--RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 296
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y ++I +++ H+R V +RDLKP N+LLD +G++++SD GL+ H + G
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVG 352
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKISAAEFT 232
T Y+APEVL S+AD +S G +LF LL G+ PF + + +
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 233 CPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKP---P 275
P S R L+ +L + R+ E+ E +F+ + Y P P
Sbjct: 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 472
Query: 276 VFEEKKDTNLDDVE 289
E + D+
Sbjct: 473 PRGEVNAADAFDIG 486
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 7e-61
Identities = 79/304 (25%), Positives = 137/304 (45%), Gaps = 26/304 (8%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++ V K + R +G+G F +V + TG+ A K L+K+++ K K E
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM--KEDEARRYFQQLIN 122
++ V VV L +K + +VL + GG+L I + G+ E A Y ++
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
++ H + +RDLKPEN+LLD +G++++SD G L+ V + + GT Y+AP
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLG---LAVHVPEGQTIKGRVGTVGYMAP 354
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLS 238
EV+ + Y + D W+ G +L+ ++AG PF + + + S
Sbjct: 355 EVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS 413
Query: 239 FTARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPPVFEEKKDTN 284
AR L +++L +P R+ + E+ E FK +PP + +
Sbjct: 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIY 473
Query: 285 LDDV 288
DV
Sbjct: 474 CKDV 477
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-59
Identities = 54/284 (19%), Positives = 94/284 (33%), Gaps = 35/284 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ IG G F V G A+K K ++ A L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYC 127
+VVR + + I E+ GG L D I + R KE E + Q+ + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 128 HSRGVYHRDLKPENLLLDAYGNL-------------------KVSDFGLSALSQQVRDDG 168
HS + H D+KP N+ + K+ D G V
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH------VTRIS 185
Query: 169 LLHTTCGTPNYVAPEVLN-DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
G ++A EVL + + AD+++ + + + + +I
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQW---HEIR 241
Query: 228 AAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
P LS +L+ ++ P+P R + +++
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-55
Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 15/274 (5%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+GT+ V R+ +A+K + + + ++ + E+A K +KH N+V+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEA--RRYFQQLINAVDYCHSRGV 132
I I +E V GG L + G +K++E Y +Q++ + Y H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 133 YHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN--DRG 189
HRD+K +N+L++ Y G LK+SDFG S + T GT Y+APE+++ RG
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRG 201
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEF--TCPPWLSFTARKLIA 246
Y + AD+WS G + + G PF + K+ + P +S A+ I
Sbjct: 202 YGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVFEEK 280
+ +P+P R ++L DE+ K K + K
Sbjct: 261 KCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-55
Identities = 70/134 (52%), Positives = 96/134 (71%), Gaps = 1/134 (0%)
Query: 309 EEQPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPANEIINKIEEAAKPLGF 367
+E P+ MNAFE+I+LS+GLNL LFD QDF KR+TRF SR +EII IE A +GF
Sbjct: 1 DEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGF 60
Query: 368 DVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNLSTC 427
H +N+K RLE + + + G L V E+++VAPSL MV+VRKA G+TLE+HKFYK L +
Sbjct: 61 KSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSK 120
Query: 428 LEDVVWKTEEDMQE 441
LE+++W+ E + +
Sbjct: 121 LENIIWRATEGIPK 134
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-55
Identities = 64/328 (19%), Positives = 114/328 (34%), Gaps = 72/328 (21%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILD-------KEKVLK------------- 51
+E + +G G F V A+N A+K + +EKV++
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 52 -----------------------------------HKMAEQIKREVATMKLVKHPNVVRL 76
+ ++ M N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDE---ARRYFQQLINAVDYCHSRGVY 133
+ K ++I ++ L D + +++ E F Q+ AV++ HS+G+
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD----------GLLHTTCGTPNYVAPE 183
HRDLKP N+ +KV DFGL Q ++ GT Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF-TAR 242
++ Y D++S G+ILF LL Y + + + +F +
Sbjct: 247 QIHGNNYSHK-VDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEH 303
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKK 270
++ +L P+P R +I+E+ F+
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 4e-54
Identities = 65/267 (24%), Positives = 112/267 (41%), Gaps = 22/267 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G G+F +V ++ +TG A+K + E E+ + P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--------EELVACAGLSSPR 111
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V LY + + I +E + GG L I G + ED A Y Q + ++Y H+R +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 133 YHRDLKPENLLLDAYGNL-KVSDFGLSALSQQVRDDGLLHTTC------GTPNYVAPEVL 185
H D+K +N+LL + G+ + DFG + ++ DGL + GT ++APEV+
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHAL---CLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTAR 242
+ D D+WS ++ +L G P+ L KI++ PP +
Sbjct: 229 MGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 243 KLIARILDPNPMTRITIPEILEDEWFK 269
+ I L P+ R + E+
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-52
Identities = 78/315 (24%), Positives = 136/315 (43%), Gaps = 60/315 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE IGEG++ V RN +TG+ VA+K + ++ + K+A RE+ +K +K
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL---REIRMLKQLK 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+V L EV K ++ +V E+ + ++ + R + E + Q + AV++CH
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYV------A 181
HRD+KPEN+L+ + +K+ DFG + L+ + + V +
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY----YD-----DEVATRWYRS 170
Query: 182 PEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYKKISA--------- 228
PE+L D Y D+W+ G + LL+G P S++ LY
Sbjct: 171 PELLVGDTQY--GPPVDVWAIGCVFAELLSGVPLWP-GKSDVDQLYLIRKTLGDLIPRHQ 227
Query: 229 ---------AEFTCPPW------------LSFTARKLIARILDPNPMTRITIPEILEDEW 267
+ P +S+ A L+ L +P R+T ++L +
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
Query: 268 FKKDYKPPVFEEKKD 282
F+ + ++ D
Sbjct: 288 FENIREIEDLAKEHD 302
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-51
Identities = 67/272 (24%), Positives = 129/272 (47%), Gaps = 18/272 (6%)
Query: 11 GKYE-VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
G++ IG G+F V ++ET VA L K+ K ++ K E +K ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 83
Query: 70 HPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
HPN+VR Y + K I +V E +T G L + MK R + +Q++ +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 126 YCHSRG--VYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ H+R + HRDLK +N+ + G++K+ D GL+ L + GTP ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAP 199
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAE--FTCPPWLSF 239
E+ + YD S D+++ G+ + + P+ + N +Y+++++ +
Sbjct: 200 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271
+++I + N R +I ++L +F+++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-51
Identities = 80/321 (24%), Positives = 132/321 (41%), Gaps = 70/321 (21%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----RE 61
+ + KYE +GEG++ V RN +TG VA+K + + + +K RE
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-------KMVKKIAMRE 74
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQ 119
+ +K ++H N+V L EV K + ++V EFV + + + ++Y Q
Sbjct: 75 IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQ 132
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN 178
+IN + +CHS + HRD+KPEN+L+ G +K+ DFG + L+ + +
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV----YD-----D 183
Query: 179 YV------APEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK--KI 226
V APE+L D Y A D+W+ G ++ + G P DS++ LY
Sbjct: 184 EVATRWYRAPELLVGDVKY--GKAVDVWAIGCLVTEMFMGEPLFP-GDSDIDQLYHIMMC 240
Query: 227 ----------------SAAEFTCPPW------------LSFTARKLIARILDPNPMTRIT 258
A P LS L + L +P R
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300
Query: 259 IPEILEDEWFKKDYKPPVFEE 279
E+L ++F+ D F +
Sbjct: 301 CAELLHHDFFQMDGFAERFSQ 321
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 86/312 (27%), Positives = 127/312 (40%), Gaps = 58/312 (18%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVA 63
+K R +YE +GEG FA V AR+ T + VA+K L K + RE+
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLI 121
++ + HPN++ L + G K+ I +V +F+ + N + + Y +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTL 122
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTT 173
++Y H + HRDLKP NLLLD G LK++DFGL+ A + QV
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-------- 174
Query: 174 CGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK----- 224
T Y APE+L R Y D+W+ G IL LL +LP DS+L L +
Sbjct: 175 --TRWYRAPELLFGARMY--GVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTRIFETL 229
Query: 225 ---------KIS----AAEFTCP---------PWLSFTARKLIARILDPNPMTRITIPEI 262
+ F LI + NP RIT +
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289
Query: 263 LEDEWFKKDYKP 274
L+ ++F P
Sbjct: 290 LKMKYFSNRPGP 301
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 8e-50
Identities = 79/326 (24%), Positives = 131/326 (40%), Gaps = 71/326 (21%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQI 58
+S + +Y +GEGT+ +V A ++ T E VA+K L+ E+ E +
Sbjct: 24 VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-------EGV 76
Query: 59 K----REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
REV+ +K ++H N++ L V+ ++ ++ E+ +L + + + +
Sbjct: 77 PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK 135
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-----GNLKVSDFGLS--------ALS 161
+ QLIN V++CHSR HRDLKP+NLLL LK+ DFGL+ +
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 162 QQVRDDGLLHTTCGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD- 216
++ T Y PE+L R Y ST+ D+WS I +L P D
Sbjct: 196 HEII----------TLWYRPPEILLGSRHY--STSVDIWSIACIWAEMLMKTPLFPGDSE 243
Query: 217 ----------------------SNL---MNLYKKISAAEF--TCPPWLSFTARKLIARIL 249
+ L + K L L+ +L
Sbjct: 244 IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAML 303
Query: 250 DPNPMTRITIPEILEDEWFKKDYKPP 275
+ +P+ RI+ LE +F + P
Sbjct: 304 EMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 98/313 (31%), Positives = 142/313 (45%), Gaps = 72/313 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
KYE IGEGT+ V A+N ET E VALK LD + E + RE+ +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-------EGVPSSALREICLL 55
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+VRL++V+ S K+ +V EF + FD +G + + + + QL+
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKG 113
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTTCG 175
+ +CHSR V HRDLKP+NLL++ G LK+++FGL+ S +V
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---------- 163
Query: 176 TPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAA-- 229
T Y P+VL + Y ST+ D+WS G I L P + L +I
Sbjct: 164 TLWYRPPDVLFGAKLY--STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLG 220
Query: 230 ---EFTCP------------------------PWLSFTARKLIARILDPNPMTRITIPEI 262
E P P L+ T R L+ +L NP+ RI+ E
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
Query: 263 LEDEWFKKDYKPP 275
L+ +F D+ PP
Sbjct: 281 LQHPYF-SDFCPP 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 5e-49
Identities = 83/323 (25%), Positives = 131/323 (40%), Gaps = 77/323 (23%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REV 62
+++ +G GT+A V N TG VALK LD E E RE+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--------EGTPSTAIREI 54
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG-----ELFDKIVNHGRMKEDEARRYF 117
+ MK +KH N+VRLY+V+ ++ K+ +V EF+ + ++ + + +
Sbjct: 55 SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT 176
QL+ + +CH + HRDLKP+NLL++ G LK+ DFGL+ A V +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--------TFS 166
Query: 177 PN-----YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD----------- 216
Y AP+VL R Y ST+ D+WSCG IL ++ G P +
Sbjct: 167 SEVVTLWYRAPDVLMGSRTY--STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224
Query: 217 ------------SNL------------MNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
+ L +L + + L + +L N
Sbjct: 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT---KEPLDGNLMDFLHGLLQLN 281
Query: 253 PMTRITIPEILEDEWFKKDYKPP 275
P R++ + L WF + Y
Sbjct: 282 PDMRLSAKQALHHPWFAEYYHHA 304
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-48
Identities = 88/317 (27%), Positives = 142/317 (44%), Gaps = 69/317 (21%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----R 60
+ + KY+ +GEGT+ V A++S G VALK LD E E I R
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-------EGIPSTAIR 68
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQ 118
E++ +K + HPN+V L +V+ S+ + +V EF+ ++ D+ N +++ + + Y
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLY 126
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTP 177
QL+ V +CH + HRDLKP+NLL+++ G LK++DFGL+ A VR T
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--------SYTH 178
Query: 178 N-----YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD------------ 216
Y AP+VL + Y ST+ D+WS G I ++ G P
Sbjct: 179 EVVTLWYRAPDVLMGSKKY--STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236
Query: 217 -----------SNLMNLYKKISAAEFTCP------PWLSFTARKLIARILDPNPMTRITI 259
L +K+ + F P L++ +L +P RI+
Sbjct: 237 GTPNPREWPQVQELPL-WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA 295
Query: 260 PEILEDEWFKKDYKPPV 276
+ + +F KD P +
Sbjct: 296 RDAMNHPYF-KDLDPQI 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-48
Identities = 82/320 (25%), Positives = 126/320 (39%), Gaps = 62/320 (19%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKRE 61
P +YE IG G + V AR+ +G VALK + + RE
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 62 VATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIVNHGRMKED 111
VA ++ ++ HPNVVRL +V + K+ +V E V DK + +
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPAE 120
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-------ALSQQV 164
+ +Q + +D+ H+ + HRDLKPEN+L+ + G +K++DFGL+ AL+ V
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMN 221
T Y APEVL Y +T D+WS G I + +S
Sbjct: 181 V----------TLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQ 227
Query: 222 LYK-----------------KISAAEFTCP---------PWLSFTARKLIARILDPNPMT 255
L K + F P + + +L+ +L NP
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 287
Query: 256 RITIPEILEDEWFKKDYKPP 275
RI+ L+ + KD P
Sbjct: 288 RISAFRALQHSYLHKDEGNP 307
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-48
Identities = 38/125 (30%), Positives = 60/125 (48%), Gaps = 6/125 (4%)
Query: 312 PVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHK 371
MNAF++IS S G NL LF + + R RF S A ++ ++EE V K
Sbjct: 3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAK 62
Query: 372 K-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKN-LSTCLE 429
K + M++E G+KGN + E+ Q+ L M+EVRK + + + L
Sbjct: 63 KETWGMKIE----GQKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFV 118
Query: 430 DVVWK 434
++V +
Sbjct: 119 ELVHE 123
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-47
Identities = 95/307 (30%), Positives = 140/307 (45%), Gaps = 69/307 (22%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
KY IGEGT+ V A+N GE ALK L+KE E I RE++ +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-------EGIPSTTIREISIL 54
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+V+LY+V+ +K ++ +V E + +L D G ++ A+ + QL+N
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNG 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN---- 178
+ YCH R V HRDLKP+NLL++ G LK++DFGL+ A VR T
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--------KYTHEIVTL 164
Query: 179 -YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYKKISAA---- 229
Y AP+VL + Y ST D+WS G I ++ G P S L +I
Sbjct: 165 WYRAPDVLMGSKKY--STTIDIWSVGCIFAEMVNGTPLFP-GVSEADQLM-RIFRILGTP 220
Query: 230 -EFTCP------------------------PWLSFTARKLIARILDPNPMTRITIPEILE 264
P L + L++++L +P RIT + LE
Sbjct: 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
Query: 265 DEWFKKD 271
+FK++
Sbjct: 281 HAYFKEN 287
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-47
Identities = 76/268 (28%), Positives = 134/268 (50%), Gaps = 15/268 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 81
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
V + Y TK++I++E++ GG D ++ G + E + ++++ +DY HS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYD 191
HRD+K N+LL +G +K++DFG++ Q+ D + T GTP ++APEV+ YD
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIAR 247
AD+WS G+ L G P + + M + I PP L S ++ +
Sbjct: 198 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEA 253
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPP 275
L+ P R T E+L+ ++ ++ K
Sbjct: 254 CLNKEPSFRPTAKELLKHKFILRNAKKT 281
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 85/322 (26%), Positives = 128/322 (39%), Gaps = 69/322 (21%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----RE 61
V KYE IG+GTF +V AR+ +TG+ VALK +++ EK E RE
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-------EGFPITALRE 66
Query: 62 VATMKLVKHPNVVRLYEVM--------GSKTKIFIVLEFV----TGGELFDKIVNHGRMK 109
+ ++L+KH NVV L E+ K I++V +F G L + +
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFT 122
Query: 110 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDG 168
E +R Q L+N + Y H + HRD+K N+L+ G LK++DFGL+ A S
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 169 LLHTTC-GTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--------------- 210
+T T Y PE+L +R Y DLW G I+ +
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDY--GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240
Query: 211 -----------------YLP-FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
++ L+ K+ A LI ++L +
Sbjct: 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV-RDPYALDLIDKLLVLD 299
Query: 253 PMTRITIPEILEDEWFKKDYKP 274
P RI + L ++F D P
Sbjct: 300 PAQRIDSDDALNHDFFWSDPMP 321
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 28/277 (10%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ IG G+F V A G VA+KIL ++ + + REVA MK ++HPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNI 96
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ---QLINAVDYCHSR 130
V + + IV E+++ G L+ + G ++ + RR + ++Y H+R
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 131 G--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LK NLL+D +KV DFGLS L + + GTP ++APEVL D
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------TCPPWLSF 239
+ +D++S GVIL+ L P+ + +N + ++A F P +
Sbjct: 215 PSN-EKSDVYSFGVILWELATLQQPWGN---LNPAQVVAAVGFKCKRLEIPRNLNPQV-- 268
Query: 240 TARKLIARILDPNPMTRITIPEILED-EWFKKDYKPP 275
+I P R + I++ K PP
Sbjct: 269 --AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 75/316 (23%), Positives = 124/316 (39%), Gaps = 47/316 (14%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
EV +G G F V A+ + VA+K ++ E K E+ + V HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERK-----AFIVELRQLSRVNHPNI 63
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI---NAVDYCHSR 130
V+LY + +V+E+ GG L++ + + A + V Y HS
Sbjct: 64 VKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 131 ---GVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
+ HRDLKP NLLL A G LK+ DFG + Q + G+ ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFE 176
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------TCPPWL 237
Y D++S G+IL+ ++ PFD+ + +I A P +
Sbjct: 177 GSNYS-EKCDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 238 SFTARKLIARILDPNPMTRITIPEILED-EWFKKDY----KPPVFEEKKDTNLDD----- 287
L+ R +P R ++ EI++ + + +P + + +
Sbjct: 234 ----ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVE 289
Query: 288 VEAVFKDSEVCWMEHH 303
F + W H
Sbjct: 290 PYVDFAEFYRLWSVDH 305
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 71/313 (22%), Positives = 122/313 (38%), Gaps = 72/313 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
Y +GEGT+A V ++ T VALK L+ E E REV+ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--------EGAPCTAIREVSLL 54
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+V L++++ ++ + +V E++ + D + + + QL+
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRG 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTTCG 175
+ YCH + V HRDLKP+NLL++ G LK++DFGL+ +V
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---------- 162
Query: 176 TPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK------- 224
T Y P++L Y ST D+W G I + + G P + L+
Sbjct: 163 TLWYRPPDILLGSTDY--STQIDMWGVGCIFYEMATGRPLFP-GSTVEEQLHFIFRILGT 219
Query: 225 -------------KISAAEFTCP---------PWLSFTARKLIARILDPNPMTRITIPEI 262
+ + P L L+ ++L RI+ +
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279
Query: 263 LEDEWFKKDYKPP 275
++ +F +
Sbjct: 280 MKHPFFLSLGERI 292
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 87/328 (26%), Positives = 133/328 (40%), Gaps = 74/328 (22%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALK--ILDKEKVLKHKMAEQ 57
M + + R +YE IGEG + KV AR+ G VALK + + E
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-------EG 53
Query: 58 IK----REVATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIV 103
+ REVA ++ ++ HPNVVRL++V +TK+ +V E V DK+
Sbjct: 54 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV- 112
Query: 104 NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS----- 158
+ + + QL+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+
Sbjct: 113 PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 159 --ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAG--YLP 213
AL+ V T Y APEVL Y +T DLWS G I +
Sbjct: 173 QMALTSVVV----------TLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRRKPLFR 220
Query: 214 FDDSNLMNLYK-----------------KISAAEFTCP---------PWLSFTARKLIAR 247
S++ L K + F + + L+ +
Sbjct: 221 -GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK 279
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPP 275
L NP RI+ L +F+ +
Sbjct: 280 CLTFNPAKRISAYSALSHPYFQDLERCK 307
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-45
Identities = 60/265 (22%), Positives = 119/265 (44%), Gaps = 24/265 (9%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
VG+ IG G+F V + + + VA+K+L + + K EV ++ +H N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRG 131
++ + ++ IV ++ G L+ + + + + + +Q +DY H++
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLK N+ L +K+ DFGL+ + G+ ++APEV+ + +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 192 GST--ADLWSCGVILFVLLAGYLPFDDSNLM----------NLYKKISAAEFTCPPWLSF 239
+ +D+++ G++L+ L+ G LP+ + N +L +S CP +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM-- 258
Query: 240 TARKLIARILDPNPMTRITIPEILE 264
++L+A L R + P IL
Sbjct: 259 --KRLMAECLKKKRDERPSFPRILA 281
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-45
Identities = 58/270 (21%), Positives = 115/270 (42%), Gaps = 29/270 (10%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
E+G IG+G F +V R + E VA++++D E+ + KREV + +H N
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHEN 90
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRG 131
VV S + I+ G L+ + + ++ R+ Q+++ + Y H++G
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H+DLK +N+ D G + ++DFGL + Q R + L G ++APE++
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 189 GYDGST--------ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------SAAEFTCP 234
D +D+++ G I + L A PF + ++ + ++
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILE 264
+ ++ R T ++++
Sbjct: 270 KEI----SDILLFCWAFEQEERPTFTKLMD 295
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 77/271 (28%), Positives = 139/271 (51%), Gaps = 10/271 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ IGEG+ V AR +G VA+K++D K + E + EV M+ +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHF 102
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NVV +Y+ ++++++EF+ GG L D IV+ R+ E++ + ++ A+ Y H++G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +++LL G +K+SDFG A Q +D + GTP ++APEV++ Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARI 248
D+WS G+++ ++ G P+ + + K++ + + +S R + R+
Sbjct: 220 TE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L +P R T E+L+ + + P
Sbjct: 279 LVRDPQERATAQELLDHPFLLQTGLPECLVP 309
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-44
Identities = 75/271 (27%), Positives = 133/271 (49%), Gaps = 10/271 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA++ ++ ++ K E I E+ M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARI 248
D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 195 PK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L+ + R + E+L+ ++ K
Sbjct: 254 LEMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 44/279 (15%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
G +G+G F + + ETGE + +K L + + +EV M+ ++HPNV
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---------RMKEDEARRYFQQLINAV 124
++ V+ ++ + E++ GG L I + +D A +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS--------GM 121
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL------------SQQVRDDGLLHT 172
Y HS + HRDL N L+ N+ V+DFGL+ L S + D +T
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231
G P ++APE++N R YD D++S G++L ++ D + ++ F
Sbjct: 182 VVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240
Query: 232 ------TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CPP + R D +P R + ++
Sbjct: 241 DRYCPPNCPPSF----FPITVRCCDLDPEKRPSFVKLEH 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-44
Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 34/273 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKLVK 69
E + IG+G F V R + VA+K L + + + ++ +REV M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+V+LY + +V+EFV G+L+ ++++ +K R + ++Y
Sbjct: 82 HPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 129 SRG--VYHRDLKPENLLLDAYG-----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
++ + HRDL+ N+ L + KV+DFGLS S + G ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA 194
Query: 182 PEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------F 231
PE + Y AD +S +IL+ +L G PFD+ + + E
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CPP L R +I +P R I++
Sbjct: 254 DCPPRL----RNVIELCWSGDPKKRPHFSYIVK 282
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-44
Identities = 69/264 (26%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y++ +G G + V A ++ VA+K + K + ++ +REV + H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V + +V ++V+E++ G L + I +HG + D A + Q+++ + + H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTC--GTPNYVAPEVLND 187
+ HRD+KP+N+L+D+ LK+ DFG++ ALS+ L T GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET----SLTQTNHVLGTVQYFSPEQAKG 186
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCP----PWLSFTAR 242
D T D++S G++L+ +L G PF+ ++ + K I + + +
Sbjct: 187 EATDECT-DIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 243 KLIARILDPNPMTR-ITIPEILED 265
+I R + + R TI E+ +D
Sbjct: 246 NVILRATEKDKANRYKTIQEMKDD 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-43
Identities = 45/269 (16%), Positives = 98/269 (36%), Gaps = 36/269 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ E ++ R G + +K+L + + E +++ HPNV
Sbjct: 13 NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNV 69
Query: 74 VRLYEVM--GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD------ 125
+ + ++ ++ G L++ + D+++ + A+D
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA----VKFALDMARGMA 125
Query: 126 YCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ H+ + L ++++D ++S + Q P +VAPE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPE 178
Query: 184 VLNDRGYDGST--ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------TCPP 235
L + D + AD+WS V+L+ L+ +PF D + M + K++ P
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 236 WLSFTARKLIARILDPNPMTRITIPEILE 264
+ KL+ ++ +P R I+
Sbjct: 239 HV----SKLMKICMNEDPAKRPKFDMIVP 263
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 66/265 (24%), Positives = 120/265 (45%), Gaps = 19/265 (7%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
++ + + G Y + R +G G V A ++ VALK++ + +++RE
Sbjct: 25 AESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQRE 84
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
T ++ P+VV +++ ++++ + + G +L + G + A +Q+
Sbjct: 85 ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIG 144
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDDGLLHT--TCGTPN 178
+A+D H+ G HRD+KPEN+L+ A + DFG+ SA + D+ L T GT
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT----DEKLTQLGNTVGTLY 200
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y+APE ++ AD+++ +L+ L G P+ L + I+ A P S
Sbjct: 201 YMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA----IPRPS 255
Query: 239 FTARKL-------IARILDPNPMTR 256
+ IAR + NP R
Sbjct: 256 TVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-43
Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 25/290 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ IG G A V+ A + E VA+K ++ EK +++ +E+ M HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM--DELLKEIQAMSQCHHPN 74
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD--------KIVNHGRMKEDEARRYFQQLINAV 124
+V Y K ++++V++ ++GG + D G + E ++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLL--HTTCGTPNYVA 181
+Y H G HRD+K N+LL G+++++DFG+SA L+ T GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 182 PEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK---------KISAAE 230
PEV+ RGYD AD+WS G+ L G P+ M L + +
Sbjct: 195 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253
Query: 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEK 280
+ RK+I+ L +P R T E+L ++F+K +EK
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-42
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 21/277 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHP 71
E +G GT +V R +TG +A+K + + + ++I ++ +K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-R 130
+V+ + + T +FI +E + K G + E + ++ A+ Y
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GV HRD+KP N+LLD G +K+ DFG+S ++ DD + G Y+APE ++
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 191 DGST----ADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPWL------SF 239
AD+WS G+ L L G P+ + + K+ E PP L S
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE---PPLLPGHMGFSG 258
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
+ + L + R ++LE + K+ V
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 74/272 (27%), Positives = 133/272 (48%), Gaps = 12/272 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++V +GEG++ V A + ETG+ VA+K + E L ++I +E++ M+ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSP 84
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSR 130
+VV+ Y T ++IV+E+ G + D I + + + EDE Q + ++Y H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL+ G+ K++DFG++ Q +T GTP ++APEV+ + GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK--KISAAEFTCPPWLSFTARKLIAR 247
+ AD+WS G+ + G P+ D + M ++ F P S + +
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L +P R T ++L+ + + + +
Sbjct: 262 CLVKSPEQRATATQLLQHPFVRSAKGVSILRD 293
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-42
Identities = 77/277 (27%), Positives = 133/277 (48%), Gaps = 15/277 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+ +G+G F KV A+N ETG A K+++ + + E E+ + HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHP 76
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V+L K++I++EF GG + ++ + E + + +Q++ A+++ HS+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-----L 185
+ HRDLK N+L+ G+++++DFG+SA + ++ + GTP ++APEV +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK--KISAAEFTCPPWLSFTAR 242
D YD AD+WS G+ L + P + N M L K K P S R
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
+ LD NP TR + ++LE + E
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-42
Identities = 69/256 (26%), Positives = 116/256 (45%), Gaps = 12/256 (4%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+G +G G ++V AR+ VA+K+L + + +RE + H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 71 PNVVRLY---EVMGSKTKI-FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
P +V +Y E + +IV+E+V G L D + G M A A+++
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ HRD+KP N+++ A +KV DFG++ A++ GT Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCP----PWLSFT 240
D + D++S G +L+ +L G PF DS + Y+ + + P LS
Sbjct: 192 RGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSAD 249
Query: 241 ARKLIARILDPNPMTR 256
++ + L NP R
Sbjct: 250 LDAVVLKALAKNPENR 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 69/272 (25%), Positives = 115/272 (42%), Gaps = 36/272 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA-EQIKREVATMKLVKHPN 72
+ IG G F KV A G+ VA+K + E +++E ++KHPN
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++ L V + + +V+EF GG L + R+ D + Q+ ++Y H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 133 Y---HRDLKPENLLLDAYG--------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
HRDLK N+L+ LK++DFGL+ + + G ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMA 182
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------T 232
PEV+ + +D+WS GV+L+ LL G +PF ++ T
Sbjct: 183 PEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRG---IDGLAVAYGVAMNKLALPIPST 238
Query: 233 CPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CP KL+ +P+P +R + IL+
Sbjct: 239 CPEPF----AKLMEDCWNPDPHSRPSFTNILD 266
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 85/314 (27%), Positives = 130/314 (41%), Gaps = 73/314 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + IG G+F V A+ ++GE VA+K KVL+ K + RE+ M+ + H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKN--RELQIMRKLDHC 107
Query: 72 NVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLI 121
N+VRL S + +VL++V ++ ++ R K + Y QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN- 178
++ Y HS G+ HRD+KP+NLLLD LK+ DFG + L + G PN
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------------GEPNV 214
Query: 179 -YV------APEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF--------------- 214
Y+ APE+ Y +++ D+WS G +L LL G F
Sbjct: 215 SYICSRYYRAPELIFGATDY--TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 215 ------DDSNLMN-LYKKISAAEFTCPPWLSF-------TARKLIARILDPNPMTRITIP 260
+ MN Y + + PW A L +R+L+ P R+T
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 261 EILEDEWFKKDYKP 274
E +F + P
Sbjct: 333 EACAHSFFDELRDP 346
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 11 GKYEVGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
G YE+ IG+G V AR TGE V ++ ++ E +M ++ E+ KL
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDY 126
HPN+V + ++++V F+ G D I H M E Q ++ A+DY
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC--------GTPN 178
H G HR +K ++L+ G + +S + + G
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNL---SMISHGQRQRVVHDFPKYSVKVLP 200
Query: 179 YVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
+++PEVL N +GYD +D++S G+ L G++PF D
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPAT 243
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 11/271 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG- 131
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S L + + + GT +Y++PE L Y
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-----SFVGTRSYMSPERLQGTHY 207
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
+D+WS G+ L + G P + L + + R L+
Sbjct: 208 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG-DAAETPPRPRTPGRPLN 265
Query: 251 PNPMTRITIPEILEDEWFKKDYKPPVFEEKK 281
M I E + + PP
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-40
Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 35/257 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKIL----DKEKVLKHKMAEQIKREVATM 65
G+YEV I G + A + G PV LK L D E E +
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE------AQAMAMAERQFL 133
Query: 66 KLVKHPNVVRLYEV-----MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
V HP++V+++ +IV+E+V G L ++ EA Y ++
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEI 191
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDDGLLHTTCGTPNY 179
+ A+ Y HS G+ + DLKPEN++L LK+ D G S ++ G L GTP +
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINS----FGYL---YGTPGF 243
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF 239
APE++ R D+++ G L L + + L + +
Sbjct: 244 QAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKT--YDSY-- 297
Query: 240 TARKLIARILDPNPMTR 256
+L+ R +DP+P R
Sbjct: 298 --GRLLRRAIDPDPRQR 312
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 29/279 (10%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK+E+ +K
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 70 HPNVVRLYE------VMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D K +KE+ ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197
Query: 182 PEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236
PEV+ D YD +DLWS G+ + G P D + M I P
Sbjct: 198 PEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---APR 253
Query: 237 L-----SFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
L S + I L N R ++++ + +
Sbjct: 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-40
Identities = 73/294 (24%), Positives = 128/294 (43%), Gaps = 26/294 (8%)
Query: 1 MSQPKIKRRVGK------YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM 54
+ P + K + R IG G+F V FAR+ E VA+K + ++
Sbjct: 38 LKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 97
Query: 55 AEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
+ I +EV ++ ++HPN ++ + ++V+E+ G V+ ++E E
Sbjct: 98 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 157
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTT 173
+ + Y HS + HRD+K N+LL G +K+ DFG ++ ++ ++
Sbjct: 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSF 210
Query: 174 CGTPNYVAPEV---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230
GTP ++APEV +++ YDG D+WS G+ L P + N M+ I+ E
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269
Query: 231 FTCPPWL-----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
P L S R + L P R T +L+ + ++ P V +
Sbjct: 270 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-40
Identities = 88/311 (28%), Positives = 132/311 (42%), Gaps = 59/311 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + IG G+F V A+ E+ E VA+K KVL+ K RE+ M++VKHP
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIK-----KVLQDK--RFKNRELQIMRIVKHP 92
Query: 72 NVVRLYEVMGS------KTKIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQL 120
NVV L S + + +VLE+V E + H M + Y QL
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ ++ Y HS G+ HRD+KP+NLLLD G LK+ DFG + + + + C + Y
Sbjct: 151 LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA--KILIAGEPNVSYIC-SRYY 207
Query: 180 VAPEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPFD-DSNLMNLYKKI---------- 226
APE+ Y +T D+WS G ++ L+ G F +S + L + I
Sbjct: 208 RAPELIFGATNY--TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265
Query: 227 ------SAAEFTCPPW------------LSFTARKLIARILDPNPMTRITIPEILEDEWF 268
+ E P A LI+R+L+ P R+T E L +F
Sbjct: 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
Query: 269 KKDYKPPVFEE 279
+ +
Sbjct: 326 -DELRTGEARM 335
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 64/285 (22%), Positives = 121/285 (42%), Gaps = 32/285 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHP 71
+ IG G + V + +G+ +A+K + + K +Q+ ++ M+ P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV------NHGRMKEDEARRYFQQLINAVD 125
+V+ Y + + +I +E ++ FDK + E+ + + A++
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 126 YCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+ + HRD+KP N+LLD GN+K+ DFG+S Q+ D G Y+APE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPER 196
Query: 185 L----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCPPWL-- 237
+ + +GYD +D+WS G+ L+ L G P+ N + + ++ + PP L
Sbjct: 197 IDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD---PPQLSN 252
Query: 238 ------SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
S + + L + R E+L+ + + V
Sbjct: 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 70/302 (23%), Positives = 133/302 (44%), Gaps = 58/302 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
Y++ R +G G +++V A N E V +KIL K ++IKRE+ ++ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGG 90
Query: 71 PNVVRLYEVM---GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
PN++ L +++ S+T + E V + ++ + + + R Y +++ A+DYC
Sbjct: 91 PNIITLADIVKDPVSRTPALVF-EHVNNTDF-KQLYQ--TLTDYDIRFYMYEILKALDYC 146
Query: 128 HSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL- 185
HS G+ HRD+KP N+++D + L++ D+GL+ ++ + + + PE+L
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 203
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF--------------------DDSNLMNLYKK 225
+ + YD S D+WS G +L ++ PF D + ++ Y
Sbjct: 204 DYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 226 ISAAEF-------TCPPWLSF-----------TARKLIARILDPNPMTRITIPEILEDEW 267
F + W F A + ++L + +R+T E +E +
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 268 FK 269
F
Sbjct: 323 FY 324
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 28/281 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHP 71
E +G G + V+ R+ +G+ +A+K + + + +++ ++ +M+ V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-----NHGRMKEDEARRYFQQLINAVDY 126
V Y + + ++I +E + DK + ED + ++ A+++
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 127 CHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV- 184
HS V HRD+KP N+L++A G +K+ DFG+S + DD G Y+APE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERI 181
Query: 185 ---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPWL--- 237
LN +GY +D+WS G+ + L P+D K++ P L
Sbjct: 182 NPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP---SPQLPAD 237
Query: 238 --SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
S ++ L N R T PE+++ +F
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 9e-38
Identities = 70/346 (20%), Positives = 124/346 (35%), Gaps = 78/346 (22%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIK 59
+ +R +E G +G GT+ V A+ + + ALK ++ +
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----- 66
Query: 60 REVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFV--------TGGELFDKIVNHGRMK 109
RE+A ++ +KHPNV+ L +V S K++++ ++ ++
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 110 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN----LKVSDFGLSALSQQVR 165
+ Q+++ + Y H+ V HRDLKP N+L+ G +K++D G A
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNSP 185
Query: 166 DDGLLHTTCG--TPNYVAPEVL-NDRGYDGSTA-DLWSCGVIL----------------- 204
L T Y APE+L R Y + A D+W+ G I
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHY--TKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243
Query: 205 ----------------------------FVLLAGYLPFDDSNLMNLYKKISAAEF--TCP 234
+ + N Y S ++
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP--PVFE 278
A L+ ++L +P+ RIT + ++D +F +D P VF
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFA 349
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 42/253 (16%), Positives = 80/253 (31%), Gaps = 39/253 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+Y + G + A ++ VAL +D + VL + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
P V R+ +V+ ++ +V E++ GG L + V A R Q L A D H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GV P + + G++ ++ +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------- 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-------PWLSFTARK 243
D+ G L+ LL P ++ + + P + F
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 244 LIARILDPNPMTR 256
+ AR + + R
Sbjct: 239 VAARSVQGDGGIR 251
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 78/347 (22%), Positives = 142/347 (40%), Gaps = 65/347 (18%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + ++ + +++V R G+GTF V+ + TG VA+K KV++ R
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQDPRFR--NR 65
Query: 61 EVATMKL---VKHPNVVRLYEVMGSKTK-------IFIVLEFVTGGELFDKIVNHGRMK- 109
E+ M+ + HPN+V+L + + + +V+E+V L N+ R +
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQV 124
Query: 110 ---EDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQ 163
+ + QLI ++ H S V HRD+KP N+L++ A G LK+ DFG + +
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA--KKL 182
Query: 164 VRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF------- 214
+ + C + Y APE+ ++ Y +TA D+WS G I ++ G F
Sbjct: 183 SPSEPNVAYIC-SRYYRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239
Query: 215 --------------DDSNLMN-LYKKISAAEFTCPPW----------LSFTARKLIARIL 249
+ +N + + PW + A L++ +L
Sbjct: 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALL 299
Query: 250 DPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 296
P R+ E L +F + P + + +L + F +E
Sbjct: 300 QYLPEERMKPYEALCHPYF-DELHDPATKLPNNKDLPEDLFRFLPNE 345
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-36
Identities = 54/296 (18%), Positives = 107/296 (36%), Gaps = 56/296 (18%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G + +V GE VA+KI + + + E+ +++H N+
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR----DEKSWFRETELYNTVMLRHENI 64
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ S T+++++ + G L+D + + R + + + + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSAL--SQQVRDDGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ + + D + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVILFVLLAGY----------LPFDDSNLMN--- 221
+APEVL++ D+W+ G++L+ + PF D +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 222 -------LYKKI------SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+ L+ KL+ NP R+T I +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLA----KLMKECWYQNPSARLTALRIKK 295
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 59/296 (19%), Positives = 121/296 (40%), Gaps = 56/296 (18%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ + IG+G + +V + GE VA+K+ + + + E+ L++H N+
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENI 93
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ + GS T+++++ ++ G L+D + + + + ++ + + H+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ + D +T GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVIL---------FVLLAGY-LPFDDSNLMN--- 221
+ PEVL++ AD++S G+IL ++ Y LP+ D +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 222 -------LYKKI------SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
KK+ + C + KL+ NP +R+T + +
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMG----KLMTECWAHNPASRLTALRVKK 324
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-34
Identities = 76/340 (22%), Positives = 126/340 (37%), Gaps = 86/340 (25%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY +G+T+G G+F V + E+G+ ALK KVL+ RE+ MK++ H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQD--PRYKNRELDIMKVLDHV 60
Query: 72 NVVRLYEVMGSKTK--------------------------------------IFIVLEFV 93
N+++L + + + +++E+V
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 94 TGGELFDKIVNHGRMK----EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-G 148
L + + R + Y QL AV + HS G+ HRD+KP+NLL+++
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVL 207
LK+ DFG + + + + + C + Y APE+ L Y + DLWS G + L
Sbjct: 180 TLKLCDFGSA--KKLIPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCVFGEL 235
Query: 208 LAGYLPF---------------------DDSNLMN-LYKKISAAEFTCPPWLSF------ 239
+ G F + MN Y ++ W
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295
Query: 240 -TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
A L+ +IL P RI E + +F +
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFF-DHLRNSYES 334
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 77/325 (23%), Positives = 139/325 (42%), Gaps = 58/325 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y IGEG + V A ++ VA+K K +H+ ++ RE+ + +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRH 84
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
N++ + +++ + T ++IV + + +L K++ + D + Q++ +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV----- 180
Y HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D T YV
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWY 197
Query: 181 -APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-------SAAEF 231
APE+ LN +GY + D+WS G IL +L+ F + ++ I S +
Sbjct: 198 RAPEIMLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 232 TC---------------PPWLSFT---------ARKLIARILDPNPMTRITIPEILEDEW 267
C + + A L+ ++L NP RI + + L +
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 268 FKKDYKP---PVFEEKKDTNLDDVE 289
++ Y P P+ E +++ +
Sbjct: 317 LEQYYDPSDEPIAEAPFKFDMELDD 341
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 59/294 (20%), Positives = 114/294 (38%), Gaps = 52/294 (17%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +IG+G F +V + GE VA+KI + + + E+ +++H N+
Sbjct: 45 VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI 98
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ + G+ T++++V ++ G LFD +N + + + + + + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ D D + GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVILFVLLAGY----------LPFDDSNLMN--- 221
+APEVL+D AD+++ G++ + + LP+ D +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 222 -------LYKK----ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+K I +C K++ N R+T I +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVM--AKIMRECWYANGAARLTALRIKK 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 51/235 (21%), Positives = 93/235 (39%), Gaps = 23/235 (9%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + ++ G F V + E VA+KI + K + Q +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVW--KAQLLNEYVAVKIFPIQ----DKQSWQNEY 67
Query: 61 EVATMKLVKHPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMK 109
EV ++ +KH N+++ ++++ F G L D + + +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 110 EDEAR--RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
E AR Y + I + H + HRD+K +N+LL ++DFGL+ + +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGST----ADLWSCGVILFVLLAGYLPFDDSN 218
G H GT Y+APEVL D+++ G++L+ L + D
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 86/355 (24%), Positives = 152/355 (42%), Gaps = 75/355 (21%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y+ +G G + V A +++TG VA+K L + + + A++ RE+ +K +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V +++V + G +L + IV ++ +D + Q++ +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y HS + HRDLKP NL ++ LK+ DFGL+ + D + YV
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEM-------TGYVATRW 194
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------- 226
APE+ LN Y+ T D+WS G I+ LL G F ++ ++ K I
Sbjct: 195 YRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253
Query: 227 -------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPMTRITIPEILEDE 266
SA + + ++F A L+ ++L + RIT + L
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 267 WFKKDYKP---PVFE------EKKDTNLDDV-EAVFKDSEVCWMEHHVTEQKEEQ 311
+F + + P PV + E +D +D+ + EV + +E+
Sbjct: 314 YFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLTYD--EV--ISFVPPPLDQEE 364
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 69/314 (21%), Positives = 119/314 (37%), Gaps = 54/314 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y + +G G V A +++ + VA+K + VL + RE+ ++ + H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----VLTDPQSVKHALREIKIIRRLDH 67
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGG--------ELFD----KIVNHGRMKEDEARRYFQ 118
N+V+++E++G E + ++ G + E+ AR +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLS-ALSQQVRDDGLLHTTCGT 176
QL+ + Y HS V HRDLKP NL ++ LK+ DFGL+ + G L T
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 177 PNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--------- 226
Y +P + L+ Y D+W+ G I +L G F ++ + + I
Sbjct: 188 KWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 227 --------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPMTRITIPEILED 265
+ T A + +IL +PM R+T E L
Sbjct: 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306
Query: 266 EWFKKDYKP---PV 276
+ P P+
Sbjct: 307 PYMSIYSFPMDEPI 320
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 80/329 (24%), Positives = 134/329 (40%), Gaps = 62/329 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+++ +GEG + V A + TGE VA+K K + + A + RE+ +K KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFKH 68
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
N++ ++ + + ++I+ E + +L ++++ + +D + + Q + AV
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL--SALSQQVRDDGLLHTTCGTPNYV--- 180
H V HRDLKP NLL+++ +LKV DFGL + G +V
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 181 ---APEV-LNDRGYDGSTADLWSCGVILFVLLAG--------YL------------PFDD 216
APEV L Y D+WSCG IL L Y P D
Sbjct: 187 WYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 217 SNL--------------MNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPE 261
++L + +Y + F P ++ L+ R+L +P RIT E
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMF---PRVNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 262 ILEDEWFKKDYKP---PVFEEKKDTNLDD 287
LE + + + P P E + +
Sbjct: 303 ALEHPYLQTYHDPNDEPEGEPIPPSFFEF 331
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-33
Identities = 78/326 (23%), Positives = 139/326 (42%), Gaps = 65/326 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y +G G + V A + +GE VA+K L + + ++ A++ RE+ +K ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V + ++V+ F+ +L + + E++ + Q++ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y HS GV HRDLKP NL ++ LK+ DFGL+ R T YV
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTRW 188
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------- 226
APEV L+ Y+ T D+WS G I+ +L G F + ++ +I
Sbjct: 189 YRAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247
Query: 227 -------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPMTRITIPEILEDE 266
+A + + P FT A L+ ++L+ + R+T + L
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307
Query: 267 WFKKDYKP---PVFEEKKDTNLDDVE 289
+F+ P ++ D +L+ +
Sbjct: 308 FFEPFRDPEEETEAQQPFDDSLEHEK 333
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 87/356 (24%), Positives = 146/356 (41%), Gaps = 75/356 (21%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y + +G G + V A + TG VA+K L + + ++ A++ RE+ +K ++H
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRH 83
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V ++V+ F+ G +L K++ H ++ ED + Q++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ R T YV
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVTRW 190
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------- 226
APEV LN Y T D+WS G I+ ++ G F S+ ++ K+I
Sbjct: 191 YRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249
Query: 227 -------SAAEF--TCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDE 266
A + P S A L+ ++L + R+T E L
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309
Query: 267 WFKKDYKP---PVFE------EKKDTNLDDV-EAVFKDSEVCWMEHHVTEQKEEQP 312
+F+ + P + + D LD+ +K EV + Q +
Sbjct: 310 YFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYK--EV--LSFKPPRQLGARV 361
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 78/359 (21%), Positives = 150/359 (41%), Gaps = 76/359 (21%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y+ + IG G V A ++ VA+K L + +++ A++ RE+ MK V H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMK-EDEARRYFQ-QLIN 122
N++ L V + ++IV+E + L I +M+ + E Y Q++
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI----QMELDHERMSYLLYQMLC 138
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y AP
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAP 195
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI---------------- 226
EV+ GY D+WS G I+ ++ G + F ++ ++ + K+
Sbjct: 196 EVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 227 --------------------------SAAEFTCPPWLSFTARKLIARILDPNPMTRITIP 260
A+ + AR L++++L + RI++
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 261 EILEDEWFKK--------DYKPPVFE---EKKDTNLDDV-EAVFKDSEVCWMEHHVTEQ 307
E L+ + P + + ++++ +++ E ++K EV +EHH
Sbjct: 315 EALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYK--EVMDLEHHHHHH 371
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 75/356 (21%), Positives = 140/356 (39%), Gaps = 77/356 (21%)
Query: 1 MSQPKIKRRVGKYEVGRT-------------IGEGTFAKVKFARNSETGEPVALKILDKE 47
MS+ K+ + EVG + IG G V A ++ VA+K L
Sbjct: 39 MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--S 96
Query: 48 KVLKHKM-AEQIKREVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFD 100
+ +++ A++ RE+ MK V H N++ L V + +++V+E + L
Sbjct: 97 RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-C 154
Query: 101 KIVNHGRMKEDEARRYFQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159
+++ + E Y Q++ + + HS G+ HRDLKP N+++ + LK+ DFG
Sbjct: 155 QVIQMEL--DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG--- 209
Query: 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L++ ++ T Y APEV+ GY D+WS G I+ ++ + F +
Sbjct: 210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDY 268
Query: 220 MNLYKKI------------------------------------------SAAEFTCPPWL 237
++ + K+ A+
Sbjct: 269 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 328
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKK----DYKPPVFEEKKDTNLDDVE 289
+ AR L++++L +P RI++ + L+ + + D LD+ E
Sbjct: 329 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 384
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 42/228 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKM-AEQIKREVATMKLVK 69
+YE+ IG G++ V A + VA+K IL V + + ++I RE+A + +
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRLN 110
Query: 70 HPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINA 123
H +VV++ +++ K ++++VLE + K+ + + L+
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN---- 178
V Y HS G+ HRDLKP N L++ ++KV DFGL+ + + L + +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 179 --------------YV------APEV-LNDRGYDGSTA-DLWSCGVIL 204
+V APE+ L Y + A D+WS G I
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIF 274
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 77/351 (21%), Positives = 135/351 (38%), Gaps = 81/351 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMK-LVK 69
KYE+ + +G+G + V + + TGE VA+K + ++ A++ RE+ + L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILTELSG 67
Query: 70 HPNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAVDY 126
H N+V L V+ + +++V +++ +L ++ + E ++Y QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANIL-EPVHKQYVVYQLIKVIKY 124
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-------- 178
HS G+ HRD+KP N+LL+A ++KV+DFGLS +R N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 179 -----YV------APEV-LNDRGYDGSTADLWSCGVILFVLLAG---------------- 210
YV APE+ L Y D+WS G IL +L G
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 211 ----------------------YL---------PFDDSNLMNLYKKISAAEFTCPPWLSF 239
+ + + K + +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKP---PVFEEKKDTNLDD 287
A L+ ++L NP RI+ + L+ + + P P + ++D
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIND 354
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 33/227 (14%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y + IG G++ V A + T + VA+K + ++ + + ++I RE+ + +K
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKS 84
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAV 124
++RLY+++ ++IVLE +L K+ +E + L+
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDL-KKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP------- 177
++ H G+ HRDLKP N LL+ ++KV DFGL+ +D +++
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 178 -------NYV------APEV-LNDRGYDGSTADLWSCGVILFVLLAG 210
++V APE+ L Y + D+WS G I LL
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 69/330 (20%), Positives = 127/330 (38%), Gaps = 65/330 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM--------AEQIKREVA 63
Y V R I G++ V +S G PVA+K + + +++ RE+
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 64 TMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMK-EDEARRYF 117
+ HPN++ L ++ + +++V E + +L ++++ R+ + +YF
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDL-AQVIHDQRIVISPQHIQYF 139
Query: 118 Q-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
++ + H GV HRDL P N+LL ++ + DF L+++ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTADANKTHYVTH 196
Query: 177 PNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-------SA 228
Y APE+ + +G+ D+WS G ++ + F S N KI
Sbjct: 197 RWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 229 AEFTC----------------PPWLSFT---------ARKLIARILDPNPMTRITIPEIL 263
+ P ++T A LIA++L+ NP RI+ + L
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315
Query: 264 EDEWFKKDYKP---PV-------FEEKKDT 283
+F+ + P F+E
Sbjct: 316 RHPYFESLFDPLDLTEGLSERFHFDESVTD 345
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-29
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 33/217 (15%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ IG G + V + S PVA+K+ ++ ++ + + L++H N+
Sbjct: 16 KLLELIGRGRYGAVY--KGSLDERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNI 69
Query: 74 VRLY-----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
R + + +V+E+ G L + H + R + + Y H
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLH 128
Query: 129 S---------RGVYHRDLKPENLLLDAYGNLKVSDFGLS------ALSQQVRDDGLLHTT 173
+ + HRDL N+L+ G +SDFGLS L + +D +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 174 CGTPNYVAPEVLNDR------GYDGSTADLWSCGVIL 204
GT Y+APEVL D+++ G+I
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 35/229 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
+Y + R +G G F+ V A++ VA+KI+ +K E + E+ ++ V
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74
Query: 70 ----------HPNVVRLY---EVMGSKTK-IFIVLEFVTGGELFD--KIVNHGRMKEDEA 113
++++L G + +V E V G L K H +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133
Query: 114 RRYFQQLINAVDYCHSR-GVYHRDLKPENLLLD------AYGNLKVSDFGLSALSQQVRD 166
++ +QL+ +DY H R G+ H D+KPEN+L++ +K++D G +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188
Query: 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215
D + T Y +PEVL + AD+WS ++F L+ G F+
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFE 236
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 21/226 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVK 69
+YEV + IG+G+F +V A + + + VALK++ EK + Q E+ + L K
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRK 152
Query: 70 HP-----NVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLIN 122
NV+ + E + I + E + L++ K R++ ++
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+D H + H DLKPEN+LL G +KV DFG S Q ++T + Y
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYR 266
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
APEV+ Y D+WS G IL LL GY + + +
Sbjct: 267 APEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACM 311
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 25/273 (9%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+G IG G F +V R VA+K +E + A+ +E +K HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAK-FLQEARILKQYSHPNI 174
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGV 132
VRL V K I+IV+E V GG+ + G ++ + ++Y S+
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY----VAPEVLNDR 188
HRDL N L+ LK+SDFG+S + DG+ + G APE LN
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 189 GYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA-----AEFTCPPWLSFTA 241
Y S+ D+WS G++L+ G P+ + + + + CP +
Sbjct: 291 RY--SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV---- 344
Query: 242 RKLIARILDPNPMTRITIPEILED-EWFKKDYK 273
+L+ + P R + I ++ + +K ++
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 18/235 (7%)
Query: 15 VGRTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F VK + + + VA+KIL K + + +++ E M+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VR+ + +V+E G L + + +K+ Q+ + Y
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLNDRG 189
HRDL N+LL K+SDFGLS + D+ P + APE +N
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 190 YDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
+ S+ D+WS GV+++ G P+ + + E CP +
Sbjct: 197 F--SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 249
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 13/197 (6%)
Query: 16 GRTIGEGTFAKVKFAR-NSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+G+F V+ ++ +G+ VA+K L + + + + + REV M + H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
++RLY V+ + +V E G L D++ H G RY Q+ + Y S+
Sbjct: 83 LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLNDR 188
HRDL NLLL +K+ DFGL Q +D APE L R
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 189 GYDGSTA-DLWSCGVIL 204
+ S A D W GV L
Sbjct: 200 TF--SHASDTWMFGVTL 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 13/219 (5%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G + +V + VA+K L KE E+ +E A MK +KHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED---TMEVEEFLKEAAVMKEIKHPNL 278
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRG 131
V+L V + +I+ EF+T G L D + R + Q+ +A++Y +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY--VAPEVLNDRG 189
HR+L N L+ +KV+DFG LS+ + D APE L
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 396 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 23/228 (10%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+ IG+G+F +V A + E VA+KI+ +K Q + EV ++L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNK 109
Query: 71 P------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLIN 122
+V L + + +V E + L+D + N + + R++ QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 123 AVDYCHSR--GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
A+ + + + H DLKPEN+LL +K+ DFG S Q ++ +
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRF 223
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
Y +PEVL YD + D+WS G IL + G F +N ++ KI
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E + PVA+K L +E E I E M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMASVDNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V RL + + + ++ + + G L D + H + + Q+ ++Y R
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
+ HRDL N+L+ ++K++DFGL+ L + + + G P ++A E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R Y + D+WS GV ++ ++ G P+D + + E C +
Sbjct: 194 RIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 64/291 (21%), Positives = 122/291 (41%), Gaps = 53/291 (18%)
Query: 11 GKYEV-------GRTIGEGTFAKVKFAR-NSETGEPVALKIL-----DKEKVLKHKMAEQ 57
G E+ + +G G F VK + + VA+K++ +++ +
Sbjct: 1 GHMELKREEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSEDEFFQ------ 52
Query: 58 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRY 116
E TM + HP +V+ Y V + I+IV E+++ G L + + +HG+ ++ +
Sbjct: 53 ---EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM 109
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG- 175
+ + + S HRDL N L+D +KVSDFG +++ V DD + +
Sbjct: 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG---MTRYVLDDQYVSSVGTK 166
Query: 176 -----TPNYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 228
+ APEV + Y S+ D+W+ G++++ V G +P+D + K+S
Sbjct: 167 FPVKWS----APEVFHYFKY--SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
Query: 229 AE-----FTCPPWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKKDY 272
+ +++ P R T ++L + +KD
Sbjct: 221 GHRLYRPHLASDTI----YQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ +TIG+G F V G VA+K + K A+ E + M ++H N+
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-KNDA----TAQAFLAEASVMTQLRHSNL 76
Query: 74 VRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
V+L V + K ++IV E++ G L D + + GR ++ + A++Y
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRG 189
HRDL N+L+ KVSDFGL+ + +D G L P + APE L ++
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKK 190
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ + +D+WS G++L+ + G +P+ L ++ ++
Sbjct: 191 FS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 64/337 (18%), Positives = 121/337 (35%), Gaps = 89/337 (26%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ V R +G+GTF +V ++ + + A+K++ K K K E +K +++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQN 90
Query: 71 -----PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINA 123
N+V+ + + ++ E G L++ I + ++ + Y +++ A
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYG-------------------------NLKVSDFGLS 158
++Y + H DLKPEN+LLD +K+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-C 208
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY------- 211
A + T Y APEV+ + G+D S +D+WS G +L L G
Sbjct: 209 A----TFKSDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHE 263
Query: 212 --------------LP--------------FDDSNLMNLY-------KKISAAEFTCPPW 236
+P + + + + L C P
Sbjct: 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323
Query: 237 LSFTARK----LIARILDPNPMTRITIPEILEDEWFK 269
+ + IL +P R + E+L+ ++ +
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 75/342 (21%), Positives = 119/342 (34%), Gaps = 95/342 (27%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+YE+ T+GEG F KV + + G VA+KI+ + E + E+ ++ +
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 70 HP------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLI 121
V++ E I IV E + G +D I +G + D R+ Q+
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGN-------------------LKVSDFGLSALSQ 162
+V++ HS + H DLKPEN+L +KV DFG +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 163 QVRDDGLLHTTCGTPNYV------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+ H+T V APEV+ G+ D+WS G IL G+ F
Sbjct: 189 EH------HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPT 236
Query: 217 SNLMNLYKKISAAEFTCPPWLSFTARK--------------------------------- 243
+ + P + RK
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 244 -----------LIARILDPNPMTRITIPEILEDEWFKKDYKP 274
LI ++L+ +P RIT+ E L+ +F K
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-23
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMKLV 68
+ +G G + +V + VA+K L + E+ LK E A MK +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---------EAAVMKEI 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDY 126
KHPN+V+L V + +I+ EF+T G L D + N + Q+ +A++Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYV 180
+ HRDL N L+ +KV+DFG LS+ + D T
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKFPIKWT---- 179
Query: 181 APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
APE L + S D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 180 APESLAYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-22
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 17/220 (7%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G+G F +V N T VA+K L + + E MK ++H
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEK 323
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
+V+LY V+ S+ I+IV E+++ G L D + + Q+ + + Y
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL+ N+L+ KV+DFG L++ + D+ P + APE
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 189 GYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+WS G++L + G +P+ + ++
Sbjct: 440 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F V+ R TGE VA+K L + +H +RE+ +K ++H
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHL--RDFEREIEILKSLQHD 71
Query: 72 NVVRLYEV--MGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ V + + +++E++ G L D + H R+ + +Y Q+ ++Y
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--------TPNYV 180
++ HRDL N+L++ +K+ DFG L++ + D
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFG---LTKVLPQDKEFFKVKEPGESPIFWY---- 184
Query: 181 APEVLNDRGYDGSTA-DLWSCGVIL 204
APE L + + S A D+WS GV+L
Sbjct: 185 APESLTESKF--SVASDVWSFGVVL 207
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 17/220 (7%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G+G F +V N T VA+K L + + E MK ++H
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEK 240
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
+V+LY V+ S+ I+IV E+++ G L D + + Q+ + + Y
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL+ N+L+ KV+DFG L++ + D+ P + APE
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 189 GYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+WS G++L + G +P+ + ++
Sbjct: 357 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 21/220 (9%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ +TIG+G F V G VA+K + K A+ E + M ++H N+
Sbjct: 196 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-KN----DATAQAFLAEASVMTQLRHSNL 248
Query: 74 VRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
V+L V + K ++IV E++ G L D + + GR ++ + A++Y
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRG 189
HRDL N+L+ KVSDFGL+ + +D G L P + APE L ++
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKK 362
Query: 190 YDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ ST D+WS G++L+ + G +P+ L ++ ++
Sbjct: 363 F--STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 26/204 (12%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F V+ R TGE VA+K L + +H +RE+ +K ++H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHL--RDFEREIEILKSLQHD 102
Query: 72 NVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ V + + + +++E++ G L D + H R+ + +Y Q+ ++Y
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-NYVA 181
++ HRDL N+L++ +K+ DFGL+ + Q V++ G P + A
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES------PIFWYA 216
Query: 182 PEVLNDRGYDGSTA-DLWSCGVIL 204
PE L + + S A D+WS GV+L
Sbjct: 217 PESLTESKF--SVASDVWSFGVVL 238
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 15/224 (6%)
Query: 14 EVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ + IG G +V + + PVA+K L K + + E + M H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTE-RQRRDFLSEASIMGQFDH 109
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
PN++RL V+ IV E++ G L + H G+ + + + + Y
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLN 186
G HRDL N+L+D+ KVSDFGLS + + D +TT G + APE +
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 228
R + S+A D+WS GV+++ VL G P+ + ++ +
Sbjct: 228 FRTF--SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +GEG F KV N TGE VA+K L + +H+ K+E+ ++ + H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHE 93
Query: 72 NVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
++++ + + +V+E+V G L D + H + + + QQ+ + Y H+
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA 152
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQ-----QVRDDGLLHTTCGTPNYV--- 180
+ HRDL N+LLD +K+ DFGL+ A+ + +VR+DG P V
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VFWY 204
Query: 181 APEVLNDRGYDGSTA-DLWSCGVIL 204
APE L + + A D+WS GV L
Sbjct: 205 APECLKEYKF--YYASDVWSFGVTL 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +GEG F KV+ R TGE VA+K L E H +K+E+ ++ + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHE 83
Query: 72 NVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ + I +++EF+ G L + + + ++ + +Y Q+ +DY
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-NYVA 181
SR HRDL N+L+++ +K+ DFGL+ + V+DD P + A
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------PVFWYA 197
Query: 182 PEVLNDRGYDGSTA-DLWSCGVIL 204
PE L + A D+WS GV L
Sbjct: 198 PECLMQSKF--YIASDVWSFGVTL 219
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 70/343 (20%), Positives = 115/343 (33%), Gaps = 95/343 (27%)
Query: 11 GKYEVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+YE+ +GEGTF KV ++ VALKI+ K E + E+ +K +K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIK 74
Query: 70 HP------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLI 121
V + + + I E + G F+ + + R QL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGN-------------------LKVSDFGLSALSQ 162
+A+ + H + H DLKPEN+L ++V+DFG +
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 163 QVRDDGLLHTTCGTPNYV------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD- 215
+ HTT V PEV+ + G+ D+WS G ILF G+ F
Sbjct: 194 EH------HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQT 241
Query: 216 DSNL--------------MNLYKKISAAEF---TCPPWLSFTARK--------------- 243
N ++ + ++ W ++
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 244 -----------LIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
L+ R+L+ +P RIT+ E L +F
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-22
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 34/234 (14%)
Query: 11 GKYEV-------GRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQ-IKRE 61
GK+ + + IG G F V ++ VA+K + +E M+E+ E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTI-RE----GAMSEEDFIEE 53
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQL 120
M + HP +V+LY V + I +V EF+ G L D + G + +
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG----- 175
+ Y V HRDL N L+ +KVSDFG +++ V DD +T
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG---MTRFVLDDQYTSSTGTKFPVK 170
Query: 176 -TPNYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
+PEV + Y S+ D+WS GV+++ V G +P+++ + + + I
Sbjct: 171 WA----SPEVFSFSRY--SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E + PVA+K L +E E I E M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMASVDNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V RL + + + ++ + + G L D + H + + Q+ ++Y R
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
+ HRDL N+L+ ++K++DFGL+ L + + + G P ++A E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R Y + D+WS GV ++ ++ G P+D + + E C +
Sbjct: 194 RIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-22
Identities = 61/232 (26%), Positives = 92/232 (39%), Gaps = 20/232 (8%)
Query: 19 IGEGTFAKVKFAR-NSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ + VA+K+L + E++ RE M + +P +VRL
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 76 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLNDRGYDG 192
DL N+LL K+SDFGLS DD P + APE +N R +
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKF-- 190
Query: 193 STA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
S+ D+WS GV ++ L G P+ + I + CPP L
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-22
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIK---REVATMKLV 68
+G+G F V+ R TG VA+K L+H +Q + RE+ +K +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK------QLQHSGPDQQRDFQREIQILKAL 81
Query: 69 KHPNVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
+V+ V G + + +V+E++ G L D + H R+ Y Q+ ++
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-N 178
Y SR HRDL N+L+++ ++K++DFGL+ L VR+ G P
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------PIF 195
Query: 179 YVAPEVLNDRGYDGSTA-DLWSCGVIL 204
+ APE L+D + S D+WS GV+L
Sbjct: 196 WYAPESLSDNIF--SRQSDVWSFGVVL 220
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-22
Identities = 48/237 (20%), Positives = 101/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E+ + PV +K++ ++K + + + + + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQA-VTDHMLAIGSLDHA 75
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
++VRL + + + +V +++ G L D + H G + + Q+ + Y
Sbjct: 76 HIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
G+ HR+L N+LL + ++V+DFG++ L + D P ++A E ++
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
Y + D+WS GV ++ ++ G P+ L + + E C +
Sbjct: 192 GKY--THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV 246
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
E+GR IGEG F V N VA+K K + + +E TM+
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTC-KNCTSDSVREKFL-QEALTMRQF 73
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYC 127
HP++V+L V+ ++ ++I++E T GEL + + Y QL A+ Y
Sbjct: 74 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYVA 181
S+ HRD+ N+L+ + +K+ DFG LS+ + D + G A
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWM----A 185
Query: 182 PEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
PE +N R + ++A D+W GV ++ +L+ G PF ++ +I
Sbjct: 186 PESINFRRF--TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 22/238 (9%)
Query: 15 VGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ + +G G F +V + S+ VA+K L K + E + M HP
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
N++RL V+ + IV E++ G L + H + + + + + + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYV---APEVLN 186
G HRDL N+L+++ KVSDFG L + + DD +TT G + +PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFG---LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R + ++A D+WS G++L+ V+ G P+ + + ++ K + CP L
Sbjct: 224 YRKF--TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 15 VGRTIGEGTFAKVKFAR-NSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ IG G F +V + +G+ PVA+K L K + + + E M H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVD-FLGEAGIMGQFSH 105
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
N++RL V+ + I+ E++ G L + G + + + + Y +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLN 186
HRDL N+L+++ KVSDFGLS + + D +TT G + APE ++
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAPEAIS 223
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDD-SN 218
R + ++A D+WS G++++ V+ G P+ + SN
Sbjct: 224 YRKF--TSASDVWSFGIVMWEVMTYGERPYWELSN 256
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 52/237 (21%)
Query: 4 PKIKRRVGKYEV-------GRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHK 53
++K ++ + GR +G+G F V + + + VA+K+L K ++
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASS 67
Query: 54 MAEQIKREVATMKLVKHPNVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGR 107
E+ RE A MK HP+V +L V G ++L F+ G+L ++ R
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-R 126
Query: 108 MKEDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160
+ E+ Q L+ VD Y SR HRDL N +L + V+DFGLS
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS-- 184
Query: 161 SQQVRDDGLLHTTCGTPNY-------------VAPEVLNDRGYDGSTADLWSCGVIL 204
R +++ +Y +A E L D Y +D+W+ GV +
Sbjct: 185 ----RK---IYSG----DYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTM 229
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 3e-21
Identities = 59/232 (25%), Positives = 91/232 (39%), Gaps = 20/232 (8%)
Query: 19 IGEGTFAKVKFAR-NSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ + VA+K+L + E++ RE M + +P +VRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 401
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLNDRGYDG 192
+L N+LL K+SDFGLS DD + APE +N R +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKF-- 516
Query: 193 STA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
S+ D+WS GV ++ L G P+ + I + CPP L
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 568
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 37/230 (16%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMKL 67
++ +G G F +V N T VA+K L + L E MK
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA---------EANLMKQ 64
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVD 125
++H +VRLY V+ ++ I+I+ E++ G L D + +K + Q+ +
Sbjct: 65 LQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNY 179
+ R HRDL+ N+L+ + K++DFG L++ + D+ T
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFG---LARLIEDNEYTAREGAKFPIKWT--- 177
Query: 180 VAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
APE +N + + D+WS G++L ++ G +P+ + + +
Sbjct: 178 -APEAINYGTF--TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-21
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 23/202 (11%)
Query: 14 EVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ R +GEG F +V + + VA+K K+ L +K E+ E MK + H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDH 72
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
P++V+L ++ + +I++E GEL + + +K Y Q+ A+ Y S
Sbjct: 73 PHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYVAPE 183
HRD+ N+L+ + +K+ DFG LS+ + D+ + +PE
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFG---LSRYIEDEDYYKASVTRLPIKWM----SPE 184
Query: 184 VLNDRGYDGSTA-DLWSCGVIL 204
+N R + +TA D+W V +
Sbjct: 185 SINFRRF--TTASDVWMFAVCM 204
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 8e-21
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 18/220 (8%)
Query: 16 GRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
GR IGEG F V N VA+K K + +E TM+ H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAM--AVAIKTC-KNCTSDSVREK-FLQEALTMRQFDH 450
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
P++V+L V+ ++ ++I++E T GEL + + Y QL A+ Y S
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLND 187
+ HRD+ N+L+ + +K+ DFG LS+ + D + G P ++APE +N
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 188 RGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
R + S +D+W GV ++ +L+ G PF ++ +I
Sbjct: 567 RRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 49/200 (24%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ + +G G F +V A ++ VA+K + + E MK ++H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 245
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRG 131
V+L+ V+ +K I+I+ EF+ G L D + + K+ + + Q+ + + R
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYVAPEVL 185
HRDL+ N+L+ A K++DFG L++ + D+ T APE +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFG---LARVIEDNEYTAREGAKFPIKWT----APEAI 357
Query: 186 NDRGYDGSTA-DLWSCGVIL 204
N + + D+WS G++L
Sbjct: 358 NFGSF--TIKSDVWSFGILL 375
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 73/372 (19%), Positives = 118/372 (31%), Gaps = 125/372 (33%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
G+Y V R +G G F+ V + + + + VA+K++ E E+ +K V+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLLKSVRN 92
Query: 70 ----HPN---VVRLY---EVMGSKTK-IFIVLEFVTGGELFD--KIVNHGRMKEDEARRY 116
PN VV+L ++ G I +V E V G L N+ + ++
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 117 FQQLINAVDYCHSR-GVYHRDLKPENLLL------------------------------- 144
QQ++ +DY H++ + H D+KPEN+LL
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 145 ------------------DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-YVAPEVL 185
+K++D G + + T Y + EVL
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK--------------------- 224
GY+ + AD+WS + F L G F+ + +
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 225 --KISAAEFT----------CPPWLSF---------------TARKLIARILDPNPMTRI 257
K S FT PW F + +L+ P R
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 258 TIPEILEDEWFK 269
T E L W
Sbjct: 385 TAAECLRHPWLN 396
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 39/230 (16%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQ-IKREVATMKLVKHP 71
+ +G G F VK+ + + VA+K++ KE M+E E M + H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQY--DVAIKMI-KE----GSMSEDEFIEEAKVMMNLSHE 79
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V+LY V + IFI+ E++ G L + + R + + + + A++Y S+
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---------- 180
HRDL N L++ G +KVSDFG LS+ V DD Y
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFG---LSRYVLDD----------EYTSSVGSKFPVR 186
Query: 181 --APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
PEVL + S+ D+W+ GV+++ + G +P++ + I
Sbjct: 187 WSPPEVLMYSKF--SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-20
Identities = 59/238 (24%), Positives = 92/238 (38%), Gaps = 27/238 (11%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
I IG G F V N A+K L Q E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRI-TDIGEVSQFLTE 76
Query: 62 VATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQ 119
MK HPNV+ L + + S+ +VL ++ G+L + I N + + Q
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHT 172
+ + Y S+ HRDL N +LD +KV+DFGL+ S + L
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-- 194
Query: 173 TCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
P V A E L + + + +D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 195 ----P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 60/220 (27%), Positives = 88/220 (40%), Gaps = 46/220 (20%)
Query: 14 EVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+G+ +GEG F V + T VA+K + K + E+ E A MK H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 71 PNVVRLYEV-----MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AV 124
PNV+RL V K ++L F+ G+L ++ R++ Q L+ V
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154
Query: 125 D------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----------D 167
D Y +R HRDL N +L + V+DFGLS +
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRI 208
Query: 168 GLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+ P V A E L DR Y S +D+W+ GV +
Sbjct: 209 AKM------P--VKWIAIESLADRVYT-SKSDVWAFGVTM 239
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 66/300 (22%), Positives = 110/300 (36%), Gaps = 38/300 (12%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
I IG G F V N A+K L + Q E
Sbjct: 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NR-ITDIGEVSQFLTEG 141
Query: 63 ATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQL 120
MK HPNV+ L + + S+ +VL ++ G+L + I N + + Q+
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-------ALSQQVRDDGLLHTT 173
+ + S+ HRDL N +LD +KV+DFGL+ S + L
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL--- 258
Query: 174 CGTPNYV---APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAA 229
P V A E L + + + +D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 259 ---P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
Query: 230 E-----FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTN 284
CP L +++ + P R + E++ + + E N
Sbjct: 313 RRLLQPEYCPDPL----YEVMLKCWHPKAEMRPSFSELVSR--ISAIFSTFIGEHYVHVN 366
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 9e-19
Identities = 58/215 (26%), Positives = 87/215 (40%), Gaps = 37/215 (17%)
Query: 16 GRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHPN 72
IGEG F +V AR A+K + KE K + E+ + L HPN
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRD-FAGELEVLCKLGHHPN 87
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------FQQLIN- 122
++ L + +++ +E+ G L D + ++ D A QQL++
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
A D Y + HRDL N+L+ K++DFGLS R +
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYVKKTMG 201
Query: 177 --PNYV---APEVLNDRGYDGSTA-DLWSCGVILF 205
P V A E LN Y +T D+WS GV+L+
Sbjct: 202 RLP--VRWMAIESLNYSVY--TTNSDVWSYGVLLW 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 52/222 (23%), Positives = 78/222 (35%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G G F +V N + VA+K L E +++ E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV---CSEQDELDFLMEALIIS 88
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD 125
H N+VR V FI++E + GG+L + + L++ A D
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 126 ------YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD---------- 166
Y HRD+ N LL G K+ DFG++ RD
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRASYYRKG 202
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+L P V PE + + T D WS GV+L
Sbjct: 203 GCAML------P--VKWMPPEAFMEGIFTSKT-DTWSFGVLL 235
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 53/222 (23%), Positives = 78/222 (35%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G G F +V N + VA+K L E +++ E +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV---CSEQDELDFLMEALIIS 129
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD 125
H N+VR V FI+LE + GG+L + + L++ A D
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 126 ------YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD---------- 166
Y HRD+ N LL G K+ DFG++ RD
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYYRKG 243
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+L P V PE + + S D WS GV+L
Sbjct: 244 GCAML------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLL 276
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G+G+F V K E VA+K + E M E+I+ E + MK
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEA---ASMRERIEFLNEASVMK 83
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---FQQLIN- 122
+VVRL V+ +++E +T G+L + + + ++I
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
A + Y ++ HRDL N ++ +K+ DFG++ RD
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKG 197
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
GLL P V +PE L D + + +D+WS GV+L
Sbjct: 198 GKGLL------P--VRWMSPESLKDGVFT-TYSDVWSFGVVL 230
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 44/214 (20%), Positives = 73/214 (34%), Gaps = 39/214 (18%)
Query: 14 EVGRTIGEGTFAKV-------KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
++G+GTF K+ V LK+LDK +E + M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMS 67
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
+ H ++V Y V + +V EFV G L + + + +QL A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNL--------KVSDFGLSALSQQVRDDGLLHTTCGTP 177
+ + H ++ +N+LL + K+SD G +S V
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG---ISITVLPK---------- 174
Query: 178 NY-------VAPEVLNDRGYDGSTADLWSCGVIL 204
+ V PE + + D WS G L
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 30/208 (14%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R IG+G F V + A+K L + + E RE M+ +
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRI--QCAIKSL-SRIT-EMQQVEAFLREGLLMRGL 79
Query: 69 KHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDY 126
HPNV+ L + + + ++L ++ G+L I + R + + Q+ ++Y
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHTTCGTPNY 179
+ HRDL N +LD +KV+DFGL+ S Q L P
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------P-- 191
Query: 180 V---APEVLNDRGYDGSTADLWSCGVIL 204
V A E L + + +D+WS GV+L
Sbjct: 192 VKWTALESLQTYRFT-TKSDVWSFGVLL 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 36/239 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+ VG+ IG G F +++ +N T E VA+K+ E + Q+ E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAP--QLHLEYRFYKQLGS 63
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ ++Y +VLE G +LFD QLI+ ++Y
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLEL-LGPSLEDLFDL--CDRTFSLKTVLMIAIQLISRMEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVS-----DFGLSALSQQVRD-DGLLH-------TT 173
HS+ + +RD+KPEN L+ GN DF L+++ D + H +
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA---LAKEYIDPETKKHIPYREHKSL 177
Query: 174 CGTPNYVAPEVLND-RGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKIS 227
GT Y++ +N G + S DL + G + L G LP L Y+KI
Sbjct: 178 TGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 54/228 (23%), Positives = 89/228 (39%), Gaps = 51/228 (22%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
G+T+G G F KV A S+ VA+K+L L + A + E+ + L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA--LMSELKVLSYL 83
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------FDKIVNHGRMKEDEARRY 116
H N+V L ++ E+ G+L + M++DE
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 117 FQQLI-------NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169
+ L+ + + S+ HRDL N+LL K+ DFG L++ +++D
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG---LARDIKNDS- 199
Query: 170 LHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
NYV APE + + Y +D+WS G+ L+
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 25/217 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
K+ +GR IG G+F ++ N +T E VA+K+ E V Q+ E + L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP--QLLYESKIYRILQG 61
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
+ + +V++ + G L D R + Q+IN V++ H
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 129 SRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD-DGLLHTT-------CGTP 177
S+ HRD+KP+N L+ + + DFG L+++ RD H GT
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFG---LAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 178 NYVAPEVLNDRGYDGS-TADLWSCGVILFVLLAGYLP 213
Y + V G + S DL S G +L L G LP
Sbjct: 178 RYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-17
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 32/236 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+Y +GR IG G+F + + GE VA+K+ E V Q+ E K +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHP--QLHIESKIYKMMQG 63
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ + +V+E + G +LF+ + Q+I+ ++Y
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDD-GLLHTT-------CG 175
HS+ HRD+KP+N L+ + + DFG L+++ RD H G
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG---LAKKYRDARTHQHIPYRENKNLTG 177
Query: 176 TPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKIS 227
T Y + + G + S DL S G +L G LP + Y++IS
Sbjct: 178 TARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 47/222 (21%)
Query: 16 GRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G+T+G G F KV A + VA+K+L K + + E+ M L +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIMSHLGQ 108
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY-------FQQLIN 122
H N+V L + ++ E+ G+L + + R+ E + + L++
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 123 -AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
+ + S+ HRD+ N+LL K+ DFGL+ RD
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RD------IMN 216
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
NY+ APE + D Y +D+WS G++L+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 53/226 (23%), Positives = 84/226 (37%), Gaps = 54/226 (23%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ +GEG F KV + VA+K L KE + +RE + ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ--DFQREAELLTML 100
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL--------FDKIVNHGRMKEDEARRYFQQL 120
+H ++VR + V + +V E++ G+L D + G QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 121 IN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------- 166
+ A Y HRDL N L+ +K+ DFG+S RD
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYSTDYY 214
Query: 167 ----DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
+L P + PE + R + +T D+WS GV+L
Sbjct: 215 RVGGRTML------P--IRWMPPESILYRKF--TTESDVWSFGVVL 250
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 52/227 (22%), Positives = 84/227 (37%), Gaps = 54/227 (23%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+GE F KV E + VA+K L K+K E + E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREE-FRHEAMLRARL 69
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------FQQ 119
+HPNVV L V+ + ++ + + G+L + +V + +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 120 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------ 166
++ Y S V H+DL N+L+ N+K+SD GL R+
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVYAADY 183
Query: 167 -----DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
+ LL P + APE + + S D+WS GV+L
Sbjct: 184 YKLLGNSLL------P--IRWMAPEAIMYGKF--SIDSDIWSYGVVL 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 55/228 (24%)
Query: 16 GRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
G+ +GEG F +V A VA+K+L K + +++ I E+ MK +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEMEMMKMI 131
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRYFQ 118
KH N++ L +++++E+ + G L + ++ E + +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 119 QLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD----- 166
L++ A Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------RDIHHID 245
Query: 167 ------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+L+
Sbjct: 246 YYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 59/227 (25%)
Query: 16 GRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLV 68
R +GEG F KV ++ VA+K L K+ +A + RE + +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPT----LAARKDFQREAELLTNL 74
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRYFQQ 119
+H ++V+ Y V G + +V E++ G+L I+ G+ ++ + Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 120 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------ 166
+++ A Y S+ HRDL N L+ A +K+ DFG+S RD
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVYSTDY 188
Query: 167 -----DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
+L P + PE + R + +T D+WS GVIL
Sbjct: 189 YRVGGHTML------P--IRWMPPESIMYRKF--TTESDVWSFGVIL 225
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G F KV R G VA+K L +E+ ++ Q + EV + + H N++RL
Sbjct: 38 LGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLR- 93
Query: 79 VMG---SKTKIFIVLEFVTGG----ELFDKIVNHG------RMK--EDEAR--RYFQQLI 121
G + T+ +V ++ G L ++ + R + AR Y
Sbjct: 94 --GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--- 148
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPN 178
D+C + + HRD+K N+LLD V DFGL+ L D H T GT
Sbjct: 149 ---DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRGTIG 200
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221
++APE L+ G D++ GV+L L+ G FD + L N
Sbjct: 201 HIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 34/246 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
Y+VGR IGEG+F + N + VA+K E Q++ E T K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAP--QLRDEYRTYKLLAG 64
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ +Y +V++ G +L D + +Q++ V
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDL-LGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQS 121
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLK-----VSDFGLSALSQQVRD-DGLLH-------TT 173
H + + +RD+KP+N L+ + V DFG + + RD H
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG---MVKFYRDPVTKQHIPYREKKNL 178
Query: 174 CGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKISAA 229
GT Y++ + G + S DL + G + L G LP + Y++I
Sbjct: 179 SGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236
Query: 230 EFTCPP 235
+ + P
Sbjct: 237 KQSTPL 242
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 55/230 (23%)
Query: 14 EVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+ +GEG F +V A + VA+K+L K+ + +++ + E+ MK
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 95
Query: 67 -LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRY 116
+ KH N++ L +++++E+ + G L + ++ + E +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 117 FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--- 166
F+ L++ Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 209
Query: 167 --------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+++
Sbjct: 210 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 58/231 (25%), Positives = 91/231 (39%), Gaps = 56/231 (24%)
Query: 16 GRTIGEGTF-----AKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+T+GEG F A + VA+K+L KE ++ + + E +K V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRD-LLSEFNVLKQVNH 85
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------------FDKIVNHGRMKEDEA 113
P+V++LY + +++E+ G L + DE
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 114 RRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
LI+ A Y + HRDL N+L+ +K+SDFGLS RD
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS------RD 199
Query: 167 DGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
++ +YV A E L D Y + +D+WS GV+L+
Sbjct: 200 ---VYE---EDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 61/237 (25%), Positives = 88/237 (37%), Gaps = 54/237 (22%)
Query: 8 RRVGKYEVGRTIGEGTFAKV-KFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATM 65
G +GEG F V K N VA+K L + ++ +Q +E+ M
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 66 KLVKHPNVVRL-------------YEVM--GSKTKIFIVLEFVTGGELFDKIVNHG---- 106
+H N+V L Y M GS L L
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGS-------LLDR----LSCLDGTPPLSWH 133
Query: 107 -RMK--EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163
R K + A +++ H HRD+K N+LLD K+SDFGL+ S+
Sbjct: 134 MRCKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE- 184
Query: 164 VRDDGLLHTT---CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217
T GT Y+APE L RG +D++S GV+L ++ G D+
Sbjct: 185 --KFAQTVMTSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F KV + G VALK E + + + E+ T+ +HP++V L
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD------YCHSRGV 132
+ ++ ++ +++ G L + +G + + Q+L + Y H+R +
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPNYVAPE-----V 184
HRD+K N+LLD K++DFG+S + H + GT Y+ PE
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGT---ELDQTHLSTVVKGTLGYIDPEYFIKGR 217
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217
L ++ +D++S GV+LF +L S
Sbjct: 218 LTEK------SDVYSFGVVLFEVLCARSAIVQS 244
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 55/235 (23%), Positives = 85/235 (36%), Gaps = 62/235 (26%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
E R IGEG F +V E VA+K+L KE+ A+ +RE A M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQAD-FQREAALMAEF 107
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------------FDKIVNHGRMKED 111
+PN+V+L V + ++ E++ G+L D
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 112 EARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164
+ + A Y R HRDL N L+ +K++DFGLS
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 221
Query: 165 RD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
R+ + + P + PE + Y +T D+W+ GV+L
Sbjct: 222 RNIYSADYYKADGNDAI------P--IRWMPPESIFYNRY--TTESDVWAYGVVL 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 55/230 (23%)
Query: 14 EVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+ +GEG F +V A + VA+K+L K+ + +++ + E+ MK
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 141
Query: 67 -LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRY 116
+ KH N++ L +++++E+ + G L + ++ + E +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 117 FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--- 166
F+ L++ Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 255
Query: 167 --------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+++
Sbjct: 256 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 50/225 (22%)
Query: 16 GRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G+ +G G F +V A + T VA+K+L KE + + E+ + +
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA-LMSELKILIHIGH 89
Query: 70 HPNVVRLYEV-MGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRYFQQ 119
H NVV L + +++EF G L + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 120 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172
LI + + SR HRDL N+LL +K+ DFGL+ RD ++
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD---IYK 200
Query: 173 TCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
P+YV APE + DR Y +D+WS GV+L+
Sbjct: 201 ---DPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 56/233 (24%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
E G+ +G G F KV A + VA+K+L KEK + + E+ M L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREA-LMSELKMMTQL 105
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL----------------FDKIVNHGRMKED 111
H N+V L I+++ E+ G+L + +ED
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 112 EARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164
F+ L+ A + + HRDL N+L+ +K+ DFGL+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219
Query: 165 RDDGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
RD + + NYV APE L + Y +D+WS G++L+
Sbjct: 220 RD---IMS---DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 4e-15
Identities = 39/192 (20%), Positives = 59/192 (30%), Gaps = 48/192 (25%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMK 66
K + IGEG F +V PVA+KI+ D K E+I E+ K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 67 LV---------KHPNVVRLYEV------------------------------MGSKTKIF 87
+ + + L V ++F
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDA 146
IVLEF GG +++ A+ QL ++ + HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 147 YGNLKVSDFGLS 158
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 46/236 (19%), Positives = 88/236 (37%), Gaps = 46/236 (19%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++ +G+ IG G F + A + E A + KV + + E+ + V
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHV---VKVEYQE-NGPLFSELKFYQRVAK 92
Query: 71 PNVVRLYEVMGSKTKI-------------------FIVLEFVTGGELFDKIVNHGRMKED 111
+ ++ + + F+V+E + G +L +G K+
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALSQQVRDDGL 169
+ ++++ ++Y H H D+K NLLL +V +D+G LS + +G
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG---LSYRYCPNGN 208
Query: 170 L----------HTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLAGYLP 213
H GT + + L+ +G S +D+ G + L G LP
Sbjct: 209 HKQYQENPRKGHN--GTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 1e-12
Identities = 71/462 (15%), Positives = 134/462 (29%), Gaps = 113/462 (24%)
Query: 32 NSETGE---------PVALKILDKEKVLKHKMAEQIKREVATMKLVKH----PNVV---- 74
+ ETGE V K + + + + + + + H + V
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDN--FDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL 65
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
RL+ + SK + +V +FV E+ N+ + Q + Y R +
Sbjct: 66 RLFWTLLSKQE-EMVQKFV--EEVLRI--NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 135 RD---LKPENLL-LDAYGNLKVSDFGLSALSQQVRDDGL-LH--TTCGTPNYVAPEVLND 187
D N+ L Y L+ AL + + + G +VA +V
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLR------QALLELRPAKNVLIDGVLGSGK-TWVALDVCLS 173
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKI-----SAAEFTCPPWLSF 239
+ F L ++ L L +I S ++ + L
Sbjct: 174 YKVQ----CKMDFKI--FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 240 -TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEK-------KDTNLDDVEAV 291
+ + + R+L P + +L + K + F + + D +
Sbjct: 228 HSIQAELRRLLKSKPYENCLL--VLLNVQNAKAWN--AFNLSCKILLTTRFKQVTDFLSA 283
Query: 292 FKDSEVCWMEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPA 351
+ + H +T +E L L K L+ QD RE T+ P
Sbjct: 284 ATTTHISLDHHSMTLTPDE------VKSL--LLKYLDC-----RPQDLPREVLTTN--PR 328
Query: 352 NEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAK 411
++ I A ++ +N K L E + V
Sbjct: 329 --RLSII--AES-------IRDGLATWDNWKHVNCDKLTTIIESS--------LNVL--- 366
Query: 412 GDTLEFHKFYKNLSTCLEDV---------VW--KTEEDMQEM 442
+ E+ K + LS +W + D+ +
Sbjct: 367 -EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV 407
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 3e-10
Identities = 73/449 (16%), Positives = 135/449 (30%), Gaps = 136/449 (30%)
Query: 42 KILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVL------EFVT 94
++ K V + + ++++ A ++L NV+ + V+GS KT + +
Sbjct: 124 QVFAKYNVSRLQPYLKLRQ--ALLELRPAKNVL-IDGVLGSGKT----WVALDVCLSYKV 176
Query: 95 GGELFDKI--VNHGRMKEDEAR-RYFQQLINAVD--YC----HSRGVYHR--DLK----- 138
++ KI +N E Q+L+ +D + HS + R ++
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 139 -------PENLL-LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
LL L N K +A + + +L TT R
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKA----WNAFNLSCK---ILLTT--------------R-- 273
Query: 191 DGSTAD-LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
D L + L + + +L K +L + L +L
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK----------YLDCRPQDLPREVL 323
Query: 250 DPNPMTRITIPEILEDE---WFKKDYKPPVFEEKKDT-------NLDDVE--------AV 291
NP I E + D W D V +K T L+ E +V
Sbjct: 324 TTNPRRLSIIAESIRDGLATW---DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
Query: 292 FKDS--------EVCWMEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRET 343
F S + W + K + V +N SL E+ K
Sbjct: 381 FPPSAHIPTILLSLIWFD----VIKSDVMVVVNKLHKYSL-----------VEKQPK--- 422
Query: 344 RFTSRCPANEIINKIEEAAKPLGFDVHKK---NYKMRLENMKAGRKGNLNVATE---VFQ 397
T P+ + K++ + +H+ +Y + K +L +
Sbjct: 423 ESTISIPSIYLELKVKLENEY---ALHRSIVDHYNIP----KTFDSDDLIPPYLDQYFYS 475
Query: 398 -VAPSLHMVEVRKAKGDTLEFHKFYKNLS 425
+ H+ + + TL F + +
Sbjct: 476 HIG--HHLKNIEHPERMTL-FRMVFLDFR 501
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 41/237 (17%), Positives = 84/237 (35%), Gaps = 45/237 (18%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++VG IG+G F + + + + E V KV + E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCI-YLADMNSSESVGSDAPCVVKVEPSD-NGPLFTELKFYQRAAK 92
Query: 71 PNVVRLYEVMGSKTKI-------------------FIVLEFVTG---GELFDKIVNHGRM 108
P ++ + + F++++ G ++++ N R
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRF 149
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALSQQVRD 166
+ ++++ ++Y H H D+K NLLL+ +V D+G L+ +
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG---LAYRYCP 206
Query: 167 DGLL--------HTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLAGYLP 213
+G+ GT + + ++ G S DL G + L G+LP
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 36/244 (14%), Positives = 78/244 (31%), Gaps = 59/244 (24%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETG--------EPVALKI------LDKEKVLKHKMA- 55
++++ + A + T + +LK+ L E+ + A
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 56 -EQIKREVATMKLVKHPNVVRLYEVMGSKTKI--FIVLEFVTGGELFDKIVNHGRMKEDE 112
Q+ + + G F+VL + G L + +
Sbjct: 102 PLQVNKWKKLYST-PLLAIPTCMG-FGVHQDKYRFLVLPSL-GRSLQSALDVSPK----- 153
Query: 113 ARRYF---------QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALS 161
+L++A+++ H H ++ EN+ +D +V + +G +
Sbjct: 154 --HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG---FA 208
Query: 162 QQVRDDG----------LLHTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLA 209
+ G H G +++ ++ +G S +DL S G + L
Sbjct: 209 FRYCPSGKHVAYVEGSRSPHE--GDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLY 263
Query: 210 GYLP 213
G+LP
Sbjct: 264 GFLP 267
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 1e-07
Identities = 15/86 (17%), Positives = 36/86 (41%), Gaps = 2/86 (2%)
Query: 346 TSRCPANEIINKIEEAAKPLGFDVHKKN-YKMRLENMKAGRKGNLNVATEVFQVA-PSLH 403
TS N+++ +I + D +K + + + A + + EV ++ SL+
Sbjct: 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLN 93
Query: 404 MVEVRKAKGDTLEFHKFYKNLSTCLE 429
V ++ G ++ F ++ L+
Sbjct: 94 GVRFKRISGTSIAFKNIASKIANELK 119
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 25/99 (25%)
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ +++ SR HRDL N+LL +K+ DFGL+ RD P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD------IYKDPD 248
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILF 205
YV APE + DR Y +D+WS GV+L+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 22/99 (22%), Positives = 40/99 (40%), Gaps = 9/99 (9%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
++G+ +G G F +V A + T VA+K+L + A E+ + +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM--SELKILIHI 82
Query: 68 VKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH 105
H NVV L + +++EF G L + +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 25/159 (15%), Positives = 58/159 (36%), Gaps = 28/159 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI-------------- 58
+G+ +GEG + V + + +K K+ E+
Sbjct: 92 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 59 -KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 117
+ E ++ ++ V ++Y G+ +++E + EL+ ++ +
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGNA----VLMELIDAKELYR-------VRVENPDEVL 199
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156
++ V + RG+ H DL N+L+ + + DF
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.0 bits (93), Expect = 9e-04
Identities = 32/168 (19%), Positives = 55/168 (32%), Gaps = 26/168 (15%)
Query: 13 YEVGRTIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+G I G A V +A +A+KI E KM E + +
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 71 P-------------NVVRLYEVMGSKTKIF------IVLEFVTGGELFDKIVNH--GRMK 109
P N+ R E S + + +++EF+ EL + +K
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 110 EDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFG 156
E + F ++ V + + H DL N++ + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI--DKVYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 443 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.98 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.87 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.87 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.69 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.55 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.47 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.37 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.37 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.15 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.12 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 98.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.73 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.33 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.3 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.26 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.19 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.17 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.85 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.64 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.17 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.41 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.59 | |
| 3ost_A | 128 | Serine/threonine-protein kinase KCC4; kinase assoc | 80.47 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-69 Score=523.91 Aligned_cols=262 Identities=31% Similarity=0.578 Sum_probs=244.4
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45678999999999999999999999999999999999877655556788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+|||||+||+|++++.+.+.++|..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876544444
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 247 (443)
....+.|||+.|||||++.+..|+ .++|||||||++|+|++|.+||.+.+...++.+|..+.+.+|..+|+++++||.+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 556778999999999999988885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCChhh------hhcCccccc
Q 013407 248 ILDPNPMTRITIPE------ILEDEWFKK 270 (443)
Q Consensus 248 mL~~dP~~R~t~~e------il~hp~~~~ 270 (443)
||+.||.+|||++| |++||||+.
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 99999999999998 478999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-69 Score=514.78 Aligned_cols=261 Identities=49% Similarity=0.920 Sum_probs=224.7
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
+..+++|++++.||+|+||+||+|+++.+|+.||||++++.........+++.+|+.+|++++|||||++++++.+++.+
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 56789999999999999999999999999999999999887665555567899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+ +|+|++.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 164 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--- 164 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---
Confidence 9999999 689999999999999999999999999999999999999999999999999999999999999986432
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 246 (443)
.....+.+||+.|+|||++.+..|++.++|||||||++|+|++|++||.+.+...+++.+..+.+.+|.++|+++++||.
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 33445789999999999999988888899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCChhhhhcCcccccc
Q 013407 247 RILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+||+.||++|||++|+++||||+.+
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHccCChhHCcCHHHHHcCcccccC
Confidence 9999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-65 Score=506.02 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=230.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
..|++.+.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999998754332 356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
|||+||+|++++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 227 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 227 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCB
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCcc
Confidence 99999999998876 6799999999999999999999999999999999999999999999999999986543 23345
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCHHHHHHHHH
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIAR 247 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~ 247 (443)
.+.|||+.|||||++.+..|+ .++|||||||++|+|++|.+||.+.+..+.+..+..... ..+..+|+++++||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 678999999999999888885 899999999999999999999999998888888866532 3334589999999999
Q ss_pred hcCCCCCCCCChhhhhcCccccccCC
Q 013407 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
||+.||++|||++|+|+||||++...
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-66 Score=511.26 Aligned_cols=261 Identities=29% Similarity=0.570 Sum_probs=230.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+|++|+|||||++++++.+++.+|
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 45789999999999999999999999999999999998765433 34678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
||||||+||+|+++|... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 999999999999999754 35799999999999999999999999999999999999999999999999999865431
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKL 244 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~l 244 (443)
.....+.|||+.|||||++.+..|+ .++|||||||+||+|++|++||.+.+..+++.++..+.+ +.+..+|+++++|
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL 256 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred -cccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 1223567899999999999988885 899999999999999999999999999999888887765 4566799999999
Q ss_pred HHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 245 IARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
|.+||+.||++|||++|+|+||||++..
T Consensus 257 i~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 9999999999999999999999998643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-66 Score=500.56 Aligned_cols=257 Identities=33% Similarity=0.607 Sum_probs=227.6
Q ss_pred cccEEEEeEeeccCcEEEEEEEEC---CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
.++|++++.||+|+||+||+|++. .+++.||||++++......+ ..++.+|+.+|++++|||||++++++.+++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999884 46889999999875543221 34678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+|||||+||+|++++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--H 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--C
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999985432 2
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 246 (443)
.....+.|||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+..+.+..+..+.+.+|..+|+++++||.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 3345678999999999999988886 899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 247 RILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 247 ~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
+||+.||++||| ++|+++||||+.
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999999998 579999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-64 Score=505.87 Aligned_cols=256 Identities=28% Similarity=0.463 Sum_probs=231.1
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++++.||+|+||.||+|+++.+|+.||||++....... .+.+.+|+.+|+.++|||||++++++.+.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998654332 356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
|||.||+|++++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... .....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 304 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 304 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCB
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCccc
Confidence 99999999998865 5799999999999999999999999999999999999999999999999999986533 23345
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHHHHHHHH
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIAR 247 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~ 247 (443)
.+.|||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+..+.+..+.... +..+..+|+++++||.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 678999999999999988885 89999999999999999999999999888888876653 33445689999999999
Q ss_pred hcCCCCCCCCChhhhhcCccccccCC
Q 013407 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
||..||.+|||++|+|+||||++...
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 99999999999999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-62 Score=505.61 Aligned_cols=409 Identities=37% Similarity=0.668 Sum_probs=314.2
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
-...+++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34678999999999999999999999999999999999987665444456789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~-- 168 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-- 168 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999986432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
.....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++..+.+..|..+++++.+||
T Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 247 (476)
T 2y94_A 169 -GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLL 247 (476)
T ss_dssp -TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred -cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHH
Confidence 3345677999999999999988887789999999999999999999999999889999999888888999999999999
Q ss_pred HHhcCCCCCCCCChhhhhcCccccccCCCCccccccc--CCchhhh---hhhcc-----chh--hhc-----cc------
Q 013407 246 ARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKD--TNLDDVE---AVFKD-----SEV--CWM-----EH------ 302 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~--~~~~~~~---~~~~~-----~~~--~~~-----~~------ 302 (443)
.+||..||.+|||++++++||||+.......++.... ....+.+ ..... .+. +.. +.
T Consensus 248 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~ 327 (476)
T 2y94_A 248 KHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYH 327 (476)
T ss_dssp HHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC--------------------------
T ss_pred HHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHH
Confidence 9999999999999999999999987543222111100 0000000 00000 000 000 00
Q ss_pred -----ccc-ccc-c----cCCcc---------cchhhhhhcCCCCC------CcccCc--c----cccccccceEEecCC
Q 013407 303 -----HVT-EQK-E----EQPVA---------MNAFELISLSKGLN------LGNLFD--A----EQDFKRETRFTSRCP 350 (443)
Q Consensus 303 -----~~~-~~~-~----~~~~~---------~~~~~~~~~~~~~~------~~~~~~--~----~~~~~~~trf~s~~~ 350 (443)
... .+. + .+|.. ...-+..+.+.... ++.+.. . ....+...++.|+.+
T Consensus 328 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~~~ 407 (476)
T 2y94_A 328 LIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSR 407 (476)
T ss_dssp -----CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEECSC
T ss_pred HHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCccCCC
Confidence 000 000 0 00000 00000000000000 110100 0 012345567889999
Q ss_pred HHHHHHHHHHHhccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeeEEEEEecCCCchHH
Q 013407 351 ANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEF 417 (443)
Q Consensus 351 ~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le~ 417 (443)
|.+||..+..|++.||+.|+.. .+.++++.........+.|.+++|+++++.+||||++..|+.++|
T Consensus 408 p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 408 PNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp HHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred HHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 9999999999999999999976 799998654443345678999999999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-63 Score=479.91 Aligned_cols=254 Identities=26% Similarity=0.501 Sum_probs=222.1
Q ss_pred cccE-EEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CC
Q 013407 10 VGKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KT 84 (443)
Q Consensus 10 ~~~y-~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~ 84 (443)
-++| ++.+.||+|+||+||+|.+..++..||+|++.+..... ...+.+.+|+.+|++++|||||++++++.+ +.
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 3566 78889999999999999999999999999998765433 346789999999999999999999999865 45
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeeCCCCcEEEcc-CCCeEEeecCccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDA-YGNLKVSDFGLSALS 161 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~-~~~~kl~DFGla~~~ 161 (443)
.+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 68999999999999999999899999999999999999999999999 999999999999984 799999999999753
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc-HHHHHHHhhcCcc--CCCCCCC
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAAEF--TCPPWLS 238 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~--~~~~~~s 238 (443)
. .....+.+|||.|||||++.+ .| +.++|||||||++|+|++|++||.+.+ ...++..+..+.. .++...+
T Consensus 183 ~----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 R----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred C----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 2 234567899999999999875 56 489999999999999999999997654 4566666665543 3445688
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 239 FTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+++++||.+||+.||++|||++|+|+||||++
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-63 Score=487.10 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=224.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..++.|++.+.||+|+||+||+|+++.+|+.||||+++++.. ..+|+.+|+.++|||||++++++.+++.+|
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456789999999999999999999999999999999986543 246999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-CeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 166 (443)
||||||+||+|++++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+.......
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999999989999999999999999999999999999999999999999988 599999999987644222
Q ss_pred CC---ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCHH
Q 013407 167 DG---LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFT 240 (443)
Q Consensus 167 ~~---~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~ 240 (443)
.. ...+.|||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+...+..++..... ..|+.+|+.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 11 12346899999999999988885 899999999999999999999998877777777766543 357789999
Q ss_pred HHHHHHHhcCCCCCCCCChhhh-------------hcCccccccC
Q 013407 241 ARKLIARILDPNPMTRITIPEI-------------LEDEWFKKDY 272 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~ei-------------l~hp~~~~~~ 272 (443)
+.+||.+||+.||.+|||+.|+ ++|||+....
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 9999999999999999999997 5799987543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-61 Score=487.48 Aligned_cols=260 Identities=28% Similarity=0.403 Sum_probs=225.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------CC
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------KT 84 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 84 (443)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+++.+|+.+|+.++|||||++++++.+ .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 479999999999999999999999999999999976443 23345788899999999999999999999764 36
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.+|||||||. |+|++.+...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7999999996 689999999999999999999999999999999999999999999999999999999999999865332
Q ss_pred --cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC---------
Q 013407 165 --RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--------- 233 (443)
Q Consensus 165 --~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 233 (443)
.......+.+||+.|+|||++.+..+++.++||||+|||+|+|++|++||.+.+..+.+..|.......
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 223345678999999999999887777899999999999999999999999999888777764322111
Q ss_pred ----------------------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 234 ----------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 234 ----------------------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.+.+|+++++||.+||..||.+|||++|+|+||||++..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 123688999999999999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=500.45 Aligned_cols=261 Identities=29% Similarity=0.458 Sum_probs=231.3
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHH---HHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE---QIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~---~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
....+++|++++.||+|+||+||+|+++.+|+.||||++.+.......... ..++++.+++.++|||||++++++.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 356789999999999999999999999999999999999886654332223 33445777888899999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
.+.+|+|||||+||+|+++|...+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998643
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc---HHHHHHHhhcCccCCCCCCCH
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPPWLSF 239 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~ 239 (443)
. ....+.||||.|||||++.+...++.++|||||||++|+|++|.+||.+.+ ...+...+....+.+|..+|+
T Consensus 344 ~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 344 K----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp S----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence 2 334678999999999999754334599999999999999999999997643 445667777888889999999
Q ss_pred HHHHHHHHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 240 TARKLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
++++||.+||+.||.+|++ ++||++||||+.
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999998 699999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-60 Score=462.04 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=204.4
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 84 (443)
-+++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 4678999999999999999999999999999999997643 2334578999999999999999999999986544
Q ss_pred --------EEEEEEeccCCCchHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEe
Q 013407 85 --------KIFIVLEFVTGGELFDKIVNHGRM---KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (443)
Q Consensus 85 --------~~~lv~E~~~gg~L~~~i~~~~~l---~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~ 153 (443)
.+|+|||||.||+|.+++...+.+ ++..++.++.||++||+|||++||+||||||+|||++.+|.+||+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence 479999999999999999876654 456789999999999999999999999999999999999999999
Q ss_pred ecCcccccccccCC----------CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HH
Q 013407 154 DFGLSALSQQVRDD----------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NL 222 (443)
Q Consensus 154 DFGla~~~~~~~~~----------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~ 222 (443)
|||+|+........ ....+.|||+.|||||++.+..|+ .++|||||||++|+|++ ||...... ..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 99999875442211 122456899999999999988885 89999999999999996 88654322 33
Q ss_pred HHHhhcCccC-CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 223 YKKISAAEFT-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 223 ~~~i~~~~~~-~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
...+....++ .++..++.+.+||.+||+.||.+|||+.|+++||||+.
T Consensus 237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 3444433321 11235678899999999999999999999999999974
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-59 Score=464.30 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=210.2
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEEC---CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (443)
+..-++|++.+.||+|+||+||+|+++ .+++.||||.+.+.. ...++.+|+.+|+.+ +|||||++++++.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 344578999999999999999999874 467889999987543 134678999999998 69999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC-CCeEEeecCccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALS 161 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~~kl~DFGla~~~ 161 (443)
.+.+|+||||++||+|++.+ +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999999998 459999999999999999999999999999999999999877 79999999999754
Q ss_pred cccc--------------------------CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCC
Q 013407 162 QQVR--------------------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (443)
Q Consensus 162 ~~~~--------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~ 215 (443)
.... ......+.+||+.|+|||++.+..+++.++||||+|||+|+|++|++||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 3211 11223456899999999999887666799999999999999999999995
Q ss_pred C-CcHHHHHHHhhc--------------------------------------Ccc----------------CCCCCCCHH
Q 013407 216 D-SNLMNLYKKISA--------------------------------------AEF----------------TCPPWLSFT 240 (443)
Q Consensus 216 ~-~~~~~~~~~i~~--------------------------------------~~~----------------~~~~~~s~~ 240 (443)
. .+..+....|.. ... .....+|++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 4 333333322210 000 011237899
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+++||++||+.||++|||++|+|+||||+.
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-59 Score=452.27 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=221.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
.-++|.+.+.||+|+||+||+|.+. .++..||||+++... ....+.+.+|+.+|++++|||||++++++.++
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3467999999999999999999875 357889999997542 33467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCe
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH-------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~-------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~ 150 (443)
+.+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 9999999999999999999764 369999999999999999999999999999999999999999999
Q ss_pred EEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC
Q 013407 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (443)
Q Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 229 (443)
||+|||+|+..............+||+.|||||++.+..|+ .++||||+||+||||+| |+.||.+.+..+....+..+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999865433222223345799999999999988885 89999999999999998 99999999988888888776
Q ss_pred c-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 230 E-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 230 ~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
. .+.|+.+|+++.+|+.+||+.||++|||+.++ |+|++
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 5 46778899999999999999999999999999 45664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=486.49 Aligned_cols=259 Identities=30% Similarity=0.584 Sum_probs=235.0
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.+++|++++.||+|+||.||+|.++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999999999999999999976542 234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC--CCeEEeecCccccccccc
Q 013407 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 165 (443)
|||||.||+|+++|.. .+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-- 309 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 309 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence 9999999999999964 4679999999999999999999999999999999999999854 8999999999986532
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 241 (443)
.....+.|||+.|||||++.+..|. .++|||||||++|+|++|.+||.+.+..+.+..|....+.++ +.+|+++
T Consensus 310 -~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 310 -KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp -TSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred -CCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 3445678999999999999998885 899999999999999999999999999999999988876655 3589999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
++||.+||..||.+|||++|+|+||||+....+
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 999999999999999999999999999976544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-58 Score=450.67 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=215.0
Q ss_pred ccccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
.-.+|.+.+.||+|+||+||+|.+. .+++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3457999999999999999999864 367899999997532 33467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH---------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~---------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~ 148 (443)
+.+|||||||+||+|.+++... +++++.++..++.||+.||.|||+++|+||||||+|||+++++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 9999999999999999999754 3589999999999999999999999999999999999999999
Q ss_pred CeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhh
Q 013407 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS 227 (443)
Q Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 227 (443)
++||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..+....+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999865443333334457899999999999988875 89999999999999999 999999998888888887
Q ss_pred cC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 228 AA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 228 ~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+ .+..|+.+++++.+|+.+||+.||++|||+.||+++
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 66 467788899999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=444.93 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=223.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
...+.+++.+.||+|+||+||+|... .+++.||||++.... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 45678999999999999999999863 467889999997543 22335689999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA 146 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~ 146 (443)
.+.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999999643 35899999999999999999999999999999999999999
Q ss_pred CCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHH
Q 013407 147 YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKK 225 (443)
Q Consensus 147 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~ 225 (443)
++++||+|||+|+..............+||+.|||||++.+..|+ .++||||+||+||||+| |..||.+.+..+....
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999866544333445567899999999999988775 99999999999999998 8999999998888888
Q ss_pred hhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 226 ISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 226 i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+..+. .+.|+.+++.+.+|+.+||+.||.+|||+.||+++
T Consensus 260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 87764 46777899999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=442.19 Aligned_cols=264 Identities=43% Similarity=0.817 Sum_probs=243.5
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
.....+++|++.+.||+|+||.||+|.+..+|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 345678999999999999999999999999999999999987554 3345678899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 166 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV- 166 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS-
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC-
Confidence 9999999999999999999889999999999999999999999999999999999999999999999999999975432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 244 (443)
.......+||+.|+|||++.+..+++.++|||||||++|+|++|.+||.+.+.......+..+.+..|..+++++.+|
T Consensus 167 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244 (328)
T ss_dssp --SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred --CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 334567789999999999998888878999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 245 IARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
|++||..||.+|||++|+++||||+...
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=442.73 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=205.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..+++++.+.||+|+||+||+|++.. .||||+++.... ..+..+.+.+|+.+|++++|||||++++++.+ +.+||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 45688899999999999999998643 599999975432 33456789999999999999999999998854 56899
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+++++++||+|||+|+........
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999999764 57999999999999999999999999999999999999999999999999999876543334
Q ss_pred CccccccCCCcccchhhhccCC--CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHH-HHHhhcCcc-----CCCCCCCH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL-YKKISAAEF-----TCPPWLSF 239 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~-~~~i~~~~~-----~~~~~~s~ 239 (443)
....+.+||+.|||||++.+.. .++.++|||||||+||||+||+.||.+.+.... ...+..+.. ..++.+++
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 268 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK 268 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence 4456779999999999996432 235899999999999999999999988665543 333433321 23456899
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 240 TARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
++.+|+.+||+.||++|||+.|++++
T Consensus 269 ~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 269 AMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999988654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-55 Score=432.49 Aligned_cols=260 Identities=33% Similarity=0.613 Sum_probs=238.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..+++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 35789999999999999999999999999999999998765444445678899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+||||++||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++..... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999874322 22
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 247 (443)
....+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+....+..+......+|..+++++++||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 345567899999999999887774 8999999999999999999999999988999999888888999999999999999
Q ss_pred hcCCCCCCCC-----ChhhhhcCccccc
Q 013407 248 ILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 248 mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
||..||.+|| +++++++||||..
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999 8999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=439.09 Aligned_cols=261 Identities=34% Similarity=0.630 Sum_probs=233.3
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (443)
...+++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 35678999999999999999999999999999999999886655555567888999999988 79999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-- 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-- 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--
Confidence 999999999999999999889999999999999999999999999999999999999999999999999999874322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+..+.+..+..+...+|.++++.+.+||
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 22334567899999999999887774 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCh------hhhhcCccccc
Q 013407 246 ARILDPNPMTRITI------PEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~t~------~eil~hp~~~~ 270 (443)
++||..||.+||++ +++++||||+.
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 99999999999998 89999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-56 Score=441.53 Aligned_cols=254 Identities=23% Similarity=0.377 Sum_probs=216.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCC-----CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEe
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGS 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~ 82 (443)
.-++|++++.||+|+||+||+|.+..+ ++.||||.+..... ....+.+.+|+.+|++++| ||||++++++..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 346899999999999999999997654 36799999976432 2345679999999999965 999999999865
Q ss_pred -CCEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc
Q 013407 83 -KTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD 145 (443)
Q Consensus 83 -~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~ 145 (443)
.+.+|+|||||++|+|.++|... ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 46799999999999999999753 3489999999999999999999999999999999999999
Q ss_pred cCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcH-HHHH
Q 013407 146 AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL-MNLY 223 (443)
Q Consensus 146 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~-~~~~ 223 (443)
+++.+||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+. ....
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999865432222233456899999999999988875 89999999999999998 9999988654 4445
Q ss_pred HHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 224 KKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 224 ~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..+..+ .+..|+.+++++.+||.+||+.||.+|||+.||++|
T Consensus 299 ~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 555554 467788899999999999999999999999999987
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=439.99 Aligned_cols=263 Identities=48% Similarity=0.902 Sum_probs=239.0
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
....+++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 35678999999999999999999999999999999999987655444445689999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
.|+||||+ +|+|++.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~-- 160 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-- 160 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT--
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC--
Confidence 99999999 789999998888999999999999999999999999999999999999999999999999999976433
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+......+..+..+.+..|..+|+.+.+||
T Consensus 161 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 161 -GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp -SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHH
T ss_pred -CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 2344567899999999999888877789999999999999999999999887776666777777788889999999999
Q ss_pred HHhcCCCCCCCCChhhhhcCccccccC
Q 013407 246 ARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
++||..||.+|||++|+++||||+...
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHHhChhhccCC
Confidence 999999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=425.38 Aligned_cols=257 Identities=34% Similarity=0.718 Sum_probs=237.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..+++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45789999999999999999999999999999999998765544444677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999975432
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 247 (443)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+......+|+.+++++.+||.+
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 23467899999999999887775 8999999999999999999999999999999999888889999999999999999
Q ss_pred hcCCCCCCCC-----ChhhhhcCccccc
Q 013407 248 ILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 248 mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
||..||.+|| +++++++||||+.
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999 8999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-55 Score=432.99 Aligned_cols=262 Identities=31% Similarity=0.591 Sum_probs=237.0
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (443)
....+++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|..+++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 456789999999999999999999999999999999999876544444456788999999877 9999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999874322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 244 (443)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+......+|.++++++++|
T Consensus 171 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 171 -GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 22334567899999999999887774 8999999999999999999999999999999999888888999999999999
Q ss_pred HHHhcCCCCCCCCChh-hhhcCccccc
Q 013407 245 IARILDPNPMTRITIP-EILEDEWFKK 270 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~-eil~hp~~~~ 270 (443)
|.+||..||.+||++. ++++||||+.
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccC
Confidence 9999999999999998 9999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=427.24 Aligned_cols=261 Identities=30% Similarity=0.540 Sum_probs=237.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (443)
...+++|++++.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 45789999999999999999999999999999999999886654444567788999999988 79999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999874322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
........+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+....++.+......+|..+++++.+||
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 252 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 22345567899999999999887774 89999999999999999999999999999999999998999999999999999
Q ss_pred HHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
.+||..||.+||+ ++++++||||+.
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999995 699999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-54 Score=427.14 Aligned_cols=258 Identities=33% Similarity=0.648 Sum_probs=239.2
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
...+++|++++.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 35789999999999999999999999999999999999876654444567889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999975432
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 246 (443)
...+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+....+..+..+...+|..+++++.+||.
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 23457899999999999887775 899999999999999999999999999999999999989999999999999999
Q ss_pred HhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 247 RILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 247 ~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
+||+.||.+||+ ++++++||||..
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999999999998 999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=424.49 Aligned_cols=261 Identities=31% Similarity=0.586 Sum_probs=234.9
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (443)
...+++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 34678999999999999999999999999999999999987665666677899999999988 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999874322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCC---------CcHHHHHHHhhcCccCCCCC
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---------SNLMNLYKKISAAEFTCPPW 236 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~~~~ 236 (443)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.. ......++.+......+|..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 2234556789999999999988777 4899999999999999999999975 23345667777788888999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCh------hhhhcCccccc
Q 013407 237 LSFTARKLIARILDPNPMTRITI------PEILEDEWFKK 270 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~------~eil~hp~~~~ 270 (443)
++..+++||.+||+.||.+||++ +++++||||+.
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999999999999995 79999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=427.17 Aligned_cols=261 Identities=34% Similarity=0.595 Sum_probs=234.1
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
....-++|++++.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 34556789999999999999999999999999999999987543221 124678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC----CeEEeecCcc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLS 158 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~----~~kl~DFGla 158 (443)
...+|+||||+.||+|++++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999999998888999999999999999999999999999999999999998877 7999999999
Q ss_pred cccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---- 234 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---- 234 (443)
..... .......+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+....+..+..+.+.++
T Consensus 167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp EECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eEcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 76433 233456789999999999987777 4899999999999999999999999999898999888877665
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 235 ~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+.+++.+++||.+||..||.+|||+.|+++||||+.
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 458999999999999999999999999999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=434.48 Aligned_cols=261 Identities=30% Similarity=0.575 Sum_probs=232.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (443)
...+++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|..+++++ +||||+++++++.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45678999999999999999999999999999999999887655555556788999999887 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-- 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999974222
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC---------cHHHHHHHhhcCccCCCCC
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------NLMNLYKKISAAEFTCPPW 236 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~~ 236 (443)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|.+||... ....+++.+......+|..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred CCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 23345678999999999999988774 8999999999999999999999642 2334677788888899999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCh------hhhhcCccccc
Q 013407 237 LSFTARKLIARILDPNPMTRITI------PEILEDEWFKK 270 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~------~eil~hp~~~~ 270 (443)
+++++++||++||+.||.+||++ +|+++||||+.
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 99999999999999999999995 79999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=434.01 Aligned_cols=265 Identities=36% Similarity=0.658 Sum_probs=232.5
Q ss_pred CccccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 013407 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (443)
Q Consensus 2 ~~~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 81 (443)
+........++|++.+.||+|+||.||+|.+..+|+.||+|++.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 80 (444)
T 3soa_A 2 ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSIS 80 (444)
T ss_dssp -----CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred CccccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence 33444556689999999999999999999999999999999998765432 34567899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc---cCCCeEEeecCcc
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGLS 158 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~~~~kl~DFGla 158 (443)
+.+..|+||||+.||+|++.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999999999999999999999999999999999999999999999999999999998 4578999999999
Q ss_pred cccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC---
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--- 235 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--- 235 (443)
..... ........+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+....+..+..+.+.+|.
T Consensus 161 ~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 237 (444)
T 3soa_A 161 IEVEG--EQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237 (444)
T ss_dssp BCCCT--TCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred EEecC--CCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc
Confidence 75433 22334567899999999999887774 8999999999999999999999999999999988888765543
Q ss_pred -CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 236 -WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 236 -~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 47999999999999999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=425.23 Aligned_cols=261 Identities=34% Similarity=0.587 Sum_probs=228.8
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHH-HhcCCCCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~ 85 (443)
....++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4567899999999999999999999999999999999988765554455677778877 577899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999875322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+....+..+......+|+.++..+++||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 23345677999999999999887775 89999999999999999999999999999999998888888999999999999
Q ss_pred HHhcCCCCCCCCCh----hhhhcCccccc
Q 013407 246 ARILDPNPMTRITI----PEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~t~----~eil~hp~~~~ 270 (443)
.+||+.||.+||++ .++++||||+.
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999999997 69999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=418.08 Aligned_cols=263 Identities=40% Similarity=0.695 Sum_probs=227.2
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.+++|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 578999999999999999999999999999999999765432 234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998665433334
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhcCccCCC--CCCCHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP--PWLSFTARKLI 245 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~li 245 (443)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.. ..+..+.......+ ..+++.+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 4556789999999999988877678899999999999999999999876543 33333333333333 34899999999
Q ss_pred HHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 246 ARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
.+||..||.+|||++|+++||||+....
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhccccc
Confidence 9999999999999999999999986543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=423.78 Aligned_cols=261 Identities=27% Similarity=0.547 Sum_probs=235.1
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
....+++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34568899999999999999999999999999999999987765555556788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-- 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999985432
Q ss_pred CCCccccccCCCcccchhhhcc---CCCCCCchhhhhhhHHHHHHhhCCCCCCCC---cHHHHHHHhhcCccCCCCCCCH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTCPPWLSF 239 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~ 239 (443)
.....+.+||+.|+|||++.. .+| +.++|||||||++|+|++|..||... ........+......+|..+++
T Consensus 168 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~ 245 (384)
T 4fr4_A 168 -ETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ 245 (384)
T ss_dssp -TCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred -CCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence 334567889999999999964 234 58999999999999999999999743 4456667777778888999999
Q ss_pred HHHHHHHHhcCCCCCCCCC-hhhhhcCccccc
Q 013407 240 TARKLIARILDPNPMTRIT-IPEILEDEWFKK 270 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t-~~eil~hp~~~~ 270 (443)
.+.+||.+||..||.+||+ ++++++||||..
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 9999999999999999998 899999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=433.69 Aligned_cols=261 Identities=34% Similarity=0.619 Sum_probs=228.0
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
...+++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34678999999999999999999999999999999999876554555567788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 9999999999999999988899999999999999999999998 9999999999999999999999999999875322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
........+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 2233456789999999999988777 489999999999999999999999999999999998888899999999999999
Q ss_pred HHhcCCCCCCCC-----ChhhhhcCccccc
Q 013407 246 ARILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 246 ~~mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
.+||+.||.+|| |++|+++||||..
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999 9999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=407.27 Aligned_cols=259 Identities=28% Similarity=0.489 Sum_probs=228.3
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
++...++|++.+.||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence 4556789999999999999999999999999999999997654332 4568899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 168 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-- 168 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred EEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC--
Confidence 99999999999999998764 699999999999999999999999999999999999999999999999999875433
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTAR 242 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~ 242 (443)
........+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+.......+... ....|..++..+.
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 22234556899999999999888774 8999999999999999999999988776555444322 3445667899999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+||.+||+.||.+|||+.|+++||||+..
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=402.34 Aligned_cols=263 Identities=36% Similarity=0.685 Sum_probs=236.7
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
....+++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 34578999999999999999999999999999999999987665544446789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
.|+||||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence 999999999999999998888999999999999999999999999999999999999999999999999998864322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......|..++..+.+||
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (279)
T 3fdn_A 162 --SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred --ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence 22345679999999999987666 489999999999999999999999999888888888888889999999999999
Q ss_pred HHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 246 ARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
.+||+.||.+|||+.|+++||||+....
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHhccChhhCCCHHHHhhCccccCCcc
Confidence 9999999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=418.35 Aligned_cols=256 Identities=37% Similarity=0.696 Sum_probs=230.5
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999999999999999999875543 33457799999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC---CeEEeecCcccccccccC
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~~~ 166 (443)
|||+.||+|++.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~--- 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--- 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT---
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC---
Confidence 99999999999998888899999999999999999999999999999999999998654 599999999975432
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC----CCCHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTAR 242 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~ 242 (443)
.......+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+....+..+..+.+.+|. .++++++
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 2334567899999999999887775 8999999999999999999999999988888888887765553 3799999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 243 KLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+||.+||..||.+|||+.++++||||..
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=402.59 Aligned_cols=258 Identities=33% Similarity=0.505 Sum_probs=218.2
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 5789999999999999999999999999999999986543 233456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i-~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||+.+ +|.+.+ ...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence 999987 555555 4467899999999999999999999999999999999999999999999999999976532 223
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCC-CCCCcHHHHHHHhhcCc-----------------
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAAE----------------- 230 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~P-f~~~~~~~~~~~i~~~~----------------- 230 (443)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..| |.+.+.......+....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 345568999999999998776557999999999999999988777 56666555555442210
Q ss_pred ------------cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 231 ------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 231 ------------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
....+.+++.+++||.+||+.||.+|||++|+++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01123478899999999999999999999999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=428.48 Aligned_cols=263 Identities=34% Similarity=0.574 Sum_probs=230.3
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.....++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 34567899999999999999999999999999999999987554333334568899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus 144 ~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999999998876 579999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCcccchhhhccCC---CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--cCCC--CCCC
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP--PWLS 238 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s 238 (443)
.....+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|.+||.+.+....+.++.... +.+| ..+|
T Consensus 223 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 223 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp -EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred -cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 11234678999999999997654 23589999999999999999999999999888888886542 3444 4689
Q ss_pred HHHHHHHHHhcCCCCCC--CCChhhhhcCccccc
Q 013407 239 FTARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~--R~t~~eil~hp~~~~ 270 (443)
+++++||.+||..+|.+ |++++||++||||+.
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 99999999999999988 999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=411.63 Aligned_cols=261 Identities=34% Similarity=0.609 Sum_probs=224.6
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEEC---CCCceEEEEEeechhhhh-HHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
....++|++.+.||+|+||.||+|++. .+|+.||+|++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 356789999999999999999999985 689999999998754322 2234668899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
.+.+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999987533
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHH
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 242 (443)
. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|+.+++.++
T Consensus 173 ~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 173 H--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred c--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 2 2223456789999999999987776 489999999999999999999999999888888888888889999999999
Q ss_pred HHHHHhcCCCCCCCC-----ChhhhhcCccccc
Q 013407 243 KLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 243 ~li~~mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
+||.+||..||.+|| +++++++||||+.
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 999999999999999 8899999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=411.99 Aligned_cols=255 Identities=25% Similarity=0.494 Sum_probs=229.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 4679999999999999999999999999999999997543 234568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc--CCCeEEeecCccccccccc
Q 013407 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~ 165 (443)
||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 999999999999997654 7999999999999999999999999999999999999987 78999999999976532
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 241 (443)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+.+.++ +.+|.++
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 157 -GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred -CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 233456789999999999987655 5899999999999999999999999998888888888777665 3589999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+||.+||..||.+|||+.|+++||||+..
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=400.19 Aligned_cols=264 Identities=49% Similarity=0.907 Sum_probs=231.4
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
-...+++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 34578999999999999999999999999999999999987654444456789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
.|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~-- 163 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-- 163 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC--
Confidence 999999999999999998888999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 245 (443)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+..+....|..++..+.++|
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 242 (276)
T 2h6d_A 164 -GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred -CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHH
Confidence 2233456799999999999877776689999999999999999999999988888888888888888888999999999
Q ss_pred HHhcCCCCCCCCChhhhhcCccccccC
Q 013407 246 ARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.+||+.||.+|||+.++++||||+...
T Consensus 243 ~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 243 MHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHccCChhhCCCHHHHHhChhhccCc
Confidence 999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=409.55 Aligned_cols=260 Identities=37% Similarity=0.613 Sum_probs=230.8
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3445789999999999999999999999999999999986543211 1246788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC----CeEEeecCccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSA 159 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~----~~kl~DFGla~ 159 (443)
...|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999999998888999999999999999999999999999999999999999887 79999999997
Q ss_pred ccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----C
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~ 235 (443)
.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ +
T Consensus 167 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 167 KIDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp ECCT---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred ECCC---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 6532 223445689999999999987776 4899999999999999999999999888888777776665554 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 58999999999999999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=405.09 Aligned_cols=261 Identities=36% Similarity=0.676 Sum_probs=221.3
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh-----------------------HHHHHHHHHHHH
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----------------------HKMAEQIKREVA 63 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~~~~Ei~ 63 (443)
...+++|++.+.||+|+||.||+|.+..+++.||||++.+..... ....+.+.+|+.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 456899999999999999999999999999999999997654321 112356889999
Q ss_pred HHhcCCCCCcceEEEEEEe--CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCc
Q 013407 64 TMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (443)
Q Consensus 64 il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 141 (443)
+++.++||||+++++++.+ ...+|+||||+.+++|.+.+ ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 9999999999999999986 67899999999999998754 34679999999999999999999999999999999999
Q ss_pred EEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCC--CCCchhhhhhhHHHHHHhhCCCCCCCCcH
Q 013407 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAGYLPFDDSNL 219 (443)
Q Consensus 142 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~~ 219 (443)
||++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+.
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 9999999999999999976433 2223345689999999999976542 35789999999999999999999999888
Q ss_pred HHHHHHhhcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 220 MNLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 220 ~~~~~~i~~~~~~~~--~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
......+.......| +.+++.+.+||.+||+.||.+|||+.|+++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 777777766655444 468999999999999999999999999999999963
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=416.20 Aligned_cols=259 Identities=42% Similarity=0.758 Sum_probs=217.5
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|++..+++.||||++...... .+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 4568999999999999999999999999999999999765432 246789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC--eEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~--~kl~DFGla~~~~~~~ 165 (443)
+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|.....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 99999999999999988889999999999999999999999999999999999999987765 99999999874322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH----HHHHHHhhcCccCCCC--CCCH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPP--WLSF 239 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~--~~s~ 239 (443)
.......+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+. ......+.......|. .+++
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 22334567999999999998888876669999999999999999999987543 3455556556555555 4799
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
.+.+||.+||..||.+|||+.|+++||||.+...
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 9999999999999999999999999999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=428.16 Aligned_cols=263 Identities=27% Similarity=0.498 Sum_probs=229.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 34568999999999999999999999999999999999875543333344588999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~- 228 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED- 228 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-
Confidence 999999999999999987 578999999999999999999999999999999999999999999999999999754321
Q ss_pred CCCccccccCCCcccchhhhcc----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCCCC---
Q 013407 166 DDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--- 236 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~--- 236 (443)
........+||+.|+|||++.. ...++.++|||||||++|+|++|.+||.+.+..+.+.++... .+.+|..
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 308 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence 1112334689999999999962 233358999999999999999999999999988888887543 3455543
Q ss_pred CCHHHHHHHHHhcCCCCCC--CCChhhhhcCccccc
Q 013407 237 LSFTARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~--R~t~~eil~hp~~~~ 270 (443)
+|+++++||++||..+|++ |++++|+++||||+.
T Consensus 309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 8999999999999998888 999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-52 Score=397.93 Aligned_cols=264 Identities=34% Similarity=0.711 Sum_probs=238.0
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
+.....+++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR 86 (284)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence 44556789999999999999999999999999999999999876544444456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
+..|+||||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 243 (443)
......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+......+|+.++..+++
T Consensus 167 ----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 167 ----LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241 (284)
T ss_dssp ----SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred ----cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHH
Confidence 223456799999999999887764 899999999999999999999999888888888888888888999999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 244 LIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
||.+||..||.+|||++++++||||+...
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 99999999999999999999999998644
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=445.03 Aligned_cols=260 Identities=30% Similarity=0.540 Sum_probs=238.5
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (443)
..+++|++++.||+|+||.||+|.+..+++.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4678999999999999999999999999999999999876554444567788999999988 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+.||+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--T
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--C
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999975322 2
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 246 (443)
.....+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+..++++.|......+|..+++++.+||+
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 3345677999999999999888874 899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCh-----hhhhcCccccc
Q 013407 247 RILDPNPMTRITI-----PEILEDEWFKK 270 (443)
Q Consensus 247 ~mL~~dP~~R~t~-----~eil~hp~~~~ 270 (443)
+||+.||.+||++ +||++||||+.
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 9999999999998 99999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=412.92 Aligned_cols=257 Identities=35% Similarity=0.657 Sum_probs=223.0
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH--HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
-++|++.+.||+|+||.||+|.+..+|+.||||++........ ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4689999999999999999999999999999999986543221 12467899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC---eEEeecCcccc
Q 013407 88 IVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSAL 160 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~---~kl~DFGla~~ 160 (443)
+||||+.|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998887542 35899999999999999999999999999999999999987665 99999999976
Q ss_pred cccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CC
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PW 236 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~ 236 (443)
... ........+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.. ...+..+..+.+..+ +.
T Consensus 183 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 183 LGE--SGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CCT--TSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred ecC--CCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence 543 1222345689999999999988777 489999999999999999999998864 455666666665554 35
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
++..+++||.+||..||.+|||+.++++||||+.
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 8999999999999999999999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=398.49 Aligned_cols=264 Identities=34% Similarity=0.643 Sum_probs=211.4
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
.++..+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp HHCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred ccccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 35678899999999999999999999999999999999998765444444578999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999999875 5799999999999999999999999999999999999999999999999999876443
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 243 (443)
. .......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......|..++.++.+
T Consensus 165 ~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (278)
T 3cok_A 165 P--HEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD 241 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHH
T ss_pred C--CCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHH
Confidence 2 122335679999999999987666 4889999999999999999999998776666666666667778889999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 244 LIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
||.+||..||.+|||++++++||||...
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 9999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=395.11 Aligned_cols=264 Identities=35% Similarity=0.579 Sum_probs=240.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45679999999999999999999999999999999998766555556678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+||||+.|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--c
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998764321 2
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 247 (443)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+..+.+..+.......|..+++.+.+||.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 22345679999999999987666 48999999999999999999999999888888888888888888999999999999
Q ss_pred hcCCCCCCCCChhhhhcCccccccCCC
Q 013407 248 ILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
||+.||.+|||++++++||||.....+
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HcccChhhCcCHHHHhhChheecCCcC
Confidence 999999999999999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=413.64 Aligned_cols=266 Identities=24% Similarity=0.386 Sum_probs=223.6
Q ss_pred cccccccccEEEEeEeecc--CcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 013407 4 PKIKRRVGKYEVGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G--~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 81 (443)
+......++|++++.||+| +||.||+|.+..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 3455688999999999999 9999999999999999999999875433 345678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
+.+.+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 999999999999999999999876 679999999999999999999999999999999999999999999999999876
Q ss_pred cccccc-----CCCccccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-
Q 013407 160 LSQQVR-----DDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231 (443)
Q Consensus 160 ~~~~~~-----~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~- 231 (443)
...... ........+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||.+.+.......+..+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 432211 1122334589999999999987 345 5899999999999999999999987654433332221111
Q ss_pred ---------------------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCc
Q 013407 232 ---------------------------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 266 (443)
Q Consensus 232 ---------------------------------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp 266 (443)
+.+..+++.+.+||.+||+.||.+|||+.|+++||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 13345789999999999999999999999999999
Q ss_pred ccccc
Q 013407 267 WFKKD 271 (443)
Q Consensus 267 ~~~~~ 271 (443)
||+..
T Consensus 336 ~f~~~ 340 (389)
T 3gni_B 336 FFKQI 340 (389)
T ss_dssp GGGGC
T ss_pred HHHHH
Confidence 99864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=422.29 Aligned_cols=261 Identities=27% Similarity=0.491 Sum_probs=227.3
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|..++..++||||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999875544443455688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999999999875 479999999999999999999999999999999999999999999999999997543311
Q ss_pred CCCccccccCCCcccchhhhcc-------CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCC--
Q 013407 166 DDGLLHTTCGTPNYVAPEVLND-------RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP-- 234 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~-------~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~-- 234 (443)
.......+||+.|+|||++.. ..| +.++|||||||++|+|++|.+||.+.+....+.++... ...+|
T Consensus 217 -~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 217 -TVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp -CEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred -ccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 112235689999999999973 234 58999999999999999999999999988888877653 23334
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCC---CChhhhhcCccccc
Q 013407 235 -PWLSFTARKLIARILDPNPMTR---ITIPEILEDEWFKK 270 (443)
Q Consensus 235 -~~~s~~~~~li~~mL~~dP~~R---~t~~eil~hp~~~~ 270 (443)
..+|+++++||++||. +|.+| ++++|+++||||+.
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 5699999999999999 99998 58999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=403.59 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=215.7
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.....++|++++.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 3456789999999999999999999995 589999999976432 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.|+||||+.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~- 171 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI- 171 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS-
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC-
Confidence 9999999985 788877654 4599999999999999999999999999999999999999999999999999986532
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--c-----------
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F----------- 231 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~----------- 231 (443)
........+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.... .
T Consensus 172 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 172 -PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp -CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred -CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 22234456799999999999875555699999999999999999999998876554444432210 0
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 232 -----------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 232 -----------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
...+.+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 011336789999999999999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=397.95 Aligned_cols=256 Identities=32% Similarity=0.490 Sum_probs=214.6
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++++.||+|+||.||+|.+ .+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999999 67899999999765432 22345788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||+.+ +|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence 999986 898888764 67999999999999999999999999999999999999999999999999999765321 22
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--cc---------------
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EF--------------- 231 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~--------------- 231 (443)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2345678999999999976555569999999999999999999999988776655444221 00
Q ss_pred ------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 232 ------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 232 ------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.....+++++.+||.+||..||.+|||++|+++||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 011347889999999999999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=405.84 Aligned_cols=248 Identities=21% Similarity=0.305 Sum_probs=194.6
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----EE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----KI 86 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 86 (443)
.+|.+.+.||+|+||+||+|.+ +|+.||||+++..... ......|+..+.+++|||||++++++.+.+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999997 5889999999764321 223446777778899999999999987653 68
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
||||||++||+|.+++.. .+++++.+..++.|++.||.|||++ ||+||||||+|||++.++++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999976 5699999999999999999999987 9999999999999999999999999999
Q ss_pred cccccccC--CCccccccCCCcccchhhhccCCC-----CCCchhhhhhhHHHHHHhhCCCCCCCC--------------
Q 013407 159 ALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDDS-------------- 217 (443)
Q Consensus 159 ~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~-------------- 217 (443)
+....... .......+||+.|||||++.+... ++.++|||||||+||||+||.+||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86543221 112335689999999999975421 246899999999999999997766321
Q ss_pred -cHHHHHHHhhcCc--cCCCCC-----CCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 218 -NLMNLYKKISAAE--FTCPPW-----LSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 218 -~~~~~~~~i~~~~--~~~~~~-----~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
........+.... +..|.. .+..+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2223333333332 233332 23467899999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=403.10 Aligned_cols=264 Identities=35% Similarity=0.579 Sum_probs=240.4
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34678999999999999999999999999999999998766555556778999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+||||+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--c
Confidence 99999999999999988889999999999999999999999999999999999999999999999999999765322 2
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 247 (443)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.......|..+++.+.+||.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 23345679999999999987766 48999999999999999999999998888888888888888888999999999999
Q ss_pred hcCCCCCCCCChhhhhcCccccccCCC
Q 013407 248 ILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
||+.||.+|||++++++||||+..+.+
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HccCChhHCcCHHHHhcCccccCCCcc
Confidence 999999999999999999999976654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=428.93 Aligned_cols=261 Identities=27% Similarity=0.400 Sum_probs=233.5
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999876655444457889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
|+||||+.||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999764 369999999999999999999999999999999999999999999999999997643
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC----cHHHHHHHhhcCccCCCCCCC
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWLS 238 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s 238 (443)
.. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+. ....+.+.+......+|+.++
T Consensus 341 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s 417 (543)
T 3c4z_A 341 AG--QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417 (543)
T ss_dssp TT--CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred CC--CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence 31 2223456899999999999887775 8999999999999999999999875 345677778778888889999
Q ss_pred HHHHHHHHHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 239 FTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
+.+++||.+||..||.+||+ ++++++||||+.
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 99999999999999999996 489999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=431.59 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=232.7
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 35678899999999999999999999999999999999876654444456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
|+||||+.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 99999999999999998754 499999999999999999999999999999999999999999999999999975432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc----HHHHHHHhhcCccCCCCCCCHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLSFT 240 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~ 240 (443)
.......+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+ .......+......+|..+|++
T Consensus 339 --~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 339 --GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp --TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred --CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 2334567899999999999887775 89999999999999999999998753 4556667777777788889999
Q ss_pred HHHHHHHhcCCCCCCCC-----ChhhhhcCccccc
Q 013407 241 ARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
+++||.+||..||.+|| +++|+++||||+.
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 99999999999999999 7899999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=414.49 Aligned_cols=262 Identities=29% Similarity=0.409 Sum_probs=210.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC--
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT-- 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-- 84 (443)
..+++|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 35689999999999999999999999999999999996543 23334577889999999997 999999999997544
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.+|+||||+. ++|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7999999998 589888876 57999999999999999999999999999999999999999999999999999754321
Q ss_pred -------------------cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHH
Q 013407 165 -------------------RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK 225 (443)
Q Consensus 165 -------------------~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 225 (443)
.........+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0112334568999999999998755556999999999999999999999999887776665
Q ss_pred hhcCcc-----------------------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 013407 226 ISAAEF-----------------------------------------------TCPPWLSFTARKLIARILDPNPMTRIT 258 (443)
Q Consensus 226 i~~~~~-----------------------------------------------~~~~~~s~~~~~li~~mL~~dP~~R~t 258 (443)
+..... ..+..+++++.+||.+||..||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 532100 011256889999999999999999999
Q ss_pred hhhhhcCccccccC
Q 013407 259 IPEILEDEWFKKDY 272 (443)
Q Consensus 259 ~~eil~hp~~~~~~ 272 (443)
++|+|+||||+.-.
T Consensus 323 ~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 323 ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHTTSTTTTTTC
T ss_pred HHHHhCCHHHHHhc
Confidence 99999999997543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=389.51 Aligned_cols=258 Identities=36% Similarity=0.686 Sum_probs=231.0
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 457899999999999999999999999999999999876543 3345788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC---eEEeecCccccccccc
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVR 165 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~---~kl~DFGla~~~~~~~ 165 (443)
||||+.|++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~-- 160 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-- 160 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS--
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc--
Confidence 9999999999999988889999999999999999999999999999999999999987665 99999999875432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 241 (443)
........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+..+....| ..+++.+
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 161 -SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp -SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred -CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 223345679999999999988777 4899999999999999999999999988888888877765544 3579999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+||.+||+.||.+|||+.|+++||||+..
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 999999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=410.17 Aligned_cols=260 Identities=27% Similarity=0.540 Sum_probs=229.6
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.+...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 34567899999999999999999999999999999999976432 224578899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc--CCCeEEeecCcccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQ 162 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~~~~kl~DFGla~~~~ 162 (443)
+|+||||+.||+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999999999997654 7999999999999999999999999999999999999974 4779999999998643
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCC
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLS 238 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s 238 (443)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ ..++
T Consensus 203 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 203 P---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp T---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred C---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence 2 233456689999999999987776 4899999999999999999999999888888887776655443 3579
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
+++.+||.+||..||.+|||+.++++||||+...
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 9999999999999999999999999999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=403.00 Aligned_cols=260 Identities=29% Similarity=0.458 Sum_probs=207.0
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++++.||+|+||.||+|.+..+|+.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 357899999999999999999999999999999999764421 223567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 89 VLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 999998 5999888653 359999999999999999999999999999999999999999999999999997653
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc------------
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 230 (443)
. ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 160 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 I--PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp S--CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred C--CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 2 12234456899999999999765545689999999999999999999999988776655543210
Q ss_pred ----------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 231 ----------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 231 ----------------------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
...+..++.++.+||.+||+.||.+|||++|+++||||+..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 0011246889999999999999999999999999999987553
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=408.17 Aligned_cols=254 Identities=35% Similarity=0.646 Sum_probs=222.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (443)
...++|++.+.||+|+||.||+|.+..+|+.||||++.+... ...+|+.++.++ +||||+++++++.+...+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 345789999999999999999999999999999999976542 234688888877 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC-C---CeEEeecCcccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-G---NLKVSDFGLSALSQ 162 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~---~~kl~DFGla~~~~ 162 (443)
|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+... + .+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999999999998899999999999999999999999999999999999998543 3 49999999998643
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCC---CcHHHHHHHhhcCccCCC----C
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---SNLMNLYKKISAAEFTCP----P 235 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~~----~ 235 (443)
. ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+ .+.......+..+.+..+ +
T Consensus 172 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 172 A--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp C--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred C--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 3 22345567899999999999876665 899999999999999999999986 455677778877776554 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+|.++++||++||..||.+|||+.++++||||...
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 589999999999999999999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=396.52 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=216.6
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 6799999999999999999999999999999999866432 333456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|||+.+++|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--cccc
Confidence 99999999999988888899999999999999999999999999999999999999999999999999976442 2223
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--------------------
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------- 229 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------- 229 (443)
....+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 345689999999999987555569999999999999999999999988766554433211
Q ss_pred -ccCCC----------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 230 -EFTCP----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 230 -~~~~~----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..+.+ +.++..+.+||.+||..||.+|||++|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 01111 347888999999999999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=427.46 Aligned_cols=260 Identities=36% Similarity=0.660 Sum_probs=233.0
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999998765443344678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE---ccCCCeEEeecCcccccccc
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~ 164 (443)
+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 181 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc-
Confidence 999999999999999998999999999999999999999999999999999999999 5678999999999976533
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC--C--CCCHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--P--WLSFT 240 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--~--~~s~~ 240 (443)
.......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+.......+..+.+.++ . .+|+.
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 182 --SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp --CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred --ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 233456789999999999976 45 5899999999999999999999999999888888887765443 2 38999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
+++||++||+.||.+|||+.++++||||+...
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 99999999999999999999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=389.56 Aligned_cols=257 Identities=40% Similarity=0.693 Sum_probs=231.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
+...++|++.+.||+|+||.||+|.+..++..||+|++....... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 345678999999999999999999999999999999998654322 46788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE---ccCCCeEEeecCccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 163 (443)
|+||||+.|++|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999999999888899999999999999999999999999999999999999 7889999999999875432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC----CCCH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSF 239 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~ 239 (443)
.......+||+.|+|||++.+. + +.++||||||+++|+|++|..||...+.......+..+....|. .+++
T Consensus 162 ---~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 162 ---GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ---TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred ---ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 2334566899999999998654 4 58999999999999999999999999988888888888776664 5899
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=402.98 Aligned_cols=255 Identities=36% Similarity=0.681 Sum_probs=205.4
Q ss_pred ccccEEEE---eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC
Q 013407 9 RVGKYEVG---RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT 84 (443)
Q Consensus 9 ~~~~y~~~---~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 84 (443)
...+|++. +.||+|+||.||+|.+..+|+.||||++.+.. ...+.+|+.+++.+. ||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 35678886 78999999999999999999999999997542 346778999999997 999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC---CeEEeecCccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALS 161 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~~kl~DFGla~~~ 161 (443)
..|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999999989999999999999999999999999999999999999998766 7999999999754
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc-------HHHHHHHhhcCccCCC
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKISAAEFTCP 234 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i~~~~~~~~ 234 (443)
.. ........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+ .......+..+.+.++
T Consensus 160 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 160 PP--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp CC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred CC--CCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 33 22334567899999999999887775 89999999999999999999998643 3466777777776655
Q ss_pred C----CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 235 P----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 235 ~----~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
. .+++++++||.+||..||.+|||+.++++||||+...
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 3 4899999999999999999999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=390.44 Aligned_cols=262 Identities=39% Similarity=0.689 Sum_probs=227.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.+++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 568999999999999999999999999999999999765432 245788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||||+.|++|.+.+.....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999999999887889999999999999999999999999999999999999999999999999998654433333
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhcCccCC--CCCCCHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTC--PPWLSFTARKLI 245 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~--~~~~s~~~~~li 245 (443)
.....+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.. ..+..+....... ...+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 4456789999999999988777668899999999999999999999876543 2333333332222 245899999999
Q ss_pred HHhcCCCCCCCCChhhhhcCccccccC
Q 013407 246 ARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.+||..||.+|||++++++||||+...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChh
Confidence 999999999999999999999998654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=403.67 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=213.5
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
....+++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 45678999999999999999999999999999999999976543 22345677899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc-----cCCCeEEeecCcccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-----AYGNLKVSDFGLSAL 160 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-----~~~~~kl~DFGla~~ 160 (443)
+|+||||+.| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999985 9999999988999999999999999999999999999999999999995 444599999999986
Q ss_pred cccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--cC------
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FT------ 232 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~------ 232 (443)
.... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.... ..
T Consensus 187 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 187 FGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 5432 2234456789999999999876655699999999999999999999999888776655543210 00
Q ss_pred ---CC-------------------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 233 ---CP-------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 233 ---~~-------------------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+ ..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 00 1167899999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=423.56 Aligned_cols=261 Identities=34% Similarity=0.636 Sum_probs=229.7
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH----------HHHHHHHHHHHHHhcCCCCCcceE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH----------KMAEQIKREVATMKLVKHPNVVRL 76 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv~l 76 (443)
+...++|++++.||+|+||+||+|.+..+++.||+|++.+...... ...+.+.+|+.+++.++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 4456889999999999999999999999999999999987543321 234678999999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC---CeEEe
Q 013407 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVS 153 (443)
Q Consensus 77 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~~kl~ 153 (443)
++++.+...+|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999999998888999999999999999999999999999999999999999876 69999
Q ss_pred ecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC
Q 013407 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233 (443)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 233 (443)
|||+|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+.+
T Consensus 192 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 192 DFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp CCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred ECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999986533 233456789999999999874 45 589999999999999999999999999999999988887665
Q ss_pred C----CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 234 P----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 234 ~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
+ +.+|+++++||++||..||.+|||++|+|+||||+...
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 5 45899999999999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=397.97 Aligned_cols=260 Identities=33% Similarity=0.589 Sum_probs=231.2
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
....++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4456789999999999999999999999999999999986543221 1246788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC----CeEEeecCccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSA 159 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~----~~kl~DFGla~ 159 (443)
...|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999999888899999999999999999999999999999999999999888 79999999987
Q ss_pred ccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----C
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~ 235 (443)
.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ +
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 5433 223345679999999999987766 4899999999999999999999999888888888877766554 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 58899999999999999999999999999999974
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=422.24 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=213.4
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (443)
..++|++++.||+|+||.||+|.+..+|+.||||++.+.. ......+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4689999999999999999999999999999999998653 3344567889999999999999999999999654
Q ss_pred -CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
..+|+||||+.+ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 468999999986 5666664 359999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC----------
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---------- 232 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---------- 232 (443)
. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+..+.+.++......
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 3345667899999999999988775 8999999999999999999999998877666655321100
Q ss_pred -----------------C----CCC-----------CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 233 -----------------C----PPW-----------LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 233 -----------------~----~~~-----------~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
+ |.. .++++++||.+||..||.+|||++|+|+||||+..+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 0 000 1567999999999999999999999999999987553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=422.44 Aligned_cols=262 Identities=35% Similarity=0.630 Sum_probs=230.3
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.+...++|++++.||+|+||.||+|.+..+++.||||++.+...... ....+.+|+.++++++||||+++++++.+...
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 34566899999999999999999999999999999999986543322 34678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc---cCCCeEEeecCcccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~~~~kl~DFGla~~~~ 162 (443)
+|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|....
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999999998888999999999999999999999999999999999999995 45679999999998654
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC--C--CCC
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--P--WLS 238 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--~--~~s 238 (443)
. .......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+.......+..+.+.++ . .+|
T Consensus 176 ~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 176 Q---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp C---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred C---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 3 233456689999999999975 35 5899999999999999999999999998888888887765443 2 379
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
+++++||.+||..||.+|||+.++|+||||+....
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 99999999999999999999999999999987543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=421.34 Aligned_cols=257 Identities=36% Similarity=0.647 Sum_probs=223.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++++.||+|+||.||+|.+..++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+|
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 344579999999999999999999999999999999987543222 2467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC---CCeEEeecCcccccccc
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQQV 164 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~ 164 (443)
+||||+.||+|++.+.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+|.....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~- 191 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN- 191 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT-
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC-
Confidence 999999999999999888899999999999999999999999999999999999999764 4599999999986543
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC----CCCHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFT 240 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~ 240 (443)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+.++. .+|+.
T Consensus 192 --~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 192 --QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp --TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred --CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 223456789999999999864 45 58999999999999999999999999999888888887665442 48999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+++||.+||+.||.+|||+.++|+||||+.
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 999999999999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=387.39 Aligned_cols=258 Identities=32% Similarity=0.589 Sum_probs=220.7
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.+...++|++.+.||+|+||.||+|.+..++..||+|++....... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 4556789999999999999999999999999999999998754322 35678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE---ccCCCeEEeecCcc
Q 013407 86 IFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLS 158 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~~kl~DFGla 158 (443)
.|+||||+.||+|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999998854 3679999999999999999999999999999999999999 45678999999999
Q ss_pred cccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC---C
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---P 235 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---~ 235 (443)
..... .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......+ .
T Consensus 175 ~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
T 3is5_A 175 ELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249 (285)
T ss_dssp CC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--C
T ss_pred eecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccC
Confidence 75433 223345679999999999864 44 5899999999999999999999999888777776655544332 2
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.+++.+.+||.+||+.||.+|||+.|+++||||++
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 37899999999999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=392.74 Aligned_cols=265 Identities=32% Similarity=0.617 Sum_probs=229.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh-HHHHHHHHHHHHHHhcCCCCCcceEEEEE--EeCC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVM--GSKT 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~ 84 (443)
+.+++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 45789999999999999999999999999999999998755332 23457899999999999999999999998 4556
Q ss_pred EEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
..|+||||+.++ |.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 899999999876 7677665 4579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccchhhhccCC-CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHH
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 241 (443)
............||+.|+|||++.+.. +.+.++||||||+++|+|++|..||.+.+.......+..+....+..+++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 433334445667999999999997543 3357899999999999999999999999988888888888888888999999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
.+||.+||..||.+|||+.++++||||+....
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999999999999999999987544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=417.70 Aligned_cols=260 Identities=28% Similarity=0.360 Sum_probs=200.2
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----CC
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-----KT 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~ 84 (443)
.++|++++.||+|+||.||+|.+..+|+.||||++.+.. ......+++.+|+.+|+.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999999999999999997543 233446789999999999999999999999843 36
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.+|+||||+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 7999999985 699999998889999999999999999999999999999999999999999999999999999865422
Q ss_pred cCC-------------------------CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh----------
Q 013407 165 RDD-------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA---------- 209 (443)
Q Consensus 165 ~~~-------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~---------- 209 (443)
... ......+||+.|+|||++.....++.++||||||||+|+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 111 123456899999999987544444699999999999999998
Q ss_pred -CCCCCCCCcH--------------------HHHHHHhhc--C--------------------c---------cCCCCCC
Q 013407 210 -GYLPFDDSNL--------------------MNLYKKISA--A--------------------E---------FTCPPWL 237 (443)
Q Consensus 210 -G~~Pf~~~~~--------------------~~~~~~i~~--~--------------------~---------~~~~~~~ 237 (443)
|.+||.+.+. .+....+.. + . ....+..
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 7788876541 111111100 0 0 0112346
Q ss_pred CHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
++++.+||.+||..||.+|||++|+|+||||+.-
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 8999999999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=402.27 Aligned_cols=265 Identities=30% Similarity=0.417 Sum_probs=221.6
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----- 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 82 (443)
..+++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+++.++||||+++++++.+
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 46899999999999999999999999999999999997654322 223567799999999999999999999877
Q ss_pred ---CCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 83 ---KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 83 ---~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
.+.+|+||||+.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999986 777776654 67999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCC
Q 013407 159 ALSQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236 (443)
Q Consensus 159 ~~~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (443)
....... ........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+.......++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 8654321 22234556899999999999775555699999999999999999999999988776666554322211111
Q ss_pred --------------------------------CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 237 --------------------------------LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 237 --------------------------------~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
.++.+.+||.+||..||.+|||++|+++||||+....+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 26779999999999999999999999999999875544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=400.43 Aligned_cols=256 Identities=36% Similarity=0.662 Sum_probs=209.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34567999999999999999999999999999999997643 2356889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc---CCCeEEeecCcccccccc
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~ 164 (443)
+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 203 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH- 203 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc-
Confidence 99999999999999988888999999999999999999999999999999999999975 78999999999886432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhcCccCCC----CCCCH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP----PWLSF 239 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~s~ 239 (443)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ..+..+.......+ +.++.
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 204 --QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp -----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred --ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 223446789999999999987766 48999999999999999999999876544 35666666554332 34789
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
++.+||.+||..||.+|||+.++++||||....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999999999999998643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=399.49 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=212.1
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++++.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 57899999999999999999999999999999999754321 1122456799999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||+.| +|.+.+...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence 999985 8888887654 599999999999999999999999999999999999999999999999999875432 222
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-----------------
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------------- 231 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------------- 231 (443)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 334567899999999998755556899999999999999999999999887766555432100
Q ss_pred -------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 232 -------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 232 -------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
..++.+++++.+||.+||+.||.+|||++|+++||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 01124688999999999999999999999999999998644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=393.82 Aligned_cols=260 Identities=29% Similarity=0.422 Sum_probs=213.3
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh--HHHHHHHHHHHHHHhcCC---CCCcceEEEEEEe
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVK---HPNVVRLYEVMGS 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~ 82 (443)
...++|++.+.||+|+||+||+|.+..+|+.||||++....... ......+.+|+.+++.++ ||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34689999999999999999999999999999999997543211 111235667777777764 9999999999977
Q ss_pred CC-----EEEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeec
Q 013407 83 KT-----KIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 83 ~~-----~~~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DF 155 (443)
.. .+++||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 55 5899999997 599999987654 999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc--C-
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--T- 232 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~- 232 (443)
|++..... .......+||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.+.......+..... .
T Consensus 165 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 165 GLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccccCC---CcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99975432 2334567899999999999887774 899999999999999999999999887776665532110 0
Q ss_pred ------------------------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 233 ------------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 233 ------------------------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
..+.+++.+.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1134788999999999999999999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=404.12 Aligned_cols=255 Identities=31% Similarity=0.517 Sum_probs=224.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH-----HHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-----KMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
...++|++.+.||+|+||.||+|.+..+++.||||++.+...... .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 345789999999999999999999999999999999987543221 123457789999999999999999999999
Q ss_pred CCEEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 83 KTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 83 ~~~~~lv~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
.+.+|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999766 99999999889999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHH
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 241 (443)
.. .......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .........|..+++++
T Consensus 181 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKEL 251 (335)
T ss_dssp CT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHH
T ss_pred CC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHH
Confidence 32 2334567899999999999988887789999999999999999999997633 22334455666789999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+||.+||+.||.+|||++++++||||+..
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=409.89 Aligned_cols=262 Identities=27% Similarity=0.391 Sum_probs=211.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (443)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+++.+|+.+++.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 4578999999999999999999999999999999997643 3334567899999999999999999999999776
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 67999999987 59999999888899999999999999999999999999999999999999999999999999986543
Q ss_pred ccCC--------------------CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhC-----------CC
Q 013407 164 VRDD--------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-----------YL 212 (443)
Q Consensus 164 ~~~~--------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G-----------~~ 212 (443)
.... ......+||+.|+|||++.....++.++|||||||++|+|++| .+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2211 2246678999999999975545456999999999999999984 45
Q ss_pred CCCCCcH-----------------HHHHHHh------------------------hcCccCC-------CCCCCHHHHHH
Q 013407 213 PFDDSNL-----------------MNLYKKI------------------------SAAEFTC-------PPWLSFTARKL 244 (443)
Q Consensus 213 Pf~~~~~-----------------~~~~~~i------------------------~~~~~~~-------~~~~s~~~~~l 244 (443)
+|.+.+. .+....+ ....... .+.+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 5544321 1111111 1111111 13579999999
Q ss_pred HHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 245 IARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
|.+||..||.+|||++|+|+||||+.-.
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=398.81 Aligned_cols=258 Identities=34% Similarity=0.602 Sum_probs=227.1
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh-----hhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (443)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 4689999999999999999999998999999999976431 1223456788999999999 799999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
+..|+||||+.|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999875433
Q ss_pred ccCCCccccccCCCcccchhhhccC-----CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---- 234 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---- 234 (443)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+.+.......+..+.+..+
T Consensus 253 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 253 ---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred ---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 2334567899999999998632 1235889999999999999999999999888887777777665543
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 235 ~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..++..+.+||.+||..||.+|||+.++++||||++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 357899999999999999999999999999999973
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=390.07 Aligned_cols=254 Identities=28% Similarity=0.483 Sum_probs=222.7
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
.|...+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 488889999999999999999999999999999764422 24678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
|+.|++|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--ccccc
Confidence 9999999998764 57999999999999999999999999999999999999999999999999998764331 22234
Q ss_pred cccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCHHHHHHHHHh
Q 013407 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARI 248 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~m 248 (443)
..+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+..... ..+..+++.+.+||.+|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 56899999999999877664 899999999999999999999998887777666655432 23345789999999999
Q ss_pred cCCCCCCCCChhhhhcCccccccC
Q 013407 249 LDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 249 L~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
|+.||.+|||+.++++||||....
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999998643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=392.83 Aligned_cols=261 Identities=32% Similarity=0.571 Sum_probs=217.9
Q ss_pred ccccccEEEE-eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 013407 7 KRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (443)
Q Consensus 7 ~~~~~~y~~~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (443)
+...++|++. +.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++++ +||||+++++++.+.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 4556789995 789999999999999999999999999976432 2346788999999885 7999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC---eEEeecCccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALS 161 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~---~kl~DFGla~~~ 161 (443)
.+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999999988889999999999999999999999999999999999999998776 999999998754
Q ss_pred ccccC-----CCccccccCCCcccchhhhcc-----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCc-------------
Q 013407 162 QQVRD-----DGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSN------------- 218 (443)
Q Consensus 162 ~~~~~-----~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~------------- 218 (443)
..... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 32111 112335679999999999864 234 488999999999999999999998753
Q ss_pred --HHHHHHHhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 219 --LMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 219 --~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
....+..+..+...+| ..+++.+++||.+||..||.+|||+.|+++||||+..
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2345666766766665 3589999999999999999999999999999999853
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=407.86 Aligned_cols=255 Identities=35% Similarity=0.628 Sum_probs=210.9
Q ss_pred ccccccEEEE-eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEe--
Q 013407 7 KRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGS-- 82 (443)
Q Consensus 7 ~~~~~~y~~~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~-- 82 (443)
+..+++|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 4567889987 6899999999999999999999999999642 2466788887 45589999999999876
Q ss_pred --CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc---CCCeEEeec
Q 013407 83 --KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDF 155 (443)
Q Consensus 83 --~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~~kl~DF 155 (443)
...+|+||||+.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 677999999999999999998754 5999999999999999999999999999999999999998 788999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH----HHHHHhhcCcc
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAEF 231 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~ 231 (443)
|++..... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+.. .....+..+.+
T Consensus 209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred ccccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 99975432 2334577899999999999877775 8999999999999999999999865432 23445555555
Q ss_pred CCC----CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 232 TCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 232 ~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
.++ ..++.++++||++||..||.+|||+.++++||||.....
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 444 348999999999999999999999999999999986543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=402.93 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=214.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (443)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+++.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 3578999999999999999999999999999999996643 2344567899999999999999999999999765
Q ss_pred -CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
..+|+||||+ |++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3469999999 7899988876 679999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-----------
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------- 231 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 231 (443)
. .....+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+.....
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 234568999999999998744446899999999999999999999999887666555432110
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 232 --------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 232 --------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
...+..++.+.+||.+||..||.+|||++++++||||....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 12245689999999999999999999999999999998644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=396.75 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=220.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
-..+++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 3578999999999999999999999999999999999876432 333456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 999999999999888887888999999999999999999999999999999999999999999999999999754332
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC-----------------
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA----------------- 229 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------- 229 (443)
.......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 223445679999999999987655568999999999999999999999988766544433211
Q ss_pred --ccCC------------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 230 --EFTC------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 230 --~~~~------------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.... .+.+++.+.+||.+||+.||.+|||+.|+++||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0011 1247899999999999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=398.30 Aligned_cols=264 Identities=34% Similarity=0.558 Sum_probs=221.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhh--hHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
..-++|++.+.||+|+||.||+|.+..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 4457899999999999999999999999999999999876432 23345789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 013407 86 IFIVLEFVTGGELFDKIVN----------------------------------------HGRMKEDEARRYFQQLINAVD 125 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~~~~qi~~aL~ 125 (443)
.|+||||++||+|.+.+.. ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999998852 112467889999999999999
Q ss_pred HHHHCCcEeeeCCCCcEEEccCC--CeEEeecCcccccccccCCC--ccccccCCCcccchhhhccC-CCCCCchhhhhh
Q 013407 126 YCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDDG--LLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSC 200 (443)
Q Consensus 126 ~LH~~givHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSl 200 (443)
|||++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++.+. ...+.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 89999999998654322221 23466799999999999652 334589999999
Q ss_pred hHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 201 GVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 201 Gvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
||++|+|++|..||.+.+.......+......++. .+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 99999999999999998888777777665543332 378999999999999999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=395.76 Aligned_cols=266 Identities=24% Similarity=0.418 Sum_probs=222.9
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT- 84 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 84 (443)
.....++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 3456789999999999999999999999999999999998766555666778999999999999999999999987654
Q ss_pred ---EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 85 ---KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 85 ---~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
..|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 35999999999999999988889999999999999999999999999999999999999999999999999999765
Q ss_pred ccccCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC----CCC
Q 013407 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPW 236 (443)
Q Consensus 162 ~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~ 236 (443)
...... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+....... ++.
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 432211 223346799999999999887764 89999999999999999999999988776655554443322 234
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
++.++.+||.+||+.||.+||+..+++.|+|++...
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 899999999999999999999999999999997543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=383.03 Aligned_cols=263 Identities=32% Similarity=0.522 Sum_probs=228.3
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh------hhHHHHHHHHHHHHHHhcCC-CCCcceEEE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV------LKHKMAEQIKREVATMKLVK-HPNVVRLYE 78 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~ 78 (443)
.....++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+.+++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 34567899999999999999999999999999999999975431 11234567889999999995 999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 79 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
++.+....|+||||+.+++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999999998889999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccchhhhcc-----CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 233 (443)
..... .......+||+.|+|||++.+ ....+.++||||||+++|+|++|..||.+.+.......+..+....
T Consensus 172 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 172 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 75432 223445679999999999852 2223589999999999999999999999988887777777665544
Q ss_pred C----CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 234 P----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 234 ~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+ +.++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 3 2478999999999999999999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=383.13 Aligned_cols=257 Identities=36% Similarity=0.649 Sum_probs=225.1
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
-++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3689999999999999999999999999999999986543221 1246789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC----CeEEeecCcccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQ 162 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~----~~kl~DFGla~~~~ 162 (443)
|+||||+.+++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888899999999999999999999999999999999999998877 89999999987543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCC
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLS 238 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s 238 (443)
. ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+ +.++
T Consensus 164 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 164 A---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred C---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 3 222345679999999999987766 4899999999999999999999999888888777776665544 4578
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 239 FTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..+.+||.+||..||.+|||+.++++||||+.
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=388.17 Aligned_cols=256 Identities=36% Similarity=0.684 Sum_probs=226.4
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 4557899999999999999999999999999999999764322 2356889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE---ccCCCeEEeecCcccccccc
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~ 164 (443)
+||||+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 999999999999999888899999999999999999999999999999999999999 7789999999999875322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFT 240 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 240 (443)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+..+...++ +.+++.
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 162 ---GIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp ---BTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred ---CccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 233456799999999999876664 899999999999999999999999888888888877655433 457999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+.+||.+||..||.+|||+.++++||||+..
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=398.23 Aligned_cols=265 Identities=28% Similarity=0.407 Sum_probs=214.4
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh--HHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
.++...++|++++.||+|+||.||+|.+..+|+.||||++....... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 35567899999999999999999999999999999999997643221 1123467899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
.+..|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999999986 888888654 46899999999999999999999999999999999999999999999999999865
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccC---C---
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT---C--- 233 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~---~--- 233 (443)
.. ........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+..+... ... .
T Consensus 163 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 163 GS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TS--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred cC--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 33 2233456789999999999976554568999999999999999999999998877666655321 000 0
Q ss_pred --------------------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 234 --------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 234 --------------------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.+.++.++.+||.+||..||.+|||+.|+++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 034578999999999999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=395.31 Aligned_cols=251 Identities=25% Similarity=0.423 Sum_probs=215.5
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----CCCcceEEEEEEe
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----HPNVVRLYEVMGS 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~~~~ 82 (443)
..-++|++.+.||+|+||.||+|.+..+++.||||++.... .......+|+.+++.+. ||||+++++++..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 34578999999999999999999999999999999997432 23456778999999996 9999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc--------------
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------------- 146 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-------------- 146 (443)
.+..|+||||+ |++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 899999998754 5999999999999999999999999999999999999975
Q ss_pred -----------CCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCC
Q 013407 147 -----------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (443)
Q Consensus 147 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~ 215 (443)
++.+||+|||+|..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCCC
Confidence 78999999999975332 23456799999999999887775 89999999999999999999999
Q ss_pred CCcHHHHHHHhhcCccCCCC----------------------------------------------CCCHHHHHHHHHhc
Q 013407 216 DSNLMNLYKKISAAEFTCPP----------------------------------------------WLSFTARKLIARIL 249 (443)
Q Consensus 216 ~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~s~~~~~li~~mL 249 (443)
+.+..+....+.....+.|. ..++.+.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 88776655554332222211 12367789999999
Q ss_pred CCCCCCCCChhhhhcCcccc
Q 013407 250 DPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 250 ~~dP~~R~t~~eil~hp~~~ 269 (443)
+.||.+|||+.|+|+||||+
T Consensus 341 ~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 341 QIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGC
T ss_pred cCChhhCCCHHHHhcCcccC
Confidence 99999999999999999995
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=401.41 Aligned_cols=253 Identities=32% Similarity=0.554 Sum_probs=217.4
Q ss_pred ccEEE--EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 11 GKYEV--GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 11 ~~y~~--~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
+.|.+ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34555 6789999999999999999999999999986543 234678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE--ccCCCeEEeecCccccccccc
Q 013407 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~ 165 (443)
||||++|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~-- 241 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-- 241 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT--
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC--
Confidence 99999999999988654 469999999999999999999999999999999999999 5567899999999986533
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 241 (443)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ +.+++++
T Consensus 242 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 242 -REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp -TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred -ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 223445679999999999976655 5899999999999999999999999988888888776655444 3589999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
++||.+||..||.+|||+.|+++||||+.
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=394.70 Aligned_cols=265 Identities=25% Similarity=0.426 Sum_probs=217.7
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEe
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGS 82 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~ 82 (443)
.+...-++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+++.++| |||+++++++.+
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 34556778999999999999999999984 688999999986543 23345789999999999976 999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
...+|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 81 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 81 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred CCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999999999 55789999999999999999999999999999999999999999999999997 5889999999998654
Q ss_pred cccCCCccccccCCCcccchhhhcc----------CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH-HHHHHHhhc--C
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLND----------RGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISA--A 229 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~----------~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~--~ 229 (443)
...........+||+.|+|||++.+ ....+.++|||||||++|+|++|..||..... ......+.. .
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 4333333456789999999999864 13335889999999999999999999987433 233333332 3
Q ss_pred ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 230 EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 230 ~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
...+|...+..+.+||.+||+.||.+|||+.++++||||+....
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 44567778899999999999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=385.32 Aligned_cols=259 Identities=22% Similarity=0.390 Sum_probs=219.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.-++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 44689999999999999999999999999999999976655555667889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 167 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LT 167 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-cc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999997654321 12
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-----CCCCCCCHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-----TCPPWLSFTARK 243 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~s~~~~~ 243 (443)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......+...... ..++.+++.+.+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp -------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred ccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 2344679999999999988776 4889999999999999999999999887665444433322 234568999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 244 LIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
+|.+||..||.+||+..+.+.+.|..
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999999999999777777776643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=401.06 Aligned_cols=260 Identities=25% Similarity=0.427 Sum_probs=217.4
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC--CCCcceEEEEEEeCCEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--HPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~ 86 (443)
.-.+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999865 88999999987543 3345678999999999996 59999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999 56789999999988999999999999999999999999999999999999996 58999999999986544322
Q ss_pred CCccccccCCCcccchhhhccC----------CCCCCchhhhhhhHHHHHHhhCCCCCCCCcH-HHHHHHhhcC--ccCC
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDR----------GYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAA--EFTC 233 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~----------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~--~~~~ 233 (443)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||..... ......+... ...+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 2234567899999999998652 2345899999999999999999999987533 3344444433 3456
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 234 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 234 ~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
|.+.+..+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 778899999999999999999999999999999998654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=392.99 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=221.6
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
.+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999997654444445678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||+. |+|.+.+. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9998 57877775 456799999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCCcccchhhhc---cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC--CCCCCCHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPPWLSFTARKL 244 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~l 244 (443)
....+||+.|+|||++. ...+ +.++|||||||++|+|++|..||.+.+.......+.....+ .+..++..+.+|
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 23467999999999985 3344 58999999999999999999999988776665555444322 234589999999
Q ss_pred HHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 245 IARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
|.+||+.||.+|||++++++||||.....
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 99999999999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=394.41 Aligned_cols=260 Identities=25% Similarity=0.433 Sum_probs=219.7
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----C
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 84 (443)
-++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 359999999999999999999999999999999997533 233457889999999999999999999999665 4
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
..|+||||+.| +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 78999999985 89988876 56999999999999999999999999999999999999999999999999999865443
Q ss_pred cC-CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc------------
Q 013407 165 RD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------ 231 (443)
Q Consensus 165 ~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------ 231 (443)
.. .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 22 22345668999999999986655456899999999999999999999998776555444321100
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 232 -------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 232 -------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
...+.+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 011447899999999999999999999999999999987543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=378.39 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=215.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (443)
...++|++.+.||+|+||.||+|.+..+++.||+|++........ ....+.+|+..+..+ +||||+++++++.+.+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 346789999999999999999999999999999999986543332 356788899999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC---------------
Q 013407 87 FIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--------------- 147 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~--------------- 147 (443)
|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999764 679999999999999999999999999999999999999854
Q ss_pred ----CCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHH
Q 013407 148 ----GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223 (443)
Q Consensus 148 ----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~ 223 (443)
..+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--- 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred cCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence 4799999999875432 123469999999999987655557999999999999999999887655432
Q ss_pred HHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 224 KKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 224 ~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
..+..+. ...|..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 3333333 35667799999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=387.57 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=205.2
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEeCCEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
++|++.+.||+|+||+||+|.+..+|+.||||++.......... .....|+..+ +..+||||+++++++.+.+..|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 67999999999999999999999999999999986543333333 3344455554 444999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||+ +++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---CC
Confidence 9999 66888887654 4699999999999999999999999999999999999999999999999999875432 22
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc--CCCCCCCHHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--TCPPWLSFTARKLIA 246 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~~li~ 246 (443)
.....+||+.|+|||++.+ .+ +.++||||+||++|+|++|..|+.+... +..+..+.. ..+..+++.+.+||.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred CCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHH
Confidence 3345679999999999876 45 5899999999999999999776655433 223332222 234568999999999
Q ss_pred HhcCCCCCCCCChhhhhcCccccc
Q 013407 247 RILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 247 ~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+||+.||.+|||++++++||||++
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=407.47 Aligned_cols=258 Identities=36% Similarity=0.652 Sum_probs=210.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh-----HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
..++|++.+.||+|+||.||+|.+..+++.||||++.+..... ......+.+|+.++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3578999999999999999999999999999999998765321 1223358899999999999999999999864
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC---CeEEeecCcccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSAL 160 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~~kl~DFGla~~ 160 (443)
...|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 55899999999999999998888999999999999999999999999999999999999997654 599999999986
Q ss_pred cccccCCCccccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhcCccCCC---
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP--- 234 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~--- 234 (443)
... .......+||+.|+|||++.+ ....+.++|||||||++|+|++|.+||.+.... .....+..+....+
T Consensus 292 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 292 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp CC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred cCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 532 233456789999999999853 222347899999999999999999999865432 34455555555443
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 235 -PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 235 -~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 347999999999999999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=377.94 Aligned_cols=256 Identities=25% Similarity=0.469 Sum_probs=219.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----C
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----K 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~ 83 (443)
..-..|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 3445699999999999999999999999999999999865543 3346789999999999999999999999865 4
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeeCCCCcEEEc-cCCCeEEeecCcccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLD-AYGNLKVSDFGLSAL 160 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 160 (443)
..+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 678999999999999999998889999999999999999999999999 99999999999998 789999999999865
Q ss_pred cccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc-HHHHHHHhhcCcc--CCCCCC
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAAEF--TCPPWL 237 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~--~~~~~~ 237 (443)
.. .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.... .......+..+.. ..+...
T Consensus 182 ~~----~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (290)
T 1t4h_A 182 KR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp CC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred cc----ccccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCC
Confidence 32 223445679999999999874 34 589999999999999999999998744 4455555544422 334557
Q ss_pred CHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 889999999999999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=391.00 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=210.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--- 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 84 (443)
..+++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 45689999999999999999999999999999999997644 2234578999999999999999999999985543
Q ss_pred ------------------------------------------------------EEEEEEeccCCCchHHHHHhCCC---
Q 013407 85 ------------------------------------------------------KIFIVLEFVTGGELFDKIVNHGR--- 107 (443)
Q Consensus 85 ------------------------------------------------------~~~lv~E~~~gg~L~~~i~~~~~--- 107 (443)
..|+||||+.|++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987653
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC----------CccccccCCC
Q 013407 108 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD----------GLLHTTCGTP 177 (443)
Q Consensus 108 l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~ 177 (443)
.++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ......+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 456678999999999999999999999999999999999999999999999865432111 1234467999
Q ss_pred cccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC-CCCCCHHHHHHHHHhcCCCCCCC
Q 013407 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSFTARKLIARILDPNPMTR 256 (443)
Q Consensus 178 ~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~s~~~~~li~~mL~~dP~~R 256 (443)
.|+|||++.+..+ +.++|||||||++|+|++|..|+.. .......+.....+. +...++.+.+||.+||+.||.+|
T Consensus 241 ~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 9999999988777 4899999999999999999877532 122233333332211 12357889999999999999999
Q ss_pred CChhhhhcCccccc
Q 013407 257 ITIPEILEDEWFKK 270 (443)
Q Consensus 257 ~t~~eil~hp~~~~ 270 (443)
||+.|+++||||+.
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=398.09 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=210.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----- 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 82 (443)
...++|++++.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 456799999999999999999999999999999999865432 23479999999999999999999843
Q ss_pred ---------------------------------CCEEEEEEeccCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHH
Q 013407 83 ---------------------------------KTKIFIVLEFVTGGELFDKI----VNHGRMKEDEARRYFQQLINAVD 125 (443)
Q Consensus 83 ---------------------------------~~~~~lv~E~~~gg~L~~~i----~~~~~l~e~~~~~~~~qi~~aL~ 125 (443)
...+++||||+.| +|.+.+ ...+.+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 665555 44678999999999999999999
Q ss_pred HHHHCCcEeeeCCCCcEEEc-cCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHH
Q 013407 126 YCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 204 (443)
Q Consensus 126 ~LH~~givHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil 204 (443)
|||++||+||||||+|||++ .++.+||+|||+|..... .......+||+.|+|||++.+....+.++||||+||++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999999998 678999999999985433 23344567899999999998766556999999999999
Q ss_pred HHHhhCCCCCCCCcHHHHHHHhhcC-----------------cc------------CCCCCCCHHHHHHHHHhcCCCCCC
Q 013407 205 FVLLAGYLPFDDSNLMNLYKKISAA-----------------EF------------TCPPWLSFTARKLIARILDPNPMT 255 (443)
Q Consensus 205 ~~ll~G~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~s~~~~~li~~mL~~dP~~ 255 (443)
|+|++|.+||.+.+..+....+... .. .+|..+++++.+||.+||..||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999998877655554321 00 134457889999999999999999
Q ss_pred CCChhhhhcCccccc
Q 013407 256 RITIPEILEDEWFKK 270 (443)
Q Consensus 256 R~t~~eil~hp~~~~ 270 (443)
|||+.|+++||||+.
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=397.77 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=209.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 84 (443)
..++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 56899999999999999999999999999999999976432 3344677889999999999999999999997665
Q ss_pred --EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 85 --~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
.+|+||||+.| +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999985 7888875 469999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC---------
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--------- 233 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 233 (443)
. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+.......
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 2234456899999999999887775 89999999999999999999999988776666554321100
Q ss_pred ---------------------------CC------CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 234 ---------------------------PP------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 234 ---------------------------~~------~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
|. ..+..+++||.+||..||.+|||++|+++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 00 0156789999999999999999999999999998644
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=380.65 Aligned_cols=261 Identities=33% Similarity=0.548 Sum_probs=226.4
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCC
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--SKT 84 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~ 84 (443)
+...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 35688999999999999999999999999999999999865432 334678999999999999999999999874 467
Q ss_pred EEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeeeCCCCcEEEccCCCeEEeec
Q 013407 85 KIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NILl~~~~~~kl~DF 155 (443)
..|+||||++|++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 899999999999999998753 34999999999999999999999999 999999999999999999999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCC
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCP 234 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~ 234 (443)
|++...... .......+||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+..+.. ..|
T Consensus 161 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 161 GLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237 (279)
T ss_dssp CHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC
T ss_pred chheeeccc--cccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC
Confidence 998764321 1122346799999999999877664 899999999999999999999999888887777777655 566
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 235 ~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
..++.++.++|.+||+.||.+|||+.++++|+|+..+
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 6789999999999999999999999999999999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=395.93 Aligned_cols=262 Identities=31% Similarity=0.550 Sum_probs=224.0
Q ss_pred cccccEEEEeEeeccCcEEEEEEEEC---CCCceEEEEEeechhhh-hHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (443)
..+++|++.+.||+|+||.||+|++. .+++.||||++.+.... .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 45689999999999999999999984 58899999999764321 111234577899999999 69999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
...+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccchhhhccC-CCCCCchhhhhhhHHHHHHhhCCCCCCCC----cHHHHHHHhhcCccCCCCCC
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWL 237 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~ 237 (443)
... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ........+.......|+.+
T Consensus 211 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 211 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 221 1223456899999999999753 23358899999999999999999999743 33455566666677788889
Q ss_pred CHHHHHHHHHhcCCCCCCCC-----ChhhhhcCccccc
Q 013407 238 SFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
+..+.+||.+||..||.+|| |++++++||||+.
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 99999999999999999999 9999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=398.05 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=201.5
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (443)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3479999999999999999999999999999999997643 2333467888999999999999999999998654
Q ss_pred -CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
..+|+||||+ +++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 6899888865 679999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc------------
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 230 (443)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 23456899999999999874555689999999999999999999999988766555443210
Q ss_pred -----------cCC--------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 231 -----------FTC--------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 231 -----------~~~--------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
... .+..++.+.+||.+||..||.+|||+.++|+||||....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 000 124678999999999999999999999999999998644
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=385.42 Aligned_cols=261 Identities=28% Similarity=0.440 Sum_probs=216.8
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
.......++|++.+.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 44556778999999999999999999987 5788999999765432 33457789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--cEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
...|+||||+.||+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999987654 999999999999999999999999 999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhh--cCccCCCCC
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS--AAEFTCPPW 236 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~ 236 (443)
...... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+. ......|..
T Consensus 187 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 187 RLKAST--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred cccccc--ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 754321 122345679999999999988776 489999999999999999999999988777666653 345667788
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhc--Cccccc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILE--DEWFKK 270 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~--hp~~~~ 270 (443)
+++.+.+||.+||..||.+|||+.++++ +++++.
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999987 455544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=387.09 Aligned_cols=258 Identities=31% Similarity=0.528 Sum_probs=221.4
Q ss_pred ccccEEEE-eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 013407 9 RVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 9 ~~~~y~~~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (443)
.-++|.+. +.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.+ +||||+++++++.+....
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 34578887 89999999999999999999999999998654322 2346788999999999 569999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc---CCCeEEeecCccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALS 161 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~~kl~DFGla~~~ 161 (443)
|+||||+.||+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999999998553 67999999999999999999999999999999999999988 789999999999865
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCC
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWL 237 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 237 (443)
.. .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+.......+ +.+
T Consensus 185 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 260 (327)
T 3lm5_A 185 GH---ACELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260 (327)
T ss_dssp ------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred CC---ccccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhccc
Confidence 33 2223456899999999999877764 899999999999999999999999888877777665544333 348
Q ss_pred CHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 8999999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=392.27 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=219.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 34678999999999999999999999999999999997643 2334678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+||||++|++|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999999999888999999999999999999999996 9999999999999999999999999998754332
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHH---------------------
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK--------------------- 225 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~--------------------- 225 (443)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 22346799999999999887664 899999999999999999999987665433221
Q ss_pred ---------------------hhcCcc-CCC-CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 226 ---------------------ISAAEF-TCP-PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 226 ---------------------i~~~~~-~~~-~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+..... ..+ ..++.++.+||.+||+.||.+|||++++++||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 111111 111 237889999999999999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=378.48 Aligned_cols=260 Identities=23% Similarity=0.377 Sum_probs=205.4
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
+....++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.++...++.++||||+++++++.+.+.
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 35677899999999999999999999999999999999976432 22234455666667889999999999999999999
Q ss_pred EEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 86 IFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
.|+||||+.| +|.+.+. ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999999985 7766654 356899999999999999999999998 999999999999999999999999999876
Q ss_pred cccccCCCccccccCCCcccchhhhc---cCCCCCCchhhhhhhHHHHHHhhCCCCCCCC-cHH-HHHHHhhcCccCCC-
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLM-NLYKKISAAEFTCP- 234 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~-~~~~~i~~~~~~~~- 234 (443)
... .......+||+.|+|||++. .....+.++||||+||++|+|++|..||... ... .....+.......+
T Consensus 160 ~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 160 LVD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred ccc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 433 22233457999999999972 2233358999999999999999999999863 333 33333443333333
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 235 ~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 458999999999999999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=406.89 Aligned_cols=251 Identities=16% Similarity=0.203 Sum_probs=207.2
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHH---HHhcCCCCCcceEE-------
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA---TMKLVKHPNVVRLY------- 77 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~---il~~l~hpnIv~l~------- 77 (443)
...++|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+. +++.++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 34578999999999999999999999999999999998654444455678999994 55555899999998
Q ss_pred EEEEeCCE-----------------EEEEEeccCCCchHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHCCcE
Q 013407 78 EVMGSKTK-----------------IFIVLEFVTGGELFDKIVNHGRMKE-------DEARRYFQQLINAVDYCHSRGVY 133 (443)
Q Consensus 78 ~~~~~~~~-----------------~~lv~E~~~gg~L~~~i~~~~~l~e-------~~~~~~~~qi~~aL~~LH~~giv 133 (443)
+++.+.+. .|+||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 77776643 89999999 6799999987665665 78888999999999999999999
Q ss_pred eeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccC-----------CCCCCchhhhhhhH
Q 013407 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-----------GYDGSTADLWSCGV 202 (443)
Q Consensus 134 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-----------~~~~~~~DIwSlGv 202 (443)
||||||+|||++.++.+||+|||+|... .......+| +.|+|||++.+. .| +.++|||||||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~ 301 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGL 301 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHH
Confidence 9999999999999999999999998742 223456678 999999999876 55 58999999999
Q ss_pred HHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 203 ILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 203 il~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
++|+|++|..||.+.+.......+. ..++.+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999998765443333332 234568999999999999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=400.10 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=213.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC------CCCCcceEEEEEEe
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV------KHPNVVRLYEVMGS 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~~ 82 (443)
...+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 3468999999999999999999999999999999997543 2345677788888777 57899999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC--eEEeecCcc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLS 158 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~--~kl~DFGla 158 (443)
...+|+||||+. ++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999996 59999987654 5999999999999999999999999999999999999999987 999999998
Q ss_pred cccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC------
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT------ 232 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------ 232 (443)
.... ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 250 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 250 CYEH-----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp EETT-----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eecC-----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 6432 23446789999999999988777 48999999999999999999999988876655443211000
Q ss_pred -----------------------------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 013407 233 -----------------------------------------------------CPPWLSFTARKLIARILDPNPMTRITI 259 (443)
Q Consensus 233 -----------------------------------------------------~~~~~s~~~~~li~~mL~~dP~~R~t~ 259 (443)
.+...++.+.+||.+||+.||.+|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 001236789999999999999999999
Q ss_pred hhhhcCccccccCC
Q 013407 260 PEILEDEWFKKDYK 273 (443)
Q Consensus 260 ~eil~hp~~~~~~~ 273 (443)
+|+|+||||+....
T Consensus 404 ~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 404 GQALRHPWLRRRLP 417 (429)
T ss_dssp HHHHTSTTTC----
T ss_pred HHHhCChhhccCCC
Confidence 99999999987543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=394.03 Aligned_cols=257 Identities=24% Similarity=0.501 Sum_probs=226.2
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHH--------------HHHHHHHHHHHHhcCCCCCc
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK--------------MAEQIKREVATMKLVKHPNV 73 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~hpnI 73 (443)
..+++|++.+.||+|+||.||+|.+ +|+.||||++......... ..+.+.+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 4568999999999999999999999 8999999999875443211 12678999999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEE
Q 013407 74 VRLYEVMGSKTKIFIVLEFVTGGELFDK------IVN--HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLL 144 (443)
Q Consensus 74 v~l~~~~~~~~~~~lv~E~~~gg~L~~~------i~~--~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl 144 (443)
+++++++.+.+..|+||||+.||+|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+||++
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999988 655 5679999999999999999999999 999999999999999
Q ss_pred ccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccC-CCCCCchhhhhhhHHHHHHhhCCCCCCCCcH-HHH
Q 013407 145 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNL 222 (443)
Q Consensus 145 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~ 222 (443)
+.++.+||+|||++..... .......||+.|+|||++.+. .+.+.++|||||||++|+|++|..||...+. ...
T Consensus 186 ~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred cCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9999999999999876432 134456799999999999876 4543489999999999999999999998776 677
Q ss_pred HHHhhcCccCCC-------------------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 223 YKKISAAEFTCP-------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 223 ~~~i~~~~~~~~-------------------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
...+..+....| +.+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 777777766666 568999999999999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=385.75 Aligned_cols=258 Identities=36% Similarity=0.663 Sum_probs=214.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhh-----hHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
..++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 447899999999999999999999999999999999765431 112234688999999999999999999999766
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC---eEEeecCcccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSAL 160 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~---~kl~DFGla~~ 160 (443)
. .|+||||+.|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 5 8999999999999999988889999999999999999999999999999999999999987665 99999999875
Q ss_pred cccccCCCccccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhcCccCCC---
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP--- 234 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~--- 234 (443)
... .......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...... .....+..+.....
T Consensus 167 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 167 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 432 222345679999999999842 233358999999999999999999999765432 33444444444332
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 235 -PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 235 -~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..++..+.+||.+||..||.+|||++++++||||+.
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 357899999999999999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=384.84 Aligned_cols=264 Identities=28% Similarity=0.432 Sum_probs=218.0
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK- 83 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 83 (443)
......++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 33455689999999999999999999999999999999996432 233456788999999999999999999998654
Q ss_pred ----CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 84 ----TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 84 ----~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
...|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 67999999997 589888876 579999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCC--------CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--
Q 013407 160 LSQQVRDD--------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-- 229 (443)
Q Consensus 160 ~~~~~~~~--------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-- 229 (443)
........ ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 65432111 11234579999999999876455568999999999999999999999988765544332110
Q ss_pred c------------------------c------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 230 E------------------------F------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 230 ~------------------------~------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
. . ..++.+++++.+||.+||..||.+|||+.++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0 0 01135789999999999999999999999999999998644
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=384.62 Aligned_cols=251 Identities=25% Similarity=0.451 Sum_probs=211.2
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEe--CCE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS--KTK 85 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 85 (443)
..++|++++.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+++.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 4578999999999999999999999999999999997432 356889999999997 9999999999988 678
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-CeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 164 (443)
.++||||+.+++|.+.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~- 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT-
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC-
Confidence 999999999999998874 489999999999999999999999999999999999999777 899999999975433
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC-cHHHHHHH-------------hhcCc
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKK-------------ISAAE 230 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~-------------i~~~~ 230 (443)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +....... +....
T Consensus 184 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 223455689999999999987555569999999999999999999999543 22221111 11111
Q ss_pred cCC------------------------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 231 FTC------------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 231 ~~~------------------------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
... +..+++++.+||.+||+.||.+|||++|+++||||+.-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 111 12278999999999999999999999999999999853
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=377.50 Aligned_cols=259 Identities=28% Similarity=0.472 Sum_probs=227.4
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.-++|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 346799999999999999999999999999999999765432 235788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 174 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QI 174 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BC
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--cc
Confidence 9999999999998865 67999999999999999999999999999999999999999999999999998764332 12
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIAR 247 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 247 (443)
......||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.... ...+..++..+.+||.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 23456799999999999877775 89999999999999999999999888776666655443 34556789999999999
Q ss_pred hcCCCCCCCCChhhhhcCccccccCC
Q 013407 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
||..||.+|||+.++++||||.....
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HcCCChhhCcCHHHHhhChhhhcCCC
Confidence 99999999999999999999986543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=378.18 Aligned_cols=260 Identities=35% Similarity=0.644 Sum_probs=228.0
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.+...++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 3456789999999999999999999999999999999997654322 235678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC---CCeEEeecCcccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQ 162 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~~kl~DFGla~~~~ 162 (443)
.|+||||+.+++|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999999888899999999999999999999999999999999999999764 469999999987653
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCC
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLS 238 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s 238 (443)
. ........||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+....+ ..++
T Consensus 176 ~---~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 176 Q---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp C---CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred C---CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 3 2223345689999999998754 4 5899999999999999999999999888888887777655433 3479
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.++.+||.+||..||.+|||+.++++||||++.
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=379.52 Aligned_cols=256 Identities=29% Similarity=0.484 Sum_probs=217.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
..++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 45789999999999999999999999999999999975432 235678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
||||+++++|.+.+.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 9999999999998865 5679999999999999999999999999999999999999999999999999876432211
Q ss_pred CccccccCCCcccchhhhc-----cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCH
Q 013407 168 GLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSF 239 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~ 239 (443)
......+||+.|+|||++. +..+ +.++||||||+++|+|++|..||...+.......+..... ..+..++.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred cccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 1123457999999999984 3344 5899999999999999999999998887776666655433 23456889
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.+.+||.+||..||.+|||+.++++||||+.
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 9999999999999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=377.86 Aligned_cols=256 Identities=29% Similarity=0.482 Sum_probs=217.4
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..-++|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999997643 1356889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+||||+.+++|.+++. ....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 9999999999999986 4578999999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARK 243 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~ 243 (443)
........||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+... .+..+..++..+.+
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 1223456799999999999887765 8899999999999999999999987766554444333 23345568999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 244 LIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
||.+||..||.+|||+.++++||||+..
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 9999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=389.71 Aligned_cols=256 Identities=24% Similarity=0.417 Sum_probs=221.3
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEEC-------CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 78 (443)
....++|++++.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 345679999999999999999999874 245679999997643 233467899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcE
Q 013407 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (443)
Q Consensus 79 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 142 (443)
++.+.+.+|+||||+.||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998653 478999999999999999999999999999999999
Q ss_pred EEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHH
Q 013407 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (443)
Q Consensus 143 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~ 221 (443)
|++.++.+||+|||++................||+.|+|||++.+..|. .++|||||||++|+|++ |..||.+.+..+
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999865433222233445678899999999887764 89999999999999999 999999988777
Q ss_pred HHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 222 LYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 222 ~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
....+..+. ...|..++..+.+||.+||..||.+|||+.|++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777766553 45667799999999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=394.86 Aligned_cols=251 Identities=31% Similarity=0.428 Sum_probs=207.5
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 84 (443)
...+|++.+.||+|+||.||+|.+..+++ ||+|.+..... ...+|+.+++.++||||+++++++....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 45689999999999999999999987766 88888765332 2237999999999999999999985433
Q ss_pred --EEEEEEeccCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc-cCCCeEEeecCc
Q 013407 85 --KIFIVLEFVTGGELFDKI----VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGL 157 (443)
Q Consensus 85 --~~~lv~E~~~gg~L~~~i----~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-~~~~~kl~DFGl 157 (443)
.+|+||||+.++. .+.+ .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 110 ~~~~~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 110 EVFLNLVLEYVPETV-YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp CEEEEEEEECCSEEH-HHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceEEEEEeeccCccH-HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 4889999998753 3333 2357899999999999999999999999999999999999999 789999999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--------
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------- 229 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------- 229 (443)
|..... .......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 189 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 189 AKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 976432 223345678999999999977655569999999999999999999999998876555443221
Q ss_pred ---------cc------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 230 ---------EF------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 230 ---------~~------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.. .+++.+++++.+||.+||+.||.+|||+.|+++||||+.-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 00 1234478999999999999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=381.91 Aligned_cols=262 Identities=28% Similarity=0.475 Sum_probs=197.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++...+..|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 4567999999999999999999999989999999999764422 23567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 88 IVLEFVTGGELFDKIVN--------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~--------~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999999874 4569999999999999999999999999999999999999999999999999987
Q ss_pred cccccc---CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-----
Q 013407 160 LSQQVR---DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----- 231 (443)
Q Consensus 160 ~~~~~~---~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----- 231 (443)
...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 643321 112234567999999999987533335899999999999999999999988665544333322211
Q ss_pred -----CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 232 -----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 232 -----~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.....++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1223578899999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=382.47 Aligned_cols=254 Identities=23% Similarity=0.426 Sum_probs=210.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--E
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--K 85 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 85 (443)
..-++|++.+.||+|+||.||+|.+..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 44578999999999999999999999999999999998654332 2466789999999999999999999998765 7
Q ss_pred EEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE----ccCCCeEEeecCcc
Q 013407 86 IFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~~~~kl~DFGla 158 (443)
.|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999999999999997644 39999999999999999999999999999999999999 77788999999999
Q ss_pred cccccccCCCccccccCCCcccchhhhc--------cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc----HHHHHHHh
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLN--------DRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKI 226 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~--------~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i 226 (443)
..... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.... .......+
T Consensus 164 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 164 RELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred eecCC---CCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 76433 23344567999999999986 2344 589999999999999999999996422 23344443
Q ss_pred hcCcc---------------------C----CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcc
Q 013407 227 SAAEF---------------------T----CPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267 (443)
Q Consensus 227 ~~~~~---------------------~----~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~ 267 (443)
..+.. + .+..++..+.+||++||+.||.+|||++|+++||=
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 32221 1 11124567899999999999999999999999973
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=382.84 Aligned_cols=264 Identities=23% Similarity=0.351 Sum_probs=202.4
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCc---eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
...-++|++++.||+|+||.||+|.+..++. .||||++....... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3456789999999999999999999877665 79999997654333 3467899999999999999999999999877
Q ss_pred CEE------EEEEeccCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeE
Q 013407 84 TKI------FIVLEFVTGGELFDKIVNHG------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (443)
Q Consensus 84 ~~~------~lv~E~~~gg~L~~~i~~~~------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~k 151 (443)
... |+||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 665 99999999999999986532 599999999999999999999999999999999999999999999
Q ss_pred EeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-
Q 013407 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA- 229 (443)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~- 229 (443)
|+|||++................+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999999765433222223345578899999999887764 89999999999999999 99999988877777766554
Q ss_pred ccCCCCCCCHHHHHHHHHhcCCCCCCCCC-------hhhhhcCccccccC
Q 013407 230 EFTCPPWLSFTARKLIARILDPNPMTRIT-------IPEILEDEWFKKDY 272 (443)
Q Consensus 230 ~~~~~~~~s~~~~~li~~mL~~dP~~R~t-------~~eil~hp~~~~~~ 272 (443)
....++.+++.+.+||.+||+.||.+||| +++++.|||+....
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 45667789999999999999999999999 77788999997644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=395.52 Aligned_cols=252 Identities=29% Similarity=0.406 Sum_probs=208.5
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 82 (443)
...+|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34479999999999999999999999999999999875431 23479999999999999999998843
Q ss_pred CCEEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC-CCeEEeecCc
Q 013407 83 KTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGL 157 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~~kl~DFGl 157 (443)
...+++||||+.+ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 2347799999986 5655543 35689999999999999999999999999999999999999965 5689999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhc---------
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--------- 228 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------- 228 (443)
++.... .......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus 204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 985432 22234568999999999997764456899999999999999999999998876655444321
Q ss_pred --------CccC------------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 229 --------AEFT------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 229 --------~~~~------------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
..+. +++.+++++.+||.+||..||.+|||+.|+++||||..-
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0111 234568999999999999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=387.66 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=213.1
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE---
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI--- 86 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~--- 86 (443)
-++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 468999999999999999999999999999999997643 2334567889999999999999999999999877654
Q ss_pred ---EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 87 ---FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 87 ---~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999998 58887773 4599999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc------------
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------ 231 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------ 231 (443)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 197 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 197 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred -----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 234567899999999998744446899999999999999999999998876665554422100
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 232 -------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 232 -------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
..++.+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 1123468999999999999999999999999999999853
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=380.09 Aligned_cols=251 Identities=28% Similarity=0.452 Sum_probs=212.2
Q ss_pred ccccEEEEeEeeccCcEEEEEEEE-CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC------CcceEEEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARN-SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP------NVVRLYEVMG 81 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l~~~~~ 81 (443)
..++|++.+.||+|+||.||+|.+ ..+++.||||++.... ...+.+.+|+.+++.++|+ +|+++++++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 347999999999999999999998 5688999999997532 2356788999999988765 4999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-------------
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA------------- 146 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~------------- 146 (443)
+.+..|+||||+ +++|.+.+...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred ------CCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH
Q 013407 147 ------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220 (443)
Q Consensus 147 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~ 220 (443)
++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 66899999999875322 23456799999999999887774 8999999999999999999999987766
Q ss_pred HHHHHhhcCccCC--------------------------------------------CCCCCHHHHHHHHHhcCCCCCCC
Q 013407 221 NLYKKISAAEFTC--------------------------------------------PPWLSFTARKLIARILDPNPMTR 256 (443)
Q Consensus 221 ~~~~~i~~~~~~~--------------------------------------------~~~~s~~~~~li~~mL~~dP~~R 256 (443)
+....+.....+. +...++.+.+||.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 5444332211111 11235678999999999999999
Q ss_pred CChhhhhcCccccc
Q 013407 257 ITIPEILEDEWFKK 270 (443)
Q Consensus 257 ~t~~eil~hp~~~~ 270 (443)
||+.|+++||||+.
T Consensus 321 pt~~ell~hp~f~~ 334 (339)
T 1z57_A 321 ITLREALKHPFFDL 334 (339)
T ss_dssp CCHHHHTTSGGGGG
T ss_pred cCHHHHhcCHHHHH
Confidence 99999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=377.89 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=210.6
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-------
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG------- 81 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------- 81 (443)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 4579999999999999999999999999999999987543 334678899999999999999999999873
Q ss_pred -------eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc-cCCCeEEe
Q 013407 82 -------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVS 153 (443)
Q Consensus 82 -------~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-~~~~~kl~ 153 (443)
+....|+||||+. |+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4478999999998 599988864 6799999999999999999999999999999999999997 56789999
Q ss_pred ecCccccccccc-CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-
Q 013407 154 DFGLSALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231 (443)
Q Consensus 154 DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~- 231 (443)
|||++....... .........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998654321 122334567899999999987644456899999999999999999999998877665554432110
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 232 -----------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 232 -----------------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
..++.++.++.+||.+||+.||.+|||++++++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 0124578999999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=377.79 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=216.4
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe-
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS- 82 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 82 (443)
.+....++|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 345567899999999999999999999999999999999975432 235688999999999 79999999999976
Q ss_pred -----CCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeec
Q 013407 83 -----KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 83 -----~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DF 155 (443)
....|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 56899999999999999999864 57999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhc-----cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 230 (443)
|++...... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 174 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 174 GVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp TTTC---------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred cCceecCcC--ccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 998764331 12234567999999999986 3334 588999999999999999999999887766555554433
Q ss_pred cC--CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 231 FT--CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 231 ~~--~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
.+ .+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 22 235589999999999999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=386.24 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=205.1
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
.....+++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+|+..++.++||||+++++++.+..
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 3456789999999999999999999999999999999998654322 234567788888899999999999986533
Q ss_pred -------EEEEEEeccCCCchHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHH--HCCcEeeeCCCCcEEEcc-CCCe
Q 013407 85 -------KIFIVLEFVTGGELFDK----IVNHGRMKEDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLDA-YGNL 150 (443)
Q Consensus 85 -------~~~lv~E~~~gg~L~~~----i~~~~~l~e~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~~-~~~~ 150 (443)
.+|+||||+.++ |.+. +.....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 388999999874 4333 335678999999999999999999999 999999999999999997 8999
Q ss_pred EEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc
Q 013407 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (443)
Q Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 230 (443)
||+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 172 kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999986543 2233456799999999999776655699999999999999999999999988776655543210
Q ss_pred c--------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 231 F--------------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 231 ~--------------------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
. ..+...++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 0 111225678999999999999999999999999999987543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=390.96 Aligned_cols=260 Identities=20% Similarity=0.292 Sum_probs=223.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEE-----ECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
...++|++++.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 345789999999999999999999 44577889999996432 23345578899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC---CeEE
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNH-------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKV 152 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~~kl 152 (443)
....|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999999764 3589999999999999999999999999999999999999655 4999
Q ss_pred eecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-
Q 013407 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE- 230 (443)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~- 230 (443)
+|||+|................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999865443333344556789999999999887775 89999999999999998 999999998888888776654
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 231 ~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
...+..++..+.+||.+||+.||.+|||+.++++|.|+..
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 4566778999999999999999999999999999988654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=386.34 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=211.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh--------hhHHHHHHHHHHHHHHhcCCCCCcceEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--------LKHKMAEQIKREVATMKLVKHPNVVRLYE 78 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 78 (443)
....++|++.+.||+|+||.||+|.+.. |+.||||++..... ......+.+.+|+.++++++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 3456899999999999999999999865 89999999965322 22334578999999999999999999999
Q ss_pred EEEe-----CCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEE
Q 013407 79 VMGS-----KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (443)
Q Consensus 79 ~~~~-----~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl 152 (443)
++.. ...+|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9843 447899999998 5888887654 47999999999999999999999999999999999999999999999
Q ss_pred eecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--
Q 013407 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-- 230 (443)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-- 230 (443)
+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 176 ~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 176 CDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999874332 2233456799999999999874445689999999999999999999999887666555442210
Q ss_pred ----------------------c--------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 231 ----------------------F--------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 231 ----------------------~--------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
. ..++..++.+.+||.+||+.||.+|||+.|+++||||+.-+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 0 1123468899999999999999999999999999999875543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=377.46 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=222.9
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEE
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 78 (443)
+......++|++.+.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 444556789999999999999999999983 456889999997543 2344678999999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 013407 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGR------------------------MKEDEARRYFQQLINAVDYCHSRGVYH 134 (443)
Q Consensus 79 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~~------------------------l~e~~~~~~~~qi~~aL~~LH~~givH 134 (443)
++.+.+..|+||||+.||+|.+++..... +++..++.++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999987543 899999999999999999999999999
Q ss_pred eeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCC
Q 013407 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLP 213 (443)
Q Consensus 135 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~P 213 (443)
|||||+||+++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..|
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998765432221222345678899999999876664 89999999999999999 9999
Q ss_pred CCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 214 FDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 214 f~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
|.+.+.......+..+. ...+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp STTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99888777777666553 45667799999999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=376.54 Aligned_cols=265 Identities=31% Similarity=0.439 Sum_probs=218.0
Q ss_pred CCccccccccccEEEEeEeeccCcEEEEEEEEC-CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCcceE
Q 013407 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRL 76 (443)
Q Consensus 1 ~~~~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l 76 (443)
|.+..+....++|++.+.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++
T Consensus 1 m~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~ 79 (326)
T 1blx_A 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRL 79 (326)
T ss_dssp ----CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCE
T ss_pred CCCccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEee
Confidence 455666677799999999999999999999995 678899999997643221 1123456777777666 89999999
Q ss_pred EEEEE-----eCCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC
Q 013407 77 YEVMG-----SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (443)
Q Consensus 77 ~~~~~-----~~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~ 149 (443)
++++. .....|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 80 FDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC
Confidence 99987 5678999999998 59999997653 4999999999999999999999999999999999999999999
Q ss_pred eEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC
Q 013407 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (443)
Q Consensus 150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~ 229 (443)
+||+|||++...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+...
T Consensus 159 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 159 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp EEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEecCcccccccCC---CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 999999998764322 22345679999999999987766 48999999999999999999999988877665554321
Q ss_pred c---------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 230 E---------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 230 ~---------------------------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
. ...++.++..+++||.+||..||.+|||+.++++||||+.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0 01224578899999999999999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=370.89 Aligned_cols=256 Identities=31% Similarity=0.533 Sum_probs=209.4
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 82 (443)
..++|++++.||+|+||.||+|.+..+|+.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 357899999999999999999999999999999999653 2345778999999999999999999998754
Q ss_pred -------CCEEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEee
Q 013407 83 -------KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSD 154 (443)
Q Consensus 83 -------~~~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~D 154 (443)
....|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 467899999999999999998544 688999999999999999999999999999999999999999999999
Q ss_pred cCccccccccc------------CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCC-CcHHH
Q 013407 155 FGLSALSQQVR------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMN 221 (443)
Q Consensus 155 FGla~~~~~~~------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~ 221 (443)
||++....... ........+||+.|+|||++.+....+.++|||||||++|+|++ ||.. .+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99987643211 11223456799999999999866545689999999999999998 6653 33345
Q ss_pred HHHHhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 222 LYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 222 ~~~~i~~~~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
....+......+|+ ..+..+.++|.+||+.||.+|||+.++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 55566555544443 356779999999999999999999999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=377.27 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=218.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCce---EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEP---VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~---vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
...++|++.+.||+|+||.||+|.+..+++. ||||++.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 4567999999999999999999999866654 9999997543 2334577899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..|+||||+.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999999754 5799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCC-ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHH
Q 013407 164 VRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (443)
Q Consensus 164 ~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (443)
..... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+ ..+.+..+++.
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA 282 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence 22111 12234567889999999877764 89999999999999999 99999998888887777665 45667779999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhc
Q 013407 241 ARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
+.+||.+||..||.+|||+.++++
T Consensus 283 l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 283 LHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=392.57 Aligned_cols=256 Identities=17% Similarity=0.194 Sum_probs=196.2
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC--CCCCcceEE-------E
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV--KHPNVVRLY-------E 78 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~ 78 (443)
....+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+++|+.+++.+ +||||++++ +
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 3445699999999999999999999999999999999886554445567888885544444 699988765 5
Q ss_pred EEEeC-----------------CEEEEEEeccCCCchHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHHCCcEe
Q 013407 79 VMGSK-----------------TKIFIVLEFVTGGELFDKIVNHG-RMKEDEA------RRYFQQLINAVDYCHSRGVYH 134 (443)
Q Consensus 79 ~~~~~-----------------~~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~------~~~~~qi~~aL~~LH~~givH 134 (443)
++... ..+|+||||+. |+|.+++...+ .+++... ..++.||+.||.|||++||+|
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 55433 34899999999 79999997643 3444444 566699999999999999999
Q ss_pred eeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCC
Q 013407 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYL 212 (443)
Q Consensus 135 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~ 212 (443)
|||||+|||++.+|.+||+|||+|..... ......||+.|+|||++.+ ..| +.++|||||||++|+|++|..
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSC
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999985432 2224567799999999976 455 589999999999999999999
Q ss_pred CCCCCcHHH--HHHH-----hhcCccCC--CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 213 PFDDSNLMN--LYKK-----ISAAEFTC--PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 213 Pf~~~~~~~--~~~~-----i~~~~~~~--~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
||.+..... .+.. .....+.+ ++.+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 998764321 1111 01112222 3468999999999999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=389.14 Aligned_cols=249 Identities=26% Similarity=0.436 Sum_probs=206.3
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC--------CCCcceEEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--------HPNVVRLYEVMG 81 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~~~~~ 81 (443)
.++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 478999999999999999999999999999999997532 23567889999999985 788999999987
Q ss_pred ----eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCC------
Q 013407 82 ----SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYG------ 148 (443)
Q Consensus 82 ----~~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~------ 148 (443)
+...+|+||||+ +++|.+.+... +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 567899999999 56777777654 5699999999999999999999999 999999999999999775
Q ss_pred -------------------------------------------CeEEeecCcccccccccCCCccccccCCCcccchhhh
Q 013407 149 -------------------------------------------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185 (443)
Q Consensus 149 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl 185 (443)
.+||+|||+|..... .....+||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhh
Confidence 799999999976432 23456799999999999
Q ss_pred ccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc------HHHHHHHhhc--Cc---------------------------
Q 013407 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN------LMNLYKKISA--AE--------------------------- 230 (443)
Q Consensus 186 ~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~------~~~~~~~i~~--~~--------------------------- 230 (443)
.+..|. .++|||||||++|+|++|..||...+ .......+.. +.
T Consensus 266 ~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred cCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 887775 89999999999999999999997643 1121111111 00
Q ss_pred -------------cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 231 -------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 231 -------------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
...+...+..+.+||.+||+.||.+|||++|+++||||+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 011222356789999999999999999999999999996
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=394.38 Aligned_cols=261 Identities=26% Similarity=0.404 Sum_probs=196.6
Q ss_pred cccccEEE-EeEeeccCcEEEEEEEEC--CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--
Q 013407 8 RRVGKYEV-GRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-- 82 (443)
Q Consensus 8 ~~~~~y~~-~~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 82 (443)
..-+.|++ ++.||+|+||.||+|.+. .+++.||||++..... ...+.+|+.+|+.++||||+++++++.+
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 34456887 558999999999999976 5788999999975432 2357789999999999999999999954
Q ss_pred CCEEEEEEeccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE----ccCCC
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGN 149 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~~~ 149 (443)
...+|+||||+.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 7789999999975 888877532 249999999999999999999999999999999999999 67789
Q ss_pred eEEeecCccccccccc-CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH--------
Q 013407 150 LKVSDFGLSALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-------- 220 (443)
Q Consensus 150 ~kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-------- 220 (443)
+||+|||+|....... ........+||+.|+|||++.+..+.+.++|||||||++|+|++|.+||.+.+..
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 9999999998654321 1123456789999999999987665569999999999999999999999765431
Q ss_pred -HHHHHhhcC--ccCC------------------------------------CCCCCHHHHHHHHHhcCCCCCCCCChhh
Q 013407 221 -NLYKKISAA--EFTC------------------------------------PPWLSFTARKLIARILDPNPMTRITIPE 261 (443)
Q Consensus 221 -~~~~~i~~~--~~~~------------------------------------~~~~s~~~~~li~~mL~~dP~~R~t~~e 261 (443)
+....+... .... ....++.+.+||.+||..||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 222222110 0000 0112678999999999999999999999
Q ss_pred hhcCccccccCCC
Q 013407 262 ILEDEWFKKDYKP 274 (443)
Q Consensus 262 il~hp~~~~~~~~ 274 (443)
+|+||||+....+
T Consensus 331 ~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 331 AMQDPYFLEDPLP 343 (405)
T ss_dssp HHTSGGGTSSSCC
T ss_pred HhcChhhccCCCC
Confidence 9999999875443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=381.40 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=212.4
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE----
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK---- 85 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 85 (443)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999997643 233456788999999999999999999999987654
Q ss_pred --EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 86 --IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 86 --~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
+|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999998 58877764 4599999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--------------
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------- 229 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 229 (443)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 2335678999999999987444468999999999999999999999988766554443210
Q ss_pred -----------------ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 230 -----------------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 230 -----------------~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
....++.+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 011234578999999999999999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=374.62 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=213.2
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++++.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 34678999999999999999999999999999999998543 234467899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||+.||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999987 5679999999999999999999999999999999999999999999999999997653321
Q ss_pred CC------------CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHH---HhhcCc
Q 013407 166 DD------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISAAE 230 (443)
Q Consensus 166 ~~------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i~~~~ 230 (443)
.. ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.......... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 11 111256899999999999887774 89999999999999999999997532211000 000011
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 231 ~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
...|+.+++.+.++|.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2346678899999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=371.97 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=211.8
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
+..+..+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106 (309)
T ss_dssp -------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred cCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence 44567899999999999999999999999999999999999876655555668899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
+..|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999875433
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFT 240 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~ 240 (443)
.. ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..... ..++.+++.
T Consensus 187 ~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 187 EK-LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp -----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred cc-cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHH
Confidence 21 122345679999999999987666 4889999999999999999999998876655554443322 345678999
Q ss_pred HHHHHHHhcCCCCCCCC-Chhhhhc
Q 013407 241 ARKLIARILDPNPMTRI-TIPEILE 264 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~-t~~eil~ 264 (443)
+.++|.+||+.||.+|| |++++++
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999999 7777764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=379.09 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=222.5
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 81 (443)
....++|++++.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 345689999999999999999999986 355889999997643 2334678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeC
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNH------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDl 137 (443)
+.+..|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999764 56999999999999999999999999999999
Q ss_pred CCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCC
Q 013407 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216 (443)
Q Consensus 138 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~ 216 (443)
||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999765433222233456789999999999877764 89999999999999999 9999999
Q ss_pred CcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 217 SNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 217 ~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+.......+..+.. ..|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 888887777766654 5677899999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=385.56 Aligned_cols=255 Identities=23% Similarity=0.388 Sum_probs=216.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEE-----ECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 81 (443)
...++|++++.||+|+||.||+|. +..+++.||||++..... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 456899999999999999999999 556778999999975432 23456789999999999 7899999999988
Q ss_pred eCC-EEEEEEeccCCCchHHHHHhCCC-----------------------------------------------------
Q 013407 82 SKT-KIFIVLEFVTGGELFDKIVNHGR----------------------------------------------------- 107 (443)
Q Consensus 82 ~~~-~~~lv~E~~~gg~L~~~i~~~~~----------------------------------------------------- 107 (443)
+.+ .+|+||||+.||+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 48999999999999999976543
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcccccc
Q 013407 108 -------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (443)
Q Consensus 108 -------------l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 174 (443)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++................
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 8999999999999999999999999999999999999999999999999998654322222334567
Q ss_pred CCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHH-HHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCC
Q 013407 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISAA-EFTCPPWLSFTARKLIARILDP 251 (443)
Q Consensus 175 gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~ 251 (443)
||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.. .....+..+ ....|..+++++.++|.+||..
T Consensus 257 ~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp ECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 89999999999887775 89999999999999998 99999886543 333344333 4566778999999999999999
Q ss_pred CCCCCCChhhhhcC
Q 013407 252 NPMTRITIPEILED 265 (443)
Q Consensus 252 dP~~R~t~~eil~h 265 (443)
||.+|||+.++++|
T Consensus 336 dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRPTFSELVEH 349 (359)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=364.80 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=219.9
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 345679999999999999999999986 4677999999765432 24688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999999999654 468999999999999999999999999999999999999999999999999997543321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
. .......||+.|+|||++.+..++ .++||||+|+++|+|++ |..||.+.+.......+..+ ....|..+++.+.+
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T 4hcu_A 161 Y-TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 238 (269)
T ss_dssp H-HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred c-ccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHH
Confidence 1 112344578889999999877764 89999999999999999 99999999888888877666 44556678999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcC
Q 013407 244 LIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~h 265 (443)
+|.+||+.||.+|||+.++++|
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=381.73 Aligned_cols=254 Identities=31% Similarity=0.536 Sum_probs=221.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH---HHHHHHHHHHHHHhcCC--CCCcceEEEEEEe
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVK--HPNVVRLYEVMGS 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~ 82 (443)
...++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.++++++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 456789999999999999999999999999999999987543221 11245678999999996 5999999999999
Q ss_pred CCEEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc-cCCCeEEeecCcccc
Q 013407 83 KTKIFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSAL 160 (443)
Q Consensus 83 ~~~~~lv~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-~~~~~kl~DFGla~~ 160 (443)
.+..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 9999999999986 89999999888999999999999999999999999999999999999999 778999999999876
Q ss_pred cccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHH
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 240 (443)
... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+ .+.......+..++++
T Consensus 200 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~ 269 (320)
T 3a99_A 200 LKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE 269 (320)
T ss_dssp CCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHH
T ss_pred ccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHH
Confidence 532 223456799999999999887776788999999999999999999997643 2334455667789999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+.+||.+||..||.+|||++++++||||+..
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 9999999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=382.47 Aligned_cols=256 Identities=23% Similarity=0.410 Sum_probs=223.4
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCC-------CceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSET-------GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 78 (443)
...-++|++++.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 44568999999999999999999997543 3579999997643 233467899999999999 9999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcE
Q 013407 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (443)
Q Consensus 79 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 142 (443)
++.+.+..|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998754 499999999999999999999999999999999999
Q ss_pred EEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHH
Q 013407 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (443)
Q Consensus 143 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~ 221 (443)
|++.++.+||+|||+|................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999865443322334455678899999999877664 89999999999999999 999999988888
Q ss_pred HHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 222 LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 222 ~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
....+..+ ....|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87777665 445677799999999999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=376.99 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=210.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCC-ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC------cceEEEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN------VVRLYEVMG 81 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~~~ 81 (443)
.-++|++.+.||+|+||.||+|.+..++ +.||+|++.... ...+.+.+|+.+++.++|++ ++.+++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3479999999999999999999998776 689999997532 23467888999999997655 999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE---------------
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL--------------- 144 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl--------------- 144 (443)
..+..|+||||+ +++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999999 667878776653 69999999999999999999999999999999999999
Q ss_pred ----ccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH
Q 013407 145 ----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220 (443)
Q Consensus 145 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~ 220 (443)
+.++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 6678999999999975322 23456799999999999887775 8999999999999999999999987765
Q ss_pred HHHHHhhcCccCCC--------------------------------------------CCCCHHHHHHHHHhcCCCCCCC
Q 013407 221 NLYKKISAAEFTCP--------------------------------------------PWLSFTARKLIARILDPNPMTR 256 (443)
Q Consensus 221 ~~~~~i~~~~~~~~--------------------------------------------~~~s~~~~~li~~mL~~dP~~R 256 (443)
.....+.......| ...+..+.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 54433322111111 1124578899999999999999
Q ss_pred CChhhhhcCccccc
Q 013407 257 ITIPEILEDEWFKK 270 (443)
Q Consensus 257 ~t~~eil~hp~~~~ 270 (443)
||+.|+++||||+.
T Consensus 326 pt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 326 ITLAEALLHPFFAG 339 (355)
T ss_dssp CCHHHHTTSGGGGG
T ss_pred cCHHHHhcChhhcC
Confidence 99999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=385.87 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=218.4
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|+.++||||+++++++.+.+..|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 34578999999999999999999999899999999987532 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999999997654 699999999999999999999999999999999999999999999999999875322111
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (443)
........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+|
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111112235678999999987666 489999999999999998 99999998877776666554 456677799999999
Q ss_pred HHHhcCCCCCCCCChhhhhc
Q 013407 245 IARILDPNPMTRITIPEILE 264 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~ 264 (443)
|.+||+.||.+|||+.++++
T Consensus 348 i~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=367.84 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=211.5
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|.....||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 3333448999999999999999999999999997643 2345678999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-CCCeEEeecCcccccccccCC
Q 013407 92 FVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~---~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 167 (443)
|+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++...... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--N 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--C
Confidence 999999999997652 4678999999999999999999999999999999999987 899999999998754331 1
Q ss_pred CccccccCCCcccchhhhccCC-CCCCchhhhhhhHHHHHHhhCCCCCCCCcHH--HHHH-HhhcCccCCCCCCCHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLM--NLYK-KISAAEFTCPPWLSFTARK 243 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~~~-~i~~~~~~~~~~~s~~~~~ 243 (443)
.......||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...... .... .........|..+++.+.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence 2234567999999999997543 2358999999999999999999999754322 2222 2223345567779999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 244 LIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
||.+||..||.+|||+.++++||||+...
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=382.31 Aligned_cols=253 Identities=31% Similarity=0.441 Sum_probs=211.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CC-----CcceEEEEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HP-----NVVRLYEVMG 81 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~~~~ 81 (443)
...++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ |+ +|+++++++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 34689999999999999999999999999999999997532 23566788899888885 55 4999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeeeCCCCcEEEc--cCCCeEEeec
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLD--AYGNLKVSDF 155 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~--~~~~~kl~DF 155 (443)
..+..|+||||+.| +|.+.+... +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999999965 999999765 46999999999999999999999 57999999999999995 4788999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC-
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP- 234 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~- 234 (443)
|+|..... .....+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+....+.......|
T Consensus 206 G~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 206 GSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp TTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred cCceeccc-----ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99976432 23456899999999999887775 899999999999999999999999887766555432110000
Q ss_pred -----------------------------------CC----------------------------CCHHHHHHHHHhcCC
Q 013407 235 -----------------------------------PW----------------------------LSFTARKLIARILDP 251 (443)
Q Consensus 235 -----------------------------------~~----------------------------~s~~~~~li~~mL~~ 251 (443)
+. .++.+++||.+||+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 00 013789999999999
Q ss_pred CCCCCCChhhhhcCcccccc
Q 013407 252 NPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 252 dP~~R~t~~eil~hp~~~~~ 271 (443)
||.+|||++|+|+||||+..
T Consensus 360 dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CTTTSCCHHHHTTSGGGCC-
T ss_pred ChhhCCCHHHHhcCcccccC
Confidence 99999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=362.48 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=218.6
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456789999999999999999999886 5677999999765432 24688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||++|++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999997754 59999999999999999999999999999999999999999999999999987543321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 243 (443)
. .......||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..+. ...|...++.+.+
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 159 Y-VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp E-EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred h-hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 1 112234567789999999877764 88999999999999999 999999988887777776654 3455668999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcC
Q 013407 244 LIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~h 265 (443)
+|.+||+.||.+|||+.+++++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=370.58 Aligned_cols=264 Identities=25% Similarity=0.421 Sum_probs=214.1
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC--CCCcceEEEEEEeC
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--HPNVVRLYEVMGSK 83 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~ 83 (443)
+...-++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 4455678999999999999999999985 4889999999765432 334678899999999997 59999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
+..|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++.....
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 99999999 567899999999889999999999999999999999999999999999999965 8999999999986544
Q ss_pred ccCCCccccccCCCcccchhhhccC----------CCCCCchhhhhhhHHHHHHhhCCCCCCCCcH-HHHHHHhhcC--c
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDR----------GYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAA--E 230 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~----------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~--~ 230 (443)
..........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||..... ......+... .
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 258 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence 3322233456799999999998652 2335789999999999999999999987532 2333333322 3
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 231 ~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
..+|...+..+.+||.+||..||.+|||+.++++||||+....
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 4566778899999999999999999999999999999987543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=375.06 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=209.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceE----EEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPV----ALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
...++|++.+.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 34578999999999999999999998887755 777765432 222356789999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
. .++++||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|....
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999977 4579999999999999999999999999999999999999999999999999998765
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHH
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (443)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+ ....++.++..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999887774 89999999999999999 99999988777666666554 45667789999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 241 ARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+.+++.+||+.||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=376.35 Aligned_cols=254 Identities=33% Similarity=0.573 Sum_probs=212.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH---HHHHHHHHHHHHHhcC----CCCCcceEEEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLV----KHPNVVRLYEVM 80 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~hpnIv~l~~~~ 80 (443)
...++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 456789999999999999999999999999999999976543221 1223466799999988 899999999999
Q ss_pred EeCCEEEEEEec-cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc-cCCCeEEeecCcc
Q 013407 81 GSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLS 158 (443)
Q Consensus 81 ~~~~~~~lv~E~-~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-~~~~~kl~DFGla 158 (443)
.+.+..++|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999999 78999999999888899999999999999999999999999999999999999 7899999999998
Q ss_pred cccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCC
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s 238 (443)
..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+......++..++
T Consensus 188 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 188 ALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHVS 257 (312)
T ss_dssp EECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTSC
T ss_pred hhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccCC
Confidence 76533 223456799999999999887776668999999999999999999997643 23345566778899
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
..+.+||.+||..||.+|||++++++||||+..
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 999999999999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=376.50 Aligned_cols=254 Identities=19% Similarity=0.349 Sum_probs=215.2
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCce----EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEP----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
...++|++.+.||+|+||.||+|.+..+++. ||+|.+..... ......+.+|+.+++.++||||+++++++. .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 3457899999999999999999999888876 67776654321 112345778999999999999999999986 4
Q ss_pred CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
+..++||||+.+|+|.+.+... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 5689999999999999999875 579999999999999999999999999999999999999999999999999998765
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHH
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (443)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+ ....|..++.+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred cccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence 43333344556788899999999877764 89999999999999999 99999988877777766655 45666778999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 241 ARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+.++|.+||..||.+|||+.++++|
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=365.46 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=209.0
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCC---CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 81 (443)
......++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 4456778999999999999999999998654 4569999986532 2344678999999999999999999999984
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
.+..|+||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 567899999999999999997654 699999999999999999999999999999999999999999999999999986
Q ss_pred cccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCC
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLS 238 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 238 (443)
..... ........+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....++.++
T Consensus 166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (281)
T 1mp8_A 166 MEDST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 243 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred cCccc-ccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCC
Confidence 54321 1122344578899999999877764 89999999999999996 99999988777777666555 356677899
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 239 FTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+.+.++|.+||..||.+|||+.+++++
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=363.37 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=217.0
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 355679999999999999999999886 5778999999765432 24688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999976 5679999999999999999999999999999999999999999999999999997643321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 243 (443)
. .......||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+..+. ...|...++.+.+
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 252 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred c-ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHH
Confidence 1 11233457888999999987776 489999999999999998 999999988888777776663 4456678999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcC
Q 013407 244 LIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~h 265 (443)
||.+||+.||.+|||+.++++|
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 253 IMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=376.52 Aligned_cols=258 Identities=20% Similarity=0.320 Sum_probs=215.7
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEE-----CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 80 (443)
....++|++.+.||+|+||.||+|.+ ..++..||||++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34567999999999999999999997 3456789999997543 222356889999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeC
Q 013407 81 GSKTKIFIVLEFVTGGELFDKIVNHG-----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137 (443)
Q Consensus 81 ~~~~~~~lv~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDl 137 (443)
.+.+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 99999999999999999999997653 2799999999999999999999999999999
Q ss_pred CCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCC
Q 013407 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216 (443)
Q Consensus 138 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~ 216 (443)
||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999865443222223445678899999999877764 89999999999999998 9999988
Q ss_pred CcHHHHHH-HhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcc
Q 013407 217 SNLMNLYK-KISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267 (443)
Q Consensus 217 ~~~~~~~~-~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~ 267 (443)
.+...... .+..+ ....|..+++.+.+||.+||..||.+|||+.++++|-.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 66443333 33333 34566778999999999999999999999999998743
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=366.96 Aligned_cols=248 Identities=23% Similarity=0.284 Sum_probs=212.2
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCC-------ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETG-------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 80 (443)
...++|++.+.||+|+||.||+|.+..++ ..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45679999999999999999999998777 4699999976432 2356789999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC--------eE
Q 013407 81 GSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--------LK 151 (443)
Q Consensus 81 ~~~~~~~lv~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~--------~k 151 (443)
.+.+..|+||||+.||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 999999999999999999999999999999999999999887 99
Q ss_pred EeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc
Q 013407 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE 230 (443)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 230 (443)
|+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++ |.+||...+...... .....
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~ 234 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDR 234 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTT
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-Hhhcc
Confidence 999999864322 2345689999999999874445689999999999999999 556666555444333 33345
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 231 ~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
...|...++++.+||.+||+.||.+|||+.++++|
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55667788999999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=375.89 Aligned_cols=254 Identities=32% Similarity=0.587 Sum_probs=185.6
Q ss_pred ccccccEEEEe-EeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 013407 7 KRRVGKYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--- 82 (443)
Q Consensus 7 ~~~~~~y~~~~-~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 82 (443)
....++|++.+ .||+|+||.||+|.+..+|+.||||++..... ...+....++.++||||+++++++..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 35678999965 69999999999999999999999999975321 12223334567799999999999876
Q ss_pred -CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC---CCeEEeecC
Q 013407 83 -KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFG 156 (443)
Q Consensus 83 -~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~~kl~DFG 156 (443)
....|+||||+.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 556899999999999999998754 69999999999999999999999999999999999999864 459999999
Q ss_pred cccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHH----HHHhhcCccC
Q 013407 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----YKKISAAEFT 232 (443)
Q Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~ 232 (443)
++..... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||........ ...+......
T Consensus 177 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 177 FAKETTQ----NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp TCEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred cceeccc----cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 9875432 233456899999999999776664 889999999999999999999987654432 2233333332
Q ss_pred CC----CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 233 CP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 233 ~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.+ ..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 22 35899999999999999999999999999999998643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=359.96 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=205.5
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh-HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
....++|++.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 456789999999999999999999984 7889999987643322 2234678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeeeCCCCcEEEcc--------CCCeEEee
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG---VYHRDLKPENLLLDA--------YGNLKVSD 154 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~--------~~~~kl~D 154 (443)
.|+||||+.|++|.+.+. .+.+++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999988875 468999999999999999999999999 899999999999986 67899999
Q ss_pred cCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc--cC
Q 013407 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FT 232 (443)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~ 232 (443)
||++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.... ..
T Consensus 160 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3dtc_A 160 FGLAREWHRT----TKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC
T ss_pred CCcccccccc----cccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC
Confidence 9998754332 2234579999999999987766 489999999999999999999999888776665554443 45
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 233 CPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 233 ~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 567789999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=366.01 Aligned_cols=261 Identities=24% Similarity=0.382 Sum_probs=200.9
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
.....+++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+.++..+++.++||||+++++++.+.+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 3456788999999999999999999999999999999999765432 223345556666788899999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
..|+||||+ ++.+...... .+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999 4455444433 56899999999999999999999996 99999999999999999999999999987543
Q ss_pred cccCCCccccccCCCcccchhhhcc----CCCCCCchhhhhhhHHHHHHhhCCCCCCCC-cHHHHHHHhhcCcc-CCC--
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAAEF-TCP-- 234 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~-~~~-- 234 (443)
. .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||... ........+..... ..|
T Consensus 177 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (318)
T 2dyl_A 177 D---DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS
T ss_pred C---CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence 3 222345679999999999952 223358999999999999999999999873 44455555544432 222
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 235 ~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..+++.+.+||.+||..||.+|||++++++||||+.
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 347999999999999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=369.89 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=221.3
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 81 (443)
....++|++.+.||+|+||.||+|.+. .+++.||||++..... ......+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 445679999999999999999999876 3578899999975432 233567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeE
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNH----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~k 151 (443)
+.+..|+||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 999999999999999999998753 4579999999999999999999999999999999999999999999
Q ss_pred EeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc
Q 013407 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE 230 (443)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 230 (443)
|+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 9999999765433222223345678999999999877664 89999999999999999 899999988887777776554
Q ss_pred -cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 231 -FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 231 -~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
...+..++..+.+||.+||+.||.+|||+.++++|
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 35567799999999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=369.44 Aligned_cols=256 Identities=22% Similarity=0.363 Sum_probs=216.9
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEE-----CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 80 (443)
....++|++.+.||+|+||.||+|.+ ..+++.||||++..... ....+.+.+|+.+++++ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 34567999999999999999999985 45778999999976432 23457899999999999 999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcE
Q 013407 81 GSKTKIFIVLEFVTGGELFDKIVNHG------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (443)
Q Consensus 81 ~~~~~~~lv~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 142 (443)
.+.+..|+||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 99999999999999999999997654 489999999999999999999999999999999999
Q ss_pred EEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHH
Q 013407 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (443)
Q Consensus 143 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~ 221 (443)
+++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999865443222223345678899999999877664 89999999999999998 999998765443
Q ss_pred H-HHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 222 L-YKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 222 ~-~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
. ...+... ....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 3 3333322 334566789999999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=370.93 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=219.9
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEEC-------CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 77 (443)
.....++|++++.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 3445689999999999999999999975 356789999997543 233467889999999999 899999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCc
Q 013407 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (443)
Q Consensus 78 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 141 (443)
+++.+.+..|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 99999999999999999999999998654 38999999999999999999999999999999999
Q ss_pred EEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHH
Q 013407 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM 220 (443)
Q Consensus 142 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~ 220 (443)
||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 9999999999999999976543221122234457889999999987666 489999999999999999 99999998888
Q ss_pred HHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 221 NLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 221 ~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.....+..+. ...+..++..+.++|.+||..||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7777766553 45667789999999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=364.65 Aligned_cols=254 Identities=22% Similarity=0.375 Sum_probs=209.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEE----ECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
....++|++++.||+|+||.||+|. +..+++.||||++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3456899999999999999999998 56789999999997543 3345788999999999999999999999854
Q ss_pred --CCEEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 83 --KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 83 --~~~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
...+|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 456899999999999999998754 49999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH----------------HH
Q 013407 160 LSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----------------NL 222 (443)
Q Consensus 160 ~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----------------~~ 222 (443)
........ .......||+.|+|||++.+..++ .++||||||+++|+|++|..||...... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 65432211 122344577889999999887774 8999999999999999999998754322 11
Q ss_pred HHHhh-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 223 YKKIS-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 223 ~~~i~-~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
...+. ....+.|..+++++.+||.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22222 2345667789999999999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=378.60 Aligned_cols=253 Identities=24% Similarity=0.445 Sum_probs=207.6
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----------CCCcceEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----------HPNVVRLY 77 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~ 77 (443)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ..+.+.+|+.++++++ ||||++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 45799999999999999999999999999999999975432 3456788999998886 89999999
Q ss_pred EEEEeCC----EEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccC---
Q 013407 78 EVMGSKT----KIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAY--- 147 (443)
Q Consensus 78 ~~~~~~~----~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~--- 147 (443)
+++...+ .+++||||+ |++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9987654 799999999 88999999763 4699999999999999999999998 99999999999999543
Q ss_pred ---CCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH-----
Q 013407 148 ---GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----- 219 (443)
Q Consensus 148 ---~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----- 219 (443)
+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4799999999976433 2334579999999999988777 4899999999999999999999986542
Q ss_pred -HHHHHHhh------------------------------------------cCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 013407 220 -MNLYKKIS------------------------------------------AAEFTCPPWLSFTARKLIARILDPNPMTR 256 (443)
Q Consensus 220 -~~~~~~i~------------------------------------------~~~~~~~~~~s~~~~~li~~mL~~dP~~R 256 (443)
......+. .....++...+.++.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111111 11122333456789999999999999999
Q ss_pred CChhhhhcCccccccC
Q 013407 257 ITIPEILEDEWFKKDY 272 (443)
Q Consensus 257 ~t~~eil~hp~~~~~~ 272 (443)
||++|+++||||+...
T Consensus 326 pt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTL 341 (373)
T ss_dssp BCHHHHHTCGGGTTCT
T ss_pred CCHHHHhhChhhhccc
Confidence 9999999999998643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=373.14 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=210.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 87 (443)
.-++|++.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+++.+ +||||+++++++.+....|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34789999999999999999999999999999999875432 23578999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC-----eEEeecCccccc
Q 013407 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-----LKVSDFGLSALS 161 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~-----~kl~DFGla~~~ 161 (443)
+||||+ |++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 9999999986 468999999999999999999999999999999999999998887 999999999865
Q ss_pred ccccCCC-----ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC---cHHHHHHHhhcCccCC
Q 013407 162 QQVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTC 233 (443)
Q Consensus 162 ~~~~~~~-----~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~ 233 (443)
....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 4322211 1246789999999999988777 48999999999999999999999874 3445555554443333
Q ss_pred CC-----CCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 234 PP-----WLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 234 ~~-----~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
+. .++ ++.++|.+||..||.+||+++++++
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 21 244 9999999999999999999998876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=357.39 Aligned_cols=249 Identities=19% Similarity=0.313 Sum_probs=216.4
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-- 83 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 83 (443)
.....++|++.+.||+|+||.||+|.+. ++.||||++...... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 4567899999999999999999999984 788999999865432 33457799999999999999999999999887
Q ss_pred CEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
...++||||++||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78999999999999999998765 4899999999999999999999999 9999999999999999999999998865
Q ss_pred ccccccCCCccccccCCCcccchhhhccCCCCC--CchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC--ccCCCC
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG--STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPP 235 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~--~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~ 235 (443)
... .....||+.|+|||++.+..+.. .++|||||||++|+|++|..||.+.+.......+... ....|.
T Consensus 162 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3kmu_A 162 SFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234 (271)
T ss_dssp TTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred eec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC
Confidence 321 23457899999999998765542 2799999999999999999999988877765555433 445677
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+++.+.++|.+||+.||.+|||++++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 79999999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=360.92 Aligned_cols=250 Identities=21% Similarity=0.262 Sum_probs=212.2
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 87 (443)
.-++|++.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+++.+ +|+|++++++++.+....|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 45689999999999999999999999999999999875432 23578899999999 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC-----eEEeecCccccc
Q 013407 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-----LKVSDFGLSALS 161 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~-----~kl~DFGla~~~ 161 (443)
+||||+ |++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999 999999998754 5999999999999999999999999999999999999988776 999999999865
Q ss_pred ccccCC-----CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC---cHHHHHHHhhcCcc--
Q 013407 162 QQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEF-- 231 (443)
Q Consensus 162 ~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~-- 231 (443)
...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +....+..+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 443221 12345679999999999988776 48999999999999999999999874 33344444433222
Q ss_pred ---CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 232 ---TCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 232 ---~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..++.+++++.+||.+||+.||.+|||++++++.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1234688999999999999999999999999763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=361.31 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=217.0
Q ss_pred CCccccccccccEEEEeEeeccCcEEEEEEEECC---CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEE
Q 013407 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY 77 (443)
Q Consensus 1 ~~~~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 77 (443)
|+.+..+...++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp --CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred CCCccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5567778889999999999999999999998654 34469999997653 233457899999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecC
Q 013407 78 EVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (443)
Q Consensus 78 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFG 156 (443)
+++.+. ..|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 80 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 80 GIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence 998754 568999999999999999764 459999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCC
Q 013407 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCP 234 (443)
Q Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~ 234 (443)
++....... ........||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..+ ..+.|
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 159 LSRYIEDED-YYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred CCccccccc-ccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 987654321 1122345678899999999877764 89999999999999998 99999877666665555544 44566
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 235 PWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 235 ~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..+++.+.++|.+||..||.+|||+.+++++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 7789999999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=370.20 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=209.5
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceE----EEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPV----ALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
...++|++++.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 34678999999999999999999998888876 555554322 122356788999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
. .++++||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 88999999999999999764 579999999999999999999999999999999999999999999999999998754
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHH
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (443)
............||+.|+|||++.+..|. .++|||||||++|+|++ |..||.+.+.......+..+ ....++.++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999887775 89999999999999999 99999988777766666555 35667789999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 241 ARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+.+||.+||..||.+|||+.++++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=361.90 Aligned_cols=255 Identities=30% Similarity=0.534 Sum_probs=207.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..+++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 46789999999999999999999999999999999998654444555678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 88 IVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999998864 46799999999999999999999999999999999999999999999999999876433
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc--HHHHHHHhhcCccCC--CCCCCH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISAAEFTC--PPWLSF 239 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~~~--~~~~s~ 239 (443)
. ........||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.. .......+....++. +..++.
T Consensus 189 ~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 189 K--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred C--CccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 2 2223456799999999999877664 89999999999999999999997643 334555555544332 245899
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 240 TARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
++.+||.+||..||.+|||+.+++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=370.57 Aligned_cols=260 Identities=20% Similarity=0.282 Sum_probs=217.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEE-----ECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
...++|++++.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 456799999999999999999999 55678899999996432 23345678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC---CCeEE
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKV 152 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~~kl 152 (443)
....|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999998753 48999999999999999999999999999999999999954 45999
Q ss_pred eecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-c
Q 013407 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-E 230 (443)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~ 230 (443)
+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+ .
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 999998765433222333456789999999999877764 89999999999999998 99999988887777776655 3
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 231 ~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
...+..++..+.++|.+||..||.+|||+.++++|.|+..
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 4556678999999999999999999999999999988753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=369.50 Aligned_cols=252 Identities=22% Similarity=0.366 Sum_probs=216.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceE--EEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPV--ALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~v--AiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (443)
...++|++.+.||+|+||.||+|.+..++..+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45689999999999999999999998888765 999987432 223456789999999999 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC
Q 013407 85 KIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~ 148 (443)
..|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 699999999999999999999999999999999999999999
Q ss_pred CeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhh
Q 013407 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS 227 (443)
Q Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 227 (443)
.+||+|||++...... .......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+.
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999998743221 122344578899999999876664 89999999999999998 999999998888888776
Q ss_pred cC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 228 AA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 228 ~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+ ....+..+++.+.+||.+||..||.+|||+++++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65 345667789999999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=355.54 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=218.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 34679999999999999999999986 5778999999865432 256889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+||||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999999999765 5689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 244 (443)
.......||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+..+. ...|..++..+.++
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 160 -TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp -HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred -cccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence 11233457889999999987776 489999999999999999 999999988888777776663 44566789999999
Q ss_pred HHHhcCCCCCCCCChhhhhcC
Q 013407 245 IARILDPNPMTRITIPEILED 265 (443)
Q Consensus 245 i~~mL~~dP~~R~t~~eil~h 265 (443)
+.+||+.||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=360.29 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=216.5
Q ss_pred cccccccEEEEe-EeeccCcEEEEEEEE--CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 6 IKRRVGKYEVGR-TIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 6 ~~~~~~~y~~~~-~LG~G~~g~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
+....++|++.+ .||+|+||.||+|.+ ..+++.||||++..... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 344567899998 999999999999954 56788999999976532 233467899999999999999999999999 5
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
.+..|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 67789999999999999999988889999999999999999999999999999999999999999999999999987643
Q ss_pred cccCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCH
Q 013407 163 QVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSF 239 (443)
Q Consensus 163 ~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~ 239 (443)
..... .......||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+.......+..+. ...|..+++
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 247 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 32111 112234567899999999876664 89999999999999999 999999988887777776553 456778999
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 240 TARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+.++|.+||+.||.+|||+.++++
T Consensus 248 ~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 248 EMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=367.55 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=216.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEE-----CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 80 (443)
....++|++.+.||+|+||.||+|.+ ..+++.||||++..... ....+.+.+|+.+++++ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 34567999999999999999999985 45678999999976432 33456789999999999 799999999998
Q ss_pred EeCC-EEEEEEeccCCCchHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEE
Q 013407 81 GSKT-KIFIVLEFVTGGELFDKIVNHGR----------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (443)
Q Consensus 81 ~~~~-~~~lv~E~~~gg~L~~~i~~~~~----------------l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIL 143 (443)
...+ .+|+||||+.||+|.+++..... +++..++.++.||+.||.|||++||+||||||+||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7654 59999999999999999987654 899999999999999999999999999999999999
Q ss_pred EccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHH-H
Q 013407 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-N 221 (443)
Q Consensus 144 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~-~ 221 (443)
++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.... .
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 999999999999999765432222223345688999999999887764 89999999999999998 99999876533 3
Q ss_pred HHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 222 LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 222 ~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
....+..+ ....|..+++.+.++|.+||..||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33444333 455677799999999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=361.44 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=221.3
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.....++|++.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34567899999999999999999999999999999999975432 34678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
.|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999999864 4599999999999999999999999999999999999999999999999999976433
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (443)
.. ........||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+.......+... ....|..+++.+
T Consensus 164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (288)
T 3kfa_A 164 DT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241 (288)
T ss_dssp SS-SEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred Cc-cccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHH
Confidence 21 1122344578899999999877764 89999999999999999 99999988777666666554 455667799999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhc
Q 013407 242 RKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+||.+||..||.+|||+.++++
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999999999999999976
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=367.98 Aligned_cols=254 Identities=21% Similarity=0.253 Sum_probs=205.7
Q ss_pred cccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
+.+-...++|++.+.||+|+||.||+|.+. ++.||||++..... ......+|+.+++.++||||+++++++.+.
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 445567789999999999999999999875 78999999975432 234556799999999999999999999774
Q ss_pred C----EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcEeeeCCCCcEEEccCCC
Q 013407 84 T----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR----------GVYHRDLKPENLLLDAYGN 149 (443)
Q Consensus 84 ~----~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~----------givHrDlkp~NILl~~~~~ 149 (443)
. .+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 3 47999999999999999976 4599999999999999999999999 9999999999999999999
Q ss_pred eEEeecCcccccccccCCCccccccCCCcccchhhhccCCC----CCCchhhhhhhHHHHHHhhCCCCCCCCc-------
Q 013407 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY----DGSTADLWSCGVILFVLLAGYLPFDDSN------- 218 (443)
Q Consensus 150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~----~~~~~DIwSlGvil~~ll~G~~Pf~~~~------- 218 (443)
+||+|||+|...............+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+..
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999986554333333455789999999999976322 2357899999999999999999997542
Q ss_pred ---------HHHHHHHhhcCcc--CCCCC-----CCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 219 ---------LMNLYKKISAAEF--TCPPW-----LSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 219 ---------~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.......+..... ..+.. .+..+.+||.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1222222222211 11111 2345999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=359.27 Aligned_cols=258 Identities=23% Similarity=0.336 Sum_probs=219.4
Q ss_pred cccccccEEEEe-EeeccCcEEEEEEEEC--CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 6 IKRRVGKYEVGR-TIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 6 ~~~~~~~y~~~~-~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
+...-++|.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 445667888887 9999999999999864 467889999997643 233467899999999999999999999999 4
Q ss_pred CCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
.+..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 56699999999999999998654 56999999999999999999999999999999999999999999999999999765
Q ss_pred ccccC-CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCC
Q 013407 162 QQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLS 238 (443)
Q Consensus 162 ~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s 238 (443)
..... ........||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+. ...|+.++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 239 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence 33211 1112334578999999999876664 89999999999999998 999999888777777776653 56677899
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcCcc
Q 013407 239 FTARKLIARILDPNPMTRITIPEILEDEW 267 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~hp~ 267 (443)
+.+.++|.+||..||.+|||+.++++|.+
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=369.33 Aligned_cols=257 Identities=21% Similarity=0.348 Sum_probs=216.2
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCc-----eEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEE
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV 79 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 79 (443)
.....++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34456789999999999999999999977664 79999997643 233457899999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc
Q 013407 80 MGSKTKIFIVLEFVTGGELFDKIVN--------------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD 145 (443)
Q Consensus 80 ~~~~~~~~lv~E~~~gg~L~~~i~~--------------~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~ 145 (443)
+.+.+..|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 9999999999999999999999865 24589999999999999999999999999999999999999
Q ss_pred cCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHH
Q 013407 146 AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYK 224 (443)
Q Consensus 146 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~ 224 (443)
.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999865433222223345678899999999877764 89999999999999998 999998765443333
Q ss_pred Hh-hcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 225 KI-SAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 225 ~i-~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+ ..+ ....|...+..+.+||.+||+.||.+|||+.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 32 222 344567789999999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=364.68 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=207.8
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECC---CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
...-++|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3456799999999999999999998765 456899999976533 233457789999999999999999999998765
Q ss_pred C-----EEEEEEeccCCCchHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEE
Q 013407 84 T-----KIFIVLEFVTGGELFDKIV------NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (443)
Q Consensus 84 ~-----~~~lv~E~~~gg~L~~~i~------~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl 152 (443)
. ..|+||||+.+|+|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 5 3599999999999999984 3356999999999999999999999999999999999999999999999
Q ss_pred eecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-c
Q 013407 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-E 230 (443)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~ 230 (443)
+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+ .
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 999998765432222223345678899999999877664 89999999999999999 99999988877776666555 4
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 231 ~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
...+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45667789999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=367.47 Aligned_cols=257 Identities=21% Similarity=0.349 Sum_probs=192.9
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~ 85 (443)
....++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+. +++.++||||+++++++.+.+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 4567899999999999999999999999999999999976432 222344555555 7888899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 86 IFIVLEFVTGGELFDKIVN-----HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
.|+||||+.| +|.+.+.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999986 77777653 57799999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCCccccccCCCcccchhhhc----cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhcCcc-CC
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEF-TC 233 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~-~~ 233 (443)
..... .......||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.. .....+..+.. ..
T Consensus 175 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 175 QLVDS---IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp C---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred ecccc---cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 54321 2223447999999999983 3344 58999999999999999999999875432 22223322221 11
Q ss_pred C----CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 234 P----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 234 ~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+ ..+++.+.+||.+||..||.+|||+.++++||||..
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 1 347899999999999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=356.18 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=209.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHH----HHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM----AEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
...++|++.+.||+|+||.||+|.+..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 45679999999999999999999999999999999997644332211 16789999999999999999999999766
Q ss_pred CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeeCCCCcEEEccCCC-----eEEeec
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGN-----LKVSDF 155 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~-----~kl~DF 155 (443)
. ++||||+.+|+|.+.+... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6 6999999999999988654 47999999999999999999999999 999999999999988876 999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccC-CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHH--HHHHhhcC--c
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN--LYKKISAA--E 230 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~--~~~~i~~~--~ 230 (443)
|++.... .......||+.|+|||++... ...+.++|||||||++|+|++|..||...+... ....+... .
T Consensus 174 g~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 174 GLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp TTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred Ccccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 9987422 223456799999999998432 223588999999999999999999998654332 23333322 3
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 231 ~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4566779999999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=360.54 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=208.4
Q ss_pred cccEEEEeEeeccCcEEEEEEE----ECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 013407 10 VGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-- 83 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 83 (443)
-.+|++++.||+|+||.||+|. +..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3569999999999999999999 567899999999976542 22356789999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
..+|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 678999999999999999944 4679999999999999999999999999999999999999999999999999998654
Q ss_pred cccCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc---------------HHHHHHHh
Q 013407 163 QVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---------------LMNLYKKI 226 (443)
Q Consensus 163 ~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---------------~~~~~~~i 226 (443)
..... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.... .......+
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 32111 123345688899999999877765 88999999999999999999864321 11222333
Q ss_pred hc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 227 SA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 227 ~~-~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.. .....|+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 32 245567789999999999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=374.00 Aligned_cols=253 Identities=22% Similarity=0.359 Sum_probs=206.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEEC---CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
..++|++.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 4568999999999999999999986 457789999997543 23345789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999999999998754 6999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCC-ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 013407 165 RDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (443)
Q Consensus 165 ~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (443)
.... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+ ..+.+..++..+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 279 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279 (373)
T ss_dssp -------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHH
T ss_pred CccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 1111 11223457789999999887775 89999999999999998 99999988888777777655 345566789999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhc
Q 013407 242 RKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+||.+||+.||.+|||+.++++
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=363.30 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=212.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCC----ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
..-++|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 34578999999999999999999986553 359999997543 233456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
+..|+||||+.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999999764 679999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCC-ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCH
Q 013407 163 QVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (443)
Q Consensus 163 ~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 239 (443)
...... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+ ..+.+..++.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 277 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred cccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence 321111 12233467899999999877664 89999999999999998 99999988887777777655 4556677899
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 240 TARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+.++|.+||+.||.+||++.+++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=372.62 Aligned_cols=257 Identities=22% Similarity=0.334 Sum_probs=212.2
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
.+....++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44567789999999999999999999974 68899999987543 223567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
..|+||||+.||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999886543 589999999999999999999999999999999999999999999999999976
Q ss_pred cccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHH------H-HHHhhcCcc--
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN------L-YKKISAAEF-- 231 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~------~-~~~i~~~~~-- 231 (443)
.............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..... . ......+..
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred cccccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 443333333445679999999999987766 489999999999999999999997643221 1 011111111
Q ss_pred --------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCc
Q 013407 232 --------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 266 (443)
Q Consensus 232 --------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp 266 (443)
..++..+..+.+++.+||+.||.+|||+.++++|-
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11222456789999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=355.19 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=212.2
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 82 (443)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3478999999999999999999999999999999997543 246689999999999999999998854
Q ss_pred ----------CCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCe
Q 013407 83 ----------KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (443)
Q Consensus 83 ----------~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~ 150 (443)
...+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 45689999999999999999754 579999999999999999999999999999999999999999999
Q ss_pred EEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc
Q 013407 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (443)
Q Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 230 (443)
||+|||++...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||... ......+...
T Consensus 162 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~- 234 (284)
T 2a19_B 162 KIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG- 234 (284)
T ss_dssp EECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT-
T ss_pred EECcchhheecccc---ccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc-
Confidence 99999998764332 22345679999999999987766 48999999999999999999988532 2333333333
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 231 ~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
..+..++..+.+||.+||..||.+|||+.++++|.|...
T Consensus 235 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 -IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 345678999999999999999999999999999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=378.74 Aligned_cols=245 Identities=24% Similarity=0.447 Sum_probs=212.8
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-E
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-K 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~ 85 (443)
....++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+|++++||||+++++++.... .
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 345789999999999999999999984 6799999997643 2457889999999999999999999986654 7
Q ss_pred EEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
+|+||||+.+|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999999987543 79999999999999999999999999999999999999999999999999874322
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (443)
......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++.+
T Consensus 342 -----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 342 -----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 415 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred -----cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 12234678899999999887775 89999999999999998 99999988777666666655 456778899999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhc
Q 013407 242 RKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+||.+||..||.+|||+.++++
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=354.83 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=214.5
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCc---eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
+...--.|++.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 16 i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 33444578888999999999999999765544 79999987532 33346788999999999999999999999987
Q ss_pred CCEE-EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 83 KTKI-FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 83 ~~~~-~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
.+.. ++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred CCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 6655 999999999999999976 45689999999999999999999999999999999999999999999999999975
Q ss_pred ccccc--CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCC
Q 013407 161 SQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPW 236 (443)
Q Consensus 161 ~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 236 (443)
..... .........||+.|+|||++.+..+. .++|||||||++|+|++ |.+||...+.......+..+ ....+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY 252 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTT
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCcc
Confidence 43321 12233455688999999999877764 89999999999999999 66667776666666665554 3456677
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
++..+.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=357.56 Aligned_cols=252 Identities=23% Similarity=0.435 Sum_probs=198.0
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
...-++|++.+.||+|+||.||+|.+.. .||+|++..... .....+.+.+|+.+++.++||||++++++. .....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 4556799999999999999999998643 599999976433 334467899999999999999999999965 55668
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
++||||+.|++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999999999954 4569999999999999999999999999999999999999999999999999997654433
Q ss_pred CCCccccccCCCcccchhhhc---cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhcCccC-----CCCC
Q 013407 166 DDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFT-----CPPW 236 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~-----~~~~ 236 (443)
.........||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.. .....+..+... .+..
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 333445667999999999986 3334 47899999999999999999999875544 344444443322 2235
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7899999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=367.35 Aligned_cols=254 Identities=15% Similarity=0.192 Sum_probs=201.8
Q ss_pred cccEEEEeEeeccCcEEEEEEEECC---CCceEEEEEeechhhhhHH--------HHHHHHHHHHHHhcCCCCCcceEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHK--------MAEQIKREVATMKLVKHPNVVRLYE 78 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~~ 78 (443)
-++|++.+.||+|+||.||+|.+.. ++..||||++......... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 7889999999764321110 1134668899999999999999999
Q ss_pred EEEe----CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC--CeEE
Q 013407 79 VMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG--NLKV 152 (443)
Q Consensus 79 ~~~~----~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~--~~kl 152 (443)
++.+ ....|+||||+ |++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9987 78899999999 999999998877999999999999999999999999999999999999999887 9999
Q ss_pred eecCcccccccccCC-----CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCC--cHHHHHHH
Q 013407 153 SDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--NLMNLYKK 225 (443)
Q Consensus 153 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~--~~~~~~~~ 225 (443)
+|||+|......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 999999765432211 12245689999999999987766 48999999999999999999999652 22222221
Q ss_pred hhcCccCCC---------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 226 ISAAEFTCP---------PWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 226 i~~~~~~~~---------~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
........| ..++.++.++|.+||..||.+|||++++++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 111111122 2688999999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=361.75 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=206.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE----eCC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG----SKT 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~ 84 (443)
.-++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 4568999999999999999999999999999999986532 334577899999999999999999999986 345
Q ss_pred EEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 85 KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
..|+||||+.+|+|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999999999998875 46799999999999999999999999999999999999999999999999998875
Q ss_pred cccccCCC-------ccccccCCCcccchhhhccCCC--CCCchhhhhhhHHHHHHhhCCCCCCCCcHH--HHHHHhh-c
Q 013407 161 SQQVRDDG-------LLHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAGYLPFDDSNLM--NLYKKIS-A 228 (443)
Q Consensus 161 ~~~~~~~~-------~~~~~~gt~~y~APEvl~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~~~~i~-~ 228 (443)
........ ......||+.|+|||++.+..+ .+.++|||||||++|+|++|..||...... .....+. .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 43211110 1123568999999999875442 258999999999999999999999642111 1111111 2
Q ss_pred CccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 229 AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 229 ~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
...+.++.++..+.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2334456789999999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=356.30 Aligned_cols=257 Identities=23% Similarity=0.313 Sum_probs=212.8
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCC---ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEE-
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM- 80 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~- 80 (443)
.++....+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++
T Consensus 19 ~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred ecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 34566778999999999999999999975433 358999987532 334467899999999999999999999985
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 81 GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 81 ~~~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
.+++..|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccc
Confidence 5567889999999999999999763 468999999999999999999999999999999999999999999999999997
Q ss_pred cccccc--CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCC
Q 013407 160 LSQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPP 235 (443)
Q Consensus 160 ~~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~ 235 (443)
...... .........||+.|+|||++.+..+. .++||||||+++|+|++ |.+||.+.+.......+..+. ...|.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 255 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc
Confidence 653322 11223345678899999999887764 89999999999999999 778888777666666655554 34466
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 236 WLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 236 ~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.++..+.++|.+||..||.+|||+.++++
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78999999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=353.94 Aligned_cols=249 Identities=21% Similarity=0.281 Sum_probs=206.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEE-EEeCCEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV-MGSKTKIF 87 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~ 87 (443)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+++.++|++++..+.. .......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 45789999999999999999999999999999999876432 2357899999999998876655554 46778899
Q ss_pred EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE---ccCCCeEEeecCccccccc
Q 013407 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 163 (443)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 8999999974 4679999999999999999999999999999999999999 4889999999999986544
Q ss_pred ccCC-----CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc---HHHHHHHhhcCccCCC-
Q 013407 164 VRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCP- 234 (443)
Q Consensus 164 ~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~- 234 (443)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ....+..+.......+
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 3221 12345679999999999988776 489999999999999999999998643 2223333333322222
Q ss_pred ----CCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 235 ----PWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 235 ----~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 568999999999999999999999999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=354.68 Aligned_cols=245 Identities=24% Similarity=0.445 Sum_probs=206.6
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~ 85 (443)
....++|++.+.||+|+||.||+|.+ +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+ .+.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 45678999999999999999999987 47899999997543 34678899999999999999999998754 457
Q ss_pred EEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
.|+||||+.+++|.+++...+. +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999999999999976543 89999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (443)
. .....+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..+ ....+..+++.+
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 T-----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred c-----ccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 1 2344678999999999877664 89999999999999998 99999988777766666554 445667799999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhc
Q 013407 242 RKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.++|.+||..||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=366.88 Aligned_cols=252 Identities=15% Similarity=0.198 Sum_probs=201.0
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCC-----CceEEEEEeechhhhhHHH--------HHHHHHHHHHHhcCCCCCcceEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKM--------AEQIKREVATMKLVKHPNVVRLY 77 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~hpnIv~l~ 77 (443)
++|++++.||+|+||.||+|.+..+ ++.||||++.......... ......|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4899999999999999999998764 5889999987643211111 12344577788889999999999
Q ss_pred EEEEeC----CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc--cCCCe
Q 013407 78 EVMGSK----TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD--AYGNL 150 (443)
Q Consensus 78 ~~~~~~----~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~--~~~~~ 150 (443)
+++... ...|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 998764 5689999999 99999999876 6799999999999999999999999999999999999999 88999
Q ss_pred EEeecCcccccccccCC-----CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHH
Q 013407 151 KVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYK 224 (443)
Q Consensus 151 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~ 224 (443)
||+|||+|......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ....
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 99999999765433221 12234569999999999988776 48999999999999999999999863221 1111
Q ss_pred Hhh----cC------ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 225 KIS----AA------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 225 ~i~----~~------~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
... .. ....+..++.++.+++.+||..||.+||++.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 110 00 00112457899999999999999999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=362.20 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=212.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEE----ECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--e
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--S 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~ 82 (443)
.-++|++.+.||+|+||.||+|. +..+++.||||++.... ....+.+.+|+.++++++||||+++++++. +
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 45699999999999999999999 56788999999997643 334567899999999999999999999886 5
Q ss_pred CCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~ 161 (443)
....|+||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 6779999999999999999976 456999999999999999999999999999999999999999999999999999865
Q ss_pred ccccCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH---------------HHHHH
Q 013407 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------------NLYKK 225 (443)
Q Consensus 162 ~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------------~~~~~ 225 (443)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 432111 12234568889999999987766 48999999999999999999999754432 22222
Q ss_pred hhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 226 ISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 226 i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+..+ ....++.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222 345677799999999999999999999999999764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=357.15 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=207.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECC-CCc--eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSE-TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
...++|++.+.||+|+||.||+|.+.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 455789999999999999999998643 333 68999998765444456678999999999999999999999998765
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
.++||||+.+++|.+.+... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 88999999999999998764 5699999999999999999999999999999999999999999999999999876533
Q ss_pred ccCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc--cCCCCCCCH
Q 013407 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLSF 239 (443)
Q Consensus 164 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~ 239 (443)
.... .......||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+.......+.... .+.+..++.
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence 2111 112345678899999999876664 89999999999999999 999999988887777775543 345567899
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 240 TARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+.++|.+||..||.+|||+.+++++
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=376.02 Aligned_cols=252 Identities=23% Similarity=0.434 Sum_probs=207.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--E
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--K 85 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 85 (443)
..-++|++.+.||+|+||.||+|.+..+|+.||||++....... ..+.+.+|+.++++++||||+++++++.+.. .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 34578999999999999999999999999999999998654332 2466789999999999999999999998755 7
Q ss_pred EEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE----ccCCCeEEeecCcc
Q 013407 86 IFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~~~~kl~DFGla 158 (443)
.|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997643 39999999999999999999999999999999999999 77778999999999
Q ss_pred cccccccCCCccccccCCCcccchhhhcc--------CCCCCCchhhhhhhHHHHHHhhCCCCCCCC----cHHHHHHHh
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLND--------RGYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKI 226 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~--------~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i 226 (443)
...... ......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||... ...+...++
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 764332 22345679999999999864 233 47899999999999999999999642 223444444
Q ss_pred hcCccC-------------------CC------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 227 SAAEFT-------------------CP------PWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 227 ~~~~~~-------------------~~------~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..+... .| ..++..+.++|++||+.||.+|||+++++++
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 333211 11 1245678899999999999999999998653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=376.75 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=214.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. ....|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 45578999999999999999999985 467899999976432 2467899999999999999999999986 66789
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999999754 368999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
. .......+|+.|+|||++....+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.+.+
T Consensus 339 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 339 Y-TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp H-HTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred e-eccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 111234467889999999877764 89999999999999999 99999998888777777655 45667789999999
Q ss_pred HHHHhcCCCCCCCCChhhhhc
Q 013407 244 LIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~ 264 (443)
||.+||..||.+|||++++++
T Consensus 417 li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=353.32 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=203.2
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEE-EEeCCEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV-MGSKTKIF 87 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~ 87 (443)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+.. +.+....+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 44789999999999999999999999999999999765432 2357889999999988776666554 47788899
Q ss_pred EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE---ccCCCeEEeecCccccccc
Q 013407 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 163 (443)
+||||+ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 8999999974 4679999999999999999999999999999999999999 7889999999999986544
Q ss_pred ccCC-----CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH---HHHHHhhcCccCCC-
Q 013407 164 VRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKKISAAEFTCP- 234 (443)
Q Consensus 164 ~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~~~~~~~~- 234 (443)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.. ..+..+.......|
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 3221 12345689999999999988776 48999999999999999999999864321 22333332222222
Q ss_pred ----CCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 235 ----PWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 235 ----~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
..+++.+.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 567899999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=383.46 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=218.4
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
....+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|++++||||+++++++.+...+|
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 345689999999999999999999998899999999976432 2457889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999999864 458999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
........+|+.|+|||++....+. .++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++.+.+
T Consensus 373 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 450 (495)
T 1opk_A 373 -YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 450 (495)
T ss_dssp -EECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -eeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1112234567889999999877664 89999999999999999 99999988877766666554 45567789999999
Q ss_pred HHHHhcCCCCCCCCChhhhhc
Q 013407 244 LIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~ 264 (443)
||.+||+.||.+|||+.++++
T Consensus 451 li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 451 LMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=349.94 Aligned_cols=250 Identities=21% Similarity=0.352 Sum_probs=214.0
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 445689999999999999999999985 5678999999764321 3578899999999999999999999864 568
Q ss_pred EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
|+||||+.|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999999987543 6999999999999999999999999999999999999999999999999999765332
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (443)
.. .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..+....+..+ ....+..++..+.
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (279)
T 1qpc_A 163 EY-TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240 (279)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cc-ccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHH
Confidence 11 11233457889999999987666 489999999999999999 99999998887777777655 3455667899999
Q ss_pred HHHHHhcCCCCCCCCChhhhhc
Q 013407 243 KLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~ 264 (443)
++|.+||..||.+|||+.++++
T Consensus 241 ~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 241 QLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999976
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=366.06 Aligned_cols=248 Identities=16% Similarity=0.216 Sum_probs=203.1
Q ss_pred cccccEEEEeEeeccCcEEEEEE-----EECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC---CCCcceEEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEV 79 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a-----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~ 79 (443)
..-++|++.+.||+|+||.||+| .+..+++.||||++.... ...+.+|+.+++.++ |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34568999999999999999999 466789999999997543 335677888888886 9999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc--------
Q 013407 80 MGSKTKIFIVLEFVTGGELFDKIVN-----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------- 146 (443)
Q Consensus 80 ~~~~~~~~lv~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-------- 146 (443)
+...+..|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999973 567999999999999999999999999999999999999998
Q ss_pred ---CCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHH
Q 013407 147 ---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223 (443)
Q Consensus 147 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~ 223 (443)
++.+||+|||+|...............+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 899999999999765443334445667899999999999887775 89999999999999999999996543211
Q ss_pred HHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCc
Q 013407 224 KKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 266 (443)
Q Consensus 224 ~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp 266 (443)
..........+.+....+++.+||+.+|.+|++..+.+.+.
T Consensus 293 --~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 293 --CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp --EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred --eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 00011111224577899999999999999997765555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=351.83 Aligned_cols=235 Identities=33% Similarity=0.590 Sum_probs=196.2
Q ss_pred cccccccEEEE-eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEe-
Q 013407 6 IKRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGS- 82 (443)
Q Consensus 6 ~~~~~~~y~~~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~- 82 (443)
.+..+++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.+
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 45678899998 7899999999999999999999999999642 2456788887 66699999999999987
Q ss_pred ---CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc---CCCeEEee
Q 013407 83 ---KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSD 154 (443)
Q Consensus 83 ---~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~~kl~D 154 (443)
...+|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 778999999999999999998754 6999999999999999999999999999999999999998 78899999
Q ss_pred cCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHH----hhcCc
Q 013407 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK----ISAAE 230 (443)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~----i~~~~ 230 (443)
||++.... +..+ +.++|||||||++|+|++|..||.+.+....... +....
T Consensus 164 fg~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 218 (299)
T 3m2w_A 164 FGFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218 (299)
T ss_dssp CTTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred cccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence 99886321 1223 4789999999999999999999987655443221 22233
Q ss_pred cCCC----CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 231 FTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 231 ~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
...| ..+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 3333 458999999999999999999999999999999987543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=372.64 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=195.8
Q ss_pred cccccccccE-EEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 013407 4 PKIKRRVGKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (443)
Q Consensus 4 ~~~~~~~~~y-~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 81 (443)
+.....+++| .+.+.||+|+||+||.+. ..+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.
T Consensus 7 p~~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 79 (434)
T 2rio_A 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSET 79 (434)
T ss_dssp -CCSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cchhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 4455555554 556889999999998754 4579999999987543 24567899999876 8999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC-------
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNHGRMK-------EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY------- 147 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~~~l~-------e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~------- 147 (443)
+.+.+|+||||+. |+|.+++....... +..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 9999999999996 59999998755432 33457899999999999999999999999999999754
Q ss_pred ------CCeEEeecCcccccccccCC--CccccccCCCcccchhhhcc------CCCCCCchhhhhhhHHHHHHhh-CCC
Q 013407 148 ------GNLKVSDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLND------RGYDGSTADLWSCGVILFVLLA-GYL 212 (443)
Q Consensus 148 ------~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~------~~~~~~~~DIwSlGvil~~ll~-G~~ 212 (443)
+.+||+|||++......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 47999999999865432211 12345689999999999965 1334689999999999999999 999
Q ss_pred CCCCCcHHHHHHHhhcCccCCC-------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 213 PFDDSNLMNLYKKISAAEFTCP-------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 213 Pf~~~~~~~~~~~i~~~~~~~~-------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
||.+..... ..+..+....+ ..+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 239 Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 239 PFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 998654433 22222322222 124678999999999999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=375.38 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=196.9
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
+|.+.+.||+|+||+|+. ....+|+.||||++...... .+.+|+.+++.+ +||||+++++++.+....|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 599999999999999764 33457899999999764322 356899999999 7999999999999999999999
Q ss_pred eccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc---C--CCeEEeecCcccccccc
Q 013407 91 EFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---Y--GNLKVSDFGLSALSQQV 164 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~--~~~kl~DFGla~~~~~~ 164 (443)
||+. |+|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||+|......
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9997 59999997654 4666678899999999999999999999999999999953 2 35789999999865432
Q ss_pred cC-CCccccccCCCcccchhhhccC--CCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCccCC---CCCC
Q 013407 165 RD-DGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTC---PPWL 237 (443)
Q Consensus 165 ~~-~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~ 237 (443)
.. .......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||...........+....... +...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 11 1233456899999999999742 223478999999999999999 999997665544433332222211 2224
Q ss_pred CHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+..+.+||.+||+.||.+|||+.++++||||..
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 667899999999999999999999999999964
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=349.43 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=197.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEe--
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGS-- 82 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~-- 82 (443)
....++|++.+.||+|+||.||+|.+ +|+.||||++.... .....+|.+++.. ++||||+++++++.+
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34567999999999999999999997 68899999997543 2344556666655 799999999998644
Q ss_pred --CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEeeeCCCCcEEEccCCCeEE
Q 013407 83 --KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH--------SRGVYHRDLKPENLLLDAYGNLKV 152 (443)
Q Consensus 83 --~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~givHrDlkp~NILl~~~~~~kl 152 (443)
....|+||||+.+|+|.+++.. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999954 67999999999999999999999 999999999999999999999999
Q ss_pred eecCcccccccccCC--CccccccCCCcccchhhhccCCCC-----CCchhhhhhhHHHHHHhhC----------CCCCC
Q 013407 153 SDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYD-----GSTADLWSCGVILFVLLAG----------YLPFD 215 (443)
Q Consensus 153 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~-----~~~~DIwSlGvil~~ll~G----------~~Pf~ 215 (443)
+|||+|......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999754332111 112345899999999999765332 2589999999999999999 88986
Q ss_pred CCc----HHHHHHHhhcC---ccCCCCC-----CCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 216 DSN----LMNLYKKISAA---EFTCPPW-----LSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 216 ~~~----~~~~~~~i~~~---~~~~~~~-----~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
... ........... ....|.. .++.+.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 432 12222222211 1222221 4567999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=373.21 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=210.4
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..-++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|++++||||+++++++.+ ...|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 445789999999999999999999865 456999999764422 3568899999999999999999999876 6789
Q ss_pred EEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999999964 3569999999999999999999999999999999999999999999999999998653311
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
........+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|+.+++.+.+
T Consensus 335 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 335 -YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -eecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1112334567899999999877764 89999999999999999 99999998888777777655 45667789999999
Q ss_pred HHHHhcCCCCCCCCChhhhhc
Q 013407 244 LIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~ 264 (443)
||.+||+.||.+|||++++++
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=362.53 Aligned_cols=245 Identities=15% Similarity=0.175 Sum_probs=202.9
Q ss_pred cccEEEEeEeeccCcEEEEEEEECC--------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcce------
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSE--------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR------ 75 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~------ 75 (443)
-++|++.+.||+|+||.||+|.+.. .++.||+|++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3799999999999999999999987 4889999999754 35778999999999999887
Q ss_pred ---------EEEEEEe-CCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEE
Q 013407 76 ---------LYEVMGS-KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (443)
Q Consensus 76 ---------l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIL 143 (443)
+++++.. ....|+||||+ |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777766 78899999999 99999999876 78999999999999999999999999999999999999
Q ss_pred EccCC--CeEEeecCcccccccccCC-----CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCC
Q 013407 144 LDAYG--NLKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216 (443)
Q Consensus 144 l~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~ 216 (443)
++.++ .+||+|||++......... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99988 8999999999765432211 12244589999999999987766 4899999999999999999999987
Q ss_pred Cc--HHHHHHHh---hcCccCCC------CCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 217 SN--LMNLYKKI---SAAEFTCP------PWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 217 ~~--~~~~~~~i---~~~~~~~~------~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.. ........ ......++ ..+++.+.+||.+||..||.+|||++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 53 22222222 22211111 236899999999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=356.89 Aligned_cols=252 Identities=29% Similarity=0.425 Sum_probs=189.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEE-------
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVM------- 80 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~------- 80 (443)
.-.+|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3458999999999999999999999999999999986543 234567889999999995 99999999998
Q ss_pred -EeCCEEEEEEeccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeeCCCCcEEEccCCCeEEee
Q 013407 81 -GSKTKIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSD 154 (443)
Q Consensus 81 -~~~~~~~lv~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kl~D 154 (443)
.....++++|||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence 34556899999996 688888754 567999999999999999999999999 99999999999999999999999
Q ss_pred cCcccccccccCC----------CccccccCCCcccchhhhc---cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHH
Q 013407 155 FGLSALSQQVRDD----------GLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221 (443)
Q Consensus 155 FGla~~~~~~~~~----------~~~~~~~gt~~y~APEvl~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~ 221 (443)
||++......... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 9999865432111 1112457999999999983 3334 589999999999999999999998765443
Q ss_pred HHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcc
Q 013407 222 LYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267 (443)
Q Consensus 222 ~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~ 267 (443)
..... .....+...+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 261 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 261 IVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 32221 123334557889999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=356.51 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=205.8
Q ss_pred EEEEeEeeccCcEEEEEEEE----CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEE
Q 013407 13 YEVGRTIGEGTFAKVKFARN----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKI 86 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 86 (443)
|++++.||+|+||.||++.. ..+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 49999999999999988753 4578899999997653 23346789999999999999999999999987 4689
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
|+||||+.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999999764 599999999999999999999999999999999999999999999999999986543211
Q ss_pred C-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH---------------HHHHHhhcC-
Q 013407 167 D-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------------NLYKKISAA- 229 (443)
Q Consensus 167 ~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------------~~~~~i~~~- 229 (443)
. .......||+.|+|||++.+..+. .++|||||||++|+|++|..||...... .....+..+
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred ccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 1 122345688899999999877765 8999999999999999999999764322 112222222
Q ss_pred ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 230 EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 230 ~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
....+..++..+.+||.+||+.||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 34566779999999999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=351.37 Aligned_cols=243 Identities=28% Similarity=0.464 Sum_probs=200.1
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.++++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45679999999999999999999974 7889999986532 34678899999999999999999998864 478
Q ss_pred EEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEeeeCCCCcEEEccCCC-eEEeecCcccc
Q 013407 88 IVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHS---RGVYHRDLKPENLLLDAYGN-LKVSDFGLSAL 160 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~~~-~kl~DFGla~~ 160 (443)
+||||++||+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998765 37899999999999999999999 89999999999999999887 79999999875
Q ss_pred cccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc--HHHHHHHhhc-CccCCCCCC
Q 013407 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISA-AEFTCPPWL 237 (443)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~-~~~~~~~~~ 237 (443)
... ......||+.|+|||++.+..+. .++|||||||++|+|++|..||.... .......+.. .....+..+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQT-----HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred ccc-----ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 432 12345699999999999877664 89999999999999999999998543 2233333333 334555678
Q ss_pred CHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 238 SFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 238 s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+..+.++|.+||+.||.+|||+++++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=362.51 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=208.1
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
.+....++|++.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 34456789999999999999999999864 68899999997654322 1236889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSR---GVYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
..++||||+.||+|.+.+.... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 9999999999999999997643 499999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc--------HHHHHHHhhcC
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--------LMNLYKKISAA 229 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--------~~~~~~~i~~~ 229 (443)
+...... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||+... ...........
T Consensus 181 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 181 AKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp CEECCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred ccccCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 9865432 2223345569999999999987666 489999999999999999999996211 11111111110
Q ss_pred -c----------cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcc
Q 013407 230 -E----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267 (443)
Q Consensus 230 -~----------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~ 267 (443)
. ...++..+..+.+++.+||+.||.+|||+.++++|-+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 0 0111223467999999999999999999999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=383.65 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=211.0
Q ss_pred cEEEE-eEeeccCcEEEEEEEE--CCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 12 KYEVG-RTIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 12 ~y~~~-~~LG~G~~g~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.+.+. +.||+|+||.||+|.+ ..+++.||||++..... .....+.+.+|+.+|++++|||||++++++.+ ...++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999955 45678999999976432 33345789999999999999999999999975 45889
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC-C
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-D 167 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~ 167 (443)
||||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|........ .
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999999999999888999999999999999999999999999999999999999999999999999986543211 1
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLI 245 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 245 (443)
.......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+. ...|..++.++.+||
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 605 (635)
T ss_dssp --------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 122334578899999999887775 89999999999999998 999999998888877776663 566778999999999
Q ss_pred HHhcCCCCCCCCChhhhhc
Q 013407 246 ARILDPNPMTRITIPEILE 264 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~ 264 (443)
.+||..||.+|||++++++
T Consensus 606 ~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=365.72 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=203.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCC---ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-SK 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~ 83 (443)
..-..|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++. .+
T Consensus 86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 33456899999999999999999875432 468999986532 2334678999999999999999999999864 45
Q ss_pred CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
+..|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 6889999999999999999765 458999999999999999999999999999999999999999999999999997543
Q ss_pred cccCC--CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCC
Q 013407 163 QVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLS 238 (443)
Q Consensus 163 ~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s 238 (443)
..... .......||+.|+|||++.+..+. .++|||||||++|+|++ |.+||.+.+..+....+..+. ...|..++
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~ 322 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 322 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 32111 112334578899999999877774 89999999999999999 789998876655555555443 45567789
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 239 FTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..+.++|.+||..||.+|||+.+++++
T Consensus 323 ~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 323 DPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=354.08 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=203.7
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhh-hhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
|..++.||+|+||.||+|.+ +++.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 33458899999999999986 578999999975432 223456789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 92 FVTGGELFDKIVN---HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 92 ~~~gg~L~~~i~~---~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999864 3469999999999999999999999999999999999999999999999999987654332222
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH----HHHHHhhcCc-----------cCC
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAE-----------FTC 233 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~-----------~~~ 233 (443)
.....+||+.|+|||++.+. + +.++||||||+++|+|++|.+||...... .....+.... ...
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 23456799999999998753 4 58999999999999999999999875432 2222221111 112
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 234 PPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 234 ~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+...+..+.+++.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22345778999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=351.63 Aligned_cols=249 Identities=21% Similarity=0.359 Sum_probs=196.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeC--
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGSK-- 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~-- 83 (443)
...++|++.+.||+|+||.||+|.+. ++.||||++.... .....+|..++.. ++||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34578999999999999999999985 8899999996533 1233445555554 4999999999999877
Q ss_pred --CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeeeCCCCcEEEccCCCeEEe
Q 013407 84 --TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVS 153 (443)
Q Consensus 84 --~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NILl~~~~~~kl~ 153 (443)
...|+||||+.||+|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 789999999999999999976 4799999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccccccCCC--ccccccCCCcccchhhhccCCCCCC-----chhhhhhhHHHHHHhhC----------CCCCCC
Q 013407 154 DFGLSALSQQVRDDG--LLHTTCGTPNYVAPEVLNDRGYDGS-----TADLWSCGVILFVLLAG----------YLPFDD 216 (443)
Q Consensus 154 DFGla~~~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~~~~-----~~DIwSlGvil~~ll~G----------~~Pf~~ 216 (443)
|||++.......... .....+||+.|+|||++.+..+... ++|||||||++|+|++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999997543321111 1235689999999999987665432 38999999999999999 778764
Q ss_pred Cc-----HHHHHHHhhcC--ccCCCC-----CCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 217 SN-----LMNLYKKISAA--EFTCPP-----WLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 217 ~~-----~~~~~~~i~~~--~~~~~~-----~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.. .......+... ....|. .+++.+.+||.+||+.||.+|||+.++++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 32 12222222211 223332 245679999999999999999999999886
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=379.70 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=209.1
Q ss_pred cccEEEEe-EeeccCcEEEEEEEECC--CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 10 VGKYEVGR-TIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 10 ~~~y~~~~-~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
-+++.+.+ .||+|+||.||+|.+.. ++..||||++..... ....+.+.+|+.+|+.++||||+++++++.+ +.+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 34566666 89999999999998753 556799999976432 2235678999999999999999999999976 569
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999999998654 469999999999999999999999999999999999999999999999999998653321
Q ss_pred CC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHH
Q 013407 166 DD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTAR 242 (443)
Q Consensus 166 ~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 242 (443)
.. .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+. ...|+.+++++.
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 569 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 11 111233467899999999877775 89999999999999998 999999988888877776663 567778999999
Q ss_pred HHHHHhcCCCCCCCCChhhhhc
Q 013407 243 KLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~ 264 (443)
+||.+||..||.+|||+.++++
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=352.06 Aligned_cols=253 Identities=22% Similarity=0.372 Sum_probs=209.5
Q ss_pred cccccEEEEeEeeccCcEEEEEEE----ECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (443)
...++|++++.||+|+||.||+|. +..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 355789999999999999999998 46689999999997532 33457899999999999999999999998654
Q ss_pred C--EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 84 T--KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 84 ~--~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
+ .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4 789999999999999999876 4699999999999999999999999999999999999999999999999999986
Q ss_pred cccccCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH----------------HHH
Q 013407 161 SQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----------------NLY 223 (443)
Q Consensus 161 ~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----------------~~~ 223 (443)
....... .......+|+.|+|||++.+..+. .++|||||||++|+|++|..||...... .+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 5432111 112334578889999999877664 8999999999999999999998653211 111
Q ss_pred HHhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 224 KKISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 224 ~~i~~-~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
..+.. ...+.|..++.++.+||.+||..||.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22222 234566779999999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=354.51 Aligned_cols=261 Identities=20% Similarity=0.296 Sum_probs=194.8
Q ss_pred ccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--
Q 013407 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-- 82 (443)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 82 (443)
.....+++|++.+.||+|+||.||+|.+ +++.||||++...... ......|+..+..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheecccccc
Confidence 4457889999999999999999999986 6889999999754321 1122344444556899999999986532
Q ss_pred ---CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEeeeCCCCcEEEccCCCe
Q 013407 83 ---KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR---------GVYHRDLKPENLLLDAYGNL 150 (443)
Q Consensus 83 ---~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~---------givHrDlkp~NILl~~~~~~ 150 (443)
...+|+||||++||+|.+++... ..++..+..++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 34689999999999999999764 458999999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccccc------CCCccccccCCCcccchhhhccCC------CCCCchhhhhhhHHHHHHhhCCCCCCC-C
Q 013407 151 KVSDFGLSALSQQVR------DDGLLHTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLAGYLPFDD-S 217 (443)
Q Consensus 151 kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~APEvl~~~~------~~~~~~DIwSlGvil~~ll~G~~Pf~~-~ 217 (443)
||+|||++....... ........+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.. .
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999997653211 112233567999999999997631 223679999999999999999776532 1
Q ss_pred c-----------------HHHHHHHhhc--CccCCCCC------CCHHHHHHHHHhcCCCCCCCCChhhhh------cCc
Q 013407 218 N-----------------LMNLYKKISA--AEFTCPPW------LSFTARKLIARILDPNPMTRITIPEIL------EDE 266 (443)
Q Consensus 218 ~-----------------~~~~~~~i~~--~~~~~~~~------~s~~~~~li~~mL~~dP~~R~t~~eil------~hp 266 (443)
. .......+.. ....+|.. +++.+.+||.+||+.||.+|||+.|++ .++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1 1111111111 12223322 345799999999999999999999994 466
Q ss_pred cccccC
Q 013407 267 WFKKDY 272 (443)
Q Consensus 267 ~~~~~~ 272 (443)
|-++..
T Consensus 320 ~~~~~~ 325 (336)
T 3g2f_A 320 WERNKS 325 (336)
T ss_dssp CCC---
T ss_pred HHhccc
Confidence 765543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=374.48 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=214.3
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|++++||||+++++++.+ ..+|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 455789999999999999999999865 456999999764422 3568899999999999999999999876 6789
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999999999643 569999999999999999999999999999999999999999999999999997643211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
. .......++..|+|||++....+. .++|||||||++|+|++ |..||.+....+....+..+ ....|..++..+.+
T Consensus 418 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 418 Y-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp H-HTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred e-ecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 0 111234567889999999877664 89999999999999999 99999998888777777655 45667789999999
Q ss_pred HHHHhcCCCCCCCCChhhhhc
Q 013407 244 LIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~ 264 (443)
||.+||+.||.+|||++++++
T Consensus 496 li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=388.27 Aligned_cols=259 Identities=28% Similarity=0.395 Sum_probs=207.8
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--- 82 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 82 (443)
.+..+++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 4567799999999999999999999999999999999987542 23346788999999999999999999998765
Q ss_pred ---CCEEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC---eEEe
Q 013407 83 ---KTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVS 153 (443)
Q Consensus 83 ---~~~~~lv~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~---~kl~ 153 (443)
.+..|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 677899999999999999998754 6999999999999999999999999999999999999998775 9999
Q ss_pred ecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHH--------
Q 013407 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK-------- 225 (443)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~-------- 225 (443)
|||++..... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+......+..
T Consensus 167 DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 167 DLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp SCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred cccccccccc---ccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 9999986533 2233456899999999999877774 899999999999999999999976533221100
Q ss_pred ------hhcCcc------C----CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 226 ------ISAAEF------T----CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 226 ------i~~~~~------~----~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
...+.. + .++.+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 011111 1 11225678999999999999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.45 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=210.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
....++|++.+.||+|+||.||+|.+.. .||+|++...... ....+.+.+|+.+++.++||||+++++++.+...+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 4567899999999999999999999853 4999999764322 12235677899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc-
Q 013407 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV- 164 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 164 (443)
|+||||+.|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999999999997754 699999999999999999999999999999999999998 689999999998754321
Q ss_pred --cCCCccccccCCCcccchhhhccC--------CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC-
Q 013407 165 --RDDGLLHTTCGTPNYVAPEVLNDR--------GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC- 233 (443)
Q Consensus 165 --~~~~~~~~~~gt~~y~APEvl~~~--------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~- 233 (443)
..........||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+..+..+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 122233455799999999998742 223588999999999999999999999988877777766554332
Q ss_pred -CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 234 -PPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 234 -~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+..++.++.++|.+||..||.+|||+.++++.
T Consensus 264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 23578999999999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=378.15 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=214.2
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCC---CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
...++|++.+.||+|+||.||+|.+..+ +..||||.+.... .....+.+.+|+.+++.++||||+++++++. .+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 4567899999999999999999998654 4569999986532 3344578999999999999999999999985 45
Q ss_pred EEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..|+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 6899999999999999997654 699999999999999999999999999999999999999999999999999986533
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (443)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|+.+++.+
T Consensus 544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 544 ST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred Cc-ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 21 1122334578899999999877764 89999999999999997 99999998888877777655 356778899999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcC
Q 013407 242 RKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+||.+||..||.+|||+.++++.
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=366.44 Aligned_cols=251 Identities=18% Similarity=0.211 Sum_probs=196.2
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-CCc---------c---
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNV---------V--- 74 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnI---------v--- 74 (443)
.....|++.+.||+|+||.||+|.+..+|+.||||++...........+.+++|+.+++.++| +|. +
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 344569999999999999999999999999999999974443333335779999999999987 221 1
Q ss_pred ---------eEEEEEEe-----CCEEEEEEeccCCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q 013407 75 ---------RLYEVMGS-----KTKIFIVLEFVTGGELFDKIVN-------HGRMKEDEARRYFQQLINAVDYCHSRGVY 133 (443)
Q Consensus 75 ---------~l~~~~~~-----~~~~~lv~E~~~gg~L~~~i~~-------~~~l~e~~~~~~~~qi~~aL~~LH~~giv 133 (443)
.+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 11111111 23467788876 5799888841 23477888999999999999999999999
Q ss_pred eeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhc----------cCCCCCCchhhhhhhHH
Q 013407 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN----------DRGYDGSTADLWSCGVI 203 (443)
Q Consensus 134 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~----------~~~~~~~~~DIwSlGvi 203 (443)
||||||+|||++.++.+||+|||++...... ....+| +.|+|||++. ...| +.++|||||||+
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvi 306 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLA 306 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHH
Confidence 9999999999999999999999998754332 455678 9999999993 3334 479999999999
Q ss_pred HHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 204 LFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 204 l~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+|+|++|+.||.+.+.......+. .....+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 999999999998876544333332 223457899999999999999999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=361.82 Aligned_cols=249 Identities=21% Similarity=0.281 Sum_probs=207.8
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCCEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~ 87 (443)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|..+..++......|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 457899999999999999999999999999999998754322 357789999999976 66667777778889999
Q ss_pred EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE---ccCCCeEEeecCccccccc
Q 013407 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 163 (443)
+||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 8999999975 5679999999999999999999999999999999999999 6889999999999986544
Q ss_pred ccCC-----CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc---HHHHHHHhhcCcc----
Q 013407 164 VRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEF---- 231 (443)
Q Consensus 164 ~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~---- 231 (443)
.... ......+||+.|+|||++.+..+. .++|||||||+||+|++|..||.+.. ....+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 3221 112367899999999999887774 89999999999999999999998743 2333443332221
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 232 -TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 232 -~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
..+..++.++.+||.+||..||.+||++.++++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 222457899999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=345.17 Aligned_cols=247 Identities=22% Similarity=0.344 Sum_probs=202.0
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeCC---
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGSKT--- 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~--- 84 (443)
.++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|+++++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 46899999999999999999998 58899999997532 2456788888887 78999999999998776
Q ss_pred -EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEeeeCCCCcEEEccCCCeEEeec
Q 013407 85 -KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH--------SRGVYHRDLKPENLLLDAYGNLKVSDF 155 (443)
Q Consensus 85 -~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~givHrDlkp~NILl~~~~~~kl~DF 155 (443)
..|+||||+.+|+|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 89999999999999999976 46999999999999999999999 899999999999999999999999999
Q ss_pred CcccccccccCC--CccccccCCCcccchhhhccCCCC-----CCchhhhhhhHHHHHHhhC----------CCCCCCCc
Q 013407 156 GLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYD-----GSTADLWSCGVILFVLLAG----------YLPFDDSN 218 (443)
Q Consensus 156 Gla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~-----~~~~DIwSlGvil~~ll~G----------~~Pf~~~~ 218 (443)
|++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999765432111 023455799999999999765322 1579999999999999999 88997642
Q ss_pred -----HHHHHHHhhcCc--cCCCCC-----CCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 219 -----LMNLYKKISAAE--FTCPPW-----LSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 219 -----~~~~~~~i~~~~--~~~~~~-----~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.......+.... ...|.. .+..+.+||.+||+.||.+|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 233444443322 222221 33578999999999999999999999876
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=365.03 Aligned_cols=244 Identities=23% Similarity=0.290 Sum_probs=196.4
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhh-----hHHHHHHHHHHHHHHhcCC---------CCCcc
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVK---------HPNVV 74 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnIv 74 (443)
..++|++++.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 457899999999999999999998 6899999999875421 1223467888999988885 88888
Q ss_pred eEEEEEE------------------------------eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 013407 75 RLYEVMG------------------------------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124 (443)
Q Consensus 75 ~l~~~~~------------------------------~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL 124 (443)
++.+++. +.+.+|+||||+.+|++.+.+.. +.+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 8877642 26889999999999988877754 6789999999999999999
Q ss_pred HHHH-HCCcEeeeCCCCcEEEccCC--------------------CeEEeecCcccccccccCCCccccccCCCcccchh
Q 013407 125 DYCH-SRGVYHRDLKPENLLLDAYG--------------------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183 (443)
Q Consensus 125 ~~LH-~~givHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 183 (443)
.||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9999 99999999999999999987 899999999986542 2458999999999
Q ss_pred hhccCCCCCCchhhhhhhHH-HHHHhhCCCCCCCCcH-HHHHHHhh-cCccC--C----CCCCCHHHHHHHHHhcCCCCC
Q 013407 184 VLNDRGYDGSTADLWSCGVI-LFVLLAGYLPFDDSNL-MNLYKKIS-AAEFT--C----PPWLSFTARKLIARILDPNPM 254 (443)
Q Consensus 184 vl~~~~~~~~~~DIwSlGvi-l~~ll~G~~Pf~~~~~-~~~~~~i~-~~~~~--~----~~~~s~~~~~li~~mL~~dP~ 254 (443)
++.+.. +.++||||+|++ .+++++|..||.+... ......+. ..... . ++.+|+++++||++||+.|
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 998655 589999998777 7789999999964321 11222222 11111 1 1236889999999999977
Q ss_pred CCCChhhhh-cCcccc
Q 013407 255 TRITIPEIL-EDEWFK 269 (443)
Q Consensus 255 ~R~t~~eil-~hp~~~ 269 (443)
|++|+| +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=334.06 Aligned_cols=223 Identities=19% Similarity=0.236 Sum_probs=189.8
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
-++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 37899999999999999999999999999999999876655555668899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|||+.|++|.+++.. .....++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 999999999999854 34666789999999999999999999999999999999999999998554
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHH---HhhcCccC----CCCCCCHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISAAEFT----CPPWLSFTAR 242 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i~~~~~~----~~~~~s~~~~ 242 (443)
|++| + +.++|||||||++|+|++|..||.+.+...... +....... .++.+++.+.
T Consensus 175 ---------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 ---------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp ---------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred ---------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 3332 3 588999999999999999999998765432110 11111111 2356899999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcC
Q 013407 243 KLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~h 265 (443)
+||.+||+.||.+| |+.++++.
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHcccCCccC-CHHHHHHH
Confidence 99999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=375.25 Aligned_cols=241 Identities=26% Similarity=0.390 Sum_probs=200.3
Q ss_pred cccEEEEeEeeccCcEEEEEEEECC-CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE---
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK--- 85 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--- 85 (443)
.++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 3899999999999999999999976 78999999986532 23345678899999999999999999999987655
Q ss_pred --EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 86 --IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 86 --~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
.|+||||+.|++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 7999999999999987754 79999999999999999999999999999999999999884 999999999875432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 243 (443)
....+||+.|+|||++.+. + +.++|||||||++|+|++|.+||.+...... .........++.+.+
T Consensus 234 ------~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~~l~~ 299 (681)
T 2pzi_A 234 ------FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYDSYGR 299 (681)
T ss_dssp ------CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------CTTCHHHHHCHHHHH
T ss_pred ------CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccc------cccccccccCHHHHH
Confidence 1456799999999998764 3 5899999999999999999999876321100 000000124678999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 244 LIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
||.+||+.||.+||+..+.+.|+|+.
T Consensus 300 li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 300 LLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHhhhccCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=322.98 Aligned_cols=232 Identities=15% Similarity=0.142 Sum_probs=164.3
Q ss_pred EeeccCcEEEEEEEECCCCceEEEEEeechhh-------hhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEE
Q 013407 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKV-------LKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 18 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv 89 (443)
.++.|+.|.+..++....|+.||+|++.+... ..+...+.+.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46678888888777777899999999976421 1233456799999999999 799999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|||++|++|.+.|...+.+++. .++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCcc
Confidence 9999999999999998888875 4899999999999999999999999999999999999999999986543 2234
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL 249 (443)
..+.+||+.|+|||++.+. + ...+|+||+|++++.|.+|..||. ..+. ..++ .......+...++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~-~-~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~----~~~~-~~~~~~~l~~~l~ 460 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN-K-SWNGFWRSAPVHPFNLPQPWSNWL--------YAVW----QEPV-ERWNFVLLLALFE 460 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHH----TSCG-GGCSHHHHHHHHH
T ss_pred ccCceechhhccHHHhCCC-C-CCcccccccccchhhhccccchhH--------HHhh----cCCC-CCCcHHHHHHHHh
Confidence 5678999999999999764 3 367899999999998877655431 1111 1111 1123456777788
Q ss_pred CCCCCCCCChhhhhcCcccc
Q 013407 250 DPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 250 ~~dP~~R~t~~eil~hp~~~ 269 (443)
..+|..|+.......|+|..
T Consensus 461 ~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 461 KKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp TGGGSCCGGGSSCCHHHHHH
T ss_pred CCCCCCCCChhhhccchhHH
Confidence 88888888887777777754
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=232.62 Aligned_cols=130 Identities=52% Similarity=0.886 Sum_probs=118.0
Q ss_pred CCcccchhhhhhcCCCCCCcccCcccc-cccccceEEecCCHHHHHHHHHHHhccCCcEEEeecceEEEEEeecCCCcce
Q 013407 311 QPVAMNAFELISLSKGLNLGNLFDAEQ-DFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNL 389 (443)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 389 (443)
.|..+|||++||+|+|+|||+||+..+ .++|+|||+|+.++++|+++||++++.+||.|++++++++++++.+|++|.|
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l 82 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL 82 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence 577899999999999999999997543 2688999999999999999999999999999999888999999999999999
Q ss_pred EEEEEEEEEcCCeeEEEEEecCCCchHHHHHHHHHHHhcccceeccchhhh
Q 013407 390 NVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNLSTCLEDVVWKTEEDMQ 440 (443)
Q Consensus 390 ~~~~~i~~~~~~~~~v~~~~~~Gd~le~~~~~~~~~~~l~d~v~~~~~~~~ 440 (443)
++.++||+|+|+++||||+|++||++||+++|++|++.|+||||+|+++.+
T Consensus 83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~~~~~~~ 133 (143)
T 2ehb_D 83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWRATEGIP 133 (143)
T ss_dssp EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC------
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceecCCCCCc
Confidence 999999999999999999999999999999999999999999999998654
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=213.66 Aligned_cols=120 Identities=30% Similarity=0.465 Sum_probs=106.4
Q ss_pred CcccchhhhhhcCCCCCCcccCcccccccccceEEecCCHHHHHHHHHHHhccCCcEEEeecceEEEEEeecCCCcceEE
Q 013407 312 PVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNV 391 (443)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 391 (443)
|..+|||++||+|+|+|||+||+..+..+++|||+|+.|+++|+++||++|+++||.|+++++. +++.++++|.|++
T Consensus 3 ~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l~v 79 (123)
T 2zfd_B 3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNFAM 79 (123)
T ss_dssp -CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTEEE
T ss_pred cccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccEEE
Confidence 5679999999999999999999754445779999999999999999999999999999988665 5677899999999
Q ss_pred EEEEEEEcCCeeEEEEEecCCCchHHHHHH-HHHHHhcccceec
Q 013407 392 ATEVFQVAPSLHMVEVRKAKGDTLEFHKFY-KNLSTCLEDVVWK 434 (443)
Q Consensus 392 ~~~i~~~~~~~~~v~~~~~~Gd~le~~~~~-~~~~~~l~d~v~~ 434 (443)
.++|++|+|+++||||+|++||++||++|| ++|++.|+||||+
T Consensus 80 ~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 80 VVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 999999999999999999999999999977 7899999999984
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=270.05 Aligned_cols=188 Identities=22% Similarity=0.236 Sum_probs=143.9
Q ss_pred EEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhh-----hHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
...+.||+|+||.||+|. ..+..+|+|........ .....+++.+|+.++++++||||+++..+..+.+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 345689999999999994 45788999987543322 22234668999999999999999954444446677799
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||||++|++|.+++.. +..++.||++||.|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999865 6789999999999999999999999999999998 99999999998654321111
Q ss_pred -----ccccccCCCcccchhhhcc--CCCCCCchhhhhhhHHHHHHhhCCCCC
Q 013407 169 -----LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPF 214 (443)
Q Consensus 169 -----~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf 214 (443)
...+.+||+.|+|||++.. .+|. ..+|+||..+-..+...++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhcccc
Confidence 1246789999999999976 5564 6789999988887777666655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=223.17 Aligned_cols=144 Identities=18% Similarity=0.239 Sum_probs=115.5
Q ss_pred EEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH---------------HHHHHHHHHHHHHhcCCCCCcceEEEE
Q 013407 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---------------KMAEQIKREVATMKLVKHPNVVRLYEV 79 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l~~~ 79 (443)
+++.||+|+||.||+|.+ .+|+.||||++........ .....+.+|+.+++.++|+++.. +
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~---~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK---V 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC---E
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCe---E
Confidence 339999999999999999 8899999999965332110 13467899999999998544444 4
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 80 MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 80 ~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
+.. +..|+||||++|++|.+ +. ...+..++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|.
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred Eec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 433 45699999999999987 42 134567999999999999999999999999999999 9999999999986
Q ss_pred ccccccCCCccccccCCCcccchhhhc
Q 013407 160 LSQQVRDDGLLHTTCGTPNYVAPEVLN 186 (443)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APEvl~ 186 (443)
++..|.|||.+.
T Consensus 241 ---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 241 ---------------EVGEEGWREILE 252 (282)
T ss_dssp ---------------ETTSTTHHHHHH
T ss_pred ---------------ECCCCCHHHHHH
Confidence 245578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=191.85 Aligned_cols=140 Identities=23% Similarity=0.302 Sum_probs=110.3
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCce--EEEEEeechhhh---------------------hHHHHHHHHHHHHHHhcC
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEP--VALKILDKEKVL---------------------KHKMAEQIKREVATMKLV 68 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~--vAiK~i~~~~~~---------------------~~~~~~~~~~Ei~il~~l 68 (443)
-|.+.+.||+|+||.||+|.+..+|+. ||||++...... .......+.+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778888 999997543211 011224688999999999
Q ss_pred CCCCc--ceEEEEEEeCCEEEEEEeccCC-C----chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeeeCCCC
Q 013407 69 KHPNV--VRLYEVMGSKTKIFIVLEFVTG-G----ELFDKIVNHGRMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPE 140 (443)
Q Consensus 69 ~hpnI--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH-~~givHrDlkp~ 140 (443)
.|++| ..+++. ...++||||+.+ | .|.+.... .++..+..++.||+.||.||| +.||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88754 445543 356899999942 3 66665432 345678899999999999999 999999999999
Q ss_pred cEEEccCCCeEEeecCcccc
Q 013407 141 NLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 141 NILl~~~~~~kl~DFGla~~ 160 (443)
|||++. .++|+|||+|..
T Consensus 201 NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SEEESS--SEEECCCTTCEE
T ss_pred HEEEcC--cEEEEECccccc
Confidence 999998 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.9e-19 Score=176.04 Aligned_cols=136 Identities=19% Similarity=0.230 Sum_probs=102.7
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhh---------------hHH----HHHHHHHHHHHHhcCCCCCc
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL---------------KHK----MAEQIKREVATMKLVKHPNV 73 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~---------------~~~----~~~~~~~Ei~il~~l~hpnI 73 (443)
|.+++.||+|++|.||+|.+. +|+.||||++...... ... ..-...+|...|.++.++++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999985 6899999997542110 000 11224578888888865554
Q ss_pred --ceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCC--
Q 013407 74 --VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-- 149 (443)
Q Consensus 74 --v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~-- 149 (443)
...++. . ..+|||||+.|+.|.... ..+.+..++.||+.+|.+||+.||+||||||.|||++++|.
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 333332 2 237999999998885432 22345678999999999999999999999999999998773
Q ss_pred --------eEEeecCccc
Q 013407 150 --------LKVSDFGLSA 159 (443)
Q Consensus 150 --------~kl~DFGla~ 159 (443)
+.|+||+-+-
T Consensus 246 d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CTTSEEEEEEECCCTTCE
T ss_pred cccccccceEEEEeCCcc
Confidence 8899999654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=129.77 Aligned_cols=144 Identities=17% Similarity=0.139 Sum_probs=116.1
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 85 (443)
...++.|++...+|.|+.+.||++... +..+++|+........ ...+.+|+.+++.+. +..+.+++++..+.+.
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 456788999999999999999999753 6789999987532111 235889999999984 6778899999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS------------------------------------ 129 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~------------------------------------ 129 (443)
.|+||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999999876531 222345788999999999998
Q ss_pred -----------------------CCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 130 -----------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 130 -----------------------~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
.+++|+|++|.||++++++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998755567999997653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.31 E-value=2.9e-12 Score=120.12 Aligned_cols=139 Identities=14% Similarity=0.124 Sum_probs=104.7
Q ss_pred cccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC--cceEEEEEEeC
Q 013407 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVMGSK 83 (443)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~ 83 (443)
+...+..|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+..+.
T Consensus 15 l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 15 WVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp GTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred HHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 345566788766555677799999965 457789999976431 235778999999885434 56789988888
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG-------------------------------- 131 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-------------------------------- 131 (443)
+..|+||||++|.+|. . ...+ ...++.+++..|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 8899999999998873 2 1122 2356778888888888653
Q ss_pred --------------------------cEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 132 --------------------------VYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 132 --------------------------ivHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
++|+|++|.||+++.++.+.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999865
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.20 E-value=1.3e-10 Score=95.82 Aligned_cols=85 Identities=18% Similarity=0.268 Sum_probs=76.0
Q ss_pred EEecCCHHHHHHHHHHHhccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEc-CCeeEEEEEecCCCchHHHHHHH
Q 013407 345 FTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHKFYK 422 (443)
Q Consensus 345 f~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~~ 422 (443)
.+|+.+|++|+..|++++..+|+.|+.+ .|.+++....+..++.+.|.+||+++. +++++|+|+|.+||.+.|+++|.
T Consensus 33 tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc~ 112 (120)
T 3ose_A 33 TTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (120)
T ss_dssp CEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHHH
Confidence 4688999999999999999999999987 488888765445567899999999996 79999999999999999999999
Q ss_pred HHHHhcc
Q 013407 423 NLSTCLE 429 (443)
Q Consensus 423 ~~~~~l~ 429 (443)
+|.+.|+
T Consensus 113 ~il~~L~ 119 (120)
T 3ose_A 113 KIANELK 119 (120)
T ss_dssp HHHHHCC
T ss_pred HHHHHhc
Confidence 9988775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=4.1e-11 Score=118.45 Aligned_cols=140 Identities=23% Similarity=0.365 Sum_probs=107.1
Q ss_pred EEeEeeccCcEEEEEEEECCCCceEEEEEee--chhhhhHHHHHHHHHHHHHHhcCC--CCCcceEEEEEEeC---CEEE
Q 013407 15 VGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVK--HPNVVRLYEVMGSK---TKIF 87 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~~ 87 (443)
-++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+++.+. +..+.+++.++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4677999999999998864 4678999876 32211 12356889999999997 45688999988776 4589
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-------------------------------------- 129 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-------------------------------------- 129 (443)
+||||++|..+.+.. ...++......++.+++.+|..||+
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999998774421 2347888889999999999999997
Q ss_pred --------------------CCcEeeeCCCCcEEEccCCC--eEEeecCcccc
Q 013407 130 --------------------RGVYHRDLKPENLLLDAYGN--LKVSDFGLSAL 160 (443)
Q Consensus 130 --------------------~givHrDlkp~NILl~~~~~--~kl~DFGla~~ 160 (443)
.+++|+|++|.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999998764 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.5e-11 Score=118.89 Aligned_cols=185 Identities=17% Similarity=0.186 Sum_probs=124.2
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCC--cceEEEEEEeCC---EEEEE
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPN--VVRLYEVMGSKT---KIFIV 89 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpn--Iv~l~~~~~~~~---~~~lv 89 (443)
++.++.|....||++. ..+++|+.... .....+.+|..+++.+ .+.. +.+.+....+.. ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3568999999999763 46899986532 2356789999999888 3332 455655544333 35899
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS---------------------------------------- 129 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------- 129 (443)
||+++|..|.+... ..++.++...++.|++..+..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865433 357888888899999999999996
Q ss_pred ------------------CCcEeeeCCCCcEEEcc--CCCeEEeecCcccccccccCCCccccccCCCcccchhhhcc--
Q 013407 130 ------------------RGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-- 187 (443)
Q Consensus 130 ------------------~givHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-- 187 (443)
..++|+|++|.||+++. .+.+.|+||+.+...+...+-....... .-.+|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~---~~~~~~~~~~~l 249 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD---EEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT---TSCCHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc---cccCHHHHHHHH
Confidence 13699999999999998 4567899999886532210000000000 0022322110
Q ss_pred CCCCC-----------CchhhhhhhHHHHHHhhCCCCCC
Q 013407 188 RGYDG-----------STADLWSCGVILFVLLAGYLPFD 215 (443)
Q Consensus 188 ~~~~~-----------~~~DIwSlGvil~~ll~G~~Pf~ 215 (443)
..|.. ...+.|++|.++|.+.+|..+|-
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01111 12589999999999999988763
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.87 E-value=3.3e-09 Score=87.42 Aligned_cols=86 Identities=13% Similarity=0.202 Sum_probs=74.7
Q ss_pred EEecCCHHHHHHHHHHHhccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEc-CCeeEEEEEecCCCchHHHHHHH
Q 013407 345 FTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHKFYK 422 (443)
Q Consensus 345 f~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~~ 422 (443)
.+|+.+|++|+..|..+++.+|+.|+.. .|.+++....+..+..+.|.+||+++. .+++.|+|+|.+||.+.|+++|.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~ 112 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHH
Confidence 3478899999999999999999999975 788887653334456899999999995 68999999999999999999999
Q ss_pred HHHHhccc
Q 013407 423 NLSTCLED 430 (443)
Q Consensus 423 ~~~~~l~d 430 (443)
+|...|+=
T Consensus 113 ~IL~eLkL 120 (126)
T 1v5s_A 113 KIANELKL 120 (126)
T ss_dssp HHHHHTTC
T ss_pred HHHHHHhc
Confidence 99998873
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=1.3e-07 Score=75.31 Aligned_cols=85 Identities=20% Similarity=0.340 Sum_probs=73.2
Q ss_pred EEecCCHHHHHHHHHHHhccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeeEEEEEecCCC--------ch
Q 013407 345 FTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGD--------TL 415 (443)
Q Consensus 345 f~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd--------~l 415 (443)
..|...|.+|+..|..|++.+|+.|+.. .|.++++.........+.+.+++|++.++.+|+||++..|| .+
T Consensus 12 IrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~~~~~ 91 (106)
T 4eai_A 12 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHTI 91 (106)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSSCHHH
T ss_pred ceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCCcCcE
Confidence 3578889999999999999999999987 79999875443334579999999999999999999999994 89
Q ss_pred HHHHHHHHHHHhcc
Q 013407 416 EFHKFYKNLSTCLE 429 (443)
Q Consensus 416 e~~~~~~~~~~~l~ 429 (443)
+|-++|.++...|.
T Consensus 92 ~F~d~ca~li~~la 105 (106)
T 4eai_A 92 EFFEMCANLIKILA 105 (106)
T ss_dssp HHHHHHHHHHHHCC
T ss_pred eHHHHHHHHHHHHh
Confidence 99999988876653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.8e-07 Score=88.03 Aligned_cols=140 Identities=15% Similarity=0.189 Sum_probs=102.3
Q ss_pred cccEEEEeEeeccCcE-EEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEE
Q 013407 10 VGKYEVGRTIGEGTFA-KVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g-~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 87 (443)
+..|+... +..|..+ .||+......+..+++|+-... ....+.+|...|+.+. +--|.+++.++.+.+..|
T Consensus 24 l~g~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~ 96 (272)
T 4gkh_A 24 LYGYRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAW 96 (272)
T ss_dssp HTTCEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred ccCCeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEE
Confidence 33454433 4445444 6898887777788999986543 2456788999998884 333778889999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-------------------------------------- 129 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-------------------------------------- 129 (443)
+|||+++|.++.+..... ......+..++...|.-||+
T Consensus 97 lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 999999998887765432 22334566777777777774
Q ss_pred --------------------CCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 130 --------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 130 --------------------~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
..++|+|+.|.||+++.++.+-|+||+.+..
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999877677999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=3.6e-07 Score=88.11 Aligned_cols=134 Identities=20% Similarity=0.263 Sum_probs=98.1
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC---CcceEEEEEE-eCCEEEEEEe
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP---NVVRLYEVMG-SKTKIFIVLE 91 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lv~E 91 (443)
++.++.|....||+. |..+++|+... ......+.+|..+|+.+.+. .|.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 356889999999988 56789998532 22356789999999999642 3667777664 4556789999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR----------------------------------------- 130 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~----------------------------------------- 130 (443)
+++|..|.+... ..++......+..|+...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988866322 2356666666667777666666642
Q ss_pred -------------------CcEeeeCCCCcEEEcc---CCCe-EEeecCccccc
Q 013407 131 -------------------GVYHRDLKPENLLLDA---YGNL-KVSDFGLSALS 161 (443)
Q Consensus 131 -------------------givHrDlkp~NILl~~---~~~~-kl~DFGla~~~ 161 (443)
.++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 4554 89999987653
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.55 E-value=9.7e-07 Score=74.36 Aligned_cols=72 Identities=17% Similarity=0.298 Sum_probs=60.0
Q ss_pred EEecCCHHHHHHHHHHHhccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeeEEEEEecCCCchH
Q 013407 345 FTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 416 (443)
Q Consensus 345 f~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le 416 (443)
..|...|.+||..|..|++.||+.|+.. .|.++++.+.......+.|.+++|++.++.|||||++..||+.|
T Consensus 9 IrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 9 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 3578899999999999999999999986 79999876444333468999999999999999999999999754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=7.7e-07 Score=88.85 Aligned_cols=80 Identities=15% Similarity=0.155 Sum_probs=51.1
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhh-hhH---HHHHHHHHHHHHHhcCCC--C-CcceEEEEEEeCCEEEE
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-LKH---KMAEQIKREVATMKLVKH--P-NVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~h--p-nIv~l~~~~~~~~~~~l 88 (443)
.+.||.|..+.||++....+++.+++|....... ... ....++..|..+++.+.. | .+.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5679999999999998766678899998653211 000 012456788999887742 3 35566654 3445689
Q ss_pred EEeccCCCc
Q 013407 89 VLEFVTGGE 97 (443)
Q Consensus 89 v~E~~~gg~ 97 (443)
|||++.|..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998743
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2.2e-06 Score=73.14 Aligned_cols=72 Identities=17% Similarity=0.298 Sum_probs=60.1
Q ss_pred EEecCCHHHHHHHHHHHhccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeeEEEEEecCCCchH
Q 013407 345 FTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 416 (443)
Q Consensus 345 f~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le 416 (443)
..|+..|.+||..|..|++.||+.|+.. .|.++++.........+.|.+++|++.++.|||||++..||+.|
T Consensus 23 IrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 23 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 3588899999999999999999999986 79999875433323468999999999999999999999999866
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.35 E-value=4.2e-06 Score=68.27 Aligned_cols=70 Identities=17% Similarity=0.318 Sum_probs=57.6
Q ss_pred ecCCHHHHHHHHHHHhccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeeEEEEEecCCCchH
Q 013407 347 SRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 416 (443)
Q Consensus 347 s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le 416 (443)
|...|.+|+..|..|++.+|+.|+.. .|.++++.........+.+.+++|++.++.+|+||++..||..|
T Consensus 14 S~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~ 84 (130)
T 4eag_A 14 SQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVE 84 (130)
T ss_dssp CCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-----
T ss_pred cCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhh
Confidence 67789999999999999999999987 79999876555445578999999999999999999999999644
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=1.9e-06 Score=72.00 Aligned_cols=85 Identities=16% Similarity=0.181 Sum_probs=69.5
Q ss_pred EEecCCHHHHHHHHHHHhccCCcEEEee----------cceEEEEEeecCC-----CcceEEEEEEEEEcCCeeEEEEEe
Q 013407 345 FTSRCPANEIINKIEEAAKPLGFDVHKK----------NYKMRLENMKAGR-----KGNLNVATEVFQVAPSLHMVEVRK 409 (443)
Q Consensus 345 f~s~~~~~~~~~~l~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-----~~~l~~~~~i~~~~~~~~~v~~~~ 409 (443)
..|+..|.+||..|..|++.||+.|+.. .|.|+++...+.. ...+.|.+++|++.++.+||||++
T Consensus 17 IRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YLlDFk~ 96 (137)
T 2qrd_A 17 VRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVKS 96 (137)
T ss_dssp EEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEEE
T ss_pred cccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEEEEEEe
Confidence 3578899999999999999999999964 4778876543321 246899999999999999999999
Q ss_pred cCCC---------------c----hHHHHHHHHHHHhcc
Q 013407 410 AKGD---------------T----LEFHKFYKNLSTCLE 429 (443)
Q Consensus 410 ~~Gd---------------~----le~~~~~~~~~~~l~ 429 (443)
..|+ . ++|-.+|.+|...|.
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa 135 (137)
T 2qrd_A 97 NGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 135 (137)
T ss_dssp EEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred cCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence 9999 5 889999987766554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=1.6e-06 Score=85.03 Aligned_cols=85 Identities=11% Similarity=0.155 Sum_probs=56.4
Q ss_pred EEEeEe-eccCcEEEEEEEEC---C---CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-C--CCcceEEEEEEeC
Q 013407 14 EVGRTI-GEGTFAKVKFARNS---E---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-H--PNVVRLYEVMGSK 83 (443)
Q Consensus 14 ~~~~~L-G~G~~g~V~~a~~~---~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~ 83 (443)
...+.| +.|....+|+.... . ++..+++|+..............+.+|..+++.+. + ..+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88999999988653 1 15678999875432000000135678888888884 2 3577888877655
Q ss_pred ---CEEEEEEeccCCCch
Q 013407 84 ---TKIFIVLEFVTGGEL 98 (443)
Q Consensus 84 ---~~~~lv~E~~~gg~L 98 (443)
+..|+|||+++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 356899999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.12 E-value=2.6e-05 Score=75.48 Aligned_cols=135 Identities=14% Similarity=0.152 Sum_probs=77.5
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----CCCcceEE-E--EEEeCCEEE
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----HPNVVRLY-E--VMGSKTKIF 87 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 87 (443)
.+.|+.|..+.||++... +..+++|+..... ..+..|..+++.|. .|.++... + +....+..|
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 345677788999998763 3358999987521 22334555555442 34444310 0 123467889
Q ss_pred EEEeccCCCchH--------------HHHHh-CCCC--C-----------HH--------H-------------------
Q 013407 88 IVLEFVTGGELF--------------DKIVN-HGRM--K-----------ED--------E------------------- 112 (443)
Q Consensus 88 lv~E~~~gg~L~--------------~~i~~-~~~l--~-----------e~--------~------------------- 112 (443)
++|+|++|..+. ..+.. ...+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999985431 11111 0101 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHH-------------HCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 113 ----ARRYFQQLINAVDYCH-------------SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 113 ----~~~~~~qi~~aL~~LH-------------~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
...+..++..++.+|+ ..+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223344566665 2579999999999999888899999999764
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=98.00 E-value=2.5e-05 Score=67.33 Aligned_cols=84 Identities=19% Similarity=0.255 Sum_probs=68.5
Q ss_pred EEecCCHHHHHHHHHHHhccCCcEEEee----cceEEEEEeec---------CCCcceEEEEEEEEEcCCeeEEEEEecC
Q 013407 345 FTSRCPANEIINKIEEAAKPLGFDVHKK----NYKMRLENMKA---------GRKGNLNVATEVFQVAPSLHMVEVRKAK 411 (443)
Q Consensus 345 f~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~---------~~~~~l~~~~~i~~~~~~~~~v~~~~~~ 411 (443)
..|+..|.+||..|..|++.||+.|++. .|.++++.... +....+.|.+++|++.++.|||||+ ..
T Consensus 55 IrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLDfk-~~ 133 (179)
T 3t4n_A 55 IRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFK-FD 133 (179)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEEEE-EE
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEEEE-ec
Confidence 3578899999999999999999999974 68888874311 1123599999999999999999999 88
Q ss_pred C----------------------CchHHHHHHHHHHHhcc
Q 013407 412 G----------------------DTLEFHKFYKNLSTCLE 429 (443)
Q Consensus 412 G----------------------d~le~~~~~~~~~~~l~ 429 (443)
| .+..|-.+|.+|.-.|.
T Consensus 134 G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa 173 (179)
T 3t4n_A 134 GWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELA 173 (179)
T ss_dssp EEECC----------------CCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCccHHHHHHHHHHHHH
Confidence 8 77889999987766664
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00012 Score=70.62 Aligned_cols=75 Identities=17% Similarity=0.268 Sum_probs=60.0
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEEEEec
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
.+.|+.|....+|+... ++..+++|+..... ...+.+|...|+.|. ...+.+.+.+....+..|+||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 46789999999999875 46678999876431 456788999988883 35688999888888899999999
Q ss_pred cCCCch
Q 013407 93 VTGGEL 98 (443)
Q Consensus 93 ~~gg~L 98 (443)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.73 E-value=9.8e-05 Score=74.16 Aligned_cols=31 Identities=19% Similarity=0.284 Sum_probs=27.5
Q ss_pred HCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 129 ~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
...++|+|++|.||+++.++ +.++||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 46799999999999998876 99999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00026 Score=64.03 Aligned_cols=123 Identities=18% Similarity=0.094 Sum_probs=80.8
Q ss_pred CchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccccc
Q 013407 96 GELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173 (443)
Q Consensus 96 g~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 173 (443)
-+|.+.+.. +.+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|++-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 367777764 5689999999999999999887622 2222344567999999999987764 2110
Q ss_pred cCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCC
Q 013407 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252 (443)
Q Consensus 174 ~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~d 252 (443)
.....+.|||... ...+.+.=|||||+++|.-+--.+|= .-++.+|+++.+||..|....
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTCC
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhcc
Confidence 1233577888763 22347789999999999776432221 123458999999999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00013 Score=69.60 Aligned_cols=71 Identities=14% Similarity=0.044 Sum_probs=45.5
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEecc-
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFV- 93 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~- 93 (443)
++.|+.|....+|++ ..+++|+...... ..-...+|..+++.+...++ .+++.+. ...-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 688999999999998 4589998764311 01123468888877742222 4665543 33457899999
Q ss_pred CCCch
Q 013407 94 TGGEL 98 (443)
Q Consensus 94 ~gg~L 98 (443)
.|..|
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00031 Score=67.98 Aligned_cols=135 Identities=16% Similarity=0.206 Sum_probs=71.8
Q ss_pred eEeeccCcEE-EEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCEEEEEEecc
Q 013407 17 RTIGEGTFAK-VKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEFV 93 (443)
Q Consensus 17 ~~LG~G~~g~-V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~~ 93 (443)
+.|+.|+... +|+... .+|..+++|....... ..+..|+.+++.+.. -.+.+++.+..+.+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 4566665554 556653 2356778876544210 234567777777632 23566776643333 7899999
Q ss_pred CCCchHHHHHhC--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 013407 94 TGGELFDKIVNH--------------------------GRMKEDEAR-------R-YF------------QQLINAVDYC 127 (443)
Q Consensus 94 ~gg~L~~~i~~~--------------------------~~l~e~~~~-------~-~~------------~qi~~aL~~L 127 (443)
.|..+.+.+... ..++..... . +. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 876665443211 011121110 0 00 0111122222
Q ss_pred ------HHCCcEeeeCCCCcEEEccC----CCeEEeecCcccc
Q 013407 128 ------HSRGVYHRDLKPENLLLDAY----GNLKVSDFGLSAL 160 (443)
Q Consensus 128 ------H~~givHrDlkp~NILl~~~----~~~kl~DFGla~~ 160 (443)
+...++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 13469999999999999874 6789999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00046 Score=66.23 Aligned_cols=139 Identities=15% Similarity=0.142 Sum_probs=77.8
Q ss_pred EEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC--cceEEEE------EEeCCE
Q 013407 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEV------MGSKTK 85 (443)
Q Consensus 14 ~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~ 85 (443)
.-.+.|+.|....+|++... +| .+++|+..... ....+..|..+++.+...+ +.+++.. ....+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 34567888988999998763 23 68999987521 1234556777777663211 2333211 123467
Q ss_pred EEEEEeccCCCchH--------------HHHHh-CCCC--------CHHHHHHH---------------HHHHHHHHHHH
Q 013407 86 IFIVLEFVTGGELF--------------DKIVN-HGRM--------KEDEARRY---------------FQQLINAVDYC 127 (443)
Q Consensus 86 ~~lv~E~~~gg~L~--------------~~i~~-~~~l--------~e~~~~~~---------------~~qi~~aL~~L 127 (443)
.+++|++++|..+. ..+.. ...+ ....-... -..+...+..+
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 79999999985431 11111 0011 10000000 01133445555
Q ss_pred HH-------CCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 128 HS-------RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 128 H~-------~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
+. .+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 52 369999999999999886656899999765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00036 Score=69.11 Aligned_cols=136 Identities=16% Similarity=0.186 Sum_probs=82.0
Q ss_pred eEeeccCcEEEEEEEECC-------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEE
Q 013407 17 RTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 88 (443)
+.|..|....+|++.... +++.+++|+.... .. ....+.+|..+++.|. +.-..++++++.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 567778888899988642 3578999986321 11 1345568999998884 3334677776653 29
Q ss_pred EEeccCCCchH--------------HHH---HhC----C-CCC--HHHHHHHHHHHHH-------------------HHH
Q 013407 89 VLEFVTGGELF--------------DKI---VNH----G-RMK--EDEARRYFQQLIN-------------------AVD 125 (443)
Q Consensus 89 v~E~~~gg~L~--------------~~i---~~~----~-~l~--e~~~~~~~~qi~~-------------------aL~ 125 (443)
||||++|..|. +.+ ... + ... ...+.+|+.++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999985542 111 111 1 111 3455566655432 233
Q ss_pred HHH----H----CCcEeeeCCCCcEEEccC----CCeEEeecCcccc
Q 013407 126 YCH----S----RGVYHRDLKPENLLLDAY----GNLKVSDFGLSAL 160 (443)
Q Consensus 126 ~LH----~----~givHrDlkp~NILl~~~----~~~kl~DFGla~~ 160 (443)
.|. + ..++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 2 258999999999999876 7899999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00058 Score=68.78 Aligned_cols=73 Identities=16% Similarity=0.200 Sum_probs=49.4
Q ss_pred EeEeeccCcEEEEEEEECC-------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCEEE
Q 013407 16 GRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKIF 87 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 87 (443)
++.|+.|....||++.... ++..+++|+..... . ...+.+|..+++.+...+ ..++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4678889999999998653 25789999874321 1 123447888888884333 3677776542 2
Q ss_pred EEEeccCCCc
Q 013407 88 IVLEFVTGGE 97 (443)
Q Consensus 88 lv~E~~~gg~ 97 (443)
+|+||++|..
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998733
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0046 Score=58.31 Aligned_cols=79 Identities=11% Similarity=0.072 Sum_probs=54.8
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC---CCcceEEEEEEeCCEEEE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH---PNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~~~~~l 88 (443)
+..-++.+|.|..+.||+... .+|+.|.+|+-....... ...+.+|...|+.|.- --+.+.+.+. . -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceE
Confidence 445678899999999999986 468899999865432211 2356789999888842 2355665542 2 378
Q ss_pred EEeccCCCch
Q 013407 89 VLEFVTGGEL 98 (443)
Q Consensus 89 v~E~~~gg~L 98 (443)
||||+.++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0013 Score=63.26 Aligned_cols=75 Identities=17% Similarity=0.148 Sum_probs=47.1
Q ss_pred eEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CcceEEEE-----EEeCCEEEEE
Q 013407 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEV-----MGSKTKIFIV 89 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~-----~~~~~~~~lv 89 (443)
..|+ |....||++.. .+|+.+++|+...... . ...+..|..+++.+... .+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 78889998764 3466799999864321 1 23566788887777421 23333332 2235667899
Q ss_pred EeccCCCc
Q 013407 90 LEFVTGGE 97 (443)
Q Consensus 90 ~E~~~gg~ 97 (443)
|++++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998844
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0014 Score=64.40 Aligned_cols=74 Identities=15% Similarity=0.082 Sum_probs=44.6
Q ss_pred EeEeeccCcEEEEEEEECC--------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCEE
Q 013407 16 GRTIGEGTFAKVKFARNSE--------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKI 86 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 86 (443)
.+.|+.|....+|++.... .+..+++|+...... . ......|..+++.+...+ +.++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4568888889999988643 136789998754221 1 112357888888874333 45676554 22
Q ss_pred EEEEeccCCCc
Q 013407 87 FIVLEFVTGGE 97 (443)
Q Consensus 87 ~lv~E~~~gg~ 97 (443)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998854
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0046 Score=60.04 Aligned_cols=31 Identities=19% Similarity=0.319 Sum_probs=27.4
Q ss_pred CCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 130 ~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
.+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888899999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0083 Score=60.80 Aligned_cols=75 Identities=13% Similarity=0.192 Sum_probs=48.5
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEeccC
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~ 94 (443)
++.|+.|....+|++.....+..+++|+..... .... ...+|..+++.|...++ .++++++. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 467888999999999875545789999874321 1011 12578999988864444 57777663 2 25999998
Q ss_pred CCch
Q 013407 95 GGEL 98 (443)
Q Consensus 95 gg~L 98 (443)
|..|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.64 E-value=0.017 Score=57.85 Aligned_cols=75 Identities=13% Similarity=0.088 Sum_probs=48.3
Q ss_pred EeEeeccCcEEEEEEEECCC-------CceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEE
Q 013407 16 GRTIGEGTFAKVKFARNSET-------GEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 87 (443)
++.|..|....+|++..... +..+++|+..... . ..-...+|..+++.+. +.-..++++.+. + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---G-KFYDSKVELDVFRYLSNINIAPNIIADFP--E--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence 45677788899999887521 5789999864321 1 1112357888888874 333456665432 2 6
Q ss_pred EEEeccCCCch
Q 013407 88 IVLEFVTGGEL 98 (443)
Q Consensus 88 lv~E~~~gg~L 98 (443)
.||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998553
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.17 E-value=0.13 Score=50.80 Aligned_cols=29 Identities=31% Similarity=0.448 Sum_probs=25.1
Q ss_pred cEeeeCCCCcEEE------ccCCCeEEeecCcccc
Q 013407 132 VYHRDLKPENLLL------DAYGNLKVSDFGLSAL 160 (443)
Q Consensus 132 ivHrDlkp~NILl------~~~~~~kl~DFGla~~ 160 (443)
++|+|+.+.||++ ++++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.41 E-value=3.1 Score=37.31 Aligned_cols=82 Identities=16% Similarity=0.108 Sum_probs=64.7
Q ss_pred CCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHHCCcEeeeCCCCcEEEccC
Q 013407 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD-YCHSRGVYHRDLKPENLLLDAY 147 (443)
Q Consensus 69 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~-~LH~~givHrDlkp~NILl~~~ 147 (443)
.||+. -..+-.+++.+.+.++.-+++.-+..++ .++..+.++++.+|+.... ++ ..-+|--|.|+||++|.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 68888 5566688888888888877766677774 4888899998888887665 33 445677899999999999
Q ss_pred CCeEEeecCc
Q 013407 148 GNLKVSDFGL 157 (443)
Q Consensus 148 ~~~kl~DFGl 157 (443)
+.+++.-.|+
T Consensus 121 ~~p~i~hRGi 130 (219)
T 4ano_A 121 LEPFFLHVGV 130 (219)
T ss_dssp CCEEESCCEE
T ss_pred CcEEEEEcCC
Confidence 9999987775
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.59 E-value=1.9 Score=38.49 Aligned_cols=106 Identities=18% Similarity=0.260 Sum_probs=73.2
Q ss_pred EEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHH
Q 013407 40 ALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119 (443)
Q Consensus 40 AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~q 119 (443)
-++.+.++.+...+. .|+.+| ...||+.+.. .+-.+.+.+.+.++.-..+.-+..+ ..++....++++.+
T Consensus 20 ~~~~~~ks~ik~~~~-----~el~LL-~~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~n 89 (215)
T 4ann_A 20 DMREIPKSSIKPEHF-----HLMYLL-EQHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLN 89 (215)
T ss_dssp CEEEEEGGGSCGGGG-----GGGGGG-GSCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHH
T ss_pred HHHHhcHhhccccCH-----HHHHHH-hccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHH
Confidence 355666655443221 223222 2268999877 6777778888877776654445555 34788899999999
Q ss_pred HHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 120 i~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
|+....++ ..-+|--|.|+||+++.++.+++.=-|+
T Consensus 90 i~~l~~~~--~~r~tf~L~P~NL~f~~~~~p~i~~RGi 125 (215)
T 4ann_A 90 IKNLEEVN--RTRYTFVLAPDELFFTRDGLPIAKTRGL 125 (215)
T ss_dssp GGGGGGGG--GSSEECCCSGGGEEECTTSCEEESCCEE
T ss_pred HHHHHHHh--cCceEEEEecceEEEcCCCCEEEEEccC
Confidence 98877443 4446778999999999999999987775
|
| >3ost_A Serine/threonine-protein kinase KCC4; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.69A {Saccharomyces cerevisiae} PDB: 3osm_A | Back alignment and structure |
|---|
Probab=80.47 E-value=21 Score=28.72 Aligned_cols=85 Identities=12% Similarity=0.185 Sum_probs=60.5
Q ss_pred eEEecCCHHHHHHHHHHHh---ccCCcE-EEeecceEEEEEeecCCC----cceEEEEEEEEEcCCe-eEEEEEecCCCc
Q 013407 344 RFTSRCPANEIINKIEEAA---KPLGFD-VHKKNYKMRLENMKAGRK----GNLNVATEVFQVAPSL-HMVEVRKAKGDT 414 (443)
Q Consensus 344 rf~s~~~~~~~~~~l~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~----~~l~~~~~i~~~~~~~-~~v~~~~~~Gd~ 414 (443)
.+++..+..++...|...+ ++.|+. ++.+.....|.+.....+ .+..|.|+|++=. +. .+|-|++.+|..
T Consensus 28 ~l~t~v~k~~~~~~L~~LL~~Wk~yGlkdv~~D~~~~~ItGrvs~~N~L~LRsv~F~i~i~~~g-n~~Slv~f~q~rGSs 106 (128)
T 3ost_A 28 EIHAKIPEKRLYEGLHKLLEGWKQYGLKNLVFNITNMIITGKLVNDSILFLRSTLFEIMVLPNG-DGRSLIKFNKKTGST 106 (128)
T ss_dssp CEEESSCHHHHHHHHHHHHHTCGGGTEEEEEEETTTTEEEEEECCCCSSSCCCEEEEEEEEECS-TTCEEEEEEESSSCH
T ss_pred EEEEecCHHHHHHHHHHHHHHHHHhCccceEecCCCCEEEEEEccccccccceeEEEEEEeecC-CceEEEEEEEeeccH
Confidence 3778888888888888888 466763 555533333333222211 2688999999755 66 999999999999
Q ss_pred hHHHHHHHHHHHhcc
Q 013407 415 LEFHKFYKNLSTCLE 429 (443)
Q Consensus 415 le~~~~~~~~~~~l~ 429 (443)
--|++++..|..-|+
T Consensus 107 stf~klv~eiEkVL~ 121 (128)
T 3ost_A 107 KTLTKLATEIQIILQ 121 (128)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999987766553
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 443 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-91 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-88 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-85 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-82 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-81 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-81 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-80 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-80 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-77 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-77 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-77 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-76 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-76 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-74 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-73 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-73 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-73 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-73 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-72 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-71 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-71 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-70 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-69 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-67 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-65 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-62 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-62 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-62 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-61 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-60 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-59 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-58 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-56 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-54 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-51 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-22 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 3e-21 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (701), Expect = 7e-91
Identities = 96/260 (36%), Positives = 150/260 (57%), Gaps = 5/260 (1%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+GR +G+G F V AR ++ +ALK+L K ++ K + Q++REV ++HP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++RLY T+++++LE+ G ++ ++ + E Y +L NA+ YCHS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+KPENLLL + G LK++DFG S + T CGT +Y+ PE++ R +D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
DLWS GV+ + L G PF+ + YK+IS EFT P +++ AR LI+R+L
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 252 NPMTRITIPEILEDEWFKKD 271
NP R + E+LE W +
Sbjct: 242 NPSQRPMLREVLEHPWITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 267 bits (684), Expect = 3e-88
Identities = 107/267 (40%), Positives = 157/267 (58%), Gaps = 5/267 (1%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
V +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+E+ K++
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 61
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL+ V Y H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YVAPE+L R
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCPPW--LSFTARKLIA 246
+ D+WSCG++L +LAG LP+D S+ Y + PW + L+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYK 273
+IL NP RITIP+I +D W+ K K
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (668), Expect = 1e-85
Identities = 85/287 (29%), Positives = 146/287 (50%), Gaps = 8/287 (2%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
QP+ K+R ++ G+ +GEG+F+ V AR T A+KIL+K ++K + RE
Sbjct: 1 QPR-KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN 122
M + HP V+LY K++ L + GEL I G E R Y ++++
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
A++Y H +G+ HRDLKPEN+LL+ +++++DFG + + ++ GT YV+P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
E+L ++ ++DLW+ G I++ L+AG PF N +++KI E+ P AR
Sbjct: 180 ELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 289
L+ ++L + R+ E+ K P F + +++
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAH---PFF---ESVTWENLH 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 254 bits (649), Expect = 9e-82
Identities = 72/280 (25%), Positives = 132/280 (47%), Gaps = 14/280 (5%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ K Y++ +G G F V TG K ++ L +K E+
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEI 77
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLI 121
+ M + HP ++ L++ K ++ ++LEF++GGELFD+I +M E E Y +Q
Sbjct: 78 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ + H + H D+KPEN++ + ++K+ DFG L+ ++ D ++ T T +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTTATAEF 194
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235
APE+++ D+W+ GV+ +VLL+G PF + + + + ++
Sbjct: 195 AAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+S A+ I +L P R+T+ + LE W K D+
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 251 bits (643), Expect = 2e-81
Identities = 70/282 (24%), Positives = 120/282 (42%), Gaps = 10/282 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ R IG G+F V FAR+ E VA+K + ++ + I +EV ++ ++HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N ++ + ++V+E+ G V+ ++E E + + Y HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG 189
+ HRD+K N+LL G +K+ DFG +++ ++ GTP ++APEV+ D G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--LSFTARKLIAR 247
D+WS G+ L P + N M+ I+ E S R +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 289
L P R T +L+ + ++ P V + D V
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (640), Expect = 3e-81
Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 18/285 (6%)
Query: 6 IKRRVG---KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ R + +E+ +G+G F KV A+N ET A K++D + + E E+
Sbjct: 4 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEI 60
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLI 121
+ HPN+V+L + + ++I++EF GG + ++ R + E + + +Q +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A++Y H + HRDLK N+L G++K++DFG+SA + R + GTP ++A
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMA 178
Query: 182 PEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTC 233
PEV+ DR YD AD+WS G+ L + P + N M + KI+ +E
Sbjct: 179 PEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 234 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
P S + + + L+ N R T ++L+ + D P+ E
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 2e-80
Identities = 76/279 (27%), Positives = 135/279 (48%), Gaps = 14/279 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
KY IG+G V A + TG+ VA++ ++ ++ E I E+ M+ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKN 76
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
V HRD+K +N+LL G++K++DFG A + T GTP ++APEV+ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIAR 247
D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 194 G-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 248 ILDPNPMTRITIPEILEDEWFKK----DYKPPVFEEKKD 282
LD + R + E+L+ ++ K P+ K+
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 249 bits (637), Expect = 4e-80
Identities = 83/307 (27%), Positives = 141/307 (45%), Gaps = 14/307 (4%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ K + Y++ +G G F V TG A K + E +++E
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKE 73
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQL 120
+ TM +++HP +V L++ ++ ++ EF++GGELF+K+ + H +M EDEA Y +Q+
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 121 INAVDYCHSRGVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + H H DLKPEN++ LK+ DFGL+A + + T GT
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAE 190
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----CP 234
+ APEV + G D+WS GV+ ++LL+G PF N + + + ++
Sbjct: 191 FAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKD 294
+S + I ++L +P TR+TI + LE W P + + + K
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKT 309
Query: 295 SEVCWME 301
W E
Sbjct: 310 KYDAWPE 316
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 4e-77
Identities = 86/271 (31%), Positives = 135/271 (49%), Gaps = 16/271 (5%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R YEV TIG G++ + + R G+ + K LD + + + + + EV ++ +
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 60
Query: 69 KHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLIN 122
KHPN+VR Y+ + +T ++IV+E+ GG+L I + + E+ R QL
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 123 AVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
A+ CH R V HRDLKP N+ LD N+K+ DFGL+ + D GTP
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTP 178
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW 236
Y++PE +N Y+ +D+WS G +L+ L A PF + L KI +F P
Sbjct: 179 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEW 267
S ++I R+L+ R ++ EILE+
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 239 bits (611), Expect = 4e-77
Identities = 87/275 (31%), Positives = 138/275 (50%), Gaps = 19/275 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH------KMAEQIKREVATM 65
YE +G G + V+ + T + A+KI+D ++ E +EV +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 66 -KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
K+ HPN+++L + + T F+V + + GELFD + + E E R+ + L+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + HRDLKPEN+LLD N+K++DFG S Q+ L CGTP+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180
Query: 185 L-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW- 236
+ ++ G D+WS GVI++ LLAG PF M + + I + +F P W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 237 -LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
S T + L++R L P R T E L +F++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 239 bits (612), Expect = 7e-77
Identities = 97/271 (35%), Positives = 149/271 (54%), Gaps = 13/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ +G G F++V A + T + VA+K + K+ + ++ E+A + +KHP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHP 67
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V L ++ S ++++++ V+GGELFD+IV G E +A R Q+++AV Y H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL D + +SDFG LS+ +L T CGTP YVAPEVL +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFG---LSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKL 244
Y + D WS GVI ++LL GY PF D N L+++I AE+ +S +A+
Sbjct: 185 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I +++ +P R T + L+ W D
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 2e-76
Identities = 66/271 (24%), Positives = 125/271 (46%), Gaps = 15/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + +G G F V + + + K + K +K+E++ + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
N++ L+E S ++ ++ EF++G ++F++I + E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 131 GVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D++PEN++ +K+ +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFG---QARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKL 244
+ D+WS G +++VLL+G PF + + I AE+T +S A
Sbjct: 179 VVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+ R+L +R+T E L+ W K+ +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 4e-76
Identities = 85/285 (29%), Positives = 145/285 (50%), Gaps = 15/285 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHP 71
+ + + +G+G+F KV A +T + A+K L K+ VL E E + L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+ ++ +K +F V+E++ GG+L I + + A Y ++I + + HS+G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ +RDLK +N+LLD G++K++DFG+ + D +T CGTP+Y+APE+L + Y+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
S D WS GV+L+ +L G PF + L+ I P WL A+ L+ ++
Sbjct: 182 HS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 252 NPMTRITIP-EILEDEWFK---------KDYKPPVFEEKKDTNLD 286
P R+ + +I + F+ K+ PP F K + D
Sbjct: 241 EPEKRLGVRGDIRQHPLFREINWEELERKEIDPP-FRPKVKSPFD 284
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 236 bits (603), Expect = 2e-75
Identities = 96/296 (32%), Positives = 164/296 (55%), Gaps = 25/296 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+++ RT+G G+F +V R+ G A+K+L KE V++ K E E + +V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++R++ +IF++++++ GGELF + R A+ Y ++ A++Y HS+ +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLD G++K++DFG + V +T CGTP+Y+APEV++ + Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNK 180
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
S D WS G++++ +LAGY PF DSN M Y+KI AE PP+ + + L++R++ +
Sbjct: 181 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 253 PMTRI-----TIPEILEDEWFKKD-------------YKPPVFEEKKDT-NLDDVE 289
R+ ++ WFK+ Y+PP+ + + DT D
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYP 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 9e-74
Identities = 66/310 (21%), Positives = 117/310 (37%), Gaps = 52/310 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR- 130
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S D + ++ GT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHY 180
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSN-------------------------------- 218
+D+WS G+ L + G P +
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 219 ----------LMNLYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDE 266
+ L I P S + + + L NP R + +++
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 267 WFKKDYKPPV 276
+ K+ V
Sbjct: 300 FIKRSDAEEV 309
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 232 bits (593), Expect = 3e-73
Identities = 83/295 (28%), Positives = 137/295 (46%), Gaps = 24/295 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--- 69
+ V R IG G F +V R ++TG+ A+K LDK+++ + E + LV
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
P +V + + K+ +L+ + GG+L + HG E + R Y ++I +++ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R V +RDLKP N+LLD +G++++SD GL+ H + GT Y+APEVL
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGV 181
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPPWLSFTARKLIA 246
S+AD +S G +LF LL G+ PF + + P S R L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 247 RILDPNPMTRITIP-----EILEDEWFK---------KDYKPPVFEEKKDTNLDD 287
+L + R+ E+ E +F+ + Y PP+ + + N D
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAAD 296
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 4e-73
Identities = 97/287 (33%), Positives = 144/287 (50%), Gaps = 24/287 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK---MAEQIKREVATMKLV 68
Y+ G +G G FA VK R TG A K + K + + E I+REV+ +K +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPNV+ L+EV +KT + ++LE V GGELFD + + E+EA + +Q++N V Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 129 SRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S + H DLKPEN++L +K+ DFG L+ ++ GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----CPPWLSFT 240
+N AD+WS GVI ++LL+G PF +SA + S
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFK---------KDYKPPVFE 278
A+ I R+L +P R+TI + L+ W K + P FE
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 6e-73
Identities = 83/282 (29%), Positives = 131/282 (46%), Gaps = 20/282 (7%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM---AEQIKREVATMKL 67
+Y+VG +G G F V PVA+K ++K+++ ++ EV +K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 68 VK--HPNVVRLYEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAV 124
V V+RL + ++LE +LFD I G ++E+ AR +F Q++ AV
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 125 DYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+CH+ GV HRD+K EN+L+D G LK+ DFG AL D + GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
+ Y G +A +WS G++L+ ++ G +PF+ +I + +S +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNL 285
LI L P R T EI W + P +E + +L
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLP---QETAEIHL 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 7e-73
Identities = 68/270 (25%), Positives = 128/270 (47%), Gaps = 18/270 (6%)
Query: 11 GKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
G++ + IG G+F V ++ET VA L K+ K + ++ K E +K ++
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 66
Query: 70 HPNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
HPN+VR Y+ S K I +V E +T G L + MK R + +Q++ +
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 126 YCHSRG--VYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ H+R + HRDLK +N+ + G++K+ D GL+ L GTP ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAP 182
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAA--EFTCPPWLSF 239
E+ YD S D+++ G+ + + P+ + N +Y+++++ +
Sbjct: 183 EMYE-EKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFK 269
+++I + N R +I ++L +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 6e-72
Identities = 94/299 (31%), Positives = 150/299 (50%), Gaps = 21/299 (7%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K + ++ + +G+GTF KV R TG A+KIL KE ++ E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+HP + L + ++ V+E+ GGELF + E+ AR Y ++++A++Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HSR V +RD+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
D Y + D W GV+++ ++ G LPF + + L++ I E P LS A+ L+A
Sbjct: 179 DNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 247 RILDPNPMTRI-----TIPEILEDEWFKK-------------DYKPPVFEEKKDTNLDD 287
+L +P R+ E++E +F +KP V E DD
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDD 296
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 2e-71
Identities = 95/333 (28%), Positives = 149/333 (44%), Gaps = 25/333 (7%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
Q K + Y+V + +G G KV N T E ALK+L + +RE
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARRE 54
Query: 62 VATM-KLVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEAR 114
V + + P++VR+ +V + + IV+E + GGELF +I + G E EA
Sbjct: 55 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 114
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174
+ + A+ Y HS + HRD+KPENLL + + +++ L T C
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA----- 229
TP YVAPEVL YD S D+WS GVI+++LL GY PF ++ + + +
Sbjct: 175 YTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233
Query: 230 -EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD 286
EF P W +S + LI +L P R+TI E + W + K P L
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 293
Query: 287 DVEAVFKDSEVCWMEHHVTEQKEEQPVAMNAFE 319
+ + ++D + T + + + + + E
Sbjct: 294 EDKERWEDVKEEMTSALATMRVDYEQIKIKKIE 326
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 224 bits (571), Expect = 3e-71
Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 10/268 (3%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+G +G G ++V AR+ VA+K+L + + +RE + H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 71 PNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
P +V +Y+ ++T +IV+E+V G L D + G M A A+++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ HRD+KP N+++ A +KV DFG++ ++ GT Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241
D +D++S G +L+ +L G PF + +++ + + P LS
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFK 269
++ + L NP R + + +
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 3e-70
Identities = 58/263 (22%), Positives = 119/263 (45%), Gaps = 14/263 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+ VG+ IG G+F V + VA+K+L+ ++ + K EV ++ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRH 63
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHS 129
N++ + ++ IV ++ G L+ + + + + + +Q +DY H+
Sbjct: 64 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ + HRDLK N+ L +K+ DFGL+ + + G+ ++APEV+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 190 YDGST--ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF------TA 241
+ + +D+++ G++L+ L+ G LP+ + N + + + P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 242 RKLIARILDPNPMTRITIPEILE 264
++L+A L R P+IL
Sbjct: 243 KRLMAECLKKKRDERPLFPQILA 265
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 220 bits (562), Expect = 5e-69
Identities = 92/306 (30%), Positives = 156/306 (50%), Gaps = 24/306 (7%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++ +++ +T+G G+F +V ++ E+G A+KILDK+KV+K K E E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ V P +V+L + +++V+E+V GGE+F + GR E AR Y Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+Y HS + +RDLKPENLL+D G ++V+DFG + R G T CGTP +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALA 206
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ +GY+ + D W+ GV+++ + AGY PF + +Y+KI + + P S
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 242 RKLIARILDPNPMTRI-----TIPEILEDEWFKKD-------------YKPPVFEEKKDT 283
+ L+ +L + R + +I +WF + P +
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTS 325
Query: 284 NLDDVE 289
N DD E
Sbjct: 326 NFDDYE 331
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 5e-67
Identities = 79/309 (25%), Positives = 118/309 (38%), Gaps = 43/309 (13%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
V KYE IG+GTF +V AR+ +TG+ VALK + E K RE+ ++L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQL 65
Query: 68 VKHPNVVRLYEV--------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
+KH NVV L E+ K I++V +F + E +R Q
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GLLHTTCGTP 177
L+N + Y H + HRD+K N+L+ G LK++DFGL+ ++ T
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-- 235
Y PE+L G DLW G I+ + + + IS + P
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 236 ------------------------------WLSFTARKLIARILDPNPMTRITIPEILED 265
A LI ++L +P RI + L
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
Query: 266 EWFKKDYKP 274
++F D P
Sbjct: 306 DFFWSDPMP 314
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-65
Identities = 73/291 (25%), Positives = 113/291 (38%), Gaps = 32/291 (10%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK--MAEQIKREVATMKLVKHP 71
E +GEG FA V AR+ T + VA+K + + K + RE+ ++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++ L + G K+ I +V +F+ N + + Y + ++Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLKP NLLLD G LK++DFGL+ + T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLA--KSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----------------- 234
G D+W+ G IL LL + ++ +I T
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 235 -----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
LI + NP RIT + L+ ++F P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 5e-65
Identities = 69/316 (21%), Positives = 129/316 (40%), Gaps = 42/316 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y IGEG + V A ++ VA+K + + ++ RE+ + +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 71 PNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ + +++ + T K ++ + G +L+ ++ + D + Q++ + Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKY 124
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVL 185
HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D T T Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----------- 234
+ + D+WS G IL +L+ F + ++ I +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 235 --------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
P A L+ ++L NP RI + + L + ++ Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 275 ---PVFEEKKDTNLDD 287
P+ E +++
Sbjct: 305 SDEPIAEAPFKFDMEL 320
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 4e-64
Identities = 60/258 (23%), Positives = 116/258 (44%), Gaps = 18/258 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ ++ +TIG+G F V G VA+K + + A+ E + M ++H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHS 60
Query: 72 NVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCH 128
N+V+L V + K ++IV E++ G L D + + GR + D ++ + A++Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
HRDL N+L+ KVSDFGL+ + +D T + APE L ++
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK 175
Query: 189 GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246
+ +D+WS G++L+ + + G +P+ L ++ ++ P +++
Sbjct: 176 KFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 247 RILDPNPMTRITIPEILE 264
+ R + ++ E
Sbjct: 235 NCWHLDAAMRPSFLQLRE 252
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-62
Identities = 65/260 (25%), Positives = 103/260 (39%), Gaps = 10/260 (3%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +G+G+F V+ S VA+K L + + + + + REV M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
H N++RLY V + +V E G L D++ H G RY Q+ + Y
Sbjct: 70 HRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLND 187
S+ HRDL NLLL +K+ DFGL Q D ++ + APE L
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 188 RGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKL 244
R + + +D W GV L+ + G P+ N + KI P +
Sbjct: 189 RTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 245 IARILDPNPMTRITIPEILE 264
+ + P R T + +
Sbjct: 248 MVQCWAHKPEDRPTFVALRD 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 201 bits (512), Expect = 2e-62
Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 33/288 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IGEGT+ V A+N+ GE ALK + EK + RE++ +K +KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V+LY+V+ +K ++ +V E + V G ++ A+ + QL+N + YCH R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDLKP+NLL++ G LK++DFGL+ T Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT------------------- 232
+T D+WS G I ++ G F + + +I T
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 233 ----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
L + L++++L +P RIT + LE +FK+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (513), Expect = 2e-62
Identities = 79/293 (26%), Positives = 129/293 (44%), Gaps = 33/293 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ IGEGT+ V ARN TGE VALK + + + RE++ +K + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V+L +V+ ++ K+++V EF+ + F + + Y QL+ + +CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
V HRDLKP+NLL++ G +K++DFGL+ T Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---------------- 234
+ D+WS G I ++ F + ++ +I T
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 235 -------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
P L R L++++L +P RI+ L +F+ KP
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 3e-62
Identities = 88/294 (29%), Positives = 134/294 (45%), Gaps = 34/294 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE IGEGT+ V A+N ET E VALK + + + RE+ +K +KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++V+ S K+ +V EF +G + + + + QL+ + +CHSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDLKP+NLL++ G LK+++FGL+ T Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 192 GSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAAEFT------------------ 232
++ D+WS G I L P F +++ + K+I T
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 233 -----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
P L+ T R L+ +L NP+ RI+ E L+ +F D+ PP
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFCPP 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-62
Identities = 55/261 (21%), Positives = 103/261 (39%), Gaps = 11/261 (4%)
Query: 17 RTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F VK + + + VA+KIL E + +++ E M+ + +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIV 71
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
R+ + ++ +V+E G L + + +K+ Q+ + Y H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGS 193
RDL N+LL K+SDFGLS + + T + APE +N +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDP 251
+D+WS GV+++ + G P+ + + E CP L+
Sbjct: 191 -SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 252 NPMTRITIPEI---LEDEWFK 269
+ R + L + ++
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-61
Identities = 81/317 (25%), Positives = 137/317 (43%), Gaps = 47/317 (14%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + +G G + V A + TG VA+K L + A++ RE+ +K ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHE 77
Query: 72 NVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V + T ++V+ F+ G K++ H ++ ED + Q++ +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEVI 190
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--------- 236
+ T D+WS G I+ ++ G F S+ ++ K+I T P
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 237 ----------------------LSFTARKLIARILDPNPMTRITIPEILEDEWFKK--DY 272
S A L+ ++L + R+T E L +F+ D
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
Query: 273 KPPVFEEKKDTNLDDVE 289
+ +K D + DDV+
Sbjct: 311 EDEPQVQKYDDSFDDVD 327
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 5e-61
Identities = 75/303 (24%), Positives = 121/303 (39%), Gaps = 49/303 (16%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y + IG G+F V A+ ++GE VA+K + ++K RE+ M+ + H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCN 74
Query: 73 VVRLYEVM------GSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINA 123
+VRL + + +VL++V + + Y QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ Y HS G+ HRD+KP+NLLLD LK+ DFG ++Q+ + + Y AP
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRYYRAP 191
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-------- 234
E++ S+ D+WS G +L LL G F + ++ +I T
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 235 ---------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273
P A L +R+L+ P R+T E +F +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311
Query: 274 PPV 276
P V
Sbjct: 312 PNV 314
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-60
Identities = 61/260 (23%), Positives = 100/260 (38%), Gaps = 13/260 (5%)
Query: 19 IGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ R + VA+K+L + + E++ RE M + +P +VRL
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 75 IGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 136 DLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
DL N+LL K+SDFGLS AL + APE +N R +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192
Query: 195 ADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPN 252
+D+WS GV ++ L+ G P+ + I + CPP L++
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 253 PMTRITIPEI---LEDEWFK 269
R + + ++
Sbjct: 253 WEDRPDFLTVEQRMRACYYS 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-60
Identities = 56/256 (21%), Positives = 107/256 (41%), Gaps = 10/256 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F VK+ + VA+K++ + + + ++ E M + H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V+LY V + IFI+ E++ G L + + R + + + + A++Y S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
HRDL N L++ G +KVSDFGLS + + + PEVL +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 192 GSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIARIL 249
+D+W+ GV+++ + + G +P++ + I P S ++
Sbjct: 180 SK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 250 DPNPMTRITIPEILED 265
R T +L +
Sbjct: 239 HEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 8e-60
Identities = 52/285 (18%), Positives = 110/285 (38%), Gaps = 35/285 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATM- 65
E G+ +G G F KV A + VA+K+L ++ E + E+ M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-------------------- 105
+L H N+V L I+++ E+ G+L + + +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 106 ---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ ++ + Q+ +++ + HRDL N+L+ +K+ DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221
+ + ++APE L + Y +D+WS G++L+ + + G P+ +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 222 LYKKI--SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+ K+ + + P + + ++ + R + P +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-59
Identities = 77/280 (27%), Positives = 136/280 (48%), Gaps = 16/280 (5%)
Query: 7 KRRVG--KYEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKR 60
+VG +E+ + +G G + KV R +TG+ A+K+L K ++ K K E +
Sbjct: 18 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77
Query: 61 EVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
E ++ ++ P +V L+ ++TK+ ++L+++ GGELF + R E E + Y +
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
++ A+++ H G+ +RD+K EN+LLD+ G++ ++DFGLS +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPP 235
V D WS GV+++ LL G PF + ++I +E P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 236 WLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270
+S A+ LI R+L +P R+ EI E +F+K
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (493), Expect = 3e-59
Identities = 59/261 (22%), Positives = 103/261 (39%), Gaps = 12/261 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
++ + IG G F +V G+ VA+K L K E + M
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD 85
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCH 128
HPNV+ L V+ T + I+ EF+ G L N G+ + + + + Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPNYVAPEVL 185
HRDL N+L+++ KVSDFGLS + D + + APE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 186 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243
R + + +D+WS G++++ +++ G P+ D ++ I P +
Sbjct: 206 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264
Query: 244 LIARILDPNPMTRITIPEILE 264
L+ + R +I+
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVN 285
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-59
Identities = 56/264 (21%), Positives = 105/264 (39%), Gaps = 6/264 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE--KVLKHKMAEQIKREVATMKLVKH 70
++ + +G G F V GE V + + KE + K ++I E M V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
P+V RL + + T I G L + + + Q+ ++Y R
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRDL N+L+ ++K++DFGL+ L + ++A E + R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 191 DGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARI 248
+D+WS GV ++ L+ G P+D + + E PP + ++ +
Sbjct: 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 249 LDPNPMTRITIPEILED-EWFKKD 271
+ +R E++ + +D
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARD 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 5e-59
Identities = 62/272 (22%), Positives = 113/272 (41%), Gaps = 17/272 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F +V + T VA+K L + E +E MK ++H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
+V+LY V+ S+ I+IV E+++ G L D + ++ + Q+ + + Y
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
HRDL+ N+L+ KV+DFGL+ L + + + APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIAR 247
+ +D+WS G++L L G +P+ + ++ CPP + L+ +
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 248 ILDPNPMTRITIPEILE--DEWFKK---DYKP 274
P R T + +++F Y+P
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 7e-59
Identities = 81/299 (27%), Positives = 124/299 (41%), Gaps = 42/299 (14%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +YE IGEG + KV AR+ + G VALK + + + M REVA ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLR 62
Query: 67 L---VKHPNVVRLYEVM-----GSKTKIFIVLEFVTGGEL-FDKIVNHGRMKEDEARRYF 117
+HPNVVRL++V +TK+ +V E V + V + + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
QL+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+ + + T
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTL 179
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----- 232
Y APEVL Y DLWS G I + F S+ ++ KI
Sbjct: 180 WYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 233 ----------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269
+ + L+ + L NP RI+ L +F+
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-58
Identities = 55/263 (20%), Positives = 108/263 (41%), Gaps = 14/263 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ +G G F +V VA+K L + + + E MK ++H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCHS 129
+VRLY V ++ I+I+ E++ G L D + +K ++ Q+ + +
Sbjct: 69 RLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R HRDL+ N+L+ + K++DFGL+ L + + + APE +N
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGT 186
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIAR 247
+ +D+WS G++L ++ G +P+ + + + P +L+
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 248 ILDPNPMTRITIPEILE--DEWF 268
P R T + +++F
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-58
Identities = 59/255 (23%), Positives = 100/255 (39%), Gaps = 10/255 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ IG G F V + VA+K + + + + E E M + HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V+LY V + I +V EF+ G L D G + + + Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDL N L+ +KVSDFG++ T + +PEV + Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 192 GSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARIL 249
S +D+WS GV+++ + + G +P+++ + + + IS P S +++
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 250 DPNPMTRITIPEILE 264
P R +L
Sbjct: 240 KERPEDRPAFSRLLR 254
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-58
Identities = 73/298 (24%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ +G G + V A +++TG VA+K L + A++ RE+ +K +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 72 NVVRLYEVMGSKTKIF----IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
NV+ L +V + + L G + IV ++ +D + Q++ + Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
HS + HRDLKP NL ++ LK+ DFGL+ D + T Y APE++ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIMLN 192
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL---------- 237
+ T D+WS G I+ LL G F ++ ++ K I T L
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 238 ---------------------SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
+ A L+ ++L + RIT + L +F + + P
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 8e-58
Identities = 61/300 (20%), Positives = 111/300 (37%), Gaps = 28/300 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
+ IGEG F +V AR + G + I ++ E+ + KL HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARR 115
N++ L + +++ +E+ G L D + + +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
+ + +DY + HRDL N+L+ K++DFG LS+
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGRL 188
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTC 233
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 189 PVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 234 PPWLSFTARKLIARILDPNPMTRITIPEILED-EWFKKDYKPPV----FEEKKDTNLDDV 288
P L+ + P R + +IL ++ K V +E+ +D
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCS 307
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (480), Expect = 2e-57
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 12/278 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G + +V + VA+K L ++ E+ +E A MK +KHP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHP 73
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCHS 129
N+V+L V + +I+ EF+T G L D + R + Q+ +A++Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRDL N L+ +KV+DFGLS L + APE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 190 YDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKISA-AEFTCPPWLSFTARKLIAR 247
+ + W+ GV+L+ + G P+ +L +Y+ + P +L+
Sbjct: 193 FSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNL 285
NP R + EI + F+ ++ ++ + L
Sbjct: 252 CWQWNPSDRPSFAEIH--QAFETMFQESSISDEVEKEL 287
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 2e-57
Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 15/262 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ E+GR IGEG F V VA+K + E+ +E TM+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYC 127
HP++V+L V+ ++ ++I++E T GEL V + Y QL A+ Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC--GTPNYVAPEVL 185
S+ HRD+ N+L+ + +K+ DFG LS+ + D + ++APE +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 186 NDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243
N R + + +D+W GV ++ +L+ G PF ++ +I E PP T
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 244 LIARILDPNPMTRITIPEILED 265
L+ + +P R E+
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (472), Expect = 3e-56
Identities = 61/284 (21%), Positives = 101/284 (35%), Gaps = 34/284 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
E R IGEG F +V AR E VA+K+L +E M +RE A M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR------------------- 107
+PN+V+L V + ++ E++ G+L + + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 108 -----MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ E +Q+ + Y R HRDL N L+ +K++DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDDSNLMN 221
++ PE + Y +D+W+ GV+L+ + + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 222 LYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+ + CP L+ P R + I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 1e-54
Identities = 51/287 (17%), Positives = 94/287 (32%), Gaps = 27/287 (9%)
Query: 9 RVG-KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
RVG +Y +GR IG G+F + + GE VA+K+ + Q+ E K+
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKM 58
Query: 68 VKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
++ + G+ +V+E + + Q+I+ ++Y
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 127 CHSRGVYHRDLKPENLL---LDAYGNLKVSDFGLS-----ALSQQVRDDGLLHTTCGTPN 178
HS+ HRD+KP+N L + + DFGL+ A + Q GT
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------- 231
Y + DL S G +L G LP+ +K
Sbjct: 179 YASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 232 -TCPPWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKKDYKP 274
+ + + ++ + + ++ +
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 182 bits (462), Expect = 2e-54
Identities = 67/300 (22%), Positives = 122/300 (40%), Gaps = 54/300 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
Y++ R +G G +++V A N E V +KIL K ++IKRE+ ++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89
Query: 71 PNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
PN++ L +++ +V E V + + + + R Y +++ A+DYCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 129 SRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
S G+ HRD+KP N+++D L++ D+GL+ + + + PE+L D
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVD 203
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSN--------------LMNLYKKISAAEFTC 233
+ D+WS G +L ++ PF + +LY I
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 234 PPW------------------------LSFTARKLIARILDPNPMTRITIPEILEDEWFK 269
P +S A + ++L + +R+T E +E +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-54
Identities = 56/280 (20%), Positives = 108/280 (38%), Gaps = 30/280 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATM- 65
+ G+T+G G F KV A S+ VA+K+L L + E + E+ +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 81
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG------------------R 107
L H N+V L ++ E+ G+L + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 108 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
+ ++ + Q+ + + S+ HRDL N+LL K+ DFGL+ + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
+ ++APE + + +D+WS G+ L+ L + G P+ + + + K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 227 --SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
P ++ D +P+ R T +I++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-53
Identities = 59/280 (21%), Positives = 113/280 (40%), Gaps = 29/280 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGE-------PVALKILDKEKVLKHKMAEQIKREVAT 64
+ +G+ +GEG F +V A + VA+K+L + K + E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------R 107
MK + KH N++ L +++++E+ + G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 108 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
+ + Q+ ++Y S+ HRDL N+L+ +K++DFGL+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++APE L DR Y +D+WS GV+L+ + G P+ + L+K +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 227 SAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265
P + ++ P R T +++ED
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-52
Identities = 54/260 (20%), Positives = 102/260 (39%), Gaps = 11/260 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ IG G F +V + PVA+K L K E M
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQF 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYC 127
H N++RL V+ + I+ E++ G L + G + + + + Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT-TCGTPNYVAPEVLN 186
+ HRDL N+L+++ KVSDFGLS + + + + + APE ++
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244
R + + +D+WS G++++ ++ G P+ + + + K I+ P +L
Sbjct: 187 YRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 245 IARILDPNPMTRITIPEILE 264
+ + R +I+
Sbjct: 246 MMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-51
Identities = 61/268 (22%), Positives = 106/268 (39%), Gaps = 12/268 (4%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
I IG G F V N A+K L++ Q E
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEG 79
Query: 63 ATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQL 120
MK HPNV+ L + + S+ +VL ++ G+L + I N + + Q+
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPN 178
+ + S+ HRDL N +LD +KV+DFGL+ D + + T
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPW 236
++A E L + + +D+WS GV+L+ L+ G P+ D N ++ + P +
Sbjct: 200 WMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 237 LSFTARKLIARILDPNPMTRITIPEILE 264
+++ + P R + E++
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 173 bits (439), Expect = 2e-51
Identities = 50/273 (18%), Positives = 92/273 (33%), Gaps = 25/273 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
Y+VGR IGEG+F + N + VA+K + A Q++ E T KL+
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAG 59
Query: 71 -PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ +Y +V++ + + + +Q++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 130 RGVYHRDLKPENLLLDAY-----GNLKVSDFGLSAL-----SQQVRDDGLLHTTCGTPNY 179
+ + +RD+KP+N L+ + V DFG+ ++Q GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL---YKKISAAEFTCPPW 236
++ R DL + G + L G LP+ Y++I + + P
Sbjct: 180 MSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 237 -----LSFTARKLIARILDPNPMTRITIPEILE 264
K + + +
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-51
Identities = 71/331 (21%), Positives = 130/331 (39%), Gaps = 60/331 (18%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNH 75
Query: 71 PNVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
N++ L V + +++V+E + + + Q++ +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGI 132
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+ HS G+ HRDLKP N+++ + LK+ DFGL+ + ++ T Y APEV
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEV 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW-------- 236
+ GY + D+WS G I+ ++ + F + ++ + K+ T P
Sbjct: 190 ILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 237 ----------------------------------LSFTARKLIARILDPNPMTRITIPEI 262
+ AR L++++L +P RI++ +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 263 LEDEWFKKDYKPPVFE----EKKDTNLDDVE 289
L+ + Y P E + D LD+ E
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQLDERE 339
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-49
Identities = 52/285 (18%), Positives = 109/285 (38%), Gaps = 22/285 (7%)
Query: 12 KYEVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V K E VA+K +++ ++ + + E + MK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMK 78
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----------MKEDEARRY 116
+VVRL V+ +++E +T G+L + + + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
++ + + Y ++ HRDL N ++ +K+ DFG++ +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAE-FTCP 234
+++PE L D + + WS GV+L+ + P+ + + + + P
Sbjct: 199 VRWMSPESLKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKKDYKPPVF 277
+L+ NP R + EI+ E + ++ F
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-49
Identities = 58/279 (20%), Positives = 108/279 (38%), Gaps = 29/279 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+ ++G+ +G G F +V A + T VA+K+L + H + E+ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILI 71
Query: 67 LVKH-PNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNHGR----------------M 108
+ H NVV L + +++EF G L + + +
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168
+ Y Q+ +++ SR HRDL N+LL +K+ DFGL+ + D
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNLMNLYKKI- 226
++APE + DR Y +D+WS GV+L+ + + P+ + + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 227 -SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
P + + + + P R T E++E
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-48
Identities = 55/295 (18%), Positives = 111/295 (37%), Gaps = 48/295 (16%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ +IG+G F +V + GE VA+KI + + + + E+ +++H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 71 PNVVRLYEVM----GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ G+ T++++V ++ G LFD + N + + + + + +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115
Query: 127 CHS--------RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGT 176
H + HRDLK +N+L+ G ++D GL+ D D + GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 177 PNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFD---------------D 216
Y+APEVL+D AD+++ G++ + + D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 217 SNLMNLYKKISAAEF-------TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
++ + K + + K++ N R+T I +
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (375), Expect = 1e-41
Identities = 54/327 (16%), Positives = 107/327 (32%), Gaps = 63/327 (19%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-------REVA 63
+Y + R +G G F+ V A++ VA+KI+ +KV ++IK +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT-----GGELFDKIVNHGRMKEDEARRYFQ 118
+ ++++L + K + + V K H + ++ +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 119 QLINAVDYC-HSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDGLLHTTCGT 176
QL+ +DY G+ H D+KPEN+L++ + ++ L D + T
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK------------ 224
Y +PEVL + AD+WS ++F L+ G F+ + K
Sbjct: 193 REYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 225 ------------------------------------KISAAEFTCPPWLSFTARKLIARI 248
+ ++ + ++ +
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPP 275
L +P R ++ W K
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 1e-22
Identities = 33/213 (15%), Positives = 69/213 (32%), Gaps = 42/213 (19%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---------------EQ 57
+G+ +GEG + V + E +K K+
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 58 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 117
+ E ++ ++ V ++Y G+ +++E + R++ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK-------ELYRVRVENPDEVL 109
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
++ V + RG+ H DL N+L+ G + + DF S + +L
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV--- 165
Query: 178 NYVAPEVLND---RGYDGSTADLWSCGVILFVL 207
+ R Y + D+ S I +L
Sbjct: 166 -----RNIITYFSRTY-RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.0 bits (213), Expect = 3e-21
Identities = 12/86 (13%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 346 TSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVA-PSLH 403
TS ++++ +I + D ++ + + + + + EV ++ SL+
Sbjct: 16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLN 75
Query: 404 MVEVRKAKGDTLEFHKFYKNLSTCLE 429
V ++ G ++ F ++ L+
Sbjct: 76 GVRFKRISGTSIAFKNIASKIANELK 101
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 443 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.42 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.75 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.11 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.96 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.58 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.99 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.66 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-65 Score=488.50 Aligned_cols=258 Identities=37% Similarity=0.713 Sum_probs=240.6
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.+++|++++.||+|+||+||+|+++.+|+.||+|++.+....+....+.+.+|+.+++.++|||||++++++.+++.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 36899999999999999999999999999999999988766555556789999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||||++||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.... ..
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~~ 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SS 159 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----CC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----CC
Confidence 99999999999999988899999999999999999999999999999999999999999999999999997543 23
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~m 248 (443)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+..+....+.+|+.+|+++++||.+|
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 34567899999999999988775 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCChhhhhcCcccccc
Q 013407 249 LDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 249 L~~dP~~R~t~~eil~hp~~~~~ 271 (443)
|+.||.+|||++|+|+||||+..
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCCc
Confidence 99999999999999999999754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-65 Score=489.40 Aligned_cols=262 Identities=39% Similarity=0.694 Sum_probs=228.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
-+++|++++.||+|+||+||+|+++.+|+.||||++++.... +..+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 468999999999999999999999999999999999875432 234678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||||++||+|++++...+.+++..++.++.||++||+|||++||+||||||+|||++.++++||+|||+|+.........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998765544444
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhhcCccCCC--CCCCHHHHHHH
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP--PWLSFTARKLI 245 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~li 245 (443)
...+.+||+.|+|||++.+..|++.++|||||||++|+|++|++||...+.. ..+..+.......+ +.+|+++++||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 5567899999999999998888778899999999999999999999876543 33333333333222 35899999999
Q ss_pred HHhcCCCCCCCCChhhhhcCccccccC
Q 013407 246 ARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 246 ~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
.+||+.||++|||++|+++||||++..
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 999999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-64 Score=487.79 Aligned_cols=261 Identities=31% Similarity=0.583 Sum_probs=235.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 45789999999999999999999999999999999988766555556789999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++++|.+||+|||+|+.........
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 99999999999999998999999999999999999999999999999999999999999999999999998765444444
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~m 248 (443)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+....+.++..+.+.+|..+|+++++||++|
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 244 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTT
T ss_pred ccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 55667899999999999988775 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCChhhh------hcCccccc
Q 013407 249 LDPNPMTRITIPEI------LEDEWFKK 270 (443)
Q Consensus 249 L~~dP~~R~t~~ei------l~hp~~~~ 270 (443)
|+.||.+|||++|+ ++||||+.
T Consensus 245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999985 67888753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-63 Score=488.72 Aligned_cols=260 Identities=33% Similarity=0.611 Sum_probs=242.4
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 46789999999999999999999999999999999999876655555678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+||||++||+|++++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999985432 23
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 247 (443)
....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+...+++.+..+.+.+|..+|+++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 345678999999999999998885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCC-----hhhhhcCccccc
Q 013407 248 ILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 248 mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
||++||.+|++ ++|+++||||+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hccCCchhhcccccccHHHHHcCccccc
Confidence 99999999994 899999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-62 Score=473.83 Aligned_cols=253 Identities=29% Similarity=0.503 Sum_probs=225.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++.+.||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 47999999999999999999999999999999998654332 467899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcc
Q 013407 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (443)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (443)
||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... .....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~ 173 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKR 173 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCB
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccccc
Confidence 99999999988765 5799999999999999999999999999999999999999999999999999986533 22344
Q ss_pred ccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHHHHHHH
Q 013407 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 171 ~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~ 247 (443)
...+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+.......+... .+..|+.+|+++++||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 567899999999999988775 8999999999999999999999988876655554332 344567799999999999
Q ss_pred hcCCCCCCCCChhhhhcCccccc
Q 013407 248 ILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
||++||.+|||++|+|+||||+.
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-62 Score=476.78 Aligned_cols=255 Identities=35% Similarity=0.726 Sum_probs=238.9
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 67899999999999999999999999999999999887655555567899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|||+.||+|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999986432 2
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL 249 (443)
..+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+.++..+...+|+.+|++++++|.+||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 3467899999999999988886 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC-----ChhhhhcCccccc
Q 013407 250 DPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 250 ~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
..||.+|+ |++++++||||+.
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhCHHhccccchhhHHHHHcCccccc
Confidence 99999996 8999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-62 Score=473.74 Aligned_cols=256 Identities=38% Similarity=0.695 Sum_probs=214.6
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
-++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356999999999999999999999999999999998765432 245788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc---cCCCeEEeecCcccccccccC
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~~~ 166 (443)
||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+. +++.+||+|||+|.....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--- 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--- 162 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence 99999999999999989999999999999999999999999999999999999995 578999999999985432
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHHHH
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTAR 242 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~ 242 (443)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+....+..+...++ +.+|++++
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ----------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 3344567899999999999988775 899999999999999999999999998888888887765443 45899999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+||.+||+.||++|||++|+++||||+..
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-62 Score=464.91 Aligned_cols=256 Identities=34% Similarity=0.569 Sum_probs=218.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKI 86 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 86 (443)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.+.... +...+.+.+|+.+|++++|||||++++++.+ .+.+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 467899999999999999999999999999999999876543 3346789999999999999999999999854 5668
Q ss_pred EEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 87 FIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999998854 467999999999999999999999976 99999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc-CCCCC
Q 013407 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW 236 (443)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 236 (443)
|+.... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+..++..++..+.+ ..|..
T Consensus 161 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (269)
T d2java1 161 ARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred eeeccc--CCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 987543 22334567899999999999887775 899999999999999999999999998888888887765 45667
Q ss_pred CCHHHHHHHHHhcCCCCCCCCChhhhhcCccc
Q 013407 237 LSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (443)
Q Consensus 237 ~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~ 268 (443)
+|+++++||.+||+.||.+|||++|+++|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999999995
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-61 Score=477.12 Aligned_cols=257 Identities=33% Similarity=0.650 Sum_probs=239.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 45789999999999999999999999999999999998876555555678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 167 (443)
+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 9999999999999999989999999999999999999999999999999999999999999999999999986432
Q ss_pred CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 013407 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 168 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 247 (443)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+....+.++..+.+..|+.+|+++.+||++
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred -ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 23467899999999999988885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCC-----ChhhhhcCccccc
Q 013407 248 ILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 248 mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
||..||.+|+ |++++++||||+.
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HhhhCHHhccccccccHHHHHcCccccC
Confidence 9999999995 9999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-62 Score=469.39 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=224.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
+.|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 469999999999999999999999999999999976432 23467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|...... ...
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence 99999999998765 567999999999999999999999999999999999999999999999999998754331 112
Q ss_pred cccccCCCcccchhhhc-----cCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCHHH
Q 013407 170 LHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTA 241 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~-----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~ 241 (443)
..+.+||+.|+|||++. +..| +.++|||||||++|+|++|.+||.+.+..+.+.++..+.. ..|+.+|+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 34578999999999984 2334 5899999999999999999999999888877777766643 3456689999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
++||.+||+.||.+|||++|+++||||+..
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-61 Score=470.22 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=228.5
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 91 (443)
+|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999987665555566789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCccc
Q 013407 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (443)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 171 (443)
||.||+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 999999988888888999999999999999999999999999999999999999999999999999975432 24
Q ss_pred cccCCCcccchhhhccC--CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC--CCCCCHHHHHHHHH
Q 013407 172 TTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--PPWLSFTARKLIAR 247 (443)
Q Consensus 172 ~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~s~~~~~li~~ 247 (443)
..+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+..+..+. +..+|+++++||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 56899999999998642 223589999999999999999999999988887777766654432 34589999999999
Q ss_pred hcCCCCCCCCChhhhhcCccccccCC
Q 013407 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
||+.||.+|||++|+|+||||.+...
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 99999999999999999999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-61 Score=469.84 Aligned_cols=258 Identities=30% Similarity=0.581 Sum_probs=235.7
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHh-cCCCCCcceEEEEEEeCCEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l 88 (443)
+++|++++.||+|+||+||+|.++.+|+.||||++.+......+..+.+.+|+.++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 578999999999999999999999999999999998766544444566677777765 6899999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999975433 233
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~m 248 (443)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+...++.++..+.+.+|..+|+++++||++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 34567899999999999988886 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCChh-hhhcCccccc
Q 013407 249 LDPNPMTRITIP-EILEDEWFKK 270 (443)
Q Consensus 249 L~~dP~~R~t~~-eil~hp~~~~ 270 (443)
|+.||.+|||+. ++++||||+.
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999995 8999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.5e-61 Score=473.13 Aligned_cols=259 Identities=30% Similarity=0.575 Sum_probs=232.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 457899999999999999999999999999999999976542 23567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc--CCCeEEeecCcccccccc
Q 013407 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 164 (443)
+||||++||+|++++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~- 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc-
Confidence 99999999999999954 467999999999999999999999999999999999999964 57899999999986432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFT 240 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 240 (443)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+.+..+.......+ +.+|++
T Consensus 179 --~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 179 --KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp --TSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred --ccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 3345567899999999999988885 899999999999999999999999999998888887766554 358999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
+++||.+||..||++|||++|+|+||||+....
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999999999999999999999999987554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-61 Score=462.43 Aligned_cols=256 Identities=37% Similarity=0.627 Sum_probs=231.8
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 579999999999999999999999999999999987543321 13567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC----CeEEeecCccccccc
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQQ 163 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~----~~kl~DFGla~~~~~ 163 (443)
+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||+|.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 9999999999999999888999999999999999999999999999999999999998876 499999999986533
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 239 (443)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..+......++ +.+|+
T Consensus 170 ---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 170 ---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp ---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred ---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 233456789999999999988767 5899999999999999999999999999998888888776654 46899
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
++++||++||+.||.+|||++|+++||||+.
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-60 Score=472.70 Aligned_cols=259 Identities=27% Similarity=0.542 Sum_probs=233.4
Q ss_pred ccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 7 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
+...++|++++.||+|+||+||+|++..+|+.||||++++.... ....+.+|+.+|++++|||||++++++.+++.+
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34568899999999999999999999999999999999875432 245788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc--cCCCeEEeecCccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD--AYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~--~~~~~kl~DFGla~~~~~ 163 (443)
|+|||||+||+|++.+...+ ++++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999999999999886654 699999999999999999999999999999999999998 568999999999986543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCH
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 239 (443)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+.+..+..+.+.+| +.+|+
T Consensus 182 ---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 182 ---DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 3445678899999999999888775 899999999999999999999999999998888888776554 45899
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
++++||.+||+.||.+|||++|+|+||||+...
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 999999999999999999999999999998654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-60 Score=453.94 Aligned_cols=252 Identities=25% Similarity=0.504 Sum_probs=219.8
Q ss_pred ccE-EEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCE
Q 013407 11 GKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTK 85 (443)
Q Consensus 11 ~~y-~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 85 (443)
++| ++.+.||+|+||+||+|.+..+++.||+|++...... ....+.+.+|+++|++++|||||++++++.+ ...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 455 7888999999999999999999999999999876543 3346789999999999999999999999865 456
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeeeCCCCcEEEc-cCCCeEEeecCcccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLD-AYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~ 162 (443)
+|+||||++||+|.+++.+.+.+++..++.++.||++||+|||++| |+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 8999999999999999998889999999999999999999999999 99999999999996 57899999999997532
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc-HHHHHHHhhcCcc--CCCCCCCH
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAAEF--TCPPWLSF 239 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~--~~~~~~s~ 239 (443)
.....+.+||+.|+|||++.+ .| +.++|||||||++|+|++|++||.+.. ...+++.+..+.. .++...++
T Consensus 167 ----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 167 ----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240 (270)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence 233456789999999999875 46 589999999999999999999997654 4556666665533 23445889
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
++++||.+||+.||++|||++|+|+||||+
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-61 Score=471.30 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=218.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..-++|++++.||+|+||+||+|++..+|+.||+|++.+.. .....+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34578999999999999999999999999999999997643 2334578899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|......
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999999988899999999999999999999997 49999999999999999999999999999865432
Q ss_pred CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHH----------------------
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---------------------- 224 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~---------------------- 224 (443)
...+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+......
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 23467899999999999988875 89999999999999999999997754322110
Q ss_pred --------------------HhhcCc-cCCCC-CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 225 --------------------KISAAE-FTCPP-WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 225 --------------------~i~~~~-~~~~~-~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
.+.... ...|. .+|.++++||.+||+.||.+|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000000 11111 26889999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.4e-60 Score=469.74 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=226.0
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHH---HHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE---QIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~---~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
.+++|++++.||+|+||.||+|++..+|+.||||++.+.......... ...+|+.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 478999999999999999999999999999999999876554332223 33445778888899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 999999999999999999989999999999999999999999999999999999999999999999999999986433
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcH---HHHHHHhhcCccCCCCCCCHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCPPWLSFTAR 242 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~ 242 (443)
......+||+.|+|||++....+++.++|||||||++|+|++|+.||.+.+. ......+.......|+.+|++++
T Consensus 160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 2345678999999999997555446899999999999999999999987543 34445555566777888999999
Q ss_pred HHHHHhcCCCCCCCCC-----hhhhhcCccccc
Q 013407 243 KLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t-----~~eil~hp~~~~ 270 (443)
+||.+||+.||.+||| ++|+++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 799999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-59 Score=451.10 Aligned_cols=258 Identities=32% Similarity=0.541 Sum_probs=230.0
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh------HHHHHHHHHHHHHHhcCC-CCCcceEEEEEEe
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK------HKMAEQIKREVATMKLVK-HPNVVRLYEVMGS 82 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 82 (443)
.++|++.+.||+|+||+||+|++..+|+.||||++.+..... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999998754321 234467889999999997 9999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
++.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccchhhhccC-----CCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCC---
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--- 234 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--- 234 (443)
. .......+||+.|+|||++.+. ...+.++||||+||++|+|++|+.||.+.+.....+.+..+....+
T Consensus 162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 3 2334557899999999998632 2335899999999999999999999999998888888877765433
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 235 -PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 235 -~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
+.+|+++++||.+||++||.+|||++|+|+||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 258999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-60 Score=461.95 Aligned_cols=255 Identities=25% Similarity=0.493 Sum_probs=231.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (443)
.+++|++++.||+|+||+||+|.++.+|+.||||++.+.... ...+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 578999999999999999999999999999999999875432 3468899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC--CCeEEeecCccccccccc
Q 013407 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 165 (443)
|||||+||+|++++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence 999999999999998765 79999999999999999999999999999999999999854 479999999987543
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC----CCCHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTA 241 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~ 241 (443)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+.+..+..+.+.++. .+|+++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred cCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 23345667899999999999887775 8999999999999999999999999999999999888777663 589999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
++||.+||..||.+|||++|+++||||++.
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-59 Score=451.55 Aligned_cols=256 Identities=27% Similarity=0.363 Sum_probs=216.3
Q ss_pred EEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhh--HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 013407 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (443)
Q Consensus 15 ~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 92 (443)
.++.||+|+||+||+|+++.+|+.||||++....... ....+.+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4688999999999999999999999999997654322 12235788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCcccc
Q 013407 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (443)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 172 (443)
+.|+++.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... .......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Ccccccc
Confidence 99988887777778899999999999999999999999999999999999999999999999999975433 2233456
Q ss_pred ccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccC--------------------
Q 013407 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-------------------- 232 (443)
Q Consensus 173 ~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-------------------- 232 (443)
.+||+.|+|||++....+++.++||||+||++|+|++|.+||.+.+..+...++......
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 789999999999976665579999999999999999999999998887776665321000
Q ss_pred C--------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 233 C--------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 233 ~--------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
. .+.+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0 123688999999999999999999999999999998643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=449.68 Aligned_cols=252 Identities=31% Similarity=0.543 Sum_probs=222.9
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHH---HHHHHHHHHHHHhcCC--CCCcceEEEEEEeCC
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK---MAEQIKREVATMKLVK--HPNVVRLYEVMGSKT 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~ 84 (443)
-++|++++.||+|+||+||+|++..+|+.||||++.+....... ...++.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999999999999999999875433211 1234678999999996 899999999999999
Q ss_pred EEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccC-CCeEEeecCcccccc
Q 013407 85 KIFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQ 162 (443)
Q Consensus 85 ~~~lv~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~~kl~DFGla~~~~ 162 (443)
..|+||||+.+ +++++.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|....
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 6888899888899999999999999999999999999999999999999855 789999999997543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHH
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 242 (443)
. ....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+ .+..+...+++.+|++++
T Consensus 163 ~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 163 D----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp S----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHH
T ss_pred c----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHH
Confidence 2 334567899999999999888887788999999999999999999998643 355667778889999999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
+||++||+.||.+|||++|+++||||+.-
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-58 Score=444.41 Aligned_cols=262 Identities=29% Similarity=0.450 Sum_probs=219.5
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++++.||+|+||+||+|.+..+|+.||||++..... .+...+++.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 5799999999999999999999999999999999976542 223456889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCC
Q 013407 90 LEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (443)
Q Consensus 90 ~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 168 (443)
|||+.++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|..... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Ccc
Confidence 99998654433333 345799999999999999999999999999999999999999999999999999976533 233
Q ss_pred ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc------------------
Q 013407 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------ 230 (443)
Q Consensus 169 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 230 (443)
.....+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+..+...++....
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 44566899999999999888888899999999999999999999999888766554432110
Q ss_pred cCC-----------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 231 FTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 231 ~~~-----------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
... .+.+|+++.+||++||..||.+|||++|+++||||+.-.+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 000 12367899999999999999999999999999999865443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-58 Score=453.41 Aligned_cols=255 Identities=35% Similarity=0.604 Sum_probs=217.4
Q ss_pred ccccccEEEEe-EeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEe--
Q 013407 7 KRRVGKYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGS-- 82 (443)
Q Consensus 7 ~~~~~~y~~~~-~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~-- 82 (443)
...+++|++.+ .||+|+||+||+|++..+|+.||||++... ..+.+|+.++.+ ++|||||++++++.+
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 44688999875 699999999999999999999999999652 356789998654 589999999999876
Q ss_pred --CCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc---CCCeEEeec
Q 013407 83 --KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDF 155 (443)
Q Consensus 83 --~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~~kl~DF 155 (443)
...+|+|||||+||+|++++... ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 46799999999999999999874 46999999999999999999999999999999999999986 467999999
Q ss_pred CcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHH----HHHHhhcCcc
Q 013407 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEF 231 (443)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~ 231 (443)
|+|+.... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+... +...+..+.+
T Consensus 159 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 159 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp TTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred ceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence 99986443 3345567899999999999888775 89999999999999999999998765433 3444555555
Q ss_pred CCCC----CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCC
Q 013407 232 TCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (443)
Q Consensus 232 ~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~ 273 (443)
.+|. .+|+++++||++||+.||++|||+.|+++||||.....
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 5553 38999999999999999999999999999999986544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-57 Score=436.93 Aligned_cols=257 Identities=32% Similarity=0.467 Sum_probs=219.6
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++++.||+|+||+||+|+++ +|+.||||++...... +...+++.+|+.+|++++|||||++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 579999999999999999999996 7899999999775432 33457899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
|||+.++.+.......+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+|++|||+|...... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccc
Confidence 999998888777777889999999999999999999999999999999999999999999999999999865432 223
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-------------------
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------- 230 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------- 230 (443)
.....||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+..+...++....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3455799999999999887777899999999999999999999999887766655542110
Q ss_pred ----------cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 231 ----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 231 ----------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
...++.+++.+.+||++||+.||++|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0112346889999999999999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.7e-57 Score=432.93 Aligned_cols=260 Identities=25% Similarity=0.425 Sum_probs=218.9
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 84 (443)
.-++|++.+.||+|+||+||+|.+..+|+.||||++.++...+....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3467999999999999999999999999999999998877666667788999999999999999999999987643
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
.+|+||||++|++|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 48999999999999999999899999999999999999999999999999999999999999999999999998754332
Q ss_pred c-CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC----CCCCCH
Q 013407 165 R-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSF 239 (443)
Q Consensus 165 ~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~ 239 (443)
. ........+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+..+...++....... ++.+|+
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp --------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred cccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 2 22334567899999999999887775 89999999999999999999999988887776665554432 345899
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcCcccc
Q 013407 240 TARKLIARILDPNPMTRITIPEILEDEWFK 269 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~hp~~~ 269 (443)
++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999999999999999999655556677764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=435.82 Aligned_cols=263 Identities=29% Similarity=0.377 Sum_probs=217.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 82 (443)
.+++|++++.||+|+||+||+|++..+|+.||||++.++... .....++.+|+.+|++++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 479999999999999999999999999999999999765433 2344678899999999999999999998854
Q ss_pred --CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 83 --KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 83 --~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
...+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 456899999999887776666677899999999999999999999999999999999999999999999999999976
Q ss_pred ccccc--CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCCCC---
Q 013407 161 SQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--- 235 (443)
Q Consensus 161 ~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--- 235 (443)
..... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+.......++
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 54321 2233455789999999999987655569999999999999999999999988877665554332111110
Q ss_pred -----------------------------CCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 236 -----------------------------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 236 -----------------------------~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
..++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 0367789999999999999999999999999998643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-56 Score=431.62 Aligned_cols=257 Identities=31% Similarity=0.426 Sum_probs=213.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCC-CceEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEe--
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGS-- 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-- 82 (443)
..++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.| +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 457999999999999999999999765 6679999997643322 1223456788877766 79999999999853
Q ss_pred ---CCEEEEEEeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 83 ---KTKIFIVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 83 ---~~~~~lv~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
...+|++|||+.++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 357899999999887754443 3467999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC---------
Q 013407 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------- 229 (443)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------- 229 (443)
..... .......+||+.|+|||++.+..|+ .++||||+||++|+|++|++||.+.+..+....+...
T Consensus 164 ~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 164 RIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 75433 2334567899999999999988885 8999999999999999999999998877666554221
Q ss_pred ------------------ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 230 ------------------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 230 ------------------~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
...+++.+++.+++||++||+.||.+|||++|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 00123447889999999999999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-55 Score=421.15 Aligned_cols=258 Identities=32% Similarity=0.477 Sum_probs=223.6
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 89 (443)
+++|++++.||+|+||+||+|++..+|+.||||++..... ......++.+|+.+|+.++||||+++++++.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4799999999999999999999999999999999976543 334568899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
+|++.|++|...+...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|...... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC--Ccc
Confidence 999999999999998899999999999999999999999999999999999999999999999999999865432 223
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCC-CCCcHHHHHHHhhcCc------------------
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAAE------------------ 230 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~~------------------ 230 (443)
.....+++.|+|||++.+..+.+.++||||+||++|+|++|..|| .+.+..+...++....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 344567899999999987777679999999999999999999885 4555555555432110
Q ss_pred -----------cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 231 -----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 231 -----------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
...++.+++.+.+||++||+.||.+|||++|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 1122346889999999999999999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-56 Score=435.39 Aligned_cols=253 Identities=20% Similarity=0.339 Sum_probs=214.7
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCc-----eEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (443)
-++|++++.||+|+||+||+|++..+++ .||+|.+..... ......+.+|+.+|+++ +|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3689999999999999999999876544 699999875432 22346788999999998 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCC
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHG-----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 140 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~ 140 (443)
+.+|+|||||+||+|.++|.... .+++..++.++.||+.||+|||++||+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999997642 4899999999999999999999999999999999
Q ss_pred cEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcH
Q 013407 141 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL 219 (443)
Q Consensus 141 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~ 219 (443)
|||++.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++||||+||++|+|++ |.+||.+.+.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999865543333334456789999999999887775 89999999999999997 8999988665
Q ss_pred HHHHHHh-hcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 220 MNLYKKI-SAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 220 ~~~~~~i-~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.....++ ..+ .++.|..+|+++++||.+||+.||++|||++||++|
T Consensus 273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5444444 333 456677899999999999999999999999999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=435.41 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=212.4
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----- 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 84 (443)
-++|++++.||+|+||+||+|.+..+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4799999999999999999999999999999999986543 4445678999999999999999999999997654
Q ss_pred -EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 -KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 -~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
.+|+||||+ |++|...+ ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 55666655 45789999999999999999999999999999999999999999999999999997543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc-------------
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------- 230 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 230 (443)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+.......+....
T Consensus 173 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 234567899999999999877777799999999999999999999999887665543332110
Q ss_pred ------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 231 ------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 231 ------------------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
....+.+++++.+||++||..||.+|||++|+|+||||+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 01224578999999999999999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-56 Score=424.57 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=212.0
Q ss_pred eEeeccCcEEEEEEEEC--CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013407 17 RTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (443)
Q Consensus 17 ~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 94 (443)
+.||+|+||+||+|.+. .+++.||||++..... +....+.+.+|+.+|++++|||||++++++.++ ..|+||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 47999999999999864 4567899999976443 334567899999999999999999999999754 5789999999
Q ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCC-Cccccc
Q 013407 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTT 173 (443)
Q Consensus 95 gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~ 173 (443)
||+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999999899999999999999999999999999999999999999999999999999999865432111 122345
Q ss_pred cCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCC
Q 013407 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDP 251 (443)
Q Consensus 174 ~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~ 251 (443)
.||+.|+|||++.+..|+ .++||||+||++|+|++ |++||.+.+..+....+..+ .++.|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 789999999999887774 89999999999999998 99999998888888887765 4567788999999999999999
Q ss_pred CCCCCCChhhh---hcCccc
Q 013407 252 NPMTRITIPEI---LEDEWF 268 (443)
Q Consensus 252 dP~~R~t~~ei---l~hp~~ 268 (443)
||.+|||++++ |+|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 99999999998 466664
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-56 Score=425.54 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=207.3
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..-++|++++.||+|+||+||+|+.. ..||||++...... ....+.+.+|+.+|++++|||||++++++. ...+|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 34578999999999999999999853 35999999765433 334678999999999999999999999875 45689
Q ss_pred EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 88 IVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+||||++||+|.+++... +.+++..+..++.||++||+|||++||+||||||+|||++.++++||+|||+|+.......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999999754 5699999999999999999999999999999999999999999999999999987654434
Q ss_pred CCccccccCCCcccchhhhccCC--CCCCchhhhhhhHHHHHHhhCCCCCCCCcHHH-HHHHhhcCcc-----CCCCCCC
Q 013407 167 DGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEF-----TCPPWLS 238 (443)
Q Consensus 167 ~~~~~~~~gt~~y~APEvl~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~~-----~~~~~~s 238 (443)
.....+.+||+.|+|||++.+.. .++.++||||+||++|+|++|+.||.+.+... ....+..+.. ..+..++
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence 44456678999999999996432 23589999999999999999999998866543 3344443322 2345689
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 239 FTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
+++.+||.+||+.||++|||++|++++
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-55 Score=424.49 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=209.7
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCc---eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (443)
..++|++.+.||+|+||+||+|.++.+++ .||||.+..... ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45789999999999999999999987665 588998865432 3345679999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
+|+||||++||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999988774 56999999999999999999999999999999999999999999999999999865443
Q ss_pred cCCCc---cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCH
Q 013407 165 RDDGL---LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (443)
Q Consensus 165 ~~~~~---~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 239 (443)
..... .....||+.|+|||++.+..|+ .++|||||||++|+|+| |.+||.+.+..+....+..+ ..+.|..++.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 260 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence 22111 1224579999999999887775 89999999999999998 89999999888888887665 4566777999
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 240 TARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 240 ~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+.+||.+||+.||.+|||+.|++++
T Consensus 261 ~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 261 ALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-55 Score=425.51 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=218.2
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++.+.||+|+||+||+|.+..+|+.||||++..... ..+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 355789999999999999999999999999999999976432 2457889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999999999754 578999999999999999999999999999999999999999999999999998653321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCC-CCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~-~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
........||+.|+|||++.+..|+ .++||||+||++|+|++|. +||.+.+....++.+..+ ....|+.+|+++.+
T Consensus 170 -~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 247 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247 (287)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -ceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence 1122334589999999999888775 8999999999999999955 455666666777666554 45677789999999
Q ss_pred HHHHhcCCCCCCCCChhhhhc
Q 013407 244 LIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~ 264 (443)
||.+||+.||.+|||++++++
T Consensus 248 li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 248 LMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999965
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=422.56 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=219.7
Q ss_pred cccEEEEeE-eeccCcEEEEEEEECC--CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 10 VGKYEVGRT-IGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 10 ~~~y~~~~~-LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
-++|.+.+. ||+|+||+||+|.++. ++..||||++.+.. .....+.+.+|+.+|++++|||||++++++.++ .+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence 367888885 9999999999998764 34579999997543 233467899999999999999999999998754 58
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999998765 4579999999999999999999999999999999999999999999999999998654322
Q ss_pred C-CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHH
Q 013407 166 D-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTAR 242 (443)
Q Consensus 166 ~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 242 (443)
. .......+||+.|+|||++.+..|+ .++||||+||++|+|+| |..||.+.+..+....+..+. ...|+.+|+++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 242 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1 1223356789999999999887775 89999999999999998 999999988888888887664 567888999999
Q ss_pred HHHHHhcCCCCCCCCChhhh---hcCcccc
Q 013407 243 KLIARILDPNPMTRITIPEI---LEDEWFK 269 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~ei---l~hp~~~ 269 (443)
+||.+||+.||++|||+.+| |+|+|+.
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999888 6777764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-55 Score=431.09 Aligned_cols=261 Identities=26% Similarity=0.445 Sum_probs=215.2
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----EE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----KI 86 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 86 (443)
++|++++.||+|+||+||+|.+..+|+.||||++.+.. .....+++.+|+.+|++++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997643 3345678899999999999999999999997653 23
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 166 (443)
+++++|+.||+|++++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|........
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 444556679999999976 5799999999999999999999999999999999999999999999999999986544322
Q ss_pred -CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC----------------
Q 013407 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---------------- 229 (443)
Q Consensus 167 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 229 (443)
.......+||+.|+|||++....+++.++||||+||++|+|++|..||.+.+..+........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 233456789999999999976666679999999999999999999999987765443332110
Q ss_pred ---------cc------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccCCC
Q 013407 230 ---------EF------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (443)
Q Consensus 230 ---------~~------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~~~ 274 (443)
.. ...+.+|+++++||.+||+.||.+|||++|+|+||||+....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 00 0123478899999999999999999999999999999865543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=417.15 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=208.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++++.||+|+||+||+|.+. +++.||||++...... .+.+.+|+.++++++|||||++++++.+.+.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 58999999999999999999986 5678999999764432 356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....... ..
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 999999999998755 5689999999999999999999999999999999999999999999999999986543221 22
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~ 247 (443)
.....||+.|+|||++.+..|+ .++||||+||++|+|++ |.+||...+..+....+..+ ....|..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3346799999999999988875 89999999999999999 68888888888888887766 345667789999999999
Q ss_pred hcCCCCCCCCChhhhhcC
Q 013407 248 ILDPNPMTRITIPEILED 265 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~h 265 (443)
||+.||++|||++|+++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=419.58 Aligned_cols=255 Identities=21% Similarity=0.359 Sum_probs=218.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
..-++|++++.||+|+||+||+|.++ +++.||||++...... .+.+.+|+.+|++++|||||++++++.+ +..|
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 34579999999999999999999985 5778999999764322 3568999999999999999999998754 5679
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+||||+++|+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+|+......
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999999999977543 369999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
........||+.|+|||++.+..|+ .++||||+||++|+|+| |.+||...+..+..+.+..+ ....|..+++++.+
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 241 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -cccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHH
Confidence 1223456789999999999877775 89999999999999999 56677777777777777665 45667789999999
Q ss_pred HHHHhcCCCCCCCCChhhhhc--Cccccc
Q 013407 244 LIARILDPNPMTRITIPEILE--DEWFKK 270 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~--hp~~~~ 270 (443)
||.+||+.||++|||++++++ |+||+.
T Consensus 242 li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 242 LMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999988 788753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=429.28 Aligned_cols=261 Identities=31% Similarity=0.559 Sum_probs=225.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEE---CCCCceEEEEEeechhhh-hHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARN---SETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSK 83 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~---~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~ 83 (443)
.+++|++++.||+|+||+||+|.+ ..+|+.||||++.+.... +....+.+.+|+.+|++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 568999999999999999999987 447899999999765432 12234568899999999976 8999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..+|++|||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999976543
Q ss_pred ccCCCccccccCCCcccchhhhccCC-CCCCchhhhhhhHHHHHHhhCCCCCCCCcHH----HHHHHhhcCccCCCCCCC
Q 013407 164 VRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAEFTCPPWLS 238 (443)
Q Consensus 164 ~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s 238 (443)
. ......+.+||+.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+.. ...........+.|..+|
T Consensus 182 ~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 182 D-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp G-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred c-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 2 223345678999999999997654 4468899999999999999999999875433 344444556677788899
Q ss_pred HHHHHHHHHhcCCCCCCCC-----ChhhhhcCccccc
Q 013407 239 FTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (443)
Q Consensus 239 ~~~~~li~~mL~~dP~~R~-----t~~eil~hp~~~~ 270 (443)
+++.+||.+||++||.+|| |++|+++||||+.
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999999 5899999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=429.60 Aligned_cols=250 Identities=30% Similarity=0.393 Sum_probs=209.9
Q ss_pred cEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------CCE
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------KTK 85 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~ 85 (443)
+|+.++.||+|+||+||+|++..+|+.||||++.+... ...+|+.+|++++||||+++++++.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999999999999999999999999976432 23479999999999999999999843 345
Q ss_pred EEEEEeccCCCchH---HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-CeEEeecCccccc
Q 013407 86 IFIVLEFVTGGELF---DKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALS 161 (443)
Q Consensus 86 ~~lv~E~~~gg~L~---~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~~kl~DFGla~~~ 161 (443)
+|+||||+.++.+. ........+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999876432 2334566899999999999999999999999999999999999999875 8999999998754
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcC------------
Q 013407 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------ 229 (443)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------ 229 (443)
.. .....+.+||+.|+|||++.+..+++.++||||+||++|+|++|.+||...+..+.+..+...
T Consensus 174 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 33 334456789999999999877665679999999999999999999999988766655444210
Q ss_pred -----ccC------------CCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCcccccc
Q 013407 230 -----EFT------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (443)
Q Consensus 230 -----~~~------------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~ 271 (443)
... ..+..++++.+||++||..||.+|||+.|+|+||||+.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 011 123478999999999999999999999999999999753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=411.62 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=220.7
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 90 (443)
++|++++.||+|+||+||+|+++ +++.||||++++.... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 57899999999999999999985 6788999999875433 246889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccCCCc
Q 013407 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (443)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 169 (443)
||+.+|+|.+++.. ...+++..+.+++.||++||.|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence 99999999998654 457999999999999999999999999999999999999999999999999999865442 2223
Q ss_pred cccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHH
Q 013407 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIAR 247 (443)
Q Consensus 170 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~ 247 (443)
....+||+.|+|||++.+..|+ .++||||+||++|+|+| |+.||.+.+..+...++..+ ....|...++++.+||++
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3446789999999999988885 89999999999999998 89999999988888888776 445667789999999999
Q ss_pred hcCCCCCCCCChhhhhcC
Q 013407 248 ILDPNPMTRITIPEILED 265 (443)
Q Consensus 248 mL~~dP~~R~t~~eil~h 265 (443)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=428.30 Aligned_cols=256 Identities=27% Similarity=0.366 Sum_probs=215.4
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----C
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 84 (443)
-+||++++.||+|+||+||+|++..+|+.||||++.+... .....+++.+|+.+|++++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3689999999999999999999999999999999986543 333456789999999999999999999998643 3
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
..+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 44666777889999998854 6799999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCccCC-----------
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----------- 233 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----------- 233 (443)
...+.+||+.|+|||++.+..+.+.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 33456799999999998887777899999999999999999999999888766655543221111
Q ss_pred --------------------CCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 234 --------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 234 --------------------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
...+++++++||++||..||.+|||++|+|+||||++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 124788999999999999999999999999999998644
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=411.25 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=207.6
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCC---ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
-++|++++.||+|+||+||+|.+..++ ..||||.+.... .....+.+.+|+.+|++++|||||++++++. .+.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 368999999999999999999986543 458888885432 3344678999999999999999999999986 5678
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
|+||||+++|+|.+++.. .+.+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||+|+.....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~- 161 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS- 161 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-
Confidence 999999999999998765 457999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 243 (443)
........+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+..+.+..+..+. .+.|+.+|+++.+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 12223456789999999999887775 89999999999999998 999999988888888877664 5678889999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcC
Q 013407 244 LIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~h 265 (443)
||.+||+.||.+|||+.||++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-53 Score=419.40 Aligned_cols=250 Identities=25% Similarity=0.452 Sum_probs=209.2
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEe--CCE
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS--KTK 85 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 85 (443)
..++|++++.||+|+||+||+|++..+|+.||||++.+.. .+++.+|+.+|+.++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 4578999999999999999999999999999999997533 356889999999995 9999999999974 456
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC-CeEEeecCcccccccc
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQV 164 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 164 (443)
+|+||||+.+++|.... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 99999999999987653 5799999999999999999999999999999999999998765 589999999986543
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH-HHHHHhh-------------cCc
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKIS-------------AAE 230 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~-------------~~~ 230 (443)
.......+||+.|+|||++.+...++.++||||+||++|+|++|..||...... .....+. ...
T Consensus 183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 233456789999999999987666579999999999999999999999764322 1111110 000
Q ss_pred c------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccc
Q 013407 231 F------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (443)
Q Consensus 231 ~------------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~ 270 (443)
. .....+|+++.+||++||..||.+|||++|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0 011226889999999999999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=416.68 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=211.9
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCc----eEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
.+|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.++++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 679999999999999999999988876 47888776432 222456799999999999999999999999865 56
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+++|||+.+|+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 7888999999999888664 579999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 243 (443)
.........||+.|+|||++.+..|+ .++||||+||++|+|+| |.+||.+.+..+....+..+. ++.|+.+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 33334445689999999999887775 89999999999999998 899999988777777776654 5677889999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcCc
Q 013407 244 LIARILDPNPMTRITIPEILEDE 266 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~hp 266 (443)
||.+||..||.+|||+.|+++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999883
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=406.04 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=209.3
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCC----ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
..+.|++.+.||+|+||+||+|.+..++ ..||||++..... ......+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 4467999999999999999999987654 3699999975432 233567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccc
Q 013407 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 163 (443)
..++||||+.+|++.+.+... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999999988654 5799999999999999999999999999999999999999999999999999987544
Q ss_pred ccCC-CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhC-CCCCCCCcHHHHHHHhhcC-ccCCCCCCCHH
Q 013407 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (443)
Q Consensus 164 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (443)
.... .......||+.|+|||++.+..|+ .++||||+||++|+|++| .+||.+.+..+.+..+..+ ..+.|..++..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence 2221 123345689999999999887775 899999999999999994 6666677777777777665 45667779999
Q ss_pred HHHHHHHhcCCCCCCCCChhhhhc
Q 013407 241 ARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 241 ~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
+.+||.+||+.||++|||+.|+++
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-54 Score=424.51 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=205.5
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 82 (443)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+... +.....++.+|+.++++++|||||++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 35789999999999999999999999999999999987543 34456789999999999999999999999953
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccc
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~ 162 (443)
...+|+||||+.|+ +++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++....
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 47899999999765 44544 3579999999999999999999999999999999999999999999999999987544
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHHhhcCc------------
Q 013407 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (443)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 230 (443)
. .......+||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+......++....
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred c---ccccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 3 2334566899999999999887775 89999999999999999999999887665544432110
Q ss_pred ----------cCC--------------C------CCCCHHHHHHHHHhcCCCCCCCCChhhhhcCccccccC
Q 013407 231 ----------FTC--------------P------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (443)
Q Consensus 231 ----------~~~--------------~------~~~s~~~~~li~~mL~~dP~~R~t~~eil~hp~~~~~~ 272 (443)
... + ...|+++.+||++||..||++|||++|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 000 0 01367889999999999999999999999999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-53 Score=406.42 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=214.4
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (443)
...++|++++.||+|+||+||+|++..+ +.||||++...... .+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 3468999999999999999999999755 56999999765432 3568899999999999999999999854 5689
Q ss_pred EEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 88 IVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 88 lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
+||||+.+|+|...+.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~- 166 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN- 166 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC-
Confidence 99999999999888754 357999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 166 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
........+||+.|+|||++....++ .++||||+||++|+|++ |.+||.+.+..+....+..+ ..+.++.+++++++
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 245 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred CceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence 12223446799999999999887775 89999999999999999 56667777777777777655 45678889999999
Q ss_pred HHHHhcCCCCCCCCChhhhhc--Ccccccc
Q 013407 244 LIARILDPNPMTRITIPEILE--DEWFKKD 271 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~--hp~~~~~ 271 (443)
||.+||+.||++|||++++++ |+||+..
T Consensus 246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999987 8888753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-53 Score=408.54 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=220.1
Q ss_pred cccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (443)
-++|++++.||+|+||+||+|+.+ .+++.||||+++... ..+..+.+.+|+.+|++++||||+++++++.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 468999999999999999999875 356789999997543 2334678999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCC
Q 013407 85 KIFIVLEFVTGGELFDKIVNHG------------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 140 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~ 140 (443)
..+++|||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999986532 3889999999999999999999999999999999
Q ss_pred cEEEccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCC-CCCCCCcH
Q 013407 141 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNL 219 (443)
Q Consensus 141 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~-~Pf~~~~~ 219 (443)
|||++.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|+|++|. +||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999876554444445567899999999999988875 8999999999999999984 78999998
Q ss_pred HHHHHHhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 220 MNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 220 ~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+....+..+.. ..|..+++++.+||.+||+.||++|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888877754 456779999999999999999999999999964
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=406.14 Aligned_cols=254 Identities=23% Similarity=0.410 Sum_probs=218.9
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCC-------ceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETG-------EPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV 79 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 79 (443)
..-++|++++.||+|+||.||+|++..++ ..||||++++... ......+.+|...+.++ +|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 44589999999999999999999976544 3699999976542 23356788888888888 89999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEE
Q 013407 80 MGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (443)
Q Consensus 80 ~~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIL 143 (443)
+.+++.+|+||||+.+|+|.++|... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999999999999754 34899999999999999999999999999999999999
Q ss_pred EccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHH
Q 013407 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNL 222 (443)
Q Consensus 144 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~ 222 (443)
++.++.+||+|||++...............+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 999999999999999877665444455667899999999999887775 89999999999999998 7999999988888
Q ss_pred HHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 223 YKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 223 ~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
+..+..+ .+..|.++++++.+||.+||+.||.+|||+.|+++
T Consensus 247 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8887665 46778889999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-53 Score=409.43 Aligned_cols=254 Identities=23% Similarity=0.366 Sum_probs=204.1
Q ss_pred ccccEEEEeEeeccCcEEEEEEEECC-----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (443)
.-++|++++.||+|+||.||+|.+.. +++.||||++..... ....+.+.+|..++.++ +||||+.+++++.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 34789999999999999999999754 456899999975432 22345677788777776 68999999998765
Q ss_pred -CCEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEc
Q 013407 83 -KTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD 145 (443)
Q Consensus 83 -~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~ 145 (443)
...+|+|||||+||+|.+++... ..+++..+..++.||++||+|||++||+||||||+|||++
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 168 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence 45689999999999999999753 2489999999999999999999999999999999999999
Q ss_pred cCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhC-CCCCCCCcHH-HHH
Q 013407 146 AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLM-NLY 223 (443)
Q Consensus 146 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~-~~~ 223 (443)
.++++||+|||+|+..............+||+.|+|||++.+..| +.++||||+||++|+|++| .+||.+.+.. ...
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999986554333334456789999999999988777 4899999999999999986 6788876543 334
Q ss_pred HHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 224 KKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 224 ~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
..+..+ .+..|..+++++.+||.+||+.||++|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444443 456777899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-53 Score=403.60 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=206.1
Q ss_pred cccEEEEeEeeccCcEEEEEEEECC-CC--ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSE-TG--EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~-~~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (443)
-++|++.+.||+|+||+||+|++.. ++ ..||||++.+......+..+.+.+|+.+|++++|||||++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4679999999999999999998643 33 3689999987666556667889999999999999999999999976 467
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCccccccccc
Q 013407 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 165 (443)
++||||+++|+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999988765 4569999999999999999999999999999999999999999999999999998754432
Q ss_pred CCC-ccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcCc--cCCCCCCCHHH
Q 013407 166 DDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTA 241 (443)
Q Consensus 166 ~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~ 241 (443)
... ......||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+..+....+.... ++.++.+|+.+
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 222 2234567889999999988766 488999999999999998 899999999988888876553 35566789999
Q ss_pred HHHHHHhcCCCCCCCCChhhhhc
Q 013407 242 RKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 242 ~~li~~mL~~dP~~R~t~~eil~ 264 (443)
.+||.+||+.||++|||+++|++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=407.53 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=216.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCce--EEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEP--VALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (443)
...++|++.+.||+|+||+||+|.++.+|.. ||||.+.... ..+..+.+.+|+.+|+++ +|||||++++++.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4668999999999999999999999888764 6777765432 233456789999999999 7999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCC
Q 013407 85 KIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (443)
Q Consensus 85 ~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~ 148 (443)
.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999654 5699999999999999999999999999999999999999999
Q ss_pred CeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhC-CCCCCCCcHHHHHHHhh
Q 013407 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKIS 227 (443)
Q Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~ 227 (443)
.+||+|||+|+..... ......+||+.|+|||.+.+..|+ .++|||||||++|+|++| .+||.+.+..+.+..+.
T Consensus 165 ~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred ceEEcccccccccccc---ccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999754432 222355799999999999887775 889999999999999996 57899999888888887
Q ss_pred cC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 228 AA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 228 ~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.+ .+..|..+++++.+||.+||+.||++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 65 456677899999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-53 Score=399.35 Aligned_cols=245 Identities=24% Similarity=0.436 Sum_probs=208.7
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCCEE
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-SKTKI 86 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~ 86 (443)
...++|++++.||+|+||.||+|.+ .|+.||||+++++. ..+.+.+|+.++++++||||+++++++. +.+.+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 4567899999999999999999998 47789999997543 3467889999999999999999999885 45678
Q ss_pred EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccc
Q 013407 87 FIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 164 (443)
|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++|+||||||+|||++.+|++|++|||+++....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence 99999999999999996543 589999999999999999999999999999999999999999999999999975432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 013407 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (443)
Q Consensus 165 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (443)
.....++|+.|+|||++.+..++ .++||||+||++|+|++ |.+||...+..+....+..+ ..+.|+.++++++
T Consensus 156 ----~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (262)
T d1byga_ 156 ----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred ----CCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 23455789999999999887774 89999999999999998 89999998888888887664 5677888999999
Q ss_pred HHHHHhcCCCCCCCCChhhhhcC
Q 013407 243 KLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 243 ~li~~mL~~dP~~R~t~~eil~h 265 (443)
+||++||+.||.+|||+.+++++
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=402.36 Aligned_cols=254 Identities=19% Similarity=0.271 Sum_probs=221.8
Q ss_pred cccccEEEEeEeeccCcEEEEEEEECC-----CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 013407 8 RRVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (443)
Q Consensus 8 ~~~~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (443)
..-++|++++.||+|+||+||+|.+.. ++..||||++++.. .......+.+|+.++++++|||||++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 345899999999999999999998752 35789999997643 23345678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEE
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNH----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl 152 (443)
....++||||+.+|+|.+++... ..++...+..++.|+++||.|||+++|+||||||+|||+++++++||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 99999999999999999988643 24788999999999999999999999999999999999999999999
Q ss_pred eecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhC-CCCCCCCcHHHHHHHhhcCc-
Q 013407 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAE- 230 (443)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~- 230 (443)
+|||+|+..............+||+.|+|||.+.+..+. .++||||+||++|+|++| .+||.+.+..+.+..+..+.
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 999999876554333334455789999999999887775 899999999999999998 68999999888888877664
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 231 ~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
...|+.+++.+.+||.+||+.||++|||+.++++
T Consensus 254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4567789999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=400.25 Aligned_cols=253 Identities=21% Similarity=0.358 Sum_probs=215.5
Q ss_pred ccccEEEEeEeeccCcEEEEEEEEC-----CCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 013407 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (443)
.-++|++++.||+|+||.||+|++. .+++.||||++.+... ......+.+|+.+++++ +|||||++++++.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 3479999999999999999999863 4667899999976542 23456788999999999 69999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEE
Q 013407 83 KTKIFIVLEFVTGGELFDKIVNHG------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL 144 (443)
Q Consensus 83 ~~~~~lv~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl 144 (443)
....|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 999999999999999999987643 58999999999999999999999999999999999999
Q ss_pred ccCCCeEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhh-CCCCCCCCcHHHHH
Q 013407 145 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLY 223 (443)
Q Consensus 145 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~ 223 (443)
+.++++|++|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+....+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987654333333445689999999999987666 489999999999999998 77777776654444
Q ss_pred H-HhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 224 K-KISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 224 ~-~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
. .+..+ ....|..+++.+.+||.+||+.||.+|||+++|++
T Consensus 258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3 33333 34556678999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=385.58 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=205.5
Q ss_pred EEEEeEeeccCcEEEEEEEECCCC---ceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCEEEE
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFI 88 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~l 88 (443)
+.+.+.||+|+||+||+|.+..++ ..||||.+++.. .....+++.+|+++|++++|||||++++++.+ +...++
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 344688999999999999986643 358999987532 34456789999999999999999999999765 568999
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCcccccccccC-
Q 013407 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD- 166 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 166 (443)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++.......
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999999988754 4578889999999999999999999999999999999999999999999999986543221
Q ss_pred -CCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCC-CcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 013407 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAA-EFTCPPWLSFTARK 243 (443)
Q Consensus 167 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (443)
........||+.|+|||.+....+ +.++||||||+++|+|++|..||.. .+..+....+..+ .+..|+.+++++.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHH
Confidence 112234568999999999988777 4899999999999999997776654 4444555555544 45667789999999
Q ss_pred HHHHhcCCCCCCCCChhhhhcC
Q 013407 244 LIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 244 li~~mL~~dP~~R~t~~eil~h 265 (443)
||.+||+.||++|||+.|+++|
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-49 Score=382.93 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=203.1
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCEEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKIFIV 89 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv 89 (443)
++|++++.||+|+||.||+|++..+|+.||||++..+.. .+.+.+|+++++.++|+| |+.+.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 479999999999999999999999999999999876432 235788999999998765 55566777888999999
Q ss_pred EeccCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc---CCCeEEeecCccccccccc
Q 013407 90 LEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQVR 165 (443)
Q Consensus 90 ~E~~~gg~L~~~i-~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~ 165 (443)
|||+.+ +|.+.+ ...+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+......
T Consensus 82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 999955 555555 44568999999999999999999999999999999999999853 4579999999998765432
Q ss_pred CC-----CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHHHHHHH---hhcCcc-----C
Q 013407 166 DD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK---ISAAEF-----T 232 (443)
Q Consensus 166 ~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~---i~~~~~-----~ 232 (443)
.. ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||........... ...... .
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 21 123456899999999999988775 899999999999999999999987654432221 111111 1
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCChh---hhhcCccccccC
Q 013407 233 CPPWLSFTARKLIARILDPNPMTRITIP---EILEDEWFKKDY 272 (443)
Q Consensus 233 ~~~~~s~~~~~li~~mL~~dP~~R~t~~---eil~hp~~~~~~ 272 (443)
.++.+|+++.++|.+||..||.+||++. ++|+|+|.+..+
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 2346889999999999999999999987 457788765543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.3e-48 Score=373.34 Aligned_cols=248 Identities=21% Similarity=0.260 Sum_probs=206.5
Q ss_pred cccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCCEEEE
Q 013407 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 10 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~l 88 (443)
-++|++++.||+|+||+||+|++..+|+.||||++..... ...+++|+++++.++| +||+.+++++.+....|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 3689999999999999999999999999999999876432 2357789999999975 899999999999999999
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEcc-----CCCeEEeecCcccccc
Q 013407 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-----YGNLKVSDFGLSALSQ 162 (443)
Q Consensus 89 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-----~~~~kl~DFGla~~~~ 162 (443)
||||+ |++|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 67999888765 47999999999999999999999999999999999999974 5789999999998764
Q ss_pred cccCC-----CccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCc---HHHHHHHhhcCcc---
Q 013407 163 QVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEF--- 231 (443)
Q Consensus 163 ~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~--- 231 (443)
..... ....+.+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.. ....+.++.....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 32211 223456899999999999987775 89999999999999999999997643 2233333322211
Q ss_pred --CCCCCCCHHHHHHHHHhcCCCCCCCCChhhhhc
Q 013407 232 --TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (443)
Q Consensus 232 --~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 264 (443)
..++.+|+++.+++..|+..+|++||+.+.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123458899999999999999999999876643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=372.09 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=193.6
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----EE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----KI 86 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 86 (443)
.+|.+.+.||+|+||.||+|+. +|+.||||++..+... ......|+..++.++|||||++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 5799999999999999999986 6889999999754321 122345666677889999999999987653 68
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcEeeeCCCCcEEEccCCCeEEeecCcc
Q 013407 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS--------RGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (443)
Q Consensus 87 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~--------~givHrDlkp~NILl~~~~~~kl~DFGla 158 (443)
|+||||+++|+|.+++.+. .++++....++.|++.||.|+|+ +||+||||||+|||++.++++||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999864 69999999999999999999996 59999999999999999999999999999
Q ss_pred cccccccC--CCccccccCCCcccchhhhccCCC-----CCCchhhhhhhHHHHHHhhCCCCCCCC--------------
Q 013407 159 ALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDDS-------------- 217 (443)
Q Consensus 159 ~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~-------------- 217 (443)
+....... .......+||+.|+|||++.+... .+.++|||||||+||+|++|.+||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 86543221 122345789999999999875431 236799999999999999998887431
Q ss_pred -cHHHHHHHhhcCcc--CCCCC-----CCHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 013407 218 -NLMNLYKKISAAEF--TCPPW-----LSFTARKLIARILDPNPMTRITIPEILED 265 (443)
Q Consensus 218 -~~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~mL~~dP~~R~t~~eil~h 265 (443)
.............. .+|.. ....+.+|+.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12222222222222 22222 22358899999999999999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-46 Score=373.24 Aligned_cols=250 Identities=23% Similarity=0.430 Sum_probs=196.2
Q ss_pred ccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----------CCCcceEEEE
Q 013407 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----------HPNVVRLYEV 79 (443)
Q Consensus 11 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~~ 79 (443)
+||++++.||+|+||+||+|++..+|+.||||++.+... ..+.+.+|+.+++.++ ||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 579999999999999999999999999999999986542 2356778998888875 5789999988
Q ss_pred EEe--CCEEEEEEeccCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeeeCCCCcEEEccCCC----
Q 013407 80 MGS--KTKIFIVLEFVTGGELFDKI---VNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGN---- 149 (443)
Q Consensus 80 ~~~--~~~~~lv~E~~~gg~L~~~i---~~~~~l~e~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~---- 149 (443)
+.. ....+++|+++..+...... .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 45677777777655433322 334579999999999999999999998 89999999999999987764
Q ss_pred --eEEeecCcccccccccCCCccccccCCCcccchhhhccCCCCCCchhhhhhhHHHHHHhhCCCCCCCCcHH------H
Q 013407 150 --LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM------N 221 (443)
Q Consensus 150 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~------~ 221 (443)
++++|||.|..... .....+||+.|+|||++.+..|+ .++||||+||++++|++|+.||...+.. .
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999875432 23457899999999999988885 8999999999999999999999754321 1
Q ss_pred HHHHh---h---------c------------------------------CccCCCCCCCHHHHHHHHHhcCCCCCCCCCh
Q 013407 222 LYKKI---S---------A------------------------------AEFTCPPWLSFTARKLIARILDPNPMTRITI 259 (443)
Q Consensus 222 ~~~~i---~---------~------------------------------~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~ 259 (443)
..... . . .....+...++++.+||.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11000 0 0 0011112246789999999999999999999
Q ss_pred hhhhcCccccc
Q 013407 260 PEILEDEWFKK 270 (443)
Q Consensus 260 ~eil~hp~~~~ 270 (443)
+|+|+||||+.
T Consensus 323 ~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 323 GGLVNHPWLKD 333 (362)
T ss_dssp HHHHTCGGGTT
T ss_pred HHHhcCcccCC
Confidence 99999999984
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=9.5e-27 Score=208.99 Aligned_cols=136 Identities=18% Similarity=0.283 Sum_probs=109.4
Q ss_pred EEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhh---------------hHHHHHHHHHHHHHHhcCCCCCcceEE
Q 013407 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL---------------KHKMAEQIKREVATMKLVKHPNVVRLY 77 (443)
Q Consensus 13 y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~ 77 (443)
|.+++.||+|+||+||+|.+. +|+.||||++...... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468899999999999999985 6899999987532110 011234566799999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeeeCCCCcEEEccCCCeEEeecCc
Q 013407 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (443)
Q Consensus 78 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~~kl~DFGl 157 (443)
++.. .+++|||+.++.+. .+++..+..++.||+.||.|||++||+||||||+|||++++ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 7642 27999999986542 35666778899999999999999999999999999999965 489999999
Q ss_pred cccc
Q 013407 158 SALS 161 (443)
Q Consensus 158 a~~~ 161 (443)
|...
T Consensus 149 a~~~ 152 (191)
T d1zara2 149 SVEV 152 (191)
T ss_dssp CEET
T ss_pred cccC
Confidence 8754
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.42 E-value=3.7e-13 Score=105.70 Aligned_cols=85 Identities=14% Similarity=0.234 Sum_probs=78.7
Q ss_pred EEecCCHHHHHHHHHHHhccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEc-CCeeEEEEEecCCCchHHHHHHH
Q 013407 345 FTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHKFYK 422 (443)
Q Consensus 345 f~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~~ 422 (443)
.+|+.+|++|+.+|+++++.+|+.|+.+ +|.++.+...+++++.++|.++|+++. +++++|+|+|.+||.++|+++|.
T Consensus 15 tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~~ 94 (102)
T d1ul7a_ 15 TTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 94 (102)
T ss_dssp CCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHHH
T ss_pred cCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHHH
Confidence 4688999999999999999999999877 699999887888899999999999996 79999999999999999999999
Q ss_pred HHHHhcc
Q 013407 423 NLSTCLE 429 (443)
Q Consensus 423 ~~~~~l~ 429 (443)
+|...|+
T Consensus 95 ~il~~l~ 101 (102)
T d1ul7a_ 95 KIANELK 101 (102)
T ss_dssp HHHHHCC
T ss_pred HHHHhcc
Confidence 9988775
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.75 E-value=1.1e-08 Score=93.64 Aligned_cols=148 Identities=17% Similarity=0.155 Sum_probs=105.8
Q ss_pred ccccccccccEEEEeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 013407 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG 81 (443)
Q Consensus 3 ~~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 81 (443)
.|.....+..|+..+..+.++.+.||+.. ..++.+++|+........ ...+.+|...++.+. +--+.+++.+..
T Consensus 6 ~~~l~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~ 80 (263)
T d1j7la_ 6 SPELKKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp CHHHHHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred CHHHHHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence 45566778899998887767778999876 356678899886543222 235677888887774 333678888888
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------
Q 013407 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-------------------------------- 129 (443)
Q Consensus 82 ~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~-------------------------------- 129 (443)
+++..|+||++++|..+.+..... .....+..++...+..||+
T Consensus 81 ~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 81 HDGWSNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred cCCceEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 899999999999998876544221 1223345555566666663
Q ss_pred ---------------------------CCcEeeeCCCCcEEEccCCCeEEeecCcccc
Q 013407 130 ---------------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (443)
Q Consensus 130 ---------------------------~givHrDlkp~NILl~~~~~~kl~DFGla~~ 160 (443)
..++|+|+.|.||++++++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1379999999999999866667999997753
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.41 E-value=8e-07 Score=72.21 Aligned_cols=72 Identities=17% Similarity=0.298 Sum_probs=61.9
Q ss_pred EEecCCHHHHHHHHHHHhccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeeEEEEEecCCCchH
Q 013407 345 FTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 416 (443)
Q Consensus 345 f~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le 416 (443)
+.|+..|.+||..+..|+++||+.|+.. .|.++++.........+.+.+++|+++++.|||||++..|+-.|
T Consensus 5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 3578899999999999999999999976 79999987655556689999999999999999999999998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.17 E-value=1.5e-06 Score=78.57 Aligned_cols=135 Identities=16% Similarity=0.148 Sum_probs=87.5
Q ss_pred ccccEEEEeEeeccC-cEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCE
Q 013407 9 RVGKYEVGRTIGEGT-FAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSKTK 85 (443)
Q Consensus 9 ~~~~y~~~~~LG~G~-~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~ 85 (443)
.+..+.... +..|. -+.||+... .++..+++|...... ...+.+|...++.+.. -.+.+++.+..+.+.
T Consensus 9 ~l~g~~~~~-~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~ 80 (255)
T d1nd4a_ 9 RLFGYDWAQ-QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 80 (255)
T ss_dssp TTTTCEEEE-CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred hccCCceEE-cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccc
Confidence 444555544 44444 478998875 456678999865432 2246778888877742 336778888888889
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 013407 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS------------------------------------ 129 (443)
Q Consensus 86 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qi~~aL~~LH~------------------------------------ 129 (443)
.|+||++++|..+.+. ..+... ...++...|.-||+
T Consensus 81 ~~~v~~~i~G~~~~~~-----~~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (255)
T d1nd4a_ 81 DWLLLGEVPGQDLLSS-----HLAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 152 (255)
T ss_dssp EEEEEECCSSEETTTS-----CCCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred eEEEEEeeeccccccc-----cccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccch
Confidence 9999999998665221 111111 11233333333331
Q ss_pred ----------------------CCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 130 ----------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 130 ----------------------~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
..++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 153 ~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 153 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 137999999999999987667899999765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.11 E-value=2.8e-06 Score=82.50 Aligned_cols=81 Identities=16% Similarity=0.167 Sum_probs=51.4
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechh-hhh---HHHHHHHHHHHHHHhcCC-C--CCcceEEEEEEeCCEEEE
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEK-VLK---HKMAEQIKREVATMKLVK-H--PNVVRLYEVMGSKTKIFI 88 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~-~~~---~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 88 (443)
.+.||.|....||++.+..+++.+++|.-.... ... .....+...|...|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999987788899999754311 000 001345667888887763 2 346677654 4455678
Q ss_pred EEeccCCCch
Q 013407 89 VLEFVTGGEL 98 (443)
Q Consensus 89 v~E~~~gg~L 98 (443)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.96 E-value=1.9e-05 Score=62.69 Aligned_cols=85 Identities=18% Similarity=0.260 Sum_probs=64.6
Q ss_pred EEecCCHHHHHHHHHHHhccCCcEEEeec----------ceEEEEEee-----cCCCcceEEEEEEEEEcCCeeEEEEE-
Q 013407 345 FTSRCPANEIINKIEEAAKPLGFDVHKKN----------YKMRLENMK-----AGRKGNLNVATEVFQVAPSLHMVEVR- 408 (443)
Q Consensus 345 f~s~~~~~~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~-----~~~~~~l~~~~~i~~~~~~~~~v~~~- 408 (443)
..|+..|-+||..|..|+++||+.|+..+ +.|+++... ......+.+.+++|+++++.+||||+
T Consensus 7 IRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlDFK~ 86 (127)
T d2qrda1 7 VRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVKS 86 (127)
T ss_dssp EEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEEE
T ss_pred cccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEEEcc
Confidence 34889999999999999999999998653 678887432 22344688999999999999999997
Q ss_pred ----ecCC--------------CchHHHHHHHHHHHhcc
Q 013407 409 ----KAKG--------------DTLEFHKFYKNLSTCLE 429 (443)
Q Consensus 409 ----~~~G--------------d~le~~~~~~~~~~~l~ 429 (443)
.+.| .+.+|-.+|.+|-..|.
T Consensus 87 dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~ 125 (127)
T d2qrda1 87 NGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 125 (127)
T ss_dssp EEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred CCcccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence 1222 24668888876665543
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.58 E-value=9.2e-05 Score=61.71 Aligned_cols=65 Identities=18% Similarity=0.238 Sum_probs=48.8
Q ss_pred EEecCCHHHHHHHHHHHhccCCcEEEee----cceEEEEEee---------cCCCcceEEEEEEEEEcCCeeEEEEEe
Q 013407 345 FTSRCPANEIINKIEEAAKPLGFDVHKK----NYKMRLENMK---------AGRKGNLNVATEVFQVAPSLHMVEVRK 409 (443)
Q Consensus 345 f~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~---------~~~~~~l~~~~~i~~~~~~~~~v~~~~ 409 (443)
..|+..|-+||..|..|+++||+.|+.. .+.++++... ......+.+.+++|++.++.+||||+-
T Consensus 50 IRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlDFK~ 127 (171)
T d2qlva1 50 IRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFKF 127 (171)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEEEEE
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEEEec
Confidence 3589999999999999999999999865 3778886421 111235899999999999999999973
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.99 E-value=0.0013 Score=62.94 Aligned_cols=77 Identities=17% Similarity=0.226 Sum_probs=51.7
Q ss_pred cEEEEeEeeccCcEEEEEEEECC-------CCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 013407 12 KYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK 83 (443)
Q Consensus 12 ~y~~~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 83 (443)
..++ +.|+.|..-.+|++.... ..+.|.+++.-... . .-...+|..+++.+. +.-..++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 3444 568889999999998653 23567787764211 1 224568999998884 4334578887753
Q ss_pred CEEEEEEeccCCCch
Q 013407 84 TKIFIVLEFVTGGEL 98 (443)
Q Consensus 84 ~~~~lv~E~~~gg~L 98 (443)
.+|+||+.|..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 589999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.93 E-value=0.00095 Score=62.17 Aligned_cols=69 Identities=19% Similarity=0.163 Sum_probs=44.3
Q ss_pred cEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCc--ceEE-----EEEEeCCEEEEEEeccCCC
Q 013407 24 FAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV--VRLY-----EVMGSKTKIFIVLEFVTGG 96 (443)
Q Consensus 24 ~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI--v~l~-----~~~~~~~~~~lv~E~~~gg 96 (443)
--.||++.. .+|+.|++|+....... .+++..|...+..|...++ +... ..+......+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357998886 46888999998654321 3457778888877742221 1111 1234567789999999873
Q ss_pred c
Q 013407 97 E 97 (443)
Q Consensus 97 ~ 97 (443)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.66 E-value=0.0035 Score=57.60 Aligned_cols=137 Identities=16% Similarity=0.133 Sum_probs=71.8
Q ss_pred EeEeeccCcEEEEEEEECCCCceEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-----CCcceEE---EEEEeCCEEE
Q 013407 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-----PNVVRLY---EVMGSKTKIF 87 (443)
Q Consensus 16 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-----pnIv~l~---~~~~~~~~~~ 87 (443)
.+.|..|.--+.|+.... +| .+++|+...... .+.+..|+.++..|.. |..+... .+..-.....
T Consensus 23 ~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 444557777888988763 34 589999865321 2345667777777742 2222110 0122345566
Q ss_pred EEEeccCCCchH--------------HHHHh---CC------CCCHH------------------HHHHHHHHHHHHHHH
Q 013407 88 IVLEFVTGGELF--------------DKIVN---HG------RMKED------------------EARRYFQQLINAVDY 126 (443)
Q Consensus 88 lv~E~~~gg~L~--------------~~i~~---~~------~l~e~------------------~~~~~~~qi~~aL~~ 126 (443)
.++.+..|.... ..+.. .. ..... .....+..+...+.-
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 777777663320 00000 00 00000 111122222222222
Q ss_pred HH----HCCcEeeeCCCCcEEEccCCCeEEeecCccc
Q 013407 127 CH----SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (443)
Q Consensus 127 LH----~~givHrDlkp~NILl~~~~~~kl~DFGla~ 159 (443)
.+ ..|++|+|+.+.||+++.++..-|+||+.+.
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 22 2579999999999999988777899999764
|